Virus name	Accession ID	Collection date	Location	Host	Passage	Specimen	Additional host information	Sequencing technology	Assembly method	Comment	Comment type	Lineage	Clade
hCoV-19/Switzerland/BL-ETHZ-480546/2021	EPI_ISL_1004058	2021-02-02	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.22	GH
hCoV-19/Switzerland/BL-ETHZ-481181/2021	EPI_ISL_1004139	2021-02-04	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.22	GH
hCoV-19/England/MILK-1215F51/2021	EPI_ISL_1006616	2021-02-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Denmark/DCGC-44098/2021	EPI_ISL_1024476	2021-02-01	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-44141/2021	EPI_ISL_1024519	2021-02-01	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (FRAMESHIFT confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-45518/2020	EPI_ISL_1025896	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/USA/CA-CZB-19831/2020	EPI_ISL_1030430	2020-12-24	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.36.10	GH
hCoV-19/USA/CA-CZB-19705/2020	EPI_ISL_1030436	2020-12-21	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.523	GH
hCoV-19/Indonesia/PA-NIHRD-WGS124/2021	EPI_ISL_1048406	2021-01-05	Asia / Indonesia / Papua	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench			B.1.466.2	GH
hCoV-19/England/MILK-11C98CB/2021	EPI_ISL_1050826	2021-01-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.18	GH
hCoV-19/Canada/NS-NML-5416/2020	EPI_ISL_1055600	2020-11-21	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/NS-NML-5442/2020	EPI_ISL_1055623	2020-11-20	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/NS-NML-5450/2020	EPI_ISL_1055630	2020-11-18	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/NS-NML-5482/2020	EPI_ISL_1055658	2020-10-31	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/NS-NML-5526/2020	EPI_ISL_1055689	2020-07-29	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/NS-NML-5564/2020	EPI_ISL_1055719	2020-12-06	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.26	GH
hCoV-19/Canada/NS-NML-5565/2020	EPI_ISL_1055720	2020-12-09	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.26	GH
hCoV-19/Canada/NS-NML-5566/2020	EPI_ISL_1055721	2020-12-06	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.26	GH
hCoV-19/Canada/NS-NML-5567/2020	EPI_ISL_1055722	2020-12-08	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.26	GH
hCoV-19/Canada/NS-NML-16217/2021	EPI_ISL_1055736	2021-01-14	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/NS-NML-16219/2021	EPI_ISL_1055738	2021-01-14	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36	GH
hCoV-19/Canada/NS-NML-16220/2021	EPI_ISL_1055739	2021-01-15	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36	GH
hCoV-19/Canada/NS-NML-16236/2021	EPI_ISL_1055748	2021-01-25	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36	GH
hCoV-19/Hong Kong/HKCH_227/2020	EPI_ISL_1061404	2020-10-02	Asia / Hong Kong	Human	Original	Nasopharyngeal aspirate and throat swab		Illumina				B.1.36.27	GH
hCoV-19/Hong Kong/HKCH_349/2020	EPI_ISL_1061405	2020-11-11	Asia / Hong Kong	Human	Original	Nasopharyngeal swab and throat swab		Illumina				B.1.36	GH
hCoV-19/Hong Kong/HKCH_373/2020	EPI_ISL_1061406	2020-11-19	Asia / Hong Kong	Human	Original	Throat saliva		Illumina				B.1.36.27	GH
hCoV-19/Hong Kong/HKCH_374/2020	EPI_ISL_1061407	2020-11-19	Asia / Hong Kong	Human	Original	Nasopharyngeal swab and throat swab		Illumina				B.1.36.27	GH
hCoV-19/Hong Kong/HKCH_380/2020	EPI_ISL_1061408	2020-11-21	Asia / Hong Kong	Human	Original	Nasopharyngeal aspirate and throat swab		Illumina				B.1.36.27	GH
hCoV-19/Hong Kong/HKCH_382/2020	EPI_ISL_1061409	2020-11-21	Asia / Hong Kong	Human	Original	Nasopharyngeal aspirate and throat swab		Illumina				B.1.36.27	GH
hCoV-19/Hong Kong/HKCH_385/2020	EPI_ISL_1061410	2020-11-21	Asia / Hong Kong	Human	Original	Nasopharyngeal swab and throat swab		Illumina				B.1.36.27	GH
hCoV-19/Hong Kong/HKCH_390/2020	EPI_ISL_1061411	2020-11-22	Asia / Hong Kong	Human	Original	Nasopharyngeal swab and throat swab		Illumina				B.1.36.27	GH
hCoV-19/Denmark/DCGC-46799/2021	EPI_ISL_1066309	2021-02-15	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Israel/CVL-3434/2021	EPI_ISL_1073477	2021-01-25	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina MiSeq		Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/Singapore/220/2021	EPI_ISL_1081947	2021-02-20	Asia / Singapore	Human	Original			Illumina MiSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Singapore/223/2021	EPI_ISL_1081950	2021-02-18	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.466.2	GH
hCoV-19/Finland/14M12/2020	EPI_ISL_418401	2020-03-14	Europe / Finland	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA-MEM			B.1.465	GH
hCoV-19/Finland/14M16/2020	EPI_ISL_418404	2020-03-14	Europe / Finland	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA-MEM			B.1.465	GH
hCoV-19/Finland/14M26/2020	EPI_ISL_418406	2020-03-14	Europe / Finland	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA-MEM			B.1.465	GH
hCoV-19/India/GJ-GBRC8/2020	EPI_ISL_435055	2020-04-22	Asia / India / Gujarat / Gandhinagar	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/DL-NCDC-01475/2020	EPI_ISL_435065	2020-03-15	Asia / India / Delhi	Human	Original			Nanopore MinION	Reference based			B.1.36	GH
hCoV-19/India/DL-NCDC-01711/2020	EPI_ISL_435066	2020-03-18	Asia / India / Delhi	Human	Original			Nanopore MinION	Reference based			B.1.36	GH
hCoV-19/India/DL-NCDC-01712/2020	EPI_ISL_435067	2020-03-18	Asia / India / Delhi	Human	Original			Nanopore MinION	Reference based			B.1.36	GH
hCoV-19/India/DL-NCDC-01757/2020	EPI_ISL_435068	2020-03-18	Asia / India / Delhi	Human	Original			Nanopore MinION	Reference based			B.1.36	GH
hCoV-19/England/CAMB-82FDC/2020	EPI_ISL_443482	2020-04-14	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.465	GH
hCoV-19/Denmark/ALAB-SSI-1260/2020	EPI_ISL_444832	2020-03-11	Europe / Denmark	Human	Original			Nanopore MinION				B.1.465	GH
hCoV-19/India/GJ-GBRC58/2020	EPI_ISL_447033	2020-05-03	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12	NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.36.8	GH
hCoV-19/India/GJ-GBRC60/2020	EPI_ISL_447035	2020-05-03	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC61/2020	EPI_ISL_447036	2020-05-03	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/India/GJ-GBRC62/2020	EPI_ISL_447037	2020-05-03	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC64/2020	EPI_ISL_447039	2020-05-03	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC65a/2020	EPI_ISL_447040	2020-05-03	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC66/2020	EPI_ISL_447042	2020-05-03	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.465	GH
hCoV-19/India/GJ-GBRC68/2020	EPI_ISL_447045	2020-05-03	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC69/2020	EPI_ISL_447046	2020-05-04	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC71/2020	EPI_ISL_447048	2020-04-27	Asia / India / Gujarat / Gandhinagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC72a/2020	EPI_ISL_447049	2020-04-29	Asia / India / Gujarat / Gandhinagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC72b/2020	EPI_ISL_447050	2020-04-29	Asia / India / Gujarat / Gandhinagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC73/2020	EPI_ISL_447051	2020-04-29	Asia / India / Gujarat / Gandhinagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC75/2020	EPI_ISL_447053	2020-04-29	Asia / India / Gujarat / Gandhinagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/Switzerland/VD-ETHZ-110470/2020	EPI_ISL_451888	2020-04-06	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1	G
hCoV-19/Portugal/PT0404/2020	EPI_ISL_454128	2020-03-18	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.22	GH
hCoV-19/Netherlands/NoordHolland_14/2020	EPI_ISL_461204	2020-04-26	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore				B.1.465	GH
hCoV-19/Netherlands/NoordHolland_20/2020	EPI_ISL_461210	2020-04-24	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.22	GH
hCoV-19/Netherlands/NoordHolland_24/2020	EPI_ISL_461214	2020-05-06	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NoordHolland_27/2020	EPI_ISL_461217	2020-05-06	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NoordHolland_29/2020	EPI_ISL_461219	2020-05-02	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NoordHolland_35/2020	EPI_ISL_461224	2020-05-15	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Utrecht_35/2020	EPI_ISL_461233	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Utrecht_38/2020	EPI_ISL_461236	2020-04-12	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Utrecht_40/2020	EPI_ISL_461238	2020-04-28	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Utrecht_41/2020	EPI_ISL_461239	2020-04-29	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Utrecht_43/2020	EPI_ISL_461241	2020-04-14	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Utrecht_45/2020	EPI_ISL_461243	2020-04-14	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Utrecht_50/2020	EPI_ISL_461246	2020-05-22	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Zeeland_1/2020	EPI_ISL_461247	2020-03-21	Europe / Netherlands / Zeeland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Zeeland_17/2020	EPI_ISL_461255	2020-03-24	Europe / Netherlands / Zeeland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Zeeland_2/2020	EPI_ISL_461258	2020-03-24	Europe / Netherlands / Zeeland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Zeeland_3/2020	EPI_ISL_461268	2020-03-29	Europe / Netherlands / Zeeland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Zeeland_32/2020	EPI_ISL_461271	2020-04-25	Europe / Netherlands / Zeeland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_120/2020	EPI_ISL_461293	2020-04-20	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_121/2020	EPI_ISL_461294	2020-04-21	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_122/2020	EPI_ISL_461295	2020-04-21	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_123/2020	EPI_ISL_461296	2020-04-21	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_124/2020	EPI_ISL_461297	2020-04-23	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_150/2020	EPI_ISL_461323	2020-04-17	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_201/2020	EPI_ISL_461373	2020-05-03	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_202/2020	EPI_ISL_461374	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_203/2020	EPI_ISL_461375	2020-05-03	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_204/2020	EPI_ISL_461376	2020-05-04	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_205/2020	EPI_ISL_461377	2020-05-04	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_206/2020	EPI_ISL_461378	2020-05-06	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_207/2020	EPI_ISL_461379	2020-05-06	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_208/2020	EPI_ISL_461380	2020-05-06	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_209/2020	EPI_ISL_461381	2020-05-06	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_210/2020	EPI_ISL_461382	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_211/2020	EPI_ISL_461383	2020-05-07	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_212/2020	EPI_ISL_461384	2020-05-07	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_213/2020	EPI_ISL_461385	2020-05-08	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_214/2020	EPI_ISL_461386	2020-05-08	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_216/2020	EPI_ISL_461388	2020-05-08	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_217/2020	EPI_ISL_461389	2020-05-09	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_218/2020	EPI_ISL_461390	2020-05-09	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_219/2020	EPI_ISL_461391	2020-05-10	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_220/2020	EPI_ISL_461392	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_221/2020	EPI_ISL_461393	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_223/2020	EPI_ISL_461395	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_224/2020	EPI_ISL_461396	2020-05-12	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_225/2020	EPI_ISL_461397	2020-05-14	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_226/2020	EPI_ISL_461398	2020-05-03	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Austria/CeMM0385/2020	EPI_ISL_475827	2020-04-01	Europe / Austria / Mayrhofen	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.22	GH
hCoV-19/Austria/CeMM0441/2020	EPI_ISL_475864	2020-03-22	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.465	GH
hCoV-19/Austria/CeMM0448/2020	EPI_ISL_475865	2020-04-21	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.465	GH
hCoV-19/Oman/14233/2020	EPI_ISL_491149	2020-04-10	Asia / Oman / South Batinah / Barka	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.36	GH
hCoV-19/Oman/14251/2020	EPI_ISL_491150	2020-04-10	Asia / Oman / South Batinah / Barka	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.36	GH
hCoV-19/Oman/16908/2020	EPI_ISL_491152	2020-04-12	Asia / Oman / South Batinah / Barka	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.36	GH
hCoV-19/Oman/11374/2020	EPI_ISL_491155	2020-04-07	Asia / Oman / South Batinah / Barka	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.36	GH
hCoV-19/Oman/14235/2020	EPI_ISL_491156	2020-04-10	Asia / Oman / South Batinah / Barka	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.36	GH
hCoV-19/Oman/14264/2020	EPI_ISL_491157	2020-04-10	Asia / Oman / South Batinah / Barka	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.36	GH
hCoV-19/Oman/20616/2020	EPI_ISL_491158	2020-04-15	Asia / Oman / Muscat / Bawshar	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.36	GH
hCoV-19/Oman/15253/2020	EPI_ISL_491159	2020-04-12	Asia / Oman / Muscat / Bawshar	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.36	GH
hCoV-19/Oman/14237/2020	EPI_ISL_491160	2020-04-10	Asia / Oman / South Batinah / Barka	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.36	GH
hCoV-19/Australia/ACT0084/2020	EPI_ISL_498543	2020-06-15	Oceania / Australia / Australian Capital Territory	Human	Original			Nanopore				B.1.523	GH
hCoV-19/Singapore/688/2020	EPI_ISL_498586	2020-07-16	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/USA/WA-UW-11089/2020	EPI_ISL_501092	2020-06-18	North America / USA / Washington	Human	Original			NextSeq 500		Gap of 2 nucleotides when compared to the reference sequence.	info	B.1.170	GH
hCoV-19/Saudi Arabia/KAIMRC07/2020	EPI_ISL_507013	2020-03-12	Asia / Saudi Arabia	Human	unknown	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Saudi Arabia/KAIMRC11/2020	EPI_ISL_507017	2020-03-16	Asia / Saudi Arabia	Human	unknown	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	G
hCoV-19/Saudi Arabia/KAIMRC59/2020	EPI_ISL_507024	2020-03-30	Asia / Saudi Arabia	Human	unknown	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Saudi Arabia/KAIMRC60/2020	EPI_ISL_507025	2020-03-31	Asia / Saudi Arabia	Human	unknown	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Saudi Arabia/KAIMRC62/2020	EPI_ISL_507026	2020-04-01	Asia / Saudi Arabia	Human	unknown	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Saudi Arabia/KAIMRC63/2020	EPI_ISL_507027	2020-04-02	Asia / Saudi Arabia	Human	unknown	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Saudi Arabia/KAIMRC64/2020	EPI_ISL_507028	2020-04-03	Asia / Saudi Arabia	Human	unknown	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Saudi Arabia/KAIMRC69/2020	EPI_ISL_507030	2020-04-05	Asia / Saudi Arabia	Human	unknown	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Saudi Arabia/KAIMRC70/2020	EPI_ISL_507031	2020-04-06	Asia / Saudi Arabia	Human	unknown	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Saudi Arabia/KFSHRC27/2020	EPI_ISL_507032	2020-03-23	Asia / Saudi Arabia	Human	unknown	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Saudi Arabia/KFSHRC43/2020	EPI_ISL_507036	2020-03-27	Asia / Saudi Arabia	Human	unknown	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/India/KA-IB58/2020	EPI_ISL_508332	2020-05-27	Asia / India / Karnataka / Chikkaballapura	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20	Gap of 1 nucleotide at refpos 28.	info	B.1.36.8	GH
hCoV-19/India/WB-S64/2020	EPI_ISL_508454	2020-05-24	Asia / India / West Bengal / North 24 Parganas	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-TF1/2020	EPI_ISL_508489	2020-06-12	Asia / India / Haryana / Faridabad	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-TF12/2020	EPI_ISL_508491	2020-06-17	Asia / India / Haryana / Faridabad	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-TF13/2020	EPI_ISL_508492	2020-06-17	Asia / India / Haryana / Faridabad	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-TF14/2020	EPI_ISL_508493	2020-06-17	Asia / India / Haryana / Faridabad	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-TF15/2020	EPI_ISL_508494	2020-06-17	Asia / India / Haryana / Faridabad	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-TF2/2020	EPI_ISL_508496	2020-06-14	Asia / India / Haryana / Palwal	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-TF20/2020	EPI_ISL_508497	2020-06-17	Asia / India / Haryana / Faridabad	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-TF25/2020	EPI_ISL_508499	2020-06-19	Asia / India / Haryana / Faridabad	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-TF26/2020	EPI_ISL_508500	2020-06-19	Asia / India / Haryana / Palwal	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-TF27/2020	EPI_ISL_508501	2020-06-22	Asia / India / Haryana / Faridabad	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-TF30/2020	EPI_ISL_508503	2020-06-22	Asia / India / Haryana / Gurugram	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-TF4/2020	EPI_ISL_508505	2020-06-14	Asia / India / Haryana / Palwal	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-TF6/2020	EPI_ISL_508507	2020-06-14	Asia / India / Haryana / Palwal	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-TF9/2020	EPI_ISL_508509	2020-06-17	Asia / India / Haryana / Faridabad	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH757/2020	EPI_ISL_513000	2020-04-01	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH759/2020	EPI_ISL_513001	2020-04-01	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH826/2020	EPI_ISL_513002	2020-05-24	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH836/2020	EPI_ISL_513009	2020-05-24	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH837/2020	EPI_ISL_513010	2020-05-24	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH841/2020	EPI_ISL_513013	2020-05-24	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH843/2020	EPI_ISL_513015	2020-05-24	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH844/2020	EPI_ISL_513016	2020-05-24	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH846/2020	EPI_ISL_513018	2020-05-24	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH866/2020	EPI_ISL_513020	2020-05-24	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH870/2020	EPI_ISL_513024	2020-05-24	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH882/2020	EPI_ISL_513032	2020-05-24	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH889/2020	EPI_ISL_513038	2020-05-24	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH891/2020	EPI_ISL_513040	2020-05-24	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH900/2020	EPI_ISL_513041	2020-04-06	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH919/2020	EPI_ISL_513050	2020-04-06	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH921/2020	EPI_ISL_513052	2020-04-06	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH935/2020	EPI_ISL_513062	2020-04-06	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH936/2020	EPI_ISL_513063	2020-06-17	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH991/2020	EPI_ISL_513065	2020-06-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1036/2020	EPI_ISL_513073	2020-06-11	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1044/2020	EPI_ISL_513076	2020-06-13	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.466	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1046/2020	EPI_ISL_513077	2020-06-13	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1048/2020	EPI_ISL_513079	2020-06-13	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1051/2020	EPI_ISL_513081	2020-06-13	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.36.10	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1052/2020	EPI_ISL_513082	2020-06-13	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MADINAH1061/2020	EPI_ISL_513086	2020-06-13	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MADINAH1072/2020	EPI_ISL_513089	2020-06-11	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-MADINAH1079/2020	EPI_ISL_513096	2020-06-11	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Bangladesh/BCSIR-NILMRC-381/2020	EPI_ISL_514246	2020-07-21	Asia / Bangladesh / Chittagong / Chandpur	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.36.16	GH
hCoV-19/Indonesia/YO-UGM-202449/2020	EPI_ISL_516800	2020-06-22	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v. 30			B.1.459	GH
hCoV-19/Indonesia/YO-UGM-781481/2020	EPI_ISL_516829	2020-08-10	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v. 1.30			B.1	GH
hCoV-19/India/UP-NBRI-N48-TEI094/2020	EPI_ISL_516976	2020-05-25	Asia / India / Uttar Pradesh / Sambhal	Human	Original			Nanopore PromethION				B.1.36	GH
hCoV-19/India/UP-NBRI-N49-TEI217/2020	EPI_ISL_516977	2020-05-26	Asia / India / Uttar Pradesh / Barabanki	Human	Original			Nanopore PromethION				B.1.36.8	GH
hCoV-19/India/UP-NBRI-N52-TEH623/2020	EPI_ISL_516980	2020-05-25	Asia / India / Uttar Pradesh / Kannauj	Human	Original			Nanopore PromethION				B.1.36	GH
hCoV-19/India/UP-NBRI-N53-TEH628/2020	EPI_ISL_516981	2020-05-25	Asia / India / Uttar Pradesh / Kannauj	Human	Original			Nanopore PromethION				B.1.36.8	GH
hCoV-19/India/UP-NBRI-N54-TEH857/2020	EPI_ISL_516982	2020-05-25	Asia / India / Uttar Pradesh / Moradabad	Human	Original			Nanopore PromethION				B.1.36	GH
hCoV-19/India/UP-NBRI-N55-TEH861/2020	EPI_ISL_516983	2020-05-25	Asia / India / Uttar Pradesh / Moradabad	Human	Original			Nanopore PromethION				B.1.36	GH
hCoV-19/India/UP-NBRI-N56-TEH862/2020	EPI_ISL_516984	2020-05-25	Asia / India / Uttar Pradesh / Moradabad	Human	Original			Nanopore PromethION				B.1.36	GH
hCoV-19/India/UP-NBRI-N58-TEG811/2020	EPI_ISL_516986	2020-05-24	Asia / India / Uttar Pradesh / Moradabad	Human	Original			Nanopore PromethION				B.1.36	GH
hCoV-19/England/ALDP-97CBAB/2020	EPI_ISL_526310	2020-07-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.523	GH
hCoV-19/England/ALDP-97F7C2/2020	EPI_ISL_526337	2020-08-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/ALDP-97FA32/2020	EPI_ISL_526339	2020-08-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/ALDP-97FE27/2020	EPI_ISL_526341	2020-08-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/ALDP-97FE45/2020	EPI_ISL_526343	2020-08-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/ALDP-9805A6/2020	EPI_ISL_526350	2020-08-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/ALDP-9819E5/2020	EPI_ISL_526355	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/ALDP-981A1F/2020	EPI_ISL_526358	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/ALDP-982207/2020	EPI_ISL_526360	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/QEUH-960393/2020	EPI_ISL_532091	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/QEUH-960C5C/2020	EPI_ISL_532109	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-95E398/2020	EPI_ISL_537001	2020-08-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-961D94/2020	EPI_ISL_537032	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9920EC/2020	EPI_ISL_540648	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/MILK-9921CB/2020	EPI_ISL_540656	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-992231/2020	EPI_ISL_540661	2020-08-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/MILK-99251A/2020	EPI_ISL_540687	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/Norway/3214/2020	EPI_ISL_549041	2020-08-24	Europe / Norway / Viken	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3165/2020	EPI_ISL_549049	2020-08-17	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion and tracheal secretion		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/2957/2020	EPI_ISL_549059	2020-08-01	Europe / Norway / Vestlandet	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/England/MILK-9A55E7/2020	EPI_ISL_550034	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-9A50B9/2020	EPI_ISL_550051	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9A513E/2020	EPI_ISL_550088	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9A94E6/2020	EPI_ISL_551187	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-9AB138/2020	EPI_ISL_551197	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-97537D/2020	EPI_ISL_552544	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-974DF8/2020	EPI_ISL_552548	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-97551D/2020	EPI_ISL_552561	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/ALDP-982CBE/2020	EPI_ISL_552598	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/MILK-975489/2020	EPI_ISL_552613	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-975559/2020	EPI_ISL_552638	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/MILK-975B93/2020	EPI_ISL_552652	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-975B84/2020	EPI_ISL_552658	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-9756FC/2020	EPI_ISL_552690	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-956275/2020	EPI_ISL_553884	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/ALDP-6D1A04/2020	EPI_ISL_556143	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-95D7D9/2020	EPI_ISL_556170	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/MILK-95DBFB/2020	EPI_ISL_556187	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides found at refpos 25437.	info	B.1	GH
hCoV-19/England/MILK-843D20/2020	EPI_ISL_557310	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/MILK-85762E/2020	EPI_ISL_557322	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-5715F7/2020	EPI_ISL_558638	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/ALDP-5ACDA0/2020	EPI_ISL_558652	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/ALDP-5B8DDE/2020	EPI_ISL_558728	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 2 nucleotides when compared to the reference sequence.	info	B.1.465	GH
hCoV-19/England/SHEF-C290F/2020	EPI_ISL_559901	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/Scotland/QEUH-996798/2020	EPI_ISL_559984	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.36.12	GH
hCoV-19/Scotland/QEUH-9968C2/2020	EPI_ISL_559986	2020-08-29	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.36.23	GH
hCoV-19/England/ALDP-9BEB70/2020	EPI_ISL_568021	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9BC7C9/2020	EPI_ISL_568105	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9BE202/2020	EPI_ISL_568121	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9BC7BA/2020	EPI_ISL_568137	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9BDAED/2020	EPI_ISL_568162	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9BC978/2020	EPI_ISL_568169	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-9BDC50/2020	EPI_ISL_568179	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/France/PAC-IHU-0306/2020	EPI_ISL_569446	2020-03-31	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1	GH
hCoV-19/USA/WA-UW-11728/2020	EPI_ISL_570464	2020-06-16	North America / USA / Washington	Human	Original			Illumina	custom			B.1	GH
hCoV-19/USA/WA-UW-12098/2020	EPI_ISL_570489	2020-06-25	North America / USA / Washington	Human	Original			Illumina	custom			B.1	GH
hCoV-19/England/NOTT-1139B3/2020	EPI_ISL_572938	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/NOTT-113889/2020	EPI_ISL_572943	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/NOTT-113968/2020	EPI_ISL_572944	2020-09-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/SHEF-CE059/2020	EPI_ISL_572948	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/SHEF-D23FF/2020	EPI_ISL_572949	2020-09-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-9B5E43/2020	EPI_ISL_572970	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Indonesia/YO-UGM-00061/2020	EPI_ISL_575331	2020-06-16	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.1.30			B.1.459	GH
hCoV-19/Scotland/QEUH-9DC0C8/2020	EPI_ISL_575372	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-9D792C/2020	EPI_ISL_576599	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9D7A47/2020	EPI_ISL_576608	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9D7A56/2020	EPI_ISL_576609	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9D7C7E/2020	EPI_ISL_576619	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9D7FC0/2020	EPI_ISL_576637	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9D7FDF/2020	EPI_ISL_576638	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9D824E/2020	EPI_ISL_576641	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9D8AFB/2020	EPI_ISL_576648	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.471	GH
hCoV-19/England/ALDP-9D8B61/2020	EPI_ISL_576652	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Netherlands/NB-EMC-295/2020	EPI_ISL_577844	2020-08-10	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.36.23	GH
hCoV-19/Netherlands/NH-EMC-61/2020	EPI_ISL_577857	2020-08-20	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/un-EMC-784/2020	EPI_ISL_577880	2020-06-12	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/UT-EMC-70/2020	EPI_ISL_577886	2020-08-24	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/UT-EMC-74/2020	EPI_ISL_577890	2020-08-27	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.36.23	GH
hCoV-19/Netherlands/UT-EMC-75/2020	EPI_ISL_577891	2020-08-27	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Netherlands/UT-EMC-76/2020	EPI_ISL_577892	2020-08-27	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/UT-EMC-77/2020	EPI_ISL_577893	2020-08-27	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Netherlands/UT-EMC-90/2020	EPI_ISL_577906	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.523	GH
hCoV-19/Netherlands/ZH-EMC-508/2020	EPI_ISL_577937	2020-08-26	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-509/2020	EPI_ISL_577938	2020-08-26	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-513/2020	EPI_ISL_577942	2020-08-26	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-518/2020	EPI_ISL_577946	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore		NS3_G254stop results in 8.0% truncation of the protein sequence.	info	B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-519/2020	EPI_ISL_577947	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore		NS3_G254stop results in 8.0% truncation of the protein sequence.	info	B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-520/2020	EPI_ISL_577948	2020-08-26	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-521/2020	EPI_ISL_577949	2020-08-30	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-522/2020	EPI_ISL_577950	2020-09-01	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-523/2020	EPI_ISL_577951	2020-09-01	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-525/2020	EPI_ISL_577953	2020-09-01	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-526/2020	EPI_ISL_577954	2020-09-01	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/England/QEUH-9DC848/2020	EPI_ISL_581102	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9E135E/2020	EPI_ISL_581103	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/England/MILK-9E2C25/2020	EPI_ISL_581118	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-9DEF14/2020	EPI_ISL_581127	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9E21EA/2020	EPI_ISL_581151	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-9E2E6B/2020	EPI_ISL_581184	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9E30CE/2020	EPI_ISL_581186	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DE828/2020	EPI_ISL_581189	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9E2F86/2020	EPI_ISL_581195	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Canada/MB-NML-1045/2020	EPI_ISL_582405	2020-07-29	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1053/2020	EPI_ISL_582412	2020-07-29	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1060/2020	EPI_ISL_582416	2020-08-05	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1061/2020	EPI_ISL_582417	2020-08-07	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1070/2020	EPI_ISL_582424	2020-08-04	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1076/2020	EPI_ISL_582428	2020-08-05	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1077/2020	EPI_ISL_582429	2020-08-04	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1078/2020	EPI_ISL_582430	2020-08-04	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1080/2020	EPI_ISL_582432	2020-08-04	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1083/2020	EPI_ISL_582434	2020-08-05	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1085/2020	EPI_ISL_582435	2020-08-08	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1091/2020	EPI_ISL_582440	2020-08-04	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	G
hCoV-19/Canada/MB-NML-1092/2020	EPI_ISL_582441	2020-08-04	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.8	GH
hCoV-19/Canada/MB-NML-1096/2020	EPI_ISL_582443	2020-08-04	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1100/2020	EPI_ISL_582445	2020-08-05	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1102/2020	EPI_ISL_582447	2020-08-06	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1104/2020	EPI_ISL_582448	2020-08-05	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1110/2020	EPI_ISL_582450	2020-08-04	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1112/2020	EPI_ISL_582452	2020-08-05	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1116/2020	EPI_ISL_582453	2020-08-04	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1119/2020	EPI_ISL_582455	2020-08-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1122/2020	EPI_ISL_582457	2020-08-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.8	GH
hCoV-19/Canada/MB-NML-1124/2020	EPI_ISL_582458	2020-08-04	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1125/2020	EPI_ISL_582459	2020-08-04	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1128/2020	EPI_ISL_582460	2020-08-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1130/2020	EPI_ISL_582461	2020-08-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.8	GH
hCoV-19/Canada/MB-NML-1136/2020	EPI_ISL_582467	2020-08-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.8	GH
hCoV-19/Canada/MB-NML-1139/2020	EPI_ISL_582469	2020-08-06	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1140/2020	EPI_ISL_582470	2020-08-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.8	GH
hCoV-19/Canada/MB-NML-1141/2020	EPI_ISL_582471	2020-08-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1142/2020	EPI_ISL_582472	2020-08-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.8	GH
hCoV-19/Canada/MB-NML-1152/2020	EPI_ISL_582478	2020-08-01	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1153/2020	EPI_ISL_582479	2020-07-31	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1155/2020	EPI_ISL_582481	2020-08-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1156/2020	EPI_ISL_582482	2020-08-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1157/2020	EPI_ISL_582483	2020-08-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1168/2020	EPI_ISL_582489	2020-08-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1171/2020	EPI_ISL_582492	2020-08-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1176/2020	EPI_ISL_582494	2020-07-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1178/2020	EPI_ISL_582495	2020-08-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.8	GH
hCoV-19/Austria/CeMM0594/2020	EPI_ISL_583607	2020-04-02	Europe / Austria / Innsbruck	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.465	GH
hCoV-19/Austria/CeMM0595/2020	EPI_ISL_583608	2020-04-05	Europe / Austria / Innsbruck	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.465	GH
hCoV-19/Austria/CeMM0672/2020	EPI_ISL_583635	2020-04-21	Europe / Austria	Human	Original			Illumina NovaSeq	bwa			B.1.465	GH
hCoV-19/Austria/CeMM0683/2020	EPI_ISL_583643	2020-04-19	Europe / Austria	Human	Original			Illumina NovaSeq	bwa			B.1.465	GH
hCoV-19/Austria/CeMM0693/2020	EPI_ISL_583650	2020-04-13	Europe / Austria	Human	Original			Illumina NovaSeq	bwa			B.1.465	GH
hCoV-19/Austria/CeMM0703/2020	EPI_ISL_583658	2020-03-31	Europe / Austria	Human	Original			Illumina NovaSeq	bwa			B.1.465	GH
hCoV-19/Wales/PHWC-16F6DF/2020	EPI_ISL_586007	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.471	GH
hCoV-19/England/ALDP-A2EC68/2020	EPI_ISL_587134	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-A2E864/2020	EPI_ISL_587139	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-A2EC2C/2020	EPI_ISL_587143	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A2F14A/2020	EPI_ISL_587146	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A2ECD1/2020	EPI_ISL_587220	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-A2FC94/2020	EPI_ISL_587260	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-A2F308/2020	EPI_ISL_587276	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A2FBD3/2020	EPI_ISL_587291	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A2F247/2020	EPI_ISL_587297	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-A1F013/2020	EPI_ISL_587325	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9F4DA5/2020	EPI_ISL_588459	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9F369C/2020	EPI_ISL_588498	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/QEUH-9F385A/2020	EPI_ISL_588602	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9F3FDD/2020	EPI_ISL_588645	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/Wales/MILK-9E1109/2020	EPI_ISL_589787	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/QEUH-9D05A7/2020	EPI_ISL_589841	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9D06C2/2020	EPI_ISL_589889	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-9D002E/2020	EPI_ISL_589954	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-9D0D36/2020	EPI_ISL_589983	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Norway/3428/2020	EPI_ISL_590894	2020-09-09	Europe / Norway / Viken	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3280/2020	EPI_ISL_590903	2020-09-02	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.469	GH
hCoV-19/Norway/3590/2020	EPI_ISL_590924	2020-07-31	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3593/2020	EPI_ISL_590925	2020-07-31	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3571/2020	EPI_ISL_590926	2020-07-31	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3532/2020	EPI_ISL_590927	2020-09-15	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3625/2020	EPI_ISL_590931	2020-09-21	Europe / Norway / Viken	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3536/2020	EPI_ISL_590934	2020-09-05	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3578/2020	EPI_ISL_590938	2020-08-03	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3582/2020	EPI_ISL_590939	2020-07-31	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3585/2020	EPI_ISL_590940	2020-07-31	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3592/2020	EPI_ISL_590941	2020-08-02	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3594/2020	EPI_ISL_590942	2020-08-02	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3596/2020	EPI_ISL_590943	2020-08-04	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3598/2020	EPI_ISL_590944	2020-09-23	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3552/2020	EPI_ISL_590946	2020-08-06	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3564/2020	EPI_ISL_590947	2020-07-31	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3572/2020	EPI_ISL_590949	2020-07-31	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3574/2020	EPI_ISL_590950	2020-07-31	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3767/2020	EPI_ISL_590986	2020-08-07	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.1	GH
hCoV-19/Norway/3715/2020	EPI_ISL_590987	2020-09-03	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3718/2020	EPI_ISL_590988	2020-08-29	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3719/2020	EPI_ISL_590989	2020-09-03	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3725/2020	EPI_ISL_590990	2020-09-07	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3726/2020	EPI_ISL_590991	2020-09-01	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3727/2020	EPI_ISL_590992	2020-08-31	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3729/2020	EPI_ISL_590993	2020-08-31	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3731/2020	EPI_ISL_590994	2020-08-31	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3739/2020	EPI_ISL_590995	2020-09-02	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3740/2020	EPI_ISL_590996	2020-09-04	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3741/2020	EPI_ISL_590997	2020-08-30	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3743/2020	EPI_ISL_590998	2020-09-01	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3744/2020	EPI_ISL_590999	2020-09-04	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/England/ALDP-9E7604/2020	EPI_ISL_594483	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/BIRM-6429B/2020	EPI_ISL_594486	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-6435C/2020	EPI_ISL_594488	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-6436B/2020	EPI_ISL_594489	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-6437A/2020	EPI_ISL_594490	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-64389/2020	EPI_ISL_594491	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-6444A/2020	EPI_ISL_594494	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/QEUH-9F999D/2020	EPI_ISL_595741	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-9F9E61/2020	EPI_ISL_595770	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-9FA2BF/2020	EPI_ISL_595797	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36	GH
hCoV-19/Ireland/LK-NVRL-73IRL80542/2020	EPI_ISL_596912	2020-09-15	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/England/CAMC-A5844F/2020	EPI_ISL_596932	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-A58EF6/2020	EPI_ISL_596934	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-A596EE/2020	EPI_ISL_596970	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-A0B2F6/2020	EPI_ISL_599144	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-A0AB29/2020	EPI_ISL_599303	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-9F3B7F/2020	EPI_ISL_600778	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.23	GH
hCoV-19/England/QEUH-9F3289/2020	EPI_ISL_600779	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/USA/UT-QDX-1950/2020	EPI_ISL_604287	2020-03-13	North America / USA / Utah	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1	G
hCoV-19/England/MILK-A79651/2020	EPI_ISL_606871	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A79A64/2020	EPI_ISL_606890	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A7CCE3/2020	EPI_ISL_606895	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A6C93A/2020	EPI_ISL_606929	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A6E103/2020	EPI_ISL_606940	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-A6CBDA/2020	EPI_ISL_606950	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-A690ED/2020	EPI_ISL_609079	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A6929C/2020	EPI_ISL_609135	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/MILK-A6BD8A/2020	EPI_ISL_609138	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Scotland/QEUH-A5E19D/2020	EPI_ISL_609186	2020-10-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/USA/MI-UM-10036346836/2020	EPI_ISL_610061	2020-10-08	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/USA/MI-UM-10036391877/2020	EPI_ISL_610076	2020-10-12	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/USA/MI-UM-10036434093/2020	EPI_ISL_610112	2020-10-14	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/Indonesia/JT-UGM-48660/2020	EPI_ISL_610161	2020-09-01	Asia / Indonesia / Central Java	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.1.30			B.1.459	GH
hCoV-19/England/QEUH-A9EF3D/2020	EPI_ISL_611444	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/England/QEUH-A9FBFC/2020	EPI_ISL_611480	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-A9F691/2020	EPI_ISL_611483	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Denmark/DCGC-3391/2020	EPI_ISL_616150	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/Denmark/DCGC-3265/2020	EPI_ISL_616183	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-3458/2020	EPI_ISL_616222	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/Denmark/DCGC-3462/2020	EPI_ISL_616249	2020-08-31	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.36.20	GH
hCoV-19/Denmark/DCGC-3473/2020	EPI_ISL_616260	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-3492/2020	EPI_ISL_616280	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-3533/2020	EPI_ISL_616325	2020-08-31	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-3547/2020	EPI_ISL_616340	2020-08-31	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36.22	GH
hCoV-19/Denmark/DCGC-3556/2020	EPI_ISL_616349	2020-08-31	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.36.22	GH
hCoV-19/Denmark/DCGC-3607/2020	EPI_ISL_616373	2020-08-31	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-2440/2020	EPI_ISL_617615	2020-08-10	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Denmark/DCGC-2276/2020	EPI_ISL_617634	2020-08-10	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.36.23	GH
hCoV-19/Denmark/DCGC-7872/2020	EPI_ISL_618821	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.36.20	G
hCoV-19/Denmark/DCGC-7949/2020	EPI_ISL_618901	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-4206/2020	EPI_ISL_622099	2020-09-14	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/England/MILK-AB8128/2020	EPI_ISL_623384	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ABB732/2020	EPI_ISL_623394	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/MILK-ABB592/2020	EPI_ISL_623400	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/CAMC-AAFA92/2020	EPI_ISL_623426	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-AAFE1E/2020	EPI_ISL_623451	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-AB7A79/2020	EPI_ISL_623457	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-A94C9A/2020	EPI_ISL_624708	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A9478A/2020	EPI_ISL_624791	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-A3240F/2020	EPI_ISL_628352	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-ACF2C1/2020	EPI_ISL_629464	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/MILK-AC95CE/2020	EPI_ISL_629547	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/MILK-AC8E00/2020	EPI_ISL_629574	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-AC84FF/2020	EPI_ISL_629594	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-ACF3FB/2020	EPI_ISL_629651	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/MILK-AC84B3/2020	EPI_ISL_629656	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.39	GH
hCoV-19/England/ALDP-A67CEB/2020	EPI_ISL_630480	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-A67C18/2020	EPI_ISL_630515	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A6689D/2020	EPI_ISL_630516	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/ALDP-A66842/2020	EPI_ISL_630518	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A667EB/2020	EPI_ISL_630522	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A66860/2020	EPI_ISL_630524	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/ALDP-A6697C/2020	EPI_ISL_630554	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A668CA/2020	EPI_ISL_630607	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A66E40/2020	EPI_ISL_630641	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-A66824/2020	EPI_ISL_630645	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-A67CFA/2020	EPI_ISL_630652	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AD3CBD/2020	EPI_ISL_634032	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AD51F8/2020	EPI_ISL_634050	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/England/QEUH-AD2B39/2020	EPI_ISL_634078	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-AD2401/2020	EPI_ISL_634111	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AD50CE/2020	EPI_ISL_634133	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/QEUH-AD51CB/2020	EPI_ISL_634150	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/Mexico/BCN-ALSR-2451/2020	EPI_ISL_635483	2020-05-15	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/England/C200040705/2020	EPI_ISL_636733	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/India/UT-67339-CSIR-IGIB/2020	EPI_ISL_636742	2020-08-09	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-67341-CSIR-IGIB/2020	EPI_ISL_636743	2020-08-09	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-67340-CSIR-IGIB/2020	EPI_ISL_636746	2020-08-09	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-67330-CSIR-IGIB/2020	EPI_ISL_636747	2020-08-09	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-50438-CSIR-IGIB/2020	EPI_ISL_636748	2020-07-26	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-67177-CSIR-IGIB/2020	EPI_ISL_636750	2020-08-09	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-59946-CSIR-IGIB/2020	EPI_ISL_636752	2020-08-02	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-67134-CSIR-IGIB/2020	EPI_ISL_636753	2020-08-09	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-69831-CSIR-IGIB/2020	EPI_ISL_636755	2020-08-14	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-67165-CSIR-IGIB/2020	EPI_ISL_636756	2020-08-09	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-69826-CSIR-IGIB/2020	EPI_ISL_636757	2020-08-14	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-69787-CSIR-IGIB/2020	EPI_ISL_636760	2020-08-14	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-69813-CSIR-IGIB/2020	EPI_ISL_636762	2020-08-14	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-61026-CSIR-IGIB/2020	EPI_ISL_636766	2020-08-06	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based			B.1.36.22	GH
hCoV-19/India/DL-50480-CSIR-IGIB/2020	EPI_ISL_636770	2020-07-27	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based	NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/India/DL-60920-CSIR-IGIB/2020	EPI_ISL_636774	2020-08-06	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-62368-CSIR-IGIB/2020	EPI_ISL_636776	2020-08-08	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-69775-CSIR-IGIB/2020	EPI_ISL_636777	2020-08-16	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-50442-CSIR-IGIB/2020	EPI_ISL_636781	2020-07-26	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-5504375-CSIR-IGIB/2020	EPI_ISL_636787	2020-08-06	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/England/QEUH-B12B3C/2020	EPI_ISL_642572	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/CAMC-B0789D/2020	EPI_ISL_643781	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-B07596/2020	EPI_ISL_643792	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.39	GH
hCoV-19/England/CAMC-B089F3/2020	EPI_ISL_643896	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/CAMC-B07262/2020	EPI_ISL_643908	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B0744E/2020	EPI_ISL_643916	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-B09303/2020	EPI_ISL_643942	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-B21E6E/2020	EPI_ISL_646014	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B225D1/2020	EPI_ISL_646047	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B1F926/2020	EPI_ISL_646061	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/CAMC-B222E9/2020	EPI_ISL_646070	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-B21BFE/2020	EPI_ISL_646084	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-B23CAE/2020	EPI_ISL_646199	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-B21E13/2020	EPI_ISL_647321	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B21C19/2020	EPI_ISL_647376	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B21068/2020	EPI_ISL_647382	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B2104A/2020	EPI_ISL_647383	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B2138D/2020	EPI_ISL_647417	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-B218E8/2020	EPI_ISL_647427	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B22D9D/2020	EPI_ISL_647429	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B21736/2020	EPI_ISL_647435	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B216FD/2020	EPI_ISL_647443	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B1FDDF/2020	EPI_ISL_647483	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/USA/MI-UM-10036595910/2020	EPI_ISL_649994	2020-10-23	North America / USA / Michigan	Human	Original			Illumina MiSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/Sweden/20-53044/2020	EPI_ISL_654504	2020-10-04	Europe / Sweden	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Sweden/20-53045/2020	EPI_ISL_654505	2020-10-04	Europe / Sweden	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/ALDP-B5C073/2020	EPI_ISL_655750	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/ALDP-B5CDD6/2020	EPI_ISL_655761	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B5C143/2020	EPI_ISL_655875	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/ALDP-B5C107/2020	EPI_ISL_655893	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/ALDP-B5C0EC/2020	EPI_ISL_655921	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/ALDP-B5C8B7/2020	EPI_ISL_655928	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-B5C0BF/2020	EPI_ISL_655942	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/ALDP-B5C170/2020	EPI_ISL_655950	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	G
hCoV-19/England/MILK-B553DB/2020	EPI_ISL_658005	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B55450/2020	EPI_ISL_658050	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B55F22/2020	EPI_ISL_658090	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B5172E/2020	EPI_ISL_658093	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B518C1/2020	EPI_ISL_658131	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B51ABC/2020	EPI_ISL_658138	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-B5A628/2020	EPI_ISL_658145	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B548DD/2020	EPI_ISL_658148	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B5A6A0/2020	EPI_ISL_658152	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B515CA/2020	EPI_ISL_658166	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B51955/2020	EPI_ISL_658189	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-B32F3A/2020	EPI_ISL_659311	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B3342B/2020	EPI_ISL_659351	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/CAMC-B335A0/2020	EPI_ISL_659352	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B33889/2020	EPI_ISL_659371	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B33458/2020	EPI_ISL_659393	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/CAMC-B3350A/2020	EPI_ISL_659405	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B343D2/2020	EPI_ISL_659436	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/CAMC-B35544/2020	EPI_ISL_659454	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B3432D/2020	EPI_ISL_659469	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/France/ARA-SC371/2020	EPI_ISL_660352	2020-05-14	Europe / France / Auvergne-Rhone-Alpes / Saint-Etienne	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1	GH
hCoV-19/England/QEUH-B80A5A/2020	EPI_ISL_661650	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/CAMC-B7835A/2020	EPI_ISL_661679	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/CAMC-B787E5/2020	EPI_ISL_661710	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B7794A/2020	EPI_ISL_661712	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/England/QEUH-B8234E/2020	EPI_ISL_661724	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B809F3/2020	EPI_ISL_661727	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/QEUH-B80B1B/2020	EPI_ISL_661737	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-B8228D/2020	EPI_ISL_661754	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-AF4876/2020	EPI_ISL_662940	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/England/QEUH-AF56A8/2020	EPI_ISL_662990	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/LOND-12501AF/2020	EPI_ISL_665200	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/LOND-12501EB/2020	EPI_ISL_665201	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/LOND-12501FA/2020	EPI_ISL_665202	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/LOND-1250206/2020	EPI_ISL_665203	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/LOND-1250224/2020	EPI_ISL_665204	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.39	GH
hCoV-19/England/LOND-12505FE/2020	EPI_ISL_665221	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.39	GH
hCoV-19/England/LOND-12506A0/2020	EPI_ISL_665225	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.39	GH
hCoV-19/England/LOND-125096B/2020	EPI_ISL_665241	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/LOND-12509A7/2020	EPI_ISL_665242	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/Japan/IC-0308/2020	EPI_ISL_667737	2020-10-03	Asia / Japan	Human	Original		COVID-19 positive case who entered from India.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/IC-0311/2020	EPI_ISL_667740	2020-11-03	Asia / Japan	Human	Original		COVID-19 positive case who entered from India.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/IC-0312/2020	EPI_ISL_667741	2020-11-10	Asia / Japan	Human	Original		COVID-19 positive case who entered from Pakistan.	Illumina NextSeq500	A5-miseq v. 20140604			B.1.471	GH
hCoV-19/Japan/IC-0313/2020	EPI_ISL_667742	2020-11-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	A5-miseq v. 20140604	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.459	GH
hCoV-19/Japan/IC-0314/2020	EPI_ISL_667743	2020-11-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	SKESA v. 2.3.0	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.459	GH
hCoV-19/Japan/IC-0315/2020	EPI_ISL_667744	2020-11-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	A5-miseq v. 20140604	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.459	GH
hCoV-19/Japan/IC-0316/2020	EPI_ISL_667745	2020-11-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	SKESA v. 2.3.0	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.459	GH
hCoV-19/Japan/IC-0317/2020	EPI_ISL_667746	2020-11-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	SKESA v. 2.3.0	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.459	GH
hCoV-19/Japan/IC-0318/2020	EPI_ISL_667747	2020-11-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	SKESA v. 2.3.0	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.459	GH
hCoV-19/Japan/IC-0319/2020	EPI_ISL_667748	2020-11-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	BWA v. 0.7.13-r1126, picard v. 2.10.10, GATK v. 3.8.0, VarScan v. 2.4.3, VCFtools v. 0.1.12b, SKESA v. 2.3.0, A5-miseq v. 20140604	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.459	GH
hCoV-19/Japan/IC-0320/2020	EPI_ISL_667749	2020-11-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	A5-miseq v. 20140604	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.459	GH
hCoV-19/Japan/IC-0321/2020	EPI_ISL_667750	2020-11-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	SKESA v. 2.3.0	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.459	GH
hCoV-19/Japan/IC-0322/2020	EPI_ISL_667751	2020-11-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	SKESA v. 2.3.0	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.459	GH
hCoV-19/Japan/IC-0323/2020	EPI_ISL_667752	2020-11-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	A5-miseq v. 20140604	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.459	GH
hCoV-19/Japan/IC-0324/2020	EPI_ISL_667753	2020-11-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	A5-miseq v. 20140604	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.459	GH
hCoV-19/Japan/IC-0325/2020	EPI_ISL_667754	2020-11-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	SKESA v. 2.3.0	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.459	GH
hCoV-19/Australia/NSW1182/2020	EPI_ISL_667785	2020-10-22	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36	GH
hCoV-19/Australia/NSW1207/2020	EPI_ISL_667805	2020-11-07	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36	GH
hCoV-19/Taiwan/CGMH-CGU-36/2020	EPI_ISL_667809	2020-09-17	Asia / Taiwan / Taoyuan	Human	Original	Saliva		Illumina MiSeq, assembled sequences	SPAdes Version 3.14.1			B.1.36.16	GH
hCoV-19/England/QEUH-B7EB4D/2020	EPI_ISL_667814	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-B78949/2020	EPI_ISL_667897	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B7AE84/2020	EPI_ISL_667913	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Denmark/DCGC-11591/2020	EPI_ISL_671010	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-11629/2020	EPI_ISL_671036	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-11633/2020	EPI_ISL_671039	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.471	GH
hCoV-19/Denmark/DCGC-11839/2020	EPI_ISL_671166	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.8	GH
hCoV-19/Denmark/DCGC-11847/2020	EPI_ISL_671173	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.8	GH
hCoV-19/England/MILK-B9532A/2020	EPI_ISL_673603	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B994BA/2020	EPI_ISL_673632	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/England/CAMC-B98D29/2020	EPI_ISL_673653	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B98BF2/2020	EPI_ISL_673654	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B983CD/2020	EPI_ISL_673658	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B98D65/2020	EPI_ISL_673690	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B9A60E/2020	EPI_ISL_673716	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-B95111/2020	EPI_ISL_673745	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B9903E/2020	EPI_ISL_673747	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B9A5C5/2020	EPI_ISL_673795	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B9811E/2020	EPI_ISL_674926	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B986C4/2020	EPI_ISL_674951	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B96EFB/2020	EPI_ISL_674993	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B97319/2020	EPI_ISL_674999	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B3ADB0/2020	EPI_ISL_679730	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.471	GH
hCoV-19/England/MILK-B3B06B/2020	EPI_ISL_679738	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.8	GH
hCoV-19/England/MILK-B3B308/2020	EPI_ISL_679752	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.39	GH
hCoV-19/England/MILK-B3B432/2020	EPI_ISL_679757	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/India/MH-ACTREC-557/2020	EPI_ISL_700202	2020-08-29	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/India/MH-ACTREC-591/2020	EPI_ISL_700229	2020-09-04	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/India/MH-ACTREC-595/2020	EPI_ISL_700233	2020-09-05	Asia / India / Maharashtra / Mumbai	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/India/MH-ACTREC-601/2020	EPI_ISL_700239	2020-09-08	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1	GH
hCoV-19/India/MH-ACTREC-604/2020	EPI_ISL_700241	2020-09-08	Asia / India / Maharashtra / Mumbai	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/India/MH-ACTREC-625/2020	EPI_ISL_700260	2020-09-11	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/India/MH-ACTREC-626/2020	EPI_ISL_700261	2020-09-11	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/India/MH-ACTREC-633/2020	EPI_ISL_700266	2020-09-12	Asia / India / Maharashtra / Thane	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1	GH
hCoV-19/India/MH-ACTREC-634/2020	EPI_ISL_700267	2020-09-12	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/India/MH-ACTREC-640/2020	EPI_ISL_700273	2020-09-14	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/India/MH-ACTREC-641/2020	EPI_ISL_700274	2020-09-14	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/India/MH-ACTREC-642/2020	EPI_ISL_700275	2020-09-14	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/India/MH-ACTREC-646/2020	EPI_ISL_700276	2020-09-14	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/India/MH-ACTREC-647/2020	EPI_ISL_700277	2020-09-14	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/India/MH-ACTREC-659/2020	EPI_ISL_700289	2020-09-15	Asia / India / Maharashtra / Mumbai	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/India/MH-ACTREC-664/2020	EPI_ISL_700293	2020-09-16	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/India/MH-ACTREC-673/2020	EPI_ISL_700299	2020-09-18	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/India/UP-ACTREC-681/2020	EPI_ISL_700306	2020-09-19	Asia / India / Uttar Pradesh / Gorakhpur	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/India/MH-ACTREC-697/2020	EPI_ISL_700322	2020-09-25	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/England/ALDP-BB9A76/2020	EPI_ISL_702822	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-BC072A/2020	EPI_ISL_705006	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-BC0881/2020	EPI_ISL_705031	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/CAMC-BC112B/2020	EPI_ISL_705090	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-BC2324/2020	EPI_ISL_705116	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/MILK-BA998B/2020	EPI_ISL_705192	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/NORW-F6F3D/2020	EPI_ISL_706384	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.2	GH
hCoV-19/Indonesia/BT-SHSIU-01-3610/2020	EPI_ISL_707692	2020-10-04	Asia / Indonesia / Banten	Human	Original	Nasopharyngeal and oropharyngeal		Nanopore MinION				B.1.459	GH
hCoV-19/Indonesia/BT-SHSIU-01-4941/2020	EPI_ISL_707696	2020-10-15	Asia / Indonesia / Banten	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.459	GH
hCoV-19/England/204961133/2020	EPI_ISL_707704	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 1 nucleotide found at refpos 6573 (frameshift confirmed by the submitter).	info	B.1.36.39	GH
hCoV-19/Thailand/Bangkok-CONI-0319/2020	EPI_ISL_707707	2020-11-29	Asia / Thailand / Bangkok	Human	Original			Illumina iSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0321/2020	EPI_ISL_707708	2020-12-01	Asia / Thailand / Bangkok	Human	Original			Illumina iSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0322/2020	EPI_ISL_707709	2020-12-04	Asia / Thailand / Bangkok	Human	Original			Illumina iSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0323/2020	EPI_ISL_707710	2020-12-05	Asia / Thailand / Bangkok	Human	Original			Illumina iSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Belgium/ULG-10996/2020	EPI_ISL_707763	2020-11-14	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.36	GH
hCoV-19/New Zealand/20CV0628/2020	EPI_ISL_707795	2020-12-02	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/ALDP-BE966A/2020	EPI_ISL_708959	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/Denmark/DCGC-14931/2020	EPI_ISL_713529	2020-11-23	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.8	GH
hCoV-19/Denmark/DCGC-14934/2020	EPI_ISL_713531	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-15003/2020	EPI_ISL_713572	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-15022/2020	EPI_ISL_713584	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-15102/2020	EPI_ISL_713632	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-15124/2020	EPI_ISL_713642	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-15131/2020	EPI_ISL_713647	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-15184/2020	EPI_ISL_713680	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-15211/2020	EPI_ISL_713696	2020-11-23	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-16532/2020	EPI_ISL_714820	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Malaysia/IMR-WI194/2020	EPI_ISL_718307	2020-10-16	Asia / Malaysia	Human	Vero			Illumina NextSeq 500		Insertion of 113 nucleotide(s) found at refpos 0.	info	B.1.36.16	GH
hCoV-19/Malaysia/IMR-W195I/2020	EPI_ISL_718308	2020-10-16	Asia / Malaysia	Human	Vero			Illumina NextSeq 500		Insertion of 1 nucleotide(s) found at refpos 0.	info	B.1.36.16	GH
hCoV-19/Malaysia/IMR-WI310/2020	EPI_ISL_718314	2020-11-01	Asia / Malaysia	Human	Original			Illumina NextSeq 500				B.1.36.16	GH
hCoV-19/England/CAMC-C40536/2020	EPI_ISL_718417	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/CAMC-C4323C/2020	EPI_ISL_719604	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/QEUH-BA073F/2020	EPI_ISL_719612	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-BA066F/2020	EPI_ISL_719634	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-BA067E/2020	EPI_ISL_719642	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-BA0526/2020	EPI_ISL_719673	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-BA0614/2020	EPI_ISL_719722	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-BA017D/2020	EPI_ISL_719753	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-BA0623/2020	EPI_ISL_719769	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-BA1947/2020	EPI_ISL_719771	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BB211E/2020	EPI_ISL_720615	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/MILK-BFCBB0/2020	EPI_ISL_720687	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/ALDP-C049C9/2020	EPI_ISL_720709	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Scotland/CVR6134/2020	EPI_ISL_724221	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.36.26	GH
hCoV-19/Switzerland/BE-ETHZ-400075/2020	EPI_ISL_729126	2020-12-06	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BS-ETHZ-400081/2020	EPI_ISL_729130	2020-12-06	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	G
hCoV-19/Nigeria/BO-CV337/2020	EPI_ISL_730004	2020-05-01	Africa / Nigeria / Borno State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.462	O
hCoV-19/Nigeria/BO-CV339/2020	EPI_ISL_730006	2020-05-03	Africa / Nigeria / Borno State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1	GH
hCoV-19/Nigeria/BO-CV341/2020	EPI_ISL_730007	2020-05-04	Africa / Nigeria / Borno State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.462	GH
hCoV-19/Nigeria/BO-CV344/2020	EPI_ISL_730009	2020-05-06	Africa / Nigeria / Borno State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.462	GH
hCoV-19/Nigeria/BO-CV347/2020	EPI_ISL_730012	2020-05-17	Africa / Nigeria / Borno State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.467	GH
hCoV-19/Nigeria/BO-CV350/2020	EPI_ISL_730015	2020-05-23	Africa / Nigeria / Borno State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.462	GH
hCoV-19/Nigeria/BE-CV352/2020	EPI_ISL_730017	2020-06-01	Africa / Nigeria / Benue State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.462	GH
hCoV-19/Nigeria/FC-CV354/2020	EPI_ISL_730019	2020-06-24	Africa / Nigeria / Abuja	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.467	GH
hCoV-19/Nigeria/KW-CV401/2020	EPI_ISL_730048	2020-07-12	Africa / Nigeria / Kwara State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.467	GH
hCoV-19/Finland/1cF10/2020	EPI_ISL_732601	2020-10-31	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/1cF9/2020	EPI_ISL_732602	2020-10-31	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/1cG10/2020	EPI_ISL_732603	2020-10-31	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/29C11/2020	EPI_ISL_732605	2020-12-03	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/29E10/2020	EPI_ISL_732606	2020-12-03	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/29F7/2020	EPI_ISL_732609	2020-12-03	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/3CB4/2020	EPI_ISL_732612	2020-12-02	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/4CF7/2020	EPI_ISL_732613	2020-12-01	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7cB5/2020	EPI_ISL_732618	2020-10-31	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/9CA12/2020	EPI_ISL_732621	2020-12-03	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/9CB12/2020	EPI_ISL_732622	2020-12-03	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/9CH11/2020	EPI_ISL_732624	2020-12-03	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S10CB1/2020	EPI_ISL_732625	2020-10-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S10CF2/2020	EPI_ISL_732626	2020-10-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S11F9/2020	EPI_ISL_732629	2020-09-20	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S12BE11/2020	EPI_ISL_732631	2020-09-22	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S17B1/2020	EPI_ISL_732635	2020-09-20	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S1CD10/2020	EPI_ISL_732636	2020-10-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S2CA3/2020	EPI_ISL_732637	2020-10-31	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S2CB7/2020	EPI_ISL_732638	2020-10-31	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S2CG5/2020	EPI_ISL_732639	2020-10-31	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S2CG8/2020	EPI_ISL_732640	2020-10-31	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S3CA12/2020	EPI_ISL_732641	2020-10-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S3CA5/2020	EPI_ISL_732642	2020-10-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S3CB11/2020	EPI_ISL_732643	2020-10-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S3CC11/2020	EPI_ISL_732644	2020-10-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S3CD11/2020	EPI_ISL_732646	2020-10-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S3CE1/2020	EPI_ISL_732647	2020-10-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S3CG11/2020	EPI_ISL_732649	2020-10-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S3CG2/2020	EPI_ISL_732650	2020-10-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S5CD7/2020	EPI_ISL_732651	2020-10-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S9CB11/2020	EPI_ISL_732653	2020-10-31	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Switzerland/AG-ETHZ-410033/2020	EPI_ISL_737649	2020-12-16	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/AG-ETHZ-410042/2020	EPI_ISL_737651	2020-12-16	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Denmark/DCGC-18577/2020	EPI_ISL_749496	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-17888/2020	EPI_ISL_749624	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-17040/2020	EPI_ISL_750494	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/Denmark/DCGC-17351/2020	EPI_ISL_750495	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-16775/2020	EPI_ISL_750556	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Singapore/1470/2020	EPI_ISL_754085	2020-12-14	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.459	GH
hCoV-19/Singapore/1471/2020	EPI_ISL_754086	2020-12-17	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Singapore/1472/2020	EPI_ISL_754087	2020-12-15	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.456	GH
hCoV-19/Singapore/1474/2020	EPI_ISL_754089	2020-12-17	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.456	GH
hCoV-19/Singapore/1479/2020	EPI_ISL_754094	2020-12-18	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Singapore/1481/2020	EPI_ISL_754096	2020-12-15	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.19	GH
hCoV-19/Singapore/1482/2020	EPI_ISL_754097	2020-12-20	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.19	GH
hCoV-19/Singapore/1490/2020	EPI_ISL_754099	2020-12-21	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.459	GH
hCoV-19/Singapore/1491/2020	EPI_ISL_754100	2020-12-22	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Singapore/1492/2020	EPI_ISL_754101	2020-12-22	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Singapore/1493/2020	EPI_ISL_754102	2020-12-21	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Singapore/1494/2020	EPI_ISL_754103	2020-12-21	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Singapore/1498/2020	EPI_ISL_754107	2020-12-22	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.466.2	GH
hCoV-19/Germany/BE-ChVir-W2120-5976/2020	EPI_ISL_754190	2020-10-15	Europe / Germany / Berlin	Human	Original			Illumina NextSeq	bowtie2	Insertion of 2 nucleotides found at refpos 29593 (frameshift confirmed by the submitter).	info	B.1.36.20	GH
hCoV-19/Germany/NW-ChVir-D1925-5947/2020	EPI_ISL_754193	2020-10-07	Europe / Germany / North Rhine-Westphalia	Human	Original			Illumina NextSeq	bowtie2	Gap of 32 nucleotides found at refpos 27687 (frameshift confirmed by the submitter). Insertion of 2 nucleotides found at refpos 29593 (frameshift confirmed by the submitter). NS7a without BLAST coverage.	info	B.1.36.20	GH
hCoV-19/England/CAMC-C86A08/2020	EPI_ISL_756674	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-C78A27/2020	EPI_ISL_756693	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-C782C5/2020	EPI_ISL_756703	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/MILK-C7B59C/2020	EPI_ISL_756786	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/ALDP-CB5D07/2020	EPI_ISL_761141	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-CB688D/2020	EPI_ISL_761215	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-CB5D43/2020	EPI_ISL_761260	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Indonesia/BT-EIJK21/2020	EPI_ISL_766036	2020-04-09	Asia / Indonesia / Banten / South Tangerang	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550 + Sanger	Bowtie2 + iVar + in-house scripts			B.1.22	GH
hCoV-19/Australia/NSW1385/2020	EPI_ISL_768607	2020-12-25	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Thailand/Chiang Rai_MM/2020	EPI_ISL_768609	2020-12-03	Asia / Thailand / Chiang Rai	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Singapore/1505/2020	EPI_ISL_768621	2020-12-21	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Singapore/1508/2020	EPI_ISL_768624	2020-12-24	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Singapore/1509/2020	EPI_ISL_768625	2020-12-28	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.466.2	GH
hCoV-19/Singapore/1514/2020	EPI_ISL_768630	2020-12-26	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.459	GH
hCoV-19/Japan/IC-0459/2020	EPI_ISL_768668	2020-12-19	Asia / Japan	Human	Original		COVID-19 positive case who entered from Myanmar.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.36.16	GH
hCoV-19/Japan/IC-0460/2020	EPI_ISL_768669	2020-12-19	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	bwa v. 0.7.13-r1126, picard v. 2.10.10, GATK v. 3.8.0, VarScan v. 2.4.3, VCFtools v. 0.1.12b, SKESA v. 2.3.0, A5-miseq v. 20140604			B.1.459	GH
hCoV-19/Japan/IC-0463/2020	EPI_ISL_768672	2020-12-23	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.36.19	GH
hCoV-19/Japan/IC-0475/2020	EPI_ISL_768684	2020-12-23	Asia / Japan	Human	Original		COVID-19 positive case who entered from Nepal.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/IC-0480/2020	EPI_ISL_768689	2020-12-24	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	A5-miseq v. 20140604			B.1.466.2	GH
hCoV-19/Japan/IC-0482/2020	EPI_ISL_768691	2020-12-25	Asia / Japan	Human	Original		COVID-19 positive case who entered from Nepal.	Illumina NextSeq500	SKESA v. 2.3.0	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/IC-0483/2020	EPI_ISL_768692	2020-12-25	Asia / Japan	Human	Original		COVID-19 positive case who entered from Nepal.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.36.16	GH
hCoV-19/Japan/IC-0503/2020	EPI_ISL_768712	2020-12-22	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.459	GH
hCoV-19/Japan/IC-0504/2020	EPI_ISL_768713	2020-12-23	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.466.2	GH
hCoV-19/Bangladesh/CHRF-0041/2020	EPI_ISL_768736	2020-06-22	Asia / Bangladesh / Dhaka	Human	Original			Illumina / iSeq				B.1.36.16	GH
hCoV-19/England/CAMC-CB73D6/2020	EPI_ISL_778037	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/QEUH-CC2DF8/2020	EPI_ISL_778076	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-D06FA6/2020	EPI_ISL_781649	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/MILK-D0700C/2020	EPI_ISL_781680	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/CAMC-CF4B6C/2020	EPI_ISL_781718	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-C307D9/2020	EPI_ISL_782935	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-C25CD8/2020	EPI_ISL_782993	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/USA/TX-HMH-MCoV-14482/2020	EPI_ISL_787767	2020-10-07	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.2	GH
hCoV-19/Netherlands/NH-RIVM-21074/2020	EPI_ISL_791081	2020-12-15	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.221	G
hCoV-19/Argentina/PAIS-D0040/2020	EPI_ISL_792482	2020-03-27	South America / Argentina / Neuquen / Las Lajas	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Custom pipeline			B.1.110	GH
hCoV-19/Argentina/PAIS-D0042/2020	EPI_ISL_792484	2020-03-30	South America / Argentina / Neuquen / Las Lajas	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Custom pipeline			B.1.110	GH
hCoV-19/Denmark/DCGC-23194/2020	EPI_ISL_793603	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-23396/2020	EPI_ISL_793729	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-23443/2020	EPI_ISL_793758	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-25238/2020	EPI_ISL_794900	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-25239/2020	EPI_ISL_794906	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-25252/2020	EPI_ISL_794914	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-25343/2020	EPI_ISL_794969	2020-12-14	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/MILK-D7A936/2020	EPI_ISL_798409	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-D72497/2020	EPI_ISL_798428	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/MILK-D7428C/2020	EPI_ISL_798538	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-D74F1C/2020	EPI_ISL_798552	2020-12-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.7	GH
hCoV-19/England/MILK-D1AC02/2020	EPI_ISL_799724	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-D239B4/2020	EPI_ISL_799769	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-D260F8/2020	EPI_ISL_799879	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/CAMC-BC2218/2020	EPI_ISL_801003	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/USA/NY-MSHSPSP-PV14580/2020	EPI_ISL_802135	2020-07-10	North America / USA / New York / Queens	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1	GH
hCoV-19/USA/NY-MSHSPSP-PV15701/2020	EPI_ISL_802146	2020-08-03	North America / USA / New York / Queens	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1	GH
hCoV-19/USA/NY-MSHSPSP-PV17929/2020	EPI_ISL_802256	2020-09-18	North America / USA / New York / Nassau County	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1.36	GH
hCoV-19/USA/NY-MSHSPSP-PV21083/2020	EPI_ISL_802318	2020-09-30	North America / USA / New York / Brooklyn	Human	Original			Illumina MiSeq	Minimap2, Pilon			B.1.36	GH
hCoV-19/England/BIRM-6824C/2020	EPI_ISL_813005	2020-11-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-68288/2020	EPI_ISL_813008	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-68297/2020	EPI_ISL_813009	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/Denmark/DCGC-27443/2020	EPI_ISL_815608	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-27518/2020	EPI_ISL_815609	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-27556/2020	EPI_ISL_815610	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-27583/2020	EPI_ISL_815612	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-27640/2020	EPI_ISL_815613	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-27697/2020	EPI_ISL_815614	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-27734/2020	EPI_ISL_815615	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-27738/2020	EPI_ISL_815616	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-27764/2020	EPI_ISL_815618	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-27834/2020	EPI_ISL_815619	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-27837/2020	EPI_ISL_815620	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-27774/2020	EPI_ISL_815655	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (frameshift confirmed by the submitter). Gap of 4 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/TFCI-26FA9B7/2020	EPI_ISL_816840	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.470	GH
hCoV-19/England/TFCI-26FAAD2/2020	EPI_ISL_816857	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7a_Q94stop results in 23.1% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-25605/2021	EPI_ISL_819046	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/NORW-2209FE/2020	EPI_ISL_820091	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-220BCB/2020	EPI_ISL_820092	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-2229ED/2020	EPI_ISL_820093	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/MILK-E7E922/2021	EPI_ISL_821381	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.22	GH
hCoV-19/Iceland/5216/2020	EPI_ISL_828902	2020-09-07	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1			B.1.36.22	GH
hCoV-19/USA/CA-LACPHL-AF00133/2020	EPI_ISL_832114	2020-12-18	North America / USA / California / Los Angeles County	Human	Original			Illumina MiSeq	Monroe v1.0.0			B.1.36.8	GH
hCoV-19/Japan/IC-0706/2021	EPI_ISL_833367	2021-01-13	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina iSeq	A5-miseq v. 20140604			B.1.466.2	GH
hCoV-19/Japan/IC-0711/2021	EPI_ISL_833372	2021-01-12	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina iSeq	A5-miseq v. 20140604	Gap of 2 nucleotides when compared to the reference sequence.	info	B.1.468	GH
hCoV-19/Singapore/50/2021	EPI_ISL_833377	2021-01-13	Asia / Singapore	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/Singapore/51/2021	EPI_ISL_833378	2021-01-11	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.8	GH
hCoV-19/Singapore/53/2021	EPI_ISL_833380	2021-01-13	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.16	GH
hCoV-19/Singapore/55/2021	EPI_ISL_833382	2021-01-13	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.16	GH
hCoV-19/Indonesia/SN-LIPI-007/2020	EPI_ISL_833392	2020-06-03	Asia / Indonesia / South Sulawesi / Makassar	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.459	GH
hCoV-19/Indonesia/JK-LIPI012/2020	EPI_ISL_833495	2020-08-17	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.459	GH
hCoV-19/Indonesia/JK-LIPI015/2020	EPI_ISL_833498	2020-08-20	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.459	GH
hCoV-19/Indonesia/TNG-LIPI016/2020	EPI_ISL_833499	2020-08-21	Asia / Indonesia / Banten / Tangerang	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.459	GH
hCoV-19/England/MILK-EC17EA/2021	EPI_ISL_835914	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/MILK-B5A066/2020	EPI_ISL_839403	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-B5A084/2020	EPI_ISL_839404	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/MILK-B5A224/2020	EPI_ISL_839427	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.39	GH
hCoV-19/England/MILK-B5A7E9/2020	EPI_ISL_839428	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/PORT-2D7817/2020	EPI_ISL_841782	2020-12-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Denmark/DCGC-29972/2020	EPI_ISL_844019	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-30062/2020	EPI_ISL_844109	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-30093/2020	EPI_ISL_844140	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-28460/2021	EPI_ISL_845407	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-28511/2021	EPI_ISL_845416	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-31671/2021	EPI_ISL_856087	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Egypt/CUNCI-HGC9I037/2020	EPI_ISL_857337	2020-12-25	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.466	GH
hCoV-19/Egypt/CUNCI-HGC9I024/2020	EPI_ISL_857341	2020-12-25	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12	Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/India/un-SMSMC-791502/2021	EPI_ISL_857395	2021-01-11	Asia / India	Human	Original	Nasopharangeal and oesopharangeal swab		Ion Torrent				B.1.36	GH
hCoV-19/USA/ME-HETL-J0785/2021	EPI_ISL_857407	2021-01-14	North America / USA / Maine	Human	Original			Illumina Nextseq	https://github.com/tewhey-lab/SARS-CoV-2-Consensus	Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/Singapore/70/2021	EPI_ISL_857478	2021-01-05	Asia / Singapore	Human	Original			Illumina Miseq				B.1.468	GH
hCoV-19/Singapore/77/2021	EPI_ISL_857485	2021-01-14	Asia / Singapore	Human	Original			Illumina Miseq				B.1.36.16	GH
hCoV-19/United Arab Emirates/3929/2020	EPI_ISL_859903	2020-11-16	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq		Gap of 5 nucleotides when compared to the reference sequence.	info	B.1.36.1	GH
hCoV-19/United Arab Emirates/3933/2020	EPI_ISL_859904	2020-11-23	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq		Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/United Arab Emirates/3945/2020	EPI_ISL_859911	2020-11-23	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq		Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/United Arab Emirates/3968/2020	EPI_ISL_859916	2020-11-24	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq		Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/United Arab Emirates/3970/2020	EPI_ISL_859917	2020-11-24	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq		Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/United Arab Emirates/3978/2020	EPI_ISL_859920	2020-11-21	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1	GH
hCoV-19/United Arab Emirates/3985/2020	EPI_ISL_859923	2020-11-21	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq		Insertion of 7 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/United Arab Emirates/3986/2020	EPI_ISL_859924	2020-11-19	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/ALDP-FB6161/2021	EPI_ISL_863127	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Denmark/DCGC-32279/2021	EPI_ISL_869283	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-32358/2021	EPI_ISL_869362	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.469	GH
hCoV-19/Denmark/DCGC-32470/2021	EPI_ISL_869474	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/Denmark/DCGC-33268/2021	EPI_ISL_870273	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-33300/2021	EPI_ISL_870305	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-33352/2021	EPI_ISL_870362	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-33407/2021	EPI_ISL_870417	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-33453/2021	EPI_ISL_870463	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/India/UP-MRU46251/2020	EPI_ISL_871790	2020-08-25	Asia / India / Uttar Pradesh / Chandauli	Human	Original			Ion Torrent		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/Thailand/Bangkok-CONI-0426/2021	EPI_ISL_887105	2021-01-05	Asia / Thailand / Bangkok	Human	Original			Illumina MiSeq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Indonesia/JI-ITDua-34962NT/2020	EPI_ISL_888591	2020-12-24	Asia / Indonesia / East Java / Sidoarjo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14	Gap of 1 nucleotide(s) found at refpos 28254 (FRAMESHIFT confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-34965NT/2020	EPI_ISL_888593	2020-12-24	Asia / Indonesia / East Java / Sidoarjo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14	Gap of 1 nucleotide(s) found at refpos 28254 (FRAMESHIFT confirmed by the submitter).	info	B.1.470	GH
hCoV-19/Switzerland/AG-ETHZ-451448/2021	EPI_ISL_899262	2021-01-11	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/AG-ETHZ-451507/2021	EPI_ISL_899267	2021-01-11	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/AG-ETHZ-451630/2021	EPI_ISL_899268	2021-01-13	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/AG-ETHZ-451675/2021	EPI_ISL_899271	2021-01-13	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/AG-ETHZ-451676/2021	EPI_ISL_899272	2021-01-13	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/AG-ETHZ-451678/2021	EPI_ISL_899273	2021-01-13	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/AG-ETHZ-451684/2021	EPI_ISL_899274	2021-01-13	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Netherlands/NH-RIVM-21433/2020	EPI_ISL_905499	2020-12-28	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/Norway/0638/2021	EPI_ISL_906793	2021-01-12	Europe / Norway / Innlandet	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36	GH
hCoV-19/India/TG-CCMB-AE865/2020	EPI_ISL_910047	2020-08-27	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.36.8	GH
hCoV-19/India/TG-CCMB-AE895/2020	EPI_ISL_910049	2020-08-27	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AG060/2020	EPI_ISL_910102	2020-08-30	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AG087/2020	EPI_ISL_910104	2020-08-30	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.36.8	GH
hCoV-19/India/TG-CCMB-AG119/2020	EPI_ISL_910106	2020-08-30	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AG615/2020	EPI_ISL_910120	2020-08-31	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AG618/2020	EPI_ISL_910121	2020-08-31	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AG654/2020	EPI_ISL_910122	2020-08-31	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.36.8	GH
hCoV-19/India/TG-CCMB-AH201/2020	EPI_ISL_910126	2020-09-03	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AH237/2020	EPI_ISL_910127	2020-09-03	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AH268/2020	EPI_ISL_910128	2020-09-03	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AH768/2020	EPI_ISL_910135	2020-09-08	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AH828/2020	EPI_ISL_910136	2020-09-08	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AI169/2020	EPI_ISL_910147	2020-09-09	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AI268/2020	EPI_ISL_910153	2020-09-09	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AI269/2020	EPI_ISL_910154	2020-09-09	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AI920/2020	EPI_ISL_910168	2020-09-11	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/ALDP-BB4A8A/2020	EPI_ISL_916109	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/BIRM-6E668/2021	EPI_ISL_918770	2021-01-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.460	GH
hCoV-19/England/TFCI-2701EDB/2020	EPI_ISL_924792	2020-11-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.469	GH
hCoV-19/England/TFCI-2701EEA/2020	EPI_ISL_924793	2020-11-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.469	GH
hCoV-19/Denmark/DCGC-36975/2021	EPI_ISL_928116	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-36982/2021	EPI_ISL_928123	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.177.21	G
hCoV-19/Denmark/DCGC-37010/2021	EPI_ISL_928151	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-37065/2021	EPI_ISL_928206	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-37158/2021	EPI_ISL_928299	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-38267/2021	EPI_ISL_929408	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-38286/2021	EPI_ISL_929427	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-38437/2020	EPI_ISL_929578	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-39317/2021	EPI_ISL_930459	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/USA/IL-NM-4764/2020	EPI_ISL_936652	2020-12-16	North America / USA / Illinois / Chicago	Human	Original			Illumina MiSeq	ARTIC	NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.462	GH
hCoV-19/USA/IL-NM-5132/2020	EPI_ISL_936776	2020-12-24	North America / USA / Illinois / Lake County	Human	Original			Illumina MiSeq	ARTIC	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/USA/VA-DCLS-2717/2020	EPI_ISL_941257	2020-12-15	North America / USA / Virginia	Human	Original			Illumina Miseq	minimap2/ivar			B.1.36.8	GH
hCoV-19/Indonesia/BT-EIJK72/2020	EPI_ISL_947262	2020-11-12	Asia / Indonesia / Banten / Tangerang	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JK-EIJK80/2020	EPI_ISL_947273	2020-11-25	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JB-EIJK97/2020	EPI_ISL_947296	2020-12-05	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JB-EIJK113/2020	EPI_ISL_947317	2020-12-21	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/England/OXON-F45738/2020	EPI_ISL_950845	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.469	GH
hCoV-19/England/OXON-F45D09/2020	EPI_ISL_950863	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.34	GH
hCoV-19/England/OXON-F45D18/2020	EPI_ISL_950864	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.34	GH
hCoV-19/Iran/Gilan-NIC230/2020	EPI_ISL_959277	2020-08-20	Asia / Iran / Gilan	Human	Original	Throat swab		Illumina NextSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Iran/Tehran-NIC45RC/2020	EPI_ISL_959279	2020-11-05	Asia / Iran / Tehran	Human	Original	Throat swab		Illumina NextSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.468	GH
hCoV-19/USA/VA-DCLS-2795/2020	EPI_ISL_960216	2020-12-17	North America / USA / Virginia	Human	Original			Illumina Miseq	minimap2/ivar			B.1.523	GH
hCoV-19/USA/MI-MDHHS-SC23267/2021	EPI_ISL_961547	2021-01-08	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1	GH
hCoV-19/Norway/0771/2021	EPI_ISL_962896	2021-01-12	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	NS7b_Q35stop results in 20.9% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/Norway/0910/2021	EPI_ISL_962906	2021-01-14	Europe / Norway / Viken	Human	Original	Nasopharyngeal swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.1	GH
hCoV-19/Norway/7552/2020	EPI_ISL_962907	2020-12-31	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.1	GH
hCoV-19/USA/HI-H210979/2021	EPI_ISL_967755	2021-01-19	North America / USA / Hawaii	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20			B.1.36.8	GH
hCoV-19/USA/MA-CDC-STM-000003193/2021	EPI_ISL_967833	2021-01-15	North America / USA / Massachusetts	Human	Original	Nasal swab		Illumina	COVIDSEQ			B.1.36.8	GH
hCoV-19/Denmark/DCGC-39625/2021	EPI_ISL_971032	2021-02-01	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.1	GH
hCoV-19/Denmark/DCGC-40604/2021	EPI_ISL_972281	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4852/2020	EPI_ISL_973520	2020-09-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-4959/2020	EPI_ISL_973534	2020-09-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4858/2020	EPI_ISL_973575	2020-09-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-5000/2020	EPI_ISL_973585	2020-09-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5186/2020	EPI_ISL_973596	2020-09-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5309/2020	EPI_ISL_973612	2020-09-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Denmark/DCGC-41867/2021	EPI_ISL_973616	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Canada/BC-BCCDC-5006/2020	EPI_ISL_973630	2020-09-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-5010/2020	EPI_ISL_973637	2020-09-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5013/2020	EPI_ISL_973642	2020-09-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5017/2020	EPI_ISL_973649	2020-09-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5022/2020	EPI_ISL_973657	2020-09-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5023/2020	EPI_ISL_973659	2020-09-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5026/2020	EPI_ISL_973663	2020-09-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5030/2020	EPI_ISL_973669	2020-09-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5152/2020	EPI_ISL_973678	2020-09-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5157/2020	EPI_ISL_973681	2020-09-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-7322/2020	EPI_ISL_974801	2020-10-31	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6788/2020	EPI_ISL_974807	2020-11-01	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7676/2020	EPI_ISL_974821	2020-11-01	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7021/2020	EPI_ISL_974830	2020-11-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	N_Q58stop results in 86.4% truncation of the protein sequence. Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7181/2020	EPI_ISL_974836	2020-11-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7713/2020	EPI_ISL_974841	2020-11-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7714/2020	EPI_ISL_974842	2020-11-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7874/2020	EPI_ISL_974846	2020-11-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8090/2020	EPI_ISL_974847	2020-11-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10569/2020	EPI_ISL_974850	2020-11-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6830/2020	EPI_ISL_974860	2020-11-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6963/2020	EPI_ISL_974865	2020-11-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6964/2020	EPI_ISL_974866	2020-11-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7190/2020	EPI_ISL_974873	2020-11-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7192/2020	EPI_ISL_974875	2020-11-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7722/2020	EPI_ISL_974884	2020-11-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7880/2020	EPI_ISL_974886	2020-11-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6835/2020	EPI_ISL_974891	2020-11-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6837/2020	EPI_ISL_974893	2020-11-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6966/2020	EPI_ISL_974899	2020-11-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6798/2020	EPI_ISL_974933	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6845/2020	EPI_ISL_974934	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6847/2020	EPI_ISL_974936	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6849/2020	EPI_ISL_974937	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6857/2020	EPI_ISL_974940	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6858/2020	EPI_ISL_974941	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6861/2020	EPI_ISL_974944	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6867/2020	EPI_ISL_974948	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6868/2020	EPI_ISL_974949	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6898/2020	EPI_ISL_974950	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6974/2020	EPI_ISL_974953	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7436/2020	EPI_ISL_974958	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7438/2020	EPI_ISL_974959	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7448/2020	EPI_ISL_974964	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8200/2020	EPI_ISL_974970	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8201/2020	EPI_ISL_974971	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10581/2020	EPI_ISL_974975	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-10641/2020	EPI_ISL_974977	2020-11-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6878/2020	EPI_ISL_974985	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6885/2020	EPI_ISL_974988	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6886/2020	EPI_ISL_974989	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6887/2020	EPI_ISL_974990	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6900/2020	EPI_ISL_974992	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6976/2020	EPI_ISL_974993	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6979/2020	EPI_ISL_974995	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6983/2020	EPI_ISL_974997	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Indonesia/JK-NIHRD-WGS016/2021	EPI_ISL_984264	2021-01-12	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1.466.2	GH
hCoV-19/Indonesia/JK-NIHRDMI2100170/2021	EPI_ISL_984276	2021-01-05	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1.466.2	GH
hCoV-19/Indonesia/JK-NIHRDMI2100236/2021	EPI_ISL_984309	2021-01-07	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JK-NIHRDMI2100192/2021	EPI_ISL_984313	2021-01-05	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1.459	GH
hCoV-19/USA/NY-PRL-2021_0210_01A07/2021	EPI_ISL_995030	2021-02-08	North America / USA / New York / New York City	Human	Original	Nasopharyngeal swab		Illumina Miseq/NextSeq	bwa mem			B.1.471	GH
hCoV-19/England/OXON-F53755/2021	EPI_ISL_998989	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Switzerland/AG-ETHZ-451150/2021	EPI_ISL_1002840	2021-01-12	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/AG-ETHZ-451079/2021	EPI_ISL_1002841	2021-01-12	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/AG-ETHZ-451242/2021	EPI_ISL_1002884	2021-01-13	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BL-ETHZ-360178/2020	EPI_ISL_1005197	2020-11-12	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BL-ETHZ-360284/2020	EPI_ISL_1005202	2020-11-08	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.8	GH
hCoV-19/Norway/3188/2021	EPI_ISL_1013520	2021-02-04	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Hong Kong/HKPU-05402/2020	EPI_ISL_1019720	2020-11-11	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05409/2020	EPI_ISL_1019726	2020-11-12	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05427/2020	EPI_ISL_1019742	2020-11-12	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05440/2020	EPI_ISL_1019748	2020-11-14	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05444/2020	EPI_ISL_1019750	2020-11-14	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05457/2020	EPI_ISL_1019756	2020-11-15	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05472/2020	EPI_ISL_1019767	2020-11-18	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05500/2020	EPI_ISL_1019785	2020-11-20	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05501/2020	EPI_ISL_1019788	2020-11-20	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05505/2020	EPI_ISL_1019790	2020-11-20	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05506/2020	EPI_ISL_1019793	2020-11-20	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05510/2020	EPI_ISL_1019795	2020-11-20	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05514/2020	EPI_ISL_1019798	2020-11-20	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05607/2020	EPI_ISL_1019838	2020-11-22	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05634/2020	EPI_ISL_1019846	2020-11-23	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05656/2020	EPI_ISL_1019849	2020-11-23	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05662/2020	EPI_ISL_1019851	2020-11-23	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05664/2020	EPI_ISL_1019853	2020-11-23	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05666/2020	EPI_ISL_1019855	2020-11-23	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05680/2020	EPI_ISL_1019858	2020-11-23	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05681/2020	EPI_ISL_1019861	2020-11-23	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05682/2020	EPI_ISL_1019863	2020-11-23	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05692/2020	EPI_ISL_1019866	2020-11-23	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05713/2020	EPI_ISL_1019872	2020-11-24	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05719/2020	EPI_ISL_1019875	2020-11-24	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05720/2020	EPI_ISL_1019877	2020-11-24	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Scotland/QEUH-109D7C4/2021	EPI_ISL_1019878	2021-01-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/Hong Kong/HKPU-05728/2020	EPI_ISL_1019880	2020-11-24	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05733/2020	EPI_ISL_1019882	2020-11-24	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05748/2020	EPI_ISL_1019885	2020-11-24	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05759/2020	EPI_ISL_1019888	2020-11-24	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05760/2020	EPI_ISL_1019890	2020-11-24	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05783/2020	EPI_ISL_1019893	2020-11-25	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Denmark/DCGC-43862/2021	EPI_ISL_1024240	2021-02-01	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-45158/2020	EPI_ISL_1025536	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-45183/2020	EPI_ISL_1025561	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-45215/2020	EPI_ISL_1025593	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-45507/2020	EPI_ISL_1025885	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/USA/DC-CDC-LC0000358/2020	EPI_ISL_1029179	2020-12-27	North America / USA / District of Columbia	Human	Original	Nasal swab		PacBio	CLC Genomics			B.1.466.1	GH
hCoV-19/Netherlands/UT-RIVM-13221/2021	EPI_ISL_1035294	2021-02-10	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/Indonesia/JK-NIHRD-WGS070/2021	EPI_ISL_1048381	2021-01-24	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench	Gap of 15 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/Canada/NL-NML-3110/2020	EPI_ISL_1055425	2020-11-21	North America / Canada / Newfoundland and Labrador	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.36	GH
hCoV-19/Canada/NL-NML-3121/2020	EPI_ISL_1055429	2020-12-16	North America / Canada / Newfoundland and Labrador	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36	GH
hCoV-19/Canada/NL-NML-3122/2020	EPI_ISL_1055430	2020-12-16	North America / Canada / Newfoundland and Labrador	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36	GH
hCoV-19/Canada/NL-NML-5787/2020	EPI_ISL_1055437	2020-12-14	North America / Canada / Newfoundland and Labrador	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36	GH
hCoV-19/Canada/NL-NML-8802/2021	EPI_ISL_1055451	2021-01-26	North America / Canada / Newfoundland and Labrador	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-334/2020	EPI_ISL_1055455	2020-11-02	Asia / Hong Kong	Human	Original	Nasopharyngeal swab / Throat swab		Nanopore MinION				B.1.36	GH
hCoV-19/Canada/NS-NML-5150/2021	EPI_ISL_1055468	2021-01-04	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/NS-NML-5151/2021	EPI_ISL_1055469	2021-01-04	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/NS-NML-5206/2020	EPI_ISL_1055501	2020-12-18	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.26	GH
hCoV-19/Canada/NS-NML-5228/2020	EPI_ISL_1055519	2020-12-11	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.26	GH
hCoV-19/India/OR-ILSGS00026/2021	EPI_ISL_1063806	2021-01-21	Asia / India / Odisha	Human	Original			Illumina NextSeq550	Reference-based	NSP14_Y420stop results in 20.5% truncation of the protein sequence. NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/OR-ILSGS00031/2021	EPI_ISL_1063810	2021-01-23	Asia / India / Odisha	Human	Original			Illumina NextSeq550	Reference-based	NS8_L60stop results in 51.2% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/India/OR-ILSGS00034/2021	EPI_ISL_1063811	2021-01-26	Asia / India / Odisha	Human	Original			Illumina NextSeq550	Reference-based	NS8_L60stop results in 51.2% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/India/OR-ILSGS00035/2021	EPI_ISL_1063812	2021-01-26	Asia / India / Odisha	Human	Original			Illumina NextSeq550	Reference-based	NS8_L60stop results in 51.2% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/India/OR-ILSGS00032/2021	EPI_ISL_1063814	2021-01-23	Asia / India / Odisha	Human	Original			Illumina NextSeq550	Reference-based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/OR-ILSGS00033/2021	EPI_ISL_1063815	2021-01-23	Asia / India / Odisha	Human	Original			Illumina NextSeq550	Reference-based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/OR-ILSGS00036/2021	EPI_ISL_1063816	2021-01-26	Asia / India / Odisha	Human	Original			Illumina NextSeq550	Reference-based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/OR-ILSGS00021/2021	EPI_ISL_1063853	2021-01-02	Asia / India / Odisha	Human	Original			Illumina NextSeq550	Reference-based			B.1.36	GH
hCoV-19/India/OR-ILSGS00022/2021	EPI_ISL_1063854	2021-01-02	Asia / India / Odisha	Human	Original			Illumina NextSeq550	Reference-based			B.1.36	GH
hCoV-19/India/OR-ILSGS00023/2020	EPI_ISL_1063855	2020-12-16	Asia / India / Odisha	Human	Original			Illumina NextSeq550	Reference-based			B.1.36	GH
hCoV-19/India/OR-ILSGS00025/2021	EPI_ISL_1063857	2021-01-22	Asia / India / Odisha	Human	Original			Illumina NextSeq550	Reference-based			B.1.36	GH
hCoV-19/India/OR-ILSGS00027/2021	EPI_ISL_1063858	2021-01-05	Asia / India / Odisha	Human	Original			Illumina NextSeq550	Reference-based			B.1.36	GH
hCoV-19/India/OR-ILSGS00040/2020	EPI_ISL_1063865	2020-11-03	Asia / India / Odisha	Human	Original			Illumina NextSeq550	Reference-based			B.1.36.29	GH
hCoV-19/Denmark/DCGC-48026/2020	EPI_ISL_1067561	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/India/CH-ICMR-51800/2020	EPI_ISL_1072020	2020-08-25	Asia / India / Chandigarh	Human	Original	Nasopharyngeal swab		Illumina Miniseq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/Israel/CVL-2764/2021	EPI_ISL_1073509	2021-01-04	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.469	GH
hCoV-19/USA/TX-HMH-MCoV-24917/2021	EPI_ISL_1079531	2021-01-20	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.36.18	GH
hCoV-19/USA/TX-HMH-MCoV-25812/2021	EPI_ISL_1080305	2021-01-31	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/USA/TX-CDC-QDX21488144/2021	EPI_ISL_1086869	2021-01-25	North America / USA / Texas	Human	Original	Nasal swab		Illumina MiSeq	BWA v.7.12	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/France/HDF-1805/2020	EPI_ISL_414628	2020-03-02	Europe / France / Hauts-de-France / Compigne	Human	Original	Oropharyngeal swab		Illumina NextSeq 500	CLC Genomics Workbench 20			B.1	GH
hCoV-19/France/BRE-1623/2020	EPI_ISL_418219	2020-02-26	Europe / France / Bretagne / Brest	Human	Original			Illumina MiSeq	CLC Genomics Suite			B.1	GH
hCoV-19/Canada/ON-PHL-1898/2020	EPI_ISL_418377	2020-03	North America / Canada / Ontario	Human	Original			Illumina NextSeq	CLC Genomics Workbench 8.5.3	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/Finland/13M58/2020	EPI_ISL_418392	2020-03-13	Europe / Finland	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA-MEM			B.1.465	GH
hCoV-19/Finland/13M60/2020	EPI_ISL_418393	2020-03-13	Europe / Finland	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA-MEM			B.1.465	GH
hCoV-19/Finland/13M64/2020	EPI_ISL_418394	2020-03-13	Europe / Finland	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA-MEM			B.1.465	GH
hCoV-19/Finland/13M65/2020	EPI_ISL_418395	2020-03-13	Europe / Finland	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA-MEM			B.1.465	GH
hCoV-19/France/ARA-12371/2020	EPI_ISL_420604	2020-03-23	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/England/NOTT-10EA6D/2020	EPI_ISL_425631	2020-03-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.465	GH
hCoV-19/England/SHEF-CB317/2020	EPI_ISL_432505	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.465	GH
hCoV-19/USA/NY-SURV0171/2020	EPI_ISL_436055	2020-03-09	North America / USA / New York / New York City	Human	Original	Nasopharyngeal swab		Nanopore, Sanger	Minimap 2.17, Sequencher 5.4.6			B.1	O
hCoV-19/Austria/Graz-MUG16/2020	EPI_ISL_437302	2020-04-17	Europe / Austria / Styria	Human	Original	nose swab	primary patient sample	Ion Torrent				B.1.22	O
hCoV-19/Saudi Arabia/KAUST-Madinah50/2020	EPI_ISL_437490	2020-03-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah51/2020	EPI_ISL_437491	2020-03-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-Madinah53/2020	EPI_ISL_437492	2020-03-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah54/2020	EPI_ISL_437493	2020-03-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah55/2020	EPI_ISL_437494	2020-03-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Jeddah59/2020	EPI_ISL_437496	2020-03-25	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1.471	GH
hCoV-19/Saudi Arabia/KAUST-Makkah124/2020	EPI_ISL_437691	2020-03-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Makkah126/2020	EPI_ISL_437692	2020-03-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Makkah138/2020	EPI_ISL_437693	2020-03-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Makkah142/2020	EPI_ISL_437695	2020-03-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Makkah156/2020	EPI_ISL_437696	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	GH
hCoV-19/England/CAMB-81FA0/2020	EPI_ISL_438602	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/England/CAMB-83DC2/2020	EPI_ISL_438693	2020-04-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/India/GJ-GBRC26/2020	EPI_ISL_444457	2020-04-26	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC30/2020	EPI_ISL_444461	2020-04-29	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC33/2020	EPI_ISL_444464	2020-04-29	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC34/2020	EPI_ISL_444465	2020-04-29	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC35/2020	EPI_ISL_444466	2020-04-29	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC36/2020	EPI_ISL_444467	2020-04-29	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC39/2020	EPI_ISL_444470	2020-04-29	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC40/2020	EPI_ISL_444471	2020-04-29	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC41/2020	EPI_ISL_444472	2020-04-29	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC43/2020	EPI_ISL_444474	2020-04-29	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC45/2020	EPI_ISL_444476	2020-04-29	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC49/2020	EPI_ISL_444480	2020-04-30	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC51/2020	EPI_ISL_444482	2020-05-02	Asia / India / Gujarat / Prantij	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC55/2020	EPI_ISL_444486	2020-05-04	Asia / India / Gujarat / Dhansura	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/USA/IL-NM024/2020	EPI_ISL_444534	2020-03-14	North America / USA / Illinois / Chicago	Human	Original	Bronchoalveolar lavage		Nanopore MinION	ARTIC			B.1	GH
hCoV-19/USA/IL-NM027/2020	EPI_ISL_444537	2020-03-16	North America / USA / Illinois / Chicago	Human	Original	Bronchoalveolar lavage		Nanopore MinION	ARTIC			B.1	GH
hCoV-19/England/CAMB-1AF5C7/2020	EPI_ISL_448084	2020-05-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/Bangladesh/BARJ-CVASU-CTG-511/2020	EPI_ISL_450343	2020-05-09	Asia / Bangladesh / Chittagong	Human	Original	Nasopharyngeal swab		Illumina Nextseq 550	MEGAHIT v1.1.3	Submitter info: Detected 345bp deletion (true deletion) at repos 27910 and as a result NS8 is missing compared to the hCoV-19/Wuhan/WIV04/2019|EPI_ISL_402124 reference sequence.	info	B.1.36.16	GH
hCoV-19/Bangladesh/BARJ-CVASU-CTG-517/2020	EPI_ISL_450344	2020-05-03	Asia / Bangladesh / Chittagong	Human	Original	Nasopharyngeal swab		Illumina Nextseq 550	MEGAHIT v1.1.3	Submitter info: Detected 345bp deletion (true deletion) at repos 27910 and as a result NS8 is missing compared to the hCoV-19/Wuhan/WIV04/2019|EPI_ISL_402124 reference sequence.	info	B.1.36.16	GH
hCoV-19/England/CAMB-1B0AF1/2020	EPI_ISL_452938	2020-05-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/England/CAMB-1B0BB2/2020	EPI_ISL_452949	2020-05-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/England/CAMB-1B0EAA/2020	EPI_ISL_452973	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/Netherlands/Friesland_12/2020	EPI_ISL_455115	2020-03-31	Europe / Netherlands / Friesland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Friesland_14/2020	EPI_ISL_455117	2020-03-31	Europe / Netherlands / Friesland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_13/2020	EPI_ISL_455122	2020-03-12	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_14/2020	EPI_ISL_455123	2020-03-12	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_355/2020	EPI_ISL_455159	2020-04-07	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_374/2020	EPI_ISL_455177	2020-04-08	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_384/2020	EPI_ISL_455186	2020	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_421/2020	EPI_ISL_455223	2020	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_422/2020	EPI_ISL_455224	2020	Europe / Netherlands	Human	Original			Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.22	GH
hCoV-19/Netherlands/NA_423/2020	EPI_ISL_455225	2020	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_113/2020	EPI_ISL_455302	2020-04-07	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.36	GH
hCoV-19/India/OR-ILC-RMRC26/2020	EPI_ISL_455309	2020-04-04	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1	GH
hCoV-19/Malaysia/IIUM91/2020	EPI_ISL_455313	2020-04-02	Asia / Malaysia / Pahang	Human	Original	Nasopharyngeal and oropharyngeal swab	unknown	Illumina iSeq	Geneious Prime 2020.1, Medaka (ARTIC pipeline)			B.1.468	GH
hCoV-19/India/OR-RMRC49/2020	EPI_ISL_455478	2020-04-09	Asia / India / Odisha	Human	Original	Oropharyngeal swab		Illumina Nextseq 550	Reference based			B.1	GH
hCoV-19/Australia/VIC1566/2020	EPI_ISL_456484	2020-05-06	Oceania / Australia / Victoria	Human	Original			Illumina iSeq	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1	GH
hCoV-19/Australia/VIC1599/2020	EPI_ISL_456499	2020-05-10	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1	GH
hCoV-19/Australia/VIC1592/2020	EPI_ISL_456512	2020-05-11	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1	GH
hCoV-19/Australia/VIC1593/2020	EPI_ISL_456513	2020-05-11	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1	GH
hCoV-19/Australia/VIC1769/2020	EPI_ISL_456643	2020-05-20	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.36.16	GH
hCoV-19/Netherlands/NA_654/2020	EPI_ISL_461089	2020	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_656/2020	EPI_ISL_461091	2020	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_657/2020	EPI_ISL_461092	2020	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_658/2020	EPI_ISL_461093	2020	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_659/2020	EPI_ISL_461094	2020	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_660/2020	EPI_ISL_461095	2020	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_662/2020	EPI_ISL_461097	2020	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_663/2020	EPI_ISL_461098	2020	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_665/2020	EPI_ISL_461100	2020	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_677/2020	EPI_ISL_461112	2020	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_685/2020	EPI_ISL_461120	2020-04-05	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_687/2020	EPI_ISL_461122	2020-04-07	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_129/2020	EPI_ISL_461302	2020-04-25	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_130/2020	EPI_ISL_461303	2020-04-27	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Bosnia and Herzegovina/ChVir7402/2020	EPI_ISL_462470	2020-04-22	Europe / Bosnia and Herzegovina / Sarajevo	Human	Original			Illumina NextSeq	bowtie2			B.1.22	GH
hCoV-19/England/SHEF-10B22B9/2020	EPI_ISL_469926	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/Egypt/MASRI-13/2020	EPI_ISL_475748	2020-05	Africa / Egypt	Human	Original			Ion Torrent				B.1	GH
hCoV-19/Austria/CeMM0621/2020	EPI_ISL_475930	2020-04-09	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.465	GH
hCoV-19/Austria/CeMM0622/2020	EPI_ISL_475931	2020-04-09	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.465	GH
hCoV-19/England/OXON-B24E3/2020	EPI_ISL_479150	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.465	GH
hCoV-19/Bangladesh/BCSIR-NILMRC-158/2020	EPI_ISL_480447	2020-06-18	Asia / Bangladesh / Rajshahi	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.36.8	GH
hCoV-19/Egypt/MASRI-014/2020	EPI_ISL_482765	2020-04-30	Africa / Egypt	Human	Original			Ion Torrent				B.1.466	GH
hCoV-19/Egypt/MASRI-015/2020	EPI_ISL_482766	2020-05-11	Africa / Egypt	Human	Original			Ion Torrent				B.1	GH
hCoV-19/Egypt/MASRI-024/2020	EPI_ISL_482770	2020-05-11	Africa / Egypt	Human	Original			Ion Torrent				B.1	GH
hCoV-19/Egypt/MASRI-025/2020	EPI_ISL_482771	2020-05-10	Africa / Egypt	Human	Original			Ion Torrent		E_R38stop results in 50.7% truncation of the protein sequence.	info	B.1	GH
hCoV-19/Egypt/MASRI-029/2020	EPI_ISL_482774	2020-05-13	Africa / Egypt	Human	Original			Ion Torrent				B.1	GH
hCoV-19/Oman/24774/2020	EPI_ISL_491151	2020-04-17	Asia / Oman / South Batinah / Barka	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.36	GH
hCoV-19/England/SHEF-CE147/2020	EPI_ISL_493720	2020-05-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	O
hCoV-19/India/UT-AR13/2020	EPI_ISL_508160	2020-06-06	Asia / India / Uttarakhand / Dehradun	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/UT-AR14/2020	EPI_ISL_508161	2020-06-06	Asia / India / Uttarakhand / Dehradun	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/UT-AR17/2020	EPI_ISL_508164	2020-05-27	Asia / India / Uttarakhand / Pauri Garhwal	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/UP-AR20/2020	EPI_ISL_508168	2020-06-02	Asia / India / Uttar Pradesh / Muzaffarnagar	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20	Gap of 2 nucleotides found at refpos 29729.	info	B.1.36	GH
hCoV-19/India/KA-IB46/2020	EPI_ISL_508324	2020-05-09	Asia / India / Karnataka / Bengaluru Urban	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36.8	GH
hCoV-19/India/DL-MN26/2020	EPI_ISL_508418	2020-06-20	Asia / India / Delhi	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/UP-MN32/2020	EPI_ISL_508419	2020-06-27	Asia / India / Uttar Pradesh	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-MN4/2020	EPI_ISL_508420	2020-06-18	Asia / India / Delhi	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-MN8/2020	EPI_ISL_508422	2020-06-18	Asia / India / Delhi	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/MH-MW34/2020	EPI_ISL_508437	2020-06-04	Asia / India / Maharashtra / Wardha	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/Indonesia/JB-TFRIC19-L4173/2020	EPI_ISL_511879	2020-07-08	Asia / Indonesia / West Java / Bandung	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	bwa 0.7.17-r1188			B.1.470	GH
hCoV-19/India/HR-TF19/2020	EPI_ISL_511943	2020-06-17	Asia / India / Haryana / Faridabad	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-TF21/2020	EPI_ISL_511944	2020-06-17	Asia / India / Haryana / Faridabad	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/South Korea/KCDC2662/2020	EPI_ISL_522445	2020-05-19	Asia / South Korea	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/South Korea/KCDC2668/2020	EPI_ISL_522450	2020-05-27	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.36.16	GH
hCoV-19/South Korea/KCDC2680/2020	EPI_ISL_522462	2020-06-25	Asia / South Korea	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/South Korea/KCDC2731/2020	EPI_ISL_522510	2020-07-14	Asia / South Korea	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/Netherlands/ZH-EMC-444/2020	EPI_ISL_523782	2020-08-12	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-447/2020	EPI_ISL_523785	2020-08-12	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Malaysia/MGI-G873/2020	EPI_ISL_528738	2020-04-07	Asia / Malaysia / Selangor	Human	Original			Illumina MiSeq	MEGAHIT v1.2.9			B.1	GH
hCoV-19/Indonesia/JB-TFRIC19-R24754/2020	EPI_ISL_528745	2020-06-22	Asia / Indonesia / West Java	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	bwa 0.7.17-r1188			B.1.470	GH
hCoV-19/Indonesia/JB-TFRIC19-R47609/2020	EPI_ISL_528746	2020-07-21	Asia / Indonesia / West Java	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	bwa 0.7.17-r1188			B.1.470	GH
hCoV-19/Indonesia/JB-TFRIC19-R48562/2020	EPI_ISL_528748	2020-07-23	Asia / Indonesia / West Java	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	bwa 0.7.17-r1188			B.1.470	G
hCoV-19/Indonesia/JB-TFRIC19-R49542/2020	EPI_ISL_528750	2020-07-25	Asia / Indonesia / West Java	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	bwa 0.7.17-r1188			B.1	GH
hCoV-19/Indonesia/JB-TFRIC19-R49344/2020	EPI_ISL_528751	2020-07-23	Asia / Indonesia / West Java	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	bwa 0.7.17-r1188			B.1.470	GH
hCoV-19/Indonesia/JB-TFRIC19-R48875/2020	EPI_ISL_528752	2020-07-23	Asia / Indonesia / West Java	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	bwa 0.7.17-r1188			B.1.459	GH
hCoV-19/Indonesia/JB-TFRIC19-R53817/2020	EPI_ISL_528753	2020-08-04	Asia / Indonesia / West Java	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	bwa 0.7.17-r1188			B.1.470	GH
hCoV-19/Indonesia/JB-TFRIC19-R49544/2020	EPI_ISL_528759	2020-07-25	Asia / Indonesia / West Java	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	bwa 0.7.17-r1188			B.1.470	GH
hCoV-19/England/QEUH-96A85E/2020	EPI_ISL_530908	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Canada/QC-LSPQ-L00230444/2020	EPI_ISL_535917	2020-03-21	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1	GH
hCoV-19/India/UT-IMT-AO15/2020	EPI_ISL_539491	2020-06-18	Asia / India / Uttarakhand / Dehradun	Human	Original	Nasopharyngeal swab		Illumina MiSeq	MEGAHIT v1.2.9			B.1.36	GH
hCoV-19/Belgium/ULG-10276/2020	EPI_ISL_540443	2020-07-23	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network			B.1	GH
hCoV-19/Belgium/ULG-10341/2020	EPI_ISL_540508	2020-07-30	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network			B.1.466	GH
hCoV-19/England/QEUH-999003/2020	EPI_ISL_541789	2020-08-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.23	GH
hCoV-19/England/QEUH-999030/2020	EPI_ISL_541791	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-998F07/2020	EPI_ISL_541819	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9992B2/2020	EPI_ISL_541840	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9AB183/2020	EPI_ISL_551060	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9AB323/2020	EPI_ISL_551061	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9AB11A/2020	EPI_ISL_551066	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9AB01D/2020	EPI_ISL_551068	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides found at refpos 28988.	info	B.1.36.17	GH
hCoV-19/England/MILK-9AB156/2020	EPI_ISL_551076	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9AB1A1/2020	EPI_ISL_551083	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.467	GH
hCoV-19/England/MILK-9AAFE4/2020	EPI_ISL_551124	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-9AB10B/2020	EPI_ISL_551142	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9AB165/2020	EPI_ISL_551154	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9A9CFD/2020	EPI_ISL_551170	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9A9A20/2020	EPI_ISL_551175	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9946E8/2020	EPI_ISL_552298	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-994E86/2020	EPI_ISL_552397	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-994FCF/2020	EPI_ISL_552420	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-993D4E/2020	EPI_ISL_552430	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-994888/2020	EPI_ISL_552439	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-9756CF/2020	EPI_ISL_552459	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-975261/2020	EPI_ISL_552462	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-97545C/2020	EPI_ISL_552467	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-982A78/2020	EPI_ISL_552468	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-97539B/2020	EPI_ISL_552498	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-9754A7/2020	EPI_ISL_552500	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-975568/2020	EPI_ISL_552522	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/ALDP-982B39/2020	EPI_ISL_552539	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-91BD11/2020	EPI_ISL_553710	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1	GH
hCoV-19/England/ALDP-954338/2020	EPI_ISL_553745	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/ALDP-9540C8/2020	EPI_ISL_553755	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1	GH
hCoV-19/England/ALDP-95414D/2020	EPI_ISL_553845	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/MILK-81E3A4/2020	EPI_ISL_557273	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-9994CB/2020	EPI_ISL_559764	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-99C325/2020	EPI_ISL_559793	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-9AD093/2020	EPI_ISL_559817	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Australia/VIC7199/2020	EPI_ISL_564277	2020-06-27	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.471	GH
hCoV-19/England/ALDP-9BDD02/2020	EPI_ISL_568069	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9BDEB4/2020	EPI_ISL_568098	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9BE958/2020	EPI_ISL_568099	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/France/PAC-IHU-0059/2020	EPI_ISL_569278	2020-03-19	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1	GH
hCoV-19/England/MILK-9C495F/2020	EPI_ISL_572721	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-9B3A6F/2020	EPI_ISL_572722	2020-09-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-9B9FE2/2020	EPI_ISL_572723	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-9BA3A9/2020	EPI_ISL_572724	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-9D1B3B/2020	EPI_ISL_572725	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-9B9F88/2020	EPI_ISL_572727	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/QEUH-9BB01A/2020	EPI_ISL_572728	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Australia/NSW2827/2020	EPI_ISL_577597	2020-10-04	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.459	GH
hCoV-19/India/MH-NIV-229512/2020	EPI_ISL_577683	2020-09-28	Asia / India / Maharashtra	Human	Original			Ion Torrent				B.1.36.8	GH
hCoV-19/India/MH-NIV-229912/2020	EPI_ISL_577702	2020-09-28	Asia / India / Maharashtra	Human	Original			Ion Torrent				B.1.36	GH
hCoV-19/India/KA-NIV-QC-1803/2020	EPI_ISL_577714	2020-09	Asia / India / Karnataka	Human	Original			Ion Torrent				B.1.36	GH
hCoV-19/India/KA-NIV-QC-1801/2020	EPI_ISL_577715	2020-09	Asia / India / Karnataka	Human	Original			Ion Torrent		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/MH-NIV-227243/2020	EPI_ISL_577722	2020-09-26	Asia / India / Maharashtra	Human	Original			Ion Torrent				B.1.36	GH
hCoV-19/India/MH-NIV-QC-1444/2020	EPI_ISL_577727	2020-09-08	Asia / India / Maharashtra	Human	Original			Ion Torrent				B.1.36	GH
hCoV-19/mink/Netherlands/NB-EMC-29-1/2020	EPI_ISL_577755	2020-08-12	Europe / Netherlands / Limburg	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-29-10/2020	EPI_ISL_577756	2020-08-12	Europe / Netherlands / Limburg	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-29-20/2020	EPI_ISL_577758	2020-08-12	Europe / Netherlands / Limburg	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-34-2/2020	EPI_ISL_577768	2020-08-18	Europe / Netherlands / Limburg	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-34-4/2020	EPI_ISL_577770	2020-08-18	Europe / Netherlands / Limburg	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-34-5/2020	EPI_ISL_577771	2020-08-18	Europe / Netherlands / Limburg	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-39-2/2020	EPI_ISL_577783	2020-08-24	Europe / Netherlands / Limburg	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-39-3/2020	EPI_ISL_577784	2020-08-24	Europe / Netherlands / Limburg	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-39-4/2020	EPI_ISL_577785	2020-08-24	Europe / Netherlands / Limburg	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-39-5/2020	EPI_ISL_577786	2020-08-24	Europe / Netherlands / Limburg	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-41-4/2020	EPI_ISL_577791	2020-08-27	Europe / Netherlands / Limburg	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/un-EMC-783/2020	EPI_ISL_577879	2020-06-02	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/England/QEUH-9DC909/2020	EPI_ISL_581011	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-9DC945/2020	EPI_ISL_581019	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DC7C3/2020	EPI_ISL_581034	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DC392/2020	EPI_ISL_581043	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DCB8B/2020	EPI_ISL_581047	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-9DC8A2/2020	EPI_ISL_581057	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DD2A3/2020	EPI_ISL_581061	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DCA9D/2020	EPI_ISL_581089	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Canada/MB-NML-983/2020	EPI_ISL_582359	2020-07-29	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-984/2020	EPI_ISL_582360	2020-07-30	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-985/2020	EPI_ISL_582361	2020-07-30	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-992/2020	EPI_ISL_582366	2020-07-29	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1003/2020	EPI_ISL_582371	2020-07-30	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.8	GH
hCoV-19/Canada/MB-NML-1005/2020	EPI_ISL_582372	2020-07-27	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1020/2020	EPI_ISL_582386	2020-07-30	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/England/NORW-F0A23/2020	EPI_ISL_584746	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.2	GH
hCoV-19/England/QEUH-9DEC95/2020	EPI_ISL_584822	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/QEUH-9DED83/2020	EPI_ISL_584827	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/QEUH-9DEE53/2020	EPI_ISL_584830	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/QEUH-9DEE62/2020	EPI_ISL_584831	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/QEUH-9E3495/2020	EPI_ISL_584847	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.39	GH
hCoV-19/England/ALDP-A2F2FC/2020	EPI_ISL_587081	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-A2E99E/2020	EPI_ISL_587083	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-A2F8EB/2020	EPI_ISL_587110	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A2ED74/2020	EPI_ISL_587114	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A2F292/2020	EPI_ISL_587203	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-9FA48C/2020	EPI_ISL_588209	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-9F5BB9/2020	EPI_ISL_588294	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9F68A2/2020	EPI_ISL_588339	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9F490B/2020	EPI_ISL_588342	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9F663F/2020	EPI_ISL_588392	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9F6620/2020	EPI_ISL_588393	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/QEUH-9F475C/2020	EPI_ISL_588399	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9F58C1/2020	EPI_ISL_588433	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-9F5B40/2020	EPI_ISL_588435	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-9F0978/2020	EPI_ISL_589576	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.160	G
hCoV-19/England/MILK-9F19C2/2020	EPI_ISL_589671	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9F08D5/2020	EPI_ISL_589672	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-9F2035/2020	EPI_ISL_589732	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-9F191D/2020	EPI_ISL_589742	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-9F0F2B/2020	EPI_ISL_589754	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-9B7B86/2020	EPI_ISL_590530	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B7139/2020	EPI_ISL_590545	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B7333/2020	EPI_ISL_590550	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Ireland/LK-NVRL-73IRL35422/2020	EPI_ISL_596891	2020-09-08	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Scotland/QEUH-9F6A06/2020	EPI_ISL_600676	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Scotland/QEUH-9D06B3/2020	EPI_ISL_601867	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/MILK-A7DBE5/2020	EPI_ISL_606602	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A7AD00/2020	EPI_ISL_606674	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A798E2/2020	EPI_ISL_606675	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-A7A16E/2020	EPI_ISL_606697	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A796CA/2020	EPI_ISL_606737	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A79888/2020	EPI_ISL_606759	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A7A8D2/2020	EPI_ISL_606770	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A7D05F/2020	EPI_ISL_606793	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/ALDP-A6E983/2020	EPI_ISL_607910	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-A7046F/2020	EPI_ISL_607912	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.523	GH
hCoV-19/England/ALDP-A6EF45/2020	EPI_ISL_607944	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-A6C527/2020	EPI_ISL_607997	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/CAMC-A64C84/2020	EPI_ISL_609003	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A69232/2020	EPI_ISL_609041	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A925CE/2020	EPI_ISL_611136	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-A93563/2020	EPI_ISL_611174	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A92C6F/2020	EPI_ISL_611189	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-A93D89/2020	EPI_ISL_611206	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A93606/2020	EPI_ISL_611207	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-A93B16/2020	EPI_ISL_611222	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/ALDP-A9441A/2020	EPI_ISL_611262	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-A9EBB1/2020	EPI_ISL_611315	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/MILK-A18F0E/2020	EPI_ISL_612475	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36	GH
hCoV-19/England/MILK-A1919E/2020	EPI_ISL_612487	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1	G
hCoV-19/England/MILK-A19204/2020	EPI_ISL_612492	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-A19240/2020	EPI_ISL_612494	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-A192C8/2020	EPI_ISL_612498	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.28	GH
hCoV-19/England/MILK-A192D7/2020	EPI_ISL_612499	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/NORT-1B6C0E6/2020	EPI_ISL_612563	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/Denmark/DCGC-3312/2020	EPI_ISL_616066	2020-08-31	Europe / Denmark	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-3263/2020	EPI_ISL_616133	2020-08-31	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-3380/2020	EPI_ISL_616139	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-8455/2020	EPI_ISL_617395	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.36.20	GH
hCoV-19/Denmark/DCGC-1601/2020	EPI_ISL_618647	2020-04-13	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.465	GH
hCoV-19/Denmark/DCGC-1604/2020	EPI_ISL_618650	2020-04-13	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.465	GH
hCoV-19/Denmark/DCGC-1556/2020	EPI_ISL_618661	2020-04-13	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.465	GH
hCoV-19/Denmark/DCGC-7741/2020	EPI_ISL_618666	2020-10-19	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-7742/2020	EPI_ISL_618677	2020-10-19	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.36.33	GH
hCoV-19/Denmark/DCGC-7767/2020	EPI_ISL_618704	2020-10-19	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-7732/2020	EPI_ISL_618726	2020-10-19	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.36.33	GH
hCoV-19/Denmark/DCGC-7793/2020	EPI_ISL_618737	2020-10-19	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-7794/2020	EPI_ISL_618745	2020-10-19	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-4183/2020	EPI_ISL_622003	2020-09-14	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36.22	GH
hCoV-19/England/MILK-AB83D7/2020	EPI_ISL_623216	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ABB94B/2020	EPI_ISL_623240	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-AB7FF2/2020	EPI_ISL_623255	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/MILK-AB838C/2020	EPI_ISL_623306	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/MILK-AB7DDA/2020	EPI_ISL_623341	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-AA45D8/2020	EPI_ISL_624439	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-AA1A63/2020	EPI_ISL_624481	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA46A8/2020	EPI_ISL_624490	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A94F64/2020	EPI_ISL_624584	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Denmark/DCGC-8570/2020	EPI_ISL_625842	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-8687/2020	EPI_ISL_625844	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-8657/2020	EPI_ISL_625877	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-8602/2020	EPI_ISL_625934	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/England/MILK-AC94EF/2020	EPI_ISL_629314	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ACC1C7/2020	EPI_ISL_629316	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ACC26A/2020	EPI_ISL_629326	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/MILK-AC843B/2020	EPI_ISL_629334	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-ACC3D0/2020	EPI_ISL_629388	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-ACCA9F/2020	EPI_ISL_629419	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-ACF13D/2020	EPI_ISL_629480	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-ACD7E2/2020	EPI_ISL_630304	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-ACCD87/2020	EPI_ISL_630314	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-ACD14E/2020	EPI_ISL_630339	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-A679F3/2020	EPI_ISL_630367	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-A67234/2020	EPI_ISL_630414	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/ALDP-A669A9/2020	EPI_ISL_630431	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A6696D/2020	EPI_ISL_630462	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/USA/NY-NYCPHL-000220/2020	EPI_ISL_631751	2020-04-29	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	Bwa version 0.7.17-r1188	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.170	GH
hCoV-19/Yunnan/02/2020	EPI_ISL_632934	2020-09-13	Asia / China / Yunnan	Human	Original			Illumina MiSeq	CLC Genomics Workbench 12	Insertion of 1 nucleotides when compared to the reference sequence.	info	B.1.36.16	GH
hCoV-19/Indonesia/YO-UGM-10007/2020	EPI_ISL_632936	2020-08-22	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.1.30			B.1.459	GH
hCoV-19/Indonesia/YO-UGM-48651/2020	EPI_ISL_632937	2020-09-09	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.1.30			B.1.470	GH
hCoV-19/Norway/3364/2020	EPI_ISL_635104	2020-09-03	Europe / Norway / Viken	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3383/2020	EPI_ISL_635105	2020-08-18	Europe / Norway / Vestfold og Telemark	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.1	GH
hCoV-19/Norway/3720/2020	EPI_ISL_635107	2020-08-28	Europe / Norway / Viken	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3723/2020	EPI_ISL_635108	2020-09-09	Europe / Norway / Viken	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3735/2020	EPI_ISL_635109	2020-09-09	Europe / Norway / Viken	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3627/2020	EPI_ISL_635110	2020-09-25	Europe / Norway / Trndelag	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3628/2020	EPI_ISL_635111	2020-09-25	Europe / Norway / Trndelag	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3550/2020	EPI_ISL_635113	2020-08-06	Europe / Norway / Troms og Finnmark	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3563/2020	EPI_ISL_635114	2020-08-06	Europe / Norway / Troms og Finnmark	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3570/2020	EPI_ISL_635115	2020-07-31	Europe / Norway / Troms og Finnmark	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3573/2020	EPI_ISL_635117	2020-07-31	Europe / Norway / Troms og Finnmark	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3575/2020	EPI_ISL_635118	2020-07-31	Europe / Norway / Troms og Finnmark	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3808/2020	EPI_ISL_635146	2020-08-10	Europe / Norway / Rogaland	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3599/2020	EPI_ISL_635147	2020-07-31	Europe / Norway / Troms og Finnmark	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3565/2020	EPI_ISL_635148	2020-08-01	Europe / Norway / Troms og Finnmark	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3783/2020	EPI_ISL_635149	2020-08-31	Europe / Norway / Viken	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3769/2020	EPI_ISL_635150	2020-09-02	Europe / Norway / Viken	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3773/2020	EPI_ISL_635151	2020-09-04	Europe / Norway / Viken	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3776/2020	EPI_ISL_635152	2020-09-08	Europe / Norway / Viken	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3579/2020	EPI_ISL_635156	2020-07-31	Europe / Norway / Troms og Finnmark	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3586/2020	EPI_ISL_635157	2020-07-31	Europe / Norway / Troms og Finnmark	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3584/2020	EPI_ISL_635186	2020-07-31	Europe / Norway / Troms og Finnmark	Human	Original	Respiratory secretion		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Jordan/AM-ALSR-4078/2020	EPI_ISL_636438	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/Netherlands/NB-RIVM-10361/2020	EPI_ISL_636556	2020-06-13	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/NB-RIVM-10362/2020	EPI_ISL_636557	2020-06-23	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/NB-RIVM-10363/2020	EPI_ISL_636558	2020-06-15	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/NB-RIVM-10398/2020	EPI_ISL_636560	2020-10-19	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/Netherlands/ZH-RIVM-10334/2020	EPI_ISL_636595	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/ZH-RIVM-10358/2020	EPI_ISL_636599	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Sint Eustatius/BQ-RIVM-10370/2020	EPI_ISL_636600	2020-09-08	North America / Sint Eustatius	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Sint Eustatius/BQ-RIVM-10371/2020	EPI_ISL_636601	2020-09-08	North America / Sint Eustatius	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Sint Eustatius/BQ-RIVM-10372/2020	EPI_ISL_636602	2020-09-08	North America / Sint Eustatius	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Sint Eustatius/BQ-RIVM-10373/2020	EPI_ISL_636603	2020-09-07	North America / Sint Eustatius	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/England/CAMB-1B8543/2020	EPI_ISL_637859	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-9DF450/2020	EPI_ISL_637860	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A7DCC4/2020	EPI_ISL_637861	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B04FD7/2020	EPI_ISL_637862	2020-10-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B0502E/2020	EPI_ISL_637863	2020-10-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/NORW-F3871/2020	EPI_ISL_637864	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/NORW-F38F9/2020	EPI_ISL_637865	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/NORW-F3923/2020	EPI_ISL_637866	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-B11C3A/2020	EPI_ISL_642369	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B08498/2020	EPI_ISL_643606	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/CAMC-B08CAF/2020	EPI_ISL_643639	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/CAMC-B0888D/2020	EPI_ISL_643646	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B074C6/2020	EPI_ISL_643650	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.471	GH
hCoV-19/England/CAMC-B0711A/2020	EPI_ISL_643653	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B0893F/2020	EPI_ISL_643663	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B07208/2020	EPI_ISL_643665	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B07727/2020	EPI_ISL_643669	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/CAMC-B088AB/2020	EPI_ISL_643678	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B08401/2020	EPI_ISL_643690	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B0796D/2020	EPI_ISL_643724	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B0889C/2020	EPI_ISL_643734	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B08A96/2020	EPI_ISL_643742	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B07851/2020	EPI_ISL_643747	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B07B85/2020	EPI_ISL_643753	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/CAMC-B08A4B/2020	EPI_ISL_643761	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B24B37/2020	EPI_ISL_647100	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B2188E/2020	EPI_ISL_647135	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B21806/2020	EPI_ISL_647227	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B21DAD/2020	EPI_ISL_647230	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/204300490/2020	EPI_ISL_649812	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204321106/2020	EPI_ISL_649821	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204321417/2020	EPI_ISL_649825	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204321426/2020	EPI_ISL_649828	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204321427/2020	EPI_ISL_649829	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204341509/2020	EPI_ISL_649832	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204341522/2020	EPI_ISL_649833	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204341599/2020	EPI_ISL_649834	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204380844/2020	EPI_ISL_649846	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204391017/2020	EPI_ISL_649878	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204393937/2020	EPI_ISL_649887	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204393980/2020	EPI_ISL_649888	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/ALDP-B5C134/2020	EPI_ISL_655645	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/ALDP-B5CE6A/2020	EPI_ISL_655650	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-B5C125/2020	EPI_ISL_655704	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/ALDP-B5C064/2020	EPI_ISL_655720	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/ALDP-B5CEA6/2020	EPI_ISL_655722	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.38	GH
hCoV-19/England/ALDP-B5C0FB/2020	EPI_ISL_655729	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/ALDP-B5C0CE/2020	EPI_ISL_655738	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/ALDP-B5CEB5/2020	EPI_ISL_655741	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/MILK-B56C48/2020	EPI_ISL_656950	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B56923/2020	EPI_ISL_656962	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B523A1/2020	EPI_ISL_656968	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B53892/2020	EPI_ISL_656971	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-B5699C/2020	EPI_ISL_656974	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B331AC/2020	EPI_ISL_659194	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/CAMC-B33A74/2020	EPI_ISL_659289	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/QEUH-B67734/2020	EPI_ISL_661430	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AF05DD/2020	EPI_ISL_662701	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AF075F/2020	EPI_ISL_662732	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AEF98A/2020	EPI_ISL_662736	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AF078C/2020	EPI_ISL_662861	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-AEFFA6/2020	EPI_ISL_662865	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AF2553/2020	EPI_ISL_662883	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AF5699/2020	EPI_ISL_662928	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/CAMC-B231DC/2020	EPI_ISL_665028	2020-11-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMC-B23479/2020	EPI_ISL_665039	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/LOND-124F4AA/2020	EPI_ISL_665157	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/LOND-1250093/2020	EPI_ISL_665193	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/LOND-12500B1/2020	EPI_ISL_665194	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/LOND-1250154/2020	EPI_ISL_665197	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/LOND-1250163/2020	EPI_ISL_665198	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/LOND-1250190/2020	EPI_ISL_665199	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/Wales/PHWC-48C105/2020	EPI_ISL_666394	2020-11-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Japan/IC-0173/2020	EPI_ISL_667602	2020-09-30	Asia / Japan	Human	Original		COVID-19 positive case who entered from Nepal.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.36.17	GH
hCoV-19/Japan/IC-0180/2020	EPI_ISL_667609	2020-09-29	Asia / Japan	Human	Original		COVID-19 positive case who entered from Pakistan.	Illumina NextSeq500	A5-miseq v. 20140604	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/IC-0184/2020	EPI_ISL_667613	2020-10-12	Asia / Japan	Human	Original		COVID-19 positive case who entered from Nepal.	Illumina NextSeq500	A5-miseq v. 20140604			B.1.36.8	GH
hCoV-19/Japan/IC-0185/2020	EPI_ISL_667614	2020-10-15	Asia / Japan	Human	Original		COVID-19 positive case who entered from Nepal.	Illumina NextSeq500	A5-miseq v. 20140604			B.1.36	GH
hCoV-19/Japan/IC-0194/2020	EPI_ISL_667623	2020-07-02	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.459	GH
hCoV-19/Japan/IC-0201/2020	EPI_ISL_667630	2020-07-16	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.459	GH
hCoV-19/Japan/IC-0211/2020	EPI_ISL_667640	2020-06-21	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.459	GH
hCoV-19/Japan/IC-0237/2020	EPI_ISL_667666	2020-09-18	Asia / Japan	Human	Original		COVID-19 positive case who entered from Pakistan.	Illumina NextSeq500	BWA v. 0.7.13-r1126, picard v. 2.10.10, GATK v. 3.8.0, VarScan v. 2.4.3, VCFtools v. 0.1.12b, SKESA v. 2.3.0, A5-miseq v. 20140604			B.1.471	GH
hCoV-19/Japan/IC-0243/2020	EPI_ISL_667672	2020-10-02	Asia / Japan	Human	Original		COVID-19 positive case who entered from Nepal.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/IC-0245/2020	EPI_ISL_667674	2020-10-06	Asia / Japan	Human	Original		COVID-19 positive case who entered from India.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/IC-0246/2020	EPI_ISL_667675	2020-10-09	Asia / Japan	Human	Original		COVID-19 positive case who entered from Nepal.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/IC-0252/2020	EPI_ISL_667681	2020-10-19	Asia / Japan	Human	Original		COVID-19 positive case who entered from Nepal.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/IC-0262/2020	EPI_ISL_667691	2020-10-30	Asia / Japan	Human	Original		COVID-19 positive case who entered from Nepal.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/IC-0264/2020	EPI_ISL_667693	2020-10-31	Asia / Japan	Human	Original		COVID-19 positive case who entered from Pakistan.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.36.24	GH
hCoV-19/Japan/IC-0276/2020	EPI_ISL_667705	2020-11-03	Asia / Japan	Human	Original		COVID-19 positive case who entered from India.	Illumina NextSeq500	A5-miseq v. 20140604	NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/Japan/IC-0278/2020	EPI_ISL_667707	2020-11-06	Asia / Japan	Human	Original		COVID-19 positive case who entered from Nepal.	Illumina NextSeq500	SKESA v. 2.3.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/IC-0288/2020	EPI_ISL_667717	2020-11-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	A5-miseq v. 20140604			B.1.459	GH
hCoV-19/Japan/IC-0289/2020	EPI_ISL_667718	2020-11-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.459	GH
hCoV-19/Japan/IC-0293/2020	EPI_ISL_667722	2020-11-10	Asia / Japan	Human	Original		COVID-19 positive case who entered from India.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/IC-0294/2020	EPI_ISL_667723	2020-11-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina NextSeq500	A5-miseq v. 20140604			B.1.459	GH
hCoV-19/Australia/NSW1194/2020	EPI_ISL_667794	2020-10-30	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36.10	GH
hCoV-19/Australia/NSW1196/2020	EPI_ISL_667796	2020-10-11	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-9353/2020	EPI_ISL_668924	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-9415/2020	EPI_ISL_668959	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/CAMC-B9C51E/2020	EPI_ISL_673491	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B99D0A/2020	EPI_ISL_673504	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-B8E096/2020	EPI_ISL_674729	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-B95AAD/2020	EPI_ISL_674831	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/CAMC-B9847F/2020	EPI_ISL_674846	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B98424/2020	EPI_ISL_674850	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/England/CAMC-B98318/2020	EPI_ISL_674851	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-B95A16/2020	EPI_ISL_674864	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B98284/2020	EPI_ISL_674867	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B98697/2020	EPI_ISL_674893	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/Australia/NSW2648/2020	EPI_ISL_678331	2020-07-20	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Australia/NSW2871/2020	EPI_ISL_678358	2020-09-17	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina MiSeq				B.1.36.38	GH
hCoV-19/Australia/NSW2910/2020	EPI_ISL_678366	2020-10-11	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina MiSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Australia/NSW2954/2020	EPI_ISL_678380	2020-10-21	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/England/LOND-DC5B3/2020	EPI_ISL_679625	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/MILK-B3B7EE/2020	EPI_ISL_679772	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/MILK-B3BC67/2020	EPI_ISL_679798	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/Switzerland/BL-ETHZ-360153/2020	EPI_ISL_693925	2020-11-06	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina Miseq	V-pipe	NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Switzerland/BL-ETHZ-360155/2020	EPI_ISL_693927	2020-11-06	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina Miseq	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/SO-ETHZ-360158/2020	EPI_ISL_693929	2020-11-06	Europe / Switzerland / Solothurn	Human	Original	Oropharyngeal swab		Illumina Miseq	V-pipe			B.1.523	GH
hCoV-19/Switzerland/SH-ETHZ-370463/2020	EPI_ISL_693962	2020-11-16	Europe / Switzerland / Schaffhausen	Human	Original	Oropharyngeal swab		Illumina Miseq	V-pipe			B.1.467	GH
hCoV-19/France/ARA-SC122/2020	EPI_ISL_700386	2020-03-30	Europe / France / Auvergne-Rhone-Alpes / Chambery	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1	GH
hCoV-19/England/ALDP-BBA8B7/2020	EPI_ISL_701768	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-BC3BEF/2020	EPI_ISL_704005	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-BC3675/2020	EPI_ISL_704010	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-BCBC5D/2020	EPI_ISL_704019	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Wales/PHWC-490B2E/2020	EPI_ISL_706539	2020-11-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/New Zealand/20CV0639/2020	EPI_ISL_707803	2020-12-03	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Australia/NSW2946/2020	EPI_ISL_707894	2020-11-02	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina MiSeq				B.1.36.1	GH
hCoV-19/Australia/NSW2964/2020	EPI_ISL_707896	2020-10-22	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Australia/NSW2972/2020	EPI_ISL_707899	2020-10-20	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina MiSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-13662/2020	EPI_ISL_712422	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-13797/2020	EPI_ISL_712425	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/Denmark/DCGC-12956/2020	EPI_ISL_712486	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-12964/2020	EPI_ISL_712492	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-15176/2020	EPI_ISL_713676	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-15220/2020	EPI_ISL_713703	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-15254/2020	EPI_ISL_713722	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-15406/2020	EPI_ISL_713807	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-15409/2020	EPI_ISL_713809	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/England/CAMC-C3F6DD/2020	EPI_ISL_718536	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-C402C6/2020	EPI_ISL_718561	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-C3FD9C/2020	EPI_ISL_718624	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-BA225A/2020	EPI_ISL_719872	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/QEUH-BA2296/2020	EPI_ISL_719880	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/QEUH-B9E6CE/2020	EPI_ISL_719964	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/MILK-BFCBA1/2020	EPI_ISL_720865	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/QEUH-B9FBA0/2020	EPI_ISL_720917	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B9FC07/2020	EPI_ISL_720918	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/204980132/2020	EPI_ISL_723025	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.39	GH
hCoV-19/England/204980135/2020	EPI_ISL_723026	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.39	GH
hCoV-19/England/204980142/2020	EPI_ISL_723027	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.39	GH
hCoV-19/England/204990348/2020	EPI_ISL_723031	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.39	GH
hCoV-19/Netherlands/NH-RIVM-20221/2020	EPI_ISL_723194	2020-12-05	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Switzerland/SO-ETHZ-360212/2020	EPI_ISL_729253	2020-11-09	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Canada/ON-S1913/2020	EPI_ISL_729265	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-S1923/2020	EPI_ISL_729266	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-S1909/2020	EPI_ISL_729270	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-S1800/2020	EPI_ISL_729272	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36	GH
hCoV-19/Canada/ON-S1820/2020	EPI_ISL_729284	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1826/2020	EPI_ISL_729290	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1827/2020	EPI_ISL_729291	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1828/2020	EPI_ISL_729292	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1829/2020	EPI_ISL_729293	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1834/2020	EPI_ISL_729298	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1835/2020	EPI_ISL_729299	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1842/2020	EPI_ISL_729304	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1844/2020	EPI_ISL_729305	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1846/2020	EPI_ISL_729306	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-S1893/2020	EPI_ISL_729316	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1900/2020	EPI_ISL_729317	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.523	GH
hCoV-19/Canada/ON-S1901/2020	EPI_ISL_729318	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1904/2020	EPI_ISL_729320	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1905/2020	EPI_ISL_729321	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-S1906/2020	EPI_ISL_729322	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-S1908/2020	EPI_ISL_729323	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-S1912/2020	EPI_ISL_729324	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.523	GH
hCoV-19/Canada/ON-S1931/2020	EPI_ISL_729333	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Jordan/AM-ALSR-4961/2020	EPI_ISL_730234	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-4970/2020	EPI_ISL_730243	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-4991/2020	EPI_ISL_730264	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-4992/2020	EPI_ISL_730265	2020-10-04	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-4993/2020	EPI_ISL_730266	2020-10-06	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	O
hCoV-19/Jordan/AM-ALSR-4996/2020	EPI_ISL_730269	2020-10-10	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-4998/2020	EPI_ISL_730271	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5002/2020	EPI_ISL_730275	2020-10-08	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5006/2020	EPI_ISL_730279	2020-10-11	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5011/2020	EPI_ISL_730284	2020-10-07	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5014/2020	EPI_ISL_730287	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5144/2020	EPI_ISL_730383	2020-10-15	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5145/2020	EPI_ISL_730384	2020-10-18	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5146/2020	EPI_ISL_730385	2020-10-15	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/England/ALDP-C3A1C2/2020	EPI_ISL_731527	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-C3C9C8/2020	EPI_ISL_731568	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/ALDP-C3AAD6/2020	EPI_ISL_731571	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/ALDP-C3C0A5/2020	EPI_ISL_731622	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-C3CDDB/2020	EPI_ISL_731625	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-C3AA7C/2020	EPI_ISL_731632	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/England/ALDP-C3CDF9/2020	EPI_ISL_731653	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-C3B11C/2020	EPI_ISL_731656	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/Australia/SA0592/2020	EPI_ISL_732960	2020-12-19	Oceania / Australia / South Australia	Human	Original			Illumina MiSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Belgium/rega-09221021/2020	EPI_ISL_735019	2020-09-22	Europe / Belgium / Kessel-Lo	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1	GH
hCoV-19/Belgium/rega-09231007/2020	EPI_ISL_735030	2020-09-23	Europe / Belgium / Wijgmaal	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1	GH
hCoV-19/England/MILK-C52C1E/2020	EPI_ISL_736385	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-C52908/2020	EPI_ISL_736410	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-C52926/2020	EPI_ISL_736433	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-C50472/2020	EPI_ISL_736497	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/USA/UT-UPHL-2012157829/2020	EPI_ISL_747027	2020-12-02	North America / USA / Utah	Human	Original			Illumina NextSeq	BWA + Ivar 1.2.2			B.1.36.8	GH
hCoV-19/Denmark/DCGC-18797/2020	EPI_ISL_748484	2020-12-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.25	GH
hCoV-19/Denmark/DCGC-19598/2020	EPI_ISL_748488	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-17955/2020	EPI_ISL_749665	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-16895/2020	EPI_ISL_750628	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-16999/2020	EPI_ISL_750700	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Germany/BE-ChVir-W2121-4431/2020	EPI_ISL_754186	2020-10-15	Europe / Germany / Berlin	Human	Original			Illumina NextSeq	bowtie2	Insertion of 4 nucleotides found at refpos 29593 (frameshift confirmed by the submitter).	info	B.1.36.20	GH
hCoV-19/Germany/BE-ChVir-D1981-5990/2020	EPI_ISL_754187	2020-09-24	Europe / Germany / Berlin	Human	Original			Illumina MiSeq	bowtie2	Insertion of 2 nucleotides found at refpos 29593 (frameshift confirmed by the submitter).	info	B.1.36.20	GH
hCoV-19/Germany/BE-ChVir-D1917-8291/2020	EPI_ISL_754188	2020-10-06	Europe / Germany / Berlin	Human	Original			Illumina NextSeq	bowtie2	Insertion of 2 nucleotides found at refpos 29593 (frameshift confirmed by the submitter).	info	B.1.36.20	GH
hCoV-19/Germany/BE-ChVir-D1947-5915/2020	EPI_ISL_754189	2020-10-04	Europe / Germany / Berlin	Human	Original			Illumina NextSeq	bowtie2	Insertion of 2 nucleotides found at refpos 29593 (frameshift confirmed by the submitter).	info	B.1.36.20	GH
hCoV-19/Indonesia/JB-TFRIC19-R50090/2020	EPI_ISL_754241	2020-07-24	Asia / Indonesia / West Java / Tasikmalaya	Human	Original	Nasopharyngeal and oropharyngeal swab		GridION	bwa 0.7.17-r1188			B.1.459	G
hCoV-19/New Zealand/20CV0697/2020	EPI_ISL_755630	2020-12-22	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.471	GH
hCoV-19/New Zealand/20CV0701/2020	EPI_ISL_755631	2020-12-23	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.471	GH
hCoV-19/New Zealand/20CV0704/2020	EPI_ISL_755633	2020-12-27	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36.8	GH
hCoV-19/New Zealand/20CV0709/2020	EPI_ISL_755634	2020-12-25	Oceania / New Zealand / Counties Manukau	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36.8	GH
hCoV-19/Canada/ON-S1965/2020	EPI_ISL_755681	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1966/2020	EPI_ISL_755682	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.26	GH
hCoV-19/Canada/ON-S1967/2020	EPI_ISL_755683	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1968/2020	EPI_ISL_755684	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1972/2020	EPI_ISL_755686	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36	GH
hCoV-19/Canada/ON-S1973/2020	EPI_ISL_755687	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1974/2020	EPI_ISL_755688	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1975/2020	EPI_ISL_755689	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-S1976/2020	EPI_ISL_755690	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-S1977/2020	EPI_ISL_755691	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1978/2020	EPI_ISL_755692	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1984/2020	EPI_ISL_755697	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.8	GH
hCoV-19/Canada/ON-S1985/2020	EPI_ISL_755698	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/England/MILK-C7824D/2020	EPI_ISL_756843	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/QEUH-C7C258/2020	EPI_ISL_756910	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 11 nucleotide(s) found at refpos 27569 (FRAMESHIFT not confirmed by the submitter). NS7a without BLAST coverage.		B.1.469	GH
hCoV-19/England/MILK-C784B0/2020	EPI_ISL_756915	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-C7AA25/2020	EPI_ISL_756956	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/Denmark/DCGC-20544/2020	EPI_ISL_759047	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-20684/2020	EPI_ISL_759048	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-20985/2020	EPI_ISL_759050	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-21014/2020	EPI_ISL_759051	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-21048/2020	EPI_ISL_759053	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-21089/2020	EPI_ISL_759054	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-21248/2020	EPI_ISL_759057	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-21288/2020	EPI_ISL_759059	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-20359/2020	EPI_ISL_759104	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-20417/2020	EPI_ISL_759135	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-20434/2020	EPI_ISL_759144	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-20436/2020	EPI_ISL_759146	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-20437/2020	EPI_ISL_759147	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-20438/2020	EPI_ISL_759148	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.1	GH
hCoV-19/Hong Kong/VM20123554/2020	EPI_ISL_760032	2020-09-18	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36.27	GH
hCoV-19/Hong Kong/VM20123555/2020	EPI_ISL_760033	2020-09-18	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VM20123558/2020	EPI_ISL_760034	2020-09-18	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36.27	GH
hCoV-19/Hong Kong/VM20123559/2020	EPI_ISL_760035	2020-09-18	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VM20123560/2020	EPI_ISL_760036	2020-09-18	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VM20126869/2020	EPI_ISL_760037	2020-09-29	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VM20127499/2020	EPI_ISL_760038	2020-09-30	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VM20127572/2020	EPI_ISL_760039	2020-10-02	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VM20127573/2020	EPI_ISL_760040	2020-10-02	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36.27	GH
hCoV-19/Hong Kong/VM20127769/2020	EPI_ISL_760041	2020-10-03	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VM20127935/2020	EPI_ISL_760042	2020-10-04	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VM20127956/2020	EPI_ISL_760043	2020-10	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VM20128243/2020	EPI_ISL_760044	2020-10	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VB20209003/2020	EPI_ISL_760045	2020-10-06	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36.27	GH
hCoV-19/Hong Kong/VB20209026/2020	EPI_ISL_760046	2020-10-06	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36.27	GH
hCoV-19/Hong Kong/VM20128899/2020	EPI_ISL_760047	2020-10-06	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VM20129245/2020	EPI_ISL_760048	2020-10	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VM20129415/2020	EPI_ISL_760049	2020-10-08	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36.27	GH
hCoV-19/Hong Kong/VB20211407/2020	EPI_ISL_760050	2020-10-08	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VB20211660/2020	EPI_ISL_760051	2020-10-08	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VB20211661/2020	EPI_ISL_760052	2020-10-08	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VM20130028/2020	EPI_ISL_760053	2020-10-08	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36.27	GH
hCoV-19/Hong Kong/VM20130432/2020	EPI_ISL_760054	2020-10-09	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VM20131073/2020	EPI_ISL_760055	2020-10-10	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VB20214929/2020	EPI_ISL_760056	2020-10-11	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VB20219976/2020	EPI_ISL_760057	2020-10-17	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Hong Kong/VB20220907/2020	EPI_ISL_760058	2020-10-18	Asia / Hong Kong	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-CB4A01/2020	EPI_ISL_761310	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-CB5D25/2020	EPI_ISL_761322	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-CA6EBB/2020	EPI_ISL_761384	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-C889EB/2020	EPI_ISL_762666	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/ALDP-C8A0E4/2020	EPI_ISL_762693	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-C7C6B6/2020	EPI_ISL_762760	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-C889BE/2020	EPI_ISL_762789	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/205100235/2020	EPI_ISL_766260	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/204680331/2020	EPI_ISL_766267	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.39	GH
hCoV-19/England/205041401/2020	EPI_ISL_766287	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	NSP11 without BLAST coverage.	warn	B.1.36.17	GH
hCoV-19/England/205060952/2020	EPI_ISL_766288	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.471	GH
hCoV-19/England/CAMC-CB73A9/2020	EPI_ISL_778291	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/Japan/IC-0580/2020	EPI_ISL_779666	2020-10-14	Asia / Japan	Human	Original		COVID-19 positive case who entered from India.	Illumina iSeq	A5-miseq v. 20140604			B.1.36	GH
hCoV-19/Japan/IC-0581/2020	EPI_ISL_779667	2020-10-18	Asia / Japan	Human	Original		COVID-19 positive case who entered from India.	Illumina iSeq	A5-miseq v. 20140604			B.1.36	GH
hCoV-19/Japan/IC-0583/2020	EPI_ISL_779669	2020-10-28	Asia / Japan	Human	Original		COVID-19 positive case who entered from India.	Illumina iSeq	bwa v. 0.7.13-r1126, picard v. 2.10.10, GATK v. 3.8.0, VarScan v. 2.4.3, VCFtools v. 0.1.12b, SKESA v. 2.3.0, A5-miseq v. 20140604			B.1.36	GH
hCoV-19/Japan/IC-0589/2020	EPI_ISL_779675	2020-11-19	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina iSeq	SKESA v. 2.3.0			B.1.459	GH
hCoV-19/USA/TX-HMH-MCoV-19693/2020	EPI_ISL_784047	2020-11-30	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.36	GH
hCoV-19/USA/TX-HMH-MCoV-19776/2020	EPI_ISL_784116	2020-11-20	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.36	GH
hCoV-19/USA/TX-HMH-MCoV-15196/2020	EPI_ISL_786680	2020-10-21	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1	GH
hCoV-19/USA/TX-HMH-MCoV-15275/2020	EPI_ISL_786759	2020-10-19	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1	G
hCoV-19/Denmark/DCGC-23628/2020	EPI_ISL_793859	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-23684/2020	EPI_ISL_793887	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-23840/2020	EPI_ISL_793960	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/England/MILK-DAD5AF/2020	EPI_ISL_797394	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-D2DF12/2020	EPI_ISL_799928	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/QEUH-D14EC6/2020	EPI_ISL_799985	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/CAMC-BC2F6C/2020	EPI_ISL_801031	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-BC29D7/2020	EPI_ISL_801044	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-BC2922/2020	EPI_ISL_801074	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-BC14E6/2020	EPI_ISL_801105	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/BIRM-682B5/2020	EPI_ISL_813011	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-682C4/2020	EPI_ISL_813012	2020-11-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-682D3/2020	EPI_ISL_813013	2020-11-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-69DB3/2020	EPI_ISL_813052	2020-09-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/Denmark/DCGC-27545/2020	EPI_ISL_815743	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-27585/2020	EPI_ISL_815764	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-27657/2020	EPI_ISL_815812	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-27701/2020	EPI_ISL_815838	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-27704/2020	EPI_ISL_815841	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-27713/2020	EPI_ISL_815845	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-27289/2020	EPI_ISL_818049	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-27346/2020	EPI_ISL_818080	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/England/ALDP-C695DD/2020	EPI_ISL_820257	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-C698F2/2020	EPI_ISL_820263	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-E64A3B/2020	EPI_ISL_821413	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-E63119/2021	EPI_ISL_821423	2021-01-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/India/GJ-GBRC-434/2020	EPI_ISL_825034	2020-11-20	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/India/GJ-GBRC-435/2020	EPI_ISL_825035	2020-11-19	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/India/GJ-GBRC-436/2020	EPI_ISL_825036	2020-12-03	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36	GH
hCoV-19/India/GJ-GBRC-441/2020	EPI_ISL_825042	2020-11-24	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36	GH
hCoV-19/India/GJ-GBRC-458a/2020	EPI_ISL_825061	2020-12-29	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-458b/2020	EPI_ISL_825062	2020-12-29	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-459/2020	EPI_ISL_825063	2020-12-30	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12	NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.36.8	GH
hCoV-19/Singapore/30/2021	EPI_ISL_825068	2021-01-10	Asia / Singapore	Human	Original			Illumina Miseq				B.1.466.2	GH
hCoV-19/Singapore/34/2021	EPI_ISL_825072	2021-01-08	Asia / Singapore	Human	Original			Illumina Miseq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Singapore/36/2021	EPI_ISL_825074	2021-01-07	Asia / Singapore	Human	Original			Illumina Miseq				B.1.456	GH
hCoV-19/Singapore/37/2021	EPI_ISL_825075	2021-01-10	Asia / Singapore	Human	Original			Illumina Miseq				B.1.466.2	GH
hCoV-19/Singapore/38/2021	EPI_ISL_825076	2021-01-07	Asia / Singapore	Human	Original			Illumina Miseq				B.1.466.2	GH
hCoV-19/Singapore/40/2021	EPI_ISL_825078	2021-01-10	Asia / Singapore	Human	Original			Illumina Miseq				B.1.466.2	GH
hCoV-19/India/GJ-GBRC-460-R1/2020	EPI_ISL_826274	2020-10-24	Asia / India / Gujarat / Ahmedabad	Human	Original		IgG Negative. Reinfection case: first detection hCoV-19/India/GJ-GBRC-460-R1/2020 and second detection hCoV-19/India/GJ-GBRC-460-R2a/2020 and hCoV-19/India/GJ-GBRC-460-R2b/2020	Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-460-R2a/2020	EPI_ISL_826275	2020-12-13	Asia / India / Gujarat / Ahmedabad	Human	Original		IgG Negative. Reinfection case: first detection hCoV-19/India/GJ-GBRC-460-R1/2020 and second detection hCoV-19/India/GJ-GBRC-460-R2a/2020 and hCoV-19/India/GJ-GBRC-460-R2b/2021	Ion Torrent	CLC Genomics Workbench 12	NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.36.8	GH
hCoV-19/Indonesia/JK-LIPI018/2020	EPI_ISL_833500	2020-06-03	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.459	GH
hCoV-19/England/205240385/2020	EPI_ISL_837001	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/205240329/2020	EPI_ISL_837017	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/LOND-12881DB/2020	EPI_ISL_843066	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Denmark/DCGC-30253/2020	EPI_ISL_844377	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.469	GH
hCoV-19/Canada/ON-MMU-S2089/2020	EPI_ISL_845685	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiniSeq				B.1.36.26	GH
hCoV-19/Canada/ON-MMU-S2094/2020	EPI_ISL_845690	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiniSeq		NS8_Y46stop results in 62.8% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-MMU-S2096/2020	EPI_ISL_845692	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiniSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Germany/BW-FR0074/2020	EPI_ISL_852658	2020-06-27	Europe / Germany / Baden-Wurttemberg / Freiburg	Human	Original	Oropharyngeal swab		Illumina MiSeq	ARTIC V3 amplicons, bwa, lofreq, bcftools consensus			B.1.36	GH
hCoV-19/Denmark/DCGC-31792/2021	EPI_ISL_856208	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Indonesia/YO-UGM-10009/2020	EPI_ISL_862039	2020-12-27	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1	GH
hCoV-19/Finland/31ES15AB9/2020	EPI_ISL_862052	2020-08-31	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36	GH
hCoV-19/Finland/31ES18AD11/2020	EPI_ISL_862053	2020-08-31	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/30SS13A9/2020	EPI_ISL_862057	2020-09-30	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/30SS13B8/2020	EPI_ISL_862058	2020-09-30	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/30SS13C11/2020	EPI_ISL_862059	2020-09-30	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/30SS13H8/2020	EPI_ISL_862060	2020-09-30	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/30SS19C12/2020	EPI_ISL_862062	2020-09-30	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/30SS20F11/2020	EPI_ISL_862064	2020-09-30	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/30SS20H9/2020	EPI_ISL_862065	2020-09-30	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/30SS2D2/2020	EPI_ISL_862067	2020-09-30	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/30SS5H9/2020	EPI_ISL_862069	2020-09-30	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/30SS9E1/2020	EPI_ISL_862072	2020-09-30	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/30SS9E2/2020	EPI_ISL_862073	2020-09-30	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/30SS9G1/2020	EPI_ISL_862074	2020-09-30	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Iran/Tehran-04/2020	EPI_ISL_862079	2020-11-05	Asia / Iran / Tehran	Human	Original	Throat swab		Illumina NextSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Finland/29SS19G3/2020	EPI_ISL_862085	2020-09-29	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/29SS1D11/2020	EPI_ISL_862086	2020-09-29	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/29SS20A3/2020	EPI_ISL_862087	2020-09-29	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/29SS20G5/2020	EPI_ISL_862088	2020-09-29	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/29SS21B6/2020	EPI_ISL_862089	2020-09-29	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/29SS21E5/2020	EPI_ISL_862090	2020-09-29	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/29SS4C5/2020	EPI_ISL_862092	2020-09-29	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/29SS4C9/2020	EPI_ISL_862093	2020-09-29	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/29SS4D10/2020	EPI_ISL_862094	2020-09-29	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/29SS4G5/2020	EPI_ISL_862095	2020-09-29	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM	NS7a_Q76stop results in 38.0% truncation of the protein sequence.	info	B.1.36.22	GH
hCoV-19/Finland/29SS5E7/2020	EPI_ISL_862096	2020-09-29	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/29SS5F11/2020	EPI_ISL_862097	2020-09-29	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/29SS6C5/2020	EPI_ISL_862098	2020-09-29	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/29SS8E3/2020	EPI_ISL_862099	2020-09-29	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Denmark/DCGC-32504/2021	EPI_ISL_869508	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-32556/2021	EPI_ISL_869560	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-32585/2021	EPI_ISL_869589	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-32606/2021	EPI_ISL_869610	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-32609/2021	EPI_ISL_869613	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-32610/2021	EPI_ISL_869614	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26209 (frameshift confirmed by the submitter).	info	B.1.36.25	GH
hCoV-19/Denmark/DCGC-32623/2021	EPI_ISL_869627	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-32665/2021	EPI_ISL_869669	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-33648/2021	EPI_ISL_870658	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 28703 (frameshift confirmed by the submitter). Gap of 4 nucleotides when compared to the reference sequence. N without BLAST coverage.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-33662/2021	EPI_ISL_870672	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/MILK-F89282/2021	EPI_ISL_875265	2021-01-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Ireland/G-NVRL-21IRL09359/2021	EPI_ISL_875370	2021-01-12	Europe / Ireland / Galway	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.36	GH
hCoV-19/Canada/ON-SC0258/2020	EPI_ISL_876599	2020-08-26	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiSeq				B.1.36.26	GH
hCoV-19/USA/IN-CDC-STM-A100383/2021	EPI_ISL_876652	2021-01-06	North America / USA / Indiana	Human	Original	Nasal swab	screened by S dropout	Illumina	COVIDSEQ	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.8	GH
hCoV-19/England/ALDP-1092783/2021	EPI_ISL_877988	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-B56686/2021	EPI_ISL_882611	2021-01-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Indonesia/BT-SHSIU-01-6493/2021	EPI_ISL_882646	2021-01-06	Asia / Indonesia / Banten	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.470	GH
hCoV-19/Indonesia/BT-SHSIU-01-6494/2021	EPI_ISL_882656	2021-01-06	Asia / Indonesia / Banten	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.470	GH
hCoV-19/USA/AL-HGSC-JGIG/2020	EPI_ISL_883936	2020-12-08	North America / USA / Alabama / Madison County	Human	Original	Nasopharyngeal		Illumina NovaSeq 6000	bwa mem v0.7.17-r1188 iVar v1.3			B.1.471	GH
hCoV-19/Indonesia/BT-SHSIU-01-6547/2021	EPI_ISL_883957	2021-01-06	Asia / Indonesia / Banten	Human	Original	Oropharyngeal and nasopharyngeal swab		Nanopore MinION				B.1.466.2	GH
hCoV-19/Canada/QC-JUS-V5310582/2020	EPI_ISL_889915	2020-03-29	North America / Canada / Quebec	Human	Original			Illumina_NexteraFlex		Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.22	GH
hCoV-19/Switzerland/AG-ETHZ-440148/2021	EPI_ISL_899215	2021-01-03	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BE-ETHZ-450339/2021	EPI_ISL_899346	2021-01-11	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BE-ETHZ-450343/2021	EPI_ISL_899347	2021-01-11	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Norway/0636/2021	EPI_ISL_906812	2021-01-12	Europe / Norway / Innlandet	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36	GH
hCoV-19/Norway/0554/2021	EPI_ISL_906821	2021-01-12	Europe / Norway / Vestfold og Telemark	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	NS7b_Q35stop results in 20.9% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/India/TG-CCMB-AE948/2020	EPI_ISL_910053	2020-08-27	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AF156/2020	EPI_ISL_910063	2020-08-28	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.36.8	GH
hCoV-19/India/TG-CCMB-AF219/2020	EPI_ISL_910071	2020-08-28	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AF680/2020	EPI_ISL_910081	2020-08-29	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.36.8	GH
hCoV-19/India/TG-CCMB-AJ089/2020	EPI_ISL_910173	2020-09-11	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.36.8	GH
hCoV-19/India/TG-CCMB-AJ510/2020	EPI_ISL_910182	2020-09-12	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.36.8	GH
hCoV-19/India/TG-CCMB-AJ815/2020	EPI_ISL_910187	2020-09-13	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AK190/2020	EPI_ISL_910195	2020-09-14	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AK287/2020	EPI_ISL_910197	2020-09-15	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AL075/2020	EPI_ISL_910206	2020-09-17	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AL095/2020	EPI_ISL_910207	2020-09-17	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AL610/2020	EPI_ISL_910214	2020-09-18	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.36.8	GH
hCoV-19/India/TG-CCMB-AL671/2020	EPI_ISL_910215	2020-09-19	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AL687/2020	EPI_ISL_910216	2020-09-19	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AL883/2020	EPI_ISL_910220	2020-09-19	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AM166/2020	EPI_ISL_910225	2020-09-20	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AM463/2020	EPI_ISL_910231	2020-09-21	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AM593/2020	EPI_ISL_910234	2020-09-22	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AM683/2020	EPI_ISL_910235	2020-09-22	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AM740/2020	EPI_ISL_910238	2020-09-22	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AM811/2020	EPI_ISL_910239	2020-09-22	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AM857/2020	EPI_ISL_910240	2020-09-22	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AO019/2020	EPI_ISL_910265	2020-09-26	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AO022/2020	EPI_ISL_910266	2020-09-26	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AO176/2020	EPI_ISL_910269	2020-09-26	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AO708/2020	EPI_ISL_910285	2020-09-29	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AO778/2020	EPI_ISL_910288	2020-09-29	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.36.8	GH
hCoV-19/India/TG-CCMB-W980/2020	EPI_ISL_910305	2020-07-29	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.36.8	GH
hCoV-19/India/un-IGIB20210017/2020	EPI_ISL_911533	2020-12	Asia / India	Human	Original	Nasal and oropharyngeal swab		Oxford Nanopore Technology	Reference based			B.1.36	GH
hCoV-19/India/un-IGIB20210028/2020	EPI_ISL_911541	2020-12	Asia / India	Human	Original	Nasal and oropharyngeal swab		Oxford Nanopore Technology	Reference based			B.1.36	GH
hCoV-19/India/un-IGIB20210032/2020	EPI_ISL_911543	2020-12	Asia / India	Human	Original	Nasal and oropharyngeal swab		Oxford Nanopore Technology	Reference based			B.1.36	GH
hCoV-19/Canada/NS-NML-1798/2020	EPI_ISL_915003	2020-04-04	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.22	GH
hCoV-19/England/BIRM-6EC39/2020	EPI_ISL_918831	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/BIRM-6EC84/2020	EPI_ISL_918835	2020-12-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.523	GH
hCoV-19/England/BIRM-6F184/2021	EPI_ISL_918875	2021-01-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 15 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/OXON-F504CA/2021	EPI_ISL_922215	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Denmark/DCGC-35926/2021	EPI_ISL_927067	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 12357 (frameshift confirmed by the submitter). NSP8 without BLAST coverage.	info	B.1.471	GH
hCoV-19/Denmark/DCGC-38550/2021	EPI_ISL_929691	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/USA/IL-NM-5838/2021	EPI_ISL_936907	2021-01-05	North America / USA / Illinois / Chicago	Human	Original			Illumina MiSeq	ARTIC			B.1.36.8	GH
hCoV-19/USA/IL-NM-5923/2021	EPI_ISL_936967	2021-01-08	North America / USA / Illinois / Chicago	Human	Original			Illumina MiSeq	ARTIC			B.1.36.10	GH
hCoV-19/Indonesia/JK-EIJK119/2021	EPI_ISL_947322	2021-01-06	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JK-EIJK126/2021	EPI_ISL_947323	2021-01-04	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JB-EIJK128/2021	EPI_ISL_947324	2021-01-06	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline			B.1.456	GH
hCoV-19/Indonesia/BT-EIJK133/2021	EPI_ISL_947326	2021-01-01	Asia / Indonesia / Banten / Tangerang	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.466.2	GH
hCoV-19/Indonesia/BT-EIJK136/2021	EPI_ISL_947327	2021-01-07	Asia / Indonesia / Banten / Tangerang	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.466.2	GH
hCoV-19/Indonesia/JB-EIJK143/2021	EPI_ISL_947329	2021-01-08	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JB-EIJK144/2021	EPI_ISL_947330	2021-01-08	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	Custom minimap2 + iVar pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Singapore/148/2021	EPI_ISL_953391	2021-02-01	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.466.2	GH
hCoV-19/Singapore/149/2021	EPI_ISL_953392	2021-01-28	Asia / Singapore	Human	Original			Illumina MiSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Singapore/150/2021	EPI_ISL_953393	2021-01-28	Asia / Singapore	Human	Original			Illumina MiSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Singapore/152/2021	EPI_ISL_953395	2021-02-02	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.466.2	GH
hCoV-19/Canada/NB-NML-8761/2021	EPI_ISL_961625	2021-01-18	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/NB-NML-6342/2021	EPI_ISL_961638	2021-01-14	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/NB-NML-6341/2021	EPI_ISL_961642	2021-01-11	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/NB-NML-5578/2021	EPI_ISL_961646	2021-01-08	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/NB-NML-5589/2021	EPI_ISL_961647	2021-01-08	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/NB-NML-3307/2021	EPI_ISL_961657	2021-01-03	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36	GH
hCoV-19/Canada/NB-NML-3155/2020	EPI_ISL_961661	2020-12-26	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/NB-NML-3153/2020	EPI_ISL_961663	2020-12-24	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/NB-NML-3148/2020	EPI_ISL_961665	2020-12-21	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/NB-NML-3143/2020	EPI_ISL_961666	2020-12-07	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1	GH
hCoV-19/Latvia/302/2021	EPI_ISL_961839	2021-01-21	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1	GH
hCoV-19/North Macedonia/4952/2021	EPI_ISL_965147	2021-01-23	Europe / North Macedonia / Ohrid	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	CLC Genomics Workbench 20	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/USA/VA-DCLS-2892/2021	EPI_ISL_965199	2021-01-04	North America / USA / Virginia	Human	Original			Illumina Miseq	minimap2/ivar			B.1.523	GH
hCoV-19/USA/NY-NYCPHL-002859/2021	EPI_ISL_966484	2021-01-26	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.471	GH
hCoV-19/Canada/BC-BCCDC-5299/2020	EPI_ISL_971202	2020-09-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4812/2020	EPI_ISL_971235	2020-09-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4982/2020	EPI_ISL_971265	2020-09-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-4983/2020	EPI_ISL_971268	2020-09-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Denmark/DCGC-40753/2021	EPI_ISL_972430	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-40768/2021	EPI_ISL_972445	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-40923/2021	EPI_ISL_972600	2021-01-25	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Canada/BC-BCCDC-5037/2020	EPI_ISL_973716	2020-09-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5038/2020	EPI_ISL_973718	2020-09-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5147/2020	EPI_ISL_973723	2020-09-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5165/2020	EPI_ISL_973729	2020-09-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5166/2020	EPI_ISL_973731	2020-09-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5167/2020	EPI_ISL_973733	2020-09-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Denmark/DCGC-41930/2021	EPI_ISL_973738	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Canada/BC-BCCDC-5200/2020	EPI_ISL_973751	2020-09-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5202/2020	EPI_ISL_973755	2020-09-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5178/2020	EPI_ISL_973783	2020-09-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-5207/2020	EPI_ISL_973794	2020-09-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5208/2020	EPI_ISL_973795	2020-09-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5218/2020	EPI_ISL_973837	2020-09-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5219/2020	EPI_ISL_973838	2020-09-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5220/2020	EPI_ISL_973839	2020-09-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5221/2020	EPI_ISL_973840	2020-09-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5222/2020	EPI_ISL_973841	2020-09-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5223/2020	EPI_ISL_973842	2020-09-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5225/2020	EPI_ISL_973844	2020-09-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5226/2020	EPI_ISL_973845	2020-09-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5353/2020	EPI_ISL_973848	2020-09-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5357/2020	EPI_ISL_973851	2020-09-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5358/2020	EPI_ISL_973852	2020-09-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5359/2020	EPI_ISL_973853	2020-09-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5360/2020	EPI_ISL_973854	2020-09-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5361/2020	EPI_ISL_973855	2020-09-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5589/2020	EPI_ISL_973859	2020-09-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5369/2020	EPI_ISL_973870	2020-09-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5372/2020	EPI_ISL_973873	2020-09-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-5374/2020	EPI_ISL_973875	2020-09-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-5376/2020	EPI_ISL_973877	2020-09-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5377/2020	EPI_ISL_973887	2020-09-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5590/2020	EPI_ISL_973906	2020-09-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5388/2020	EPI_ISL_973914	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5396/2020	EPI_ISL_973921	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5398/2020	EPI_ISL_973923	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.26	GH
hCoV-19/Canada/BC-BCCDC-5400/2020	EPI_ISL_973924	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5402/2020	EPI_ISL_973926	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5403/2020	EPI_ISL_973927	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5407/2020	EPI_ISL_973931	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-5540/2020	EPI_ISL_973933	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5541/2020	EPI_ISL_973934	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5545/2020	EPI_ISL_973937	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5546/2020	EPI_ISL_973938	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5547/2020	EPI_ISL_973939	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5548/2020	EPI_ISL_973940	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5549/2020	EPI_ISL_973941	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5595/2020	EPI_ISL_973945	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5597/2020	EPI_ISL_973947	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5788/2020	EPI_ISL_973948	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6698/2020	EPI_ISL_973952	2020-09-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6971/2020	EPI_ISL_974903	2020-11-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7199/2020	EPI_ISL_974907	2020-11-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7277/2020	EPI_ISL_974915	2020-11-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8959/2020	EPI_ISL_976102	2020-12-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8963/2020	EPI_ISL_976106	2020-12-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9028/2020	EPI_ISL_976109	2020-12-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9030/2020	EPI_ISL_976110	2020-12-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9038/2020	EPI_ISL_976115	2020-12-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9171/2020	EPI_ISL_976121	2020-12-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9172/2020	EPI_ISL_976122	2020-12-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9253/2020	EPI_ISL_976123	2020-12-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10005/2020	EPI_ISL_976125	2020-12-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8751/2020	EPI_ISL_976130	2020-12-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8965/2020	EPI_ISL_976142	2020-12-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8966/2020	EPI_ISL_976143	2020-12-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8969/2020	EPI_ISL_976146	2020-12-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8970/2020	EPI_ISL_976147	2020-12-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9913/2020	EPI_ISL_976159	2020-12-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.18	GH
hCoV-19/Canada/BC-BCCDC-8845/2020	EPI_ISL_976164	2020-12-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9916/2020	EPI_ISL_976172	2020-12-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8761/2020	EPI_ISL_976178	2020-12-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8762/2020	EPI_ISL_976179	2020-12-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8862/2020	EPI_ISL_976189	2020-12-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9046/2020	EPI_ISL_976193	2020-12-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9048/2020	EPI_ISL_976195	2020-12-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9049/2020	EPI_ISL_976196	2020-12-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Zambia/ZMB-33949/2020	EPI_ISL_977413	2020-07-10	Africa / Zambia / Lusaka	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Field Workflow			B.1	GH
hCoV-19/Zambia/ZMB-37336/2020	EPI_ISL_977458	2020-07-28	Africa / Zambia / Lusaka	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Field Workflow			B.1.36	GH
hCoV-19/Canada/ON-PPS-21012021_0225/2021	EPI_ISL_983201	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0136/2021	EPI_ISL_983202	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0133/2021	EPI_ISL_983204	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0114/2021	EPI_ISL_983205	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PPS-21012021_0138/2021	EPI_ISL_983206	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0093/2021	EPI_ISL_983209	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0219/2021	EPI_ISL_983213	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0115/2021	EPI_ISL_983214	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0106/2021	EPI_ISL_983220	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0187/2021	EPI_ISL_983225	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0126/2021	EPI_ISL_983226	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0196/2021	EPI_ISL_983227	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0125/2021	EPI_ISL_983229	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0127/2021	EPI_ISL_983230	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0124/2021	EPI_ISL_983231	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0095/2021	EPI_ISL_983233	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0159/2021	EPI_ISL_983239	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.38	GH
hCoV-19/England/CAMC-1200733/2021	EPI_ISL_988187	2021-02-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Scotland/QEUH-117190B/2021	EPI_ISL_990121	2021-01-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/England/ALDP-119740E/2021	EPI_ISL_990475	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/Singapore/184/2021	EPI_ISL_995297	2021-02-09	Asia / Singapore	Human	Original			Illumina Miseq				B.1.466.2	GH
hCoV-19/Switzerland/BE-ETHZ-450811/2021	EPI_ISL_1002611	2021-01-09	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/SO-ETHZ-450946/2021	EPI_ISL_1002708	2021-01-10	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Iran/Qom-629/2020	EPI_ISL_1014676	2020-09-19	Asia / Iran / Qom	Human	Original	Throat swab		Illumina NextSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Iran/Ghilan-M30-241/2020	EPI_ISL_1014681	2020-08-20	Asia / Iran / Gilan	Human	Original	Throat swab		Illumina NextSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Iran/Kashmar-15K/2020	EPI_ISL_1014685	2020-12-27	Asia / Iran / Kashmar	Human	Original	Throat swab		Illumina NextSeq		Gap of 18 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Iran/Tehran-055M/2020	EPI_ISL_1014687	2020-08-17	Asia / Iran / Tehran	Human	Original	Throat swab		Illumina NextSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/Hong Kong/HKPU-04878/2020	EPI_ISL_1018289	2020-09-06	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.18	GH
hCoV-19/Hong Kong/HKPU-05516/2020	EPI_ISL_1019800	2020-11-20	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05518/2020	EPI_ISL_1019803	2020-11-20	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05525/2020	EPI_ISL_1019805	2020-11-21	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05532/2020	EPI_ISL_1019810	2020-11-21	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05541/2020	EPI_ISL_1019813	2020-11-21	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05544/2020	EPI_ISL_1019815	2020-11-21	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05568/2020	EPI_ISL_1019828	2020-11-22	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/USA/NY-Wadsworth-21007526-01/2020	EPI_ISL_1020500	2020-12-31	North America / USA / New York / Bronx	Human	Original			Illumina NextSeq	ARTIC nf pipeline			B.1.36.10	GH
hCoV-19/Denmark/DCGC-42794/2021	EPI_ISL_1023072	2021-02-08	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (FRAMESHIFT confirmed by the submitter). E without BLAST coverage.	info	B.1	GH
hCoV-19/Denmark/DCGC-45302/2020	EPI_ISL_1025680	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26161 (FRAMESHIFT confirmed by the submitter). NS3 without BLAST coverage.	info	B.1.36	GH
hCoV-19/England/MILK-125F9E4/2021	EPI_ISL_1033863	2021-02-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Hungary/2144_22/2020	EPI_ISL_1039960	2020-06-01	Europe / Hungary / Komarom-Esztergom	Human	Vero E6	Oropharyngeal swab		Illumina Miseq	in-house pipeline			B.1.22	GH
hCoV-19/Hungary/2359_5/2020	EPI_ISL_1039961	2020-06-10	Europe / Hungary / Komarom-Esztergom	Human	Vero E6	Oropharyngeal swab		Illumina Miseq	in-house pipeline			B.1.22	GH
hCoV-19/Hungary/2388_4/2020	EPI_ISL_1039962	2020-06-11	Europe / Hungary / Komarom-Esztergom	Human	Vero E6	Oropharyngeal swab		Illumina Miseq	in-house pipeline			B.1.22	GH
hCoV-19/Hungary/2248_18/2020	EPI_ISL_1039980	2020-06-04	Europe / Hungary / Komarom-Esztergom	Human	Vero E6	Oropharyngeal swab		Illumina MiSeq	In-house pipeline			B.1.22	O
hCoV-19/Hungary/2235_10/2020	EPI_ISL_1039981	2020-06-04	Europe / Hungary / Komarom-Esztergom	Human	Vero E6	Oropharyngeal swab		Illumina MiSeq	In-house pipeline			B.1.22	GH
hCoV-19/Hungary/2196_22/2020	EPI_ISL_1039983	2020-06-03	Europe / Hungary / Komarom-Esztergom	Human	Vero E6	Oropharyngeal swab		Illumina MiSeq	In-house pipeline			B.1.22	GH
hCoV-19/Hungary/2168_27/2020	EPI_ISL_1039984	2020-06-02	Europe / Hungary / Komarom-Esztergom	Human	Vero E6	Oropharyngeal swab		Illumina MiSeq	In-house pipeline			B.1.22	O
hCoV-19/Indonesia/JK-NIHRD-WGS061/2021	EPI_ISL_1048372	2021-01-07	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench			B.1.466.2	GH
hCoV-19/Canada/NS-NML-5223/2020	EPI_ISL_1055514	2020-12-12	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.26	GH
hCoV-19/Canada/NS-NML-5229/2020	EPI_ISL_1055520	2020-12-11	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.26	GH
hCoV-19/Canada/NS-NML-5234/2020	EPI_ISL_1055525	2020-12-11	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.26	GH
hCoV-19/Canada/NS-NML-5235/2020	EPI_ISL_1055526	2020-12-10	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.26	GH
hCoV-19/Canada/NS-NML-5236/2020	EPI_ISL_1055527	2020-12-10	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.26	GH
hCoV-19/Canada/NS-NML-5241/2020	EPI_ISL_1055530	2020-12-09	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.26	GH
hCoV-19/Canada/NS-NML-5245/2020	EPI_ISL_1055534	2020-12-09	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.26	GH
hCoV-19/Canada/NS-NML-5254/2020	EPI_ISL_1055539	2020-12-07	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.38	GH
hCoV-19/Canada/NS-NML-5255/2020	EPI_ISL_1055540	2020-12-07	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.26	GH
hCoV-19/South Korea/KDCA1373/2020	EPI_ISL_1063614	2020-10-03	Asia / South Korea	Human	Original			Illumina MiSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/South Korea/KDCA1374/2020	EPI_ISL_1063615	2020-10-03	Asia / South Korea	Human	Original			Illumina MiSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/South Korea/KDCA1353/2020	EPI_ISL_1063642	2020-07-15	Asia / South Korea	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/South Korea/KDCA1354/2020	EPI_ISL_1063643	2020-07-15	Asia / South Korea	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/South Korea/KDCA1355/2020	EPI_ISL_1063644	2020-07-15	Asia / South Korea	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/South Korea/KDCA1356/2020	EPI_ISL_1063645	2020-07-15	Asia / South Korea	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/South Korea/KDCA1360/2020	EPI_ISL_1063648	2020-10-16	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/South Korea/KDCA1372/2020	EPI_ISL_1063659	2020-08-13	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.36.1	GH
hCoV-19/South Korea/KDCA1377/2020	EPI_ISL_1063662	2020-10-01	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.36.34	GH
hCoV-19/South Korea/KDCA1387/2020	EPI_ISL_1063669	2020-07-15	Asia / South Korea	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/South Korea/KDCA1441/2020	EPI_ISL_1063682	2020-12-08	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.36.24	GH
hCoV-19/South Korea/KDCA1451/2020	EPI_ISL_1063686	2020-12-21	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.36.19	GH
hCoV-19/USA/NY-NYCPHL-003319/2021	EPI_ISL_1064906	2021-02-16	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.36	GH
hCoV-19/Denmark/DCGC-47649/2020	EPI_ISL_1067184	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/India/JK-ICMR-52326/2020	EPI_ISL_1073002	2020-05-28	Asia / India / Jammu and Kashmir	Human	Original			Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/India/JK-ICMR-52325/2020	EPI_ISL_1073003	2020-05-28	Asia / India / Jammu and Kashmir	Human	Original			Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/India/JK-ICMR-52324/2020	EPI_ISL_1073005	2020-05-28	Asia / India / Jammu and Kashmir	Human	Original			Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/India/JK-ICMR-52323/2020	EPI_ISL_1073006	2020-05-28	Asia / India / Jammu and Kashmir	Human	Original			Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/India/JK-ICMR-70283/2020	EPI_ISL_1073007	2020-06-09	Asia / India / Jammu and Kashmir	Human	Original			Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/India/JK-ICMR-65958/2020	EPI_ISL_1073009	2020-06-09	Asia / India / Jammu and Kashmir	Human	Original			Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/India/JK-ICMR-65960/2020	EPI_ISL_1073010	2020-06-09	Asia / India / Jammu and Kashmir	Human	Original			Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/India/JK-ICMR-65962/2020	EPI_ISL_1073011	2020-06-09	Asia / India / Jammu and Kashmir	Human	Original			Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/India/JK-ICMR-65965/2020	EPI_ISL_1073014	2020-07-24	Asia / India / Jammu and Kashmir	Human	Original			Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/India/JK-ICMR-172729/2020	EPI_ISL_1073016	2020-06-24	Asia / India / Jammu and Kashmir	Human	Original			Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/India/JK-ICMR-217486/2020	EPI_ISL_1073020	2020-08-24	Asia / India / Jammu and Kashmir	Human	Original			Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/India/JK-ICMR-217543/2020	EPI_ISL_1073022	2020-08-24	Asia / India / Jammu and Kashmir	Human	Original			Illumina MiniSeq	CLC Genomics Workbench 11.0	NS7b_E3stop results in 95.3% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/France/ARA-12877/2020	EPI_ISL_420617	2020-03-23	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1	GH
hCoV-19/France/ARA-1307/2020	EPI_ISL_420621	2020-03-24	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1	GH
hCoV-19/Denmark/ALAB-SSI463/2020	EPI_ISL_429544	2020-03-25	Europe / Denmark	Human	Original			Nanopore MinION	Artic Network			B.1.465	GH
hCoV-19/Australia/VIC1198/2020	EPI_ISL_430507	2020-03-31	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V3 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.2.1, samtools v1.10			B.1.22	GH
hCoV-19/India/GJ-GBRC12/2020	EPI_ISL_437440	2020-04-26	Asia / India / Gujarat / Surat	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/India/GJ-GBRC17a/2020	EPI_ISL_437445	2020-04-26	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC17b/2020	EPI_ISL_437446	2020-04-26	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC20/2020	EPI_ISL_437449	2020-04-26	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC23/2020	EPI_ISL_437452	2020-04-26	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/Saudi Arabia/KAUST-Makkah10/2020	EPI_ISL_437464	2020-03-23	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Megahit			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah25/2020	EPI_ISL_437469	2020-03-29	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Megahit			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah34/2020	EPI_ISL_437470	2020-03-29	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Megahit			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah38/2020	EPI_ISL_437471	2020-03-29	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Megahit			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah44/2020	EPI_ISL_437473	2020-03-29	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Megahit			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah45/2020	EPI_ISL_437474	2020-03-29	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Megahit			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Makkah159/2020	EPI_ISL_437477	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Megahit			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Makkah168/2020	EPI_ISL_437479	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Megahit			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Makkah19/2020	EPI_ISL_437481	2020-03-18	Asia / Saudi Arabia / Makkah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah23/2020	EPI_ISL_437482	2020-03-20	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah24/2020	EPI_ISL_437483	2020-03-20	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah30/2020	EPI_ISL_437485	2020-03-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah31/2020	EPI_ISL_437486	2020-03-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah47/2020	EPI_ISL_437487	2020-03-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah48/2020	EPI_ISL_437488	2020-03-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah49/2020	EPI_ISL_437489	2020-03-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Austria/CeMM0047/2020	EPI_ISL_437933	2020-03-25	Europe / Austria / Innsbruck	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.465	GH
hCoV-19/Austria/CeMM0048/2020	EPI_ISL_437934	2020-03-25	Europe / Austria / Ischgl	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.22	GH
hCoV-19/England/CAMB-84031/2020	EPI_ISL_438726	2020-04-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/England/CAMB-840D7/2020	EPI_ISL_438735	2020-04-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/Scotland/CVR1003/2020	EPI_ISL_438749	2020-03-29	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.465	GH
hCoV-19/England/CAMB-7A7DF/2020	EPI_ISL_441294	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.22	GH
hCoV-19/Kazakhstan/21399/2020	EPI_ISL_454502	2020-04-20	Asia / Kazakhstan / Nur-Sultan	Human	Original	Oropharyngeal swab		Illumina MiSeq	BWA v0.7.17-r1188			B.1	GH
hCoV-19/Kazakhstan/22517/2020	EPI_ISL_454586	2020-04-21	Asia / Kazakhstan / Nur-Sultan	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/Netherlands/NA_592/2020	EPI_ISL_455289	2020-04-09	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Australia/VIC1665/2020	EPI_ISL_456566	2020-05-09	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1	GH
hCoV-19/India/GJ-GBRC131/2020	EPI_ISL_458086	2020-05-24	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC132/2020	EPI_ISL_458087	2020-05-24	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC133/2020	EPI_ISL_458088	2020-05-24	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC134/2020	EPI_ISL_458089	2020-05-24	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.523	GH
hCoV-19/India/GJ-GBRC135a/2020	EPI_ISL_458090	2020-05-24	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC135b/2020	EPI_ISL_458091	2020-05-24	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC136a/2020	EPI_ISL_458092	2020-05-24	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC137a/2020	EPI_ISL_458094	2020-05-24	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC137b/2020	EPI_ISL_458095	2020-05-24	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36	GH
hCoV-19/India/GJ-GBRC139a/2020	EPI_ISL_458097	2020-05-24	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12	NS7a_Q94stop results in 23.1% truncation of the protein sequence.	info	B.1.36.8	GH
hCoV-19/India/GJ-GBRC139b/2020	EPI_ISL_458098	2020-05-24	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC140/2020	EPI_ISL_458099	2020-05-24	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/USA/MA-MGH-00718/2020	EPI_ISL_460315	2020-04-08	North America / USA / Massachusetts	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq				B.1.22	GH
hCoV-19/USA/CA-CSMC85/2020	EPI_ISL_475701	2020-04-04	North America / USA / California / Los Angeles County	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/Egypt/CUNCI-HGC6I016/2020	EPI_ISL_475723	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.36	GH
hCoV-19/Egypt/MASRI-2/2020	EPI_ISL_475745	2020-05	Africa / Egypt	Human	Original			Ion Torrent				B.1	GH
hCoV-19/Egypt/MASRI-11/2020	EPI_ISL_475753	2020-05	Africa / Egypt	Human	Original			Ion Torrent				B.1	GH
hCoV-19/Austria/CeMM0304/2020	EPI_ISL_475779	2020-03-29	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.465	GH
hCoV-19/Austria/CeMM0307/2020	EPI_ISL_475781	2020-03-30	Europe / Austria / Styria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.22	GH
hCoV-19/Bangladesh/CHRF-0024/2020	EPI_ISL_477134	2020-06-14	Asia / Bangladesh	Human	Original			iSeq100				B.1.36.8	GH
hCoV-19/Bangladesh/CHRF-0030/2020	EPI_ISL_477139	2020-06-11	Asia / Bangladesh	Human	Original			iSeq100				B.1.36.16	GH
hCoV-19/India/KA-InStem-NCBS-0004/2020	EPI_ISL_477207	2020-05-29	Asia / India / Karnataka	Human	Original			Illumina Hiseq	MEGAHIT v1.2.9 / ABACAS.1.3.1			B.1	GH
hCoV-19/India/KA-InStem-NCBS-0007/2020	EPI_ISL_477210	2020-06-02	Asia / India / Karnataka	Human	Original			Illumina Hiseq	MEGAHIT v1.2.9 / ABACAS.1.3.1			B.1.36.8	GH
hCoV-19/India/KA-InStem-NCBS-0008/2020	EPI_ISL_477211	2020-06-02	Asia / India / Karnataka	Human	Original			Illumina Hiseq	MEGAHIT v1.2.9 / ABACAS.1.3.1			B.1.36.8	GH
hCoV-19/England/SHEF-C72D2/2020	EPI_ISL_479225	2020-04-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/England/SHEF-CA71C/2020	EPI_ISL_479242	2020-06-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	O
hCoV-19/Japan/PG-0121/2020	EPI_ISL_479853	2020-03-11	Asia / Japan / Kanto	Human	Original	Pharyngeal swab		Illumina iSeq	SKESA v. 2.3.0			B.1	GH
hCoV-19/Japan/PG-0122/2020	EPI_ISL_479854	2020-03-11	Asia / Japan / Kanto	Human	Original	Pharyngeal swab		Illumina iSeq	A5-miseq v. 20140604			B.1	GH
hCoV-19/Japan/PG-0191/2020	EPI_ISL_479896	2020-03-13	Asia / Japan / Kanto	Human	Original	Pharyngeal swab		Illumina NextSeq500	SKESA v. 2.3.0			B.1	GH
hCoV-19/Japan/PG-0192/2020	EPI_ISL_479897	2020-03-13	Asia / Japan / Kanto	Human	Original	Pharyngeal swab		Illumina NextSeq500	A5-miseq v. 20140604			B.1	GH
hCoV-19/Japan/PG-0193/2020	EPI_ISL_479898	2020-03-16	Asia / Japan / Kanto	Human	Original	Pharyngeal swab		Illumina NextSeq500	A5-miseq v. 20140604			B.1	GH
hCoV-19/Japan/PG-0194/2020	EPI_ISL_479899	2020-03-16	Asia / Japan / Kanto	Human	Original	Pharyngeal swab		Illumina NextSeq500	SKESA v. 2.3.0			B.1	GH
hCoV-19/Scotland/EDB5428/2020	EPI_ISL_487745	2020-04-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/Scotland/EDB5405/2020	EPI_ISL_487762	2020-04-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/NOTT-11285D/2020	EPI_ISL_493553	2020-04-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/India/GJ-GBRC280/2020	EPI_ISL_495017	2020-06-18	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC282/2020	EPI_ISL_495019	2020-06-18	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC283/2020	EPI_ISL_495020	2020-06-28	Asia / India / Gujarat / Botad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC284a/2020	EPI_ISL_495021	2020-06-30	Asia / India / Gujarat / Bhavnagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12	NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.36.8	GH
hCoV-19/India/GJ-GBRC284b/2020	EPI_ISL_495022	2020-06-30	Asia / India / Gujarat / Bhavnagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12	NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.36.8	GH
hCoV-19/India/GJ-GBRC285/2020	EPI_ISL_495023	2020-07-02	Asia / India / Gujarat / Bhavnagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12	NS3_G254stop results in 8.0% truncation of the protein sequence.	info	B.1	GH
hCoV-19/India/GJ-GBRC299a/2020	EPI_ISL_495042	2020-06-15	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC300a/2020	EPI_ISL_495044	2020-06-15	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC300b/2020	EPI_ISL_495045	2020-06-15	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC301a/2020	EPI_ISL_495046	2020-06-15	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC302a/2020	EPI_ISL_495048	2020-06-15	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.113	GH
hCoV-19/India/GJ-GBRC303a/2020	EPI_ISL_495050	2020-06-15	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC306a/2020	EPI_ISL_495056	2020-06-15	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC306b/2020	EPI_ISL_495057	2020-06-15	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC308/2020	EPI_ISL_495060	2020-06-15	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC310b/2020	EPI_ISL_495064	2020-06-19	Asia / India / Gujarat / Prantij	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC311a/2020	EPI_ISL_495065	2020-06-20	Asia / India / Gujarat / Mandvi	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC313/2020	EPI_ISL_495069	2020-06-08	Asia / India / Gujarat / Nadiad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC315b/2020	EPI_ISL_495072	2020-06-17	Asia / India / Gujarat / Kamrej	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.247	G
hCoV-19/India/GJ-GBRC318b/2020	EPI_ISL_495076	2020-06-17	Asia / India / Gujarat / Surat	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC323a/2020	EPI_ISL_495079	2020-06-12	Asia / India / Gujarat / Surat	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/UT-AR22/2020	EPI_ISL_508170	2020-05-22	Asia / India / Uttarakhand / Haridwar	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1	GH
hCoV-19/India/UT-AR24/2020	EPI_ISL_508172	2020-05-30	Asia / India / Uttarakhand / Haridwar	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/UT-AR28/2020	EPI_ISL_508175	2020-06-29	Asia / India / Uttarakhand / Haridwar	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/UT-AR29/2020	EPI_ISL_508176	2020-05-26	Asia / India / Uttarakhand / Haridwar	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/UT-AR3/2020	EPI_ISL_508177	2020-06-01	Asia / India / Uttarakhand / Dehradun	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/UT-AR32/2020	EPI_ISL_508180	2020-06-04	Asia / India / Uttarakhand / Uttarkashi	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/UT-AR34/2020	EPI_ISL_508182	2020-06-08	Asia / India / Uttarakhand / Haridwar	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/UT-AR59/2020	EPI_ISL_508195	2020-06-03	Asia / India / Uttarakhand / Tehri Garhwal	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20	Gap of 3 nucleotides found at refpos 27701.	info	B.1.36	GH
hCoV-19/India/UT-AR6/2020	EPI_ISL_508196	2020-05-22	Asia / India / Uttarakhand / Haridwar	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/UP-AR66/2020	EPI_ISL_508202	2020-06-09	Asia / India / Uttar Pradesh / Muzaffarnagar	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/France/ARA-15119/2020	EPI_ISL_508900	2020-03-27	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1	GH
hCoV-19/France/ARA-16220/2020	EPI_ISL_508906	2020-03-29	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1	GH
hCoV-19/France/ARA-18634/2020	EPI_ISL_508972	2020-04-02	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1	GH
hCoV-19/Australia/VIC2081/2020	EPI_ISL_521912	2020-06-19	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.523	GH
hCoV-19/Australia/VIC2216/2020	EPI_ISL_521956	2020-06-14	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1	GH
hCoV-19/Australia/VIC2220/2020	EPI_ISL_521959	2020-06-14	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10	Gap of 6 nucleotides found at refpos 27785.	info	B.1	GH
hCoV-19/Australia/VIC2227/2020	EPI_ISL_521964	2020-06-21	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.471	GH
hCoV-19/Australia/VIC2228/2020	EPI_ISL_521965	2020-06-21	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10	Gap of 4 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Australia/VIC2257/2020	EPI_ISL_521986	2020-06-24	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/India/GJ-GBRC-382a/2020	EPI_ISL_525419	2020-06-18	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-397a/2020	EPI_ISL_525421	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-397b/2020	EPI_ISL_525422	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12	NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.36.8	GH
hCoV-19/Indonesia/JT-UGM-202538/2020	EPI_ISL_525492	2020-06-26	Asia / Indonesia / Central Java	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v 1.30			B.1.459	GH
hCoV-19/South Korea/KCDC2810/2020	EPI_ISL_526744	2020-07-31	Asia / South Korea	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/Indonesia/JI-ITD-17398NT/2020	EPI_ISL_529963	2020-07-18	Asia / Indonesia / East Java / Surabaya	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITD-4859V/2020	EPI_ISL_529965	2020-04-22	Asia / Indonesia / East Java / Surabaya	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITD-7061V/2020	EPI_ISL_529966	2020-05-05	Asia / Indonesia / East Java / Sidoarjo	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1	GH
hCoV-19/Indonesia/JI-ITD-12202V/2020	EPI_ISL_529967	2020-06-09	Asia / Indonesia / East Java / Sidoarjo	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/England/QEUH-96C4D0/2020	EPI_ISL_530924	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9696DD/2020	EPI_ISL_530949	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9657B0/2020	EPI_ISL_530969	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9658AE/2020	EPI_ISL_530995	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-96AD22/2020	EPI_ISL_531255	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-96BD30/2020	EPI_ISL_531309	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/QEUH-7948A8/2020	EPI_ISL_533106	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/Canada/QC-LSPQ-L00215879/2020	EPI_ISL_535741	2020-03-12	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.465	GH
hCoV-19/England/QEUH-98F237/2020	EPI_ISL_540364	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/New Zealand/20CV0063/2020	EPI_ISL_548104	2020-06-19	Oceania / New Zealand / Combined Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/New Zealand/20CV0203/2020	EPI_ISL_548111	2020-08-28	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/England/MILK-9C47BF/2020	EPI_ISL_549464	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/MILK-9C47EC/2020	EPI_ISL_549465	2020-09-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/MILK-9C4A01/2020	EPI_ISL_549473	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/MILK-977D22/2020	EPI_ISL_550417	2020-07-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.23	GH
hCoV-19/England/MILK-977593/2020	EPI_ISL_550422	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-97892D/2020	EPI_ISL_550423	2020-08-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-978750/2020	EPI_ISL_550428	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-978AFD/2020	EPI_ISL_550448	2020-08-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-978AEE/2020	EPI_ISL_550453	2020-08-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-97876F/2020	EPI_ISL_550460	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-977979/2020	EPI_ISL_550466	2020-07-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-9A9246/2020	EPI_ISL_551015	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9A9E33/2020	EPI_ISL_551046	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9A9E8E/2020	EPI_ISL_551048	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-99435A/2020	EPI_ISL_551705	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-995B9D/2020	EPI_ISL_551731	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-6A5BBB/2020	EPI_ISL_551745	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/MILK-993BAE/2020	EPI_ISL_552300	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.23	GH
hCoV-19/England/MILK-994EA4/2020	EPI_ISL_552310	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.23	GH
hCoV-19/England/MILK-9950BC/2020	EPI_ISL_552322	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-9951B9/2020	EPI_ISL_552339	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-994ED1/2020	EPI_ISL_552349	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-994E0E/2020	EPI_ISL_552351	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-994D89/2020	EPI_ISL_552382	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-94D815/2020	EPI_ISL_554921	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1	GH
hCoV-19/England/ALDP-94D7EB/2020	EPI_ISL_554963	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1	GH
hCoV-19/England/ALDP-95C127/2020	EPI_ISL_554975	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/ALDP-94DA3D/2020	EPI_ISL_555147	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/England/CAMC-948E36/2020	EPI_ISL_556522	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/CAMC-947A7F/2020	EPI_ISL_556533	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/CAMC-947EEC/2020	EPI_ISL_556543	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-6160F2/2020	EPI_ISL_557927	2020-07-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides found at refpos 22189.	info	B.1.36	GH
hCoV-19/England/MILK-9C2FF5/2020	EPI_ISL_566906	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/MILK-9C445E/2020	EPI_ISL_566938	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C3185/2020	EPI_ISL_566940	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-9C39AB/2020	EPI_ISL_566950	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C3E9D/2020	EPI_ISL_566961	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-9C3A8A/2020	EPI_ISL_566962	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C3844/2020	EPI_ISL_566972	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9C8B82/2020	EPI_ISL_567209	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-9C8B73/2020	EPI_ISL_567216	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-9C7EE4/2020	EPI_ISL_567228	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9C842D/2020	EPI_ISL_567238	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/QEUH-9C7D7E/2020	EPI_ISL_567251	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/India/WB-IICB-002/2020	EPI_ISL_569860	2020-09-10	Asia / India / West Bengal	Human	Original			Nanopore MinION	Minimap2			B.1.36	GH
hCoV-19/India/WB-IICB-004/2020	EPI_ISL_569862	2020-09-10	Asia / India / West Bengal	Human	Original			Nanopore MinION	Minimap2			B.1.36	GH
hCoV-19/USA/WA-UW-13102/2020	EPI_ISL_570834	2020-07-01	North America / USA / Washington	Human	Original			Illumina	custom	NSP4_L111stop results in 78.0% truncation of the protein sequence.	info	B.1	GH
hCoV-19/England/ALDP-9BCF67/2020	EPI_ISL_573084	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9CC395/2020	EPI_ISL_573102	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9CC3C2/2020	EPI_ISL_573104	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9CC5AE/2020	EPI_ISL_573114	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9CC632/2020	EPI_ISL_573119	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9CC66F/2020	EPI_ISL_573120	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9CCB8E/2020	EPI_ISL_573128	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9CCC4F/2020	EPI_ISL_573130	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Indonesia/JK-NIHRD-C0027475/2020	EPI_ISL_574433	2020-07-03	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomic Workbench			B.1.459	GH
hCoV-19/England/ALDP-9CAC6F/2020	EPI_ISL_575721	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CAD20/2020	EPI_ISL_575740	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CADF3/2020	EPI_ISL_575741	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CABF9/2020	EPI_ISL_575744	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CB1D8/2020	EPI_ISL_575747	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Australia/NSW2829/2020	EPI_ISL_577604	2020-10-04	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.459	GH
hCoV-19/India/MH-NIV-207705/2020	EPI_ISL_577661	2020-09-11	Asia / India / Maharashtra	Human	Original			Ion Torrent		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/MH-NIV-197096/2020	EPI_ISL_577672	2020-09-05	Asia / India / Maharashtra	Human	Original			Ion Torrent				B.1.36	GH
hCoV-19/New Zealand/20CV0375/2020	EPI_ISL_579113	2020-09-29	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/England/ALDP-9E9FDA/2020	EPI_ISL_580100	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-9E9B30/2020	EPI_ISL_580107	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9E9B6D/2020	EPI_ISL_580257	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9E6799/2020	EPI_ISL_580278	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/NOTT-11518C/2020	EPI_ISL_584793	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/NOTT-11519B/2020	EPI_ISL_584794	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/ALDP-9FD771/2020	EPI_ISL_587744	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9FD7BD/2020	EPI_ISL_587750	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9FD98A/2020	EPI_ISL_587767	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9FCE7D/2020	EPI_ISL_587786	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-9F1B71/2020	EPI_ISL_589601	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-9F193B/2020	EPI_ISL_589629	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9F190E/2020	EPI_ISL_589654	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/QEUH-9B7E14/2020	EPI_ISL_590605	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B72FA/2020	EPI_ISL_590608	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B7324/2020	EPI_ISL_590619	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/Scotland/CVR5082/2020	EPI_ISL_594815	2020-10-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/LOND-126259F/2020	EPI_ISL_594862	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/LOND-12625BD/2020	EPI_ISL_594864	2020-09-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.28	GH
hCoV-19/England/LOND-12625DB/2020	EPI_ISL_594865	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/LOND-126275D/2020	EPI_ISL_594872	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.523	GH
hCoV-19/England/LOND-12627B7/2020	EPI_ISL_594873	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/LOND-12627D5/2020	EPI_ISL_594874	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/LOND-1262869/2020	EPI_ISL_594876	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/LOND-126291B/2020	EPI_ISL_594881	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/MILK-9EEF6C/2020	EPI_ISL_594890	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-9EEFC6/2020	EPI_ISL_594892	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/CAMC-A586A3/2020	EPI_ISL_597054	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A58BE0/2020	EPI_ISL_597085	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A58C74/2020	EPI_ISL_597100	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A57F4F/2020	EPI_ISL_597113	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/England/CAMC-A594C6/2020	EPI_ISL_597146	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A474BC/2020	EPI_ISL_598401	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A47601/2020	EPI_ISL_598485	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Wales/QEUH-9DD8CF/2020	EPI_ISL_599713	2020-09-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DE415/2020	EPI_ISL_599720	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DDD48/2020	EPI_ISL_599724	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DCF8F/2020	EPI_ISL_599738	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DCF61/2020	EPI_ISL_599747	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DDD57/2020	EPI_ISL_599749	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DE503/2020	EPI_ISL_599756	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DE433/2020	EPI_ISL_599782	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DE8CE/2020	EPI_ISL_599785	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-A0067D/2020	EPI_ISL_600477	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9D479E/2020	EPI_ISL_601706	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-9D1D17/2020	EPI_ISL_601715	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/England/MILK-9D4910/2020	EPI_ISL_601738	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-9D1F6C/2020	EPI_ISL_601740	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9D44D3/2020	EPI_ISL_601781	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B8280/2020	EPI_ISL_602140	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A7A4B0/2020	EPI_ISL_606630	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A6E868/2020	EPI_ISL_607970	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.471	GH
hCoV-19/England/ALDP-A6C86A/2020	EPI_ISL_608219	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A6CD6B/2020	EPI_ISL_608240	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-A6FF17/2020	EPI_ISL_608255	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-A6C4C0/2020	EPI_ISL_608266	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A418C5/2020	EPI_ISL_609500	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A41634/2020	EPI_ISL_609524	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-A3E9D7/2020	EPI_ISL_609559	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-A3E6D0/2020	EPI_ISL_609565	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A3ECA1/2020	EPI_ISL_609573	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/England/CAMC-A3F226/2020	EPI_ISL_609587	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/ALDP-A85D3F/2020	EPI_ISL_610522	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-A84D8B/2020	EPI_ISL_610552	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/Denmark/DCGC-3646/2020	EPI_ISL_615418	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-3648/2020	EPI_ISL_615420	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-3696/2020	EPI_ISL_615474	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-3706/2020	EPI_ISL_615484	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-2957/2020	EPI_ISL_616719	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/Denmark/DCGC-2977/2020	EPI_ISL_616739	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1	GH
hCoV-19/Denmark/DCGC-2981/2020	EPI_ISL_616743	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/Denmark/DCGC-2982/2020	EPI_ISL_616744	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/Denmark/DCGC-2931/2020	EPI_ISL_616750	2020-08-24	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.36.22	GH
hCoV-19/Denmark/DCGC-3001/2020	EPI_ISL_616777	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-3013/2020	EPI_ISL_616791	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/Denmark/DCGC-7656/2020	EPI_ISL_618566	2020-10-19	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-7682/2020	EPI_ISL_618570	2020-10-19	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-7718/2020	EPI_ISL_618582	2020-10-19	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-7668/2020	EPI_ISL_618603	2020-10-19	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-7689/2020	EPI_ISL_618612	2020-10-19	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/Denmark/DCGC-5608/2020	EPI_ISL_620933	2020-09-28	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.469	GH
hCoV-19/Denmark/DCGC-1927/2020	EPI_ISL_622520	2020-06-22	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-1836/2020	EPI_ISL_622566	2020-07-06	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1	GH
hCoV-19/England/MILK-AB85C2/2020	EPI_ISL_623819	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-AB74F3/2020	EPI_ISL_623853	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/ALDP-AA39A0/2020	EPI_ISL_624420	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA232B/2020	EPI_ISL_624428	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Denmark/DCGC-8668/2020	EPI_ISL_625716	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-8748/2020	EPI_ISL_626067	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.25	GH
hCoV-19/Denmark/DCGC-8823/2020	EPI_ISL_626104	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-8845/2020	EPI_ISL_626120	2020-10-26	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/England/LOND-1262DE2/2020	EPI_ISL_627460	2020-10-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/LOND-DC2F8/2020	EPI_ISL_627465	2020-08-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.12	GH
hCoV-19/England/LOND-DC304/2020	EPI_ISL_627466	2020-08-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.12	GH
hCoV-19/England/MILK-A18EB6/2020	EPI_ISL_627483	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-AC95EC/2020	EPI_ISL_629226	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-AC86AE/2020	EPI_ISL_629242	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-ACC0E8/2020	EPI_ISL_629244	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ACBF46/2020	EPI_ISL_629257	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-AC7D40/2020	EPI_ISL_629262	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-ACE4EA/2020	EPI_ISL_629274	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/MILK-AC927C/2020	EPI_ISL_629275	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-ACE3B0/2020	EPI_ISL_629289	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-ACDCE3/2020	EPI_ISL_630211	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ACDD86/2020	EPI_ISL_630240	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-AC7645/2020	EPI_ISL_630289	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-AE5043/2020	EPI_ISL_633244	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-AEAB3E/2020	EPI_ISL_633255	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-AEAD65/2020	EPI_ISL_633264	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-AEAC77/2020	EPI_ISL_633294	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-AC80DD/2020	EPI_ISL_634502	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-AD000F/2020	EPI_ISL_634508	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.39	GH
hCoV-19/England/MILK-ACD1C6/2020	EPI_ISL_634509	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-AC7E98/2020	EPI_ISL_634513	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-AD5732/2020	EPI_ISL_634524	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-AD5EE2/2020	EPI_ISL_634554	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AD5ED3/2020	EPI_ISL_634567	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/Norway/4693/2020	EPI_ISL_635197	2020-10-06	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Jordan/AM-ALSR-4040/2020	EPI_ISL_636400	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-4050/2020	EPI_ISL_636410	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-4051/2020	EPI_ISL_636411	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/England/QEUH-B134F4/2020	EPI_ISL_641756	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-B11C1C/2020	EPI_ISL_642209	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B13096/2020	EPI_ISL_642280	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-B0221C/2020	EPI_ISL_642919	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B0AF1D/2020	EPI_ISL_643507	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B0852C/2020	EPI_ISL_643515	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B0B028/2020	EPI_ISL_643517	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/CAMC-B0AD9B/2020	EPI_ISL_643518	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/CAMC-B0AE7A/2020	EPI_ISL_643532	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-B0AE98/2020	EPI_ISL_643536	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B0CD99/2020	EPI_ISL_643541	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B07AB5/2020	EPI_ISL_643546	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B0B0A0/2020	EPI_ISL_643548	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B0B125/2020	EPI_ISL_643567	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B37032/2020	EPI_ISL_645232	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-B2CA7E/2020	EPI_ISL_646523	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/ALDP-B24FB3/2020	EPI_ISL_646537	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-B25F0D/2020	EPI_ISL_646563	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-B24F86/2020	EPI_ISL_646573	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-B21754/2020	EPI_ISL_647168	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-AAB36E/2020	EPI_ISL_651087	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E59stop results in 52.1% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/LIVE-DB4271/2020	EPI_ISL_651095	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1	GH
hCoV-19/England/BIRM-6AA15/2020	EPI_ISL_651098	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A23FD3/2020	EPI_ISL_651099	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/NORW-F7EA8/2020	EPI_ISL_651100	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/NORW-F7EF3/2020	EPI_ISL_651101	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/NORW-F7F2D/2020	EPI_ISL_651102	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-AAAC28/2020	EPI_ISL_651103	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-AAB44D/2020	EPI_ISL_651104	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-AAC78F/2020	EPI_ISL_651105	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-AAC822/2020	EPI_ISL_651106	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B230EE/2020	EPI_ISL_651109	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/NORW-F6AB4/2020	EPI_ISL_652355	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.2	GH
hCoV-19/England/NORW-F6B2A/2020	EPI_ISL_652357	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.2	GH
hCoV-19/England/ALDP-B5B19F/2020	EPI_ISL_655517	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/QEUH-B4024F/2020	EPI_ISL_657173	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B42605/2020	EPI_ISL_657217	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B437C5/2020	EPI_ISL_657228	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B4273F/2020	EPI_ISL_657247	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/QEUH-B40485/2020	EPI_ISL_657259	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-B4028B/2020	EPI_ISL_657281	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B40FB1/2020	EPI_ISL_658595	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/CAMC-B334C1/2020	EPI_ISL_659131	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B33713/2020	EPI_ISL_659136	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/CAMC-B33582/2020	EPI_ISL_659138	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-B33B17/2020	EPI_ISL_659165	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/QEUH-AF513E/2020	EPI_ISL_663001	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AF558D/2020	EPI_ISL_663016	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/LOND-1250F4B/2020	EPI_ISL_665649	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/NOTT-11D825/2020	EPI_ISL_665650	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-AF1590/2020	EPI_ISL_665651	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Wales/PHWC-48B5EC/2020	EPI_ISL_666259	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Japan/IC-0157/2020	EPI_ISL_667586	2020-08-28	Asia / Japan	Human	Original		COVID-19 positive case who entered from Egypt.	Illumina NextSeq500	A5-miseq v. 20140604			B.1	GH
hCoV-19/Japan/IC-0158/2020	EPI_ISL_667587	2020-09-16	Asia / Japan	Human	Original		COVID-19 positive case who entered from Nepal.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/IC-0159/2020	EPI_ISL_667588	2020-09-16	Asia / Japan	Human	Original		COVID-19 positive case who entered from Nepal.	Illumina NextSeq500	A5-miseq v. 20140604			B.1.36	GH
hCoV-19/Japan/IC-0163/2020	EPI_ISL_667592	2020-09-19	Asia / Japan	Human	Original		COVID-19 positive case who entered from India.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Denmark/DCGC-9219/2020	EPI_ISL_668856	2020-11-16	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.8	GH
hCoV-19/Denmark/DCGC-9857/2020	EPI_ISL_669232	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-9891/2020	EPI_ISL_669257	2020-11-09	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.8	GH
hCoV-19/Denmark/DCGC-9895/2020	EPI_ISL_669259	2020-11-09	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-9903/2020	EPI_ISL_669263	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-9908/2020	EPI_ISL_669268	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-9926/2020	EPI_ISL_669277	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-10893/2020	EPI_ISL_670269	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.471	GH
hCoV-19/England/QEUH-BA29FB/2020	EPI_ISL_672840	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B95B31/2020	EPI_ISL_675023	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B9813C/2020	EPI_ISL_675033	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B96F25/2020	EPI_ISL_675050	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-B95A8F/2020	EPI_ISL_675093	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/CAMC-B986B5/2020	EPI_ISL_675094	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/Saudi Arabia/KAUST-RIYADH1207/2020	EPI_ISL_678204	2020-06-15	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-RIYADH1215/2020	EPI_ISL_678207	2020-06-05	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-RIYADH1216/2020	EPI_ISL_678208	2020-06-15	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-RIYADH1219/2020	EPI_ISL_678209	2020-06-05	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-RIYADH1241/2020	EPI_ISL_678213	2020-08-11	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.36.10	GH
hCoV-19/Saudi Arabia/KAUST-RIYADH1250/2020	EPI_ISL_678216	2020-08-11	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-RIYADH1254/2020	EPI_ISL_678218	2020-07-29	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.36.10	GH
hCoV-19/Saudi Arabia/KAUST-RIYADH1261/2020	EPI_ISL_678220	2020-07-18	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-RIYADH1267/2020	EPI_ISL_678224	2020-07-18	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-RIYADH1268/2020	EPI_ISL_678225	2020-07-18	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.36.10	G
hCoV-19/Saudi Arabia/KAUST-MAKKAH1610/2020	EPI_ISL_678246	2020-04-26	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B	O
hCoV-19/Bahrain/600041988_S21_L001/2020	EPI_ISL_678261	2020-11-22	Asia / Bahrain	Human	Original	Nasopharyngeal swab		Illumina	Aviomix v. 1.0			B.1.36	GH
hCoV-19/England/LOND-1263EFD/2020	EPI_ISL_679502	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/LOND-126407E/2020	EPI_ISL_679518	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/LOND-1264111/2020	EPI_ISL_679526	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/New Zealand/20CV0604/2020	EPI_ISL_682283	2020-11-25	Oceania / New Zealand / Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.471	GH
hCoV-19/New Zealand/20CV0607/2020	EPI_ISL_682286	2020-11-25	Oceania / New Zealand / Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.471	GH
hCoV-19/New Zealand/20CV0619/2020	EPI_ISL_682295	2020-11-27	Oceania / New Zealand / Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.471	GH
hCoV-19/New Zealand/20CV0625/2020	EPI_ISL_682296	2020-11-30	Oceania / New Zealand / Canterbury	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.471	GH
hCoV-19/Switzerland/BL-ETHZ-360005/2020	EPI_ISL_693865	2020-11-12	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina Miseq	V-pipe			B.1.36.1	GH
hCoV-19/United Arab Emirates/0906/2020	EPI_ISL_699044	2020-06-26	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			B.1.36	GH
hCoV-19/England/ALDP-BB3D28/2020	EPI_ISL_701835	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/England/ALDP-BBA680/2020	EPI_ISL_702405	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/ALDP-BBA69F/2020	EPI_ISL_702410	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/ALDP-BBA644/2020	EPI_ISL_702415	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/ALDP-BBA723/2020	EPI_ISL_702430	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/ALDP-BBA5CF/2020	EPI_ISL_702434	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/ALDP-BB9320/2020	EPI_ISL_702457	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/ALDP-BBA608/2020	EPI_ISL_702462	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/NORW-F750D/2020	EPI_ISL_705431	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/Wales/PHWC-491B4B/2020	EPI_ISL_706746	2020-11-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/CAMC-BDD03E/2020	EPI_ISL_709808	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BE7040/2020	EPI_ISL_709823	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BE717A/2020	EPI_ISL_709860	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.21	GH
hCoV-19/England/MILK-BE7356/2020	EPI_ISL_709881	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/MILK-B56088/2020	EPI_ISL_709902	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B021F1/2020	EPI_ISL_709910	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ACFFD9/2020	EPI_ISL_709913	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.39	GH
hCoV-19/England/MILK-A7A15F/2020	EPI_ISL_709941	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Denmark/DCGC-14414/2020	EPI_ISL_711266	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Denmark/DCGC-14510/2020	EPI_ISL_711267	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Denmark/DCGC-13043/2020	EPI_ISL_712550	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Tunisia/ADAGE-17149/2020	EPI_ISL_712568	2020-09-29	Africa / Tunisia / Sfax	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/Denmark/DCGC-15439/2020	EPI_ISL_713827	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-15544/2020	EPI_ISL_713880	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/England/MILK-BB271C/2020	EPI_ISL_720207	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/Japan/IC-0353/2020	EPI_ISL_721568	2020-12-01	Asia / Japan	Human	Original			Illumina NextSeq500	SKESA v. 2.3.0	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.459	GH
hCoV-19/Japan/IC-0334/2020	EPI_ISL_721581	2020-11-15	Asia / Japan	Human	Original			Illumina NextSeq500	SKESA v. 2.3.0			B.1	GH
hCoV-19/Japan/IC-0337/2020	EPI_ISL_721584	2020-11-17	Asia / Japan	Human	Original			Illumina NextSeq500	SKESA v. 2.3.0			B.1.36.22	GH
hCoV-19/Japan/IC-0342/2020	EPI_ISL_721587	2020-11-20	Asia / Japan	Human	Original			Illumina NextSeq500	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/IC-0346/2020	EPI_ISL_721591	2020-11-24	Asia / Japan	Human	Original			Illumina NextSeq500	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/IC-0348/2020	EPI_ISL_721593	2020-11-27	Asia / Japan	Human	Original			Illumina NextSeq500	SKESA v. 2.3.0			B.1.470	GH
hCoV-19/Japan/IC-0349/2020	EPI_ISL_721594	2020-11-27	Asia / Japan	Human	Original			Illumina NextSeq500	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Netherlands/NB-EMC-454/2020	EPI_ISL_722803	2020-07-14	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-455/2020	EPI_ISL_722804	2020-07-15	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-457/2020	EPI_ISL_722806	2020-07-17	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-458/2020	EPI_ISL_722807	2020-07-18	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-459/2020	EPI_ISL_722808	2020-07-19	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-463/2020	EPI_ISL_722810	2020-07-24	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-464/2020	EPI_ISL_722811	2020-07-25	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-468/2020	EPI_ISL_722813	2020-07-29	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-469/2020	EPI_ISL_722814	2020-07-31	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/OV-RIVM-20117/2020	EPI_ISL_723292	2020-11-17	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/England/LOND-1264BF5/2020	EPI_ISL_724545	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/LOND-1264C6B/2020	EPI_ISL_724552	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/LOND-1264DB3/2020	EPI_ISL_724567	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/NORW-21F6CE/2020	EPI_ISL_725041	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-21F761/2020	EPI_ISL_725047	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-21F910/2020	EPI_ISL_725062	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-21FA1D/2020	EPI_ISL_725064	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-21FEC6/2020	EPI_ISL_725077	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-21FF1E/2020	EPI_ISL_725078	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-220C40/2020	EPI_ISL_725082	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-220CE6/2020	EPI_ISL_725085	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/PORT-2E9A1C/2020	EPI_ISL_727755	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Jordan/AM-ALSR-5153/2020	EPI_ISL_730392	2020-10-16	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5159/2020	EPI_ISL_730398	2020-10-18	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Thailand/SamutSakhon-CONI-0334/2020	EPI_ISL_733528	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0335/2020	EPI_ISL_733529	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0336/2020	EPI_ISL_733530	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0337/2020	EPI_ISL_733531	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0338/2020	EPI_ISL_733532	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0339/2020	EPI_ISL_733533	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0340/2020	EPI_ISL_733534	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0341/2020	EPI_ISL_733535	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0342/2020	EPI_ISL_733536	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0343/2020	EPI_ISL_733537	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0344/2020	EPI_ISL_733538	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0345/2020	EPI_ISL_733539	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0346/2020	EPI_ISL_733540	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0347/2020	EPI_ISL_733541	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0348/2020	EPI_ISL_733542	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0349/2020	EPI_ISL_733543	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0350/2020	EPI_ISL_733544	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0351/2020	EPI_ISL_733545	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0352/2020	EPI_ISL_733546	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0354/2020	EPI_ISL_733548	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0355/2020	EPI_ISL_733549	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0356/2020	EPI_ISL_733550	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0359/2020	EPI_ISL_733553	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0360/2020	EPI_ISL_733554	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0361/2020	EPI_ISL_733555	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0362/2020	EPI_ISL_733556	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0363/2020	EPI_ISL_733557	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0364/2020	EPI_ISL_733558	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0365/2020	EPI_ISL_733559	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0366/2020	EPI_ISL_733560	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0367/2020	EPI_ISL_733561	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0368/2020	EPI_ISL_733562	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0369/2020	EPI_ISL_733563	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0371/2020	EPI_ISL_733565	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0373/2020	EPI_ISL_733567	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, 2 x 150bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/env/Hong Kong/VN20001008/2020	EPI_ISL_733568	2020-12-10	Asia / Hong Kong	Environment	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Hong Kong/VB20275039/2020	EPI_ISL_733569	2020-11-24	Asia / Hong Kong	Human	Original	Throat saliva		Illumina MiSeq				B.1.36.27	GH
hCoV-19/Hong Kong/VM20192019/2020	EPI_ISL_733570	2020-12-16	Asia / Hong Kong	Human	Original	Nasopharyngeal swab and Throat swab		Illumina MiSeq				B.1.36	GH
hCoV-19/Belgium/rega-0719696/2020	EPI_ISL_734801	2020-07-19	Europe / Belgium / Landen	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1	GH
hCoV-19/Belgium/rega-0723820/2020	EPI_ISL_734825	2020-07-23	Europe / Belgium / Deurne	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.22	GH
hCoV-19/Belgium/rega-0801800/2020	EPI_ISL_734863	2020-08-01	Europe / Belgium / Brugge	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.22	GH
hCoV-19/Belgium/rega-0803755/2020	EPI_ISL_734898	2020-08-03	Europe / Belgium / Vosselaar	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1	GH
hCoV-19/England/ALDP-C48598/2020	EPI_ISL_736526	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-C504DC/2020	EPI_ISL_736542	2020-12-11	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.36.39	GH
hCoV-19/England/ALDP-C485A7/2020	EPI_ISL_736545	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-C48AD5/2020	EPI_ISL_736577	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.36.17	GH
hCoV-19/Finland/S10E4/2020	EPI_ISL_737034	2020-08-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S10AE4/2020	EPI_ISL_737037	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S10AG10/2020	EPI_ISL_737038	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/S10AH10/2020	EPI_ISL_737039	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S10AH9/2020	EPI_ISL_737040	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/S12AH3/2020	EPI_ISL_737041	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S4AA5/2020	EPI_ISL_737045	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/S4AB3/2020	EPI_ISL_737046	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/S4AD5/2020	EPI_ISL_737047	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/S4BD9/2020	EPI_ISL_737048	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S4BG9/2020	EPI_ISL_737049	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S6AA10/2020	EPI_ISL_737050	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S6AB2/2020	EPI_ISL_737051	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/S6AC11/2020	EPI_ISL_737052	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/S6AH10/2020	EPI_ISL_737053	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/S7AA11/2020	EPI_ISL_737054	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/S8AA11/2020	EPI_ISL_737055	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S8AC11/2020	EPI_ISL_737056	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S8AC7/2020	EPI_ISL_737057	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S8AE4/2020	EPI_ISL_737058	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S8AG2/2020	EPI_ISL_737059	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/S9BC1/2020	EPI_ISL_737060	2020-10-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/S12A1/2020	EPI_ISL_737061	2020-09-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/S20B7/2020	EPI_ISL_737063	2020-09-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S11AA3/2020	EPI_ISL_737070	2020-10-11	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S12H7/2020	EPI_ISL_737072	2020-10-11	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S16BC7/2020	EPI_ISL_737073	2020-10-11	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.463	GH
hCoV-19/Finland/S17AD11/2020	EPI_ISL_737074	2020-10-11	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S19AB3/2020	EPI_ISL_737075	2020-10-11	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/S22AB1/2020	EPI_ISL_737078	2020-10-11	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S6AD1/2020	EPI_ISL_737079	2020-10-11	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/S9A4/2020	EPI_ISL_737080	2020-10-11	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Canada/BC-BCCDC-7299/2020	EPI_ISL_740668	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7300/2020	EPI_ISL_740669	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7301/2020	EPI_ISL_740670	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7314/2020	EPI_ISL_740678	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7316/2020	EPI_ISL_740680	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7320/2020	EPI_ISL_740683	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7527/2020	EPI_ISL_740695	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7529/2020	EPI_ISL_740697	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7530/2020	EPI_ISL_740698	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7547/2020	EPI_ISL_740710	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.26	GH
hCoV-19/Canada/BC-BCCDC-7550/2020	EPI_ISL_740713	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7552/2020	EPI_ISL_740715	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7555/2020	EPI_ISL_740717	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7557/2020	EPI_ISL_740719	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.26	GH
hCoV-19/Canada/BC-BCCDC-7563/2020	EPI_ISL_740724	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7576/2020	EPI_ISL_740731	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7587/2020	EPI_ISL_740735	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7593/2020	EPI_ISL_740740	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7601/2020	EPI_ISL_740746	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8360/2020	EPI_ISL_740751	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8370/2020	EPI_ISL_740759	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8380/2020	EPI_ISL_740764	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8384/2020	EPI_ISL_740766	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8409/2020	EPI_ISL_740781	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8413/2020	EPI_ISL_740785	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/England/CAMC-B79E85/2020	EPI_ISL_741056	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.39	GH
hCoV-19/England/CAMC-B79F37/2020	EPI_ISL_741065	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.1	GH
hCoV-19/England/CAMC-B7A31C/2020	EPI_ISL_741098	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.469	GH
hCoV-19/USA/WA-UW-45077/2020	EPI_ISL_747204	2020-12-08	North America / USA / Washington	Human	Original	NA		Illumina	custom			B.1.36.8	GH
hCoV-19/Indonesia/JK-NIHRD-IST002/2020	EPI_ISL_747233	2020-09-18	Asia / Indonesia / Jakarta	Human	VeroE6/P3	Nasopharyngeal swab		Illumina Miseq	Dragen RNA Pathogen Detection			B.1.459	GH
hCoV-19/South Korea/KDCA0032/2020	EPI_ISL_747271	2020-08-29	Asia / South Korea	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/Denmark/DCGC-18766/2020	EPI_ISL_748543	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18809/2020	EPI_ISL_748569	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18843/2020	EPI_ISL_748592	2020-12-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18848/2020	EPI_ISL_748595	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-19651/2020	EPI_ISL_749084	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-19664/2020	EPI_ISL_749095	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-19695/2020	EPI_ISL_749117	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18311/2020	EPI_ISL_749883	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18526/2020	EPI_ISL_750021	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18571/2020	EPI_ISL_750052	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18598/2020	EPI_ISL_750071	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18617/2020	EPI_ISL_750083	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1	GH
hCoV-19/Denmark/DCGC-17179/2020	EPI_ISL_750806	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-17244/2020	EPI_ISL_750851	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-17250/2020	EPI_ISL_750855	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/India/DL-IGIB11305069/2020	EPI_ISL_751313	2020-08	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-IGIB11305043/2020	EPI_ISL_751316	2020-08	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36.8	GH
hCoV-19/India/DL-IGIB11304171/2020	EPI_ISL_751317	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/England/205260873/2020	EPI_ISL_754330	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.39	GH
hCoV-19/Canada/ON-S1944/2020	EPI_ISL_755664	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1946/2020	EPI_ISL_755666	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1952/2020	EPI_ISL_755672	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1954/2020	EPI_ISL_755674	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.26	GH
hCoV-19/Canada/ON-S1962/2020	EPI_ISL_755678	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.36	GH
hCoV-19/Canada/ON-S1963/2020	EPI_ISL_755679	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Finland/17SS10A7/2020	EPI_ISL_756249	2020-09-17	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/17SS13C11/2020	EPI_ISL_756250	2020-09-17	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/17SS4A7/2020	EPI_ISL_756252	2020-09-17	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/18ES6AH10/2020	EPI_ISL_756284	2020-08-18	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/18LS10AC5/2020	EPI_ISL_756285	2020-10-18	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/18LS2AB7/2020	EPI_ISL_756287	2020-10-18	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/18SS11E3/2020	EPI_ISL_756288	2020-09-18	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/18SS12E4/2020	EPI_ISL_756289	2020-09-18	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/18SS20D3/2020	EPI_ISL_756290	2020-09-18	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/18SS6E7/2020	EPI_ISL_756291	2020-09-18	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/18SS6F5/2020	EPI_ISL_756292	2020-09-18	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Denmark/DCGC-22471/2020	EPI_ISL_757579	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-20639/2020	EPI_ISL_759268	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/QEUH-C935CB/2020	EPI_ISL_762017	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-C81E4D/2020	EPI_ISL_762825	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/ALDP-C889AF/2020	EPI_ISL_762841	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/205120464/2020	EPI_ISL_766304	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.39	GH
hCoV-19/England/205120470/2020	EPI_ISL_766305	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.39	GH
hCoV-19/England/205120471/2020	EPI_ISL_766306	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.39	GH
hCoV-19/England/205120473/2020	EPI_ISL_766307	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.39	GH
hCoV-19/England/205120481/2020	EPI_ISL_766308	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.39	GH
hCoV-19/England/205120484/2020	EPI_ISL_766309	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.39	GH
hCoV-19/Norway/6702/2020	EPI_ISL_775305	2020-12-04	Europe / Norway / Vestfold og Telemark	Human	Original	Nasopharyngeal aspirate		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.21	GH
hCoV-19/Norway/4694/2020	EPI_ISL_775318	2020-10-07	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5389/2020	EPI_ISL_775324	2020-10-22	Europe / Norway / Vestland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.1	GH
hCoV-19/Norway/5857/2020	EPI_ISL_775338	2020-11-15	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5900/2020	EPI_ISL_775348	2020-11-22	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/6242/2020	EPI_ISL_775360	2020-11-23	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.22	GH
hCoV-19/Norway/6429/2020	EPI_ISL_775387	2020-11-25	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/6430/2020	EPI_ISL_775388	2020-11-18	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/6432/2020	EPI_ISL_775389	2020-11-28	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/6433/2020	EPI_ISL_775390	2020-11-25	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/England/ALDP-C8C11C/2020	EPI_ISL_777027	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/MILK-C90458/2020	EPI_ISL_777056	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/MILK-C6C9CF/2020	EPI_ISL_778370	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/Australia/VIC17992/2020	EPI_ISL_779607	2020	Oceania / Australia / Victoria	Human	Original			Illumina iSeq	ARTIC v3, minimap2 v2.17, ivar v1.3, samtools v1.11			B.1.36	GH
hCoV-19/Japan/IC-0601/2021	EPI_ISL_779687	2021-01-02	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina iSeq	bwa v. 0.7.13-r1126, picard v. 2.10.10, GATK v. 3.8.0, VarScan v. 2.4.3, VCFtools v. 0.1.12b, SKESA v. 2.3.0, A5-miseq v. 20140604			B.1.466.2	GH
hCoV-19/Japan/IC-0602/2021	EPI_ISL_779688	2021-01-02	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina iSeq	A5-miseq v. 20140604			B.1.466.2	GH
hCoV-19/Japan/IC-0613/2020	EPI_ISL_779699	2020-11-03	Asia / Japan	Human	Original		COVID-19 positive case who entered from Afghanistan.	Illumina iSeq	A5-miseq v. 20140604	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/England/QEUH-C32616/2020	EPI_ISL_782504	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-C31AFD/2020	EPI_ISL_782528	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-C31B90/2020	EPI_ISL_782554	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/USA/TX-HMH-MCoV-19403/2020	EPI_ISL_783819	2020-11-30	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.36	GH
hCoV-19/USA/TX-HMH-MCoV-19446/2020	EPI_ISL_783844	2020-11-30	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.36	GH
hCoV-19/USA/TX-HMH-MCoV-15374/2020	EPI_ISL_786858	2020-10-23	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.396	GH
hCoV-19/USA/TX-HMH-MCoV-15379/2020	EPI_ISL_786863	2020-10-21	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.596	G
hCoV-19/USA/TX-HMH-MCoV-12711/2020	EPI_ISL_789928	2020-08-31	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3	NSP2_S32stop results in 95.1% truncation of the protein sequence. NSP3_Q1555stop results in 20.1% truncation of the protein sequence.	info	B.1	G
hCoV-19/Denmark/DCGC-23763/2020	EPI_ISL_793919	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-23877/2020	EPI_ISL_793981	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-24910/2020	EPI_ISL_795803	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-25012/2020	EPI_ISL_795869	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/QEUH-D11FD5/2020	EPI_ISL_799332	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/MILK-D1DE36/2020	EPI_ISL_799334	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-C22B29/2020	EPI_ISL_800811	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/MILK-C228D7/2020	EPI_ISL_800822	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/MILK-C22AE0/2020	EPI_ISL_800849	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-C2288C/2020	EPI_ISL_800877	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/MILK-BB11A6/2020	EPI_ISL_801189	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/MILK-BAFFA1/2020	EPI_ISL_801224	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B82760/2020	EPI_ISL_801240	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/USA/CA-QDX-2782/2020	EPI_ISL_803017	2020-12-26	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.523	GH
hCoV-19/Indonesia/KU-NIHRD-PME9235/2020	EPI_ISL_803876	2020-10-23	Asia / Indonesia / North Kalimantan	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.15			B.1	GH
hCoV-19/England/205240373/2020	EPI_ISL_804357	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/205241696/2020	EPI_ISL_804358	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/205241703/2020	EPI_ISL_804359	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/205241705/2020	EPI_ISL_804360	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/Netherlands/FL-RIVM-10207/2020	EPI_ISL_804388	2020-04-14	Europe / Netherlands / Flevoland	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/NH-RIVM-10180/2020	EPI_ISL_804393	2020-03-26	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/NH-RIVM-10216/2020	EPI_ISL_804405	2020-04-12	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/NH-RIVM-10219/2020	EPI_ISL_804406	2020-03-17	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/NH-RIVM-10221/2020	EPI_ISL_804407	2020-04-15	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/NH-RIVM-10224/2020	EPI_ISL_804409	2020-03-31	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Egypt/CCHE57357-A-46/2020	EPI_ISL_812819	2020-08-03	Africa / Egypt	Human	Original	Nasal swab		Illumina	BWA v. 0.7.17			B.1	GH
hCoV-19/Egypt/CCHE57357-A-53/2020	EPI_ISL_812826	2020-06-18	Africa / Egypt	Human	Original	Nasal swab		Illumina	BWA v. 0.7.17			B.1	GH
hCoV-19/Egypt/CCHE57357-A-93/2020	EPI_ISL_812849	2020-07-16	Africa / Egypt	Human	Original	Nasal swab		Illumina	BWA v. 0.7.17			B.1	GH
hCoV-19/Egypt/CCHE57357-P-01/2020	EPI_ISL_812850	2020-06-18	Africa / Egypt	Human	Original	Nasal swab		Illumina	BWA v. 0.7.17			B.1	O
hCoV-19/Egypt/CCHE57357-P-03/2020	EPI_ISL_812851	2020-08-11	Africa / Egypt	Human	Original	Nasal swab		Illumina	BWA v. 0.7.17			B.1	GH
hCoV-19/Egypt/CCHE57357-P-10/2020	EPI_ISL_812852	2020-08-03	Africa / Egypt	Human	Original	Nasal swab		Illumina	BWA v. 0.7.17			B.1	G
hCoV-19/Egypt/CCHE57357-P-14/2020	EPI_ISL_812853	2020-06-11	Africa / Egypt	Human	Original	Nasal swab		Illumina	BWA v. 0.7.17			B	O
hCoV-19/Egypt/CCHE57357-P-16/2020	EPI_ISL_812854	2020-06-22	Africa / Egypt	Human	Original	Nasal swab		Illumina	BWA v. 0.7.17			B.1	GH
hCoV-19/Egypt/CCHE57357-P-17/2020	EPI_ISL_812855	2020-07-05	Africa / Egypt	Human	Original	Nasal swab		Illumina	BWA v. 0.7.17			B.1	O
hCoV-19/Egypt/CCHE57357-P-20/2020	EPI_ISL_812856	2020-06-26	Africa / Egypt	Human	Original	Nasal swab		Illumina	BWA v. 0.7.17			B.1	GH
hCoV-19/Egypt/CCHE57357-P-45/2020	EPI_ISL_812872	2020-06-26	Africa / Egypt	Human	Original	Nasal swab		Illumina	BWA v. 0.7.17			B.1	O
hCoV-19/Turkey/HSGM-17613/2020	EPI_ISL_812883	2020-12-20	Europe / Turkey / Ankara	Human	Orginal	Oropharyngeal swab		Illumina Miseq	Burrows-Wheeler Alignerv.07.17-r1188			B.1	GH
hCoV-19/Turkey/HSGM-AD9/2020	EPI_ISL_812891	2020-12-21	Europe / Turkey / Ankara	Human	Orginal	Oropharyngeal swab		Illumina Miseq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.469	GH
hCoV-19/Turkey/HSGM-AD12/2020	EPI_ISL_812893	2020-12-21	Europe / Turkey / Ankara	Human	Orginal	Oropharyngeal swab		Illumina Miseq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.469	GH
hCoV-19/England/BIRM-6E2DD/2020	EPI_ISL_813139	2020-12-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/BIRM-6E370/2020	EPI_ISL_813145	2020-12-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMB-1B60BD/2020	EPI_ISL_813160	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/Wales/PHWC-4A73D1/2020	EPI_ISL_814577	2020-12-01	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-27748/2020	EPI_ISL_815870	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/SHEF-10C9228/2021	EPI_ISL_816309	2021-01-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.24	GH
hCoV-19/Denmark/DCGC-26594/2021	EPI_ISL_817649	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-26697/2020	EPI_ISL_817710	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-26717/2020	EPI_ISL_817722	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-25846/2021	EPI_ISL_818982	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/ALDP-C6A7A9/2020	EPI_ISL_820334	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/CAMC-DD8ECE/2020	EPI_ISL_821667	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/QEUH-E8F180/2021	EPI_ISL_835548	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/ALDP-E8762F/2021	EPI_ISL_836859	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/205120212/2020	EPI_ISL_837200	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.24	GH
hCoV-19/England/NOTT-246B92/2020	EPI_ISL_840032	2020-12-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/NOTT-246C17/2020	EPI_ISL_840037	2020-12-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/NOTT-246CCC/2020	EPI_ISL_840042	2020-12-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/NOTT-246CEA/2020	EPI_ISL_840043	2020-12-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/NOTT-246D32/2020	EPI_ISL_840048	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/Norway/0180/2021	EPI_ISL_842638	2021-01-04	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.1	GH
hCoV-19/Norway/0179/2021	EPI_ISL_842640	2021-01-04	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.1	GH
hCoV-19/Denmark/DCGC-29929/2020	EPI_ISL_843976	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/England/ALDP-F82F64/2021	EPI_ISL_846211	2021-01-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/Wales/ALDP-EE6C86/2021	EPI_ISL_858151	2021-01-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/United Arab Emirates/1384/2020	EPI_ISL_859570	2020-08-28	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1	G
hCoV-19/United Arab Emirates/1387/2020	EPI_ISL_859572	2020-08-28	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1	GH
hCoV-19/United Arab Emirates/1780/2020	EPI_ISL_859581	2020-07-05	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq		Insertion of 7 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Norway/Trondheim220-S3/2020	EPI_ISL_860550	2020-09-17	Europe / Norway / Trondelag / Trondheim	Human	Vero-E6			Illumina NextSeq 500/550 Mid				B.1.36	GH
hCoV-19/Finland/28ES14AC6/2020	EPI_ISL_862103	2020-09-28	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28SS9B4/2020	EPI_ISL_862105	2020-09-28	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28SS4F2/2020	EPI_ISL_862106	2020-09-28	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/28SS7E10/2020	EPI_ISL_862109	2020-09-28	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/28SS7G1/2020	EPI_ISL_862112	2020-09-28	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/27SS12B9/2020	EPI_ISL_862113	2020-09-27	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/27SS15D10/2020	EPI_ISL_862114	2020-09-27	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/27SS15D9/2020	EPI_ISL_862115	2020-09-27	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/27SS2D9/2020	EPI_ISL_862116	2020-09-27	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/27SS2H11/2020	EPI_ISL_862117	2020-09-27	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/27SS4E10/2020	EPI_ISL_862118	2020-09-27	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/27SS7C9/2020	EPI_ISL_862119	2020-09-27	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/27SS9A7/2020	EPI_ISL_862120	2020-09-27	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Switzerland/SG-32922614/2021	EPI_ISL_864719	2021-01-07	Europe / Switzerland / Sankt Gallen	Human	Original			Illumina NovaSeq		Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/England/CAMB-A9A0E3/2020	EPI_ISL_864752	2020-12-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/Denmark/DCGC-34144/2021	EPI_ISL_871154	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Ireland/WD-NVRL-82IRL88509/2021	EPI_ISL_875457	2021-01-08	Europe / Ireland / Waterford	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol	Gap of 29 nucleotides when compared to the reference sequence.	info	B.1.562	GH
hCoV-19/Ireland/KY-NVRL-82IRL83255/2021	EPI_ISL_875480	2021-01-07	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol	Gap of 29 nucleotides when compared to the reference sequence.	info	B.1.562	GH
hCoV-19/USA/NY-CDC-STM-A100289/2021	EPI_ISL_876712	2021-01-05	North America / USA / New York	Human	Original	Nasal swab	screened by S dropout	Illumina	COVIDSEQ			B.1.36.38	GH
hCoV-19/England/ALDP-100EA3E/2021	EPI_ISL_881273	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-10B5DA6/2021	EPI_ISL_885751	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-10B6130/2021	EPI_ISL_885778	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-10B6367/2021	EPI_ISL_885799	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Czech Republic/IAB20_016_065/2020	EPI_ISL_889384	2020-04-04	Europe / Czech Republic / Olomouc	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, reference mapping			B.1.22	GH
hCoV-19/England/CAMC-10A0A01/2021	EPI_ISL_891635	2021-01-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/Switzerland/GE-32962295/2021	EPI_ISL_897748	2021-01-14	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Switzerland/GE-32977230/2021	EPI_ISL_897787	2021-01-15	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Finland/27MR10CA4_S272/2020	EPI_ISL_902790	2020-11-27	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/27MR10CC12_S274/2020	EPI_ISL_902792	2020-11-27	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/27MR18CH5_S261/2020	EPI_ISL_902796	2020-11-27	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/27MR18CH8_S262/2020	EPI_ISL_902797	2020-11-27	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/27MR1CE8_S258/2020	EPI_ISL_902800	2020-11-27	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/27MR4CC10_S267/2020	EPI_ISL_902802	2020-11-27	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/27MR6CE1_S276/2020	EPI_ISL_902806	2020-11-27	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/27MR7CE5_S270/2020	EPI_ISL_902807	2020-11-27	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28MR15CH3_S310/2020	EPI_ISL_902813	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28MR17CG5_S327/2020	EPI_ISL_902815	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28MR1CB2_S97/2020	EPI_ISL_902816	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28MR1CG11_S102/2020	EPI_ISL_902817	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28MR1CH4_S98/2020	EPI_ISL_902818	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28MR20CE3_S324/2020	EPI_ISL_902819	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28MR2CB12_S321/2020	EPI_ISL_902822	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28MR2CC12_S322/2020	EPI_ISL_902823	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28MR2CD12_S323/2020	EPI_ISL_902825	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28MR2CE11_S320/2020	EPI_ISL_902827	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28MR2CH8_S318/2020	EPI_ISL_902831	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.8	GH
hCoV-19/Finland/28MR6CC12_S301/2020	EPI_ISL_902835	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28MR6CE1_S302/2020	EPI_ISL_902836	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28MR6CF11_S303/2020	EPI_ISL_902837	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28MR7CB7_S284/2020	EPI_ISL_902839	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28MR8CA2_S304/2020	EPI_ISL_902840	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28MR8CC3_S306/2020	EPI_ISL_902844	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/28MR9CF8_S290/2020	EPI_ISL_902849	2020-11-28	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/30J1DA1_S128/2020	EPI_ISL_902860	2020-12-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/30J3DF11_S117/2020	EPI_ISL_902864	2020-12-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/30J6DC6_S116/2020	EPI_ISL_902866	2020-12-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/30J7DC7_S122/2020	EPI_ISL_902868	2020-12-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/30J7DD7_S123/2020	EPI_ISL_902869	2020-12-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/30J7DG1_S121/2020	EPI_ISL_902871	2020-12-30	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/31J13DA3_S137/2020	EPI_ISL_902875	2020-12-31	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/31J14DC5_S134/2020	EPI_ISL_902879	2020-12-31	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/31J14DC7_S136/2020	EPI_ISL_902880	2020-12-31	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/31J14DE3_S132/2020	EPI_ISL_902881	2020-12-31	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7T5DA3_S170/2021	EPI_ISL_902891	2021-01-07	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7T5DG1_S169/2021	EPI_ISL_902893	2021-01-07	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/8T19DE1_S176/2021	EPI_ISL_902895	2021-01-08	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Netherlands/LI-EMC-273/2020	EPI_ISL_904434	2020-10-15	Europe / Netherlands / Limburg	Human	Original			Illumina				B.1.22	GH
hCoV-19/Indonesia/YO-UGM-124764/2020	EPI_ISL_905731	2020-12-23	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.468	GH
hCoV-19/Nigeria/CV607/2020	EPI_ISL_906300	2020-12-17	Africa / Nigeria / Kwara State	Human	Original			Illumina Miseq	viral-ngs v2.1.18	NS8_E106stop results in 13.2% truncation of the protein sequence. Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.462	GH
hCoV-19/England/MILK-1084C2B/2021	EPI_ISL_908934	2021-01-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-AO864/2020	EPI_ISL_910291	2020-09-29	Asia / India / Telangana	Human	Original	Nasopharyngeal swab/Oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Canada/NS-NML-959/2020	EPI_ISL_914982	2020-03-28	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.22	GH
hCoV-19/Canada/NS-NML-1233/2020	EPI_ISL_914986	2020-04-04	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.22	GH
hCoV-19/Canada/ON-PHL-21-00522/2020	EPI_ISL_925646	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00523/2020	EPI_ISL_925647	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Denmark/DCGC-35645/2021	EPI_ISL_926786	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-35678/2021	EPI_ISL_926819	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-35680/2021	EPI_ISL_926821	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-35718/2020	EPI_ISL_926859	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-37307/2021	EPI_ISL_928448	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-37311/2021	EPI_ISL_928452	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-38570/2021	EPI_ISL_929711	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-38935/2021	EPI_ISL_930077	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-38956/2021	EPI_ISL_930098	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Switzerland/BL-UHB-42575295/2020	EPI_ISL_931391	2020-12-05	Europe / Switzerland / Basel-Stadt / Basel	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	In-house pipelIne COVGAP	Long stretches of NNNs (6.50% of overall sequence). E without BLAST coverage.	alert	B.1.160.14	GH
hCoV-19/Canada/MB-NML-1118/2020	EPI_ISL_937514	2020-08-05	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Singapore/128/2021	EPI_ISL_937518	2021-01-30	Asia / Singapore	Human	Original			Illumina MiSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Singapore/129/2021	EPI_ISL_937519	2021-01-31	Asia / Singapore	Human	Original			Illumina MiSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Netherlands/NB-RIVM-11276/2021	EPI_ISL_943399	2021-01-05	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Ghana/WACCBIP-GS122/2021	EPI_ISL_944652	2021-01-02	Africa / Ghana	Human	Original	Nasopharyngeal / oropharyngeal		MinION	Artic v. 1.1.3	Insertion of 1 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Scotland/QEUH-1189CE9/2021	EPI_ISL_945917	2021-01-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/England/CAMC-1164437/2021	EPI_ISL_948180	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/CAMB-A9F6DD/2021	EPI_ISL_949469	2021-01-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.39	G
hCoV-19/Indonesia/JK-NIHRD-MI210121/2021	EPI_ISL_953427	2021-01-03	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1.466.2	GH
hCoV-19/Belgium/Jessa_55-2105-000321/2021	EPI_ISL_953448	2021-02-01	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.36.38	GH
hCoV-19/North Macedonia/30754/2021	EPI_ISL_957966	2021-01-07	Europe / North Macedonia / Tetovo	Human	Original	Nasopharyngeal swab		Illumina MiSeq / Respiratory Virus Oligo Panel	Illumina BaseSpace / DRAGEN_RNA_Pathogen_Detection			B.1.36	GH
hCoV-19/England/ALDP-11B9D1A/2021	EPI_ISL_964114	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Canada/ON-PHL-21-00598/2021	EPI_ISL_966077	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/Canada/ON-PHL-21-00582/2021	EPI_ISL_966081	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00737/2021	EPI_ISL_966083	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 22 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00736/2021	EPI_ISL_966085	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 22 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00735/2021	EPI_ISL_966086	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 22 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00731/2021	EPI_ISL_966087	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 22 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00730/2021	EPI_ISL_966088	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 22 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00570/2021	EPI_ISL_966090	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/ON-PHL-21-00609/2021	EPI_ISL_966091	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00566/2021	EPI_ISL_966092	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00567/2021	EPI_ISL_966093	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00587/2021	EPI_ISL_966094	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00617/2021	EPI_ISL_966095	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00618/2021	EPI_ISL_966096	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36	GH
hCoV-19/Canada/ON-PHL-21-00593/2021	EPI_ISL_966097	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00589/2021	EPI_ISL_966098	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00586/2021	EPI_ISL_966102	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00585/2021	EPI_ISL_966104	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00756/2021	EPI_ISL_966105	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.523	GH
hCoV-19/Canada/ON-PHL-21-00623/2021	EPI_ISL_966106	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00624/2021	EPI_ISL_966107	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00763/2021	EPI_ISL_966115	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00766/2021	EPI_ISL_966123	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00627/2021	EPI_ISL_966124	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00628/2021	EPI_ISL_966125	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00798/2021	EPI_ISL_966133	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00622/2021	EPI_ISL_966138	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/BC-BCCDC-3215/2020	EPI_ISL_968708	2020-08-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-3216/2020	EPI_ISL_968709	2020-08-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-3989/2020	EPI_ISL_968716	2020-08-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 15 nucleotides when compared to the reference sequence.	info	B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-3422/2020	EPI_ISL_968757	2020-08-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-3172/2020	EPI_ISL_968768	2020-08-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-3234/2020	EPI_ISL_968783	2020-08-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-3244/2020	EPI_ISL_968792	2020-08-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-5138/2020	EPI_ISL_971199	2020-09-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5212/2020	EPI_ISL_973823	2020-09-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5213/2020	EPI_ISL_973826	2020-09-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10211/2020	EPI_ISL_974503	2020-10-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6080/2020	EPI_ISL_974505	2020-10-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6184/2020	EPI_ISL_974519	2020-10-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6292/2020	EPI_ISL_974529	2020-10-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6293/2020	EPI_ISL_974530	2020-10-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6298/2020	EPI_ISL_974535	2020-10-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6300/2020	EPI_ISL_974537	2020-10-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6655/2020	EPI_ISL_974542	2020-10-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6722/2020	EPI_ISL_974547	2020-10-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10645/2020	EPI_ISL_974556	2020-10-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6195/2020	EPI_ISL_974557	2020-10-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6196/2020	EPI_ISL_974558	2020-10-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6727/2020	EPI_ISL_974585	2020-10-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6728/2020	EPI_ISL_974586	2020-10-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6729/2020	EPI_ISL_974587	2020-10-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9929/2020	EPI_ISL_974592	2020-10-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8249/2020	EPI_ISL_975801	2020-11-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8535/2020	EPI_ISL_975803	2020-11-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8536/2020	EPI_ISL_975804	2020-11-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8540/2020	EPI_ISL_975807	2020-11-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8541/2020	EPI_ISL_975808	2020-11-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8645/2020	EPI_ISL_975809	2020-11-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8799/2020	EPI_ISL_975812	2020-11-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8801/2020	EPI_ISL_975814	2020-11-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9874/2020	EPI_ISL_975816	2020-11-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9949/2020	EPI_ISL_975818	2020-11-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8169/2020	EPI_ISL_975825	2020-11-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8170/2020	EPI_ISL_975826	2020-11-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8172/2020	EPI_ISL_975828	2020-11-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8250/2020	EPI_ISL_975831	2020-11-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8251/2020	EPI_ISL_975832	2020-11-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8258/2020	EPI_ISL_975836	2020-11-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8373/2020	EPI_ISL_975840	2020-11-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8484/2020	EPI_ISL_975841	2020-11-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	NSP3_E522stop results in 73.2% truncation of the protein sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8542/2020	EPI_ISL_975842	2020-11-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8892/2020	EPI_ISL_975843	2020-11-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9451/2020	EPI_ISL_975844	2020-11-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8179/2020	EPI_ISL_975852	2020-11-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8180/2020	EPI_ISL_975853	2020-11-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8486/2020	EPI_ISL_975865	2020-11-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8543/2020	EPI_ISL_975866	2020-11-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8703/2020	EPI_ISL_975868	2020-11-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8895/2020	EPI_ISL_975871	2020-11-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8183/2020	EPI_ISL_975879	2020-11-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8186/2020	EPI_ISL_975881	2020-11-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8275/2020	EPI_ISL_975887	2020-11-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8276/2020	EPI_ISL_975888	2020-11-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8277/2020	EPI_ISL_975889	2020-11-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8487/2020	EPI_ISL_975898	2020-11-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8488/2020	EPI_ISL_975899	2020-11-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9211/2020	EPI_ISL_976000	2020-11-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10449/2020	EPI_ISL_976011	2020-11-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-10450/2020	EPI_ISL_976012	2020-11-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8574/2020	EPI_ISL_976019	2020-12-01	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9272/2020	EPI_ISL_976027	2020-12-01	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8575/2020	EPI_ISL_976036	2020-12-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8732/2020	EPI_ISL_976038	2020-12-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8733/2020	EPI_ISL_976039	2020-12-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8734/2020	EPI_ISL_976040	2020-12-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9321/2020	EPI_ISL_976046	2020-12-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9324/2020	EPI_ISL_976049	2020-12-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9329/2020	EPI_ISL_976053	2020-12-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9548/2020	EPI_ISL_976056	2020-12-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9551/2020	EPI_ISL_976058	2020-12-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9553/2020	EPI_ISL_976059	2020-12-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9554/2020	EPI_ISL_976060	2020-12-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8583/2020	EPI_ISL_976065	2020-12-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8834/2020	EPI_ISL_976067	2020-12-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Insertion of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8943/2020	EPI_ISL_976070	2020-12-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8952/2020	EPI_ISL_976078	2020-12-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9023/2020	EPI_ISL_976079	2020-12-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Canada/BC-BCCDC-9251/2020	EPI_ISL_976082	2020-12-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10646/2020	EPI_ISL_976084	2020-12-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8744/2020	EPI_ISL_976090	2020-12-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8837/2020	EPI_ISL_976095	2020-12-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8839/2020	EPI_ISL_976096	2020-12-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/ON-PPS-21012021_0218/2021	EPI_ISL_983171	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0131/2021	EPI_ISL_983174	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0160/2021	EPI_ISL_983175	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36	GH
hCoV-19/Canada/ON-PPS-21012021_0132/2021	EPI_ISL_983176	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0174/2021	EPI_ISL_983177	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0209/2021	EPI_ISL_983178	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0122/2021	EPI_ISL_983179	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PPS-21012021_0188/2021	EPI_ISL_983180	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0197/2021	EPI_ISL_983196	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PPS-21012021_0137/2021	EPI_ISL_983197	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Australia/QLD1550/2021	EPI_ISL_985234	2021-02-12	Oceania / Australia / Queensland	Human	Original			Illumina	Samtools/iVar			AU.1	GH
hCoV-19/India/KA-NIMH-SEQ-84/2020	EPI_ISL_995174	2020-11-24	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/KA-NIMH-SEQ-86/2020	EPI_ISL_995176	2020-11-26	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/KA-NIMH-SEQ-96/2020	EPI_ISL_995183	2020-12-20	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/KA-NIMH-SEQ-99/2020	EPI_ISL_995185	2020-12-31	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/KA-NIMH-SEQ-100/2020	EPI_ISL_995186	2020-12-31	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/KA-NIMH-SEQ-101/2020	EPI_ISL_995187	2020-12-31	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Switzerland/BL-ETHZ-451007/2021	EPI_ISL_1002796	2021-01-11	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BS-ETHZ-450995/2021	EPI_ISL_1002806	2021-01-11	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/England/MILK-11C2EA2/2021	EPI_ISL_1006362	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-11C2EC0/2021	EPI_ISL_1006392	2021-01-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Norway/1947/2021	EPI_ISL_1013467	2021-01-27	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36.21	GH
hCoV-19/Norway/2907/2021	EPI_ISL_1013486	2021-02-03	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/2958/2021	EPI_ISL_1013495	2021-02-03	Europe / Norway / Innlandet	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Hong Kong/HKPU-05047/2020	EPI_ISL_1018306	2020-09-22	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05102/2020	EPI_ISL_1018316	2020-10-02	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05111/2020	EPI_ISL_1018318	2020-10-04	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05126/2020	EPI_ISL_1018321	2020-10-06	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05132/2020	EPI_ISL_1018322	2020-10-06	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05135/2020	EPI_ISL_1018323	2020-10-07	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05136/2020	EPI_ISL_1018324	2020-10-07	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05138/2020	EPI_ISL_1018325	2020-10-07	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Hong Kong/HKPU-05155/2020	EPI_ISL_1018327	2020-10-08	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05161/2020	EPI_ISL_1019637	2020-10-08	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05183/2020	EPI_ISL_1019645	2020-10-11	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05321/2020	EPI_ISL_1019647	2020-10-30	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05333/2020	EPI_ISL_1019653	2020-11-02	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05335/2020	EPI_ISL_1019658	2020-11-02	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.19	GH
hCoV-19/Hong Kong/HKPU-05342/2020	EPI_ISL_1019663	2020-11-03	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05343/2020	EPI_ISL_1019665	2020-11-03	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05352/2020	EPI_ISL_1019671	2020-11-05	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05381/2020	EPI_ISL_1019693	2020-11-09	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Hong Kong/HKPU-08396/2020	EPI_ISL_1020260	2020-12-24	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08420/2020	EPI_ISL_1020261	2020-12-24	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08450/2020	EPI_ISL_1020262	2020-12-25	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08506/2020	EPI_ISL_1020263	2020-12-26	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08512/2020	EPI_ISL_1020264	2020-12-26	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08514/2020	EPI_ISL_1020265	2020-12-26	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08540/2020	EPI_ISL_1020266	2020-12-26	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08542/2020	EPI_ISL_1020267	2020-12-27	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08545/2020	EPI_ISL_1020268	2020-12-27	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08546/2020	EPI_ISL_1020269	2020-12-27	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08547/2020	EPI_ISL_1020270	2020-12-27	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08562/2020	EPI_ISL_1020271	2020-12-27	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08568/2020	EPI_ISL_1020272	2020-12-27	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08617/2020	EPI_ISL_1020273	2020-12-28	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08623/2020	EPI_ISL_1020274	2020-12-28	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08624/2020	EPI_ISL_1020275	2020-12-28	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08625/2020	EPI_ISL_1020276	2020-12-28	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08632/2020	EPI_ISL_1020277	2020-12-28	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08633/2020	EPI_ISL_1020278	2020-12-28	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08640/2020	EPI_ISL_1020279	2020-12-28	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08641/2020	EPI_ISL_1020280	2020-12-28	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08651/2020	EPI_ISL_1020281	2020-12-28	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08738/2020	EPI_ISL_1020282	2020-12-30	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08741/2020	EPI_ISL_1020283	2020-12-30	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08801/2020	EPI_ISL_1020284	2020-12-31	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/France/PAC-IHU-3209-1/2021	EPI_ISL_1020377	2021-02-04	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Denmark/DCGC-42684/2021	EPI_ISL_1022962	2021-02-08	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/Switzerland/FR-UHB-4171672501/2020	EPI_ISL_1036114	2020-12-02	Europe / Switzerland / Freiburg / Le Mouret	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/MILK-127059E/2021	EPI_ISL_1045935	2021-02-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ARCH-REACT0000306/2020	EPI_ISL_1046894	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ARCH-REACT0004390/2020	EPI_ISL_1046949	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Belgium/rega-2600/2021	EPI_ISL_1049121	2021-01-25	Europe / Belgium / Turnhout	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Belgium/rega-2374/2020	EPI_ISL_1049143	2020-10-09	Europe / Belgium / Huldenberg	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1	GH
hCoV-19/Slovenia/17-013807-CE/2021	EPI_ISL_1056596	2021-02-06	Europe / Slovenia / Podravska	Human	Original			Illumina Miseq				B.1.36.1	GH
hCoV-19/Slovenia/5C-007712-KP/2021	EPI_ISL_1056598	2021-02-02	Europe / Slovenia / Obalnokraska	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/India/Chandigarh-ICMR-15264/2020	EPI_ISL_1063783	2020-06-05	Asia / India / Chandigarh	Human	Original	Nasopharyngeal swab		Illumina Miniseq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/Sweden/21-51283/2021	EPI_ISL_1064704	2021-02-10	Europe / Sweden / Kalmar	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.36.1	GH
hCoV-19/Sweden/21-51294/2021	EPI_ISL_1064705	2021-02-03	Europe / Sweden / Orebro	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.36.1	GH
hCoV-19/USA/TX-HMH-MCoV-25773/2021	EPI_ISL_1080266	2021-02-02	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/USA/CA-ALSR-6761/2021	EPI_ISL_1081594	2021-01-23	North America / USA / California / San Diego	Human	Original	Nasal swab		Illumina	iVar 1.3.1			B.1.36.10	GH
hCoV-19/USA/ME-CDC-QDX21530111/2021	EPI_ISL_1086408	2021-01-26	North America / USA / Maine	Human	Original	Nasal swab		Illumina MiSeq	BWA v.7.12	Gap of 22 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/Australia/VIC790/2020	EPI_ISL_427065	2020-03-31	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.22	GH
hCoV-19/France/NOR-N4427/2020	EPI_ISL_428367	2020-03-23	Europe / France / Normandie / Carentan	Human	Original	Oropharyngeal swab		Illumina NextSeq 500	CLC Genomics Suite			B.1	GH
hCoV-19/India/MP-NCDC-4874/2020	EPI_ISL_436459	2020-04-20	Asia / India / Madhya Pradesh	Human	Original			Nanopore MinION	Reference based			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Makkah181/2020	EPI_ISL_437703	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Makkah183/2020	EPI_ISL_437704	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.471	GH
hCoV-19/Saudi Arabia/KAUST-Makkah190/2020	EPI_ISL_437707	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Makkah193/2020	EPI_ISL_437708	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Makkah194/2020	EPI_ISL_437709	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Makkah198/2020	EPI_ISL_437711	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-Makkah202/2020	EPI_ISL_437712	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-Makkah203/2020	EPI_ISL_437713	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	GH
hCoV-19/England/CAMB-1AA526/2020	EPI_ISL_443649	2020-04-17	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.465	GH
hCoV-19/England/OXON-AECD3/2020	EPI_ISL_448778	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.465	GH
hCoV-19/England/OXON-AEDFE/2020	EPI_ISL_448786	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.465	GH
hCoV-19/England/OXON-AEE19/2020	EPI_ISL_448787	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.465	GH
hCoV-19/Slovenia/MB0419/2020	EPI_ISL_449799	2020-04-19	Europe / Slovenia	Human	Original			Illumina MiSeq	SPAdes			B.1.22	GH
hCoV-19/Vietnam/HCMC-35011/2020	EPI_ISL_450740	2020-03-30	Asia / Vietnam / Ho Chi Minh City	Human	Original	Nasal and throat swab		Illumina MiSeq, Sanger	Geneious Prime 2019.2.1			B.1	GH
hCoV-19/India/GJ-GBRC95a/2020	EPI_ISL_450782	2020-04-11	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC100/2020	EPI_ISL_450789	2020-05-10	Asia / India / Gujarat / Kodinar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC141a/2020	EPI_ISL_458100	2020-05-24	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC142/2020	EPI_ISL_458102	2020-05-24	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC143/2020	EPI_ISL_458103	2020-05-05	Asia / India / Gujarat / Bayad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC150a/2020	EPI_ISL_458112	2020-05-18	Asia / India / Gujarat / Himatnagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12	NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.36.8	GH
hCoV-19/India/GJ-GBRC150b/2020	EPI_ISL_458113	2020-05-18	Asia / India / Gujarat / Himatnagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12	NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.36.8	GH
hCoV-19/England/CAMB-1ADDC1/2020	EPI_ISL_459478	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/India/GJ-GBRC152/2020	EPI_ISL_461480	2020-05-02	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC155/2020	EPI_ISL_461484	2020-05-27	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC158/2020	EPI_ISL_461488	2020-05-27	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12	NS3_E242stop results in 12.4% truncation of the protein sequence.	info	B.1.36.8	GH
hCoV-19/India/GJ-GBRC159a/2020	EPI_ISL_461489	2020-05-27	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC164/2020	EPI_ISL_461499	2020-05-27	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/Bangladesh/BCSIR-NILMRC-069/2020	EPI_ISL_466638	2020-05-26	Asia / Bangladesh / Chittagong	Human	Original	Nasopharyngeal swab		Illumina Nextseq 550	NextSeq (TM) (Control Software v4)			B.1.36.16	GH
hCoV-19/Bangladesh/BCSIR-NILMRC-070/2020	EPI_ISL_466639	2020-05-26	Asia / Bangladesh / Chittagong	Human	Original	Nasopharyngeal swab		Illumina Nextseq 550	NextSeq (TM) (Control Software v4)			B.1.36.16	GH
hCoV-19/India/KA-InStem-NCBS-0055/2020	EPI_ISL_477255	2020-05-16	Asia / India / Karnataka	Human	Original			Illumina Hiseq	MEGAHIT v1.2.9 / ABACAS.1.3.1			B.1.36.8	GH
hCoV-19/India/KA-InStem-NCBS-0061/2020	EPI_ISL_477261	2020-05-18	Asia / India / Karnataka	Human	Original			Illumina Hiseq	MEGAHIT v1.2.9 / ABACAS.1.3.1	Insertion of 6 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/Japan/PG-0195/2020	EPI_ISL_479900	2020-03-16	Asia / Japan / Kanto	Human	Original	Pharyngeal swab		Illumina NextSeq500	SKESA v. 2.3.0			B.1	GH
hCoV-19/Japan/PG-0196/2020	EPI_ISL_479901	2020-03-19	Asia / Japan / Kanto	Human	Original	Pharyngeal swab		Illumina NextSeq500	SKESA v. 2.3.0			B.1	GH
hCoV-19/USA/FL-BPHL-0265/2020	EPI_ISL_480916	2020-05-04	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.170	GH
hCoV-19/USA/FL-BPHL-0266/2020	EPI_ISL_480917	2020-05-04	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.170	GH
hCoV-19/England/SHEF-C568D/2020	EPI_ISL_484454	2020-05-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/England/SHEF-C5B9D/2020	EPI_ISL_484459	2020-06-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/England/202822193/2020	EPI_ISL_490249	2020-05-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.10	GH
hCoV-19/England/CAMB-1B5458/2020	EPI_ISL_490327	2020-07-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/England/CAMB-1B5476/2020	EPI_ISL_490328	2020-07-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/India/TG-CCMB-M243/2020	EPI_ISL_495195	2020-06-08	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.36	GH
hCoV-19/Colombia/BOL-INS-84730/2020	EPI_ISL_497738	2020-03-22	South America / Colombia / Bolivar / Cartagena	Human	Original	Oropharyngeal swab		Nanopore MinION				B.1	G
hCoV-19/India/UN-N8/2020	EPI_ISL_497763	2020	Asia / India	Human	Original			Illumina MiSeq				B.1.36.8	GH
hCoV-19/India/UN-N10/2020	EPI_ISL_497765	2020	Asia / India	Human	Original			Illumina MiSeq				B.1.36.8	GH
hCoV-19/India/UN-A349/2020	EPI_ISL_497766	2020	Asia / India	Human	Original			Illumina MiSeq				B.1.36.8	GH
hCoV-19/Hong Kong/HKU-200723-015/2020	EPI_ISL_497782	2020-07-07	Asia / Hong Kong	Human	Original	Saliva		Nanopore MinION				B.1.459	GH
hCoV-19/Ireland/D-NVRL-20IRL43203/2020	EPI_ISL_501268	2020-07-10	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/France/ARA-07639/2020	EPI_ISL_508872	2020-03-11	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1	GH
hCoV-19/India/GJ-GBRC326/2020	EPI_ISL_512060	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC329/2020	EPI_ISL_512064	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC330/2020	EPI_ISL_512065	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC332a/2020	EPI_ISL_512067	2020-07-27	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC332b/2020	EPI_ISL_512068	2020-07-27	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC335a/2020	EPI_ISL_512072	2020-07-06	Asia / India / Gujarat / Mehsana	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36	GH
hCoV-19/India/GJ-GBRC335b/2020	EPI_ISL_512073	2020-07-06	Asia / India / Gujarat / Mehsana	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36	GH
hCoV-19/India/GJ-GBRC338b/2020	EPI_ISL_512076	2020-07-09	Asia / India / Gujarat / Modasa	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/Ireland/CO-NVRL-71IRL77106/2020	EPI_ISL_512093	2020-07-23	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH898/2020	EPI_ISL_513200	2020-05-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MADINAH941/2020	EPI_ISL_513203	2020-05-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH947/2020	EPI_ISL_513204	2020-05-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-MADINAH957/2020	EPI_ISL_513207	2020-05-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH958/2020	EPI_ISL_513208	2020-05-12	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH959/2020	EPI_ISL_513209	2020-05-12	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MADINAH960/2020	EPI_ISL_513210	2020-05-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MADINAH961/2020	EPI_ISL_513211	2020-05-12	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-MADINAH967/2020	EPI_ISL_513212	2020-05-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH293/2020	EPI_ISL_513216	2020-04-21	Asia / Saudi Arabia / Makkah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH294/2020	EPI_ISL_513217	2020-04-21	Asia / Saudi Arabia / Makkah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH295/2020	EPI_ISL_513218	2020-04-21	Asia / Saudi Arabia / Makkah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH300/2020	EPI_ISL_513221	2020-04-21	Asia / Saudi Arabia / Makkah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH301/2020	EPI_ISL_513222	2020-04-21	Asia / Saudi Arabia / Makkah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1.36.9	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH303/2020	EPI_ISL_513224	2020-04-21	Asia / Saudi Arabia / Makkah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1.468	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH309/2020	EPI_ISL_513226	2020-04-21	Asia / Saudi Arabia / Makkah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH727/2020	EPI_ISL_513229	2020-04-16	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH730/2020	EPI_ISL_513230	2020-04-16	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH735/2020	EPI_ISL_513231	2020-04-16	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH760/2020	EPI_ISL_513234	2020-04-18	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH762/2020	EPI_ISL_513236	2020-04-18	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH768/2020	EPI_ISL_513238	2020-04-18	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH770/2020	EPI_ISL_513240	2020-04-18	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH774/2020	EPI_ISL_513244	2020-04-18	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH777/2020	EPI_ISL_513246	2020-04-18	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH782/2020	EPI_ISL_513250	2020-04-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH783/2020	EPI_ISL_513251	2020-04-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH784/2020	EPI_ISL_513252	2020-04-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH785/2020	EPI_ISL_513253	2020-04-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH802/2020	EPI_ISL_513257	2020-04-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH808/2020	EPI_ISL_513258	2020-04-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH810/2020	EPI_ISL_513260	2020-04-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH813/2020	EPI_ISL_513262	2020-04-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH814/2020	EPI_ISL_513263	2020-04-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH815/2020	EPI_ISL_513264	2020-04-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/India/GJ-GBRC342a/2020	EPI_ISL_514582	2020-06-18	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC342b/2020	EPI_ISL_514583	2020-06-18	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC343a/2020	EPI_ISL_514584	2020-06-18	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC343b/2020	EPI_ISL_514585	2020-06-18	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC344/2020	EPI_ISL_514586	2020-06-18	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC346/2020	EPI_ISL_514588	2020-06-18	Asia / India / Gujarat / Daskroi	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC347a/2020	EPI_ISL_514589	2020-06-18	Asia / India / Gujarat / Daskroi	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC347b/2020	EPI_ISL_514590	2020-06-18	Asia / India / Gujarat / Daskroi	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC351b/2020	EPI_ISL_514597	2020-06-18	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC352a/2020	EPI_ISL_514598	2020-06-18	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC352b/2020	EPI_ISL_514599	2020-06-18	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12	NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1	GH
hCoV-19/India/GJ-GBRC355a/2020	EPI_ISL_514603	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC355b/2020	EPI_ISL_514604	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC356/2020	EPI_ISL_514605	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC357a/2020	EPI_ISL_514606	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC357b/2020	EPI_ISL_514607	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12	NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.36.8	GH
hCoV-19/India/GJ-GBRC358/2020	EPI_ISL_514608	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC359/2020	EPI_ISL_514609	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC361a/2020	EPI_ISL_514611	2020-06-05	Asia / India / Gujarat / Kalol	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC361b/2020	EPI_ISL_514612	2020-06-05	Asia / India / Gujarat / Kalol	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/Bangladesh/NGRI-NSTU-21/2020	EPI_ISL_514615	2020-07-20	Asia / Bangladesh / Chittagong / Lakshmipur / Lakshmipur	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	SPAdes v3.12.0			B.1.36.16	GH
hCoV-19/USA/CA-CDPH020/2020	EPI_ISL_515913	2020-03-07	North America / USA / California	Human	Original			Illumina MiSeq				B.1.110	GH
hCoV-19/Australia/VIC1822/2020	EPI_ISL_521872	2020-05-28	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v1200, minimap2 v2.17, ivar v1.2.2, samtools v1.11			B.1.36	GH
hCoV-19/Australia/VIC1824/2020	EPI_ISL_521874	2020-05-28	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v1200, minimap2 v2.17, ivar v1.2.2, samtools v1.11			B.1.36	GH
hCoV-19/Nigeria/OS523-CV53/2020	EPI_ISL_527893	2020-05-11	Africa / Nigeria / Osun	Human	Original			Illumina MiSeq	viral-ngs			B.1.22	GH
hCoV-19/England/QEUH-965668/2020	EPI_ISL_531005	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-965862/2020	EPI_ISL_531071	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-969567/2020	EPI_ISL_531108	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9651FE/2020	EPI_ISL_531133	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9652CE/2020	EPI_ISL_531136	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9694D3/2020	EPI_ISL_531137	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9694C4/2020	EPI_ISL_531145	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-95EE79/2020	EPI_ISL_532418	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/SHEF-10B30FA/2020	EPI_ISL_537206	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/Indonesia/SU-NIHRD-PME4745/2020	EPI_ISL_538500	2020-08-05	Asia / Indonesia / North Sumatra	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1.468	GH
hCoV-19/Indonesia/SU-NIHRD-PME4760/2020	EPI_ISL_538501	2020-08-01	Asia / Indonesia / North Sumatra	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1.468	GH
hCoV-19/Indonesia/KT-NIHRD-PME4206/2020	EPI_ISL_538502	2020-07-24	Asia / Indonesia / Central Kalimantan	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1	GH
hCoV-19/Indonesia/KS-NIHRD-PME4900/2020	EPI_ISL_538510	2020-08-06	Asia / Indonesia / South Kalimantan	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1	GH
hCoV-19/Indonesia/JI-NIHRD-PME5011/2020	EPI_ISL_538511	2020-08-01	Asia / Indonesia / East Java	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1.456	GH
hCoV-19/Indonesia/JB-NIHRD-PME4992/2020	EPI_ISL_538513	2020-07-24	Asia / Indonesia / West Java	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1.459	GH
hCoV-19/Hong Kong/VM20060398/2020	EPI_ISL_539811	2020-07-19	Asia / Hong Kong	Human	Original	Throat saliva		Illumina MiSeq				B.1.36.8	GH
hCoV-19/England/QEUH-990312/2020	EPI_ISL_539925	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9901EB/2020	EPI_ISL_539938	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-990303/2020	EPI_ISL_539979	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/QEUH-998945/2020	EPI_ISL_539995	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/Scotland/CVR4140/2020	EPI_ISL_540828	2020-08-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.36.23	GH
hCoV-19/USA/TX-HMH-4885/2020	EPI_ISL_544404	2020-06-22	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1	GH
hCoV-19/England/CAMC-9B2338/2020	EPI_ISL_549347	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/MILK-9AB727/2020	EPI_ISL_549348	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/CAMB-1B5D8A/2020	EPI_ISL_549389	2020-09-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/MILK-99A451/2020	EPI_ISL_550274	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9940F9/2020	EPI_ISL_551581	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-99433C/2020	EPI_ISL_551601	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-994044/2020	EPI_ISL_551633	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides found at refpos 22189.	info	B.1.36	GH
hCoV-19/England/MILK-9941D8/2020	EPI_ISL_551646	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/MILK-994114/2020	EPI_ISL_551675	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-94DA4C/2020	EPI_ISL_555165	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/England/ALDP-94D37E/2020	EPI_ISL_556315	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/ALDP-949D65/2020	EPI_ISL_556359	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/CAMC-94AAD6/2020	EPI_ISL_556459	2020-07-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-5169F8/2020	EPI_ISL_558973	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/QEUH-9C8A49/2020	EPI_ISL_567006	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/QEUH-9C83A8/2020	EPI_ISL_567007	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-9C8AFE/2020	EPI_ISL_567029	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9C8593/2020	EPI_ISL_567033	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9C8B46/2020	EPI_ISL_567045	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-9C8AC1/2020	EPI_ISL_567097	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-9C8BEC/2020	EPI_ISL_567115	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-9C8618/2020	EPI_ISL_567132	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9C9213/2020	EPI_ISL_567195	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Scotland/QEUH-998374/2020	EPI_ISL_568355	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.36.23	GH
hCoV-19/England/ALDP-9B647D/2020	EPI_ISL_573009	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/ALDP-9B6808/2020	EPI_ISL_573037	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9BCA66/2020	EPI_ISL_573044	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9BCA75/2020	EPI_ISL_573045	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9BCB36/2020	EPI_ISL_573053	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9BCB54/2020	EPI_ISL_573055	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9BCBAF/2020	EPI_ISL_573058	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9BCC15/2020	EPI_ISL_573065	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9BCD9A/2020	EPI_ISL_573075	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9BCE00/2020	EPI_ISL_573077	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9CAC23/2020	EPI_ISL_575539	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CB2A8/2020	EPI_ISL_575570	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CB299/2020	EPI_ISL_575571	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CAE1E/2020	EPI_ISL_575576	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-9CB79A/2020	EPI_ISL_575599	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CB1E7/2020	EPI_ISL_575609	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CB85B/2020	EPI_ISL_575621	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-9CB16F/2020	EPI_ISL_575636	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CBACE/2020	EPI_ISL_575641	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CAA0B/2020	EPI_ISL_575684	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-9DA3C1/2020	EPI_ISL_576870	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9DA4A0/2020	EPI_ISL_576876	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.471	GH
hCoV-19/England/CAMB-1B63D2/2020	EPI_ISL_576903	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMC-9DF9D9/2020	EPI_ISL_576921	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9EABD5/2020	EPI_ISL_580001	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9EA6D4/2020	EPI_ISL_580159	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-9E7613/2020	EPI_ISL_580183	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9E1F2D/2020	EPI_ISL_581304	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-9DE61F/2020	EPI_ISL_581324	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DE59A/2020	EPI_ISL_581346	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9E2D5F/2020	EPI_ISL_581360	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-9E1CDB/2020	EPI_ISL_581364	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-970451/2020	EPI_ISL_581398	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-970460/2020	EPI_ISL_581401	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/United Arab Emirates/skmc-3138700/2020	EPI_ISL_582653	2020-08-29	Asia / United Arab Emirates	Human	Original	Nasopharyngeal swab		Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.8	GH
hCoV-19/England/204180123/2020	EPI_ISL_583968	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/204180124/2020	EPI_ISL_583969	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/204180127/2020	EPI_ISL_583972	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/204180130/2020	EPI_ISL_583974	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/204180132/2020	EPI_ISL_583976	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/204180134/2020	EPI_ISL_583977	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/204180135/2020	EPI_ISL_583978	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/204180138/2020	EPI_ISL_583981	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/204180140/2020	EPI_ISL_583983	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/204180141/2020	EPI_ISL_583984	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/204180142/2020	EPI_ISL_583985	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/204180143/2020	EPI_ISL_583986	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/204180253/2020	EPI_ISL_583987	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/204180254/2020	EPI_ISL_583988	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/204180255/2020	EPI_ISL_583989	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/SHEF-CC914/2020	EPI_ISL_585051	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-A1DE2A/2020	EPI_ISL_587571	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-A1FE91/2020	EPI_ISL_587681	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9F6338/2020	EPI_ISL_588907	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9F89E9/2020	EPI_ISL_588929	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9F8A13/2020	EPI_ISL_588942	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9F568B/2020	EPI_ISL_588979	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-9F8A22/2020	EPI_ISL_588984	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9F93DB/2020	EPI_ISL_588993	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-9ECA7C/2020	EPI_ISL_594636	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-A5266D/2020	EPI_ISL_598161	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A511C7/2020	EPI_ISL_598243	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A47DDF/2020	EPI_ISL_598284	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1	GH
hCoV-19/England/MILK-A47B02/2020	EPI_ISL_598290	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-A47C5A/2020	EPI_ISL_598318	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A47847/2020	EPI_ISL_598343	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DE62E/2020	EPI_ISL_599487	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/QEUH-9DE48E/2020	EPI_ISL_599495	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DCDB2/2020	EPI_ISL_599496	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-9DCF52/2020	EPI_ISL_599497	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-9DCCA6/2020	EPI_ISL_599510	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DE2FD/2020	EPI_ISL_599528	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-9DE521/2020	EPI_ISL_599534	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DE336/2020	EPI_ISL_599547	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DCFBC/2020	EPI_ISL_599550	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DD13D/2020	EPI_ISL_599566	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DE2A2/2020	EPI_ISL_599568	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DDDDF/2020	EPI_ISL_599569	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DD05E/2020	EPI_ISL_599571	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DE327/2020	EPI_ISL_599584	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DDE27/2020	EPI_ISL_599608	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DDE36/2020	EPI_ISL_599638	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DCF70/2020	EPI_ISL_599651	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-9DCF43/2020	EPI_ISL_599653	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DE442/2020	EPI_ISL_599655	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DE293/2020	EPI_ISL_599668	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DE099/2020	EPI_ISL_599670	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/QEUH-9DE06C/2020	EPI_ISL_599674	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DE424/2020	EPI_ISL_599690	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DDB99/2020	EPI_ISL_599692	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Scotland/QEUH-9B4AD7/2020	EPI_ISL_602056	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/India/DL-ILBS-4871T/2020	EPI_ISL_605810	2020-04-06	Asia / India / Delhi / New Delhi	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Reference-based assembly method using Hisat2			B.1.36	GH
hCoV-19/India/DL-ILBS-9309D/2020	EPI_ISL_605814	2020-04-06	Asia / India / Delhi / New Delhi	Human	Original	Nasopharyngeal and oropharyngeal swab	Patient acquired infection from community	Illumina MiSeq	Reference-based assembly method using Hisat2			B.1.36	GH
hCoV-19/India/DL-ILBS-9318D/2020	EPI_ISL_605815	2020-04-05	Asia / India / Delhi / New Delhi	Human	Original	Nasopharyngeal and oropharyngeal swab	Patient acquired infection from community	Illumina MiSeq	Reference-based assembly method using Hisat2			B.1.36	GH
hCoV-19/India/DL-ILBS-9337D/2020	EPI_ISL_605816	2020-03-31	Asia / India / Delhi / New Delhi	Human	Original	Nasopharyngeal and oropharyngeal swab	Patient acquired infection from community	Illumina MiSeq	Reference-based assembly method using Hisat2			B.1.36	GH
hCoV-19/Singapore/1115/2020	EPI_ISL_605824	2020-10-20	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Australia/WA354/2020	EPI_ISL_605831	2020-10-15	Oceania / Australia / Western Australia	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/England/ALDP-A6CFFC/2020	EPI_ISL_608083	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A70274/2020	EPI_ISL_608105	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A70229/2020	EPI_ISL_608111	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A7020B/2020	EPI_ISL_608118	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A6C91C/2020	EPI_ISL_608137	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A6D15F/2020	EPI_ISL_608146	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-A6FF26/2020	EPI_ISL_608152	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-A6C82E/2020	EPI_ISL_608172	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A41C41/2020	EPI_ISL_609323	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A41F39/2020	EPI_ISL_609382	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A41C05/2020	EPI_ISL_609410	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-A4178C/2020	EPI_ISL_609432	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-A4169E/2020	EPI_ISL_609451	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A41731/2020	EPI_ISL_609477	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A84C8E/2020	EPI_ISL_610414	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-A85D8A/2020	EPI_ISL_610419	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/England/ALDP-A85E0F/2020	EPI_ISL_610463	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-A85C8D/2020	EPI_ISL_610476	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Denmark/DCGC-5271/2020	EPI_ISL_615202	2020-09-14	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-5353/2020	EPI_ISL_615284	2020-09-14	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36.22	GH
hCoV-19/Denmark/DCGC-5390/2020	EPI_ISL_615322	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-2632/2020	EPI_ISL_616511	2020-08-17	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-2633/2020	EPI_ISL_616512	2020-08-17	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/Denmark/DCGC-2882/2020	EPI_ISL_616577	2020-08-24	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/Denmark/DCGC-2891/2020	EPI_ISL_616586	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/Denmark/DCGC-2893/2020	EPI_ISL_616588	2020-08-24	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.36.22	GH
hCoV-19/Denmark/DCGC-2794/2020	EPI_ISL_616629	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-2809/2020	EPI_ISL_616645	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1	GH
hCoV-19/Denmark/DCGC-2927/2020	EPI_ISL_616651	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1	GH
hCoV-19/Denmark/DCGC-2929/2020	EPI_ISL_616679	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-2852/2020	EPI_ISL_616680	2020-08-17	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.36.38	GH
hCoV-19/Denmark/DCGC-2663/2020	EPI_ISL_617883	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1	GH
hCoV-19/Denmark/DCGC-2664/2020	EPI_ISL_617884	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1	GH
hCoV-19/Denmark/DCGC-6334/2020	EPI_ISL_621191	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.36.22	GH
hCoV-19/England/MILK-AB7E7D/2020	EPI_ISL_623722	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-AB902A/2020	EPI_ISL_623728	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.39	GH
hCoV-19/England/ALDP-AA2130/2020	EPI_ISL_624914	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA562F/2020	EPI_ISL_624918	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-AA3621/2020	EPI_ISL_624940	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Denmark/DCGC-8683/2020	EPI_ISL_626029	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-8794/2020	EPI_ISL_626047	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/England/QEUH-A4C8F7/2020	EPI_ISL_628576	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.1	GH
hCoV-19/England/QEUH-A61610/2020	EPI_ISL_628623	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-A6166B/2020	EPI_ISL_628627	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-A618B0/2020	EPI_ISL_628639	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-A64352/2020	EPI_ISL_628690	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-AD2A87/2020	EPI_ISL_629800	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/QEUH-AD26DE/2020	EPI_ISL_629812	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-AD03E8/2020	EPI_ISL_629829	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-AD0667/2020	EPI_ISL_629868	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-AD29F3/2020	EPI_ISL_629884	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AD34C4/2020	EPI_ISL_629885	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-AD2E21/2020	EPI_ISL_629910	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AD62F4/2020	EPI_ISL_629928	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/QEUH-AD2AA5/2020	EPI_ISL_629972	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA309C/2020	EPI_ISL_630821	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-AA2552/2020	EPI_ISL_630826	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA56F2/2020	EPI_ISL_630828	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/England/ALDP-AA2FCD/2020	EPI_ISL_630831	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA3014/2020	EPI_ISL_630836	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA2FBE/2020	EPI_ISL_630887	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA5030/2020	EPI_ISL_630912	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/ALDP-AA506D/2020	EPI_ISL_630943	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-AA2A35/2020	EPI_ISL_630947	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/USA/NY-NYCPHL-001011/2020	EPI_ISL_633031	2020-10-06	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1	GH
hCoV-19/England/CAMC-AEAAD7/2020	EPI_ISL_633110	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/CAMC-AEAAB9/2020	EPI_ISL_633150	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-AE50E9/2020	EPI_ISL_633178	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-AC7EA7/2020	EPI_ISL_634331	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.39	GH
hCoV-19/England/MILK-ACDA07/2020	EPI_ISL_634383	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ACD409/2020	EPI_ISL_634400	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/MILK-ACD80D/2020	EPI_ISL_634422	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/MILK-AC7B28/2020	EPI_ISL_634476	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ACCF09/2020	EPI_ISL_634477	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ACC859/2020	EPI_ISL_634489	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-AC788B/2020	EPI_ISL_634491	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Jordan/AM-ALSR-2579/2020	EPI_ISL_635778	2020-07-04	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.466	GH
hCoV-19/Jordan/AM-ALSR-2585/2020	EPI_ISL_635781	2020-06-21	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	GH
hCoV-19/Jordan/AM-ALSR-2586/2020	EPI_ISL_635782	2020-07-04	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.466	GH
hCoV-19/England/MILK-B01E82/2020	EPI_ISL_642809	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-B0266B/2020	EPI_ISL_642857	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/MILK-B05DAF/2020	EPI_ISL_642885	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-B020C7/2020	EPI_ISL_642898	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-B01ECE/2020	EPI_ISL_642901	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B05FE5/2020	EPI_ISL_642999	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Singapore/1393/2020	EPI_ISL_645120	2020-11-09	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/1394/2020	EPI_ISL_645121	2020-11-07	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/1395/2020	EPI_ISL_645122	2020-11-11	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/1396/2020	EPI_ISL_645123	2020-11-09	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/1397/2020	EPI_ISL_645124	2020-11-07	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/1398/2020	EPI_ISL_645125	2020-11-10	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.19	GH
hCoV-19/Singapore/1399/2020	EPI_ISL_645126	2020-11-09	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/1400/2020	EPI_ISL_645127	2020-11-09	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/1401/2020	EPI_ISL_645128	2020-11-07	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/1402/2020	EPI_ISL_645129	2020-11-08	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.19	GH
hCoV-19/Singapore/1403/2020	EPI_ISL_645130	2020-11-09	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/1404/2020	EPI_ISL_645131	2020-11-07	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/England/QEUH-B318E5/2020	EPI_ISL_646328	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-B23CCC/2020	EPI_ISL_646397	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-B2E3F9/2020	EPI_ISL_646401	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B20AF2/2020	EPI_ISL_647735	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/England/CAMC-B20FA8/2020	EPI_ISL_647748	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B1FE27/2020	EPI_ISL_647756	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/CAMC-B1FDC0/2020	EPI_ISL_647796	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ACFB6C/2020	EPI_ISL_652124	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-ACFCB4/2020	EPI_ISL_652132	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-B06A98/2020	EPI_ISL_652258	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-B06B0E/2020	EPI_ISL_652261	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.1	GH
hCoV-19/England/MILK-B06B95/2020	EPI_ISL_652263	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.1	GH
hCoV-19/England/MILK-B06CDE/2020	EPI_ISL_652272	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-B0701D/2020	EPI_ISL_652288	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/MILK-B39B02/2020	EPI_ISL_652303	2020-10-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/Australia/SA0548/2020	EPI_ISL_654795	2020-11-14	Oceania / Australia / South Australia	Human	Original			Illumina MiSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.36.1	GH
hCoV-19/Australia/SA0553/2020	EPI_ISL_654799	2020-11-16	Oceania / Australia / South Australia	Human	Original		unknown	Illumina MiSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.36.1	GH
hCoV-19/Australia/SA0556/2020	EPI_ISL_654800	2020-11-16	Oceania / Australia / South Australia	Human	Original		unknown	Illumina MiSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.36.1	GH
hCoV-19/Australia/SA0558/2020	EPI_ISL_654801	2020-11-16	Oceania / Australia / South Australia	Human	Original			Illumina MiSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.36.1	GH
hCoV-19/Australia/SA0559/2020	EPI_ISL_654802	2020-11-16	Oceania / Australia / South Australia	Human	Original			Illumina MiSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.36.1	GH
hCoV-19/Australia/SA0560/2020	EPI_ISL_654803	2020-11-16	Oceania / Australia / South Australia	Human	Original			Illumina MiSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.36.1	GH
hCoV-19/Australia/SA0561/2020	EPI_ISL_654804	2020-11-16	Oceania / Australia / South Australia	Human	Original			Illumina MiSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.36.1	GH
hCoV-19/Australia/SA0562/2020	EPI_ISL_654805	2020-11-16	Oceania / Australia / South Australia	Human	Original			Illumina MiSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.36.1	GH
hCoV-19/Australia/SA0563/2020	EPI_ISL_654806	2020-11-16	Oceania / Australia / South Australia	Human	Original			Illumina MiSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.36.1	GH
hCoV-19/Australia/SA0564/2020	EPI_ISL_654807	2020-11-16	Oceania / Australia / South Australia	Human	Original			Illumina MiSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.36.1	GH
hCoV-19/Australia/SA0565/2020	EPI_ISL_654808	2020-11-16	Oceania / Australia / South Australia	Human	Original			Illumina MiSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.36.1	GH
hCoV-19/Australia/SA0566/2020	EPI_ISL_654809	2020-11-16	Oceania / Australia / South Australia	Human	Original			Illumina MiSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.36.1	GH
hCoV-19/Singapore/1413/2020	EPI_ISL_654811	2020-11-11	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/1414/2020	EPI_ISL_654812	2020-11-12	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.24	GH
hCoV-19/Singapore/1415/2020	EPI_ISL_654813	2020-11-11	Asia / Singapore	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/Singapore/1416/2020	EPI_ISL_654814	2020-11-11	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.16	GH
hCoV-19/Singapore/1417/2020	EPI_ISL_654815	2020-11-11	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/1414_2/2020	EPI_ISL_654816	2020-11-13	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.24	GH
hCoV-19/Singapore/1418/2020	EPI_ISL_654817	2020-11-11	Asia / Singapore	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/England/CAMC-B5349E/2020	EPI_ISL_657002	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B56756/2020	EPI_ISL_657004	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B56BF0/2020	EPI_ISL_657008	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B42623/2020	EPI_ISL_657067	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B3FE12/2020	EPI_ISL_657075	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-B421B9/2020	EPI_ISL_657079	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B42508/2020	EPI_ISL_657110	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B40467/2020	EPI_ISL_657137	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-B433A3/2020	EPI_ISL_657139	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/QEUH-B40212/2020	EPI_ISL_657158	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B40142/2020	EPI_ISL_657161	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-B42544/2020	EPI_ISL_657180	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B433C1/2020	EPI_ISL_657182	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B51973/2020	EPI_ISL_658305	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B546A6/2020	EPI_ISL_658321	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B54688/2020	EPI_ISL_658396	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/QEUH-B41008/2020	EPI_ISL_658411	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-B40FFD/2020	EPI_ISL_658439	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B3F43E/2020	EPI_ISL_658480	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/QEUH-B4123F/2020	EPI_ISL_658481	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B344C0/2020	EPI_ISL_659635	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B35535/2020	EPI_ISL_659647	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B34660/2020	EPI_ISL_659665	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/CAMC-B356AB/2020	EPI_ISL_659692	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B340DB/2020	EPI_ISL_659731	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence. Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B349FE/2020	EPI_ISL_659740	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B345EB/2020	EPI_ISL_659741	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/204291969/2020	EPI_ISL_660745	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/QEUH-B68FB3/2020	EPI_ISL_661957	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-B68ED4/2020	EPI_ISL_661993	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/C200044010/2020	EPI_ISL_666751	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.471	GH
hCoV-19/USA/FL-BPHL-2203/2020	EPI_ISL_666825	2020-06-17	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.170	GH
hCoV-19/Denmark/DCGC-9511/2020	EPI_ISL_669012	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-9536/2020	EPI_ISL_669025	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-9550/2020	EPI_ISL_669034	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-9605/2020	EPI_ISL_669063	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-9691/2020	EPI_ISL_669113	2020-11-09	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.471	GH
hCoV-19/Denmark/DCGC-9742/2020	EPI_ISL_669139	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-10515/2020	EPI_ISL_670029	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-10616/2020	EPI_ISL_670090	2020-11-02	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.1	GH
hCoV-19/Denmark/DCGC-10621/2020	EPI_ISL_670095	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.8	GH
hCoV-19/Denmark/DCGC-10650/2020	EPI_ISL_670115	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.8	GH
hCoV-19/Denmark/DCGC-10740/2020	EPI_ISL_670174	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Australia/NSW1212/2020	EPI_ISL_672656	2020-11-19	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36.19	GH
hCoV-19/Australia/NSW1213/2020	EPI_ISL_672657	2020-11-19	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36.19	GH
hCoV-19/Australia/NSW1215/2020	EPI_ISL_672659	2020-11-17	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36	GH
hCoV-19/Australia/NSW1216/2020	EPI_ISL_672660	2020-11-14	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36	GH
hCoV-19/Australia/NSW1218/2020	EPI_ISL_672662	2020-11-13	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.459	GH
hCoV-19/England/QEUH-BA11A9/2020	EPI_ISL_672777	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B860AD/2020	EPI_ISL_673931	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-B8683C/2020	EPI_ISL_673967	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-B8E5B5/2020	EPI_ISL_673981	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B96013/2020	EPI_ISL_676100	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-B95F17/2020	EPI_ISL_676132	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-B96101/2020	EPI_ISL_676203	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-B94DA5/2020	EPI_ISL_676216	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B94103/2020	EPI_ISL_676241	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B962D1/2020	EPI_ISL_676249	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B9670F/2020	EPI_ISL_676271	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-B96383/2020	EPI_ISL_676280	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B96110/2020	EPI_ISL_676286	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/204721103/2020	EPI_ISL_678722	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1	GH
hCoV-19/England/ALDP-B5D1BB/2020	EPI_ISL_678867	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.39	GH
hCoV-19/England/ALDP-B5D2F4/2020	EPI_ISL_678885	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.28	GH
hCoV-19/England/ALDP-B5D4C1/2020	EPI_ISL_678902	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.28	GH
hCoV-19/USA/MI-UM-10036746274/2020	EPI_ISL_682170	2020-11-02	North America / USA / Michigan	Human	Original			Illumina MiSeq		NSP11 without BLAST coverage.	warn	B.1.36.17	GH
hCoV-19/USA/MI-UM-10036747057/2020	EPI_ISL_682187	2020-11-02	North America / USA / Michigan	Human	Original			Illumina MiSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/England/ALDP-BBA6AE/2020	EPI_ISL_702589	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/MILK-A91A0C/2020	EPI_ISL_706002	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-B3A70D/2020	EPI_ISL_706028	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.28	GH
hCoV-19/England/MILK-B3A7B2/2020	EPI_ISL_706036	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/MILK-B3A819/2020	EPI_ISL_706039	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/MILK-B3B159/2020	EPI_ISL_706050	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-B3B64B/2020	EPI_ISL_706072	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-B3BE34/2020	EPI_ISL_706100	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1	GH
hCoV-19/England/MILK-B3BECB/2020	EPI_ISL_706106	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.39	GH
hCoV-19/England/MILK-B3C4B9/2020	EPI_ISL_706149	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1	GH
hCoV-19/England/MILK-B3C6E0/2020	EPI_ISL_706154	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.1	GH
hCoV-19/England/MILK-B3C835/2020	EPI_ISL_706161	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Indonesia/BT-SHSIU-01-4920/2020	EPI_ISL_708652	2020-10-18	Asia / Indonesia / Banten	Human	Original			Nanopore MinION				B.1.459	GH
hCoV-19/Denmark/DCGC-14812/2020	EPI_ISL_712001	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-15971/2020	EPI_ISL_714512	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-15998/2020	EPI_ISL_714524	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-16001/2020	EPI_ISL_714526	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-16010/2020	EPI_ISL_714532	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-16060/2020	EPI_ISL_714567	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-16178/2020	EPI_ISL_714623	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Malaysia/UNIMAS-M3002/2020	EPI_ISL_718154	2020-05-07	Asia / Malaysia / Sarawak	Human	Original	Oropharyngeal swab		Nanopore MinION	Unipro UGENE v. 37			B.1	G
hCoV-19/Malaysia/UNIMAS-B066/2020	EPI_ISL_718167	2020-11-01	Asia / Malaysia / Sarawak	Human	Original	Oropharyngeal swab		Nanopore MinION	Unipro UGENE v. 37			B.1.470	GH
hCoV-19/Malaysia/UNIMAS-15695/2020	EPI_ISL_718168	2020-10-14	Asia / Malaysia / Sarawak	Human	Original	Oropharyngeal swab		Nanopore MinION	Unipro UGENE v. 37			B.1.470	GH
hCoV-19/Malaysia/UNIMAS-15723/2020	EPI_ISL_718169	2020-10-28	Asia / Malaysia / Sarawak	Human	Original	Oropharyngeal swab		Nanopore MinION	Unipro UGENE v. 37			B.1.36.19	GH
hCoV-19/Malaysia/UNIMAS-15729/2020	EPI_ISL_718170	2020-10-28	Asia / Malaysia / Sarawak	Human	Original	Oropharyngeal swab		Nanopore MinION	Unipro UGENE v. 37			B.1.36.19	GH
hCoV-19/England/CAMC-C3FEF3/2020	EPI_ISL_719348	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-C4325A/2020	EPI_ISL_719387	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/CAMC-C44839/2020	EPI_ISL_719398	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-C456B6/2020	EPI_ISL_719425	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/CAMC-C44338/2020	EPI_ISL_719482	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/MILK-BB1531/2020	EPI_ISL_720305	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.469	GH
hCoV-19/England/MILK-BB0909/2020	EPI_ISL_720323	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BB1179/2020	EPI_ISL_720362	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BB0A06/2020	EPI_ISL_720401	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/MILK-BB0ACA/2020	EPI_ISL_720458	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-BB0BE5/2020	EPI_ISL_720483	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/Japan/IC-0372/2020	EPI_ISL_721613	2020-12-04	Asia / Japan	Human	Original			Illumina NextSeq500	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/IC-0383/2020	EPI_ISL_721622	2020-12-05	Asia / Japan	Human	Original			Illumina NextSeq500	SKESA v. 2.3.0			B.1.470	GH
hCoV-19/Switzerland/BE-ETHZ-390391/2020	EPI_ISL_721772	2020-12-01	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BL-ETHZ-380275/2020	EPI_ISL_721783	2020-11-22	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BL-ETHZ-380277/2020	EPI_ISL_721785	2020-11-22	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BL-ETHZ-380344/2020	EPI_ISL_721790	2020-11-21	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BL-ETHZ-380354/2020	EPI_ISL_721795	2020-11-21	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BL-ETHZ-380394/2020	EPI_ISL_721799	2020-11-23	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/England/NORW-F8593/2020	EPI_ISL_725343	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-F85A2/2020	EPI_ISL_725344	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/ALDP-C3B99C/2020	EPI_ISL_731114	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-C2D414/2020	EPI_ISL_733626	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-C26439/2020	EPI_ISL_733733	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/CAMC-C2CF41/2020	EPI_ISL_733787	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Nigeria/NCDC-4a/2020	EPI_ISL_737201	2020-05-22	Africa / Nigeria / FCT	Human	Original	Oropharyngeal and nasal swabs		Nanopore MinION				B.1.466	GH
hCoV-19/Finland/13ES21A9/2020	EPI_ISL_737209	2020-08-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/13LS10AG11/2020	EPI_ISL_737212	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/13LS11AH1/2020	EPI_ISL_737213	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/13LS12AH5/2020	EPI_ISL_737215	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/13LS12AH8/2020	EPI_ISL_737216	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/13LS13AC1/2020	EPI_ISL_737217	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/13LS13AF9/2020	EPI_ISL_737218	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/13LS14AC1/2020	EPI_ISL_737219	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/13LS14AE1/2020	EPI_ISL_737220	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/13LS15BD5/2020	EPI_ISL_737222	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/13LS16AH3/2020	EPI_ISL_737223	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/13LS17G8/2020	EPI_ISL_737224	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/13LS3AB7/2020	EPI_ISL_737226	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/13LS3AD5/2020	EPI_ISL_737227	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/13LS5AD3/2020	EPI_ISL_737229	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/13LS6AG7/2020	EPI_ISL_737230	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/13LS7AH2/2020	EPI_ISL_737231	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/13LS8AA5/2020	EPI_ISL_737232	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/13LS9AH11/2020	EPI_ISL_737233	2020-10-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Canada/BC-BCCDC-8418/2020	EPI_ISL_740788	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8429/2020	EPI_ISL_740795	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8550/2020	EPI_ISL_740814	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8562/2020	EPI_ISL_740821	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.18	GH
hCoV-19/Canada/BC-BCCDC-8564/2020	EPI_ISL_740823	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8566/2020	EPI_ISL_740825	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8587/2020	EPI_ISL_740834	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8601/2020	EPI_ISL_740845	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8608/2020	EPI_ISL_740850	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8616/2020	EPI_ISL_740853	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8619/2020	EPI_ISL_740855	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8625/2020	EPI_ISL_740857	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Australia/NSW1243/2020	EPI_ISL_740874	2020-12-09	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36	GH
hCoV-19/Denmark/DCGC-19727/2020	EPI_ISL_749137	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18657/2020	EPI_ISL_750105	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18701/2020	EPI_ISL_750132	2020-12-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Thailand/Bangkok-Si11/2020	EPI_ISL_756375	2020-12-28	Asia / Thailand / Bangkok	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Indonesia/SU-NIHRDC-0045870/2020	EPI_ISL_756401	2020-08-28	Asia / Indonesia / North Sumatra	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection			B.1.468	GH
hCoV-19/England/ALDP-C8959B/2020	EPI_ISL_756465	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/QEUH-C92D5B/2020	EPI_ISL_762123	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-CA92DA/2020	EPI_ISL_767107	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/Singapore/1501/2020	EPI_ISL_768324	2020-12-30	Asia / Singapore	Human	Original			Nanopore MinION				B.1.466.2	GH
hCoV-19/England/MILK-C51893/2020	EPI_ISL_769603	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-C50269/2020	EPI_ISL_769624	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/MILK-C5399E/2020	EPI_ISL_769793	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Norway/6773/2020	EPI_ISL_775412	2020-12-11	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/7089/2020	EPI_ISL_775415	2020-11-27	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/7091/2020	EPI_ISL_775417	2020-11-30	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/7093/2020	EPI_ISL_775419	2020-11-30	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/7108/2020	EPI_ISL_775427	2020-12-21	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/7180/2020	EPI_ISL_775428	2020-12-27	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.1	GH
hCoV-19/Norway/7181/2020	EPI_ISL_775429	2020-12-27	Europe / Norway / Nordland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.1	GH
hCoV-19/Norway/7186/2020	EPI_ISL_775434	2020-12-22	Europe / Norway / More og Romsdal	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/7188/2020	EPI_ISL_775436	2020-12-27	Europe / Norway / Rogaland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.1	GH
hCoV-19/Norway/6054/2020	EPI_ISL_775462	2020-11-27	Europe / Norway / Oslo	Human	Original	Saliva		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5822/2020	EPI_ISL_775484	2020-11-19	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/6387/2020	EPI_ISL_775496	2020-12-03	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/6391/2020	EPI_ISL_775497	2020-12-03	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/6487/2020	EPI_ISL_775500	2020-11-09	Europe / Norway / Vestfold og Telemark	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/6515/2020	EPI_ISL_775502	2020-10-30	Europe / Norway / Vestfold og Telemark	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/6603/2020	EPI_ISL_775506	2020-12-09	Europe / Norway / Trondelag	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/6606/2020	EPI_ISL_775507	2020-12-08	Europe / Norway / Trondelag	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/6781/2020	EPI_ISL_775521	2020-12-10	Europe / Norway / Agder	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/7104/2020	EPI_ISL_775524	2020-12-21	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/7105/2020	EPI_ISL_775525	2020-12-21	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/7106/2020	EPI_ISL_775526	2020-12-21	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/7107/2020	EPI_ISL_775527	2020-12-21	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Sweden/20-53777/2020	EPI_ISL_775546	2020-12-18	Europe / Sweden / Vastmanland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with fill from reference and majority wins			B.1	GH
hCoV-19/Indonesia/LA-NIHRD-PME8719/2020	EPI_ISL_775594	2020-09-18	Asia / Indonesia / Lampung	Human	Original	Nasopharyngeal		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14	Gap of 2 nucleotides when compared to the reference sequence.	info	B.1.468	GH
hCoV-19/Indonesia/PA-NIHRD-PME8510/2020	EPI_ISL_775597	2020-09-26	Asia / Indonesia / West Papua	Human	Original	Nasopharyngeal		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1.459	GH
hCoV-19/Indonesia/NB-NIHRD-PME1393/2020	EPI_ISL_775598	2020-06-01	Asia / Indonesia / West Nusa Tenggara	Human	Original	Nasopharyngeal		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1.459	GH
hCoV-19/USA/WA-UW-47255/2020	EPI_ISL_776746	2020-12-09	North America / USA / Washington	Human	Original			Illumina	custom			B.1.36.8	GH
hCoV-19/England/MILK-C30180/2020	EPI_ISL_782744	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-C30812/2020	EPI_ISL_782750	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-C2FEC9/2020	EPI_ISL_782753	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-C307CA/2020	EPI_ISL_782754	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/USA/TX-HMH-MCoV-17984/2020	EPI_ISL_786132	2020-11-16	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.36	GH
hCoV-19/USA/TX-HMH-MCoV-14130/2020	EPI_ISL_787415	2020-10-02	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.36.26	GH
hCoV-19/USA/TX-HMH-MCoV-13760/2020	EPI_ISL_788853	2020-08-17	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.36	GH
hCoV-19/Canada/ON-A34/2020	EPI_ISL_792061	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-A37/2020	EPI_ISL_792063	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-A38/2020	EPI_ISL_792064	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.26	GH
hCoV-19/Canada/ON-A42/2020	EPI_ISL_792067	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36	GH
hCoV-19/Canada/ON-A43/2020	EPI_ISL_792068	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-A44/2020	EPI_ISL_792069	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-A46/2020	EPI_ISL_792071	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-A60/2020	EPI_ISL_792080	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-A61/2020	EPI_ISL_792081	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.26	GH
hCoV-19/Canada/ON-A62/2020	EPI_ISL_792082	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2033/2020	EPI_ISL_792084	2020-12-27	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2034/2020	EPI_ISL_792085	2020-12-28	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2036/2020	EPI_ISL_792086	2020-12-25	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2038/2020	EPI_ISL_792088	2020-12-30	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Denmark/DCGC-23800/2020	EPI_ISL_793379	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-23923/2020	EPI_ISL_793380	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-23259/2020	EPI_ISL_793413	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26161 (frameshift confirmed by the submitter). NS3 without BLAST coverage.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-22944/2020	EPI_ISL_793426	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.24	GH
hCoV-19/England/CAMC-D378CF/2020	EPI_ISL_798105	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-D379CC/2020	EPI_ISL_798110	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-D2D6D1/2020	EPI_ISL_799531	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-D19C7C/2020	EPI_ISL_799543	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-BC24B8/2020	EPI_ISL_800905	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E241stop results in 12.7% truncation of the protein sequence. NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.36.1	GH
hCoV-19/England/CAMC-BC3305/2020	EPI_ISL_800920	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/Netherlands/NH-RIVM-10171/2020	EPI_ISL_804437	2020-04-14	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/NH-RIVM-10257/2020	EPI_ISL_804457	2020-04-11	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/NH-RIVM-10262/2020	EPI_ISL_804459	2020-03-17	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/NH-RIVM-10282/2020	EPI_ISL_804462	2020-03-31	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/France/PAC-IHUCOVID-2570/2020	EPI_ISL_804516	2020-10-20	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/Turkey/HSGM-IST4/2020	EPI_ISL_812901	2020-12-21	Europe / Turkey / Ankara	Human	Orginal	Oropharyngeal swab		Illumina Miseq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.36.1	GH
hCoV-19/Turkey/HSGM-IST15/2020	EPI_ISL_812911	2020-12-21	Europe / Turkey / Ankara	Human	Orginal	Oropharyngeal swab		Illumina Miseq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.469	GH
hCoV-19/Turkey/HSGM-IST23/2020	EPI_ISL_812919	2020-12-21	Europe / Turkey / Ankara	Human	Orginal	Oropharyngeal swab		Illumina Miseq	Burrows-Wheeler Alignerv.07.17-r1188	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Thailand/Bangkok-CONI-0375/2020	EPI_ISL_812923	2020-12-20	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0379/2020	EPI_ISL_812927	2020-12-24	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0380/2020	EPI_ISL_812928	2020-12-24	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0381/2020	EPI_ISL_812929	2020-12-23	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0382/2020	EPI_ISL_812930	2020-12-23	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0383/2020	EPI_ISL_812931	2020-12-23	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0387/2020	EPI_ISL_812934	2020-12-24	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0388/2020	EPI_ISL_812935	2020-12-24	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0389/2020	EPI_ISL_812936	2020-12-24	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0390/2020	EPI_ISL_812937	2020-12-24	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0391/2020	EPI_ISL_812938	2020-12-24	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0393/2020	EPI_ISL_812940	2020-12-24	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0395/2020	EPI_ISL_812942	2020-12-24	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0396/2020	EPI_ISL_812943	2020-12-24	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0399/2020	EPI_ISL_812945	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0401/2020	EPI_ISL_812947	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0402/2020	EPI_ISL_812948	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0403/2020	EPI_ISL_812949	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0404/2020	EPI_ISL_812950	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0405/2020	EPI_ISL_812951	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0407/2020	EPI_ISL_812953	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/England/BIRM-680F7/2020	EPI_ISL_812984	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/SHEF-10CEB91/2020	EPI_ISL_816445	2020-12-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.24	GH
hCoV-19/England/SHEF-10D7834/2020	EPI_ISL_816634	2020-12-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.24	GH
hCoV-19/Denmark/DCGC-26763/2020	EPI_ISL_817744	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.24	GH
hCoV-19/Denmark/DCGC-26768/2020	EPI_ISL_817748	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-26814/2020	EPI_ISL_817775	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-26816/2020	EPI_ISL_817777	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-26844/2020	EPI_ISL_817793	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.471	GH
hCoV-19/Denmark/DCGC-26857/2020	EPI_ISL_817798	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.471	GH
hCoV-19/Denmark/DCGC-26878/2020	EPI_ISL_817811	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-26893/2020	EPI_ISL_817822	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-26936/2020	EPI_ISL_817854	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-26950/2020	EPI_ISL_817863	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-27009/2020	EPI_ISL_817900	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-27031/2020	EPI_ISL_817911	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-27045/2020	EPI_ISL_817918	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-27060/2020	EPI_ISL_817926	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.24	GH
hCoV-19/Denmark/DCGC-27067/2020	EPI_ISL_817930	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-27086/2020	EPI_ISL_817941	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-27089/2020	EPI_ISL_817943	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-27104/2020	EPI_ISL_817950	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/ALDP-E31BAD/2020	EPI_ISL_821128	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/Iceland/6053/2020	EPI_ISL_829732	2020-12-19	Europe / Iceland / Reykjavik	Human	Original			Oxford Nanopore	Artic v1	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Switzerland/BL-42488904/2020	EPI_ISL_830742	2020-10-16	Europe / Switzerland / Basel-Land / Aesch	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Indonesia/KB-NIHRD-PME9639/2020	EPI_ISL_833040	2020-09-10	Asia / Indonesia / West Kalimantan	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.15			B.1	O
hCoV-19/Myanmar/DSMRC-001/2021	EPI_ISL_833041	2021-01-04	Asia / Myanmar / Nay Pyi Taw	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BBMap			B.1.36.16	GH
hCoV-19/Turkey/IST-GLAB-N005/2020	EPI_ISL_833141	2020-12-20	Europe / Turkey / Istanbul	Human	Original	Oropharyngeal swab		Illumina NextSeq	BWA-MEM	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.16	GH
hCoV-19/Turkey/IST-GLAB-N010/2020	EPI_ISL_833143	2020-12-20	Europe / Turkey / Istanbul	Human	Original	Oropharyngeal swab		Illumina NextSeq	BWA-MEM	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.523	GH
hCoV-19/Turkey/IST-GLAB-N011/2020	EPI_ISL_833144	2020-12-20	Europe / Turkey / Istanbul	Human	Original	Oropharyngeal swab		Illumina NextSeq	BWA-MEM			B.1.469	GH
hCoV-19/Bangladesh/BCSIR-DU-08/2020	EPI_ISL_833179	2020-07-07	Asia / Bangladesh / Dhaka	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	DRAGEN RNA Pathogen Detection 3.5.15			B.1.36.22	GH
hCoV-19/England/MILK-EC16A1/2021	EPI_ISL_835736	2021-01-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/OXON-F3FC41/2020	EPI_ISL_840230	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/OXON-F3FC8D/2020	EPI_ISL_840232	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/LOND-125331F/2020	EPI_ISL_842731	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.39	GH
hCoV-19/England/LOND-12539C2/2020	EPI_ISL_842791	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36	GH
hCoV-19/England/LOND-128741F/2020	EPI_ISL_842888	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.12	GH
hCoV-19/England/LOND-128744C/2020	EPI_ISL_842891	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.39	GH
hCoV-19/Denmark/DCGC-28212/2021	EPI_ISL_845020	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-28276/2021	EPI_ISL_845047	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-28641/2021	EPI_ISL_845157	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/USA/NY-NYCPHL-002294/2021	EPI_ISL_857118	2021-01-07	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188	NS3_E261stop results in 5.5% truncation of the protein sequence. Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.36.29	GH
hCoV-19/United Arab Emirates/2372/2020	EPI_ISL_859661	2020-08-14	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1	GH
hCoV-19/United Arab Emirates/2918/2020	EPI_ISL_859680	2020-08-15	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1	GH
hCoV-19/United Arab Emirates/2920/2020	EPI_ISL_859681	2020-08-10	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1	GH
hCoV-19/United Arab Emirates/3381/2020	EPI_ISL_859760	2020-09-20	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.36	GH
hCoV-19/United Arab Emirates/3553/2020	EPI_ISL_859780	2020-10-26	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/USA/OR-OHSU-8382/2020	EPI_ISL_861974	2020-12-22	North America / USA / Oregon / Washington County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/NORW-2265C7/2020	EPI_ISL_866819	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/NORW-2265D6/2020	EPI_ISL_866820	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/TFCI-26FFA0A/2020	EPI_ISL_869003	2020-11-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.469	GH
hCoV-19/Denmark/DCGC-32996/2021	EPI_ISL_870000	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-33075/2021	EPI_ISL_870080	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-33103/2021	EPI_ISL_870108	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Australia/NSW1494/2021	EPI_ISL_872587	2021-01-22	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.466.2	GH
hCoV-19/Taiwan/NTU39/2020	EPI_ISL_872591	2020-12-05	Asia / Taiwan / Taipei	Human	Vero cells	Throat swab		Sanger				B.1.456	GH
hCoV-19/Taiwan/NTU40/2020	EPI_ISL_872592	2020-12-05	Asia / Taiwan / Taipei	Human	Vero cells	Throat swab		Sanger				B.1.456	GH
hCoV-19/Taiwan/NTU41/2020	EPI_ISL_872593	2020-12-05	Asia / Taiwan / Taipei	Human	Vero cells	Throat swab		Sanger				B.1.456	GH
hCoV-19/Taiwan/NTU42/2020	EPI_ISL_872594	2020-12-05	Asia / Taiwan / Taipei	Human	Vero cells	Throat swab		Sanger				B.1.459	GH
hCoV-19/Taiwan/NTU47/2020	EPI_ISL_872598	2020-12-19	Asia / Taiwan / Taipei	Human	Vero cells	Throat swab		Sanger				B.1.459	GH
hCoV-19/Taiwan/NTU48/2020	EPI_ISL_872599	2020-12-19	Asia / Taiwan / Taipei	Human	Vero cells	Throat swab		Sanger				B.1.459	GH
hCoV-19/Nigeria/FC-CV544/2020	EPI_ISL_872615	2020-12-03	Africa / Nigeria / Abuja	Human	Original			Illumina MiSeq	Viral-ngs v2.1.18			B.1	GH
hCoV-19/Indonesia/JI-ITDua-33281NT/2020	EPI_ISL_877419	2020-12-11	Asia / Indonesia / East Java / Sidoarjo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.466.2	GH
hCoV-19/Indonesia/JI-ITDua-33304NT/2020	EPI_ISL_877420	2020-12-11	Asia / Indonesia / East Java / Surabaya	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-33312NT/2020	EPI_ISL_877421	2020-12-11	Asia / Indonesia / East Java / Surabaya	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-33753N/2020	EPI_ISL_877422	2020-12-15	Asia / Indonesia / East Java / Sidoarjo	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-33816NT/2020	EPI_ISL_877423	2020-12-16	Asia / Indonesia / East Java / Surabaya	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-33807NT/2020	EPI_ISL_877456	2020-12-16	Asia / Indonesia / East Java / Surabaya	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.466.2	GH
hCoV-19/Indonesia/JI-ITDua-33817NT/2020	EPI_ISL_877457	2020-12-16	Asia / Indonesia / East Java / Surabaya	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.459	GH
hCoV-19/Indonesia/JI-ITDua-33862NT/2020	EPI_ISL_877458	2020-12-16	Asia / Indonesia / East Java / Sidoarjo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.468	GH
hCoV-19/Indonesia/JI-ITDua-34192NT/2020	EPI_ISL_877459	2020-12-18	Asia / Indonesia / East Java / Surabaya	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-34660NT/2020	EPI_ISL_877460	2020-12-22	Asia / Indonesia / East Java / Sidoarjo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.459	GH
hCoV-19/Australia/VIC18139/2021	EPI_ISL_877576	2021-01-18	Oceania / Australia / Victoria	Human	Original			Illumina iSeq	ARTIC v3, minimap2 v2.17, ivar v1.3, samtools v1.11			B.1.36	GH
hCoV-19/USA/CA-ALSR-5971/2020	EPI_ISL_878763	2020-12-12	North America / USA / California / San Diego	Human	Original	Nasal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/USA/LA-EVTL1519/2020	EPI_ISL_889500	2020-12-29	North America / USA / Louisiana / Caddo Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.36.10	GH
hCoV-19/Myanmar/DMR-MM06/2020	EPI_ISL_896577	2020-05	Asia / Myanmar / Yangon	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/Myanmar/DMR-MM08/2020	EPI_ISL_896579	2020-05	Asia / Myanmar / Rakhine	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/Myanmar/DMR-MM09/2020	EPI_ISL_896580	2020-05	Asia / Myanmar / Rakhine	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/Myanmar/DMR-MM11/2020	EPI_ISL_896582	2020-08	Asia / Myanmar / Rakhine	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Myanmar/DMR-MM12/2020	EPI_ISL_896583	2020-08	Asia / Myanmar / Rakhine	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Myanmar/DMR-MM13/2020	EPI_ISL_896584	2020-08	Asia / Myanmar / Rakhine	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Myanmar/DMR-MM14/2020	EPI_ISL_896585	2020-08	Asia / Myanmar / Rakhine	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Myanmar/DMR-MM15/2020	EPI_ISL_896586	2020-08	Asia / Myanmar / Rakhine	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Myanmar/DMR-MM16/2020	EPI_ISL_896587	2020-08	Asia / Myanmar / Rakhine	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Myanmar/DMR-MM17/2020	EPI_ISL_896588	2020-08	Asia / Myanmar / Rakhine	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Myanmar/DMR-MM18/2020	EPI_ISL_896589	2020-08	Asia / Myanmar / Rakhine	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Myanmar/DMR-MM19/2020	EPI_ISL_896590	2020-08	Asia / Myanmar / Rakhine	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Myanmar/DMR-MM21/2020	EPI_ISL_896592	2020-09	Asia / Myanmar / Yangon	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Myanmar/DMR-MM22/2020	EPI_ISL_896593	2020-09	Asia / Myanmar / Yangon	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Myanmar/DMR-MM23/2020	EPI_ISL_896594	2020-09	Asia / Myanmar / Yangon	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Myanmar/DMR-MM24/2020	EPI_ISL_896595	2020-09	Asia / Myanmar / Yangon	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Myanmar/DMR-MM25/2020	EPI_ISL_896596	2020-09	Asia / Myanmar / Yangon	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Myanmar/DMR-MM27/2020	EPI_ISL_896598	2020-09	Asia / Myanmar / Yangon	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Myanmar/DMR-MM28/2020	EPI_ISL_896599	2020-09	Asia / Myanmar / Yangon	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Myanmar/DMR-MM29/2020	EPI_ISL_896600	2020-09	Asia / Myanmar / Yangon	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Myanmar/DMR-MM30/2020	EPI_ISL_896601	2020-09	Asia / Myanmar / Yangon	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.16	GH
hCoV-19/Japan/PG-12242/2020	EPI_ISL_896660	2020-11-17	Asia / Japan / Mie	Human	Original			illumina iSeq	A5-miseq v. 20140604	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/PG-12249/2020	EPI_ISL_896667	2020-11-19	Asia / Japan / Mie	Human	Original			illumina iSeq	A5-miseq v. 20140604	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/PG-12250/2020	EPI_ISL_896668	2020-11-19	Asia / Japan / Mie	Human	Original			illumina iSeq	A5-miseq v. 20140604	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Finland/9T6DA7_S177/2021	EPI_ISL_902901	2021-01-09	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-9-39_S231/2021	EPI_ISL_902916	2021-01-11	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Indonesia/KB-TUH-C2114692/2020	EPI_ISL_902918	2020-09-05	Asia / Indonesia / West Kalimantan	Human	Original	nasopharyngeal swab		Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Indonesia/KB-TUH-C2122618/2020	EPI_ISL_902919	2020-09-28	Asia / Indonesia / West Kalimantan	Human	Original	nasopharyngeal swab		Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Indonesia/KB-TUH-C2131682/2020	EPI_ISL_902924	2020-10-23	Asia / Indonesia / West Kalimantan	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/USA/IN-Lilly-IPB0173-02bc13/2020	EPI_ISL_902981	2020-03-23	North America / USA / Indiana / Indianapolis	Human	Original	Nasopharyngeal swab		Ion Torrent	BWA-MEM v0.7.12, FreeBayes v1.3.1			B.1	GH
hCoV-19/USA/IN-Lilly-IPB0173-02bc25/2020	EPI_ISL_902990	2020-03-20	North America / USA / Indiana / Indianapolis	Human	Original	Nasopharyngeal swab		Ion Torrent	BWA-MEM v0.7.12, FreeBayes v1.3.1			B.1	GH
hCoV-19/England/ALDP-10E199E/2021	EPI_ISL_907742	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/Bosnia and Herzegovina/agc788/2021	EPI_ISL_918407	2021-01-11	Europe / Bosnia and Herzegovina / Sarajevo	Human	Original	Nasopharyngeal swab		Ion Torrent	IRMA			B.1	GH
hCoV-19/England/BIRM-69F17/2020	EPI_ISL_918596	2020-11-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.28	GH
hCoV-19/England/BIRM-69F44/2020	EPI_ISL_918597	2020-11-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.28	GH
hCoV-19/Canada/ON-PHL-21-00320/2020	EPI_ISL_925585	2020-10	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.523	GH
hCoV-19/Canada/ON-PHL-21-00326/2020	EPI_ISL_925588	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00334/2020	EPI_ISL_925590	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/ON-PHL-21-00335/2020	EPI_ISL_925596	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00344/2020	EPI_ISL_925597	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00367/2020	EPI_ISL_925598	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00343/2020	EPI_ISL_925602	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00342/2020	EPI_ISL_925603	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00338/2020	EPI_ISL_925605	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00337/2020	EPI_ISL_925607	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00373/2020	EPI_ISL_925609	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36	GH
hCoV-19/Canada/ON-PHL-21-00354/2020	EPI_ISL_925612	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00353/2020	EPI_ISL_925613	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00365/2020	EPI_ISL_925617	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00375/2020	EPI_ISL_925620	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00383/2020	EPI_ISL_925621	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00385/2020	EPI_ISL_925625	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00491/2020	EPI_ISL_925628	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00492/2020	EPI_ISL_925629	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36	GH
hCoV-19/Canada/ON-PHL-21-00499/2020	EPI_ISL_925630	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00503/2020	EPI_ISL_925632	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00505/2020	EPI_ISL_925639	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00513/2020	EPI_ISL_925642	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00516/2020	EPI_ISL_925649	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00537/2020	EPI_ISL_925654	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00547/2020	EPI_ISL_925655	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00514/2020	EPI_ISL_925659	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00348/2020	EPI_ISL_925701	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00340/2020	EPI_ISL_925702	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00351/2020	EPI_ISL_925704	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00352/2020	EPI_ISL_925705	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36	GH
hCoV-19/Canada/ON-PHL-21-00356/2020	EPI_ISL_925706	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00358/2020	EPI_ISL_925707	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00363/2020	EPI_ISL_925710	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00378/2020	EPI_ISL_925713	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00508/2020	EPI_ISL_925717	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00524/2020	EPI_ISL_925722	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00525/2020	EPI_ISL_925723	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00507/2020	EPI_ISL_925724	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00382/2020	EPI_ISL_925730	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00481/2020	EPI_ISL_925763	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00691/2021	EPI_ISL_925764	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00653/2021	EPI_ISL_925770	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36	GH
hCoV-19/Canada/ON-PHL-21-00649/2021	EPI_ISL_925771	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00717/2021	EPI_ISL_925773	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00701/2021	EPI_ISL_925776	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00681/2021	EPI_ISL_925778	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00646/2021	EPI_ISL_925779	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Denmark/DCGC-35822/2021	EPI_ISL_926963	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-37970/2021	EPI_ISL_929111	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-38095/2021	EPI_ISL_929236	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-38096/2021	EPI_ISL_929237	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-38104/2021	EPI_ISL_929245	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-38110/2021	EPI_ISL_929251	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.469	GH
hCoV-19/Denmark/DCGC-38117/2021	EPI_ISL_929258	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-38134/2021	EPI_ISL_929275	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-39050/2021	EPI_ISL_930192	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-39144/2021	EPI_ISL_930286	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Singapore/131/2021	EPI_ISL_937521	2021-01-31	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.459	GH
hCoV-19/Singapore/132/2021	EPI_ISL_937522	2021-01-28	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.459	GH
hCoV-19/Singapore/136/2021	EPI_ISL_937526	2021-01-29	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.471	GH
hCoV-19/Singapore/137/2021	EPI_ISL_937527	2021-01-30	Asia / Singapore	Human	Original			Illumina MiSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/England/MILK-1165A43/2021	EPI_ISL_938913	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/Indonesia/JK-NIHRD-MI2100169/2021	EPI_ISL_943548	2021-01-05	Asia / Indonesia / Jakarta	Human	Original	Oropharyngeal swab, Nasopharyngeal swab		Illumina Miseq	Dragen RNA Pathogen Detection 3.5.14			B.1.466.2	GH
hCoV-19/India/WB-IICB-046/2020	EPI_ISL_944773	2020-10-27	Asia / India / West Bengal	Human	Original			Illumina MiSeq	SPAdes			B.1	O
hCoV-19/India/WB-IICB-051/2020	EPI_ISL_944784	2020-10-26	Asia / India / West Bengal	Human	Original			Illumina MiSeq	SPAdes			B.1	O
hCoV-19/India/WB-IICB-052/2020	EPI_ISL_944788	2020-10-26	Asia / India / West Bengal	Human	Original			Illumina MiSeq	SPAdes			B.1	GH
hCoV-19/Italy/CAM-CRGS-293/2020	EPI_ISL_954184	2020-10-11	Europe / Italy / Campania	Human	Original			Illumina NextSeq 500				B.1	GH
hCoV-19/Italy/CAM-CRGS-294/2020	EPI_ISL_954185	2020-10-11	Europe / Italy / Campania	Human	Original			Illumina NextSeq 500				B.1	GH
hCoV-19/USA/CA-CZB-17506/2020	EPI_ISL_955579	2020-12-17	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.36.10	GH
hCoV-19/Germany/HH-HPI-p2967/2020	EPI_ISL_960006	2020-09-16	Europe / Germany / Hamburg	Human	Original			Illumina Miseq				B.1.22	O
hCoV-19/Germany/HH-HPI-p2969/2020	EPI_ISL_960013	2020-09-12	Europe / Germany / Hamburg	Human	Original			Illumina Miseq				B.1.22	O
hCoV-19/Germany/HH-HPI-p2981/2020	EPI_ISL_960016	2020-09-12	Europe / Germany / Hamburg	Human	Original			Illumina Miseq				B.1.22	O
hCoV-19/Germany/HH-HPI-p2882/2020	EPI_ISL_960023	2020-09-08	Europe / Germany / Hamburg	Human	Original			Illumina Miseq				B.1.22	O
hCoV-19/Germany/HH-HPI-p2970/2020	EPI_ISL_960025	2020-09-08	Europe / Germany / Hamburg	Human	Original			Illumina Miseq				B.1.22	O
hCoV-19/Germany/HH-HPI-p2936/2020	EPI_ISL_960029	2020-09-05	Europe / Germany / Hamburg	Human	Original			Illumina Miseq				B.1.22	O
hCoV-19/Germany/HH-HPI-p2821/2020	EPI_ISL_960083	2020-08-04	Europe / Germany / Hamburg	Human	Original			Illumina Miseq				B.1.36	GH
hCoV-19/Spain/VC-IBV-99016733/2020	EPI_ISL_961270	2020-12-30	Europe / Spain / Comunitat Valenciana / Alicante	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.36.1	GH
hCoV-19/Spain/VC-IBV-99016736/2020	EPI_ISL_961271	2020-12-30	Europe / Spain / Comunitat Valenciana / Alicante	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.36.1	GH
hCoV-19/Canada/ON-S2423/2020	EPI_ISL_961364	2020-11-30	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-S2427/2020	EPI_ISL_961365	2020-12-03	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-S2428/2020	EPI_ISL_961366	2020-12-03	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-S2426/2020	EPI_ISL_961367	2020-12-04	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-S2422/2021	EPI_ISL_961381	2021-01-11	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36	GH
hCoV-19/Canada/ON-S2127/2021	EPI_ISL_961384	2021-01-19	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-S2130/2021	EPI_ISL_961387	2021-01-19	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36	GH
hCoV-19/Canada/ON-S2132/2021	EPI_ISL_961389	2021-01-19	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2136/2021	EPI_ISL_961393	2021-01-19	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2137/2021	EPI_ISL_961394	2021-01-19	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Malaysia/IMR_WC65730/2021	EPI_ISL_962523	2021-01-25	Asia / Malaysia	Human	Original			Illumina NextSeq 500				B.1.466.2	GH
hCoV-19/Malaysia/IMR_WC68515/2021	EPI_ISL_962524	2021-01-26	Asia / Malaysia	Human	Original			Illumina NextSeq 500				B.1.466.2	GH
hCoV-19/England/ALDP-119F767/2021	EPI_ISL_963855	2021-01-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/Canada/ON-PHL-21-00565/2021	EPI_ISL_966045	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00750/2021	EPI_ISL_966068	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00754/2021	EPI_ISL_966069	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00792/2021	EPI_ISL_966300	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00784/2021	EPI_ISL_966302	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00787/2021	EPI_ISL_966303	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/ON-PHL-21-00576/2021	EPI_ISL_966306	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00612/2021	EPI_ISL_966309	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/BC-BCCDC-3977/2020	EPI_ISL_968639	2020-08-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-3979/2020	EPI_ISL_968641	2020-08-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 15 nucleotides when compared to the reference sequence.	info	B.1.36.38	GH
hCoV-19/Denmark/DCGC-39549/2021	EPI_ISL_970949	2021-02-01	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5130/2020	EPI_ISL_970995	2020-09-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Denmark/DCGC-41799/2021	EPI_ISL_973476	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Canada/BC-BCCDC-4995/2020	EPI_ISL_973479	2020-09-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7255/2020	EPI_ISL_974405	2020-10-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5944/2020	EPI_ISL_974411	2020-10-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6150/2020	EPI_ISL_974418	2020-10-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6151/2020	EPI_ISL_974419	2020-10-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6280/2020	EPI_ISL_974420	2020-10-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6281/2020	EPI_ISL_974421	2020-10-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6282/2020	EPI_ISL_974422	2020-10-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6283/2020	EPI_ISL_974423	2020-10-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6953/2020	EPI_ISL_974429	2020-10-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-7276/2020	EPI_ISL_974432	2020-10-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5951/2020	EPI_ISL_974436	2020-10-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5954/2020	EPI_ISL_974439	2020-10-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-5959/2020	EPI_ISL_974444	2020-10-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6066/2020	EPI_ISL_974449	2020-10-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6067/2020	EPI_ISL_974450	2020-10-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6068/2020	EPI_ISL_974451	2020-10-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6069/2020	EPI_ISL_974452	2020-10-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6070/2020	EPI_ISL_974453	2020-10-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6071/2020	EPI_ISL_974466	2020-10-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6072/2020	EPI_ISL_974467	2020-10-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6958/2020	EPI_ISL_974473	2020-10-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7462/2020	EPI_ISL_974474	2020-10-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7310/2020	EPI_ISL_974496	2020-10-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6633/2020	EPI_ISL_974701	2020-10-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7471/2020	EPI_ISL_974706	2020-10-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10478/2020	EPI_ISL_974715	2020-10-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-6749/2020	EPI_ISL_974742	2020-10-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7473/2020	EPI_ISL_974746	2020-10-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7474/2020	EPI_ISL_974747	2020-10-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7475/2020	EPI_ISL_974748	2020-10-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7477/2020	EPI_ISL_974750	2020-10-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8509/2020	EPI_ISL_974757	2020-10-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7135/2020	EPI_ISL_974774	2020-10-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7271/2020	EPI_ISL_974775	2020-10-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7666/2020	EPI_ISL_974784	2020-10-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10602/2020	EPI_ISL_974786	2020-10-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6569/2020	EPI_ISL_974787	2020-10-31	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6762/2020	EPI_ISL_974797	2020-10-31	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6763/2020	EPI_ISL_974798	2020-10-31	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8230/2020	EPI_ISL_975709	2020-11-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8456/2020	EPI_ISL_975713	2020-11-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8463/2020	EPI_ISL_975715	2020-11-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-8465/2020	EPI_ISL_975717	2020-11-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8620/2020	EPI_ISL_975721	2020-11-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8626/2020	EPI_ISL_975724	2020-11-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8629/2020	EPI_ISL_975725	2020-11-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8641/2020	EPI_ISL_975732	2020-11-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8642/2020	EPI_ISL_975733	2020-11-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10479/2020	EPI_ISL_975738	2020-11-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10480/2020	EPI_ISL_975739	2020-11-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-10481/2020	EPI_ISL_975740	2020-11-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10484/2020	EPI_ISL_975742	2020-11-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8009/2020	EPI_ISL_975749	2020-11-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8233/2020	EPI_ISL_975751	2020-11-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8235/2020	EPI_ISL_975752	2020-11-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8470/2020	EPI_ISL_975756	2020-11-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8788/2020	EPI_ISL_975761	2020-11-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8241/2020	EPI_ISL_975774	2020-11-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8353/2020	EPI_ISL_975776	2020-11-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8534/2020	EPI_ISL_975785	2020-11-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8163/2020	EPI_ISL_975795	2020-11-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8165/2020	EPI_ISL_975797	2020-11-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/MB-NML-5665/2020	EPI_ISL_979294	2020-12-16	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-5673/2020	EPI_ISL_979297	2020-12-15	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-5676/2020	EPI_ISL_979300	2020-12-18	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-16329/2021	EPI_ISL_979312	2021-01-19	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-16331/2021	EPI_ISL_979314	2021-01-22	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-16332/2021	EPI_ISL_979315	2021-01-17	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-16333/2021	EPI_ISL_979316	2021-01-20	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/MB-NML-16353/2021	EPI_ISL_979317	2021-01-29	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-16357/2021	EPI_ISL_979321	2021-01-13	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-16358/2021	EPI_ISL_979322	2021-01-22	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-16359/2021	EPI_ISL_979323	2021-01-14	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/MB-NML-16361/2021	EPI_ISL_979325	2021-01-20	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/MB-NML-16362/2021	EPI_ISL_979326	2021-01-25	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/England/ALDP-10EA0AF/2021	EPI_ISL_992289	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Switzerland/AG-ETHZ-480203/2021	EPI_ISL_1003901	2021-01-31	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/un-ETHZ-431510/2020	EPI_ISL_1004804	2020-12-30	Europe / Switzerland	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Sweden/21-50492/2021	EPI_ISL_1008446	2021-01-20	Europe / Sweden / Sormland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.469	GH
hCoV-19/Sweden/21-50612/2021	EPI_ISL_1008473	2021-01-25	Europe / Sweden / Varmland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.36.1	GH
hCoV-19/Sweden/21-50661/2021	EPI_ISL_1008492	2021-01-26	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.36.1	GH
hCoV-19/Australia/NSW-R0007/2021	EPI_ISL_1010700	2021-01-22	Oceania / Australia / New South Wales / Sydney	Human	Original			Oxford Nanopore MinION				B.1.466.2	GH
hCoV-19/Australia/NSW4136/2021	EPI_ISL_1010705	2021-01-28	Oceania / Australia / New South Wales / Sydney	Human	Original			Oxford Nanopore MinION		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Curacao/CW-RIVM-21734/2020	EPI_ISL_1014549	2020-12-26	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-21732/2020	EPI_ISL_1014551	2020-12-12	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-21730/2020	EPI_ISL_1014553	2020-12-16	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-21729/2020	EPI_ISL_1014554	2020-12-04	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-21728/2020	EPI_ISL_1014555	2020-12-26	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-21727/2020	EPI_ISL_1014556	2020-12-18	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-21723/2020	EPI_ISL_1014559	2020-10-08	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-21722/2020	EPI_ISL_1014560	2020-10-12	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-21720/2020	EPI_ISL_1014562	2020-10-30	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-21716/2020	EPI_ISL_1014566	2020-12-18	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-21715/2020	EPI_ISL_1014567	2020-12-15	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-21714/2020	EPI_ISL_1014568	2020-12-28	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-21713/2020	EPI_ISL_1014569	2020-12-18	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-21712/2020	EPI_ISL_1014570	2020-12-15	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-21706/2020	EPI_ISL_1014576	2020-11-17	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-21705/2020	EPI_ISL_1014577	2020-11-20	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-21704/2020	EPI_ISL_1014578	2020-10-13	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-11652/2021	EPI_ISL_1014583	2021-01-25	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-11649/2021	EPI_ISL_1014586	2021-01-20	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-11647/2021	EPI_ISL_1014587	2021-01-21	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-11645/2021	EPI_ISL_1014589	2021-01-18	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-11644/2021	EPI_ISL_1014590	2021-01-18	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-11643/2021	EPI_ISL_1014591	2021-01-18	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-11588/2021	EPI_ISL_1014595	2021-01-20	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Curacao/CW-RIVM-11587/2021	EPI_ISL_1014596	2021-01-19	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Hong Kong/HKPU-06217/2020	EPI_ISL_1020054	2020-11-29	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06226/2020	EPI_ISL_1020055	2020-11-29	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06235/2020	EPI_ISL_1020056	2020-11-29	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07124/2020	EPI_ISL_1020101	2020-12-09	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07139/2020	EPI_ISL_1020102	2020-12-09	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07212/2020	EPI_ISL_1020104	2020-12-10	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07214/2020	EPI_ISL_1020105	2020-12-10	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-07244/2020	EPI_ISL_1020106	2020-12-10	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-07301/2020	EPI_ISL_1020107	2020-12-11	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07309/2020	EPI_ISL_1020108	2020-12-11	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07414/2020	EPI_ISL_1020109	2020-12-12	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-07424/2020	EPI_ISL_1020110	2020-12-12	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-07425/2020	EPI_ISL_1020111	2020-12-12	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-07429/2020	EPI_ISL_1020112	2020-12-12	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07437/2020	EPI_ISL_1020113	2020-12-12	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07469/2020	EPI_ISL_1020114	2020-12-13	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-07474/2020	EPI_ISL_1020115	2020-12-13	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07476/2020	EPI_ISL_1020116	2020-12-13	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-07482/2020	EPI_ISL_1020117	2020-12-13	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07483/2020	EPI_ISL_1020118	2020-12-13	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07533/2020	EPI_ISL_1020119	2020-12-13	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07550/2020	EPI_ISL_1020120	2020-12-14	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Denmark/DCGC-44759/2021	EPI_ISL_1025137	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Hong Kong/HKU-201216-321/2020	EPI_ISL_1034717	2020-11-22	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-326/2020	EPI_ISL_1034718	2020-11-22	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-327/2020	EPI_ISL_1034719	2020-11-23	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-338/2020	EPI_ISL_1034720	2020-11-23	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-339/2020	EPI_ISL_1034721	2020-11-23	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36.27	GH
hCoV-19/Hong Kong/HKU-201216-340/2020	EPI_ISL_1034722	2020-11-23	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-343/2020	EPI_ISL_1034723	2020-11-25	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36.27	GH
hCoV-19/Hong Kong/HKU-201216-346/2020	EPI_ISL_1034724	2020-11-26	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-347/2020	EPI_ISL_1034725	2020-11-26	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-350/2020	EPI_ISL_1034726	2020-11-26	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36.27	GH
hCoV-19/Hong Kong/HKU-201216-354/2020	EPI_ISL_1034727	2020-11-28	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-357/2020	EPI_ISL_1034728	2020-11-27	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-358/2020	EPI_ISL_1034729	2020-11-28	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-359/2020	EPI_ISL_1034730	2020-11-28	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-360/2020	EPI_ISL_1034731	2020-11-28	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-361/2020	EPI_ISL_1034732	2020-11-28	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-363/2020	EPI_ISL_1034733	2020-11-28	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-364/2020	EPI_ISL_1034734	2020-11-29	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-366/2020	EPI_ISL_1034735	2020-11-29	Asia / Hong Kong	Human	Original	Throat saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Afghanistan/IMB15485/2021	EPI_ISL_1034755	2021-01-21	Asia / Afghanistan	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Afghanistan/IMB15487/2021	EPI_ISL_1034756	2021-01-21	Asia / Afghanistan	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Afghanistan/IMB15488/2021	EPI_ISL_1034757	2021-01-21	Asia / Afghanistan	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Afghanistan/IMB15490/2021	EPI_ISL_1034758	2021-01-21	Asia / Afghanistan	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Afghanistan/IMB15491/2021	EPI_ISL_1034759	2021-01-21	Asia / Afghanistan	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Malaysia/IMR_WC91520/2021	EPI_ISL_1055037	2021-02-11	Asia / Malaysia	Human	Original			Illumina NextSeq 500				B.1.466.2	GH
hCoV-19/Ireland/D-NVRL-21IRL36147/2021	EPI_ISL_1055092	2021-02-09	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36	GH
hCoV-19/South Korea/KDCA1463/2020	EPI_ISL_1063594	2020-12-31	Asia / South Korea	Human	Original			Illumina MiSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/South Korea/KDCA1473/2021	EPI_ISL_1063595	2021-01-04	Asia / South Korea	Human	Original			Illumina MiSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/South Korea/KDCA1621/2021	EPI_ISL_1063596	2021-02-12	Asia / South Korea	Human	Original			Illumina MiSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Sweden/21-51282/2021	EPI_ISL_1064703	2021-02-09	Europe / Sweden / Kalmar	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.36.1	GH
hCoV-19/Denmark/DCGC-46354/2021	EPI_ISL_1065864	2021-02-15	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-47495/2020	EPI_ISL_1067030	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-47520/2021	EPI_ISL_1067055	2021-02-15	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Saudi Arabia/KAUST-Makkah177/2020	EPI_ISL_437700	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Makkah179/2020	EPI_ISL_437702	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Makkah204/2020	EPI_ISL_437714	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-Madinah211/2020	EPI_ISL_437716	2020-04-06	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B	O
hCoV-19/Saudi Arabia/KAUST-Madinah213/2020	EPI_ISL_437717	2020-04-06	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-Makkah215/2020	EPI_ISL_437718	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.471	GH
hCoV-19/Saudi Arabia/KAUST-Makkah217/2020	EPI_ISL_437719	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Makkah227/2020	EPI_ISL_437723	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-Makkah228/2020	EPI_ISL_437724	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-Makkah230/2020	EPI_ISL_437726	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-Makkah232/2020	EPI_ISL_437728	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-Makkah233/2020	EPI_ISL_437729	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-Makkah234/2020	EPI_ISL_437730	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-Makkah237/2020	EPI_ISL_437732	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah238/2020	EPI_ISL_437733	2020-03-29	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.523	GH
hCoV-19/Saudi Arabia/KAUST-Madinah248/2020	EPI_ISL_437734	2020-03-31	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah249/2020	EPI_ISL_437735	2020-03-31	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah252/2020	EPI_ISL_437736	2020-03-30	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-Madinah253/2020	EPI_ISL_437737	2020-03-28	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah254/2020	EPI_ISL_437738	2020-03-30	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah255/2020	EPI_ISL_437739	2020-03-29	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-Madinah256/2020	EPI_ISL_437740	2020-03-30	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah257/2020	EPI_ISL_437741	2020-03-30	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah258/2020	EPI_ISL_437742	2020-03-30	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah260/2020	EPI_ISL_437743	2020-03-30	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah261/2020	EPI_ISL_437744	2020-03-30	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah262/2020	EPI_ISL_437745	2020-03-30	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-Madinah263/2020	EPI_ISL_437746	2020-03-30	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	G
hCoV-19/Saudi Arabia/KAUST-Madinah265/2020	EPI_ISL_437748	2020-03-30	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.468	GH
hCoV-19/Saudi Arabia/KAUST-Madinah266/2020	EPI_ISL_437749	2020-03-30	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah267/2020	EPI_ISL_437750	2020-03-30	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Madinah269/2020	EPI_ISL_437751	2020-03-30	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	G
hCoV-19/Saudi Arabia/KAUST-Madinah270/2020	EPI_ISL_437752	2020-03-30	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-Jeddah73/2020	EPI_ISL_437758	2020-03-30	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-Makkah97/2020	EPI_ISL_437762	2020-03-30	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/England/CAMB-7DA97/2020	EPI_ISL_441677	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/SHEF-C1C16/2020	EPI_ISL_453698	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/India/OR-RMRC24/2020	EPI_ISL_455775	2020-04-04	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1	GH
hCoV-19/India/OR-RMRC27/2020	EPI_ISL_455776	2020-04-04	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1	GH
hCoV-19/India/OR-RMRC28/2020	EPI_ISL_455777	2020-04-04	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1	GH
hCoV-19/India/OR-RMRC30/2020	EPI_ISL_455778	2020-04-04	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1	GH
hCoV-19/India/OR-RMRC38/2020	EPI_ISL_455779	2020-04-04	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1	GH
hCoV-19/India/OR-RMRC46/2020	EPI_ISL_455780	2020-04-08	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1	GH
hCoV-19/India/OR-RMRC5/2020	EPI_ISL_455782	2020-04-02	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1	GH
hCoV-19/India/OR-RMRC7/2020	EPI_ISL_455784	2020-04-02	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1	GH
hCoV-19/England/CAMB-1AF697/2020	EPI_ISL_459240	2020-05-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/CAMB-1B0244/2020	EPI_ISL_459259	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/Netherlands/Overijssel_11/2020	EPI_ISL_460800	2020-04-08	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Overijssel_12/2020	EPI_ISL_460801	2020-04-08	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Overijssel_13/2020	EPI_ISL_460802	2020-04-09	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Overijssel_14/2020	EPI_ISL_460803	2020-04-13	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Overijssel_15/2020	EPI_ISL_460804	2020-04-13	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Overijssel_17/2020	EPI_ISL_460806	2020-04-13	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Overijssel_18/2020	EPI_ISL_460807	2020-04-13	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/India/GJ-GBRC165/2020	EPI_ISL_461500	2020-05-27	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC166a/2020	EPI_ISL_461501	2020-05-27	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC166b/2020	EPI_ISL_461502	2020-05-27	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC167b/2020	EPI_ISL_461504	2020-05-27	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/England/CAMB-1B319F/2020	EPI_ISL_461553	2020-05-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/England/CAMB-1B3593/2020	EPI_ISL_461563	2020-05-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/England/CAMB-1B3B64/2020	EPI_ISL_461579	2020-05-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/India/OR-ILSCV18525/2020	EPI_ISL_463060	2020-05-13	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1.36.8	GH
hCoV-19/England/20206138804/2020	EPI_ISL_465663	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1	GH
hCoV-19/England/20206139704/2020	EPI_ISL_465666	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1	GH
hCoV-19/England/20206140304/2020	EPI_ISL_465668	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1	GH
hCoV-19/England/CAMB-1ABB7E/2020	EPI_ISL_470181	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/Israel/CVL-n-5999/2020	EPI_ISL_475014	2020-03-15	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina NextSeq	BWA			B.1	O
hCoV-19/India/GJ-GBRC204a/2020	EPI_ISL_475028	2020-06-07	Asia / India / Gujarat / Palanpur	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC219a/2020	EPI_ISL_475056	2020-06-08	Asia / India / Gujarat / Kheda	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.113	GH
hCoV-19/Egypt/CUNCI-HGC3I03/2020	EPI_ISL_479687	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1	GH
hCoV-19/Egypt/CUNCI-HGC3I06/2020	EPI_ISL_479688	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1	GH
hCoV-19/Egypt/CUNCI-HGC3I07/2020	EPI_ISL_479689	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1	GH
hCoV-19/Egypt/CUNCI-HGC3I023/2020	EPI_ISL_479695	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1	G
hCoV-19/Egypt/CUNCI-HGC3I08/2020	EPI_ISL_479698	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1	GH
hCoV-19/Egypt/CUNCI-HGC5I016/2020	EPI_ISL_479731	2020-06-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1	GH
hCoV-19/Australia/VIC1899/2020	EPI_ISL_480653	2020-06-01	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1	GH
hCoV-19/Australia/VIC2026/2020	EPI_ISL_480667	2020-06-06	Oceania / Australia / Victoria	Human	Original			Illumina iSeq	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1	GH
hCoV-19/Australia/VIC2027/2020	EPI_ISL_480668	2020-06-06	Oceania / Australia / Victoria	Human	Original			Illumina iSeq	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.471	GH
hCoV-19/Australia/VIC1951/2020	EPI_ISL_480675	2020-06-10	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10	NS8_G8stop results in 94.2% truncation of the protein sequence.	info	B.1	GH
hCoV-19/Australia/VIC1953/2020	EPI_ISL_480677	2020-06-09	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1	GH
hCoV-19/Australia/VIC1954/2020	EPI_ISL_480678	2020-06-10	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.523	GH
hCoV-19/Australia/VIC2099/2020	EPI_ISL_480708	2020-06-15	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1	GH
hCoV-19/Australia/VIC2111/2020	EPI_ISL_480717	2020-06-16	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.523	GH
hCoV-19/Australia/VIC2140/2020	EPI_ISL_480741	2020-06-20	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.36	GH
hCoV-19/Australia/VIC2141/2020	EPI_ISL_480742	2020-06-20	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.36	GH
hCoV-19/Australia/VIC2142/2020	EPI_ISL_480743	2020-06-19	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.523	GH
hCoV-19/Saudi Arabia/545/2020	EPI_ISL_490001	2020-02-13	Asia / Saudi Arabia	Human	Original	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1.468	GH
hCoV-19/Saudi Arabia/553/2020	EPI_ISL_490002	2020-02-13	Asia / Saudi Arabia	Human	Original	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Saudi Arabia/562/2020	EPI_ISL_490003	2020-02-16	Asia / Saudi Arabia	Human	Original	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1.36	GH
hCoV-19/Saudi Arabia/578/2020	EPI_ISL_490004	2020-02-17	Asia / Saudi Arabia	Human	Original	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1.36	GH
hCoV-19/Saudi Arabia/583/2020	EPI_ISL_490005	2020-02-18	Asia / Saudi Arabia	Human	Original	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Saudi Arabia/596/2020	EPI_ISL_490006	2020-02-18	Asia / Saudi Arabia	Human	Original	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1.468	GH
hCoV-19/Saudi Arabia/610/2020	EPI_ISL_490007	2020-02-20	Asia / Saudi Arabia	Human	Original	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1.456	GH
hCoV-19/Saudi Arabia/627/2020	EPI_ISL_490008	2020-02-23	Asia / Saudi Arabia	Human	Original	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Saudi Arabia/640/2020	EPI_ISL_490009	2020-02-24	Asia / Saudi Arabia	Human	Original	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Saudi Arabia/656/2020	EPI_ISL_490010	2020-02-26	Asia / Saudi Arabia	Human	Original	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Saudi Arabia/671/2020	EPI_ISL_490011	2020-02-27	Asia / Saudi Arabia	Human	Original	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Saudi Arabia/677/2020	EPI_ISL_490012	2020-03-01	Asia / Saudi Arabia	Human	Original	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Australia/NSW615/2020	EPI_ISL_490024	2020-05-27	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36	GH
hCoV-19/Australia/NSW633/2020	EPI_ISL_490042	2020-07-01	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36.1	GH
hCoV-19/England/SHEF-C5EB2/2020	EPI_ISL_490601	2020-04-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	O
hCoV-19/Scotland/EDB6640/2020	EPI_ISL_493963	2020-05-28	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.36	GH
hCoV-19/USA/WA-S1801/2020	EPI_ISL_496227	2020-06-02	North America / USA / Washington / Spokane County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.170	GH
hCoV-19/Bangladesh/BCSIR-NILMRC-288/2020	EPI_ISL_498816	2020-07-14	Asia / Bangladesh / Rangpur / Nilphamari	Human	Original	Nasopharyngeal swab		NextSeq 550	DRAGEN RNA Pathogen Detection 3.5.14			B.1.36.16	GH
hCoV-19/Ireland/SO-NVRL-70IRL90620/2020	EPI_ISL_500573	2020-07-02	Europe / Ireland / Sligo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/WW-NVRL-70IRL98345/2020	EPI_ISL_500575	2020-07-04	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/WD-NVRL-70IRL98816/2020	EPI_ISL_500576	2020-07-04	Europe / Ireland / Waterford	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol	Gap of 3 nucleotides found at refpos 22189.	info	B.1.36	GH
hCoV-19/Ireland/LK-NVRL-71IRL00996/2020	EPI_ISL_500578	2020-07-04	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/WD-NVRL-71IRL06455/2020	EPI_ISL_500581	2020-07-06	Europe / Ireland / Waterford	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol	Gap of 3 nucleotides found at refpos 22189.	info	B.1.36	GH
hCoV-19/Ireland/WD-NVRL-71IRL06472/2020	EPI_ISL_500582	2020-07-06	Europe / Ireland / Waterford	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol	Gap of 3 nucleotides found at refpos 22189.	info	B.1.36	GH
hCoV-19/Ireland/KK-NVRL-71IRL07034/2020	EPI_ISL_500583	2020-07-07	Europe / Ireland / Kilkenny	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/LM-NVRL-71IRL07120/2020	EPI_ISL_500584	2020-07-07	Europe / Ireland / Leitrim	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/D-NVRL-71IRL07157/2020	EPI_ISL_500585	2020-07-07	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/D-NVRL-71IRL07177/2020	EPI_ISL_500587	2020-07-07	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/D-NVRL-71IRL07206/2020	EPI_ISL_500588	2020-07-07	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/D-NVRL-71IRL07248/2020	EPI_ISL_500589	2020-07-07	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/WW-NVRL-71IRL07442/2020	EPI_ISL_500591	2020-07-07	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/KY-NVRL-71IRL24965/2020	EPI_ISL_500595	2020-07-10	Europe / Ireland / Kerry	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1087/2020	EPI_ISL_513100	2020-06-11	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MADINAH1102/2020	EPI_ISL_513108	2020-06-13	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-MADINAH1108/2020	EPI_ISL_513112	2020-06-11	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	O
hCoV-19/Saudi Arabia/KAUST-MADINAH1109/2020	EPI_ISL_513113	2020-06-11	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-MADINAH1110/2020	EPI_ISL_513114	2020-06-11	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MADINAH273/2020	EPI_ISL_513121	2020-04-01	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH274/2020	EPI_ISL_513122	2020-04-01	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH276/2020	EPI_ISL_513123	2020-04-01	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH280/2020	EPI_ISL_513124	2020-04-01	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH281/2020	EPI_ISL_513125	2020-04-01	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH282/2020	EPI_ISL_513126	2020-04-01	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH333/2020	EPI_ISL_513127	2020-04-24	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH335/2020	EPI_ISL_513128	2020-04-20	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH342/2020	EPI_ISL_513129	2020-04-24	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH344/2020	EPI_ISL_513131	2020-04-24	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH346/2020	EPI_ISL_513132	2020-04-24	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH347/2020	EPI_ISL_513133	2020-04-24	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH354/2020	EPI_ISL_513134	2020-04-23	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH355/2020	EPI_ISL_513135	2020-04-23	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH357/2020	EPI_ISL_513136	2020-04-23	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH360/2020	EPI_ISL_513137	2020-04-23	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH361/2020	EPI_ISL_513138	2020-04-23	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH362/2020	EPI_ISL_513139	2020-04-23	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH364/2020	EPI_ISL_513141	2020-04-23	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH368/2020	EPI_ISL_513142	2020-04-23	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MADINAH378/2020	EPI_ISL_513143	2020-04-24	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH380/2020	EPI_ISL_513144	2020-04-24	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH384/2020	EPI_ISL_513145	2020-04-24	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH387/2020	EPI_ISL_513146	2020-04-24	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1.468	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH391/2020	EPI_ISL_513147	2020-04-24	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH393/2020	EPI_ISL_513148	2020-04-24	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH396/2020	EPI_ISL_513149	2020-04-24	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH397/2020	EPI_ISL_513150	2020-04-24	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH398/2020	EPI_ISL_513151	2020-04-24	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH399/2020	EPI_ISL_513152	2020-04-24	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH404/2020	EPI_ISL_513153	2020-04-24	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH406/2020	EPI_ISL_513154	2020-04-24	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH435/2020	EPI_ISL_513156	2020-04-23	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH437/2020	EPI_ISL_513157	2020-04-23	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH444/2020	EPI_ISL_513158	2020-04-20	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH446/2020	EPI_ISL_513159	2020-04-20	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH450/2020	EPI_ISL_513160	2020-04-21	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH452/2020	EPI_ISL_513161	2020-04-21	Asia / Saudi Arabia / Madinah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH511/2020	EPI_ISL_513162	2020-04-12	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-MADINAH515/2020	EPI_ISL_513164	2020-04-07	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH519/2020	EPI_ISL_513166	2020-04-05	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus	Insertion of 6 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH521/2020	EPI_ISL_513167	2020-04-06	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH603/2020	EPI_ISL_513169	2020-04-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH605/2020	EPI_ISL_513170	2020-05-06	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH609/2020	EPI_ISL_513172	2020-05-06	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MADINAH644/2020	EPI_ISL_513173	2020-04-21	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-MADINAH647/2020	EPI_ISL_513174	2020-05-08	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MADINAH655/2020	EPI_ISL_513175	2020-04-30	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH684/2020	EPI_ISL_513176	2020-05-01	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH687/2020	EPI_ISL_513177	2020-05-08	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH691/2020	EPI_ISL_513179	2020-05-06	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH694/2020	EPI_ISL_513180	2020-05-08	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH702/2020	EPI_ISL_513181	2020-04-30	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus	Insertion of 4 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH704/2020	EPI_ISL_513182	2020-04-01	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-MADINAH710/2020	EPI_ISL_513183	2020-04-01	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MADINAH713/2020	EPI_ISL_513186	2020-04-01	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MADINAH715/2020	EPI_ISL_513187	2020-04-01	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH716/2020	EPI_ISL_513188	2020-04-01	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MADINAH851/2020	EPI_ISL_513191	2020-05-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH857/2020	EPI_ISL_513193	2020-05-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.36.10	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH858/2020	EPI_ISL_513194	2020-05-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MADINAH862/2020	EPI_ISL_513197	2020-05-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-MADINAH896/2020	EPI_ISL_513199	2020-05-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Netherlands/GE-EMC-224/2020	EPI_ISL_523205	2020-04-21	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-230/2020	EPI_ISL_523210	2020-06-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-231/2020	EPI_ISL_523211	2020-06-19	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-239/2020	EPI_ISL_523218	2020	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Netherlands/GE-EMC-278/2020	EPI_ISL_523257	2020-05-28	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-279/2020	EPI_ISL_523258	2020-05-28	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-296/2020	EPI_ISL_523275	2020-08-07	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Netherlands/GE-EMC-297/2020	EPI_ISL_523276	2020-08-07	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Netherlands/GE-EMC-298/2020	EPI_ISL_523277	2020-08-07	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Netherlands/GE-EMC-300/2020	EPI_ISL_523279	2020-06-05	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/England/CAMB-7E47A/2020	EPI_ISL_524568	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/QEUH-95E36B/2020	EPI_ISL_537145	2020-08-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/SHEF-10B3090/2020	EPI_ISL_537243	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/SHEF-10B2FD0/2020	EPI_ISL_537257	2020-05-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/SHEF-10B2FA3/2020	EPI_ISL_537259	2020-05-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/Indonesia/JI-NIHRD-PME0999/2020	EPI_ISL_538498	2020-06-11	Asia / Indonesia / East Java	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1.470	GH
hCoV-19/Indonesia/JI-NIHRD-PME2054/2020	EPI_ISL_538499	2020-06-29	Asia / Indonesia / East Java	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1.470	GH
hCoV-19/India/TG-CCMB-AA41/2020	EPI_ISL_539739	2020-08-10	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.36.8	GH
hCoV-19/India/TG-CCMB-AC391/2020	EPI_ISL_539741	2020-08-19	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.36.8	GH
hCoV-19/England/NOTT-1131E8/2020	EPI_ISL_540710	2020-09-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/NOTT-1132A9/2020	EPI_ISL_540718	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/SHEF-D1F38/2020	EPI_ISL_540770	2020-08-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	GH
hCoV-19/USA/CA-CZB-3923/2020	EPI_ISL_548535	2020-07-25	North America / USA / California / Contra Costa County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.36	GH
hCoV-19/Norway/2866/2020	EPI_ISL_549122	2020-07-07	Europe / Norway / Innlandet	Human	Original	Upper respiratory secretion and tracheal secretion		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/England/MILK-99CEF7/2020	EPI_ISL_549841	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-99CEE8/2020	EPI_ISL_549844	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-99D3AC/2020	EPI_ISL_549876	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/MILK-9A52B3/2020	EPI_ISL_550097	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-9A85C6/2020	EPI_ISL_550189	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9A5523/2020	EPI_ISL_550193	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-9A6D66/2020	EPI_ISL_550227	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9A5417/2020	EPI_ISL_550235	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9AA148/2020	EPI_ISL_550824	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.22	GH
hCoV-19/England/MILK-9AACED/2020	EPI_ISL_550839	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9AA306/2020	EPI_ISL_550842	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/England/MILK-9AA315/2020	EPI_ISL_550859	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/England/MILK-975F6A/2020	EPI_ISL_552789	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/ALDP-94DC46/2020	EPI_ISL_555682	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/ALDP-6CD528/2020	EPI_ISL_556243	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/England/ALDP-63CCA7/2020	EPI_ISL_556288	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/ALDP-748551/2020	EPI_ISL_557543	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/ALDP-9CD0F7/2020	EPI_ISL_566309	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CD455/2020	EPI_ISL_566313	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CD543/2020	EPI_ISL_566339	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CD82C/2020	EPI_ISL_566360	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CDA17/2020	EPI_ISL_566363	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CD604/2020	EPI_ISL_566372	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-9C8A2B/2020	EPI_ISL_567081	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/ALDP-9C610A/2020	EPI_ISL_567636	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C5FB6/2020	EPI_ISL_567639	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C52BD/2020	EPI_ISL_567657	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C628F/2020	EPI_ISL_567665	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C5DF8/2020	EPI_ISL_567682	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-9BE211/2020	EPI_ISL_568201	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Wales/PHWC-16CBF1/2020	EPI_ISL_574147	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.471	GH
hCoV-19/England/ALDP-9CAD7B/2020	EPI_ISL_575408	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CBE68/2020	EPI_ISL_575427	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CB7D6/2020	EPI_ISL_575445	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CABCC/2020	EPI_ISL_575498	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CBD3E/2020	EPI_ISL_575511	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-9CB2B7/2020	EPI_ISL_575517	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CABAE/2020	EPI_ISL_575523	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CA9FF/2020	EPI_ISL_575531	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-9D916E/2020	EPI_ISL_576703	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9D9210/2020	EPI_ISL_576709	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9D9535/2020	EPI_ISL_576737	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9D9614/2020	EPI_ISL_576748	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9D9641/2020	EPI_ISL_576751	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9D9869/2020	EPI_ISL_576763	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-991B82/2020	EPI_ISL_577027	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/MILK-9D5478/2020	EPI_ISL_577060	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.28	GH
hCoV-19/England/MILK-9E12F7/2020	EPI_ISL_577069	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-9E1AD1/2020	EPI_ISL_577095	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.28	GH
hCoV-19/Ireland/KK-NVRL-72IRL40595/2020	EPI_ISL_578306	2020-08-18	Europe / Ireland / Kilkenny	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/LK-NVRL-72IRL34726/2020	EPI_ISL_578310	2020-08-15	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/LK-NVRL-73IRL25283/2020	EPI_ISL_578312	2020-09-05	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/LK-NVRL-73IRL28235/2020	EPI_ISL_578315	2020-09-06	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/WX-NVRL-72IRL33081/2020	EPI_ISL_578334	2020-08-15	Europe / Ireland / Wexford	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/England/ALDP-9E9C1F/2020	EPI_ISL_580060	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9EA917/2020	EPI_ISL_580082	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9E6D4C/2020	EPI_ISL_580604	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-9E675D/2020	EPI_ISL_580612	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-9E6F91/2020	EPI_ISL_580627	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Wales/MILK-9F01E9/2020	EPI_ISL_580671	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9E2E7A/2020	EPI_ISL_581206	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DE785/2020	EPI_ISL_581226	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9E33A7/2020	EPI_ISL_581241	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9E30BF/2020	EPI_ISL_581253	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DE758/2020	EPI_ISL_581262	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9E2205/2020	EPI_ISL_581281	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/QEUH-9DE5C7/2020	EPI_ISL_581285	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9E2E4D/2020	EPI_ISL_581290	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-998857/2020	EPI_ISL_581384	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/QEUH-9992FE/2020	EPI_ISL_581387	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/Canada/MB-NML-1186/2020	EPI_ISL_582500	2020-08-10	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1187/2020	EPI_ISL_582501	2020-08-10	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1188/2020	EPI_ISL_582502	2020-08-10	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Austria/CeMM1045/2020	EPI_ISL_583862	2020-04-06	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.465	GH
hCoV-19/Austria/CeMM1083/2020	EPI_ISL_583885	2020-07-19	Europe / Austria	Human	Original			Illumina NovaSeq	bwa			B.1.36	GH
hCoV-19/England/ALDP-A2D8FC/2020	EPI_ISL_586805	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-A1E72E/2020	EPI_ISL_587414	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-A1E867/2020	EPI_ISL_587452	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-A1E4BE/2020	EPI_ISL_587462	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/England/QEUH-A1E296/2020	EPI_ISL_587510	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/QEUH-9F384B/2020	EPI_ISL_588690	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9F89CB/2020	EPI_ISL_588831	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9F21E7/2020	EPI_ISL_589039	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-9F2642/2020	EPI_ISL_589041	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9F9775/2020	EPI_ISL_589093	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/Japan/IC-0033/2020	EPI_ISL_591375	2020-06-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Saudi Arabia.	Illumina NextSeq500	SKESA v. 2.3.0			B.1	GH
hCoV-19/Japan/IC-0045/2020	EPI_ISL_591387	2020-05-29	Asia / Japan	Human	Original		COVID-19 positive case who entered from Pakistan.	Illumina iSeq	A5-miseq v. 20140604			B.1	GH
hCoV-19/Japan/IC-0053/2020	EPI_ISL_591395	2020-06-07	Asia / Japan	Human	Original		COVID-19 positive case who entered from Pakistan.	Illumina NextSeq500	SKESA v. 2.3.0			B.1	GH
hCoV-19/England/BIRM-64635/2020	EPI_ISL_594500	2020-09-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-64671/2020	EPI_ISL_594502	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-646DB/2020	EPI_ISL_594506	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-64732/2020	EPI_ISL_594511	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-64E5B/2020	EPI_ISL_594523	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-64E6A/2020	EPI_ISL_594524	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-64E97/2020	EPI_ISL_594526	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-64EB5/2020	EPI_ISL_594527	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-64FFE/2020	EPI_ISL_594539	2020-09-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/BIRM-65388/2020	EPI_ISL_594551	2020-09-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-653A6/2020	EPI_ISL_594552	2020-09-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/BIRM-654A3/2020	EPI_ISL_594560	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-65573/2020	EPI_ISL_594566	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-65591/2020	EPI_ISL_594568	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-655CE/2020	EPI_ISL_594569	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-65661/2020	EPI_ISL_594574	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-6568F/2020	EPI_ISL_594575	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-6584D/2020	EPI_ISL_594586	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/ALDP-A51D4B/2020	EPI_ISL_598126	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-A0BDB9/2020	EPI_ISL_599443	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/England/QEUH-9DC14D/2020	EPI_ISL_601237	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DBD4A/2020	EPI_ISL_601266	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DA6C8/2020	EPI_ISL_601269	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9E0B66/2020	EPI_ISL_601291	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/Australia/SA0519/2020	EPI_ISL_603124	2020-10-24	Oceania / Australia / South Australia	Human	Original			Illumina MiSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/USA/CA-QDX-1579/2020	EPI_ISL_603893	2020-03-18	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.110	GH
hCoV-19/England/MILK-A7B9FC/2020	EPI_ISL_607350	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A7B66E/2020	EPI_ISL_607424	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/MILK-A6B458/2020	EPI_ISL_608722	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A6AD30/2020	EPI_ISL_608739	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-A6AF94/2020	EPI_ISL_608749	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A69DE6/2020	EPI_ISL_608758	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A4175F/2020	EPI_ISL_609354	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-A41E78/2020	EPI_ISL_609368	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-A41959/2020	EPI_ISL_609392	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Hong Kong/HKPU-5135/2020	EPI_ISL_610201	2020-10-07	Asia / Hong Kong	Human	Original	Respiratory specimen		Nanopore	ARTIC-nCoV-bioinformaticsSOP v. v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-5138/2020	EPI_ISL_610202	2020-10-07	Asia / Hong Kong	Human	Original	Respiratory specimen		Nanopore	ARTIC-nCoV-bioinformaticsSOP v. v1.1.0			B.1.36.29	GH
hCoV-19/Hong Kong/HKPU-5136/2020	EPI_ISL_610203	2020-10-07	Asia / Hong Kong	Human	Original	Respiratory specimen		Nanopore	ARTIC-nCoV-bioinformaticsSOP v. v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-5111/2020	EPI_ISL_610204	2020-10-01	Asia / Hong Kong	Human	Original	Respiratory specimen		Nanopore	ARTIC-nCoV-bioinformaticsSOP v. v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-5126/2020	EPI_ISL_610214	2020-10-06	Asia / Hong Kong	Human	Original	Respiratory specimen		Nanopore	ARTIC-nCoV-bioinformaticsSOP v. v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-5102/2020	EPI_ISL_610215	2020-10-02	Asia / Hong Kong	Human	Original	Respiratory specimen		Nanopore	ARTIC-nCoV-bioinformaticsSOP v. v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-5132/2020	EPI_ISL_610222	2020-10-06	Asia / Hong Kong	Human	Original	Respiratory specimen		Nanopore	ARTIC-nCoV-bioinformaticsSOP v. v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-5161/2020	EPI_ISL_610223	2020-10-08	Asia / Hong Kong	Human	Original	Respiratory specimen		Nanopore	ARTIC-nCoV-bioinformaticsSOP v. v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-5183/2020	EPI_ISL_610224	2020-10-11	Asia / Hong Kong	Human	Original	Respiratory specimen		Nanopore	ARTIC-nCoV-bioinformaticsSOP v. v1.1.0			B.1.36	GH
hCoV-19/Wales/PHWC-482C86/2020	EPI_ISL_613277	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.36	GH
hCoV-19/Sweden/20-08964/2020	EPI_ISL_615110	2020-08-25	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.36.1	GH
hCoV-19/Denmark/DCGC-3968/2020	EPI_ISL_615881	2020-09-14	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-3969/2020	EPI_ISL_615882	2020-09-14	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-3970/2020	EPI_ISL_615883	2020-09-14	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-2704/2020	EPI_ISL_616437	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-2293/2020	EPI_ISL_617717	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/Denmark/DCGC-2486/2020	EPI_ISL_617756	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/England/MILK-AB7D9E/2020	EPI_ISL_623507	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-ABB18F/2020	EPI_ISL_623524	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-AB7F2F/2020	EPI_ISL_623586	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-AB7B94/2020	EPI_ISL_623637	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-AB1D85/2020	EPI_ISL_623679	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A94623/2020	EPI_ISL_624805	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A962C3/2020	EPI_ISL_624821	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-A95DC3/2020	EPI_ISL_624875	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-AA3612/2020	EPI_ISL_624970	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA20D9/2020	EPI_ISL_624974	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/ALDP-AA35CA/2020	EPI_ISL_625253	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/USA/IL-NM-1555/2020	EPI_ISL_626532	2020-07-14	North America / USA / Illinois / Chicago	Human	Original			Illumina MiSeq	ARTIC	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/LOND-1262E85/2020	EPI_ISL_627082	2020-10-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/NORW-F21D1/2020	EPI_ISL_627083	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/NORW-F2423/2020	EPI_ISL_627084	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-A49872/2020	EPI_ISL_627085	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-A3289A/2020	EPI_ISL_628363	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.23	GH
hCoV-19/England/QEUH-A34EC3/2020	EPI_ISL_628423	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-ACFA41/2020	EPI_ISL_629726	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/QEUH-AD03CA/2020	EPI_ISL_629777	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-AD3D32/2020	EPI_ISL_629793	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-A66FF2/2020	EPI_ISL_630693	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-A672BC/2020	EPI_ISL_630701	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-ABBC9D/2020	EPI_ISL_631091	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/QEUH-AD34F1/2020	EPI_ISL_634241	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-ACC5DA/2020	EPI_ISL_634270	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-AC79D3/2020	EPI_ISL_634278	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ACD66D/2020	EPI_ISL_634283	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-ACD69A/2020	EPI_ISL_634287	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ACCEB1/2020	EPI_ISL_634289	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-ACCC02/2020	EPI_ISL_634312	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/MILK-ACC90B/2020	EPI_ISL_634327	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ACD506/2020	EPI_ISL_634342	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/India/DL-59608-CSIR-IGIB/2020	EPI_ISL_636802	2020-08-05	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-65173-CSIR-IGIB/2020	EPI_ISL_636804	2020-08-07	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-59267-CSIR-IGIB/2020	EPI_ISL_636805	2020-08-02	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-59108-CSIR-IGIB/2020	EPI_ISL_636809	2020-08-04	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-7570807-CSIR-IGIB/2020	EPI_ISL_636811	2020-08-07	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-59149-CSIR-IGIB/2020	EPI_ISL_636813	2020-08-02	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36.16	GH
hCoV-19/India/DL-59113-CSIR-IGIB/2020	EPI_ISL_636815	2020-08-04	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-59597-CSIR-IGIB/2020	EPI_ISL_636816	2020-08-05	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-65025-CSIR-IGIB/2020	EPI_ISL_636818	2020-08-11	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-65054-CSIR-IGIB/2020	EPI_ISL_636819	2020-08-11	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-65112-CSIR-IGIB/2020	EPI_ISL_636821	2020-08-11	Asia / India / Delhi	Human	Original			Illumina MiSeq	Reference based			B.1.36.8	GH
hCoV-19/India/UT-65121-CSIR-IGIB/2020	EPI_ISL_636822	2020-08-07	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-8570838-CSIR-IGIB/2020	EPI_ISL_636823	2020-08-07	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-65137-CSIR-IGIB/2020	EPI_ISL_636824	2020-08-07	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-65158-CSIR-IGIB/2020	EPI_ISL_636828	2020-08-07	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-63116-CSIR-IGIB/2020	EPI_ISL_636829	2020-08-05	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-59223-CSIR-IGIB/2020	EPI_ISL_636830	2020-08-02	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/UT-59189-CSIR-IGIB/2020	EPI_ISL_636831	2020-08-02	Asia / India / Uttarakhand	Human	Original			Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/Lithuania/MR-LUHS-Eilnr335/2020	EPI_ISL_636867	2020-08-19	Europe / Lithuania / Marijampole apskritis	Human	Original			Illumina NextSeq 550				B.1.22	GH
hCoV-19/Lithuania/MR-LUHS-Eilnr365/2020	EPI_ISL_636874	2020-08-24	Europe / Lithuania / Marijampoles apskritis	Human	Original			Illumina NextSeq 550				B.1.22	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH893/2020	EPI_ISL_636964	2020-05-12	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	G
hCoV-19/Saudi Arabia/KAUST-MADINAH1080/2020	EPI_ISL_636967	2020-06-13	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/England/NOTT-11A0D5/2020	EPI_ISL_638589	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/Ireland/LH-NVRL-73IRL70416/2020	EPI_ISL_639830	2020-09-14	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.17	GH
hCoV-19/Ireland/LH-NVRL-73IRL70326/2020	EPI_ISL_639847	2020-09-14	Europe / Ireland / Louth	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.17	GH
hCoV-19/England/QEUH-B12E06/2020	EPI_ISL_642656	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-B12C1B/2020	EPI_ISL_642684	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-B126FF/2020	EPI_ISL_642707	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B1248C/2020	EPI_ISL_642715	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/QEUH-A8B425/2020	EPI_ISL_643087	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-A8C1D2/2020	EPI_ISL_643091	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B23D05/2020	EPI_ISL_646276	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-B31900/2020	EPI_ISL_646285	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-B205A6/2020	EPI_ISL_647540	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B20236/2020	EPI_ISL_647545	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B1FFBB/2020	EPI_ISL_647588	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B21235/2020	EPI_ISL_647607	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/England/CAMC-B20B68/2020	EPI_ISL_647647	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-B49422/2020	EPI_ISL_649218	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-B49307/2020	EPI_ISL_649266	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.22	GH
hCoV-19/England/MILK-B06BA4/2020	EPI_ISL_651526	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/SHEF-C4B25/2020	EPI_ISL_651530	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/BIRM-66E59/2020	EPI_ISL_651597	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/QEUH-AAC637/2020	EPI_ISL_652862	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.460	GH
hCoV-19/England/ALDP-B5CF58/2020	EPI_ISL_655972	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/CAMC-B5498F/2020	EPI_ISL_658246	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-B51991/2020	EPI_ISL_658272	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-B55C49/2020	EPI_ISL_658283	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-B55CB2/2020	EPI_ISL_658293	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-B55C3A/2020	EPI_ISL_658315	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B355AE/2020	EPI_ISL_659515	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B3575D/2020	EPI_ISL_659526	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B35377/2020	EPI_ISL_659575	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-B8286D/2020	EPI_ISL_661803	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B78518/2020	EPI_ISL_661930	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/QEUH-B7EC1D/2020	EPI_ISL_661932	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/QEUH-B69161/2020	EPI_ISL_662204	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-B69240/2020	EPI_ISL_662226	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-B73E5E/2020	EPI_ISL_664894	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/CAMC-B7B0E7/2020	EPI_ISL_667946	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Norway/4725/2020	EPI_ISL_668395	2020-10-21	Europe / Norway / Agder	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.1	GH
hCoV-19/Denmark/DCGC-11995/2020	EPI_ISL_671242	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.1	GH
hCoV-19/England/MILK-B95023/2020	EPI_ISL_673814	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B98B10/2020	EPI_ISL_673870	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-B85F56/2020	EPI_ISL_673873	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B8D325/2020	EPI_ISL_673901	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-B84467/2020	EPI_ISL_674207	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B887B5/2020	EPI_ISL_674214	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-B89EDD/2020	EPI_ISL_675503	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B82E5C/2020	EPI_ISL_675536	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B82B64/2020	EPI_ISL_675551	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-B96392/2020	EPI_ISL_676037	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B96A33/2020	EPI_ISL_676041	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-B960B9/2020	EPI_ISL_676053	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-B94ACC/2020	EPI_ISL_676096	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.470	GH
hCoV-19/England/MILK-B93D2E/2020	EPI_ISL_676141	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/MILK-B95BE6/2020	EPI_ISL_676150	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-B94C7B/2020	EPI_ISL_676162	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/MILK-B96329/2020	EPI_ISL_676165	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-B96374/2020	EPI_ISL_676189	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/204541008/2020	EPI_ISL_678666	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/BIRM-6A0C8/2020	EPI_ISL_679021	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-6A1A7/2020	EPI_ISL_679026	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.24	GH
hCoV-19/England/BIRM-6A2A4/2020	EPI_ISL_679036	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-6A2E0/2020	EPI_ISL_679038	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-6A408/2020	EPI_ISL_679053	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/BIRM-6A875/2020	EPI_ISL_679093	2020-11-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.28	GH
hCoV-19/Denmark/DCGC-12506/2020	EPI_ISL_682687	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 27792 (FRAMESHIFT). (Confirmed by the submitter)	info	B.1.36.8	GH
hCoV-19/Japan/PG-6979/2020	EPI_ISL_688084	2020-04-10	Asia / Japan / Tottori	Human	Original	Nasopharyngeal swab		Illumina NextSeq2000	SKESA v. 2.3.0			B.1.22	GH
hCoV-19/Taiwan/NTU31/2020	EPI_ISL_693302	2020-11-11	Asia / Taiwan / Taipei	Human	Vero E6	Throat swab		Sanger				B.1.36.16	GH
hCoV-19/Singapore/1419/2020	EPI_ISL_693307	2020-11-19	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.19	GH
hCoV-19/Singapore/1420/2020	EPI_ISL_693308	2020-11-17	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/1421/2020	EPI_ISL_693309	2020-11-19	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.19	GH
hCoV-19/Singapore/1422/2020	EPI_ISL_693310	2020-11-16	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.16	GH
hCoV-19/Singapore/1423/2020	EPI_ISL_693311	2020-11-18	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/1425/2020	EPI_ISL_693313	2020-11-20	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.469	GH
hCoV-19/Singapore/1427/2020	EPI_ISL_693315	2020-11-21	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.19	GH
hCoV-19/Singapore/1428/2020	EPI_ISL_693316	2020-11-23	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.16	GH
hCoV-19/Singapore/1429/2020	EPI_ISL_693317	2020-11-19	Asia / Singapore	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/Singapore/1430/2020	EPI_ISL_693318	2020-11-28	Asia / Singapore	Human	Original			Illumina MiSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Singapore/1431/2020	EPI_ISL_693319	2020-11-26	Asia / Singapore	Human	Original			Illumina MiSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Singapore/1432/2020	EPI_ISL_693320	2020-11-23	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.16	GH
hCoV-19/Singapore/1433/2020	EPI_ISL_693321	2020-11-23	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.16	GH
hCoV-19/Singapore/1434/2020	EPI_ISL_693322	2020-11-30	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.19	O
hCoV-19/Singapore/1437/2020	EPI_ISL_693325	2020-11-27	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Singapore/1434-2/2020	EPI_ISL_693328	2020-11-29	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.19	O
hCoV-19/Singapore/1441/2020	EPI_ISL_693330	2020-11-30	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.19	GH
hCoV-19/Singapore/1442/2020	EPI_ISL_693331	2020-11-29	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.19	GH
hCoV-19/India/MH-ACTREC-381/2020	EPI_ISL_700030	2020-07-25	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1	GH
hCoV-19/India/MH-ACTREC-480/2020	EPI_ISL_700128	2020-08-12	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1	GH
hCoV-19/India/MH-ACTREC-490/2020	EPI_ISL_700138	2020-08-13	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36.8	GH
hCoV-19/England/ALDP-BB31C2/2020	EPI_ISL_702755	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B3D00F/2020	EPI_ISL_706213	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-B3D02D/2020	EPI_ISL_706214	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Norway/5535/2020	EPI_ISL_708110	2020-11-02	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5539/2020	EPI_ISL_708114	2020-11-04	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.22	GH
hCoV-19/Norway/5544/2020	EPI_ISL_708116	2020-11-06	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5557/2020	EPI_ISL_708120	2020-11-07	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5560/2020	EPI_ISL_708121	2020-11-08	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5606/2020	EPI_ISL_708122	2020-11-09	Europe / Norway / Agder	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5607/2020	EPI_ISL_708123	2020-11-09	Europe / Norway / Agder	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5608/2020	EPI_ISL_708124	2020-11-09	Europe / Norway / Agder	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5609/2020	EPI_ISL_708125	2020-11-09	Europe / Norway / Agder	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5620/2020	EPI_ISL_708129	2020-11-10	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5656/2020	EPI_ISL_708137	2020-11-17	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5658/2020	EPI_ISL_708139	2020-11-17	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5660/2020	EPI_ISL_708140	2020-11-17	Europe / Norway / Oslo	Human	Original	Saliva		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5707/2020	EPI_ISL_708145	2020-11-08	Europe / Norway / Trndelag	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5710/2020	EPI_ISL_708147	2020-11-10	Europe / Norway / Vestfold og Telemark	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5712/2020	EPI_ISL_708149	2020-11-10	Europe / Norway / Vestfold og Telemark	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Thailand/phitsanulok-NT0076/2020	EPI_ISL_708810	2020-11-11	Asia / Thailand / Phitsanulok	Human	Vero 1	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious 10.2.12			B.1.36.16	GH
hCoV-19/Thailand/phitsanulok-MT0115/2020	EPI_ISL_708811	2020-10-26	Asia / Thailand / Phitsanulok	Human	Vero 1	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious 10.2.12			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-PH7928/2020	EPI_ISL_708812	2020-09-14	Asia / Thailand / Bangkok	Human	Vero 1	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious 10.2.12			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-14712/2020	EPI_ISL_708815	2020-09-24	Asia / Thailand / Bangkok	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious 10.2.12			B.1.36	GH
hCoV-19/Pakistan/NIBD-01-KHI/2020	EPI_ISL_708839	2020-06-06	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic Network	Gap of 244 nucleotides found at refpos 19304 (frameshift confirmed by submitter).	info	B.1.36	GH
hCoV-19/Pakistan/NIBD-02-KHI/2020	EPI_ISL_708840	2020-06-10	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Nanopore MinION		Gap of 244 nucleotides found at refpos 19304 (frameshift confirmed by submitter).	info	B.1.36	GH
hCoV-19/England/QEUH-C14E03/2020	EPI_ISL_709424	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-C14A3C/2020	EPI_ISL_709440	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/Denmark/DCGC-14462/2020	EPI_ISL_711781	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1	GH
hCoV-19/Denmark/DCGC-15531/2020	EPI_ISL_713427	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/Denmark/DCGC-16289/2020	EPI_ISL_714684	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-16404/2020	EPI_ISL_714746	2020-11-16	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/England/CAMC-C440AA/2020	EPI_ISL_719509	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/CAMC-C43F53/2020	EPI_ISL_719578	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/MILK-BB1AAB/2020	EPI_ISL_720508	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/MILK-BAC812/2020	EPI_ISL_720511	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BB09DC/2020	EPI_ISL_720512	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/MILK-BB0347/2020	EPI_ISL_720550	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BB0963/2020	EPI_ISL_720571	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/MILK-BB0295/2020	EPI_ISL_720578	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Switzerland/SH-ETHZ-340166/2020	EPI_ISL_721857	2020-10-28	Europe / Switzerland / Schaffhausen	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.17	GH
hCoV-19/Switzerland/SH-ETHZ-380309/2020	EPI_ISL_721866	2020-11-24	Europe / Switzerland / Schaffhausen	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.467	GH
hCoV-19/Switzerland/SO-ETHZ-380356/2020	EPI_ISL_721887	2020-11-21	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Netherlands/GE-EMC-380/2020	EPI_ISL_722442	2020-10-23	Europe / Netherlands / Gelderland	Human	Original			Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Netherlands/GE-EMC-384/2020	EPI_ISL_722444	2020-10-29	Europe / Netherlands / Gelderland	Human	Original			Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Netherlands/GE-EMC-388/2020	EPI_ISL_722447	2020-11-12	Europe / Netherlands / Gelderland	Human	Original			Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/CAMC-BBC035/2020	EPI_ISL_724119	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36	GH
hCoV-19/England/CAMC-BBC6CA/2020	EPI_ISL_724172	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.39	GH
hCoV-19/England/NORW-F8CBC/2020	EPI_ISL_725374	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/NORW-F98D5/2020	EPI_ISL_725406	2020	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-FA0CD/2020	EPI_ISL_725467	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/Netherlands/UT-RIVM-20379/2020	EPI_ISL_728599	2020-12-06	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/England/QEUH-C30A94/2020	EPI_ISL_731262	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Finland/11CA8/2020	EPI_ISL_732565	2020-10-31	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/11CB2/2020	EPI_ISL_732566	2020-10-31	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/11CF3/2020	EPI_ISL_732571	2020-10-31	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/13CB7/2020	EPI_ISL_732575	2020-12-03	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/14CH8/2020	EPI_ISL_732584	2020-12-02	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/16CD2/2020	EPI_ISL_732588	2020-12-03	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/16CD9/2020	EPI_ISL_732590	2020-12-03	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/18CE5/2020	EPI_ISL_732594	2020-12-03	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/1cE11/2020	EPI_ISL_732599	2020-10-31	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/England/MILK-C638BC/2020	EPI_ISL_735741	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/ALDP-C58137/2020	EPI_ISL_736070	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/CAMB-1BD818/2020	EPI_ISL_740984	2020-12-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/NORW-222D78/2020	EPI_ISL_741524	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-222EA2/2020	EPI_ISL_741542	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-222EFD/2020	EPI_ISL_741547	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-F9A0C/2020	EPI_ISL_741588	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-F9D5E/2020	EPI_ISL_741596	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/Denmark/DCGC-19901/2020	EPI_ISL_747729	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-20143/2020	EPI_ISL_748010	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-20151/2020	EPI_ISL_748016	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-20284/2020	EPI_ISL_748090	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-20316/2020	EPI_ISL_748109	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.1	GH
hCoV-19/Indonesia/JT-UNS-18_39701/2020	EPI_ISL_759701	2020-10-14	Asia / Indonesia / Central Java	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen			B.1.459	GH
hCoV-19/England/ALDP-CAFA54/2020	EPI_ISL_761001	2020-12-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.459	GH
hCoV-19/England/ALDP-CB2E16/2020	EPI_ISL_761042	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.562	GH
hCoV-19/England/ALDP-CB46EF/2020	EPI_ISL_761065	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/QEUH-CB338F/2020	EPI_ISL_761067	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/England/CAMC-C131CF/2020	EPI_ISL_761075	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/ALDP-CB6911/2020	EPI_ISL_761100	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-CA49F8/2020	EPI_ISL_762423	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Algeria/G37318-8849/2020	EPI_ISL_766863	2020-06-15	Africa / Algeria / Tipaza	Human	Original			Illumina NextSeq 500	CLC Genomics Suite			B.1.36	GH
hCoV-19/Thailand/Chonburi_SQ_KI0001/2020	EPI_ISL_768521	2020-12	Asia / Thailand / Chonburi	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Thailand/Singburi_97/2020	EPI_ISL_768523	2020-12-03	Asia / Thailand / Singburi	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Thailand/Chiang Rai_SM/2020	EPI_ISL_768528	2020-11-30	Asia / Thailand / Chiang Rai	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Thailand/Chiang Rai_PY/2020	EPI_ISL_768529	2020-12-03	Asia / Thailand / Chiang Rai	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Thailand/Samut Sakorn_692/2020	EPI_ISL_768530	2020-12-21	Asia / Thailand / Samut Sakhon	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Thailand/Samut Sakorn_849/2020	EPI_ISL_768532	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Thailand/Samut Sakorn_1235/2020	EPI_ISL_768533	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Thailand/Samut Sakorn_26/2020	EPI_ISL_768534	2020-12-20	Asia / Thailand / Samut Sakhon	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Thailand/Samut Sakorn_858/2020	EPI_ISL_768535	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Thailand/Samut Sakorn_AS/2020	EPI_ISL_768536	2020-12-17	Asia / Thailand / Samut Sakhon	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Thailand/Samut Sakorn_1184-19/2020	EPI_ISL_768537	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Thailand/Samut Sakorn_SB232/2020	EPI_ISL_768538	2020-12-21	Asia / Thailand / Samut Sakhon	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Thailand/Samut Sakorn_RB0009/2020	EPI_ISL_768539	2020-12-17	Asia / Thailand / Samut Sakhon	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Thailand/Samut Sakorn_657/2020	EPI_ISL_768540	2020-12-20	Asia / Thailand / Samut Sakhon	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Thailand/Samut Sakorn_894/2020	EPI_ISL_768541	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Thailand/Samut Sakorn_887/2020	EPI_ISL_768542	2020-12-19	Asia / Thailand / Samut Sakhon	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Thailand/Samut Sakorn_27/2020	EPI_ISL_768543	2020-12-20	Asia / Thailand / Samut Sakhon	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/Thailand/Samut Sakorn_DB0013/2020	EPI_ISL_768544	2020-12-17	Asia / Thailand / Samut Sakhon	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20, Geneious Prime			B.1.36.16	GH
hCoV-19/England/CAMC-C71C37/2020	EPI_ISL_769093	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/MILK-C4FE0F/2020	EPI_ISL_769843	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Canada/ON-S1453/2020	EPI_ISL_770830	2020-08	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36	GH
hCoV-19/Canada/ON-S1467/2020	EPI_ISL_770838	2020-08	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/ON-S1493/2020	EPI_ISL_770844	2020-08	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Japan/IC-0556/2021	EPI_ISL_779239	2021-01-02	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina iSeq	A5-miseq v. 20140604			B.1.466.2	GH
hCoV-19/Japan/IC-0569/2020	EPI_ISL_779248	2020-09-17	Asia / Japan	Human	Original			Illumina iSeq	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/IC-0573/2020	EPI_ISL_779252	2020-10-01	Asia / Japan	Human	Original			Illumina iSeq	SKESA v. 2.3.0	NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/Pakistan/JRCGR-KHI05/2020	EPI_ISL_779255	2020-05-20	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1	GH
hCoV-19/Pakistan/JRCGR-KHI06/2020	EPI_ISL_779256	2020-05-20	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1.471	GH
hCoV-19/Pakistan/JRCGR-KHI07/2020	EPI_ISL_779258	2020-05-20	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1.471	GH
hCoV-19/Pakistan/JRCGR-KHI26/2020	EPI_ISL_779260	2020-06-02	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1.36	GH
hCoV-19/Pakistan/JRCGR-KHI28/2020	EPI_ISL_779262	2020-06-02	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1.36	GH
hCoV-19/Pakistan/JRCGR-KHI29/2020	EPI_ISL_779265	2020-06-02	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1.36	GH
hCoV-19/Pakistan/JRCGR-KHI30/2020	EPI_ISL_779266	2020-06-02	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1.471	GH
hCoV-19/Pakistan/JRCGR-KHI40/2020	EPI_ISL_779267	2020-06-02	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1.471	GH
hCoV-19/Pakistan/JRCGR-KHI03/2020	EPI_ISL_779268	2020-06-03	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1	GH
hCoV-19/Pakistan/JRCGR-KHI02/2020	EPI_ISL_779269	2020-06-04	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Pakistan/JRCGR-KHI12/2020	EPI_ISL_779271	2020-06-14	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1.471	GH
hCoV-19/Pakistan/JRCGR-KHI18/2020	EPI_ISL_779272	2020-07-02	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1.260	O
hCoV-19/Pakistan/JRCGR-KHI15/2020	EPI_ISL_779275	2020-08-10	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.471	GH
hCoV-19/Pakistan/JRCGR-KHI11/2020	EPI_ISL_779279	2020-06-14	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1.471	GH
hCoV-19/Pakistan/JRCGR-KHI48/2020	EPI_ISL_779281	2020-08-04	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1.471	GH
hCoV-19/Pakistan/JRCGR-KHI45/2020	EPI_ISL_779282	2020-08-10	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.471	GH
hCoV-19/Pakistan/JRCGR-KHI13/2020	EPI_ISL_779284	2020-08-10	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1	GH
hCoV-19/Pakistan/JRCGR-KHI16/2020	EPI_ISL_779286	2020-08-10	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1.471	GH
hCoV-19/Pakistan/JRCGR-KHI41/2020	EPI_ISL_779287	2020-08-10	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1.471	GH
hCoV-19/Pakistan/JRCGR-KHI33/2020	EPI_ISL_779288	2020-06-14	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1.471	GH
hCoV-19/Pakistan/JRCGR-KHI42/2020	EPI_ISL_779289	2020-07-02	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1.471	GH
hCoV-19/Pakistan/JRCGR-KHI17/2020	EPI_ISL_779290	2020-07-02	Asia / Pakistan / Karachi	Human	Original	Nasopharyngeal swab		Illumina	Velvet v. 1.0.0			B.1.36	GH
hCoV-19/England/CAMC-CF31C5/2020	EPI_ISL_781546	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-D08FFF/2020	EPI_ISL_781582	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-C30830/2020	EPI_ISL_782829	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-C30821/2020	EPI_ISL_782888	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/CAMC-B786AC/2020	EPI_ISL_783395	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/USA/TX-HMH-MCoV-14845/2020	EPI_ISL_786329	2020-10-13	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1	G
hCoV-19/Italy/APU-PODV-15937969/2020	EPI_ISL_788958	2020-08-25	Europe / Italy / Apulia / Bari	Human	Original	Oropharyngeal swab		Illumina	SPAdes			B.1.36	GH
hCoV-19/Denmark/DCGC-23081/2020	EPI_ISL_793520	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-23143/2020	EPI_ISL_793561	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-23144/2020	EPI_ISL_793562	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-23178/2020	EPI_ISL_793589	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-24763/2020	EPI_ISL_795375	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-25166/2020	EPI_ISL_795379	2020-12-28	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Norway/6890/2020	EPI_ISL_796688	2020-12-14	Europe / Norway / Agder	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/6799/2020	EPI_ISL_796697	2020-12-08	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.22	GH
hCoV-19/England/MILK-D26131/2020	EPI_ISL_799624	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-D278C2/2020	EPI_ISL_799660	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/India/KA-CS1031/2020	EPI_ISL_811164	2020-06-17	Asia / India / Karnataka	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	Reference Based Assembly			B.1.36	GH
hCoV-19/England/MILK-E02729/2020	EPI_ISL_811869	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/Turkey/HSGM-29784/2020	EPI_ISL_814062	2020-06-15	Europe / Turkey	Human	Vero P1	Oropharyngeal swab		Illumina MiSeq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.36	GH
hCoV-19/Turkey/HSGM-29790/2020	EPI_ISL_814063	2020-06-15	Europe / Turkey	Human	Vero P1	Oropharyngeal swab		Illumina MiSeq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.36	GH
hCoV-19/Germany/BY-Cento-30357460/2020	EPI_ISL_815363	2020-09-25	Europe / Germany / Bavaria / Nuremberg	Human	Original	Oropharyngeal swab		Illumina NextSeq	Dragen 3.5.7			B.1.36.22	GH
hCoV-19/Germany/HE-Cento-36974580/2020	EPI_ISL_815388	2020-07-12	Europe / Germany / Hesse / Wiesbaden	Human	Original	Oropharyngeal swab		Illumina NextSeq	Dragen 3.5.7			B.1	GH
hCoV-19/Denmark/DCGC-27164/2020	EPI_ISL_817983	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Switzerland/BS-42485826/2020	EPI_ISL_830936	2020-10-15	Europe / Switzerland / Basel-Stadt / Basel	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP	NSP11 without BLAST coverage.	warn	B.1.36.17	GH
hCoV-19/Switzerland/BS-42485957/2020	EPI_ISL_830937	2020-10-15	Europe / Switzerland / Basel-Stadt / Basel	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP	NSP11 without BLAST coverage.	warn	B.1.36.17	GH
hCoV-19/England/OXON-F3FD20/2020	EPI_ISL_840238	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/LOND-1287A3B/2020	EPI_ISL_842971	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.39	GH
hCoV-19/England/LOND-1287B65/2020	EPI_ISL_842989	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.39	GH
hCoV-19/England/LOND-1287B74/2020	EPI_ISL_842990	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.39	GH
hCoV-19/Denmark/DCGC-28826/2021	EPI_ISL_845207	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.24	GH
hCoV-19/Denmark/DCGC-28866/2021	EPI_ISL_845220	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Australia/QLD1483/2020	EPI_ISL_849746	2020-12-26	Oceania / Australia / Queensland	Human	Original			Illumina	Samtools / iVar			B.1.36	GH
hCoV-19/Australia/QLD1484/2020	EPI_ISL_849747	2020-12-26	Oceania / Australia / Queensland	Human	Original			Illumina	Samtools / iVar			B.1.36	GH
hCoV-19/Australia/QLD1485/2020	EPI_ISL_849748	2020-12-26	Oceania / Australia / Queensland	Human	Original			Illumina	Samtools / iVar			B.1.36	GH
hCoV-19/Australia/QLD1491/2021	EPI_ISL_849752	2021-01-02	Oceania / Australia / Queensland	Human	Original			Illumina	Samtools / iVar			B.1.36	GH
hCoV-19/Australia/QLD1505/2021	EPI_ISL_849757	2021-01-09	Oceania / Australia / Queensland	Human	Original			Illumina	Samtools / iVar			B.1.36.17	GH
hCoV-19/Japan/IC-0713/2021	EPI_ISL_851042	2021-01-15	Asia / Japan	Human	Original			Illumina iSeq	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/USA/NY-NYCPHL-002005/2020	EPI_ISL_857265	2020-12-29	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.36	GH
hCoV-19/United Arab Emirates/3704/2020	EPI_ISL_859815	2020-10-22	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.36	GH
hCoV-19/United Arab Emirates/3719/2020	EPI_ISL_859822	2020-10-19	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/United Arab Emirates/3727/2020	EPI_ISL_859826	2020-10-20	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.36.22	GH
hCoV-19/United Arab Emirates/3729/2020	EPI_ISL_859828	2020-10-20	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1	GH
hCoV-19/United Arab Emirates/3746/2020	EPI_ISL_859834	2020-10-19	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.36	GH
hCoV-19/United Arab Emirates/3799/2020	EPI_ISL_859850	2020-11-16	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/United Arab Emirates/3815/2020	EPI_ISL_859855	2020-11-22	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.36	GH
hCoV-19/United Arab Emirates/3843/2020	EPI_ISL_859866	2020-11-18	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.36.22	GH
hCoV-19/United Arab Emirates/3848/2020	EPI_ISL_859869	2020-11-18	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.36.22	GH
hCoV-19/United Arab Emirates/3849/2020	EPI_ISL_859870	2020-11-18	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.36.37	GH
hCoV-19/United Arab Emirates/3851/2020	EPI_ISL_859871	2020-11-18	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.36.22	GH
hCoV-19/United Arab Emirates/3852/2020	EPI_ISL_859872	2020-11-18	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.36.22	GH
hCoV-19/Belarus/ChVir21884/2020	EPI_ISL_860815	2020-10-29	Europe / Belarus	Human	Original			Illumina MiSeq	bowtie2			B.1.36	GH
hCoV-19/England/LOND-1288E89/2020	EPI_ISL_865566	2020-12-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.28	GH
hCoV-19/England/LOND-12E87F5/2020	EPI_ISL_865695	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/TFCI-26FF1D8/2020	EPI_ISL_868893	2020-11-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.469	GH
hCoV-19/England/TFCI-26FF211/2020	EPI_ISL_868897	2020-11-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.28	GH
hCoV-19/Denmark/DCGC-34464/2020	EPI_ISL_871475	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-34487/2020	EPI_ISL_871498	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Indonesia/JI-ITDua-35379NT/2020	EPI_ISL_877538	2020-12-28	Asia / Indonesia / East Java / Sidoarjo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/England/ALDP-FB5733/2021	EPI_ISL_882162	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-FB58A9/2021	EPI_ISL_882173	2021-01-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/USA/NY-Wadsworth-21008780-01/2021	EPI_ISL_883450	2021-01-04	North America / USA / New York / New York County	Human	Original			Illumina NextSeq	Artic nf pipeline			B.1.471	GH
hCoV-19/USA/CA-CZB-16975/2020	EPI_ISL_884893	2020-12-07	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.36	GH
hCoV-19/USA/MI-CDC-LC0005449/2021	EPI_ISL_887041	2021-01-08	North America / USA / Michigan	Human	Original	Nasal swab		PacBio	CLC Genomics			B.1.36.38	GH
hCoV-19/USA/CT-CDC-LC0004484/2021	EPI_ISL_887079	2021-01-04	North America / USA / Connecticut	Human	Original	Nasal swab		PacBio	CLC Genomics	NS3_E261stop results in 5.5% truncation of the protein sequence. Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.36.29	GH
hCoV-19/Canada/QC-JUS-V5240719/2020	EPI_ISL_890614	2020-03-23	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex		Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.22	GH
hCoV-19/India/RJ-SMS-SQ-2/2020	EPI_ISL_891207	2020-12-26	Asia / India / Rajasthan / Jaipur	Human	Original	Nasopharyngeal swab		Ion Torrent				B.1.36	GH
hCoV-19/India/RJ-SMS-SQ-3/2020	EPI_ISL_891210	2020-12-26	Asia / India / Rajasthan / Jaipur	Human	Original	Nasopharyngeal swab		Ion Torrent				B.1.36	GH
hCoV-19/India/RJ-SMS-SQ-4/2020	EPI_ISL_891211	2020-12-28	Asia / India / Rajasthan / Jaipur	Human	Original	Nasopharyngeal swab		Ion Torrent				B.1.36	GH
hCoV-19/India/RJ-SMS-SQ-5/2020	EPI_ISL_891213	2020-12-28	Asia / India / Rajasthan / Jaipur	Human	Original	Nasopharyngeal swab		Ion Torrent				B.1.36	GH
hCoV-19/India/RJ-SMS-SQ-6/2020	EPI_ISL_891214	2020-12-28	Asia / India / Rajasthan / Jaipur	Human	Original	Nasopharyngeal swab		Ion Torrent				B.1.36	GH
hCoV-19/India/RJ-SMS-SQ-9/2020	EPI_ISL_891219	2020-12-28	Asia / India / Rajasthan / Jaipur	Human	Original	Nasopharyngeal swab		Ion Torrent				B.1.36	GH
hCoV-19/Singapore/100/2021	EPI_ISL_891239	2021-01-22	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.470	GH
hCoV-19/Singapore/101/2021	EPI_ISL_891240	2021-01-24	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.470	GH
hCoV-19/Singapore/103/2021	EPI_ISL_891242	2021-01-23	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.459	GH
hCoV-19/Singapore/108/2021	EPI_ISL_891247	2021-01-21	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.16	GH
hCoV-19/USA/ME-HETL-J0905/2021	EPI_ISL_906628	2021-01-12	North America / USA / Maine	Human	Original			Illumina NextSeq		Gap of 13 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/USA/ME-HETL-J1033/2021	EPI_ISL_906668	2021-01-19	North America / USA / Maine	Human	Original			Illumina NextSeq		Gap of 25 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/England/ALDP-10DE74F/2021	EPI_ISL_908576	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/Belgium/rega-2027/2021	EPI_ISL_913824	2021-01-12	Europe / Belgium / Kaggevinne	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.36.38	GH
hCoV-19/England/ALDP-BCAFA0/2020	EPI_ISL_916035	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/BIRM-6CD83/2020	EPI_ISL_918627	2020-12-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.523	GH
hCoV-19/England/BIRM-6CDA1/2020	EPI_ISL_918629	2020-12-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.523	GH
hCoV-19/England/BIRM-6CE9F/2020	EPI_ISL_918638	2020-12-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.523	GH
hCoV-19/England/BIRM-6D0D4/2020	EPI_ISL_918655	2020-12-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36	GH
hCoV-19/England/BIRM-6D159/2020	EPI_ISL_918659	2020-12-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-6D2B0/2020	EPI_ISL_918671	2020-11-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-6D423/2020	EPI_ISL_918683	2020-11-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/LOND-12E9378/2021	EPI_ISL_919981	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/LOND-13241EF/2020	EPI_ISL_920268	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.469	GH
hCoV-19/England/LOND-13242DD/2020	EPI_ISL_920282	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/England/TFCI-27005AA/2021	EPI_ISL_924517	2021-01-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/TFCI-27006D4/2021	EPI_ISL_924531	2021-01-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/Canada/ON-PHL-21-00543/2020	EPI_ISL_925660	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.1	GH
hCoV-19/Canada/ON-PHL-21-00518/2020	EPI_ISL_925661	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00538/2020	EPI_ISL_925662	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00501/2020	EPI_ISL_925663	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00497/2020	EPI_ISL_925664	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00498/2020	EPI_ISL_925665	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00500/2020	EPI_ISL_925667	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00493/2020	EPI_ISL_925668	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00519/2020	EPI_ISL_925671	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00528/2020	EPI_ISL_925675	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00688/2021	EPI_ISL_925782	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00718/2021	EPI_ISL_925786	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00683/2021	EPI_ISL_925787	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00657/2021	EPI_ISL_925788	2021-01	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00719/2021	EPI_ISL_925789	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00679/2021	EPI_ISL_925790	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00658/2021	EPI_ISL_925791	2021-01	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00704/2021	EPI_ISL_925793	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00680/2021	EPI_ISL_925800	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.8	GH
hCoV-19/Canada/ON-PHL-21-00663/2021	EPI_ISL_925805	2021-01	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00674/2021	EPI_ISL_925808	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00706/2021	EPI_ISL_925811	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00705/2021	EPI_ISL_925812	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 22 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00709/2021	EPI_ISL_925814	2021-01	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00702/2021	EPI_ISL_925817	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00669/2021	EPI_ISL_925820	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00656/2021	EPI_ISL_925821	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00654/2021	EPI_ISL_925822	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Rwanda/NRLNAT1028/2020	EPI_ISL_925864	2020-12-13	Africa / Rwanda / Kigali	Human	Original			Nanopore MinION	Artic network Midnight-1200 panel			B.1.36.18	GH
hCoV-19/Denmark/DCGC-36577/2021	EPI_ISL_927718	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/Denmark/DCGC-36906/2020	EPI_ISL_928047	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-36935/2020	EPI_ISL_928076	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-38208/2021	EPI_ISL_929349	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-38210/2021	EPI_ISL_929351	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-39190/2021	EPI_ISL_930332	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-39233/2020	EPI_ISL_930375	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/MILK-BFF6BC/2020	EPI_ISL_933504	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BFF6AD/2020	EPI_ISL_933506	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Malaysia/IMR_WI340/2020	EPI_ISL_936489	2020-11-23	Asia / Malaysia	Human	Vero			Illumina NextSeq 500				B.1.36.16	GH
hCoV-19/Malaysia/IMR_5316/2020	EPI_ISL_936490	2020-11-28	Asia / Malaysia	Human	Original			Illumina NextSeq 500				B.1.36.16	GH
hCoV-19/Belgium/Jessa_55-2105-001124/2021	EPI_ISL_960187	2021-02-04	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.36.38	GH
hCoV-19/Canada/ON-S2143/2021	EPI_ISL_961400	2021-01-19	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2156/2021	EPI_ISL_961410	2021-01-19	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-S2163/2021	EPI_ISL_961413	2021-01-19	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2164/2021	EPI_ISL_961414	2021-01-19	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2165/2021	EPI_ISL_961415	2021-01-19	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2166/2021	EPI_ISL_961416	2021-01-19	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2167/2021	EPI_ISL_961417	2021-01-19	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-S2170/2021	EPI_ISL_961419	2021-01-19	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2171/2021	EPI_ISL_961420	2021-01-19	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2175/2021	EPI_ISL_961423	2021-01-19	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2177/2021	EPI_ISL_961424	2021-01-19	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-S2178/2021	EPI_ISL_961425	2021-01-19	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2337/2021	EPI_ISL_961427	2021-01-20	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.26	GH
hCoV-19/Canada/ON-S2341/2021	EPI_ISL_961431	2021-01-20	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2342/2021	EPI_ISL_961432	2021-01-20	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2343/2021	EPI_ISL_961433	2021-01-20	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2352/2021	EPI_ISL_961438	2021-01-20	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-S2353/2021	EPI_ISL_961439	2021-01-20	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-S2356/2021	EPI_ISL_961441	2021-01-20	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2358/2021	EPI_ISL_961443	2021-01-20	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2371/2021	EPI_ISL_961452	2021-01-20	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2372/2021	EPI_ISL_961453	2021-01-20	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36	GH
hCoV-19/Canada/ON-S2374/2021	EPI_ISL_961455	2021-01-20	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2380/2021	EPI_ISL_961459	2021-01-20	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2381/2021	EPI_ISL_961460	2021-01-20	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-S2382/2021	EPI_ISL_961461	2021-01-20	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-S2383/2021	EPI_ISL_961462	2021-01-20	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00603/2021	EPI_ISL_966266	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1	GH
hCoV-19/Canada/ON-PHL-21-00795/2021	EPI_ISL_966269	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/ON-PHL-21-00746/2021	EPI_ISL_966270	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00733/2021	EPI_ISL_966273	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00778/2021	EPI_ISL_966275	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00796/2021	EPI_ISL_966276	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00741/2021	EPI_ISL_966286	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36	GH
hCoV-19/Canada/ON-PHL-21-00782/2021	EPI_ISL_966290	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00785/2021	EPI_ISL_966291	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00607/2021	EPI_ISL_966293	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00748/2021	EPI_ISL_966295	2021-01	North America / Canada / Ontario	Human	Original	Nasopharyngeal swab		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/BC-BCCDC-3607/2020	EPI_ISL_968281	2020-07-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-3254/2020	EPI_ISL_968872	2020-08-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-3719/2020	EPI_ISL_970572	2020-09-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Denmark/DCGC-40410/2021	EPI_ISL_972087	2021-01-25	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-41665/2020	EPI_ISL_973342	2020-12-28	Europe / Denmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Canada/BC-BCCDC-6764/2020	EPI_ISL_974103	2020-10-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5507/2020	EPI_ISL_974104	2020-10-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5511/2020	EPI_ISL_974107	2020-10-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5752/2020	EPI_ISL_974108	2020-10-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-5754/2020	EPI_ISL_974110	2020-10-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6101/2020	EPI_ISL_974121	2020-10-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6104/2020	EPI_ISL_974123	2020-10-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6768/2020	EPI_ISL_974128	2020-10-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6730/2020	EPI_ISL_974606	2020-10-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6305/2020	EPI_ISL_974612	2020-10-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6306/2020	EPI_ISL_974613	2020-10-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6548/2020	EPI_ISL_974614	2020-10-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6549/2020	EPI_ISL_974615	2020-10-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6664/2020	EPI_ISL_974616	2020-10-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.8	GH
hCoV-19/Canada/BC-BCCDC-6669/2020	EPI_ISL_974620	2020-10-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.8	GH
hCoV-19/Canada/BC-BCCDC-6991/2020	EPI_ISL_974622	2020-10-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6307/2020	EPI_ISL_974631	2020-10-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6550/2020	EPI_ISL_974632	2020-10-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6552/2020	EPI_ISL_974634	2020-10-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7005/2020	EPI_ISL_974636	2020-10-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7006/2020	EPI_ISL_974637	2020-10-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7007/2020	EPI_ISL_974638	2020-10-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7008/2020	EPI_ISL_974639	2020-10-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7244/2020	EPI_ISL_974644	2020-10-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7350/2020	EPI_ISL_974645	2020-10-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10473/2020	EPI_ISL_974666	2020-10-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10475/2020	EPI_ISL_974668	2020-10-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10585/2020	EPI_ISL_974671	2020-10-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6343/2020	EPI_ISL_974673	2020-10-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6344/2020	EPI_ISL_974674	2020-10-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6350/2020	EPI_ISL_974677	2020-10-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6382/2020	EPI_ISL_974697	2020-10-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7702/2020	EPI_ISL_975400	2020-11-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7704/2020	EPI_ISL_975402	2020-11-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7952/2020	EPI_ISL_975409	2020-11-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8063/2020	EPI_ISL_975419	2020-11-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8214/2020	EPI_ISL_975427	2020-11-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9846/2020	EPI_ISL_975429	2020-11-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7414/2020	EPI_ISL_975434	2020-11-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7415/2020	EPI_ISL_975435	2020-11-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7416/2020	EPI_ISL_975436	2020-11-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7417/2020	EPI_ISL_975437	2020-11-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7418/2020	EPI_ISL_975438	2020-11-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7421/2020	EPI_ISL_975439	2020-11-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7507/2020	EPI_ISL_975445	2020-11-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	G
hCoV-19/Canada/BC-BCCDC-7508/2020	EPI_ISL_975446	2020-11-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7511/2020	EPI_ISL_975448	2020-11-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7570/2020	EPI_ISL_975450	2020-11-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7573/2020	EPI_ISL_975452	2020-11-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8489/2020	EPI_ISL_975900	2020-11-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8647/2020	EPI_ISL_975905	2020-11-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8649/2020	EPI_ISL_975907	2020-11-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8650/2020	EPI_ISL_975908	2020-11-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8708/2020	EPI_ISL_975911	2020-11-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8710/2020	EPI_ISL_975912	2020-11-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8904/2020	EPI_ISL_975917	2020-11-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-10365/2020	EPI_ISL_975922	2020-11-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8191/2020	EPI_ISL_975923	2020-11-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8651/2020	EPI_ISL_975926	2020-11-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8653/2020	EPI_ISL_975927	2020-11-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8654/2020	EPI_ISL_975928	2020-11-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9883/2020	EPI_ISL_975931	2020-11-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10436/2020	EPI_ISL_975933	2020-11-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8196/2020	EPI_ISL_975937	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8197/2020	EPI_ISL_975938	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8556/2020	EPI_ISL_975942	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8567/2020	EPI_ISL_975943	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8655/2020	EPI_ISL_975944	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8658/2020	EPI_ISL_975945	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8659/2020	EPI_ISL_975946	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8661/2020	EPI_ISL_975948	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8662/2020	EPI_ISL_975949	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8663/2020	EPI_ISL_975950	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8664/2020	EPI_ISL_975951	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8720/2020	EPI_ISL_975958	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8721/2020	EPI_ISL_975959	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8907/2020	EPI_ISL_975961	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8985/2020	EPI_ISL_975964	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8986/2020	EPI_ISL_975965	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8988/2020	EPI_ISL_975967	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9884/2020	EPI_ISL_975968	2020-11-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.22	GH
hCoV-19/Canada/BC-BCCDC-8568/2020	EPI_ISL_975974	2020-11-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8668/2020	EPI_ISL_975977	2020-11-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8723/2020	EPI_ISL_975979	2020-11-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8908/2020	EPI_ISL_975981	2020-11-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8992/2020	EPI_ISL_975984	2020-11-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9083/2020	EPI_ISL_975986	2020-11-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9198/2020	EPI_ISL_975989	2020-11-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9203/2020	EPI_ISL_975993	2020-11-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9204/2020	EPI_ISL_975994	2020-11-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9210/2020	EPI_ISL_975999	2020-11-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9792/2020	EPI_ISL_976700	2020-12-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Insertion of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9793/2020	EPI_ISL_976701	2020-12-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9429/2020	EPI_ISL_976708	2020-12-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9437/2020	EPI_ISL_976714	2020-12-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9701/2020	EPI_ISL_976731	2020-12-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9575/2020	EPI_ISL_976737	2020-12-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9582/2020	EPI_ISL_976744	2020-12-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.18	GH
hCoV-19/Canada/BC-BCCDC-9801/2020	EPI_ISL_976745	2020-12-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9804/2020	EPI_ISL_976748	2020-12-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Insertion of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9703/2020	EPI_ISL_976758	2020-12-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10107/2020	EPI_ISL_976763	2020-12-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9706/2020	EPI_ISL_976773	2020-12-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-10155/2020	EPI_ISL_976782	2020-12-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10159/2020	EPI_ISL_976785	2020-12-26	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Indonesia/JT-UGM-55796/2020	EPI_ISL_985396	2020-09-14	Asia / Indonesia / Central Java	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.1.37			B.1.459	GH
hCoV-19/Indonesia/JT-UGM-60901/2020	EPI_ISL_985397	2020-09-22	Asia / Indonesia / Central Java	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.1.37	Gap of 5 nucleotide(s) found at refpos 26392 (FRAMESHIFT confirmed by submitter). E without BLAST coverage.	info	B.1.459	GH
hCoV-19/Indonesia/YO-UGM-124771/2020	EPI_ISL_985398	2020-12-23	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v. 1.37			B.1.459	GH
hCoV-19/Wales/ALDP-118AC60/2021	EPI_ISL_990016	2021-01-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/Finland/HEL-9-18/2021	EPI_ISL_995880	2021-01-11	Europe / Finland / Uusimaa	Human	Original			Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Switzerland/AG-ETHZ-451058/2021	EPI_ISL_1002236	2021-01-11	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.1	GH
hCoV-19/Switzerland/SZ-ETHZ-470587/2021	EPI_ISL_1003522	2021-01-22	Europe / Switzerland / Schwyz	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/SZ-ETHZ-470586/2021	EPI_ISL_1003524	2021-01-22	Europe / Switzerland / Schwyz	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BE-ETHZ-470252/2021	EPI_ISL_1003582	2021-01-24	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.469	GH
hCoV-19/Switzerland/un-ETHZ-431503/2020	EPI_ISL_1004805	2020-12-30	Europe / Switzerland	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/AG-ETHZ-431319/2020	EPI_ISL_1004903	2020-12-28	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Sweden/21-50777/2021	EPI_ISL_1008524	2021-01-27	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.36.1	GH
hCoV-19/Hong Kong/HKPU-05789/2020	EPI_ISL_1020022	2020-11-25	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05794/2020	EPI_ISL_1020023	2020-11-25	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05796/2020	EPI_ISL_1020024	2020-11-25	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05803/2020	EPI_ISL_1020025	2020-11-25	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05835/2020	EPI_ISL_1020026	2020-11-25	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05838/2020	EPI_ISL_1020027	2020-11-25	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05852/2020	EPI_ISL_1020028	2020-11-25	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05856/2020	EPI_ISL_1020029	2020-11-25	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05857/2020	EPI_ISL_1020030	2020-11-25	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05865/2020	EPI_ISL_1020031	2020-11-25	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05873/2020	EPI_ISL_1020032	2020-11-26	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05886/2020	EPI_ISL_1020033	2020-11-26	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05893/2020	EPI_ISL_1020034	2020-11-26	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05895/2020	EPI_ISL_1020035	2020-11-26	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05903/2020	EPI_ISL_1020036	2020-11-26	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05907/2020	EPI_ISL_1020037	2020-11-26	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05919/2020	EPI_ISL_1020038	2020-11-26	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05920/2020	EPI_ISL_1020039	2020-11-26	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05944/2020	EPI_ISL_1020040	2020-11-26	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05984/2020	EPI_ISL_1020041	2020-11-27	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-05987/2020	EPI_ISL_1020042	2020-11-27	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-05989/2020	EPI_ISL_1020043	2020-11-27	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06005/2020	EPI_ISL_1020044	2020-11-27	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06024/2020	EPI_ISL_1020045	2020-11-27	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06049/2020	EPI_ISL_1020046	2020-11-28	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06067/2020	EPI_ISL_1020047	2020-11-28	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06069/2020	EPI_ISL_1020048	2020-11-28	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06159/2020	EPI_ISL_1020049	2020-11-29	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06168/2020	EPI_ISL_1020050	2020-11-29	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06177/2020	EPI_ISL_1020051	2020-11-29	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06193/2020	EPI_ISL_1020052	2020-11-29	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06216/2020	EPI_ISL_1020053	2020-11-29	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06247/2020	EPI_ISL_1020058	2020-11-30	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06255/2020	EPI_ISL_1020059	2020-11-30	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06256/2020	EPI_ISL_1020060	2020-11-30	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06284/2020	EPI_ISL_1020061	2020-11-30	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06289/2020	EPI_ISL_1020062	2020-11-30	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06311/2020	EPI_ISL_1020063	2020-11-30	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06316/2020	EPI_ISL_1020064	2020-12-01	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06323/2020	EPI_ISL_1020065	2020-12-01	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06347/2020	EPI_ISL_1020066	2020-12-01	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06380/2020	EPI_ISL_1020067	2020-12-01	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06407/2020	EPI_ISL_1020069	2020-12-02	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06465/2020	EPI_ISL_1020070	2020-12-02	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06475/2020	EPI_ISL_1020071	2020-12-02	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06477/2020	EPI_ISL_1020072	2020-12-02	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06501/2020	EPI_ISL_1020073	2020-12-03	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06540/2020	EPI_ISL_1020074	2020-12-03	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06559/2020	EPI_ISL_1020075	2020-12-03	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06574/2020	EPI_ISL_1020076	2020-12-03	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06598/2020	EPI_ISL_1020077	2020-12-04	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06609/2020	EPI_ISL_1020078	2020-12-04	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06611/2020	EPI_ISL_1020079	2020-12-04	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06621/2020	EPI_ISL_1020080	2020-12-04	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06673/2020	EPI_ISL_1020081	2020-12-04	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06691/2020	EPI_ISL_1020083	2020-12-04	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06707/2020	EPI_ISL_1020084	2020-12-05	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06722/2020	EPI_ISL_1020086	2020-12-05	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06748/2020	EPI_ISL_1020088	2020-12-05	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06793/2020	EPI_ISL_1020089	2020-12-05	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06832/2020	EPI_ISL_1020091	2020-12-06	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06833/2020	EPI_ISL_1020092	2020-12-06	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06848/2020	EPI_ISL_1020093	2020-12-06	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06877/2020	EPI_ISL_1020094	2020-12-06	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06889/2020	EPI_ISL_1020095	2020-12-06	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-06894/2020	EPI_ISL_1020096	2020-12-06	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-06949/2020	EPI_ISL_1020098	2020-12-07	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07096/2020	EPI_ISL_1020099	2020-12-09	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Indonesia/BGR-LIPI040/2020	EPI_ISL_1020196	2020-11-09	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.468	GH
hCoV-19/Indonesia/BGR-LIPI048/2021	EPI_ISL_1020198	2021-01-14	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.466.2	GH
hCoV-19/Indonesia/BGR-LIPI057/2021	EPI_ISL_1020201	2021-01-25	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.466.2	GH
hCoV-19/Indonesia/BGR-LIPI063/2021	EPI_ISL_1020202	2021-01-26	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.466.2	GH
hCoV-19/Indonesia/TN-LIPI034/2020	EPI_ISL_1020204	2020-10-10	Asia / Indonesia / Banten / Tangerang Selatan	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.470	GH
hCoV-19/Indonesia/TN-LIPI039/2020	EPI_ISL_1020205	2020-11-05	Asia / Indonesia / Banten / Tangerang Selatan	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1.459	GH
hCoV-19/Indonesia/TNG-LIPI030/2020	EPI_ISL_1020206	2020-09-16	Asia / Indonesia / Banten / Tangerang	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION				B.1	GH
hCoV-19/Hong Kong/HKPU-07557/2020	EPI_ISL_1020216	2020-12-14	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07575/2020	EPI_ISL_1020217	2020-12-14	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07576/2020	EPI_ISL_1020218	2020-12-14	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07597/2020	EPI_ISL_1020219	2020-12-14	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07656/2020	EPI_ISL_1020220	2020-12-15	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07719/2020	EPI_ISL_1020221	2020-12-15	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07734/2020	EPI_ISL_1020222	2020-12-16	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07760/2020	EPI_ISL_1020223	2020-12-16	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-07766/2020	EPI_ISL_1020224	2020-12-16	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-07782/2020	EPI_ISL_1020225	2020-12-16	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-07816/2020	EPI_ISL_1020226	2020-12-17	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-07835/2020	EPI_ISL_1020227	2020-12-17	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07882/2020	EPI_ISL_1020229	2020-12-17	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07925/2020	EPI_ISL_1020230	2020-12-18	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07946/2020	EPI_ISL_1020231	2020-12-18	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-07988/2020	EPI_ISL_1020232	2020-12-19	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08007/2020	EPI_ISL_1020233	2020-12-19	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08048/2020	EPI_ISL_1020234	2020-12-19	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08069/2020	EPI_ISL_1020235	2020-12-19	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08073/2020	EPI_ISL_1020236	2020-12-19	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08085/2020	EPI_ISL_1020237	2020-12-20	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08095/2020	EPI_ISL_1020238	2020-12-20	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08131/2020	EPI_ISL_1020239	2020-12-20	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08132/2020	EPI_ISL_1020240	2020-12-20	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08134/2020	EPI_ISL_1020241	2020-12-20	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08136/2020	EPI_ISL_1020242	2020-12-20	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08155/2020	EPI_ISL_1020243	2020-12-21	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08157/2020	EPI_ISL_1020244	2020-12-21	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.468	GH
hCoV-19/Hong Kong/HKPU-08173/2020	EPI_ISL_1020245	2020-12-21	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08175/2020	EPI_ISL_1020246	2020-12-21	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08239/2020	EPI_ISL_1020247	2020-12-22	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08261/2020	EPI_ISL_1020248	2020-12-22	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.19	GH
hCoV-19/Hong Kong/HKPU-08269/2020	EPI_ISL_1020249	2020-12-22	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08272/2020	EPI_ISL_1020250	2020-12-22	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08285/2020	EPI_ISL_1020251	2020-12-22	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08314/2020	EPI_ISL_1020252	2020-12-23	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08338/2020	EPI_ISL_1020253	2020-12-23	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08365/2020	EPI_ISL_1020254	2020-12-24	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08371/2020	EPI_ISL_1020255	2020-12-24	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08375/2020	EPI_ISL_1020256	2020-12-24	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08376/2020	EPI_ISL_1020257	2020-12-24	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKPU-08377/2020	EPI_ISL_1020258	2020-12-24	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Hong Kong/HKPU-08387/2020	EPI_ISL_1020259	2020-12-24	Asia / Hong Kong	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.36.27	GH
hCoV-19/Denmark/DCGC-42570/2021	EPI_ISL_1022848	2021-02-08	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (FRAMESHIFT confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-42591/2021	EPI_ISL_1022869	2021-02-08	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (FRAMESHIFT confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-42598/2021	EPI_ISL_1022876	2021-02-08	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (FRAMESHIFT confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Hong Kong/HKU-201216-019/2020	EPI_ISL_1034661	2020-06-29	Asia / Hong Kong	Human	Original	Saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-264/2020	EPI_ISL_1034663	2020-09-19	Asia / Hong Kong	Human	Original	Saliva		Nanopore MinION				B.1.36.27	GH
hCoV-19/Hong Kong/HKU-201216-302/2020	EPI_ISL_1034667	2020-11-16	Asia / Hong Kong	Human	Original	Saliva		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-332/2020	EPI_ISL_1034668	2020-10-28	Asia / Hong Kong	Human	Original	Saliva		Nanopore MinION				B.1.471	GH
hCoV-19/Hong Kong/HKU-201216-333/2020	EPI_ISL_1034669	2020-10-23	Asia / Hong Kong	Human	Original	Saliva		Nanopore MinION				B.1.36	GH
hCoV-19/England/ALDP-1199062/2021	EPI_ISL_1044045	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/Japan/IC-0786/2021	EPI_ISL_1046786	2021-02-03	Asia / Japan	Human	Original			Illumina iSeq	bwa v. 0.7.13-r1126, picard v. 2.10.10, GATK v. 3.8.0, VarScan v. 2.4.3, VCFtools v. 0.1.12b, SKESA v. 2.3.0, A5-miseq v. 20140604			B.1.466.2	GH
hCoV-19/Japan/IC-0794/2021	EPI_ISL_1046789	2021-02-12	Asia / Japan	Human	Original			Illumina iSeq	SKESA v. 2.3.0			B.1.466.2	GH
hCoV-19/Japan/IC-0796/2021	EPI_ISL_1046790	2021-02-12	Asia / Japan	Human	Original			Illumina iSeq	A5-miseq v. 20140604			B.1.466.2	GH
hCoV-19/Afghanistan/IMB15483/2021	EPI_ISL_1046791	2021-01-21	Asia / Afghanistan	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Afghanistan/IMB15484/2021	EPI_ISL_1046792	2021-01-21	Asia / Afghanistan	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Afghanistan/IMB15486/2021	EPI_ISL_1046793	2021-01-21	Asia / Afghanistan	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes v3.14.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Sweden/21-51122/2021	EPI_ISL_1064653	2021-02-07	Europe / Sweden / Halland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.36	GH
hCoV-19/Sweden/21-51132/2021	EPI_ISL_1064655	2021-01-31	Europe / Sweden / Orebro	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.36.1	GH
hCoV-19/Sweden/21-51235/2021	EPI_ISL_1064697	2021-02-11	Europe / Sweden / Kronoberg	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions with lower than 20x coverage masked with N			B.1.36.1	GH
hCoV-19/Denmark/DCGC-46293/2020	EPI_ISL_1065803	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Australia/WA622/2021	EPI_ISL_1069391	2021-02-08	Oceania / Australia / Western Australia	Human	Original			Illumina iSeq				B.1.36.22	GH
hCoV-19/India/CH-ICMR-44375/2020	EPI_ISL_1069397	2020-08-09	Asia / India / Chandigarh	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/Indonesia/SU-USU-21NTv/2020	EPI_ISL_1072963	2020-10-15	Asia / Indonesia / North Sumatra / Medan	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.468	GH
hCoV-19/Indonesia/SU-USU-25NTv/2020	EPI_ISL_1072964	2020-10-09	Asia / Indonesia / North Sumatra / Medan	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.468	GH
hCoV-19/Indonesia/SU-USU-38NTv/2020	EPI_ISL_1072965	2020-12-17	Asia / Indonesia / North Sumatra / Medan	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.468	GH
hCoV-19/India/JK-ICMR-282/2020	EPI_ISL_1072991	2020-04-01	Asia / India / Jammu and Kashmir	Human	Original			Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1	GH
hCoV-19/India/JK-ICMR-52328/2020	EPI_ISL_1072997	2020-05-28	Asia / India / Jammu and Kashmir	Human	Original			Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/India/JK-ICMR-52327/2020	EPI_ISL_1072999	2020-05-28	Asia / India / Jammu and Kashmir	Human	Original			Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/Thailand/PathumThani-CONI-0512/2021	EPI_ISL_1074000	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0513/2021	EPI_ISL_1074001	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0514/2021	EPI_ISL_1074002	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0515/2021	EPI_ISL_1074003	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0516/2021	EPI_ISL_1074004	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0517/2021	EPI_ISL_1074005	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0518/2021	EPI_ISL_1074006	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0519/2021	EPI_ISL_1074007	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0520/2021	EPI_ISL_1074008	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0521/2021	EPI_ISL_1074009	2021-02-11	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0522/2021	EPI_ISL_1074010	2021-02-11	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0523/2021	EPI_ISL_1074011	2021-02-11	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0524/2021	EPI_ISL_1074012	2021-02-11	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0525/2021	EPI_ISL_1074013	2021-02-11	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0528/2021	EPI_ISL_1074014	2021-02-11	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0529/2021	EPI_ISL_1074015	2021-02-11	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0530/2021	EPI_ISL_1074016	2021-02-11	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0531/2021	EPI_ISL_1074017	2021-02-11	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0532/2021	EPI_ISL_1074018	2021-02-11	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0533/2021	EPI_ISL_1074019	2021-02-11	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0534/2021	EPI_ISL_1074020	2021-02-11	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0535/2021	EPI_ISL_1074021	2021-02-11	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0536/2021	EPI_ISL_1074022	2021-02-11	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0537/2021	EPI_ISL_1074023	2021-02-11	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0538/2021	EPI_ISL_1074024	2021-02-11	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/USA/TX-HMH-MCoV-20882/2021	EPI_ISL_1075325	2021-01-06	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1	GH
hCoV-19/USA/TX-HMH-MCoV-20893/2021	EPI_ISL_1075336	2021-01-06	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1	GH
hCoV-19/Switzerland/GE-33270365/2021	EPI_ISL_1084924	2021-02-14	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Switzerland/GE-33266996/2021	EPI_ISL_1084929	2021-02-13	Europe / Switzerland / Geneva	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Netherlands/NA_17/2020	EPI_ISL_415473	2020-03-09	Europe / Netherlands	Human	Original			Nanopore				B.1.22	G
hCoV-19/Netherlands/NA_18/2020	EPI_ISL_415474	2020-03-09	Europe / Netherlands	Human	Original			Nanopore				B.1.22	G
hCoV-19/Netherlands/NA_28/2020	EPI_ISL_415485	2020-03-12	Europe / Netherlands	Human	Original			Nanopore				B.1.22	G
hCoV-19/Netherlands/NoordBrabant_41/2020	EPI_ISL_415499	2020	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	G
hCoV-19/France/ARA-0693/2020	EPI_ISL_416758	2020-03-08	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools			B.1	GH
hCoV-19/Netherlands/NA_266/2020	EPI_ISL_422577	2020-03-30	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_301/2020	EPI_ISL_422610	2020-04-01	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_126/2020	EPI_ISL_422670	2020-03-17	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Turkey/HSGM-5602/2020	EPI_ISL_428714	2020-03-18	Europe / Turkey / Kastamonu	Human	Original	Sputum		Illumina MiSeq	Burrows-Wheeler Aligner v.07.17-r1188			B.1	GH
hCoV-19/Turkey/HSGM-5624/2020	EPI_ISL_428715	2020-03-18	Europe / Turkey / Nevsehir	Human	Original	Sputum		Illumina MiSeq	Burrows-Wheeler Aligner v.07.17-r1188			B.1.459	GH
hCoV-19/Turkey/HSGM-5711/2020	EPI_ISL_428716	2020-03-18	Europe / Turkey / Ankara	Human	Original	Sputum		Illumina MiSeq	Burrows-Wheeler Aligner v.07.17-r1188			B.1.36	GH
hCoV-19/Turkey/HSGM-8001/2020	EPI_ISL_428720	2020-03-21	Europe / Turkey / Ankara	Human	Original	Sputum		Illumina MiSeq	Burrows-Wheeler Aligner v.07.17-r1188			B.1	GH
hCoV-19/Turkey/HSGM-8003/2020	EPI_ISL_428721	2020-03-21	Europe / Turkey / Ankara	Human	Original	Sputum		Illumina MiSeq	Burrows-Wheeler Aligner v.07.17-r1188			B.1.459	GH
hCoV-19/England/CAMB-7D6B1/2020	EPI_ISL_441738	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/Chile/AR-ISPCH-2/2020	EPI_ISL_445279	2020-03-16	South America / Chile / La Araucania / Temuco	Human	Original	Throat swab		Illumina MiSeq	IRMA v0.9.3			B.1.110	GH
hCoV-19/Chile/MA-ISPCH-8/2020	EPI_ISL_445289	2020-03-20	South America / Chile / Magallanes / Punta Arenas	Human	Original	Throat swab		Illumina MiSeq	IRMA v0.9.3			B.1.110	GH
hCoV-19/Chile/LI-ISPCH-7/2020	EPI_ISL_445297	2020-03-21	South America / Chile / O'Higgins / Rancagua	Human	Original	Throat swab		Illumina MiSeq	IRMA v0.9.3			B.1.110	GH
hCoV-19/India/GJ-GBRC104/2020	EPI_ISL_451149	2020-05-07	Asia / India / Gujarat / Jamnagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC106/2020	EPI_ISL_451151	2020-05-05	Asia / India / Gujarat / Jamnagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC107/2020	EPI_ISL_451152	2020-05-09	Asia / India / Gujarat / Jamnagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC108/2020	EPI_ISL_451153	2020-05-10	Asia / India / Gujarat / Jamnagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC115/2020	EPI_ISL_451160	2020-05-03	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC117/2020	EPI_ISL_451162	2020-05-03	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/Belgium/UGent-23/2020	EPI_ISL_451164	2020-03-24	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.22	GH
hCoV-19/Netherlands/NA_610/2020	EPI_ISL_460773	2020-04-24	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_611/2020	EPI_ISL_460774	2020-04-22	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Flevoland_17/2020	EPI_ISL_460840	2020-05-22	Europe / Netherlands / Flevoland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_143/2020	EPI_ISL_460903	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_144/2020	EPI_ISL_460904	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_145/2020	EPI_ISL_460905	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_146/2020	EPI_ISL_460906	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_147/2020	EPI_ISL_460907	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_148/2020	EPI_ISL_460908	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_149/2020	EPI_ISL_460909	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_150/2020	EPI_ISL_460910	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_151/2020	EPI_ISL_460911	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_152/2020	EPI_ISL_460912	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_153/2020	EPI_ISL_460913	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_154/2020	EPI_ISL_460914	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_155/2020	EPI_ISL_460915	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_157/2020	EPI_ISL_460917	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_158/2020	EPI_ISL_460918	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_159/2020	EPI_ISL_460919	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_160/2020	EPI_ISL_460920	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_161/2020	EPI_ISL_460921	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_27/2020	EPI_ISL_460927	2020-04-14	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_28/2020	EPI_ISL_460928	2020-04-17	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_29/2020	EPI_ISL_460929	2020-04-08	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Saudi Arabia/85715/2020	EPI_ISL_469244	2020-03-15	Asia / Saudi Arabia / Jeddah	Human	Original			unknown				B.1	GH
hCoV-19/Saudi Arabia/86650/2020	EPI_ISL_469249	2020-03-15	Asia / Saudi Arabia / Jeddah	Human	Original			unknown				B.1	GH
hCoV-19/Saudi Arabia/832279/2020	EPI_ISL_469250	2020-03-15	Asia / Saudi Arabia / Jeddah	Human	Original			unknown				B.1	GH
hCoV-19/Egypt/CUNCI-HGC002-2/2020	EPI_ISL_469275	2020-05-02	Africa / Egypt / Cairo	Human	Original	Nasopharyngeal swab		Ion Torrent	Torrent Suite v. 5.12			B.1	GH
hCoV-19/England/CAMB-1ABBE7/2020	EPI_ISL_470163	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/India/TN-CCMB-C20/2020	EPI_ISL_471583	2020-04-29	Asia / India / Tamil Nadu / Chennai	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/India/TG-CCMB-L1451/2020	EPI_ISL_471590	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.458	GH
hCoV-19/India/TG-CCMB-L1452/2020	EPI_ISL_471591	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.458	GH
hCoV-19/India/TG-CCMB-L1453/2020	EPI_ISL_471592	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.458	GH
hCoV-19/India/TG-CCMB-L1454/2020	EPI_ISL_471593	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.458	GH
hCoV-19/India/TG-CCMB-L1455/2020	EPI_ISL_471594	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/India/TG-CCMB-L1456/2020	EPI_ISL_471595	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/India/TG-CCMB-L1459/2020	EPI_ISL_471596	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.458	GH
hCoV-19/India/TG-CCMB-L1460/2020	EPI_ISL_471597	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/India/TG-CCMB-L1465/2020	EPI_ISL_471598	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/India/TG-CCMB-L1466/2020	EPI_ISL_471599	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/Nigeria/OY233-CV66/2020	EPI_ISL_487091	2020-05-13	Africa / Nigeria / Oyo State	Human	Original			Illumina MiSeq	viral-ngs v2.0			B.1.462	GH
hCoV-19/Nigeria/ON191-CV49/2020	EPI_ISL_487106	2020-06-30	Africa / Nigeria / Ondo State	Human	Original			Illumina MiSeq	viral-ngs v2.0			B.1	GH
hCoV-19/Nigeria/OS589-CV46/2020	EPI_ISL_487109	2020-05-29	Africa / Nigeria / Osun State	Human	Original			Illumina MiSeq	viral-ngs v2.0	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.22	GH
hCoV-19/Nigeria/OS524-CV45/2020	EPI_ISL_487110	2020-05-11	Africa / Nigeria / Osun State	Human	Original	Saliva and Nasal Swab		Illumina MiSeq	viral-ngs v2.0			B.1.22	GH
hCoV-19/Nigeria/ON505-CV43/2020	EPI_ISL_487112	2020-05-24	Africa / Nigeria / Ondo State	Human	Original			Illumina MiSeq	viral-ngs v2.0			B.1.462	GH
hCoV-19/England/BRIS-12FA66/2020	EPI_ISL_488439	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/USA/FL-BPHL-0311/2020	EPI_ISL_489720	2020-06-02	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.170	GH
hCoV-19/USA/FL-BPHL-0314/2020	EPI_ISL_489723	2020-06-02	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.170	GH
hCoV-19/USA/FL-BPHL-0315/2020	EPI_ISL_489724	2020-06-02	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.170	GH
hCoV-19/England/SHEF-C200A/2020	EPI_ISL_490586	2020-05-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/Wales/PHWC-1695E7/2020	EPI_ISL_512484	2020-07-22	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/mink/Netherlands/NB-EMC-6-15/2020	EPI_ISL_523100	2020-05-30	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-6-16/2020	EPI_ISL_523101	2020-05-30	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-6-18/2020	EPI_ISL_523103	2020-05-30	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-6-2/2020	EPI_ISL_523104	2020-05-30	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-6-3/2020	EPI_ISL_523105	2020-05-30	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-6-7/2020	EPI_ISL_523106	2020-05-30	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-7-10/2020	EPI_ISL_523108	2020-05-30	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-7-19/2020	EPI_ISL_523109	2020-05-30	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-7-2/2020	EPI_ISL_523110	2020-05-30	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-7-3/2020	EPI_ISL_523111	2020-05-30	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-7-6/2020	EPI_ISL_523112	2020-05-30	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-9-1/2020	EPI_ISL_523119	2020-06-03	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/DR-EMC-5/2020	EPI_ISL_523123	2020-04-28	Europe / Netherlands / Drenthe	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-164/2020	EPI_ISL_523147	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/GE-EMC-165/2020	EPI_ISL_523148	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/GE-EMC-166/2020	EPI_ISL_523149	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/GE-EMC-167/2020	EPI_ISL_523150	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/GE-EMC-168/2020	EPI_ISL_523151	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/GE-EMC-169/2020	EPI_ISL_523152	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/GE-EMC-170/2020	EPI_ISL_523153	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/GE-EMC-171/2020	EPI_ISL_523154	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/GE-EMC-173/2020	EPI_ISL_523156	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/GE-EMC-186/2020	EPI_ISL_523168	2020-05-27	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-190/2020	EPI_ISL_523172	2020-04-29	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-195/2020	EPI_ISL_523177	2020-05-27	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-196/2020	EPI_ISL_523178	2020-05-28	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-197/2020	EPI_ISL_523179	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-199/2020	EPI_ISL_523181	2020-05-07	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-200/2020	EPI_ISL_523182	2020-05-11	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-201/2020	EPI_ISL_523183	2020-05-14	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-203/2020	EPI_ISL_523185	2020-05-25	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-204/2020	EPI_ISL_523186	2020-05-26	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-205/2020	EPI_ISL_523187	2020-05-26	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-206/2020	EPI_ISL_523188	2020-05-26	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-207/2020	EPI_ISL_523189	2020-05-27	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-209/2020	EPI_ISL_523191	2020-05-29	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-210/2020	EPI_ISL_523192	2020-05-29	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-211/2020	EPI_ISL_523193	2020-05-29	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-214/2020	EPI_ISL_523196	2020-04-28	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/GE-EMC-217/2020	EPI_ISL_523199	2020-03-05	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-170/2020	EPI_ISL_523293	2020	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Netherlands/NB-EMC-171/2020	EPI_ISL_523294	2020	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Netherlands/NB-EMC-174/2020	EPI_ISL_523297	2020	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Australia/QLD990/2020	EPI_ISL_530250	2020-07-10	Oceania / Australia / Queensland	Human	Original			Illumina	Samtools / iVar			B.1.523	GH
hCoV-19/Australia/QLD991/2020	EPI_ISL_530251	2020-07-10	Oceania / Australia / Queensland	Human	Original			Illumina	Samtools / iVar			B.1.523	GH
hCoV-19/England/QEUH-96DFFC/2020	EPI_ISL_530477	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-96A636/2020	EPI_ISL_531578	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-962E63/2020	EPI_ISL_531584	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9625D7/2020	EPI_ISL_531612	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9637B2/2020	EPI_ISL_531662	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/Scotland/QEUH-9637EF/2020	EPI_ISL_531677	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/QEUH-963819/2020	EPI_ISL_531684	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/QEUH-963855/2020	EPI_ISL_531745	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/England/QEUH-96365B/2020	EPI_ISL_531766	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-963882/2020	EPI_ISL_531778	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-963372/2020	EPI_ISL_531786	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Singapore/878/2020	EPI_ISL_536419	2020-08-29	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/888/2020	EPI_ISL_536429	2020-09-03	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/England/QEUH-9B897C/2020	EPI_ISL_549707	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-9B889D/2020	EPI_ISL_549714	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/England/QEUH-9B9340/2020	EPI_ISL_549751	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B847B/2020	EPI_ISL_549757	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.467	GH
hCoV-19/England/MILK-99E2AE/2020	EPI_ISL_550722	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-99C747/2020	EPI_ISL_550754	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-99C45F/2020	EPI_ISL_550758	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/MILK-9AAC74/2020	EPI_ISL_550887	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9510DA/2020	EPI_ISL_554298	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/ALDP-950F0B/2020	EPI_ISL_554318	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/England/ALDP-953CE3/2020	EPI_ISL_554430	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1	GH
hCoV-19/England/ALDP-95AD70/2020	EPI_ISL_555543	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/ALDP-94DF7A/2020	EPI_ISL_555601	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.468	GH
hCoV-19/England/CAMC-9421F7/2020	EPI_ISL_556911	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-949925/2020	EPI_ISL_556928	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/MILK-4B1F58/2020	EPI_ISL_559284	2020-06-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/ALDP-4F909D/2020	EPI_ISL_559285	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/Wales/PHWC-16B390/2020	EPI_ISL_560281	2020-09-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-9CDE75/2020	EPI_ISL_566241	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CCD2E/2020	EPI_ISL_566249	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CDE66/2020	EPI_ISL_566273	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CD75C/2020	EPI_ISL_566280	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CCDC4/2020	EPI_ISL_566292	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CD8A4/2020	EPI_ISL_566404	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CD0BB/2020	EPI_ISL_566410	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CD2E2/2020	EPI_ISL_566411	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9C987B/2020	EPI_ISL_567521	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9C9F1C/2020	EPI_ISL_567528	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/QEUH-9C98C6/2020	EPI_ISL_567529	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C4B77/2020	EPI_ISL_567540	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-9C5E5F/2020	EPI_ISL_567542	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C562A/2020	EPI_ISL_567575	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C53E7/2020	EPI_ISL_567592	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-9C4F5D/2020	EPI_ISL_567598	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C4D62/2020	EPI_ISL_567617	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-9C5BEF/2020	EPI_ISL_567618	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C5E13/2020	EPI_ISL_567631	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-9C4F11/2020	EPI_ISL_567632	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C5C73/2020	EPI_ISL_567701	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C5D70/2020	EPI_ISL_567704	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-9C602B/2020	EPI_ISL_567706	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C5CBF/2020	EPI_ISL_567707	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C5745/2020	EPI_ISL_567734	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C5305/2020	EPI_ISL_567745	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-9C601C/2020	EPI_ISL_567748	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C6094/2020	EPI_ISL_567754	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/France/PAC-IHU-0699/2020	EPI_ISL_568941	2020-04-14	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1	GH
hCoV-19/England/QEUH-9B3C0F/2020	EPI_ISL_573540	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/QEUH-9B3FE8/2020	EPI_ISL_573562	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/QEUH-9B44E8/2020	EPI_ISL_573565	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.12	GH
hCoV-19/England/QEUH-9BA497/2020	EPI_ISL_573591	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/204020547/2020	EPI_ISL_574700	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204020548/2020	EPI_ISL_574701	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204020549/2020	EPI_ISL_574702	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204020550/2020	EPI_ISL_574703	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204020551/2020	EPI_ISL_574704	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/Ireland/CE-NVRL-72IRL34583/2020	EPI_ISL_578246	2020-08-15	Europe / Ireland / Clare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/CO-NVRL-72IRL34461/2020	EPI_ISL_578250	2020-08-15	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/D-NVRL-20ILR05740/2020	EPI_ISL_578254	2020-08	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/D-NVRL-20ILR05741/2020	EPI_ISL_578255	2020-08	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1	GH
hCoV-19/Ireland/G-NVRL-20IRL40646-2/2020	EPI_ISL_578276	2020-07-07	Europe / Ireland / Galway	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Canada/NS-NML-939/2020	EPI_ISL_579571	2020-03-25	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.22	GH
hCoV-19/Canada/NS-NML-966/2020	EPI_ISL_579592	2020-03-30	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.22	GH
hCoV-19/Canada/NS-NML-1197/2020	EPI_ISL_579598	2020-03-31	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.22	GH
hCoV-19/England/ALDP-9E7455/2020	EPI_ISL_580537	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-9E7297/2020	EPI_ISL_580570	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-9EC775/2020	EPI_ISL_580573	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/ALDP-9E676C/2020	EPI_ISL_580574	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9E966C/2020	EPI_ISL_584231	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-9E9857/2020	EPI_ISL_584255	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMB-1B6554/2020	EPI_ISL_584287	2020-09-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMB-1B66BB/2020	EPI_ISL_584296	2020-09-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/France/OCC-55/2020	EPI_ISL_593870	2020-07-13	Europe / France / Occitanie	Human	Original	Nasopharyngeal swab		Pacific Biosciences Sequel I	Minimap2, bcftools			B.1.36.8	GH
hCoV-19/England/QEUH-A4D076/2020	EPI_ISL_596084	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-A5E2F4/2020	EPI_ISL_597454	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-A509FD/2020	EPI_ISL_597525	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A50034/2020	EPI_ISL_597559	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A50A72/2020	EPI_ISL_597566	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A50C9A/2020	EPI_ISL_597598	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A45D2C/2020	EPI_ISL_598775	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A45D0E/2020	EPI_ISL_598790	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Scotland/QEUH-A1E120/2020	EPI_ISL_598866	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/Germany/NW-HHU-200/2020	EPI_ISL_602474	2020-04-05	Europe / Germany / North Rhine-Westphalia / Essen	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.22	GH
hCoV-19/Germany/NW-HHU-201/2020	EPI_ISL_602475	2020-04-05	Europe / Germany / North Rhine-Westphalia / Essen	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.22	GH
hCoV-19/Germany/NW-HHU-176/2020	EPI_ISL_602498	2020-03-26	Europe / Germany / North Rhine-Westphalia / Essen	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.22	GH
hCoV-19/Germany/NW-HHU-177/2020	EPI_ISL_602499	2020-03-26	Europe / Germany / North Rhine-Westphalia / Essen	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.22	GH
hCoV-19/England/ALDP-A87517/2020	EPI_ISL_606052	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A86D7A/2020	EPI_ISL_606082	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A7BA80/2020	EPI_ISL_607346	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A7B710/2020	EPI_ISL_607352	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A7BB32/2020	EPI_ISL_607358	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A7B464/2020	EPI_ISL_607371	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A7BB23/2020	EPI_ISL_607395	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/CAMC-A64B1E/2020	EPI_ISL_608532	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/204141598/2020	EPI_ISL_609852	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/England/204191532/2020	EPI_ISL_609861	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/England/CAMC-A821FA/2020	EPI_ISL_610852	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A83074/2020	EPI_ISL_610873	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A92616/2020	EPI_ISL_610952	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-A928F2/2020	EPI_ISL_610960	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-A93E2C/2020	EPI_ISL_610991	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A93E59/2020	EPI_ISL_610993	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Denmark/DCGC-1004/2020	EPI_ISL_614434	2020-04-20	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.465	GH
hCoV-19/Denmark/DCGC-6321/2020	EPI_ISL_615803	2020-09-14	Europe / Denmark	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-3929/2020	EPI_ISL_615840	2020-09-14	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-7215/2020	EPI_ISL_619206	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.463	GH
hCoV-19/Denmark/DCGC-7346/2020	EPI_ISL_619312	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.36.33	GH
hCoV-19/Denmark/DCGC-6472/2020	EPI_ISL_620372	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-6478/2020	EPI_ISL_620378	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-6486/2020	EPI_ISL_620386	2020-10-05	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.36.17	GH
hCoV-19/New Zealand/20CV0480/2020	EPI_ISL_622815	2020-10-22	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.523	GH
hCoV-19/New Zealand/20CV0489/2020	EPI_ISL_622821	2020-10-26	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36.17	GH
hCoV-19/New Zealand/20CV0490/2020	EPI_ISL_622822	2020-10-26	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36.17	GH
hCoV-19/New Zealand/20CV0493/2020	EPI_ISL_622823	2020-10-27	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.523	GH
hCoV-19/England/204040288/2020	EPI_ISL_622833	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/England/204040292/2020	EPI_ISL_622835	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/England/204040298/2020	EPI_ISL_622836	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/England/204040300/2020	EPI_ISL_622837	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/England/204040323/2020	EPI_ISL_622838	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/England/204040324/2020	EPI_ISL_622839	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/England/204040327/2020	EPI_ISL_622840	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/England/204040334/2020	EPI_ISL_622841	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/England/204040338/2020	EPI_ISL_622842	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/England/204240973/2020	EPI_ISL_622849	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204241470/2020	EPI_ISL_622855	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.12	GH
hCoV-19/England/ALDP-AA092B/2020	EPI_ISL_625109	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-AA57D1/2020	EPI_ISL_625117	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/England/ALDP-AA0B16/2020	EPI_ISL_625135	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/England/ALDP-AA20F7/2020	EPI_ISL_625139	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-AA4A06/2020	EPI_ISL_625190	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/NOTT-1196B6/2020	EPI_ISL_627711	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/Wales/PHWC-482FD8/2020	EPI_ISL_627767	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-ABC009/2020	EPI_ISL_631032	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-ABBC7F/2020	EPI_ISL_631088	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/New Zealand/20CV0524/2020	EPI_ISL_637084	2020-11-05	Oceania / New Zealand / Combined Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/New Zealand/20CV0527/2020	EPI_ISL_637085	2020-11-08	Oceania / New Zealand / Combined Wellington	Human	Original	Nasopharyngeal swab		Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/New Zealand/20CV0531/2020	EPI_ISL_637086	2020-11-03	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/New Zealand/20CV0532/2020	EPI_ISL_637087	2020-11-08	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION		Gap of 24 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/New Zealand/20CV0542/2020	EPI_ISL_637093	2020-11-06	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36.24	GH
hCoV-19/New Zealand/20CV0545/2020	EPI_ISL_637096	2020-11-10	Oceania / New Zealand / Combined Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/204360031/2020	EPI_ISL_637118	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/204360037/2020	EPI_ISL_637119	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/204361199/2020	EPI_ISL_637121	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204381492/2020	EPI_ISL_637128	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204490119/2020	EPI_ISL_637176	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/204490329/2020	EPI_ISL_637178	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/204591850/2020	EPI_ISL_637187	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/CAMC-9DF793/2020	EPI_ISL_638423	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMC-9DF872/2020	EPI_ISL_638429	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMC-9DF8CD/2020	EPI_ISL_638433	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/CAMC-A65DDB/2020	EPI_ISL_638446	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.2	GH
hCoV-19/England/MILK-A7DE37/2020	EPI_ISL_638478	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-A7E0B8/2020	EPI_ISL_638484	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.28	GH
hCoV-19/England/MILK-A7E0C7/2020	EPI_ISL_638485	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.28	GH
hCoV-19/Australia/QLD1147/2020	EPI_ISL_639750	2020-10-21	Oceania / Australia / Queensland	Human	Original			Illumina	Samtools / iVar	Gap of 21 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/England/MILK-B02B6C/2020	EPI_ISL_643005	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B020B8/2020	EPI_ISL_643007	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-B021D3/2020	EPI_ISL_643021	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.39	GH
hCoV-19/England/MILK-B01D67/2020	EPI_ISL_643037	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B37427/2020	EPI_ISL_645506	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/CAMC-B35E67/2020	EPI_ISL_645510	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B3E4A8/2020	EPI_ISL_645517	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B1CD3C/2020	EPI_ISL_645605	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 5 nucleotides when compared to the reference sequence.	info	B.1.471	GH
hCoV-19/England/ALDP-B273F0/2020	EPI_ISL_646832	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-B24CF8/2020	EPI_ISL_646842	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B23C71/2020	EPI_ISL_646944	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/New Zealand/20CV0556/2020	EPI_ISL_649123	2020-11-11	Oceania / New Zealand / Combined Wellington	Human	Original	Nasopharyngeal swab		Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/New Zealand/20CV0563/2020	EPI_ISL_649125	2020-11-18	Oceania / New Zealand / Combined Wellington	Human	Original	Nasopharyngeal swab		Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/BIRM-66E86/2020	EPI_ISL_651413	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.471	GH
hCoV-19/England/QEUH-AAAC46/2020	EPI_ISL_651469	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-AAA8E8/2020	EPI_ISL_652718	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-AAA95E/2020	EPI_ISL_652721	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-AAAC64/2020	EPI_ISL_652736	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36	GH
hCoV-19/England/QEUH-AAAC91/2020	EPI_ISL_652739	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36	GH
hCoV-19/England/QEUH-AAB0C1/2020	EPI_ISL_652770	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-B67D7E/2020	EPI_ISL_655003	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/ALDP-B46382/2020	EPI_ISL_656247	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B463CE/2020	EPI_ISL_656327	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-B62827/2020	EPI_ISL_656374	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/MILK-B5654D/2020	EPI_ISL_657574	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B558AF/2020	EPI_ISL_657596	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-B562A0/2020	EPI_ISL_657614	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B56695/2020	EPI_ISL_657640	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B55B1F/2020	EPI_ISL_657666	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B566D1/2020	EPI_ISL_657676	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-B385C9/2020	EPI_ISL_658806	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B3817A/2020	EPI_ISL_658923	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-B37F53/2020	EPI_ISL_658925	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B388EE/2020	EPI_ISL_658929	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-B38532/2020	EPI_ISL_658939	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B38778/2020	EPI_ISL_658974	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/MILK-B38550/2020	EPI_ISL_658990	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B37D1D/2020	EPI_ISL_658995	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B387D2/2020	EPI_ISL_658999	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-B74303/2020	EPI_ISL_662098	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B1D06F/2020	EPI_ISL_664763	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-B7540F/2020	EPI_ISL_664764	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/CAMB-1BA5F6/2020	EPI_ISL_664765	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-B77625/2020	EPI_ISL_668316	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/Denmark/DCGC-11742/2020	EPI_ISL_670670	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-11816/2020	EPI_ISL_670671	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Ireland/D-NVRL-75IRL26146/2020	EPI_ISL_671885	2020-10-07	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.23	GH
hCoV-19/England/MILK-B86447/2020	EPI_ISL_674001	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-B8E3AC/2020	EPI_ISL_674022	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-B85BF8/2020	EPI_ISL_674042	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/MILK-B85E77/2020	EPI_ISL_674043	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B8D158/2020	EPI_ISL_674047	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B867F3/2020	EPI_ISL_674054	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-B8D282/2020	EPI_ISL_674069	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B868E1/2020	EPI_ISL_674077	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-B8E4A9/2020	EPI_ISL_674126	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B8D54D/2020	EPI_ISL_674131	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-B8E5F1/2020	EPI_ISL_674139	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B8D3F8/2020	EPI_ISL_674140	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/MILK-B8681E/2020	EPI_ISL_674154	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/ALDP-B83F94/2020	EPI_ISL_674182	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B8C089/2020	EPI_ISL_674189	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B842D6/2020	EPI_ISL_675328	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-B84661/2020	EPI_ISL_675430	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/MILK-B89EA0/2020	EPI_ISL_675486	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B82A49/2020	EPI_ISL_675493	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1129/2020	EPI_ISL_677987	2020-06-13	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1136/2020	EPI_ISL_677990	2020-06-11	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Denmark/DCGC-12367/2020	EPI_ISL_682548	2020-11-16	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-12399/2020	EPI_ISL_682580	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.22	GH
hCoV-19/Denmark/DCGC-12410/2020	EPI_ISL_682591	2020-11-16	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-12414/2020	EPI_ISL_682595	2020-11-16	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-12446/2020	EPI_ISL_682627	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 11083 (FRAMESHIFT). Gap of 4 nucleotides when compared to the reference sequence. (Confirmed by the submitter)	info	B.1.36.9	GH
hCoV-19/Canada/ON-UHTC_0395/2020	EPI_ISL_698081	2020-11-24	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36.38	GH
hCoV-19/Canada/ON-UHTC_0406/2020	EPI_ISL_698083	2020-11-24	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36.26	GH
hCoV-19/Canada/ON-UHTC_0405/2020	EPI_ISL_698084	2020-11-24	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36.26	GH
hCoV-19/Canada/ON-UHTC_0409/2020	EPI_ISL_698093	2020-11-24	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36	GH
hCoV-19/Canada/ON-UHTC_0382/2020	EPI_ISL_698094	2020-11-24	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36.18	GH
hCoV-19/Canada/ON-UHTC_0389/2020	EPI_ISL_698095	2020-11-24	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36.18	GH
hCoV-19/Canada/ON-UHTC_0391/2020	EPI_ISL_698096	2020-11-24	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36.18	GH
hCoV-19/Canada/ON-UHTC_0384/2020	EPI_ISL_698099	2020-11-24	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36.18	GH
hCoV-19/Canada/ON-UHTC_0383/2020	EPI_ISL_698101	2020-11-24	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36	GH
hCoV-19/Canada/ON-UHTC_0386/2020	EPI_ISL_698102	2020-11-24	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36.26	GH
hCoV-19/England/CAMC-BD239A/2020	EPI_ISL_702053	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/QEUH-BC3F6B/2020	EPI_ISL_703393	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/CAMC-BC0423/2020	EPI_ISL_704724	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-BC211B/2020	EPI_ISL_704738	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/LOND-1251E6B/2020	EPI_ISL_705956	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.469	GH
hCoV-19/England/MILK-A91714/2020	EPI_ISL_705978	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1	GH
hCoV-19/England/MILK-A917D8/2020	EPI_ISL_705987	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36	GH
hCoV-19/Norway/5713/2020	EPI_ISL_708150	2020-11-11	Europe / Norway / Vestfold og Telemark	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5735/2020	EPI_ISL_708153	2020-11-13	Europe / Norway / Mre og Romsdal	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5750/2020	EPI_ISL_708159	2020-10-29	Europe / Norway / Vestfold og Telemark	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5753/2020	EPI_ISL_708160	2020-10-29	Europe / Norway / Vestfold og Telemark	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5790/2020	EPI_ISL_708172	2020-11-17	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5791/2020	EPI_ISL_708173	2020-11-17	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5794/2020	EPI_ISL_708176	2020-11-09	Europe / Norway / Vestland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5810/2020	EPI_ISL_708180	2020-11-17	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/England/MILK-BDC1D2/2020	EPI_ISL_709575	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-BDC196/2020	EPI_ISL_709583	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/MILK-BDCB2F/2020	EPI_ISL_709584	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/Sweden/20-52918/2020	EPI_ISL_710594	2020-09-20	Europe / Sweden / Vasternorrland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with fill from reference and majority wins	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36.1	GH
hCoV-19/Denmark/DCGC-14534/2020	EPI_ISL_711822	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-14535/2020	EPI_ISL_711823	2020-11-30	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-14542/2020	EPI_ISL_711828	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-14589/2020	EPI_ISL_711860	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-15770/2020	EPI_ISL_714011	2020-11-23	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-15798/2020	EPI_ISL_714027	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-15813/2020	EPI_ISL_714037	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-15844/2020	EPI_ISL_714056	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-15855/2020	EPI_ISL_714064	2020-11-23	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-15888/2020	EPI_ISL_714085	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-15897/2020	EPI_ISL_714091	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/England/ALDP-BC7705/2020	EPI_ISL_721210	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-BC79F0/2020	EPI_ISL_721216	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-BC7AA2/2020	EPI_ISL_721237	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-BC6618/2020	EPI_ISL_721270	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/Netherlands/GE-EMC-386/2020	EPI_ISL_722453	2020-11-09	Europe / Netherlands / Gelderland	Human	Original			Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Netherlands/OV-EMC-98/2020	EPI_ISL_722463	2020-09-09	Europe / Netherlands / Overijssel	Human	Original			Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Netherlands/NB-EMC-399/2020	EPI_ISL_722476	2020	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.36.1	GH
hCoV-19/Netherlands/ZH-EMC-979/2020	EPI_ISL_722516	2020-10-19	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.469	GH
hCoV-19/England/ALDP-B76D5E/2020	EPI_ISL_723808	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/ALDP-B76DD6/2020	EPI_ISL_723813	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Netherlands/UT-RIVM-20391/2020	EPI_ISL_728611	2020-12-07	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-20404/2020	EPI_ISL_728624	2020-12-07	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Nigeria/KD-CV233/2020	EPI_ISL_729920	2020-04-20	Africa / Nigeria / Kaduna State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.462	GH
hCoV-19/Nigeria/FC-CV238/2020	EPI_ISL_729924	2020-06-02	Africa / Nigeria / Abuja	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.467	GH
hCoV-19/Nigeria/BE-CV243/2020	EPI_ISL_729928	2020-07-05	Africa / Nigeria / Benue State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.467	GH
hCoV-19/Nigeria/NI-CV244/2020	EPI_ISL_729929	2020-07-02	Africa / Nigeria / Niger State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.462	GH
hCoV-19/Nigeria/FC-CV246/2020	EPI_ISL_729931	2020-07-07	Africa / Nigeria / Abuja	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.462	GH
hCoV-19/Nigeria/AK-CV271/2020	EPI_ISL_729955	2020-07-01	Africa / Nigeria / Akwa-Ibom State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.462	GH
hCoV-19/Nigeria/BO-CV276/2020	EPI_ISL_729960	2020-04-27	Africa / Nigeria / Borno State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1	GH
hCoV-19/Nigeria/BO-CV277/2020	EPI_ISL_729961	2020-04-27	Africa / Nigeria / Borno State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.462	GH
hCoV-19/Nigeria/BO-CV278/2020	EPI_ISL_729962	2020-04-27	Africa / Nigeria / Borno State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.462	GH
hCoV-19/Nigeria/BO-CV280/2020	EPI_ISL_729964	2020-05-05	Africa / Nigeria / Borno State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.462	GH
hCoV-19/Nigeria/OS-CV286/2020	EPI_ISL_729967	2020-06-23	Africa / Nigeria / Osun State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.467	GH
hCoV-19/Nigeria/OS-CV287/2020	EPI_ISL_729968	2020-06-27	Africa / Nigeria / Osun State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1	GH
hCoV-19/Nigeria/OS-CV290/2020	EPI_ISL_729970	2020-07-03	Africa / Nigeria / Osun State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.467	GH
hCoV-19/Nigeria/OS-CV295/2020	EPI_ISL_729974	2020-07-08	Africa / Nigeria / Osun State	Human	Original			Illumina MiSeq	Viral-ngs v2.0			B.1.467	GH
hCoV-19/England/ALDP-C3B6D1/2020	EPI_ISL_730925	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-C3C3E8/2020	EPI_ISL_730984	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.562	GH
hCoV-19/England/ALDP-C3C333/2020	EPI_ISL_730998	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-C615B7/2020	EPI_ISL_735790	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-C61247/2020	EPI_ISL_735791	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/Taiwan/NTU36/2020	EPI_ISL_738064	2020-11-27	Asia / Taiwan / Taipei	Human	Vero cells	Throat swab		Sanger		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/USA/CA-CZB-13682/2020	EPI_ISL_739388	2020-11-04	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina Novaseq	minimap2 / iVar			B.1.523	GH
hCoV-19/England/NORW-F9E5B/2020	EPI_ISL_741602	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-F9FB2/2020	EPI_ISL_741605	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/PORT-2D503F/2020	EPI_ISL_741675	2020-12-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/India/TG-CCMB-BB568/2020	EPI_ISL_745198	2020-12-25	Asia / India / Telangana	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CCMB-BB648/2020	EPI_ISL_745201	2020-12-25	Asia / India / Andhra Pradesh	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION	Reference based			B.1.36.8	GH
hCoV-19/Denmark/DCGC-17491/2020	EPI_ISL_751022	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-17505/2020	EPI_ISL_751029	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-17536/2020	EPI_ISL_751051	2020-12-14	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Indonesia/KS-NIHRD-PME4901/2020	EPI_ISL_753699	2020-08-04	Asia / Indonesia / South Kalimantan	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection			B.1	GH
hCoV-19/Scotland/QEUH-C3185D/2020	EPI_ISL_757231	2020-12-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.29	GH
hCoV-19/Scotland/QEUH-C01197/2020	EPI_ISL_757243	2020-12-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence. Gap of 19 nucleotides when compared to the reference sequence. %UniqueMutations 0.07%.		B.1.36.26	GH
hCoV-19/Denmark/DCGC-21850/2020	EPI_ISL_758404	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1	GH
hCoV-19/Denmark/DCGC-21931/2020	EPI_ISL_758462	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-22109/2020	EPI_ISL_758556	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-22112/2020	EPI_ISL_758558	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Finland/23LS11B7/2020	EPI_ISL_759766	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS17B11/2020	EPI_ISL_759767	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS17B5/2020	EPI_ISL_759768	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS17E11/2020	EPI_ISL_759769	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/23LS1H5/2020	EPI_ISL_759774	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/23LS5D9/2020	EPI_ISL_759777	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/23LS5G11/2020	EPI_ISL_759778	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS6A12/2020	EPI_ISL_759780	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS6C11/2020	EPI_ISL_759781	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS6C12/2020	EPI_ISL_759782	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS6D12/2020	EPI_ISL_759783	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS6E9/2020	EPI_ISL_759784	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS6F7/2020	EPI_ISL_759785	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS6F8/2020	EPI_ISL_759786	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS6H10/2020	EPI_ISL_759787	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS7DD11/2020	EPI_ISL_759788	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS7DH3/2020	EPI_ISL_759789	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS7G2/2020	EPI_ISL_759790	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS8C1/2020	EPI_ISL_759791	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS8F3/2020	EPI_ISL_759792	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS8G1/2020	EPI_ISL_759793	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23LS9A7/2020	EPI_ISL_759794	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/23LS9H3/2020	EPI_ISL_759795	2020-10-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/23SS10F11/2020	EPI_ISL_759796	2020-09-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23SS11E11/2020	EPI_ISL_759797	2020-09-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23SS12G8/2020	EPI_ISL_759798	2020-09-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23SS13A5/2020	EPI_ISL_759799	2020-09-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23SS14A7/2020	EPI_ISL_759800	2020-09-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/23SS15G9/2020	EPI_ISL_759802	2020-09-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23SS15H5/2020	EPI_ISL_759803	2020-09-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23SS2E3/2020	EPI_ISL_759804	2020-09-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/23SS4H6/2020	EPI_ISL_759806	2020-09-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/23SS5H7/2020	EPI_ISL_759807	2020-09-23	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24ES18AE9/2020	EPI_ISL_759810	2020-08-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24LS10C4/2020	EPI_ISL_759818	2020-10-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24LS10D12/2020	EPI_ISL_759819	2020-10-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24LS10H3/2020	EPI_ISL_759820	2020-10-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24LS1C11/2020	EPI_ISL_759821	2020-10-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24LS1E5/2020	EPI_ISL_759823	2020-10-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24LS2A12/2020	EPI_ISL_759824	2020-10-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24LS6C12/2020	EPI_ISL_759825	2020-10-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24LS7G11/2020	EPI_ISL_759826	2020-10-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24SS10H11/2020	EPI_ISL_759827	2020-09-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/24SS11G1/2020	EPI_ISL_759828	2020-09-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24SS19H9/2020	EPI_ISL_759829	2020-09-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24SS4A5/2020	EPI_ISL_759831	2020-09-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24SS4F3/2020	EPI_ISL_759833	2020-09-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/24SS4G1/2020	EPI_ISL_759834	2020-09-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24SS5D8/2020	EPI_ISL_759835	2020-09-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24SS5F9/2020	EPI_ISL_759836	2020-09-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24SS6bD7/2020	EPI_ISL_759837	2020-09-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24SS7B9/2020	EPI_ISL_759840	2020-09-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/24SS9A5/2020	EPI_ISL_759841	2020-09-24	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Hong Kong/CM20000489/2020	EPI_ISL_759892	2020-12-20	Asia / Hong Kong	Human	Original	Throat and nasal swab		Illumina MiSeq				B.1.471	GH
hCoV-19/Hong Kong/VM20194998/2020	EPI_ISL_759895	2020-12-22	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.27	GH
hCoV-19/Hong Kong/VM20194997/2020	EPI_ISL_759897	2020-12-22	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/Hong Kong/VM20194999/2020	EPI_ISL_759898	2020-12-22	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/Finland/25ES3AB11/2020	EPI_ISL_759899	2020-08-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/England/QEUH-CC337D/2020	EPI_ISL_760764	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/CAMC-CB2D73/2020	EPI_ISL_760833	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-CAA5D0/2020	EPI_ISL_760854	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-CAD0BE/2020	EPI_ISL_760855	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-CB0D66/2020	EPI_ISL_760872	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Germany/SN-RKI-NP-0034/2020	EPI_ISL_763015	2020-12-08	Europe / Germany / Saxony	Human	Original		unknown	Nanopore MinION	ARTIC pipeline			B.1.36.20	GH
hCoV-19/England/CAMC-C770DB/2020	EPI_ISL_769198	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/Canada/ON-PHL-20-03812/2020	EPI_ISL_775023	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-20-03816/2020	EPI_ISL_775027	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-20-03819/2020	EPI_ISL_775029	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03820/2020	EPI_ISL_775030	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-20-03833/2020	EPI_ISL_775033	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03834/2020	EPI_ISL_775034	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/ON-PHL-20-03751/2020	EPI_ISL_775035	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03758/2020	EPI_ISL_775041	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.26	GH
hCoV-19/Canada/ON-PHL-20-03782/2020	EPI_ISL_775043	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03783/2020	EPI_ISL_775044	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03784/2020	EPI_ISL_775045	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/ON-PHL-20-03786/2020	EPI_ISL_775047	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03787/2020	EPI_ISL_775048	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03788/2020	EPI_ISL_775049	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03790/2020	EPI_ISL_775051	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.523	GH
hCoV-19/Canada/ON-PHL-20-03791/2020	EPI_ISL_775052	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03792/2020	EPI_ISL_775053	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03793/2020	EPI_ISL_775054	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03794/2020	EPI_ISL_775055	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03799/2020	EPI_ISL_775060	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03802/2020	EPI_ISL_775063	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03803/2020	EPI_ISL_775064	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/ON-PHL-20-03760/2020	EPI_ISL_775070	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.26	GH
hCoV-19/Canada/ON-PHL-20-03761/2020	EPI_ISL_775071	2020-11	North America / Canada / Ontario	Human	Original	Other		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03762/2020	EPI_ISL_775072	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03763/2020	EPI_ISL_775073	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-20-03764/2020	EPI_ISL_775074	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-20-03765/2020	EPI_ISL_775075	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-20-03766/2020	EPI_ISL_775076	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-20-03767/2020	EPI_ISL_775077	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-20-03768/2020	EPI_ISL_775078	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-20-03770/2020	EPI_ISL_775079	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03772/2020	EPI_ISL_775081	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03773/2020	EPI_ISL_775082	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/ON-PHL-20-03774/2020	EPI_ISL_775083	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/ON-PHL-20-03775/2020	EPI_ISL_775084	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/ON-PHL-20-03780/2020	EPI_ISL_775088	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03781/2020	EPI_ISL_775089	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03652/2020	EPI_ISL_775091	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03653/2020	EPI_ISL_775092	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-20-03654/2020	EPI_ISL_775093	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-20-03656/2020	EPI_ISL_775095	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.523	GH
hCoV-19/Canada/ON-PHL-20-03659/2020	EPI_ISL_775097	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-20-03661/2020	EPI_ISL_775099	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Germany/HH-hpi-p2024/2020	EPI_ISL_776328	2020-03-21	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.22	GH
hCoV-19/Germany/HH-hpi-p2027/2020	EPI_ISL_776329	2020-03-21	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.22	GH
hCoV-19/England/CAMC-CB7145/2020	EPI_ISL_777697	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/CAMC-B77C14/2020	EPI_ISL_783443	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B77F93/2020	EPI_ISL_783478	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B78D2F/2020	EPI_ISL_783498	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/USA/TX-HMH-MCoV-19045/2020	EPI_ISL_783597	2020-11-23	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.36	GH
hCoV-19/USA/TX-HMH-MCoV-18361/2020	EPI_ISL_784709	2020-11-18	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.36	GH
hCoV-19/Netherlands/NH-RIVM-20580/2020	EPI_ISL_790664	2020-12-21	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Netherlands/LI-RIVM-20591/2020	EPI_ISL_790674	2020-11-19	Europe / Netherlands / Limburg	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Indonesia/KI-NIHRD-PME5218/2020	EPI_ISL_791977	2020-08-11	Asia / Indonesia / East Kalimantan	Human	Original	Nasopharyngeal		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14	Gap of 1 nucleotide(s) found at refpos 28254 (confirmed frameshift by the submitter).	info	B.1	GH
hCoV-19/Indonesia/LA-NIHRD-PME1024/2020	EPI_ISL_791978	2020-05-23	Asia / Indonesia / Lampung	Human	Original	Nasopharyngeal		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14	Gap of 1 nucleotide(s) found at refpos 28254 (confirmed frameshift by the submitter).	info	B.1	GH
hCoV-19/Indonesia/BE-NIHRD-PME9915/2020	EPI_ISL_791979	2020-10-19	Asia / Indonesia / Bengkulu	Human	Original	Nasopharyngeal		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14	Gap of 1 nucleotide(s) found at refpos 28254 (confirmed frameshift by the submitter).	info	B.1.36.19	GH
hCoV-19/Indonesia/JI-NIHRD-PME9750/2020	EPI_ISL_791980	2020-11-09	Asia / Indonesia / East Java	Human	Original	Nasopharyngeal		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14	Gap of 1 nucleotide(s) found at refpos 28254 (confirmed frameshift by the submitter).	info	B.1.456	GH
hCoV-19/Indonesia/AC-NIHRD-PME4523/2020	EPI_ISL_791981	2020-06-18	Asia / Indonesia / Aceh	Human	Original	Nasopharyngeal		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1.468	GH
hCoV-19/Indonesia/JT-NIHRD-PME3110/2020	EPI_ISL_791982	2020-07-16	Asia / Indonesia / Central Java	Human	Original	Nasopharyngeal		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14	Gap of 1 nucleotide(s) found at refpos 28254 (confirmed frameshift by the submitter).	info	B.1.459	GH
hCoV-19/Indonesia/KI-NIHRD-PME5182/2020	EPI_ISL_791983	2020-08-11	Asia / Indonesia / East Kalimantan	Human	Original	Nasopharyngeal		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1	O
hCoV-19/Indonesia/KR-NIHRD-PME9874/2020	EPI_ISL_791985	2020-11-11	Asia / Indonesia / Riau	Human	Original	Nasopharyngeal		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14	Gap of 1 nucleotide(s) found at refpos 28254 (confirmed frameshift by the submitter). Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.468	GH
hCoV-19/Indonesia/MU-NIHRD-PME8242/2020	EPI_ISL_791986	2020-10-09	Asia / Indonesia / North Maluku	Human	Original	Nasopharyngeal		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1	GH
hCoV-19/Indonesia/JT-NIHRD-PME3225/2020	EPI_ISL_791987	2020-07-17	Asia / Indonesia / Central Java	Human	Original	Nasopharyngeal		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14	Gap of 1 nucleotide(s) found at refpos 28254 (confirmed frameshift by the submitter).	info	B.1.459	GH
hCoV-19/Denmark/DCGC-24904/2020	EPI_ISL_795411	2020-12-28	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide found at refpos 21575 (Frameshift confirmed by the submitter).	info	B.1.36	GH
hCoV-19/Denmark/DCGC-24368/2020	EPI_ISL_795500	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Norway/6728/2020	EPI_ISL_796709	2020-12-10	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/7071/2020	EPI_ISL_796714	2020-12-17	Europe / Norway / Agder	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/7070/2020	EPI_ISL_796715	2020-12-15	Europe / Norway / Agder	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/7069/2020	EPI_ISL_796716	2020-12-16	Europe / Norway / Agder	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/6894/2020	EPI_ISL_796726	2020-12-16	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/6889/2020	EPI_ISL_796729	2020-12-14	Europe / Norway / Agder	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/6722/2020	EPI_ISL_796730	2020-12-09	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/6720/2020	EPI_ISL_796732	2020-12-09	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/England/ALDP-D44504/2020	EPI_ISL_799026	2020-12-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-D1089F/2020	EPI_ISL_800421	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-D0F1C5/2020	EPI_ISL_800476	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/CAMC-D11C1A/2020	EPI_ISL_800574	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Singapore/18/2021	EPI_ISL_804000	2021-01-04	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.466.2	GH
hCoV-19/Singapore/21/2021	EPI_ISL_804003	2021-01-04	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.456	GH
hCoV-19/Singapore/22/2021	EPI_ISL_804004	2021-01-04	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.466.2	GH
hCoV-19/Singapore/23/2021	EPI_ISL_804005	2021-01-04	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.456	GH
hCoV-19/Denmark/DCGC-26447/2021	EPI_ISL_817312	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Spike_S46stop results in 96.5% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-25483/2021	EPI_ISL_818525	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-25518/2021	EPI_ISL_818540	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-25548/2021	EPI_ISL_818551	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-25662/2021	EPI_ISL_818584	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-25891/2021	EPI_ISL_818626	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-25930/2021	EPI_ISL_818633	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.469	GH
hCoV-19/England/MILK-EBCD86/2021	EPI_ISL_820820	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-EB47DB/2021	EPI_ISL_820975	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/Canada/Qc-CHUM-2016901878A/2020	EPI_ISL_825808	2020-06-17	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1	GH
hCoV-19/USA/ME-HETL-J0673/2021	EPI_ISL_832969	2021-01-07	North America / USA / Maine	Human	Original			Illumina NextSeq				B.1.466.1	GH
hCoV-19/Denmark/DCGC-29470/2021	EPI_ISL_843517	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.1	O
hCoV-19/Denmark/DCGC-29488/2021	EPI_ISL_843535	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-29508/2021	EPI_ISL_843555	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-29511/2021	EPI_ISL_843558	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-29522/2021	EPI_ISL_843569	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-29645/2020	EPI_ISL_843692	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-29651/2020	EPI_ISL_843698	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Australia/QLD1313/2020	EPI_ISL_849670	2020-03-22	Oceania / Australia / Queensland	Human	Original			Illumina	Samtools / iVar			B.1.22	GH
hCoV-19/Australia/QLD1344/2020	EPI_ISL_849686	2020-11-18	Oceania / Australia / Queensland	Human	Original			Illumina	Samtools / iVar			B.1.36.1	GH
hCoV-19/Germany/SH-ChVir21773/2020	EPI_ISL_849820	2020-12-24	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	Bowtie2			B.1.469	GH
hCoV-19/Scotland/QEUH-CAD582/2020	EPI_ISL_859064	2020-12-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/United Arab Emirates/4262/2020	EPI_ISL_860034	2020-12-29	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/United Arab Emirates/4263/2020	EPI_ISL_860035	2020-12-29	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.36	GH
hCoV-19/United Arab Emirates/4272/2020	EPI_ISL_860041	2020-12-29	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/United Arab Emirates/4279/2020	EPI_ISL_860048	2020-12-27	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq				B.1.466	GH
hCoV-19/United Arab Emirates/4284/2020	EPI_ISL_860052	2020-12-27	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq		Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/United Arab Emirates/4287/2020	EPI_ISL_860055	2020-12-27	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq		Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/United Arab Emirates/4319/2020	EPI_ISL_860078	2020-12-29	Asia / United Arab Emirates / Abu Dhabi	Human	unknown			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Japan/IC-0723/2021	EPI_ISL_860100	2021-01-16	Asia / Japan	Human	Original			Illumina iSeq	A5-miseq v. 20140604			B.1.36	GH
hCoV-19/Japan/IC-0726/2021	EPI_ISL_860103	2021-01-16	Asia / Japan	Human	Original			Illumina iSeq	SKESA v. 2.3.0			B.1.459	GH
hCoV-19/Egypt/CUNCI-HGC11I006/2021	EPI_ISL_862788	2021-01-03	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.466	GH
hCoV-19/Egypt/CUNCI-HGC11I008/2021	EPI_ISL_862789	2021-01-03	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.177	G
hCoV-19/Egypt/CUNCI-HGC11I027/2021	EPI_ISL_862797	2021-01-03	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.466	GH
hCoV-19/Egypt/CUNCI-HGC11I029/2021	EPI_ISL_862799	2021-01-03	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.466	GH
hCoV-19/Egypt/CUNCI-HGC11I036/2021	EPI_ISL_862805	2021-01-03	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.466	GH
hCoV-19/Singapore/87/2021	EPI_ISL_862825	2021-01-20	Asia / Singapore	Human	Original			Illumina Miseq				B.1.459	GH
hCoV-19/England/TFCI-26FEADE/2020	EPI_ISL_868803	2020-10-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.39	GH
hCoV-19/England/TFCI-26FEB62/2020	EPI_ISL_868812	2020-10-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/TFCI-26FEBDB/2020	EPI_ISL_868819	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/TFCI-26FEDB7/2020	EPI_ISL_868837	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.39	GH
hCoV-19/England/TFCI-26FF3A5/2020	EPI_ISL_868919	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.39	GH
hCoV-19/England/TFCI-26FF93A/2020	EPI_ISL_868990	2020-11-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.469	GH
hCoV-19/Indonesia/YO-UGM-10011/2020	EPI_ISL_872188	2020-12-27	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina Miseq	UGENE v.37			B.1.456	GH
hCoV-19/Indonesia/YO-UGM-10012/2020	EPI_ISL_872189	2020-12-27	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina Miseq	UGENE v.37			B.1	GH
hCoV-19/England/ALDP-100690C/2021	EPI_ISL_874800	2021-01-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Indonesia/JB-EIJK125/2021	EPI_ISL_889000	2021-01-07	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.459	GH
hCoV-19/Indonesia/JB-EIJK129/2021	EPI_ISL_889001	2021-01-06	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.466.2	GH
hCoV-19/Indonesia/JK-EIJK130/2021	EPI_ISL_889002	2021-01-06	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.470	GH
hCoV-19/Indonesia/BT-EIJK134/2020	EPI_ISL_889003	2020-12-31	Asia / Indonesia / Banten / Tangerang	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.466.2	GH
hCoV-19/Indonesia/BT-EIJK135/2021	EPI_ISL_889004	2021-01-01	Asia / Indonesia / Banten / Tangerang	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.466.2	GH
hCoV-19/Indonesia/JB-EIJK145/2021	EPI_ISL_889005	2021-01-11	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.456	GH
hCoV-19/Indonesia/JK-EIJK147/2021	EPI_ISL_889006	2021-01-11	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.466.2	GH
hCoV-19/Indonesia/JB-EIJK148/2021	EPI_ISL_889007	2021-01-11	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.459	GH
hCoV-19/Indonesia/BT-EIJK62/2020	EPI_ISL_889009	2020-11-09	Asia / Indonesia / Banten / South Tangerang	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.459	GH
hCoV-19/Indonesia/JB-EIJK74/2020	EPI_ISL_889010	2020-11-18	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.470	GH
hCoV-19/Indonesia/JB-EIJK82/2020	EPI_ISL_889011	2020-11-27	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.459	GH
hCoV-19/Indonesia/JB-EIJK95/2020	EPI_ISL_889012	2020-12-05	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.466.2	GH
hCoV-19/Indonesia/JB-EIJK104/2020	EPI_ISL_889013	2020-12-14	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.456	GH
hCoV-19/Indonesia/JB-EIJK107/2020	EPI_ISL_889014	2020-12-16	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.459	GH
hCoV-19/Indonesia/JB-EIJK108/2020	EPI_ISL_889015	2020-12-16	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.470	GH
hCoV-19/Indonesia/BT-EIJK110/2020	EPI_ISL_889016	2020-12-17	Asia / Indonesia / Banten / Tangerang	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.466.2	GH
hCoV-19/Indonesia/BT-EIJK118/2020	EPI_ISL_889017	2020-12-29	Asia / Indonesia / Banten / Tangerang	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.470	GH
hCoV-19/Indonesia/JB-EIJK120/2021	EPI_ISL_889018	2021-01-04	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.470	GH
hCoV-19/Indonesia/JK-EIJK121/2021	EPI_ISL_889019	2021-01-04	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.466.2	GH
hCoV-19/Indonesia/JB-EIJK58/2020	EPI_ISL_889020	2020-11-04	Asia / Indonesia / West Java / Bekasi	Human	Original	Oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.468	GH
hCoV-19/Indonesia/JB-EIJK84/2020	EPI_ISL_889021	2020-12-01	Asia / Indonesia / West Java / Bogor	Human	Original	Oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1	GH
hCoV-19/Indonesia/JB-EIJK91/2020	EPI_ISL_889022	2020-12-02	Asia / Indonesia / West Java / Bekasi	Human	Original	Oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.470	GH
hCoV-19/Japan/PG-14721/2020	EPI_ISL_892653	2020-12-01	Asia / Japan / Mie	Human	Original			illumina NextSeq500	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/PG-12969/2020	EPI_ISL_897381	2020-11-13	Asia / Japan / Mie	Human	Original			illumina NextSeq2000	SKESA v. 2.3.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/PG-12970/2020	EPI_ISL_897382	2020-11-15	Asia / Japan / Mie	Human	Original			illumina NextSeq2000	SKESA v. 2.3.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Switzerland/VS-ETHZ-450347/2021	EPI_ISL_899915	2021-01-11	Europe / Switzerland / Valais	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Indonesia/YO-UGM-124778/2020	EPI_ISL_906050	2020-12-23	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.470	GH
hCoV-19/Indonesia/YO-UGM-124777/2020	EPI_ISL_906051	2020-12-23	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.470	GH
hCoV-19/Indonesia/YO-UGM-124776/2020	EPI_ISL_906052	2020-12-23	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.470	GH
hCoV-19/England/CAMC-10C0616/2021	EPI_ISL_908675	2021-01-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Ireland/KE-NVRL-83IRL52763/2021	EPI_ISL_909905	2021-01-14	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol	Gap of 29 nucleotides when compared to the reference sequence.	info	B.1.562	GH
hCoV-19/Ireland/G-NVRL-83IRL22673/2021	EPI_ISL_909906	2021-01-11	Europe / Ireland / Galway	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol	Gap of 29 nucleotides when compared to the reference sequence.	info	B.1.562	GH
hCoV-19/Ireland/MO-NVRL-83IRL20089/2021	EPI_ISL_909907	2021-01-11	Europe / Ireland / Mayo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol	Gap of 29 nucleotides when compared to the reference sequence.	info	B.1.562	GH
hCoV-19/Ireland/KE-NVRL-83IRL52844/2021	EPI_ISL_909908	2021-01-14	Europe / Ireland / Kildare	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol	Gap of 29 nucleotides when compared to the reference sequence.	info	B.1.562	GH
hCoV-19/Ireland/D-NVRL-83IRL18158/2021	EPI_ISL_909928	2021-01-11	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36	GH
hCoV-19/Ireland/WW-NVRL-83IRL43203/2021	EPI_ISL_909944	2021-01-13	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36	GH
hCoV-19/Austria/MUW_1323920/2020	EPI_ISL_913080	2020-10-12	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 12	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-35200/2021	EPI_ISL_926340	2021-01-18	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-36466/2021	EPI_ISL_927607	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-36473/2021	EPI_ISL_927614	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-36556/2021	EPI_ISL_927697	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-37837/2020	EPI_ISL_928978	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/USA/NY-NYCPHL-002550/2021	EPI_ISL_937128	2021-01-19	North America / USA / New York / New York	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.36	GH
hCoV-19/USA/NY-NYCPHL-002665/2021	EPI_ISL_937181	2021-01-21	North America / USA / New York / New York	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.36.1	GH
hCoV-19/USA/NY-NYCPHL-002686/2021	EPI_ISL_937196	2021-01-20	North America / USA / New York / New York	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.36.8	GH
hCoV-19/Belgium/UZA-UA-0847/2021	EPI_ISL_940757	2021-01-19	Europe / Belgium / Deurne	Human	Original			Illumina MiSeq				B.1.36.1	GH
hCoV-19/Netherlands/LI-RIVM-11066/2021	EPI_ISL_943061	2021-01-19	Europe / Netherlands / Limburg	Human	Original			Nanopore MinION		Gap of 20 nucleotide(s) found at refpos 26162 (frameshift confirmed by the submitter).	info	B.1.36.1	GH
hCoV-19/Israel/CVL-5/2020	EPI_ISL_944371	2020-12-24	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina MiSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Belgium/Jessa_55-2103-000263/2021	EPI_ISL_949102	2021-01-19	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.36.38	GH
hCoV-19/Indonesia/JK-NIHRDMI2100175/2021	EPI_ISL_949183	2021-01-05	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1.466.2	GH
hCoV-19/England/LOND-E4DA1/2020	EPI_ISL_950131	2020-12-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.28	GH
hCoV-19/Indonesia/JI-ITDua-9627NTv/2020	EPI_ISL_956308	2020-05-14	Asia / Indonesia / East Java / Surabaya	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1	GH
hCoV-19/Indonesia/JI-ITDua-12418Nv/2020	EPI_ISL_956309	2020-06-10	Asia / Indonesia / East Java / Sidoarjo	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-16761NTv/2020	EPI_ISL_956310	2020-07-14	Asia / Indonesia / East Java / Surabaya	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-17047NTv/2020	EPI_ISL_956311	2020-07-16	Asia / Indonesia / East Java / Surabaya	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.36.19	GH
hCoV-19/Indonesia/JI-ITDua-35937NT/2021	EPI_ISL_956312	2021-01-01	Asia / Indonesia / East Java / Surabaya	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-36824NT/2021	EPI_ISL_956313	2021-01-08	Asia / Indonesia / East Java / Sidoarjo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.36.19	GH
hCoV-19/Indonesia/JI-ITDua-37008N/2021	EPI_ISL_956314	2021-01-11	Asia / Indonesia / East Java / Surabaya	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-36484NT/2021	EPI_ISL_956315	2021-01-04	Asia / Indonesia / East Java / Sidoarjo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-36613NT/2021	EPI_ISL_956316	2021-01-06	Asia / Indonesia / East Java / Surabaya	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Taiwan/CGMH-CGU-41/2020	EPI_ISL_956322	2020-11-12	Asia / Taiwan / Taoyuan	Human	Vero E6	Saliva		Illumina MiSeq	SPAdes Version 3.14.1	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Canada/BC-BCCDC-3875/2020	EPI_ISL_970465	2020-09-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-3704/2020	EPI_ISL_970496	2020-09-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4892/2020	EPI_ISL_970627	2020-09-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4895/2020	EPI_ISL_970634	2020-09-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.8	GH
hCoV-19/Canada/BC-BCCDC-5294/2020	EPI_ISL_970674	2020-09-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Denmark/DCGC-40255/2021	EPI_ISL_971932	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6135/2020	EPI_ISL_974006	2020-10-01	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6139/2020	EPI_ISL_974008	2020-10-01	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6518/2020	EPI_ISL_974009	2020-10-01	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5346/2020	EPI_ISL_974019	2020-10-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5483/2020	EPI_ISL_974021	2020-10-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5485/2020	EPI_ISL_974023	2020-10-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5486/2020	EPI_ISL_974024	2020-10-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5487/2020	EPI_ISL_974025	2020-10-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5558/2020	EPI_ISL_974027	2020-10-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5734/2020	EPI_ISL_974037	2020-10-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5735/2020	EPI_ISL_974038	2020-10-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5738/2020	EPI_ISL_974041	2020-10-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6288/2020	EPI_ISL_974048	2020-10-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5491/2020	EPI_ISL_974053	2020-10-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5493/2020	EPI_ISL_974055	2020-10-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5495/2020	EPI_ISL_974056	2020-10-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5497/2020	EPI_ISL_974058	2020-10-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5742/2020	EPI_ISL_974063	2020-10-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-5743/2020	EPI_ISL_974064	2020-10-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5746/2020	EPI_ISL_974065	2020-10-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6810/2020	EPI_ISL_974087	2020-10-03	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5574/2020	EPI_ISL_974131	2020-10-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5756/2020	EPI_ISL_974132	2020-10-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5757/2020	EPI_ISL_974133	2020-10-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-5977/2020	EPI_ISL_974140	2020-10-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6770/2020	EPI_ISL_974152	2020-10-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6771/2020	EPI_ISL_974153	2020-10-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6315/2020	EPI_ISL_974182	2020-10-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6780/2020	EPI_ISL_974194	2020-10-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6781/2020	EPI_ISL_974195	2020-10-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5772/2020	EPI_ISL_974198	2020-10-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10550/2020	EPI_ISL_975300	2020-11-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10551/2020	EPI_ISL_975301	2020-11-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7169/2020	EPI_ISL_975303	2020-11-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7175/2020	EPI_ISL_975307	2020-11-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7754/2020	EPI_ISL_975314	2020-11-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7755/2020	EPI_ISL_975315	2020-11-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7939/2020	EPI_ISL_975318	2020-11-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8042/2020	EPI_ISL_975321	2020-11-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8126/2020	EPI_ISL_975327	2020-11-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8514/2020	EPI_ISL_975331	2020-11-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8977/2020	EPI_ISL_975332	2020-11-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10389/2020	EPI_ISL_975336	2020-11-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10390/2020	EPI_ISL_975337	2020-11-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10392/2020	EPI_ISL_975339	2020-11-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10396/2020	EPI_ISL_975342	2020-11-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10619/2020	EPI_ISL_975345	2020-11-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7693/2020	EPI_ISL_975355	2020-11-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7699/2020	EPI_ISL_975361	2020-11-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7756/2020	EPI_ISL_975362	2020-11-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7941/2020	EPI_ISL_975365	2020-11-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7942/2020	EPI_ISL_975366	2020-11-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8129/2020	EPI_ISL_975373	2020-11-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8888/2020	EPI_ISL_975377	2020-11-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9843/2020	EPI_ISL_975379	2020-11-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10400/2020	EPI_ISL_975381	2020-11-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10403/2020	EPI_ISL_975382	2020-11-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10635/2020	EPI_ISL_975386	2020-11-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6881/2020	EPI_ISL_975387	2020-11-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.18	GH
hCoV-19/Canada/BC-BCCDC-7410/2020	EPI_ISL_975393	2020-11-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7411/2020	EPI_ISL_975394	2020-11-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7412/2020	EPI_ISL_975395	2020-11-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7504/2020	EPI_ISL_975397	2020-11-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7924/2020	EPI_ISL_975460	2020-11-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8068/2020	EPI_ISL_975468	2020-11-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8216/2020	EPI_ISL_975481	2020-11-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8217/2020	EPI_ISL_975482	2020-11-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10406/2020	EPI_ISL_975490	2020-11-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10625/2020	EPI_ISL_975493	2020-11-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7426/2020	EPI_ISL_975496	2020-11-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7429/2020	EPI_ISL_975498	2020-11-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7430/2020	EPI_ISL_975499	2020-11-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9668/2020	EPI_ISL_976605	2020-12-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9776/2020	EPI_ISL_976606	2020-12-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9331/2020	EPI_ISL_976614	2020-12-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9670/2020	EPI_ISL_976623	2020-12-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9672/2020	EPI_ISL_976624	2020-12-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9673/2020	EPI_ISL_976625	2020-12-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9674/2020	EPI_ISL_976626	2020-12-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9676/2020	EPI_ISL_976627	2020-12-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9677/2020	EPI_ISL_976628	2020-12-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9679/2020	EPI_ISL_976630	2020-12-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9784/2020	EPI_ISL_976635	2020-12-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9785/2020	EPI_ISL_976636	2020-12-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10095/2020	EPI_ISL_976645	2020-12-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9361/2020	EPI_ISL_976657	2020-12-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9362/2020	EPI_ISL_976658	2020-12-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9363/2020	EPI_ISL_976659	2020-12-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9364/2020	EPI_ISL_976660	2020-12-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9373/2020	EPI_ISL_976665	2020-12-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9425/2020	EPI_ISL_976667	2020-12-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9680/2020	EPI_ISL_976669	2020-12-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9682/2020	EPI_ISL_976671	2020-12-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9686/2020	EPI_ISL_976674	2020-12-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9987/2020	EPI_ISL_976679	2020-12-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-10098/2020	EPI_ISL_976681	2020-12-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10099/2020	EPI_ISL_976682	2020-12-21	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9687/2020	EPI_ISL_976694	2020-12-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9689/2020	EPI_ISL_976696	2020-12-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9600/2020	EPI_ISL_976796	2020-12-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9601/2020	EPI_ISL_976797	2020-12-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9603/2020	EPI_ISL_976799	2020-12-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/USA/CA-CZB-16785/2020	EPI_ISL_979015	2020-12-09	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.523	GH
hCoV-19/England/ALDP-11836F0/2021	EPI_ISL_990997	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/MILK-108C4FE/2021	EPI_ISL_993142	2021-01-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/India/KA-NIMH-SEQ-154/2021	EPI_ISL_995735	2021-01-16	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/KA-NIMH-SEQ-159/2021	EPI_ISL_995740	2021-01-18	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/KA-NIMH-SEQ-162/2021	EPI_ISL_995743	2021-01-20	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/India/KA-NIMH-SEQ-174/2021	EPI_ISL_995756	2021-01-21	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/KA-NIMH-SEQ-175/2021	EPI_ISL_995757	2021-01-21	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Afghanistan/IMB07962/2020	EPI_ISL_1001000	2020-06-02	Asia / Afghanistan	Human	Original	Oropharyngeal swab		ONT				B.1	GH
hCoV-19/Afghanistan/IMB07966/2020	EPI_ISL_1001002	2020-05-30	Asia / Afghanistan	Human	Original	Oropharyngeal swab		ONT				B.1	GH
hCoV-19/Switzerland/AG-ETHZ-461153/2021	EPI_ISL_1003302	2021-01-20	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/AG-ETHZ-461222/2021	EPI_ISL_1003303	2021-01-20	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BE-ETHZ-460385/2021	EPI_ISL_1003391	2021-01-21	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BE-ETHZ-460384/2021	EPI_ISL_1003392	2021-01-21	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/LU-ETHZ-470533/2021	EPI_ISL_1003497	2021-01-22	Europe / Switzerland / Lucerne	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/SO-ETHZ-440475/2021	EPI_ISL_1004672	2021-01-01	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Netherlands/UT-RIVM-11964/2021	EPI_ISL_1014088	2021-02-02	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-42173/2021	EPI_ISL_1022451	2021-02-08	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (FRAMESHIFT confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-42196/2021	EPI_ISL_1022474	2021-02-08	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (FRAMESHIFT confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-42221/2021	EPI_ISL_1022499	2021-02-08	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (FRAMESHIFT confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-42237/2021	EPI_ISL_1022515	2021-02-08	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (FRAMESHIFT confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-43461/2021	EPI_ISL_1023832	2021-02-01	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (FRAMESHIFT confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Hong Kong/HKU-201216-018/2020	EPI_ISL_1034468	2020-06-24	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-082/2020	EPI_ISL_1034510	2020-07-24	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-323/2020	EPI_ISL_1034619	2020-11-22	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-328/2020	EPI_ISL_1034620	2020-11-23	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-337/2020	EPI_ISL_1034621	2020-11-26	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-348/2020	EPI_ISL_1034626	2020-11-26	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36.27	GH
hCoV-19/Hong Kong/HKU-201216-349/2020	EPI_ISL_1034627	2020-11-26	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-351/2020	EPI_ISL_1034628	2020-11-27	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-352/2020	EPI_ISL_1034629	2020-11-27	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36.27	GH
hCoV-19/Curacao/CW-RIVM-13011/2021	EPI_ISL_1035771	2021-01-26	South America / Curacao / Curacao	Human	Original			Nanopore MinION				B.1.22.1	GH
hCoV-19/Belgium/UZA-UA-TKH985/2021	EPI_ISL_1040476	2021-02-04	Europe / Belgium / Elsene	Human	Original			Illumina Miseq				B.1.36.1	GH
hCoV-19/Denmark/DCGC-46148/2020	EPI_ISL_1065658	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-46267/2020	EPI_ISL_1065777	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-47371/2020	EPI_ISL_1066906	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Indonesia/SU-USU-16NTv/2020	EPI_ISL_1069153	2020-09-25	Asia / Indonesia / North Sumatra / Binjai	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.468	GH
hCoV-19/India/CH-ICMR-21262/2020	EPI_ISL_1069154	2020-06-21	Asia / India / Chandigarh	Human	Original	Throat / Nasal swab		Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/India/CH-ICMR-21873/2020	EPI_ISL_1069155	2020-06-22	Asia / India / Chandigarh	Human	Original	Throat / Nasal swab		Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/India/PB-ICMR-28061/2020	EPI_ISL_1069195	2020-07-07	Asia / India / Punjab	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/India/CH-ICMR-32201/2020	EPI_ISL_1069196	2020-07-17	Asia / India / Chandigarh	Human	Original	Throat / Nasal swab		Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36.38	GH
hCoV-19/India/PB-ICMR-32341/2020	EPI_ISL_1069197	2020-07-17	Asia / India / Punjab	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36.38	GH
hCoV-19/Belgium/ULG-12378/2021	EPI_ISL_1076412	2021-02-11	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/USA/TX-HMH-MCoV-24404/2021	EPI_ISL_1078958	2021-01-16	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.596	GH
hCoV-19/Finland/HEL-15-247/2021	EPI_ISL_1082169	2021-01-18	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.468	GH
hCoV-19/Finland/HEL-14-394/2021	EPI_ISL_1082177	2021-01-24	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-15-242/2021	EPI_ISL_1082180	2021-01-18	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.523	GH
hCoV-19/Finland/HEL-15-403/2021	EPI_ISL_1082181	2021-01-17	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-15-411/2021	EPI_ISL_1082183	2021-01-12	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-17-485/2021	EPI_ISL_1082186	2021-01-26	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-17-489/2021	EPI_ISL_1082187	2021-01-25	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-17-499/2021	EPI_ISL_1082189	2021-01-25	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-17-516/2021	EPI_ISL_1082191	2021-01-25	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-17-530/2021	EPI_ISL_1082193	2021-01-25	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-17-531/2021	EPI_ISL_1082194	2021-01-25	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-18-V163/2021	EPI_ISL_1082199	2021-01-23	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Netherlands/NB-RIVM-13817/2021	EPI_ISL_1089627	2021-02-03	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore MinION		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/USA/NY-PV09303/2020	EPI_ISL_422557	2020-03-21	North America / USA / New York / Manhattan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1	GH
hCoV-19/Netherlands/NA_268/2020	EPI_ISL_422579	2020-03-30	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/USA/FL_7169/2020	EPI_ISL_424855	2020-03-02	North America / USA / Florida	Human	Original	Sputum		Illumina MiSeq	bowtie2 2.3.3.1, bcftools 1.9			B.1.110	GH
hCoV-19/Australia/VIC837/2020	EPI_ISL_427101	2020-04-04	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.22	GH
hCoV-19/Australia/VIC845/2020	EPI_ISL_427105	2020-04-04	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.22	GH
hCoV-19/Scotland/CVR1978/2020	EPI_ISL_433270	2020-04-07	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA MiSeq				B.1	GH
hCoV-19/Northern Ireland/NIRE-10239B/2020	EPI_ISL_441407	2020-03-21	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.465	GH
hCoV-19/Sweden/20-07586/2020	EPI_ISL_445235	2020-04-20	Europe / Sweden / Vastra Gotaland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.465	GH
hCoV-19/India/GJ-GBRC78a/2020	EPI_ISL_447536	2020-05-05	Asia / India / Gujarat / Modasa	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC79a/2020	EPI_ISL_447538	2020-05-05	Asia / India / Gujarat / Modasa	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC79b/2020	EPI_ISL_447539	2020-05-05	Asia / India / Gujarat / Modasa	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC87/2020	EPI_ISL_447548	2020-04-28	Asia / India / Gujarat / Dahegam	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC90/2020	EPI_ISL_447552	2020-05-02	Asia / India / Gujarat / Gandhinagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC91/2020	EPI_ISL_447553	2020-04-27	Asia / India / Gujarat / Gandhinagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC93/2020	EPI_ISL_447555	2020-04-28	Asia / India / Gujarat / Mansa	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/Denmark/ALAB-HH-245/2020	EPI_ISL_452083	2020-04-23	Europe / Denmark	Human	Original			Nanopore MinION				B.1.465	GH
hCoV-19/Netherlands/Utrecht_10014/2020	EPI_ISL_454763	2020-03-16	Europe / Netherlands / Utrecht	Human	Original			Illumina NextSeq				B.1.22	GH
hCoV-19/Netherlands/Utrecht_10029/2020	EPI_ISL_454778	2020-04-03	Europe / Netherlands / Utrecht	Human	Original			Illumina NextSeq				B.1.22	GH
hCoV-19/Scotland/GCVR-1713A6/2020	EPI_ISL_459535	2020-03-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/Netherlands/Overijssel_26/2020	EPI_ISL_460815	2020-03-16	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Overijssel_3/2020	EPI_ISL_460819	2020-04-15	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Overijssel_4/2020	EPI_ISL_460823	2020-04-15	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Overijssel_6/2020	EPI_ISL_460825	2020-04-06	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Flevoland_14/2020	EPI_ISL_460837	2020-04-10	Europe / Netherlands / Flevoland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_100/2020	EPI_ISL_460861	2020-05-21	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_101/2020	EPI_ISL_460862	2020-05-21	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_102/2020	EPI_ISL_460863	2020-05-21	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_103/2020	EPI_ISL_460864	2020-05-21	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_104/2020	EPI_ISL_460865	2020-05-21	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_105/2020	EPI_ISL_460866	2020-05-21	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_106/2020	EPI_ISL_460867	2020-05-21	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_107/2020	EPI_ISL_460868	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_108/2020	EPI_ISL_460869	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_109/2020	EPI_ISL_460870	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_110/2020	EPI_ISL_460871	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_111/2020	EPI_ISL_460872	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_112/2020	EPI_ISL_460873	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_113/2020	EPI_ISL_460874	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_114/2020	EPI_ISL_460875	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_115/2020	EPI_ISL_460876	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_116/2020	EPI_ISL_460877	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_117/2020	EPI_ISL_460878	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_118/2020	EPI_ISL_460879	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_119/2020	EPI_ISL_460880	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_120/2020	EPI_ISL_460881	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_121/2020	EPI_ISL_460882	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_122/2020	EPI_ISL_460883	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_123/2020	EPI_ISL_460884	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_124/2020	EPI_ISL_460885	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_125/2020	EPI_ISL_460886	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_126/2020	EPI_ISL_460887	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_127/2020	EPI_ISL_460888	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_128/2020	EPI_ISL_460889	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_129/2020	EPI_ISL_460890	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/England/NORT-28C170/2020	EPI_ISL_461801	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/England/CAMB-1ABCA8/2020	EPI_ISL_470098	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/CAMB-1ACC4D/2020	EPI_ISL_489519	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/CAMB-1AC937/2020	EPI_ISL_489524	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/CAMB-1AC71F/2020	EPI_ISL_489573	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/CAMB-1AC7F1/2020	EPI_ISL_489576	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/NOTT-11269F/2020	EPI_ISL_490562	2020-07-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/India/TG-CCMB-M779/2020	EPI_ISL_495239	2020-06-12	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.36	GH
hCoV-19/India/TG-CCMB-M804/2020	EPI_ISL_495244	2020-06-12	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.36	GH
hCoV-19/India/MH-NCCS-NR2257/2020	EPI_ISL_496526	2020-05-21	Asia / India / Maharashtra	Human	Original			Illumina MiSeq		NS3_G254stop results in 8.0% truncation of the protein sequence. Gap of 1 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/India/MH-NCCS-NR2252/2020	EPI_ISL_496531	2020-05-21	Asia / India / Maharashtra	Human	Original			Illumina MiSeq		NS3_G254stop results in 8.0% truncation of the protein sequence. Gap of 2 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/India/MH-NCCS-NR2309/2020	EPI_ISL_496532	2020-05-22	Asia / India / Maharashtra	Human	Original			Illumina MiSeq		Gap of 2 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/India/MH-NCCS-NR048/2020	EPI_ISL_496555	2020-04-28	Asia / India / Maharashtra	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/India/MH-NCCS-NR049/2020	EPI_ISL_496556	2020-04-28	Asia / India / Maharashtra	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/India/MH-NCCS-NR051/2020	EPI_ISL_496557	2020-04-28	Asia / India / Maharashtra	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/India/MH-NCCS-NR2099/2020	EPI_ISL_496568	2020-05-21	Asia / India / Maharashtra	Human	Original			Illumina MiSeq		NS3_G254stop results in 8.0% truncation of the protein sequence.	info	B.1	GH
hCoV-19/India/MH-NCCS-NR2245/2020	EPI_ISL_496572	2020-05-21	Asia / India / Maharashtra	Human	Original			Illumina MiSeq				B.1	GH
hCoV-19/India/MH-NCCS-NR2246/2020	EPI_ISL_496573	2020-05-21	Asia / India / Maharashtra	Human	Original			Illumina MiSeq		NS3_G254stop results in 8.0% truncation of the protein sequence.	info	B.1	GH
hCoV-19/India/MH-NCCS-NR2249/2020	EPI_ISL_496574	2020-05-21	Asia / India / Maharashtra	Human	Original			Illumina MiSeq		NS3_G254stop results in 8.0% truncation of the protein sequence.	info	B.1	GH
hCoV-19/India/MH-NCCS-NR2254/2020	EPI_ISL_496575	2020-05-21	Asia / India / Maharashtra	Human	Original			Illumina MiSeq		NS3_G254stop results in 8.0% truncation of the protein sequence.	info	B.1	GH
hCoV-19/India/MH-NCCS-NR2307/2020	EPI_ISL_496577	2020-05-22	Asia / India / Maharashtra	Human	Original			Illumina MiSeq		NS3_G254stop results in 8.0% truncation of the protein sequence.	info	B.1	GH
hCoV-19/Hong Kong/HKU-200723-036/2020	EPI_ISL_497803	2020-07-06	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-200723-074/2020	EPI_ISL_497841	2020-07-07	Asia / Hong Kong	Human	Original	Saliva		Nanopore MinION				B.1.36	GH
hCoV-19/England/LIVE-A8F76/2020	EPI_ISL_517238	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.465	GH
hCoV-19/mink/Netherlands/NB-EMC-14-21/2020	EPI_ISL_523017	2020-06-14	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-14-25/2020	EPI_ISL_523018	2020-06-14	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-14-3/2020	EPI_ISL_523019	2020-06-14	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-14-37/2020	EPI_ISL_523020	2020-06-14	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-17-10/2020	EPI_ISL_523035	2020-07-02	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-17-16/2020	EPI_ISL_523036	2020-07-02	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-17-19/2020	EPI_ISL_523037	2020-07-02	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-17-3/2020	EPI_ISL_523038	2020-07-02	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-17-6/2020	EPI_ISL_523039	2020-07-02	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-22-1/2020	EPI_ISL_523074	2020-07-12	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-23-1/2020	EPI_ISL_523076	2020-07-14	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-23-2/2020	EPI_ISL_523077	2020-07-14	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-23-4/2020	EPI_ISL_523079	2020-07-14	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-23-5/2020	EPI_ISL_523080	2020-07-14	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-23-6/2020	EPI_ISL_523081	2020-07-14	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-23-7/2020	EPI_ISL_523082	2020-07-14	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-6-13/2020	EPI_ISL_523098	2020-05-30	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/mink/Netherlands/NB-EMC-6-14/2020	EPI_ISL_523099	2020-05-30	Europe / Netherlands / Noord-Brabant	Neovison vison	Original			Nanopore				B.1.22	GH
hCoV-19/Egypt/CUNCI-HGC7I07/2020	EPI_ISL_529145	2020-07-19	Africa / Egypt / Cairo	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1	GH
hCoV-19/England/BIRM-61841/2020	EPI_ISL_529239	2020-06-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1	GH
hCoV-19/USA/WA-S2804/2020	EPI_ISL_530161	2020-08-29	North America / USA / Washington / King County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.36.38	GH
hCoV-19/USA/WA-S2805/2020	EPI_ISL_530162	2020-08-29	North America / USA / Washington / King County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.36.38	GH
hCoV-19/England/SHEF-C0998/2020	EPI_ISL_535043	2020-05-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/England/SHEF-C6E93/2020	EPI_ISL_535062	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	O
hCoV-19/England/SHEF-C98B0/2020	EPI_ISL_535066	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/England/SHEF-CBAD6/2020	EPI_ISL_535073	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	O
hCoV-19/England/SHEF-CC273/2020	EPI_ISL_535075	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	O
hCoV-19/England/SHEF-CCDEB/2020	EPI_ISL_535079	2020-05-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	O
hCoV-19/England/SHEF-CDD62/2020	EPI_ISL_535081	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	O
hCoV-19/England/SHEF-CDE14/2020	EPI_ISL_535082	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	O
hCoV-19/England/SHEF-CE39C/2020	EPI_ISL_535085	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	O
hCoV-19/England/SHEF-CF137/2020	EPI_ISL_535088	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	O
hCoV-19/England/SHEF-D02C7/2020	EPI_ISL_535091	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	O
hCoV-19/England/LEED-2A9E3A/2020	EPI_ISL_538938	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/QEUH-9B8903/2020	EPI_ISL_549614	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B92CB/2020	EPI_ISL_549622	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B888E/2020	EPI_ISL_549631	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/QEUH-9B997B/2020	EPI_ISL_549672	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B9049/2020	EPI_ISL_549678	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B8B85/2020	EPI_ISL_549680	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-9B9CCD/2020	EPI_ISL_549687	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B894F/2020	EPI_ISL_549699	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B90FE/2020	EPI_ISL_549795	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-978134/2020	EPI_ISL_550514	2020-07-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-9775FD/2020	EPI_ISL_550515	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-977487/2020	EPI_ISL_550516	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-99D324/2020	EPI_ISL_550606	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-99D99B/2020	EPI_ISL_550619	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-99E04A/2020	EPI_ISL_550667	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-99E02C/2020	EPI_ISL_550698	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-99C765/2020	EPI_ISL_550765	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-99E1FC/2020	EPI_ISL_550780	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-990CAE/2020	EPI_ISL_551842	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-9907F8/2020	EPI_ISL_551902	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-9932C7/2020	EPI_ISL_551959	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides found at refpos 22189.	info	B.1.36	GH
hCoV-19/England/MILK-992AC0/2020	EPI_ISL_551985	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-99291E/2020	EPI_ISL_551991	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-99283F/2020	EPI_ISL_551999	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-957371/2020	EPI_ISL_554100	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/MILK-957B5B/2020	EPI_ISL_554168	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/ALDP-950EFF/2020	EPI_ISL_554171	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1	GH
hCoV-19/England/MILK-956F05/2020	EPI_ISL_554180	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/ALDP-94E410/2020	EPI_ISL_555382	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/England/CAMC-949327/2020	EPI_ISL_556767	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/India/HR-IMT-BZ124/2020	EPI_ISL_561339	2020-08-25	Asia / India / Haryana	Human	Original	Nasopharyngeal swab		Nanopore MinION	EzCOVID19			B.1.36	GH
hCoV-19/India/HR-IMT-BZ144/2020	EPI_ISL_561340	2020-08-25	Asia / India / Haryana	Human	Original	Nasopharyngeal swab		Nanopore MinION	EzCOVID19			B.1.36	GH
hCoV-19/England/ALDP-9CCE1C/2020	EPI_ISL_566125	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CD66E/2020	EPI_ISL_566127	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CE06F/2020	EPI_ISL_566131	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CD4EC/2020	EPI_ISL_566135	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CCFCE/2020	EPI_ISL_566147	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CD552/2020	EPI_ISL_566148	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CD07F/2020	EPI_ISL_566149	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CD58F/2020	EPI_ISL_566153	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CD5E9/2020	EPI_ISL_566162	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CD2D3/2020	EPI_ISL_566184	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CDA71/2020	EPI_ISL_566185	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CD631/2020	EPI_ISL_566186	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9CE050/2020	EPI_ISL_566192	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9C9E3D/2020	EPI_ISL_567372	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_G38stop results in 69.4% truncation of the protein sequence.	info	B.1.36.1	GH
hCoV-19/England/QEUH-9C9626/2020	EPI_ISL_567417	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9C9583/2020	EPI_ISL_567453	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.36.17	GH
hCoV-19/England/QEUH-9C9F85/2020	EPI_ISL_567466	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/QEUH-9CA045/2020	EPI_ISL_567470	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9C9EF1/2020	EPI_ISL_567475	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9C9D4F/2020	EPI_ISL_567481	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9C9398/2020	EPI_ISL_567502	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9C9BBE/2020	EPI_ISL_567513	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/NOTT-1133D3/2020	EPI_ISL_573418	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/NOTT-113704/2020	EPI_ISL_573421	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/NOTT-113BAE/2020	EPI_ISL_573464	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/NOTT-113C14/2020	EPI_ISL_573468	2020-09-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/Indonesia/JK-EIJK49/2020	EPI_ISL_574618	2020-06-08	Asia / Indonesia / Jakarta	Human	Original	Oropharyngeal swab		Illumina MiSeq System + Sanger	Bowtie2 + iVar + in-house scripts			B.1.459	GH
hCoV-19/England/204020544/2020	EPI_ISL_574697	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204020545/2020	EPI_ISL_574698	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204020546/2020	EPI_ISL_574699	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/Netherlands/NB-EMC-283/2020	EPI_ISL_574782	2020	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-284/2020	EPI_ISL_574783	2020	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-286/2020	EPI_ISL_574784	2020	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-287/2020	EPI_ISL_574785	2020	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Scotland/MILK-974736/2020	EPI_ISL_575802	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/MILK-974675/2020	EPI_ISL_575911	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-97497C/2020	EPI_ISL_575952	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9747DC/2020	EPI_ISL_575959	2020-08-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/Scotland/MILK-9C41FD/2020	EPI_ISL_575989	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Scotland/MILK-9C4218/2020	EPI_ISL_575993	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/France/ARA-09112-isl/2020	EPI_ISL_578177	2020-03-14	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	BGM P3	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1	GH
hCoV-19/India/WB-IICB-014/2020	EPI_ISL_578182	2020-09-10	Asia / India / West Bengal	Human	Original			Nanopore MinION	Minimap2			B.1.36	GH
hCoV-19/England/CAMC-9EC5C6/2020	EPI_ISL_580341	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/CAMC-9EC5E4/2020	EPI_ISL_580369	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9E6BCA/2020	EPI_ISL_580376	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-9EC14A/2020	EPI_ISL_580394	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-9EC292/2020	EPI_ISL_580418	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/ALDP-9E683C/2020	EPI_ISL_580437	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9E6D6A/2020	EPI_ISL_580457	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-9E718B/2020	EPI_ISL_580466	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-9EC2A1/2020	EPI_ISL_580495	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A2D971/2020	EPI_ISL_586632	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-A2D856/2020	EPI_ISL_586756	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A2E6F1/2020	EPI_ISL_586777	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/ALDP-A2DF9D/2020	EPI_ISL_586778	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A2E7A3/2020	EPI_ISL_586782	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9FD9D5/2020	EPI_ISL_587926	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9FCA2E/2020	EPI_ISL_587944	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9FD2E9/2020	EPI_ISL_587988	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	G
hCoV-19/Norway/3745/2020	EPI_ISL_591000	2020-09-04	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3747/2020	EPI_ISL_591001	2020-09-03	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3750/2020	EPI_ISL_591002	2020-09-05	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3754/2020	EPI_ISL_591004	2020-09-06	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3755/2020	EPI_ISL_591005	2020-09-07	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3629/2020	EPI_ISL_591007	2020-08-06	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3722/2020	EPI_ISL_591015	2020-09-01	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3765/2020	EPI_ISL_591016	2020-08-29	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3766/2020	EPI_ISL_591017	2020-08-29	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3806/2020	EPI_ISL_591021	2020-08-01	Europe / Norway / Rogaland	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Australia/NSW1036/2020	EPI_ISL_593688	2020-07-02	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36.38	GH
hCoV-19/Australia/NSW1048/2020	EPI_ISL_593700	2020-07-05	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Australia/NSW1055/2020	EPI_ISL_593707	2020-07-07	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36	GH
hCoV-19/Australia/NSW1068/2020	EPI_ISL_593708	2020-08-01	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1	GH
hCoV-19/Australia/NSW1100/2020	EPI_ISL_593715	2020-08-29	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36	GH
hCoV-19/Australia/NSW1101/2020	EPI_ISL_593716	2020-08-29	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36	GH
hCoV-19/Australia/NSW1102/2020	EPI_ISL_593717	2020-08-29	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36	GH
hCoV-19/Australia/NSW1120/2020	EPI_ISL_593734	2020-09-12	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36	GH
hCoV-19/Australia/NSW1126/2020	EPI_ISL_593740	2020-09-11	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36.1	GH
hCoV-19/Australia/NSW1133/2020	EPI_ISL_593745	2020-10-04	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.459	GH
hCoV-19/Australia/NSW1143/2020	EPI_ISL_593753	2020-09-30	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36	GH
hCoV-19/England/MILK-9EF0E0/2020	EPI_ISL_594900	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.28	GH
hCoV-19/England/MILK-9EF1FC/2020	EPI_ISL_594908	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-9EF235/2020	EPI_ISL_594909	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-9EFAF1/2020	EPI_ISL_594980	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/MILK-9EFBB2/2020	EPI_ISL_594985	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/England/QEUH-A4CB85/2020	EPI_ISL_596027	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-A4CE13/2020	EPI_ISL_596059	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-A4CF01/2020	EPI_ISL_596067	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-A4CF3E/2020	EPI_ISL_596069	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-A5DE2E/2020	EPI_ISL_597288	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A57C39/2020	EPI_ISL_597350	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-A5DEE2/2020	EPI_ISL_597352	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-A59C46/2020	EPI_ISL_597368	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-A5DE97/2020	EPI_ISL_597406	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A45DC2/2020	EPI_ISL_598621	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A45F9F/2020	EPI_ISL_598649	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A46611/2020	EPI_ISL_598668	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/MILK-A45D3B/2020	EPI_ISL_598673	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A4672D/2020	EPI_ISL_598736	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A458EF/2020	EPI_ISL_598739	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/MILK-A45CF2/2020	EPI_ISL_598756	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A05960/2020	EPI_ISL_599930	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A05E07/2020	EPI_ISL_599933	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-A062DD/2020	EPI_ISL_599953	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/MILK-A05748/2020	EPI_ISL_599959	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A053AE/2020	EPI_ISL_599967	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/England/MILK-A0564B/2020	EPI_ISL_599979	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-A06343/2020	EPI_ISL_599997	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Switzerland/TI-ETHZ-310517/2020	EPI_ISL_603585	2020-10-08	Europe / Switzerland / Ticino	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.467	GH
hCoV-19/Switzerland/TI-ETHZ-321395/2020	EPI_ISL_603636	2020-10-13	Europe / Switzerland / Ticino	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.467	GH
hCoV-19/Switzerland/TI-ETHZ-321526/2020	EPI_ISL_603735	2020-10-15	Europe / Switzerland / Ticino	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.467	GH
hCoV-19/England/ALDP-A6EE39/2020	EPI_ISL_607108	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-A6E121/2020	EPI_ISL_607176	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-A6E0E8/2020	EPI_ISL_607273	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/MILK-A7B024/2020	EPI_ISL_607297	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A683F4/2020	EPI_ISL_608403	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A64DCD/2020	EPI_ISL_608494	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-A64FF4/2020	EPI_ISL_608514	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Canada/ON-UHTC_0327/2020	EPI_ISL_609806	2020-09-07	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36.26	GH
hCoV-19/Canada/ON-UHTC_0356/2020	EPI_ISL_609811	2020-10-03	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36.26	GH
hCoV-19/Canada/ON-UHTC_0322/2020	EPI_ISL_609826	2020-09-06	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36.26	GH
hCoV-19/England/204100966/2020	EPI_ISL_609840	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/England/204100971/2020	EPI_ISL_609841	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/England/204100982/2020	EPI_ISL_609842	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/England/204120186/2020	EPI_ISL_609843	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/England/CAMC-A8253A/2020	EPI_ISL_610786	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A810D0/2020	EPI_ISL_610795	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Denmark/DCGC-4287/2020	EPI_ISL_615724	2020-09-07	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-4288/2020	EPI_ISL_615725	2020-09-07	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-3056/2020	EPI_ISL_616836	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-3230/2020	EPI_ISL_616890	2020-08-24	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36.22	GH
hCoV-19/Denmark/DCGC-3231/2020	EPI_ISL_616891	2020-08-31	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.36.22	GH
hCoV-19/Denmark/DCGC-7098/2020	EPI_ISL_619139	2020-10-12	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-7119/2020	EPI_ISL_619152	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/New Zealand/20CV0506/2020	EPI_ISL_622792	2020-11-01	Oceania / New Zealand / Counties Manukau	Human	Original	Nasopharyngeal swab		Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/New Zealand/20CV0427/2020	EPI_ISL_622793	2020-10-16	Oceania / New Zealand / Combined Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION		Gap of 21 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/England/ALDP-AA365E/2020	EPI_ISL_625005	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-AA16D8/2020	EPI_ISL_625011	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA5407/2020	EPI_ISL_625033	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-AA2C7B/2020	EPI_ISL_625055	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-AA1E3A/2020	EPI_ISL_625061	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/New Zealand/20CV0521/2020	EPI_ISL_626356	2020-11-03	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/England/NORW-F1B6B/2020	EPI_ISL_627619	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36	GH
hCoV-19/Bahrain/920265546_S18_L001/2020	EPI_ISL_632266	2020-06-21	Asia / Bahrain	Human	Original	Nasopharyngeal swab		Illumina	Aviomix v. 1.0			B.1	GH
hCoV-19/England/QEUH-AE1B64/2020	EPI_ISL_633412	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/QEUH-AE2A84/2020	EPI_ISL_633445	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AE2107/2020	EPI_ISL_633456	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AD43A8/2020	EPI_ISL_634700	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B0E508/2020	EPI_ISL_641946	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-B0E483/2020	EPI_ISL_641997	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-AA2A62/2020	EPI_ISL_644106	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-B365F8/2020	EPI_ISL_645422	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B371E4/2020	EPI_ISL_645426	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/CAMC-B36482/2020	EPI_ISL_645429	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/CAMC-B36604/2020	EPI_ISL_645461	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B3D694/2020	EPI_ISL_645489	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/QEUH-B2C9F9/2020	EPI_ISL_646723	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/ALDP-B25F2B/2020	EPI_ISL_646736	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-B2D6E2/2020	EPI_ISL_646880	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/QEUH-A9F215/2020	EPI_ISL_652678	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/QEUH-A9F9B6/2020	EPI_ISL_652690	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/India/HR-NIBG-TF70/2020	EPI_ISL_653888	2020-06-19	Asia / India / Haryana / Faridabad	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-NIBG-TF72/2020	EPI_ISL_653889	2020-05-21	Asia / India / Haryana / Palwal	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-NIBG-TF80/2020	EPI_ISL_653896	2020-05-25	Asia / India / Haryana / Gurugram	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-NIBG-TF88/2020	EPI_ISL_653904	2020-05-26	Asia / India / Haryana / Palwal	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-NIBG-TF89/2020	EPI_ISL_653905	2020-05-26	Asia / India / Haryana / Palwal	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-NIBG-TF95/2020	EPI_ISL_653910	2020-06-19	Asia / India / Haryana / Faridabad	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-NIBG-TF96/2020	EPI_ISL_653911	2020-06-19	Asia / India / Haryana / Faridabad	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-NIBG-TF98/2020	EPI_ISL_653913	2020-06-19	Asia / India / Haryana / Faridabad	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-NIBG-TF99/2020	EPI_ISL_653914	2020-06-19	Asia / India / Haryana / Faridabad	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20	NS8_E110stop results in 9.9% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/England/204481768/2020	EPI_ISL_653990	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.523	GH
hCoV-19/England/QEUH-B401BB/2020	EPI_ISL_657353	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B5649B/2020	EPI_ISL_657370	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/MILK-B56291/2020	EPI_ISL_657396	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B5661D/2020	EPI_ISL_657408	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B56219/2020	EPI_ISL_657413	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-B557FD/2020	EPI_ISL_657440	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/CAMC-B52A06/2020	EPI_ISL_657506	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B55881/2020	EPI_ISL_657513	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B564AA/2020	EPI_ISL_657518	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/MILK-B562EC/2020	EPI_ISL_657519	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B565A7/2020	EPI_ISL_657526	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-B56316/2020	EPI_ISL_657550	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B39425/2020	EPI_ISL_658743	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B3812F/2020	EPI_ISL_658752	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/CAMC-B3816B/2020	EPI_ISL_658769	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/CAMC-B37D0E/2020	EPI_ISL_658787	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B38101/2020	EPI_ISL_658788	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B3873C/2020	EPI_ISL_658797	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B3959B/2020	EPI_ISL_658855	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-B387E1/2020	EPI_ISL_658867	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-B38189/2020	EPI_ISL_658885	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B2345B/2020	EPI_ISL_664604	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/NOTT-11C923/2020	EPI_ISL_665904	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/NOTT-11CFD6/2020	EPI_ISL_665912	2020-11-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/NOTT-11D852/2020	EPI_ISL_665942	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.21	GH
hCoV-19/England/QEUH-A4D049/2020	EPI_ISL_665962	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.471	GH
hCoV-19/England/QEUH-A9BFE5/2020	EPI_ISL_665978	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMC-B79BAC/2020	EPI_ISL_668026	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B7768F/2020	EPI_ISL_668136	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/CAMC-B77722/2020	EPI_ISL_668190	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/Denmark/DCGC-10043/2020	EPI_ISL_669356	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-10057/2020	EPI_ISL_669367	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-10077/2020	EPI_ISL_669381	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-10105/2020	EPI_ISL_669396	2020-11-09	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.8	GH
hCoV-19/Denmark/DCGC-10153/2020	EPI_ISL_669423	2020-11-09	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.8	GH
hCoV-19/Denmark/DCGC-10176/2020	EPI_ISL_669439	2020-11-09	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-10184/2020	EPI_ISL_669442	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-10982/2020	EPI_ISL_670325	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-11008/2020	EPI_ISL_670341	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.8	GH
hCoV-19/Denmark/DCGC-11175/2020	EPI_ISL_670438	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Canada/ON-UHTC-0375/2020	EPI_ISL_671654	2020-10-04	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36.26	GH
hCoV-19/Canada/ON-UHTC-0372/2020	EPI_ISL_671657	2020-10-02	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36.26	GH
hCoV-19/Canada/ON-UHTC-0365/2020	EPI_ISL_671666	2020-10-02	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36.26	GH
hCoV-19/Canada/ON-UHTC-0367/2020	EPI_ISL_671669	2020-10-02	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36	GH
hCoV-19/Australia/NSW1191/2020	EPI_ISL_671673	2020-10-21	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/CAMC-B097AD/2020	EPI_ISL_672982	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-B82CAD/2020	EPI_ISL_675218	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-B8EE32/2020	EPI_ISL_675243	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B8F147/2020	EPI_ISL_675284	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/Sweden/20-53325/2020	EPI_ISL_676536	2020-10-26	Europe / Sweden / Gavleborg	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.36	GH
hCoV-19/France/ARA-25111/2020	EPI_ISL_676552	2020-04-14	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1	GH
hCoV-19/France/ARA-26824/2020	EPI_ISL_676565	2020-04-18	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/USA/CA-IGI-0671/2020	EPI_ISL_677864	2020-07-30	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922 / iVar 1.1 reference aligned			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH1291/2020	EPI_ISL_677922	2020-06-30	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH1301/2020	EPI_ISL_677927	2020-06-30	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH1318/2020	EPI_ISL_677930	2020-06-30	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH500/2020	EPI_ISL_677937	2020-04-15	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.471	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH533/2020	EPI_ISL_677938	2020-04-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.471	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH682/2020	EPI_ISL_677942	2020-04-28	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH719/2020	EPI_ISL_677943	2020-04-05	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.471	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH742/2020	EPI_ISL_677944	2020-04-01	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.471	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1482/2020	EPI_ISL_677969	2020-06-19	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus	NS6_E55stop results in 11.5% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1128/2020	EPI_ISL_677975	2020-06-11	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1117/2020	EPI_ISL_677977	2020-06-11	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MADINAH1120/2020	EPI_ISL_677980	2020-06-11	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MADINAH1127/2020	EPI_ISL_677986	2020-06-11	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Bahrain/341036667/2020	EPI_ISL_682319	2020-11-16	Asia / Bahrain	Human	Original	Nasopharyngeal swab		Illumina	Aviomix v. 1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-12185/2020	EPI_ISL_682366	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-12188/2020	EPI_ISL_682369	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-12271/2020	EPI_ISL_682452	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-12313/2020	EPI_ISL_682494	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.1	GH
hCoV-19/USA/MA-MASPHL-00465/2020	EPI_ISL_693098	2020-04-30	North America / USA / Massachusetts	Human	Original	Nasopharyngeal swab		Illumina MiSeq	BWA 0.7.17; iVar 1.2.2			B.1.22	GH
hCoV-19/England/CAMC-BD1A4B/2020	EPI_ISL_702136	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-BD1A96/2020	EPI_ISL_702152	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-BD43C5/2020	EPI_ISL_702259	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/CAMC-BD1771/2020	EPI_ISL_702264	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/CAMC-BD16ED/2020	EPI_ISL_702292	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-BD20B1/2020	EPI_ISL_702298	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/QEUH-BC402B/2020	EPI_ISL_703453	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-BC4164/2020	EPI_ISL_703474	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/QEUH-BC403A/2020	EPI_ISL_703525	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-BC00A7/2020	EPI_ISL_704758	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-BC04C9/2020	EPI_ISL_704766	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-BC049C/2020	EPI_ISL_704800	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/CAMC-BC0DFB/2020	EPI_ISL_704837	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/MILK-A916DB/2020	EPI_ISL_704866	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A91AEE/2020	EPI_ISL_704869	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B3A6F1/2020	EPI_ISL_704872	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B3C6B3/2020	EPI_ISL_704874	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B3CB69/2020	EPI_ISL_704877	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B3CFA9/2020	EPI_ISL_704879	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B3D5C4/2020	EPI_ISL_704882	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B3DB95/2020	EPI_ISL_704885	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-BC07B1/2020	EPI_ISL_704886	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/NORW-EEE2C/2020	EPI_ISL_704887	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/NORW-EEE3B/2020	EPI_ISL_704890	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/NORW-F642F/2020	EPI_ISL_704892	2020-11-24	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/SHEF-CE99A/2020	EPI_ISL_707004	2020-11-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.24	GH
hCoV-19/England/MILK-BDB64D/2020	EPI_ISL_709644	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BDBCA5/2020	EPI_ISL_709741	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Sweden/20-53344/2020	EPI_ISL_710602	2020-11-03	Europe / Sweden / Halland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with fill from reference and majority wins			B.1.36	GH
hCoV-19/Scotland/QEUH-BEAE61/2020	EPI_ISL_710615	2020-12-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.36.26	GH
hCoV-19/Scotland/QEUH-BEAF22/2020	EPI_ISL_710633	2020-12-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.36.26	GH
hCoV-19/Scotland/QEUH-C14C72/2020	EPI_ISL_710655	2020-12-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/Denmark/DCGC-14686/2020	EPI_ISL_711911	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1	GH
hCoV-19/Denmark/DCGC-14728/2020	EPI_ISL_711936	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-14759/2020	EPI_ISL_711960	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-14780/2020	EPI_ISL_711975	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-14804/2020	EPI_ISL_711995	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.8	GH
hCoV-19/Denmark/DCGC-16604/2020	EPI_ISL_714270	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-C42B32/2020	EPI_ISL_719048	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/MILK-BB1795/2020	EPI_ISL_720036	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/Netherlands/ZH-EMC-910/2020	EPI_ISL_722705	2020-11-03	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.469	GH
hCoV-19/England/CAMB-1BCEAE/2020	EPI_ISL_723905	2020-12-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMB-1BCECC/2020	EPI_ISL_723906	2020-12-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMB-1BCEDB/2020	EPI_ISL_723907	2020-12-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMC-B7AC4E/2020	EPI_ISL_723951	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.39	GH
hCoV-19/Netherlands/GE-RIVM-20544/2020	EPI_ISL_728759	2020-11-24	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/Belgium/rega-0501632/2020	EPI_ISL_734689	2020-05-01	Europe / Belgium / Steenokkerzeel	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1.456	GH
hCoV-19/England/ALDP-C5837D/2020	EPI_ISL_735913	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/Taiwan/NTU37/2020	EPI_ISL_740547	2020-11-26	Asia / Taiwan / Taipei	Human	Vero	Throat swab		Sanger				B.1.459	GH
hCoV-19/Canada/BC-BCCDC-6406/2020	EPI_ISL_740561	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6420/2020	EPI_ISL_740574	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6421/2020	EPI_ISL_740575	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6422/2020	EPI_ISL_740576	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6423/2020	EPI_ISL_740577	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.258.14	GH
hCoV-19/Canada/BC-BCCDC-6425/2020	EPI_ISL_740578	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6426/2020	EPI_ISL_740579	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6427/2020	EPI_ISL_740580	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6428/2020	EPI_ISL_740581	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6429/2020	EPI_ISL_740582	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6430/2020	EPI_ISL_740583	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6440/2020	EPI_ISL_740592	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-6449/2020	EPI_ISL_740597	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/England/PORT-2EE640/2020	EPI_ISL_741719	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/PORT-2F6232/2020	EPI_ISL_741753	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	GH
hCoV-19/England/PORT-2F629C/2020	EPI_ISL_741755	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	GH
hCoV-19/England/QEUH-B7C4AE/2020	EPI_ISL_741780	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-B7D2D0/2020	EPI_ISL_741850	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-B7D373/2020	EPI_ISL_741854	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-B7D434/2020	EPI_ISL_741861	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-B7D452/2020	EPI_ISL_741862	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Denmark/DCGC-17726/2020	EPI_ISL_751169	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH1534/2020	EPI_ISL_751223	2020-04-13	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	gatk bcftools consensus	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1497/2020	EPI_ISL_751228	2020-07-17	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	gatk bcftools consensus			B.1.468	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1661/2020	EPI_ISL_751230	2020-08-23	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	gatk bcftools consensus			B.1.36.10	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1667/2020	EPI_ISL_751233	2020-08-23	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	gatk bcftools consensus			B.1.36.10	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH1505/2020	EPI_ISL_751238	2020-04-14	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	gatk bcftools consensus			B.1	GH
hCoV-19/India/DL-IGIB11304887/2020	EPI_ISL_751245	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based	NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/India/DL-IGIB11303565/2020	EPI_ISL_751277	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-IGIB11304410/2020	EPI_ISL_751278	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/Finland/4LS20E5/2020	EPI_ISL_756001	2020-10-04	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/4LS20F5/2020	EPI_ISL_756002	2020-10-04	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/4LS21F5/2020	EPI_ISL_756003	2020-10-04	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/4LS5A12/2020	EPI_ISL_756004	2020-10-04	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/4LS5D11/2020	EPI_ISL_756005	2020-10-04	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/4LS8A9/2020	EPI_ISL_756007	2020-10-04	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/4LS8D7/2020	EPI_ISL_756008	2020-10-04	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/4LS8E1/2020	EPI_ISL_756009	2020-10-04	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/4LS8E7/2020	EPI_ISL_756010	2020-10-04	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/4LS8F7/2020	EPI_ISL_756011	2020-10-04	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/4LS8H3/2020	EPI_ISL_756012	2020-10-04	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/4LS9F1/2020	EPI_ISL_756013	2020-10-04	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7LS10C3/2020	EPI_ISL_756014	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7LS10E9/2020	EPI_ISL_756015	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7LS11AA7/2020	EPI_ISL_756016	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7LS11AC3/2020	EPI_ISL_756017	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/7LS11AE7/2020	EPI_ISL_756018	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/7LS11AF1/2020	EPI_ISL_756019	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7LS11AF3/2020	EPI_ISL_756020	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/7LS12AB4/2020	EPI_ISL_756021	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7LS13D9/2020	EPI_ISL_756023	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/7LS13H11/2020	EPI_ISL_756024	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7LS15AD9/2020	EPI_ISL_756025	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7LS17D7/2020	EPI_ISL_756026	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7LS22D11/2020	EPI_ISL_756028	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/7LS23E7/2020	EPI_ISL_756029	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7LS2AA1/2020	EPI_ISL_756030	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/7LS2AG5/2020	EPI_ISL_756031	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/7LS2AG8/2020	EPI_ISL_756032	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/7LS3B3/2020	EPI_ISL_756033	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7LS3BG5/2020	EPI_ISL_756034	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7LS3C6/2020	EPI_ISL_756035	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7LS4AD8/2020	EPI_ISL_756036	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7LS4AH2/2020	EPI_ISL_756037	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7LS4AH5/2020	EPI_ISL_756038	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7LS6AC3/2020	EPI_ISL_756040	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/7LS7A11/2020	EPI_ISL_756041	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/7LS7G7/2020	EPI_ISL_756042	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/7LS8B9/2020	EPI_ISL_756043	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/7LS9A9/2020	EPI_ISL_756044	2020-10-07	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/5LS16H9/2020	EPI_ISL_756046	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/5LS17A5/2020	EPI_ISL_756047	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/5LS18A5/2020	EPI_ISL_756048	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/5LS18B5/2020	EPI_ISL_756049	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/5LS18C7/2020	EPI_ISL_756050	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/5LS20C12/2020	EPI_ISL_756051	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/5LS20C8/2020	EPI_ISL_756052	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/5LS20D9/2020	EPI_ISL_756053	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/5LS20H9/2020	EPI_ISL_756054	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/5LS21D9/2020	EPI_ISL_756055	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/5LS21E9/2020	EPI_ISL_756056	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/5LS4B6/2020	EPI_ISL_756057	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/5LS4D11/2020	EPI_ISL_756058	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/5LS4D2/2020	EPI_ISL_756059	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/5LS5A7/2020	EPI_ISL_756060	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/5LS5C11/2020	EPI_ISL_756061	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/5LS5F5/2020	EPI_ISL_756063	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/5LS6B3/2020	EPI_ISL_756065	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/5LS6H7/2020	EPI_ISL_756066	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/5LS7C1/2020	EPI_ISL_756067	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/5LS7G3/2020	EPI_ISL_756068	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/5LS8B3/2020	EPI_ISL_756069	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/5LS9C7/2020	EPI_ISL_756071	2020-10-05	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/6LS10B1/2020	EPI_ISL_756072	2020-10-06	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/6LS11F1/2020	EPI_ISL_756073	2020-10-06	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/6LS12E9/2020	EPI_ISL_756074	2020-10-06	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/6LS13A10/2020	EPI_ISL_756075	2020-10-06	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/6LS13B1/2020	EPI_ISL_756076	2020-10-06	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/6LS17C1/2020	EPI_ISL_756077	2020-10-06	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/6LS18C7/2020	EPI_ISL_756078	2020-10-06	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/6LS18D8/2020	EPI_ISL_756079	2020-10-06	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/6LS1A1/2020	EPI_ISL_756082	2020-10-06	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/6LS1H7/2020	EPI_ISL_756083	2020-10-06	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/6LS3C1/2020	EPI_ISL_756084	2020-10-06	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/6LS3H9/2020	EPI_ISL_756087	2020-10-06	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/6SS7C7/2020	EPI_ISL_756088	2020-09-06	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/6SS7H1/2020	EPI_ISL_756089	2020-09-06	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/3LS10AF1/2020	EPI_ISL_756090	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/3LS10AF3/2020	EPI_ISL_756091	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/3LS12BA11/2020	EPI_ISL_756093	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/3LS12BE5/2020	EPI_ISL_756094	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/3LS17G9/2020	EPI_ISL_756096	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/3LS18AD6/2020	EPI_ISL_756097	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/3LS18AD8/2020	EPI_ISL_756098	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/3LS18AE1/2020	EPI_ISL_756099	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Indonesia/AC-NIHRD-C0057926/2020	EPI_ISL_757287	2020-09-15	Asia / Indonesia / Aceh	Human	Original	Nasopharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection			B.1.468	GH
hCoV-19/Finland/13MR5cB2/2020	EPI_ISL_757290	2020-11-13	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/14MR1cE3/2020	EPI_ISL_757291	2020-11-14	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/14MR1cG3/2020	EPI_ISL_757292	2020-11-14	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/16MR7cA4/2020	EPI_ISL_757296	2020-11-16	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/17MR11cB8/2020	EPI_ISL_757307	2020-11-17	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/18MR1cD7/2020	EPI_ISL_757320	2020-11-18	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/18MR2cA8/2020	EPI_ISL_757323	2020-11-18	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/18MR2cF1/2020	EPI_ISL_757326	2020-11-18	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/18MR2cG9/2020	EPI_ISL_757328	2020-11-18	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/18MR8cE5/2020	EPI_ISL_757333	2020-11-18	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	G
hCoV-19/Finland/1MR5cA1/2020	EPI_ISL_757342	2020-11-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/1LS10H11/2020	EPI_ISL_757343	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/1LS11G3/2020	EPI_ISL_757344	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/1LS11H2/2020	EPI_ISL_757345	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/1LS11H9/2020	EPI_ISL_757346	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/1LS13D7/2020	EPI_ISL_757349	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/1LS14C9/2020	EPI_ISL_757350	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/1LS16D10/2020	EPI_ISL_757351	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/1LS18A9/2020	EPI_ISL_757353	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/1LS1D11/2020	EPI_ISL_757354	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/1LS1D7/2020	EPI_ISL_757355	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/1LS20B8/2020	EPI_ISL_757356	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/1LS20C2/2020	EPI_ISL_757357	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/1LS23E5/2020	EPI_ISL_757358	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/1LS4C1/2020	EPI_ISL_757359	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/1LS5B5/2020	EPI_ISL_757360	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/1LS5B9/2020	EPI_ISL_757361	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/1LS6C1/2020	EPI_ISL_757362	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/1LS6F1/2020	EPI_ISL_757363	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/1LS7B6/2020	EPI_ISL_757364	2020-10-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/1SS14AA1/2020	EPI_ISL_757365	2020-09-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/1SS6AH8/2020	EPI_ISL_757367	2020-09-01	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/20SS11F9/2020	EPI_ISL_757371	2020-09-20	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/20SS16F1/2020	EPI_ISL_757374	2020-09-20	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/20SS17B1/2020	EPI_ISL_757375	2020-09-20	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/20SS20D11/2020	EPI_ISL_757376	2020-09-20	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/21ES22E3/2020	EPI_ISL_757377	2020-08-21	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.22	GH
hCoV-19/Finland/21SS13G9/2020	EPI_ISL_757381	2020-09-21	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/21SS4D3/2020	EPI_ISL_757382	2020-09-21	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/22LS19D5/2020	EPI_ISL_757385	2020-10-22	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/22SS11B3/2020	EPI_ISL_757386	2020-09-22	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/22SS11D7/2020	EPI_ISL_757388	2020-09-22	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/22SS12E11/2020	EPI_ISL_757391	2020-09-22	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/22SS4H11/2020	EPI_ISL_757392	2020-09-22	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Denmark/DCGC-22332/2020	EPI_ISL_758683	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-22343/2020	EPI_ISL_758691	2020-12-14	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-22351/2020	EPI_ISL_758697	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Finland/25LS10CB3/2020	EPI_ISL_759900	2020-10-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/25LS10CE11/2020	EPI_ISL_759901	2020-10-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/25LS10CF5/2020	EPI_ISL_759902	2020-10-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/25LS11CE1/2020	EPI_ISL_759903	2020-10-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/25LS11CF5/2020	EPI_ISL_759904	2020-10-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/25LS11CH3/2020	EPI_ISL_759905	2020-10-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/25LS13D11/2020	EPI_ISL_759906	2020-10-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/25LS13G5/2020	EPI_ISL_759908	2020-10-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/25LS13H1/2020	EPI_ISL_759909	2020-10-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/25LS1DB5/2020	EPI_ISL_759910	2020-10-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/25LS1DC1/2020	EPI_ISL_759911	2020-10-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/25LS7D8/2020	EPI_ISL_759915	2020-10-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/25SS15C3/2020	EPI_ISL_759916	2020-09-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/25SS15G11/2020	EPI_ISL_759917	2020-09-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/25SS22B6/2020	EPI_ISL_759918	2020-09-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/25SS22G3/2020	EPI_ISL_759920	2020-09-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/25SS22H2/2020	EPI_ISL_759921	2020-09-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/25SS6C12/2020	EPI_ISL_759923	2020-09-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/25SS8D9/2020	EPI_ISL_759925	2020-09-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/25SS8E1/2020	EPI_ISL_759926	2020-09-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/25SS9G5/2020	EPI_ISL_759928	2020-09-25	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26LS12CA12/2020	EPI_ISL_759929	2020-10-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26LS13CD3/2020	EPI_ISL_759931	2020-10-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26LS1CF9/2020	EPI_ISL_759932	2020-10-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26LS3DB3/2020	EPI_ISL_759934	2020-10-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26LS4CH5/2020	EPI_ISL_759937	2020-10-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26LS5CD2/2020	EPI_ISL_759938	2020-10-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26LS5CD4/2020	EPI_ISL_759939	2020-10-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26LS7CF1/2020	EPI_ISL_759941	2020-10-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26LS8CC9/2020	EPI_ISL_759943	2020-10-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26SS12D1/2020	EPI_ISL_759945	2020-09-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26SS5F4/2020	EPI_ISL_759947	2020-09-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/26SS5G5/2020	EPI_ISL_759948	2020-09-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26SS6E4/2020	EPI_ISL_759949	2020-09-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26SS6H1/2020	EPI_ISL_759950	2020-09-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26SS7B1/2020	EPI_ISL_759951	2020-09-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26SS7D3/2020	EPI_ISL_759952	2020-09-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26SS9B1/2020	EPI_ISL_759953	2020-09-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26SS9F9/2020	EPI_ISL_759954	2020-09-26	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Indonesia/JI-ITDua-4437NTv/2020	EPI_ISL_759955	2020-04-19	Asia / Indonesia / East Java / Surabaya	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1	GH
hCoV-19/Indonesia/JI-ITDua-5235NTv/2020	EPI_ISL_759956	2020-04-25	Asia / Indonesia / East Java / Surabaya	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1	GH
hCoV-19/Indonesia/JI-ITDua-5392NTv/2020	EPI_ISL_759957	2020-04-27	Asia / Indonesia / East Java / Sidoarjo	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-5748NTv/2020	EPI_ISL_759958	2020-04-29	Asia / Indonesia / East Java / Surabaya	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-16792Nv/2020	EPI_ISL_759960	2020-07-14	Asia / Indonesia / East Java / Surabaya	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14	Gap of 1 nucleotide(s) found at refpos 27792 (FRAMESHIFT confirmed by the submitter)	info	B.1	GH
hCoV-19/Indonesia/JI-ITDua-4134NTv/2020	EPI_ISL_759962	2020-04-17	Asia / Indonesia / East Java / Surabaya	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-12323Nvv/2020	EPI_ISL_759963	2020-06-09	Asia / Indonesia / East Java / Sidoarjo	Human	Vero P2	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-6033NTv/2020	EPI_ISL_759964	2020-04-30	Asia / Indonesia / East Java / Sidoarjo	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1	GH
hCoV-19/Indonesia/JI-ITDua-2858NTv/2020	EPI_ISL_759965	2020-04-09	Asia / Indonesia / East Java / Surabaya	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-1609Nv/2020	EPI_ISL_759967	2020-04-01	Asia / Indonesia / East Java / Tulungagung	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1	GH
hCoV-19/Indonesia/JI-ITDua-28257NT/2020	EPI_ISL_759968	2020-10-02	Asia / Indonesia / East Java / Surabaya	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Norway/5898/2020	EPI_ISL_759979	2020-11-21	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Norway/6142/2020	EPI_ISL_759983	2020-11-29	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/6388/2020	EPI_ISL_759984	2020-12-03	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/6390/2020	EPI_ISL_759985	2020-12-02	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/6421/2020	EPI_ISL_759986	2020-12-02	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/England/CAMC-CB3282/2020	EPI_ISL_760976	2020-12-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/England/QEUH-CAD090/2020	EPI_ISL_760990	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Netherlands/NB-EMC-479/2020	EPI_ISL_763137	2020-08-02	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-481/2020	EPI_ISL_763140	2020-08-04	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-482/2020	EPI_ISL_763141	2020-08-05	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-483/2020	EPI_ISL_763142	2020-08-06	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-485/2020	EPI_ISL_763144	2020-08-07	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-486/2020	EPI_ISL_763145	2020-08-08	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/USA/MA-MGH-03468/2020	EPI_ISL_765850	2020-11-17	North America / USA / Massachusetts	Human	Original	Nasopharynx (NP)		Illumina NovaSeq 6000				B.1.596	GH
hCoV-19/Canada/ON-PHL-20-03662/2020	EPI_ISL_775100	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-20-03663/2020	EPI_ISL_775101	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-20-03745/2020	EPI_ISL_775105	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-20-03750/2020	EPI_ISL_775109	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/ON-PHL-20-03611/2020	EPI_ISL_775119	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03618/2020	EPI_ISL_775125	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03619/2020	EPI_ISL_775126	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03622/2020	EPI_ISL_775129	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03629/2020	EPI_ISL_775135	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03634/2020	EPI_ISL_775138	2020-11	North America / Canada / Ontario	Human	Original	Other		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03639/2020	EPI_ISL_775143	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03640/2020	EPI_ISL_775144	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03641/2020	EPI_ISL_775145	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03642/2020	EPI_ISL_775146	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03644/2020	EPI_ISL_775148	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03645/2020	EPI_ISL_775149	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03646/2020	EPI_ISL_775150	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03649/2020	EPI_ISL_775152	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03667/2020	EPI_ISL_775153	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03668/2020	EPI_ISL_775154	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03669/2020	EPI_ISL_775155	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03670/2020	EPI_ISL_775156	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03676/2020	EPI_ISL_775160	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03685/2020	EPI_ISL_775168	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03686/2020	EPI_ISL_775169	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36	GH
hCoV-19/Canada/ON-PHL-20-03687/2020	EPI_ISL_775170	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03688/2020	EPI_ISL_775171	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03689/2020	EPI_ISL_775172	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-20-03690/2020	EPI_ISL_775173	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-20-03713/2020	EPI_ISL_775195	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-20-03716/2020	EPI_ISL_775198	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina NextSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Germany/HH-hpi-p2476/2020	EPI_ISL_776534	2020-06-19	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1	GH
hCoV-19/Germany/HH-hpi-p2486/2020	EPI_ISL_776543	2020-06-17	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/Germany/TH-hpi-p1690/2020	EPI_ISL_776559	2020-03-18	Europe / Germany / Thuringia	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.22	GH
hCoV-19/England/CAMC-CB75A3/2020	EPI_ISL_777803	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-CDEB0E/2020	EPI_ISL_782270	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-CEB157/2020	EPI_ISL_782309	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-CEB1DF/2020	EPI_ISL_782326	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-B78B70/2020	EPI_ISL_783532	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B77CD8/2020	EPI_ISL_783535	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/USA/TX-HMH-MCoV-19164/2020	EPI_ISL_783664	2020-11-23	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.36	G
hCoV-19/Netherlands/UT-RIVM-20867/2020	EPI_ISL_790836	2020-12-16	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.36.20	GH
hCoV-19/Denmark/DCGC-24440/2020	EPI_ISL_795544	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-24501/2020	EPI_ISL_795583	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-24543/2020	EPI_ISL_795606	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-24544/2020	EPI_ISL_795607	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/MILK-C22A95/2020	EPI_ISL_800644	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-C2293E/2020	EPI_ISL_800673	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/MILK-C228B9/2020	EPI_ISL_800729	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-C1F451/2020	EPI_ISL_800732	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/Turkey/HSGM-1125/2020	EPI_ISL_812776	2020-12-24	Europe / Turkey / Ankara	Human	Orginal	Oropharyngeal swab		Illumina Miseq	Burrows-Wheeler Alignerv.07.17-r1188	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/Egypt/CCHE57357-A-02/2020	EPI_ISL_812784	2020-05-16	Africa / Egypt	Human	Original	Nasal swab		Illumina	BWA v. 0.7.17			B.1	G
hCoV-19/Egypt/CCHE57357-A-08/2020	EPI_ISL_812789	2020-05-07	Africa / Egypt	Human	Original	Nasal swab		Illumina	BWA v. 0.7.17			B.1	GH
hCoV-19/Egypt/CCHE57357-A-09/2020	EPI_ISL_812790	2020-05-14	Africa / Egypt	Human	Original	Nasal swab		Illumina	BWA v. 0.7.17			B.1	O
hCoV-19/Norway/6727/2020	EPI_ISL_813978	2020-12-10	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Insertion of 2 nucleotides found at refpos 28251 (frameshift confirmed by the submitter).	info	B.1.36.21	GH
hCoV-19/Denmark/DCGC-27967/2020	EPI_ISL_816014	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-28133/2020	EPI_ISL_816120	2020-11-09	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.1	GH
hCoV-19/England/PORT-2E8A4A/2020	EPI_ISL_816145	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.8	GH
hCoV-19/Denmark/DCGC-27405/2020	EPI_ISL_817491	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-27410/2020	EPI_ISL_817492	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-26118/2021	EPI_ISL_818682	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-26271/2021	EPI_ISL_818722	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-26307/2021	EPI_ISL_818730	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.24	GH
hCoV-19/Denmark/DCGC-26339/2021	EPI_ISL_818740	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-26345/2021	EPI_ISL_818741	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-26346/2021	EPI_ISL_818742	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-26387/2021	EPI_ISL_818758	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/USA/CA-CSMC285/2020	EPI_ISL_824691	2020-12-08	North America / USA / California / Los Angeles County	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/USA/CA-CSMC290/2020	EPI_ISL_824696	2020-12-19	North America / USA / California / Los Angeles County	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/USA/CA-CSMC302/2020	EPI_ISL_824708	2020-12-19	North America / USA / California / Los Angeles County	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/Germany/un-ChVir21151/2020	EPI_ISL_824786	2020-12-07	Europe / Germany	Human	Original			NextSeq	bowtie2			B.1.36.1	GH
hCoV-19/England/CAMC-ED77D2/2021	EPI_ISL_836745	2021-01-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/SHEF-10D6677/2021	EPI_ISL_842326	2021-01-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.24	GH
hCoV-19/Denmark/DCGC-29624/2020	EPI_ISL_843671	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-29269/2021	EPI_ISL_843700	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (FRAMESHIFT confirmed by submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-29703/2020	EPI_ISL_843750	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-29722/2020	EPI_ISL_843769	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-28378/2021	EPI_ISL_844934	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-28423/2021	EPI_ISL_844935	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-28442/2021	EPI_ISL_844936	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-28457/2021	EPI_ISL_844937	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-28487/2021	EPI_ISL_844938	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-29056/2021	EPI_ISL_844940	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-30508/2021	EPI_ISL_847333	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 4 nucleotide(s) found at refpos 26158 (frameshift confirmed by the submitter). NS3 without BLAST coverage.	info	B.1.471	GH
hCoV-19/Denmark/DCGC-30526/2021	EPI_ISL_847344	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-30741/2021	EPI_ISL_847345	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-30967/2021	EPI_ISL_847346	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-31054/2021	EPI_ISL_847347	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-30651/2021	EPI_ISL_847407	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-30754/2021	EPI_ISL_847426	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.469	GH
hCoV-19/USA/CA-CZB-15869/2020	EPI_ISL_849980	2020-12-06	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal / oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.523	GH
hCoV-19/Denmark/DCGC-31260/2021	EPI_ISL_855640	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.469	GH
hCoV-19/Denmark/DCGC-31335/2021	EPI_ISL_855715	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/India/KA-NIMH-SEQ-69/2021	EPI_ISL_860189	2021-01-02	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/KA-NIMH-SEQ-70/2021	EPI_ISL_860190	2021-01-01	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)			B.1.36	GH
hCoV-19/Norway/7408/2020	EPI_ISL_860229	2020-12-28	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.1	GH
hCoV-19/Norway/7409/2020	EPI_ISL_860230	2020-12-30	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.1	GH
hCoV-19/Norway/7445/2020	EPI_ISL_860236	2020-12-29	Europe / Norway / Agder	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/0403/2021	EPI_ISL_860269	2021-01-09	Europe / Norway / Viken	Human	original	nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/7542/2020	EPI_ISL_860270	2020-12-11	Europe / Norway / Vestfold og Telemark	Human	original	nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/0439/2021	EPI_ISL_860274	2021-01-07	Europe / Norway / Vestland	Human	original	nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/7393/2020	EPI_ISL_860292	2020-12-14	Europe / Norway / Innlandet	Human	original	nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/7413/2020	EPI_ISL_860293	2020-12-25	Europe / Norway / Viken	Human	original	nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.1	GH
hCoV-19/Norway/0141/2021	EPI_ISL_860295	2021-01-04	Europe / Norway / Agder	Human	original	unknown		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Malaysia/HPUPM_ML6117/2020	EPI_ISL_861722	2020-10-26	Asia / Malaysia	Human	Original			Illumina Miseq	MEGAHIT v1.2.19			B.1.36.16	GH
hCoV-19/England/NORW-223524/2021	EPI_ISL_866598	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/TFCI-26FF484/2020	EPI_ISL_868933	2020-12-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/Indonesia/YO-UGM-10013/2020	EPI_ISL_872190	2020-12-27	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina Miseq	UGENE v.37			B.1.459	GH
hCoV-19/Indonesia/YO-UGM-110279/2020	EPI_ISL_877126	2020-09-07	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.470	GH
hCoV-19/Indonesia/YO-UGM-110283/2020	EPI_ISL_877127	2020-09-07	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.470	GH
hCoV-19/Indonesia/YO-UGM-110434/2020	EPI_ISL_877128	2020-09-09	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.470	GH
hCoV-19/Indonesia/YO-UGM-110286/2020	EPI_ISL_877129	2020-09-07	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.470	GH
hCoV-19/Indonesia/YO-UGM-110282/2020	EPI_ISL_877130	2020-09-07	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.470	GH
hCoV-19/Indonesia/YO-UGM-110280/2020	EPI_ISL_877131	2020-09-07	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.470	GH
hCoV-19/USA/AL-HGSC-JEQX/2020	EPI_ISL_877269	2020-11-10	North America / USA / Alabama / Etowah County	Human	Original			Illumina NovaSeq 6000	BWA mem v0.7.17-r1188 iVar v1.3			B.1.36.26	GH
hCoV-19/England/ALDP-10B61F4/2021	EPI_ISL_885510	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-10B5E67/2021	EPI_ISL_885518	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-10B5D00/2021	EPI_ISL_885527	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-10B67B6/2021	EPI_ISL_885539	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-10B5F28/2021	EPI_ISL_885540	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-10B5FEC/2021	EPI_ISL_885590	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Indonesia/YO-UGM-109996/2020	EPI_ISL_890186	2020-09-04	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.459	GH
hCoV-19/Indonesia/YO-UGM-109997/2020	EPI_ISL_890187	2020-09-04	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.459	GH
hCoV-19/Egypt/CUNCI-HGC12I037/2021	EPI_ISL_890220	2021-01-09	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.466	GH
hCoV-19/Egypt/CUNCI-HGC12I039/2021	EPI_ISL_890222	2021-01-09	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1	GH
hCoV-19/Egypt/CUNCI-HGC12I041/2021	EPI_ISL_890223	2021-01-09	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1	G
hCoV-19/Egypt/CUNCI-HGC12I042/2021	EPI_ISL_890224	2021-01-09	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.466	GH
hCoV-19/Egypt/CUNCI-HGC12I052/2021	EPI_ISL_890230	2021-01-09	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1	GH
hCoV-19/Japan/PG-12006/2020	EPI_ISL_898837	2020-11-13	Asia / Japan / Mie	Human	Original			illumina NextSeq500	SKESA v. 2.3.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/PG-12007/2020	EPI_ISL_898838	2020-11-13	Asia / Japan / Mie	Human	Original			illumina NextSeq500	A5-miseq v. 20140604	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/PG-12008/2020	EPI_ISL_898839	2020-11-15	Asia / Japan / Mie	Human	Original			illumina NextSeq500	A5-miseq v. 20140604	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/PG-12009/2020	EPI_ISL_898840	2020-11-15	Asia / Japan / Mie	Human	Original			illumina NextSeq500	SKESA v. 2.3.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/PG-12011/2020	EPI_ISL_898842	2020-11-16	Asia / Japan / Mie	Human	Original			illumina NextSeq500	SKESA v. 2.3.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/PG-12012/2020	EPI_ISL_898843	2020-11-16	Asia / Japan / Mie	Human	Original			illumina NextSeq500	A5-miseq v. 20140604	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/PG-9866/2020	EPI_ISL_902575	2020-09-03	Asia / Japan / Nara	Human	Original			illumina NextSeq500	bwa v. 0.7.13-r1126, picard v. 2.10.10, GATK v. 3.8.0, VarScan v. 2.4.3, VCFtools v. 0.1.12b, SKESA v. 2.3.0, A5-miseq v. 20140604			B.1.36	GH
hCoV-19/Indonesia/YO-UGM-124768/2020	EPI_ISL_902737	2020-12-23	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.468	GH
hCoV-19/Indonesia/YO-UGM-124760/2020	EPI_ISL_902749	2020-12-23	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.468	GH
hCoV-19/Finland/17J26CC3/2020	EPI_ISL_902758	2020-12-17	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/1T3DA1_S159/2021	EPI_ISL_902764	2021-01-01	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26MR5CA10_S243/2020	EPI_ISL_902773	2020-11-26	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26MR5CA12_S249/2020	EPI_ISL_902774	2020-11-26	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26MR5CE11_S245/2020	EPI_ISL_902776	2020-11-26	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26MR5CH11_S248/2020	EPI_ISL_902779	2020-11-26	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26MR7CA2_S239/2020	EPI_ISL_902780	2020-11-26	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26MR7CC1_S240/2020	EPI_ISL_902783	2020-11-26	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26MR7CG1_S233/2020	EPI_ISL_902788	2020-11-26	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/26MR7CH1_S238/2020	EPI_ISL_902789	2020-11-26	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Sweden/21-50075/2021	EPI_ISL_913309	2021-01-03	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with fill from reference and majority wins	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Japan/IC-0745/2021	EPI_ISL_918136	2021-01-22	Asia / Japan	Human	Original		COVID-19 positive case who entered from Nepal.	Illumina NextSeq500	SKESA v. 2.3.0	Insertion of 6 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/IC-0746/2021	EPI_ISL_918137	2021-01-22	Asia / Japan	Human	Original		COVID-19 positive case who entered from India.	Illumina NextSeq500	SKESA v. 2.3.0	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Japan/IC-0753/2021	EPI_ISL_918144	2021-01-18	Asia / Japan	Human	Original		COVID-19 positive case who entered from Hong Kong.	Illumina NextSeq500	A5-miseq v. 20140604	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Japan/IC-0754/2021	EPI_ISL_918145	2021-01-18	Asia / Japan	Human	Original		COVID-19 positive case who entered from Hong Kong.	Illumina NextSeq500	SKESA v. 2.3.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Japan/IC-0755/2021	EPI_ISL_918146	2021-01-18	Asia / Japan	Human	Original		COVID-19 positive case who entered from Hong Kong.	Illumina NextSeq500	SKESA v. 2.3.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Japan/IC-0756/2021	EPI_ISL_918147	2021-01-18	Asia / Japan	Human	Original		COVID-19 positive case who entered from Hong Kong.	Illumina NextSeq500	BWA v. 0.7.13-r1126, picard v. 2.10.10, GATK v. 3.8.0, VarScan v. 2.4.3, VCFtools v. 0.1.12b, SKESA v. 2.3.0, A5-miseq v. 20140604	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Japan/IC-0757/2021	EPI_ISL_918148	2021-01-18	Asia / Japan	Human	Original		COVID-19 positive case who entered from Hong Kong.	Illumina NextSeq500	SKESA v. 2.3.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Japan/IC-0758/2021	EPI_ISL_918149	2021-01-18	Asia / Japan	Human	Original		COVID-19 positive case who entered from Hong Kong.	Illumina NextSeq500	SKESA v. 2.3.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Japan/IC-0759/2021	EPI_ISL_918150	2021-01-18	Asia / Japan	Human	Original		COVID-19 positive case who entered from Hong Kong.	Illumina NextSeq500	SKESA v. 2.3.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Japan/IC-0760/2021	EPI_ISL_918151	2021-01-18	Asia / Japan	Human	Original		COVID-19 positive case who entered from Hong Kong.	Illumina NextSeq500	SKESA v. 2.3.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Japan/IC-0761/2021	EPI_ISL_918152	2021-01-18	Asia / Japan	Human	Original		COVID-19 positive case who entered from Hong Kong.	Illumina NextSeq500	SKESA v. 2.3.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Japan/IC-0762/2021	EPI_ISL_918153	2021-01-18	Asia / Japan	Human	Original		COVID-19 positive case who entered from Hong Kong.	Illumina NextSeq500	BWA v. 0.7.13-r1126, picard v. 2.10.10, GATK v. 3.8.0, VarScan v. 2.4.3, VCFtools v. 0.1.12b, SKESA v. 2.3.0, A5-miseq v. 20140604	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Japan/IC-0763/2021	EPI_ISL_918154	2021-01-21	Asia / Japan	Human	Original		COVID-19 positive case who entered from Hong Kong.	Illumina NextSeq500	SKESA v. 2.3.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Japan/IC-0766/2021	EPI_ISL_918157	2021-01-26	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina iSeq	SKESA v. 2.3.0	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/England/LOND-1325306/2020	EPI_ISL_920460	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36	GH
hCoV-19/England/LOND-13255C4/2020	EPI_ISL_920491	2020-11-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.469	GH
hCoV-19/Denmark/DCGC-35276/2021	EPI_ISL_926416	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-35295/2021	EPI_ISL_926435	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-35398/2020	EPI_ISL_926539	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-35485/2021	EPI_ISL_926626	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-36586/2020	EPI_ISL_927727	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-36594/2021	EPI_ISL_927735	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.469	GH
hCoV-19/Denmark/DCGC-36629/2021	EPI_ISL_927770	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-36644/2021	EPI_ISL_927785	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.469	GH
hCoV-19/Denmark/DCGC-36655/2021	EPI_ISL_927796	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-36657/2021	EPI_ISL_927798	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-36744/2021	EPI_ISL_927885	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-36772/2021	EPI_ISL_927913	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-36780/2021	EPI_ISL_927921	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Switzerland/BS-UHB-42502098/2020	EPI_ISL_931124	2020-10-24	Europe / Switzerland / Basel-Land / Binningen	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	In-house pipelIne COVGAP			B.1.36	GH
hCoV-19/Switzerland/BS-UHB-42503057/2020	EPI_ISL_931166	2020-10-25	Europe / Switzerland / Basel-Stadt / Riehen	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	In-house pipelIne COVGAP	NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.1.39	GH
hCoV-19/Switzerland/BS-UHB-42504267/2020	EPI_ISL_931182	2020-10-26	Europe / Switzerland / Basel-Stadt / Basel	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	In-house pipelIne COVGAP			B.1.36.17	GH
hCoV-19/Switzerland/BS-UHB-42504608/2020	EPI_ISL_931193	2020-10-26	Europe / Switzerland / Basel-Stadt / Basel	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	In-house pipelIne COVGAP	Stretches of NNNs (1.23% of overall sequence).	warn	B.1.36	GV
hCoV-19/Cambodia/180217/2020	EPI_ISL_933780	2020-12-31	Asia / Cambodia	Human	Original			Nanopore MinION	Geneious Prime			B.1.36.16	GH
hCoV-19/Cambodia/180346/2020	EPI_ISL_933781	2020-12-31	Asia / Cambodia	Human	Original			Nanopore MinION	Geneious Prime			B.1.36.16	GH
hCoV-19/Cambodia/180348/2020	EPI_ISL_933782	2020-12-31	Asia / Cambodia	Human	Original			Nanopore MinION	Geneious Prime			B.1.36.16	GH
hCoV-19/Cambodia/180575/2020	EPI_ISL_933783	2020-12-31	Asia / Cambodia	Human	Original			Nanopore MinION	Geneious Prime			B.1.36.16	GH
hCoV-19/England/MILK-116BB95/2021	EPI_ISL_938588	2021-01-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Belgium/UZA-UA-3226/2021	EPI_ISL_940893	2021-01-18	Europe / Belgium / Borgerhout	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/Netherlands/NH-RIVM-10860/2021	EPI_ISL_943104	2021-01-22	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Bosnia and Herzegovina/VFS-UNSA-LMGFI022/2021	EPI_ISL_955229	2021-01-21	Europe / Bosnia and Herzegovina / Prnjavor	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION	ARTIC Network			B.1.36.1	GH
hCoV-19/Indonesia/JI-ITDua-8967NTv/2020	EPI_ISL_956270	2020-05-12	Asia / Indonesia / East Java / Surabaya	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-11000NTv/2020	EPI_ISL_956271	2020-05-18	Asia / Indonesia / East Java / Surabaya	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-12009NTv/2020	EPI_ISL_956273	2020-05-23	Asia / Indonesia / East Java / Surabaya	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-12663Nv/2020	EPI_ISL_956274	2020-06-13	Asia / Indonesia / East Java / Sidoarjo	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.456	GH
hCoV-19/Indonesia/JI-ITDua-13686NTv/2020	EPI_ISL_956276	2020-06-24	Asia / Indonesia / East Java / Sidoarjo	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-17563Nv/2020	EPI_ISL_956277	2020-07-20	Asia / Indonesia / East Java / Surabaya	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-18214NTv/2020	EPI_ISL_956278	2020-07-24	Asia / Indonesia / East Java / Sidoarjo	Human	Vero P1	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-35767NT/2020	EPI_ISL_956279	2020-12-30	Asia / Indonesia / East Java / Sidoarjo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14	Gap of 1 nucleotide(s) found at refpos 28254 (FRAMESHIFT confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-36208NT/2021	EPI_ISL_956280	2021-01-04	Asia / Indonesia / East Java / Surabaya	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14	Gap of 1 nucleotide(s) found at refpos 28254 (FRAMESHIFT confirmed by the submitter).	info	B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-36471NT/2021	EPI_ISL_956281	2021-01-04	Asia / Indonesia / East Java / Sidoarjo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14	Gap of 1 nucleotide(s) found at refpos 28254 (FRAMESHIFT confirmed by the submitter). NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Malaysia/IMR_WC39298/2021	EPI_ISL_962207	2021-01-17	Asia / Malaysia	Human	Original			Illumina NextSeq 500		Insertion of 23 nucleotides when compared to the reference sequence.	info	B.1.36.8	GH
hCoV-19/Norway/2027/2021	EPI_ISL_964958	2021-01-19	Europe / Norway / Oslo	Human	original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36.21	GH
hCoV-19/Norway/1717/2021	EPI_ISL_964972	2021-01-25	Europe / Norway / Viken	Human	original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/1756/2021	EPI_ISL_964975	2021-01-25	Europe / Norway / Viken	Human	original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/1885/2021	EPI_ISL_964992	2021-01-27	Europe / Norway / Viken	Human	original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/1900/2021	EPI_ISL_964993	2021-01-27	Europe / Norway / Viken	Human	original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/1354/2021	EPI_ISL_964996	2021-01-20	Europe / Norway / Innlandet	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36	GH
hCoV-19/Norway/1355/2021	EPI_ISL_964997	2021-01-20	Europe / Norway / Innlandet	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4887/2020	EPI_ISL_970520	2020-09-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4888/2020	EPI_ISL_970522	2020-09-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Denmark/DCGC-39433/2021	EPI_ISL_970820	2021-02-01	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.1	GH
hCoV-19/Denmark/DCGC-39462/2021	EPI_ISL_970852	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Canada/BC-BCCDC-5748/2020	EPI_ISL_974092	2020-10-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-6096/2020	EPI_ISL_974098	2020-10-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6262/2020	EPI_ISL_974300	2020-10-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6917/2020	EPI_ISL_974306	2020-10-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-6922/2020	EPI_ISL_974309	2020-10-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5719/2020	EPI_ISL_974312	2020-10-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6530/2020	EPI_ISL_974324	2020-10-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6931/2020	EPI_ISL_974333	2020-10-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6939/2020	EPI_ISL_974366	2020-10-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5727/2020	EPI_ISL_974370	2020-10-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5991/2020	EPI_ISL_974383	2020-10-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6145/2020	EPI_ISL_974386	2020-10-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6147/2020	EPI_ISL_974388	2020-10-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6148/2020	EPI_ISL_974389	2020-10-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6277/2020	EPI_ISL_974394	2020-10-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7513/2020	EPI_ISL_975502	2020-11-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7784/2020	EPI_ISL_975600	2020-11-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7985/2020	EPI_ISL_975605	2020-11-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9854/2020	EPI_ISL_975616	2020-11-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10413/2020	EPI_ISL_975619	2020-11-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7787/2020	EPI_ISL_975621	2020-11-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7993/2020	EPI_ISL_975631	2020-11-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7994/2020	EPI_ISL_975632	2020-11-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7996/2020	EPI_ISL_975634	2020-11-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8146/2020	EPI_ISL_975636	2020-11-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8225/2020	EPI_ISL_975640	2020-11-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9184/2020	EPI_ISL_975643	2020-11-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9188/2020	EPI_ISL_975644	2020-11-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-10418/2020	EPI_ISL_975655	2020-11-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10419/2020	EPI_ISL_975656	2020-11-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10426/2020	EPI_ISL_975660	2020-11-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7799/2020	EPI_ISL_975661	2020-11-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7998/2020	EPI_ISL_975664	2020-11-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8002/2020	EPI_ISL_975668	2020-11-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8151/2020	EPI_ISL_975670	2020-11-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8523/2020	EPI_ISL_975683	2020-11-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8524/2020	EPI_ISL_975684	2020-11-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8526/2020	EPI_ISL_975686	2020-11-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9190/2020	EPI_ISL_975690	2020-11-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9191/2020	EPI_ISL_975691	2020-11-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9192/2020	EPI_ISL_975692	2020-11-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9193/2020	EPI_ISL_975693	2020-11-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9922/2020	EPI_ISL_975694	2020-11-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9613/2020	EPI_ISL_976807	2020-12-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9715/2020	EPI_ISL_976814	2020-12-27	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9716/2020	EPI_ISL_976831	2020-12-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9718/2020	EPI_ISL_976833	2020-12-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/USA/MA-Broad_CRSP-00373/2021	EPI_ISL_976955	2021-01-08	North America / USA / Massachusetts	Human	Original			Illumina NovaSeq 6000	Broad viral-ngs v. v2.1.19			B.1.36.1	GH
hCoV-19/USA/CA-CZB-16798/2020	EPI_ISL_979025	2020-12-09	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.36.8	GH
hCoV-19/England/MILK-11F28C9/2021	EPI_ISL_980177	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Canada/ON-PPS-21012021_0084/2021	EPI_ISL_982789	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0022/2021	EPI_ISL_982790	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0044/2021	EPI_ISL_982792	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0055/2021	EPI_ISL_982793	2021-01-18	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0049/2021	EPI_ISL_982794	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0037/2021	EPI_ISL_982800	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0168/2021	EPI_ISL_982804	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0024/2021	EPI_ISL_982807	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0006/2021	EPI_ISL_982810	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0345/2021	EPI_ISL_982815	2021-01-20	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/ON-PPS-21012021_0039/2021	EPI_ISL_982816	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0334/2021	EPI_ISL_982818	2021-01-20	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0018/2021	EPI_ISL_982825	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0059/2021	EPI_ISL_982828	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0038/2021	EPI_ISL_982830	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0029/2021	EPI_ISL_982832	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0061/2021	EPI_ISL_982836	2021-01-18	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PPS-21012021_0346/2021	EPI_ISL_982839	2021-01-20	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/ON-PPS-21012021_0082/2021	EPI_ISL_982840	2021-01-19	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/England/ALDP-10E9C60/2021	EPI_ISL_992050	2021-01-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/USA/NY-PRL-2021_0202_02E04/2021	EPI_ISL_994829	2021-01-30	North America / USA / New York / New York City	Human	Original	Nasopharyngeal swab		Illumina Miseq/NextSeq	bwa mem	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Finland/HEL-13-207/2021	EPI_ISL_995977	2021-01-21	Europe / Finland / Uusimaa	Human	Original			Illumina Miseq	BWA-MEM			B.1.36	GH
hCoV-19/Finland/HUS-41-102/2021	EPI_ISL_995983	2021-01-12	Europe / Finland / Uusimaa	Human	Original			Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HUS-41-73/2021	EPI_ISL_995986	2021-01-19	Europe / Finland / Uusimaa	Human	Original			Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HUS-41-78/2021	EPI_ISL_995991	2021-01-19	Europe / Finland / Uusimaa	Human	Original			Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HUS-41-80/2021	EPI_ISL_995993	2021-01-13	Europe / Finland / Uusimaa	Human	Original			Illumina Miseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Switzerland/AG-ETHZ-460977/2021	EPI_ISL_1003134	2021-01-18	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BE-ETHZ-460239/2021	EPI_ISL_1003142	2021-01-18	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BE-ETHZ-460238/2021	EPI_ISL_1003145	2021-01-18	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BE-ETHZ-461055/2021	EPI_ISL_1003148	2021-01-18	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BE-ETHZ-461051/2021	EPI_ISL_1003153	2021-01-18	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BE-ETHZ-461053/2021	EPI_ISL_1003154	2021-01-18	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BE-ETHZ-460363/2021	EPI_ISL_1003400	2021-01-21	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.469	GH
hCoV-19/Switzerland/BE-ETHZ-470534/2021	EPI_ISL_1003476	2021-01-22	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BS-ETHZ-431508/2020	EPI_ISL_1004762	2020-12-30	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/France/IDF_PSL_384/2020	EPI_ISL_1015121	2020-06-09	Europe / France / Ile-de-France	Human	Original	Nasopharyngeal swab		Illumina NextSeq				B.1.466.1	GH
hCoV-19/Denmark/DCGC-42378/2021	EPI_ISL_1022656	2021-02-08	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (FRAMESHIFT confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-43264/2021	EPI_ISL_1023556	2021-02-08	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (FRAMESHIFT confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-43315/2021	EPI_ISL_1023627	2021-02-01	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (FRAMESHIFT confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-44531/2021	EPI_ISL_1024909	2021-02-01	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-252/2020	EPI_ISL_1034590	2020-10-14	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-262/2020	EPI_ISL_1034594	2020-09-13	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36.18	GH
hCoV-19/Hong Kong/HKU-201216-282/2020	EPI_ISL_1034599	2020-10-06	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-289/2020	EPI_ISL_1034605	2020-10-26	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-291/2020	EPI_ISL_1034607	2020-10-30	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36.8	GH
hCoV-19/Hong Kong/HKU-201216-300/2020	EPI_ISL_1034610	2020-11-19	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36.27	GH
hCoV-19/Hong Kong/HKU-201216-305/2020	EPI_ISL_1034611	2020-11-20	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-306/2020	EPI_ISL_1034612	2020-11-20	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36.27	GH
hCoV-19/Hong Kong/HKU-201216-307/2020	EPI_ISL_1034613	2020-11-21	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-308/2020	EPI_ISL_1034614	2020-11-21	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-312/2020	EPI_ISL_1034615	2020-11-21	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-313/2020	EPI_ISL_1034616	2020-11-22	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-314/2020	EPI_ISL_1034617	2020-11-22	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-316/2020	EPI_ISL_1034618	2020-11-21	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-341/2020	EPI_ISL_1034622	2020-11-24	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-342/2020	EPI_ISL_1034623	2020-11-24	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36.27	GH
hCoV-19/Hong Kong/HKU-201216-344/2020	EPI_ISL_1034624	2020-11-25	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-345/2020	EPI_ISL_1034625	2020-11-25	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-353/2020	EPI_ISL_1034630	2020-11-27	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36.27	GH
hCoV-19/Hong Kong/HKU-201216-355/2020	EPI_ISL_1034631	2020-11-28	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36.27	GH
hCoV-19/Hong Kong/HKU-201216-356/2020	EPI_ISL_1034632	2020-11-28	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36.27	GH
hCoV-19/Hong Kong/HKU-201216-362/2020	EPI_ISL_1034633	2020-11-28	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36.27	GH
hCoV-19/Hong Kong/HKU-201216-367/2020	EPI_ISL_1034634	2020-11-29	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-368/2020	EPI_ISL_1034635	2020-11-29	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-369/2020	EPI_ISL_1034636	2020-11-29	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-372/2020	EPI_ISL_1034637	2020-11-27	Asia / Hong Kong	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Hong Kong/HKU-201216-015/2020	EPI_ISL_1034641	2020-06-25	Asia / Hong Kong	Human	Original	Nasopharyngeal swab and throat swab		Nanopore MinION				B.1	GH
hCoV-19/Hong Kong/HKU-201216-371/2020	EPI_ISL_1034655	2020-11-27	Asia / Hong Kong	Human	Original	Nasopharyngeal swab and throat swab		Nanopore MinION				B.1.36.27	GH
hCoV-19/Hong Kong/HKU-201216-188/2020	EPI_ISL_1034656	2020-08-08	Asia / Hong Kong	Human	Original	Nasopharyngeal aspirate		Nanopore MinION				B.1.36	GH
hCoV-19/Norway/7065/2020	EPI_ISL_1040153	2020-12-19	Europe / Norway / Vestland	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/England/CAMC-11AC3FA/2021	EPI_ISL_1047528	2021-01-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.469	GH
hCoV-19/Switzerland/BL-ETHZ-481375/2021	EPI_ISL_1059525	2021-01-04	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BL-ETHZ-481559/2021	EPI_ISL_1059529	2021-01-05	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Malaysia/MGI-MGI43/2021	EPI_ISL_1059900	2021-01-05	Asia / Malaysia / Selangor	Human	Original			Illumina Miseq	MEGAHIT v1.2.9			B.1.36.16	GH
hCoV-19/Malaysia/MGI-MGI52/2021	EPI_ISL_1059901	2021-01-07	Asia / Malaysia / Selangor	Human	Original			Illumina Miseq	MEGAHIT v1.2.10			B.1.36.16	GH
hCoV-19/Malaysia/MGI-DNALAB13/2020	EPI_ISL_1059902	2020-11-04	Asia / Malaysia / Negeri Sembilan	Human	Original			Illumina Miseq	MEGAHIT v1.2.11			B.1.36.16	GH
hCoV-19/India/CH-ICMR-44271/2020	EPI_ISL_1069217	2020-08-09	Asia / India / Chandigarh	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/Turkey/HSGM-4040/2021	EPI_ISL_1073804	2021-02-11	Europe / Turkey	Human	Orginal	Oropharyngeal swab		Illumina Miseq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.469	GH
hCoV-19/Turkey/HSGM-4130/2021	EPI_ISL_1073810	2021-02-11	Europe / Turkey	Human	Orginal	Oropharyngeal swab		Illumina Miseq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.36.1	GH
hCoV-19/Finland/HEL-18-V175/2021	EPI_ISL_1082201	2021-01-23	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-14-397/2021	EPI_ISL_1082207	2021-01-24	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.523	GH
hCoV-19/Finland/HEL-14-398/2021	EPI_ISL_1082208	2021-01-24	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-14-400/2021	EPI_ISL_1082209	2021-01-24	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-15-186/2021	EPI_ISL_1082211	2021-01-14	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-15-252/2021	EPI_ISL_1082216	2021-01-14	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-15-408/2021	EPI_ISL_1082220	2021-01-20	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-15-410/2021	EPI_ISL_1082222	2021-01-14	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-15-412/2021	EPI_ISL_1082223	2021-01-16	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-15-416/2021	EPI_ISL_1082224	2021-01-15	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-17-487/2021	EPI_ISL_1082226	2021-01-25	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-17-492/2021	EPI_ISL_1082227	2021-01-25	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-17-497/2021	EPI_ISL_1082229	2021-01-25	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-17-501/2021	EPI_ISL_1082230	2021-01-25	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-17-502/2021	EPI_ISL_1082231	2021-01-25	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1	GH
hCoV-19/Finland/HEL-17-508/2021	EPI_ISL_1082232	2021-01-25	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-17-529/2021	EPI_ISL_1082234	2021-01-25	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-18-V155/2021	EPI_ISL_1082238	2021-01-23	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-18-V168/2021	EPI_ISL_1082241	2021-01-24	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/HEL-18-V169/2021	EPI_ISL_1082242	2021-01-22	Europe / Finland / Uusimaa	Human	Original			Illumina MiSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/USA/PA-CDC-QDX21487958/2021	EPI_ISL_1087161	2021-01-24	North America / USA / Pennsylvania	Human	Original	Nasal swab		Illumina MiSeq	BWA v.7.12			B.1	GH
hCoV-19/Netherlands/ZuidHolland_56/2020	EPI_ISL_422924	2020-03-23	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_77/2020	EPI_ISL_422945	2020-03-26	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZuidHolland_89/2020	EPI_ISL_422956	2020-03-27	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Turkey/HSGM-8968/2020	EPI_ISL_429861	2020-03-22	Europe / Turkey / Ankara	Human	Original	Sputum		Illumina MiSeq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.36	GH
hCoV-19/Turkey/HSGM-4236/2020	EPI_ISL_429866	2020-03-16	Europe / Turkey / Afyon	Human	Original	Sputum		Illumina MiSeq	Burrows-Wheeler Alignerv.07.17-r1188			B.1	GH
hCoV-19/Turkey/HSGM-4505/2020	EPI_ISL_429867	2020-03-17	Europe / Turkey / Balikesir	Human	Original	Sputum		Illumina MiSeq	Burrows-Wheeler Alignerv.07.17-r1188			B.1	GH
hCoV-19/Turkey/HSGM-4701/2020	EPI_ISL_429869	2020-03-17	Europe / Turkey / Konya	Human	Original	Sputum		Illumina MiSeq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.36	GH
hCoV-19/Turkey/HSGM-10241/2020	EPI_ISL_429871	2020-03-23	Europe / Turkey / Ankara	Human	Original	Sputum		Illumina MiSeq	Burrows-Wheeler Alignerv.07.17-r1188			B.1	GH
hCoV-19/Egypt/NRC-03/2020	EPI_ISL_430819	2020-03-18	Africa / Egypt	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 12			B.1	GH
hCoV-19/Belgium/UGent-33/2020	EPI_ISL_434351	2020-03-28	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1	GH
hCoV-19/Belgium/UGent-36/2020	EPI_ISL_434354	2020-03-27	Europe / Belgium / Ghent	Human	Original			Nanopore MinION	Artic network			B.1.22	GH
hCoV-19/Indonesia/JI-ITD-3590NT/2020	EPI_ISL_437188	2020-04-14	Asia / Indonesia / East Java / Surabaya	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 8 and Genetyx Ver. 14			B.1.470	GH
hCoV-19/Austria/Graz-MUG3/2020	EPI_ISL_437199	2020-03-31	Europe / Austria / Styria	Human	Original	lung tissue	primary patient sample	Ion Torrent				B.1.465	O
hCoV-19/England/CAMB-76A16/2020	EPI_ISL_438454	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/BRIS-122395/2020	EPI_ISL_440745	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/CAMB-7C412/2020	EPI_ISL_441584	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/Wales/PHWC-34425/2020	EPI_ISL_446920	2020-04-16	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1	G
hCoV-19/Jordan/SR-0335/2020	EPI_ISL_450187	2020-04-08	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2			B.1	GH
hCoV-19/Scotland/EDB5370/2020	EPI_ISL_457010	2020-03-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/Scotland/EDB5376/2020	EPI_ISL_457012	2020-03-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	GH
hCoV-19/England/SHEF-C8857/2020	EPI_ISL_457631	2020-05-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/Netherlands/Flevoland_5/2020	EPI_ISL_460638	2020-04-01	Europe / Netherlands / Flevoland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_15/2020	EPI_ISL_460651	2020-04-03	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_19/2020	EPI_ISL_460655	2020-03-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_20/2020	EPI_ISL_460656	2020-03-19	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_23/2020	EPI_ISL_460659	2020-04-17	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_526/2020	EPI_ISL_460699	2020-03-27	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Belgium/HJ-0328338/2020	EPI_ISL_462192	2020-03-28	Europe / Belgium / Asper	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.22	GH
hCoV-19/India/GJ-GBRC184/2020	EPI_ISL_469024	2020-05-27	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC186b/2020	EPI_ISL_469028	2020-06-03	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC189/2020	EPI_ISL_469032	2020-06-02	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12	NS3_G254stop results in 8.0% truncation of the protein sequence.	info	B.1	GH
hCoV-19/India/GJ-GBRC190/2020	EPI_ISL_469033	2020-06-05	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC192/2020	EPI_ISL_469036	2020-06-05	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC196/2020	EPI_ISL_469041	2020-06-08	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC199/2020	EPI_ISL_469044	2020-06-08	Asia / India / Gujarat / Nadiad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC201a/2020	EPI_ISL_469046	2020-06-08	Asia / India / Gujarat / Mahemdavad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/Wales/PHWC-164519/2020	EPI_ISL_474189	2020-04-29	Europe / United Kingdom / Wales	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1	G
hCoV-19/England/SHEF-C870F/2020	EPI_ISL_475409	2020-04-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	O
hCoV-19/England/SHEF-CEC37/2020	EPI_ISL_475471	2020-04-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	O
hCoV-19/India/DL-NCDC2283-CSIR-IGIB/2020	EPI_ISL_482555	2020-05-19	Asia / India / Delhi	Human	Original			Nanopore MinION	Reference based			B.1.36	G
hCoV-19/India/DL-NCDC3652-CSIR-IGIB/2020	EPI_ISL_482563	2020-05-19	Asia / India / Delhi	Human	Original			Nanopore MinION	Reference based			B.1.36	G
hCoV-19/India/DL-NCDC3820-CSIR-IGIB/2020	EPI_ISL_482574	2020-05-20	Asia / India / Delhi	Human	Original			Nanopore MinION	Reference based			B.1	G
hCoV-19/India/GJ-GBRC254a/2020	EPI_ISL_483840	2020-06-12	Asia / India / Gujarat / Rajkot	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC255a/2020	EPI_ISL_483842	2020-06-12	Asia / India / Gujarat / Rajkot	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC255b/2020	EPI_ISL_483843	2020-06-12	Asia / India / Gujarat / Rajkot	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC257a/2020	EPI_ISL_483846	2020-06-12	Asia / India / Gujarat / Rajkot	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.113	GH
hCoV-19/India/GJ-GBRC258a/2020	EPI_ISL_483848	2020-06-12	Asia / India / Gujarat / Gondal	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.113	GH
hCoV-19/Belgium/ULG-10238/2020	EPI_ISL_498144	2020-06-26	Europe / Belgium / Lige	Human	Original			Nanopore MinION	Artic network			B.1	GH
hCoV-19/Vietnam/HCMC-05008/2020	EPI_ISL_498179	2020-03-21	Asia / Vietnam / Ho Chi Minh City	Human	unknown	Nasal and Throat Swab		Illumina MiSeq, Sanger	Geneious Prime 2019.2.1			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH506/2020	EPI_ISL_512943	2020-04-16	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH525/2020	EPI_ISL_512944	2020-04-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH528/2020	EPI_ISL_512945	2020-04-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH535/2020	EPI_ISL_512949	2020-04-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH536/2020	EPI_ISL_512950	2020-04-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH539/2020	EPI_ISL_512952	2020-04-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus	Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH542/2020	EPI_ISL_512953	2020-04-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH547/2020	EPI_ISL_512957	2020-04-21	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH558/2020	EPI_ISL_512959	2020-04-21	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH566/2020	EPI_ISL_512963	2020-04-22	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH569/2020	EPI_ISL_512964	2020-04-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH573/2020	EPI_ISL_512967	2020-04-29	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH578/2020	EPI_ISL_512971	2020-04-28	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH581/2020	EPI_ISL_512973	2020-04-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH582/2020	EPI_ISL_512974	2020-04-29	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH586/2020	EPI_ISL_512976	2020-04-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH591/2020	EPI_ISL_512981	2020-04-21	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.471	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH594/2020	EPI_ISL_512983	2020-04-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.471	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH615/2020	EPI_ISL_512987	2020-04-30	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH722/2020	EPI_ISL_512991	2020-05-04	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH723/2020	EPI_ISL_512992	2020-05-04	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH743/2020	EPI_ISL_512993	2020-04-01	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.471	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH748/2020	EPI_ISL_512996	2020-04-02	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Australia/SA0488/2020	EPI_ISL_516551	2020-08-15	Oceania / Australia / South Australia	Human	Original			Illumina NextSeq 550				B.1.36	GH
hCoV-19/Netherlands/ZH-EMC-270/2020	EPI_ISL_523612	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-271/2020	EPI_ISL_523613	2020-06-07	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-274/2020	EPI_ISL_523616	2020-06-11	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-276/2020	EPI_ISL_523618	2020-06-16	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-280/2020	EPI_ISL_523622	2020-06-18	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-283/2020	EPI_ISL_523625	2020-06-19	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-286/2020	EPI_ISL_523628	2020-06-26	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-287/2020	EPI_ISL_523629	2020-06-26	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-288/2020	EPI_ISL_523630	2020-06-26	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-289/2020	EPI_ISL_523631	2020-06-27	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-294/2020	EPI_ISL_523636	2020-07-03	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-295/2020	EPI_ISL_523637	2020-07-03	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-296/2020	EPI_ISL_523638	2020-07-03	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-298/2020	EPI_ISL_523640	2020-07-03	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-305/2020	EPI_ISL_523647	2020-07-04	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-306/2020	EPI_ISL_523648	2020-07-04	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-307/2020	EPI_ISL_523649	2020-07-04	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-308/2020	EPI_ISL_523650	2020-05-19	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-309/2020	EPI_ISL_523651	2020-05-23	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-310/2020	EPI_ISL_523652	2020-05-23	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-312/2020	EPI_ISL_523654	2020-05-23	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-315/2020	EPI_ISL_523657	2020-05-23	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Indonesia/JI-ITD-8402NT/2020	EPI_ISL_529138	2020-05-11	Asia / Indonesia / East Java / Surabaya	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14			B.1	GH
hCoV-19/England/QEUH-96BAFD/2020	EPI_ISL_531402	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/Scotland/QEUH-8937D8/2020	EPI_ISL_532753	2020-07-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Scotland/QEUH-789563/2020	EPI_ISL_533016	2020-07-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Scotland/QEUH-7894C0/2020	EPI_ISL_533027	2020-07-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-96A29C/2020	EPI_ISL_536919	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-96A117/2020	EPI_ISL_536929	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-95DDAA/2020	EPI_ISL_536982	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-95DE3E/2020	EPI_ISL_536983	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/QEUH-961787/2020	EPI_ISL_536985	2020-08-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9A42D2/2020	EPI_ISL_540223	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-96FB32/2020	EPI_ISL_540262	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B9C90/2020	EPI_ISL_549559	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B895E/2020	EPI_ISL_549597	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-99DFB7/2020	EPI_ISL_550544	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-99CA02/2020	EPI_ISL_550573	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/Wales/MILK-99C7DE/2020	EPI_ISL_550587	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Wales/MILK-992AB1/2020	EPI_ISL_552162	2020-08-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-992E2E/2020	EPI_ISL_552168	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9929C3/2020	EPI_ISL_552186	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/MILK-99519B/2020	EPI_ISL_552203	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-9952C5/2020	EPI_ISL_552218	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-99483D/2020	EPI_ISL_552249	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.23	GH
hCoV-19/England/MILK-994554/2020	EPI_ISL_552253	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-99485B/2020	EPI_ISL_552256	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-9573CC/2020	EPI_ISL_554025	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/ALDP-94DA00/2020	EPI_ISL_555309	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/England/CAMC-94B237/2020	EPI_ISL_556710	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-946409/2020	EPI_ISL_556724	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/ALDP-6B0072/2020	EPI_ISL_557960	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/MILK-56109F/2020	EPI_ISL_558326	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/MILK-58FB7C/2020	EPI_ISL_558352	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/MILK-566C5A/2020	EPI_ISL_558361	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-9C3079/2020	EPI_ISL_566824	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/MILK-9C345F/2020	EPI_ISL_566826	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-9C3A6C/2020	EPI_ISL_566836	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C3668/2020	EPI_ISL_566842	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-9C361D/2020	EPI_ISL_566851	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C40B4/2020	EPI_ISL_566860	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C3941/2020	EPI_ISL_566867	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C42EB/2020	EPI_ISL_566870	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C3EE8/2020	EPI_ISL_566874	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-9C34B9/2020	EPI_ISL_566884	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C4306/2020	EPI_ISL_566890	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9CA106/2020	EPI_ISL_567301	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9C9CCA/2020	EPI_ISL_567313	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9C9AB1/2020	EPI_ISL_567329	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-9C9A48/2020	EPI_ISL_567331	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/QEUH-9C93A7/2020	EPI_ISL_567357	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/Indonesia/JK-EIJK-38/2020	EPI_ISL_568689	2020-05-20	Asia / Indonesia / Jakarta	Human	Original	Oropharyngeal swab		Illumina MiSeq System	Bowtie2 + iVar			B.1	GH
hCoV-19/France/PAC-IHU-0967/2020	EPI_ISL_569017	2020-07-15	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/Canada/ON-UHTC-0199/2020	EPI_ISL_569969	2020-06-10	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36.34	GH
hCoV-19/USA/WA-UW-13015/2020	EPI_ISL_570941	2020-06-30	North America / USA / Washington	Human	Original			Illumina	custom			B.1	GH
hCoV-19/England/CAMC-9C1961/2020	EPI_ISL_573209	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/CAMC-9C1BA7/2020	EPI_ISL_573224	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-9C4A10/2020	EPI_ISL_573262	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/MILK-9C7215/2020	EPI_ISL_573289	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/MILK-9C72E8/2020	EPI_ISL_573294	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/MILK-9C7303/2020	EPI_ISL_573296	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/Singapore/1018/2020	EPI_ISL_574503	2020-09-24	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/England/MILK-9765FE/2020	EPI_ISL_575887	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Indonesia/YO-UGM-10001/2020	EPI_ISL_576113	2020-08-18	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.459	GH
hCoV-19/Indonesia/YO-UGM-10004/2020	EPI_ISL_576114	2020-08-20	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v. 1.30			B.1.459	GH
hCoV-19/Indonesia/YO-UGM-10003/2020	EPI_ISL_576115	2020-08-16	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v. 1.30			B.1.459	GH
hCoV-19/Indonesia/YO-UGM-10002/2020	EPI_ISL_576116	2020-08-13	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v. 1.30			B.1.459	GH
hCoV-19/Indonesia/YO-UGM-10005/2020	EPI_ISL_576128	2020-08-21	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.1.33			B.1.459	GH
hCoV-19/Indonesia/YO-UGM-10006/2020	EPI_ISL_576130	2020-08-18	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.1.30			B.1.459	GH
hCoV-19/Netherlands/ZH-EMC-579/2020	EPI_ISL_578007	2020-09-18	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/England/ALDP-9E677B/2020	EPI_ISL_580306	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/USA/CA-CZB-6978/2020	EPI_ISL_582908	2020-09-02	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.36.38	GH
hCoV-19/England/LOND-D9A6C/2020	EPI_ISL_584674	2020-09-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/LOND-D9A7B/2020	EPI_ISL_584675	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/India/GJ-GBRC-398a/2020	EPI_ISL_586513	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-398b/2020	EPI_ISL_586514	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.184	G
hCoV-19/India/GJ-GBRC-399a/2020	EPI_ISL_586515	2020-06-25	Asia / India / Gujarat / Daskroi	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-400a/2020	EPI_ISL_586517	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-402a/2020	EPI_ISL_586520	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-403a/2020	EPI_ISL_586522	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-403b/2020	EPI_ISL_586523	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.184	G
hCoV-19/India/GJ-GBRC-404a/2020	EPI_ISL_586524	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-404b/2020	EPI_ISL_586525	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-405b/2020	EPI_ISL_586527	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-406b/2020	EPI_ISL_586528	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.184	G
hCoV-19/India/GJ-GBRC-407a/2020	EPI_ISL_586529	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-407b/2020	EPI_ISL_586530	2020-06-25	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.184	G
hCoV-19/India/GJ-GBRC-411/2020	EPI_ISL_586536	2020-07-18	Asia / India / Gujarat / Limkheda	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-413a/2020	EPI_ISL_586539	2020-07-18	Asia / India / Gujarat / Dahod	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-413b/2020	EPI_ISL_586540	2020-07-18	Asia / India / Gujarat / Dahod	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-416a/2020	EPI_ISL_586544	2020-07-11	Asia / India / Gujarat / Kalyanpur	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-416b/2020	EPI_ISL_586545	2020-07-11	Asia / India / Gujarat / Kalyanpur	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC-417a/2020	EPI_ISL_586546	2020-07-18	Asia / India / Gujarat / Godhra	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-417b/2020	EPI_ISL_586547	2020-07-18	Asia / India / Gujarat / Godhra	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.184	G
hCoV-19/India/GJ-GBRC-424a/2020	EPI_ISL_586555	2020-07-14	Asia / India / Gujarat / Talala	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-424b/2020	EPI_ISL_586556	2020-07-14	Asia / India / Gujarat / Talala	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.184	G
hCoV-19/India/GJ-GBRC-427a/2020	EPI_ISL_586560	2020-07-14	Asia / India / Gujarat / Kodinar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-427b/2020	EPI_ISL_586561	2020-07-14	Asia / India / Gujarat / Kodinar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-430a/2020	EPI_ISL_586565	2020-07-15	Asia / India / Gujarat / Mangrol	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-430b/2020	EPI_ISL_586566	2020-07-15	Asia / India / Gujarat / Mangrol	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/England/ALDP-A2DA41/2020	EPI_ISL_586576	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-A2D5E6/2020	EPI_ISL_586592	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-9FD79F/2020	EPI_ISL_587806	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9FDD9D/2020	EPI_ISL_587859	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-9FAC39/2020	EPI_ISL_588126	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9FA7FC/2020	EPI_ISL_588143	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/QEUH-9FAC93/2020	EPI_ISL_588199	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-9E5B9E/2020	EPI_ISL_589416	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B46B5/2020	EPI_ISL_590400	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-9B5186/2020	EPI_ISL_590420	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B74E5/2020	EPI_ISL_590504	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B703C/2020	EPI_ISL_590512	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.23	GH
hCoV-19/England/MILK-9EF10B/2020	EPI_ISL_594901	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.28	GH
hCoV-19/England/MILK-9EF6A2/2020	EPI_ISL_594930	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.28	GH
hCoV-19/England/MILK-9EF815/2020	EPI_ISL_594946	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/MILK-9EF833/2020	EPI_ISL_594948	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMC-A5936F/2020	EPI_ISL_597164	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A57D63/2020	EPI_ISL_597215	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A514DD/2020	EPI_ISL_597906	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-A528B2/2020	EPI_ISL_597918	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A525F7/2020	EPI_ISL_597924	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/ALDP-A525E8/2020	EPI_ISL_597925	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A4621D/2020	EPI_ISL_598526	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A45885/2020	EPI_ISL_598569	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A4606E/2020	EPI_ISL_598579	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/MILK-A44BC9/2020	EPI_ISL_598594	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.16	GH
hCoV-19/England/MILK-A061FE/2020	EPI_ISL_599825	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A05B5B/2020	EPI_ISL_599837	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A063AD/2020	EPI_ISL_599850	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A05775/2020	EPI_ISL_599896	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A062CE/2020	EPI_ISL_599897	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-9FFDB9/2020	EPI_ISL_600325	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-A00868/2020	EPI_ISL_600361	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/MILK-9D3F00/2020	EPI_ISL_601697	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A7AA72/2020	EPI_ISL_606514	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A7D13E/2020	EPI_ISL_606517	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-A7D365/2020	EPI_ISL_606548	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A7D4EA/2020	EPI_ISL_606575	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A6C949/2020	EPI_ISL_607023	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A6E1A9/2020	EPI_ISL_607025	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A6C92B/2020	EPI_ISL_607044	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-A6CD89/2020	EPI_ISL_608309	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-A6D68D/2020	EPI_ISL_608343	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/CAMC-A655A6/2020	EPI_ISL_608373	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A64DDC/2020	EPI_ISL_608395	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-A3E658/2020	EPI_ISL_609615	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/CAMC-A3F11A/2020	EPI_ISL_609671	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A3EC0B/2020	EPI_ISL_609707	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A84D5E/2020	EPI_ISL_610614	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-A85D4E/2020	EPI_ISL_610624	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/CAMC-A81C36/2020	EPI_ISL_610633	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-A82C17/2020	EPI_ISL_610661	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-A82DE7/2020	EPI_ISL_610663	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/CAMC-A82E3F/2020	EPI_ISL_610667	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-A81049/2020	EPI_ISL_610689	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A93CF5/2020	EPI_ISL_611022	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A92528/2020	EPI_ISL_611031	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-A93EFF/2020	EPI_ISL_611089	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A18D22/2020	EPI_ISL_611969	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A18DAA/2020	EPI_ISL_611970	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/PORT-2D466B/2020	EPI_ISL_611971	2020-10-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Gibraltar/204421222/2020	EPI_ISL_613683	2020-10-27	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/Gibraltar/204421230/2020	EPI_ISL_613690	2020-10-27	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/Denmark/DCGC-7528/2020	EPI_ISL_618442	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-1579/2020	EPI_ISL_618525	2020-04-13	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.465	GH
hCoV-19/Denmark/DCGC-7154/2020	EPI_ISL_619053	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-7201/2020	EPI_ISL_619054	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-7348/2020	EPI_ISL_619055	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-7350/2020	EPI_ISL_619056	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-7351/2020	EPI_ISL_619057	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-6927/2020	EPI_ISL_619773	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-6928/2020	EPI_ISL_619774	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-6929/2020	EPI_ISL_619775	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-6930/2020	EPI_ISL_619776	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-6935/2020	EPI_ISL_619781	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-6946/2020	EPI_ISL_619792	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-7002/2020	EPI_ISL_619849	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-6267/2020	EPI_ISL_620027	2020-10-05	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-4549/2020	EPI_ISL_621346	2020-09-21	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/Denmark/DCGC-1860/2020	EPI_ISL_622608	2020-07-13	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-3794/2020	EPI_ISL_622666	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/Denmark/DCGC-3822/2020	EPI_ISL_622680	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/Denmark/DCGC-3827/2020	EPI_ISL_622681	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36	GH
hCoV-19/England/ALDP-AA330C/2020	EPI_ISL_623932	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-AA2AEA/2020	EPI_ISL_623952	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA56E3/2020	EPI_ISL_623953	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA3384/2020	EPI_ISL_623978	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA3D3B/2020	EPI_ISL_624323	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA2DB4/2020	EPI_ISL_624325	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA22D3/2020	EPI_ISL_624355	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA1E94/2020	EPI_ISL_624379	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-AC94D0/2020	EPI_ISL_629111	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-ACED49/2020	EPI_ISL_629144	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ACC8FF/2020	EPI_ISL_629158	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-ACCA17/2020	EPI_ISL_629161	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-ACC1D6/2020	EPI_ISL_629201	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-ACE981/2020	EPI_ISL_629202	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ACDDC2/2020	EPI_ISL_630111	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-ACDBB9/2020	EPI_ISL_630130	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Netherlands/ZH-EMC-854/2020	EPI_ISL_632736	2020-10-13	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Netherlands/ZH-EMC-885/2020	EPI_ISL_632765	2020-10-29	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Netherlands/NB-EMC-322/2020	EPI_ISL_632775	2020-07-08	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/England/CAMC-AEA864/2020	EPI_ISL_633336	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-AE51E6/2020	EPI_ISL_633362	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/England/CAMC-AEABE3/2020	EPI_ISL_633366	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-AEAAC8/2020	EPI_ISL_633378	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-AD5750/2020	EPI_ISL_634690	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Norway/4814/2020	EPI_ISL_635074	2020-10-26	Europe / Norway / Oslo	Human	Original	Nasopharyngeal swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/5057/2020	EPI_ISL_635086	2020-10-29	Europe / Norway / Oslo	Human	Original	Respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Norway/5060/2020	EPI_ISL_635087	2020-10-29	Europe / Norway / Oslo	Human	Original	Respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Jordan/AM-ALSR-3963/2020	EPI_ISL_636326	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-3964/2020	EPI_ISL_636327	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-3974/2020	EPI_ISL_636337	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-3975/2020	EPI_ISL_636338	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-3980/2020	EPI_ISL_636343	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-3981/2020	EPI_ISL_636344	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-3993/2020	EPI_ISL_636356	2020-10-02	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-4007/2020	EPI_ISL_636370	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-4039/2020	EPI_ISL_636399	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/England/CAMB-1B75CC/2020	EPI_ISL_638165	2020-10-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMB-1B77C6/2020	EPI_ISL_638166	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMB-1B790C/2020	EPI_ISL_638167	2020-10-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-A4B218/2020	EPI_ISL_638169	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-9E76F5/2020	EPI_ISL_638212	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/ALDP-9E83FD/2020	EPI_ISL_638247	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/ALDP-9E88B2/2020	EPI_ISL_638263	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/ALDP-9E890A/2020	EPI_ISL_638264	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/CAMC-B0839B/2020	EPI_ISL_643427	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B0B5DE/2020	EPI_ISL_643441	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Scotland/QEUH-AD4AFE/2020	EPI_ISL_644036	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.460	GH
hCoV-19/India/TG-CCMB-OM21/2020	EPI_ISL_644715	2020-09-20	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-OM27/2020	EPI_ISL_644721	2020-09-20	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/TG-CCMB-OM29/2020	EPI_ISL_644723	2020-09-20	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.36	GH
hCoV-19/India/TG-CCMB-OM39/2020	EPI_ISL_644733	2020-05-23	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/India/TG-CCMB-OM40/2020	EPI_ISL_644734	2020-05-26	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/England/CAMC-B3673E/2020	EPI_ISL_645358	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B3D184/2020	EPI_ISL_645369	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-B26397/2020	EPI_ISL_646621	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B24F3B/2020	EPI_ISL_646658	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-B26081/2020	EPI_ISL_646668	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B2633D/2020	EPI_ISL_646696	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/ALDP-B245C0/2020	EPI_ISL_647021	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-B24D13/2020	EPI_ISL_647047	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/Wales/PHWC-48A064/2020	EPI_ISL_652518	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/India/DL-NIBG-MN2/2020	EPI_ISL_653833	2020-06-18	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-NIBG-MN3/2020	EPI_ISL_653834	2020-06-18	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-NIBG-MN6/2020	EPI_ISL_653835	2020-06-18	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-NIBG-MN9/2020	EPI_ISL_653837	2020-06-18	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-NIBG-MN16/2020	EPI_ISL_653842	2020-06-18	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-NIBG-MN18/2020	EPI_ISL_653844	2020-06-19	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-NIBG-MN21/2020	EPI_ISL_653847	2020-06-19	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-NIBG-MN22/2020	EPI_ISL_653848	2020-06-19	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-NIBG-MN24/2020	EPI_ISL_653850	2020-06-20	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-NIBG-MN25/2020	EPI_ISL_653851	2020-06-20	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-NIBG-MN27/2020	EPI_ISL_653852	2020-06-21	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-NIBG-MN28/2020	EPI_ISL_653853	2020-06-21	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-NIBG-MN30/2020	EPI_ISL_653854	2020-06-23	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-NIBG-MN31/2020	EPI_ISL_653855	2020-06-26	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-NIBG-MN33/2020	EPI_ISL_653856	2020-06-26	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-NIBG-MN34/2020	EPI_ISL_653857	2020-06-28	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-NIBG-MN35/2020	EPI_ISL_653858	2020-06-28	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-NIBG-TF5/2020	EPI_ISL_653859	2020-06-14	Asia / India / Haryana / Palwal	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-NIBG-TF11/2020	EPI_ISL_653860	2020-06-17	Asia / India / Haryana / Faridabad	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-NIBG-TF18/2020	EPI_ISL_653861	2020-06-17	Asia / India / Haryana / Faridabad	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-NIBG-TF29/2020	EPI_ISL_653863	2020-06-22	Asia / India / Haryana / Faridabad	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-NIBG-TF31/2020	EPI_ISL_653864	2020-06-22	Asia / India / Haryana / Faridabad	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-NIBG-TF33/2020	EPI_ISL_653866	2020-06-22	Asia / India / Haryana / Palwal	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-NIBG-TF40/2020	EPI_ISL_653869	2020-05-01	Asia / India / Haryana / Palwal	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1	GH
hCoV-19/India/HR-NIBG-TF44/2020	EPI_ISL_653871	2020-05-19	Asia / India / Haryana / Gurugram	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/HR-NIBG-TF48/2020	EPI_ISL_653875	2020-05-20	Asia / India / Haryana / Gurugram	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/India/DL-NIBG-TF52/2020	EPI_ISL_653879	2020-05-20	Asia / India / Delhi / West Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.36	GH
hCoV-19/England/CAMC-B543AF/2020	EPI_ISL_656701	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/CAMC-B54002/2020	EPI_ISL_656761	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B52435/2020	EPI_ISL_656806	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/CAMC-B5221D/2020	EPI_ISL_656809	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/QEUH-B4359E/2020	EPI_ISL_657337	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B38796/2020	EPI_ISL_659029	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B3859C/2020	EPI_ISL_659031	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B38839/2020	EPI_ISL_659039	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B384EA/2020	EPI_ISL_659043	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B37D3B/2020	EPI_ISL_659045	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B388DF/2020	EPI_ISL_659068	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B2E836/2020	EPI_ISL_659927	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-B2D451/2020	EPI_ISL_660043	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/India/WB-IICB-032/2020	EPI_ISL_661305	2020-10-26	Asia / India / West Bengal	Human	Original			Nanopore MinION	Minimap2			B.1	GH
hCoV-19/India/WB-IICB-035/2020	EPI_ISL_661308	2020-10-27	Asia / India / West Bengal	Human	Original			Nanopore MinION	Minimap2			B.1.36	GH
hCoV-19/India/WB-IICB-037/2020	EPI_ISL_661310	2020-10-26	Asia / India / West Bengal	Human	Original			Nanopore MinION	Minimap2			B.1.36	O
hCoV-19/India/WB-IICB-038/2020	EPI_ISL_661311	2020-10-27	Asia / India / West Bengal	Human	Original			Nanopore MinION	Minimap2			B.1.36	GH
hCoV-19/England/MILK-B569E7/2020	EPI_ISL_662636	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/MILK-B38B7C/2020	EPI_ISL_662638	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-AF5620/2020	EPI_ISL_663115	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AF490A/2020	EPI_ISL_663144	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AF4991/2020	EPI_ISL_663147	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AF5295/2020	EPI_ISL_663156	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/England/NOTT-11CEBB/2020	EPI_ISL_665789	2020-11-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/LOND-1250C71/2020	EPI_ISL_665807	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.39	GH
hCoV-19/England/LOND-1251065/2020	EPI_ISL_665830	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/CAMC-B78A46/2020	EPI_ISL_668091	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B81673/2020	EPI_ISL_668094	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Denmark/DCGC-10085/2020	EPI_ISL_668725	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-10943/2020	EPI_ISL_670300	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-10948/2020	EPI_ISL_670304	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/CAMC-B09AFF/2020	EPI_ISL_672920	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/CAMC-B095B2/2020	EPI_ISL_672931	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-B095A3/2020	EPI_ISL_672952	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-B09DE7/2020	EPI_ISL_672953	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-B9AFA9/2020	EPI_ISL_673291	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B9ADBE/2020	EPI_ISL_673305	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/CAMC-B99766/2020	EPI_ISL_673316	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/CAMC-B991C2/2020	EPI_ISL_673318	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/MILK-B8F6C0/2020	EPI_ISL_674622	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B8DFE5/2020	EPI_ISL_674648	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-B7F7A2/2020	EPI_ISL_674691	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-B986E2/2020	EPI_ISL_675107	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B8CA8B/2020	EPI_ISL_675935	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B8C6C3/2020	EPI_ISL_675936	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/ALDP-B8491D/2020	EPI_ISL_675939	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B88937/2020	EPI_ISL_675946	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/ALDP-B847F5/2020	EPI_ISL_675976	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-B848E3/2020	EPI_ISL_675988	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH235/2020	EPI_ISL_678140	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH729/2020	EPI_ISL_678142	2020-04-08	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH798/2020	EPI_ISL_678144	2020-03-21	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH819/2020	EPI_ISL_678145	2020-04-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH825/2020	EPI_ISL_678146	2020-04-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-QATIF1353/2020	EPI_ISL_678154	2020-06-20	Asia / Saudi Arabia / Qatif	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-QATIF1443/2020	EPI_ISL_678155	2020-06-27	Asia / Saudi Arabia / Qatif	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.468	GH
hCoV-19/Saudi Arabia/KAUST-QATIF1448/2020	EPI_ISL_678156	2020-06-27	Asia / Saudi Arabia / Qatif	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.468	GH
hCoV-19/Saudi Arabia/KAUST-QATIF1452/2020	EPI_ISL_678157	2020-06-27	Asia / Saudi Arabia / Qatif	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-RIYADH1174/2020	EPI_ISL_678194	2020-06-05	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-RIYADH1176/2020	EPI_ISL_678195	2020-06-18	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.36.10	GH
hCoV-19/Saudi Arabia/KAUST-RIYADH1180/2020	EPI_ISL_678197	2020-06-15	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.468	GH
hCoV-19/Denmark/DCGC-12205/2020	EPI_ISL_682386	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Bahrain/341035032/2020	EPI_ISL_684030	2020-11-15	Asia / Bahrain	Human	Original	Nasopharyngeal swab		Illumina	Aviomix v. 1.0			B.1.36	GH
hCoV-19/England/204691107/2020	EPI_ISL_686593	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.39	GH
hCoV-19/England/204691117/2020	EPI_ISL_686594	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.39	GH
hCoV-19/United Arab Emirates/1012/2020	EPI_ISL_699144	2020-06-11	Asia / United Arab Emirates / Abu Dhabi	Human	Original			MGISEQ-T7	nCoV_Finder			A	O
hCoV-19/England/ALDP-BB53CA/2020	EPI_ISL_701979	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-BB37B1/2020	EPI_ISL_701987	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-BD1EE5/2020	EPI_ISL_702311	2020-11-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-BD43B6/2020	EPI_ISL_702367	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/ALDP-BBA653/2020	EPI_ISL_702394	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 5 nucleotides when compared to the reference sequence.	info	B.1.36.1	GH
hCoV-19/England/CAMC-BC01B3/2020	EPI_ISL_704902	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/NORW-EED89/2020	EPI_ISL_704908	2020-11-29	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-F778F/2020	EPI_ISL_704911	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-F8B37/2020	EPI_ISL_704914	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-F918F/2020	EPI_ISL_704916	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/CAMC-BC0AE5/2020	EPI_ISL_704958	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/CAMC-BC1EE8/2020	EPI_ISL_704979	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/LOND-1251AB2/2020	EPI_ISL_705472	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-A91671/2020	EPI_ISL_705473	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/MILK-B3A785/2020	EPI_ISL_705474	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-B3A7A3/2020	EPI_ISL_705475	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-B3B21A/2020	EPI_ISL_705476	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/MILK-B3B256/2020	EPI_ISL_705477	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B3B274/2020	EPI_ISL_705478	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/MILK-B3C01F/2020	EPI_ISL_705479	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-B3C03D/2020	EPI_ISL_705480	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-B3C7CF/2020	EPI_ISL_705481	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/MILK-B3CA3F/2020	EPI_ISL_705482	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-B3CDBE/2020	EPI_ISL_705483	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-B3DC74/2020	EPI_ISL_705484	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-B3DCED/2020	EPI_ISL_705485	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/NOTT-11FAA5/2020	EPI_ISL_705487	2020-11-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.21	GH
hCoV-19/England/QEUH-A6205D/2020	EPI_ISL_705489	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-BFB42F/2020	EPI_ISL_709018	2020-12-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-BF09D0/2020	EPI_ISL_709056	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BDCB10/2020	EPI_ISL_709762	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BDC21B/2020	EPI_ISL_709795	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/Gibraltar/205000710/2020	EPI_ISL_710032	2020-12	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.28	GH
hCoV-19/Denmark/DCGC-14346/2020	EPI_ISL_711394	2020-11-30	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 2 nucleotides when compared to the reference sequence.	info	B.1.36.25	GH
hCoV-19/Denmark/DCGC-13166/2020	EPI_ISL_712629	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-13209/2020	EPI_ISL_712653	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-15601/2020	EPI_ISL_713917	2020-11-23	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-15718/2020	EPI_ISL_713980	2020-11-23	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-16132/2020	EPI_ISL_714372	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-16145/2020	EPI_ISL_714373	2020-11-16	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-16139/2020	EPI_ISL_714379	2020-11-16	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 2 nucleotides when compared to the reference sequence.	info	B.1.36.25	GH
hCoV-19/England/CAMC-C439A0/2020	EPI_ISL_719182	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/MILK-BB09CD/2020	EPI_ISL_720113	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-BB0A7F/2020	EPI_ISL_720118	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BB0918/2020	EPI_ISL_720145	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BB0338/2020	EPI_ISL_720150	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BB270D/2020	EPI_ISL_720162	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-BB1540/2020	EPI_ISL_720188	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/ALDP-BC89B3/2020	EPI_ISL_721483	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/England/LOND-DA649/2020	EPI_ISL_724649	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36	GH
hCoV-19/England/LOND-DA6D0/2020	EPI_ISL_724655	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/LOND-DA6EF/2020	EPI_ISL_724656	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/LOND-DA728/2020	EPI_ISL_724659	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36	GH
hCoV-19/England/LOND-DA807/2020	EPI_ISL_724664	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/NORW-21F646/2020	EPI_ISL_725036	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/Malaysia/IMR-WC206980/2020	EPI_ISL_728165	2020-10-12	Asia / Malaysia	Human	Original			Illumina NextSeq 500		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.468	GH
hCoV-19/Malaysia/IMR-WC249886/2020	EPI_ISL_728167	2020-10-30	Asia / Malaysia	Human	Original			Illumina NextSeq 500				B.1.36.16	GH
hCoV-19/Malaysia/IMR-WC253176/2020	EPI_ISL_728170	2020-11-02	Asia / Malaysia	Human	Original			Illumina NextSeq 500				B.1.36.16	GH
hCoV-19/Singapore/1444/2020	EPI_ISL_728180	2020-12-07	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.16	GH
hCoV-19/Singapore/1445/2020	EPI_ISL_728181	2020-12-05	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Singapore/1446/2020	EPI_ISL_728182	2020-12-06	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.19	GH
hCoV-19/Singapore/1448/2020	EPI_ISL_728184	2020-12-07	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.466.2	GH
hCoV-19/Singapore/1450/2020	EPI_ISL_728186	2020-12-04	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Singapore/1454/2020	EPI_ISL_728190	2020-12-05	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Singapore/1457/2020	EPI_ISL_728193	2020-12-11	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Singapore/1458/2020	EPI_ISL_728194	2020-12-06	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.19	GH
hCoV-19/Germany/SH-ChVir9283/2020	EPI_ISL_729419	2020-09-28	Europe / Germany / Schleswig-Holstein	Human	Original			NextSeq	bowtie2	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.36.1	GH
hCoV-19/Jordan/AM-ALSR-5166/2020	EPI_ISL_730405	2020-10-15	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5173/2020	EPI_ISL_730412	2020-10-12	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5174/2020	EPI_ISL_730413	2020-10-14	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5180/2020	EPI_ISL_730419	2020-10-12	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5187/2020	EPI_ISL_730426	2020-10-16	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5188/2020	EPI_ISL_730427	2020-10-17	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/IR-ALSR-5192/2020	EPI_ISL_730431	2020-10-20	Asia / Jordan / Irbid	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/IR-ALSR-5196/2020	EPI_ISL_730434	2020-10-20	Asia / Jordan / Irbid	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/IR-ALSR-5207/2020	EPI_ISL_730445	2020-10-12	Asia / Jordan / Irbid	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/IR-ALSR-5213/2020	EPI_ISL_730451	2020-10-12	Asia / Jordan / Irbid	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/IR-ALSR-5216/2020	EPI_ISL_730454	2020-10-18	Asia / Jordan / Irbid	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/IR-ALSR-5229/2020	EPI_ISL_730467	2020-10-07	Asia / Jordan / Irbid	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/IR-ALSR-5233/2020	EPI_ISL_730471	2020-10-19	Asia / Jordan / Irbid	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/IR-ALSR-5234/2020	EPI_ISL_730472	2020-10-18	Asia / Jordan / Irbid	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/England/ALDP-C3DE22/2020	EPI_ISL_731781	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Belgium/rega-0702806/2020	EPI_ISL_734789	2020-07-02	Europe / Belgium / Wilsele	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network assembly method			B.1	GH
hCoV-19/England/ALDP-C48D36/2020	EPI_ISL_736613	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.36.24	GH
hCoV-19/England/ALDP-C486FF/2020	EPI_ISL_736662	2020-12-12	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-C507C4/2020	EPI_ISL_736682	2020-12-11	Europe / United Kingdom / England	Human	Original			ILLUMINA NovaSeq				B.1.36.17	GH
hCoV-19/Canada/BC-BCCDC-6458/2020	EPI_ISL_740606	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6464/2020	EPI_ISL_740609	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6471/2020	EPI_ISL_740616	2020-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7230/2020	EPI_ISL_740623	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7239/2020	EPI_ISL_740631	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7241/2020	EPI_ISL_740632	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7242/2020	EPI_ISL_740633	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7243/2020	EPI_ISL_740634	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7245/2020	EPI_ISL_740635	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7248/2020	EPI_ISL_740637	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7252/2020	EPI_ISL_740640	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7259/2020	EPI_ISL_740644	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7283/2020	EPI_ISL_740656	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7291/2020	EPI_ISL_740662	2020-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7293/2020	EPI_ISL_740663	2020	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7294/2020	EPI_ISL_740664	2020	North America / Canada / British Columbia	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/England/CAMC-B7A437/2020	EPI_ISL_741110	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.1	GH
hCoV-19/England/CAMC-B7B560/2020	EPI_ISL_741179	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.1	GH
hCoV-19/England/LOND-1266C4B/2020	EPI_ISL_741189	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Denmark/DCGC-18864/2020	EPI_ISL_748605	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18356/2020	EPI_ISL_749915	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18396/2020	EPI_ISL_749939	2020-12-07	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18403/2020	EPI_ISL_749944	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18413/2020	EPI_ISL_749952	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18427/2020	EPI_ISL_749959	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18474/2020	EPI_ISL_749987	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18475/2020	EPI_ISL_749988	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-17316/2020	EPI_ISL_750900	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-17318/2020	EPI_ISL_750902	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-17321/2020	EPI_ISL_750905	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-17371/2020	EPI_ISL_750939	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-17412/2020	EPI_ISL_750963	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-17417/2020	EPI_ISL_750967	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/India/DL-IGIB11304644/2020	EPI_ISL_751280	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-IGIB11304885/2020	EPI_ISL_751282	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-IGIB11305034/2020	EPI_ISL_751284	2020-08	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	G
hCoV-19/India/DL-IGIB11305086/2020	EPI_ISL_751286	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-IGIB11305231/2020	EPI_ISL_751287	2020-08	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-IGIB11301835/2020	EPI_ISL_751288	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.260	G
hCoV-19/India/DL-IGIB11303573/2020	EPI_ISL_751289	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.260	G
hCoV-19/India/DL-IGIB11304453/2020	EPI_ISL_751291	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-IGIB11305164/2020	EPI_ISL_751295	2020-08	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	G
hCoV-19/India/DL-IGIB11303588/2020	EPI_ISL_751296	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-IGIB11303760/2020	EPI_ISL_751297	2020-03	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-IGIB11303963/2020	EPI_ISL_751298	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	G
hCoV-19/India/DL-IGIB11303980/2020	EPI_ISL_751299	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1	G
hCoV-19/India/DL-IGIB11304239/2020	EPI_ISL_751300	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-IGIB11304386/2020	EPI_ISL_751301	2020	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-IGIB11304392/2020	EPI_ISL_751302	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-IGIB11304400/2020	EPI_ISL_751303	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-IGIB11304767/2020	EPI_ISL_751305	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-IGIB11304857/2020	EPI_ISL_751306	2020-07	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.184	G
hCoV-19/India/DL-IGIB11305763/2020	EPI_ISL_751309	2020-08	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/India/DL-IGIB11305615/2020	EPI_ISL_751312	2020-08	Asia / India / Delhi	Human	Original	Nasal Swab		Illumina MiSeq	Reference based			B.1.36	GH
hCoV-19/Canada/ON-S1988/2020	EPI_ISL_755701	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1991/2020	EPI_ISL_755702	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1995/2020	EPI_ISL_755705	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36	GH
hCoV-19/Canada/ON-A10/2020	EPI_ISL_755713	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-A11/2020	EPI_ISL_755714	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-A12/2020	EPI_ISL_755715	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.26	GH
hCoV-19/Canada/ON-A15/2020	EPI_ISL_755717	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-A19/2020	EPI_ISL_755719	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-A2/2020	EPI_ISL_755720	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-A23/2020	EPI_ISL_755722	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-A25/2020	EPI_ISL_755723	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-A27/2020	EPI_ISL_755725	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.38	GH
hCoV-19/Canada/ON-A3/2020	EPI_ISL_755727	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-A30/2020	EPI_ISL_755728	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-A32/2020	EPI_ISL_755730	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-A7/2020	EPI_ISL_755734	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-A9/2020	EPI_ISL_755736	2020-11-24	North America / Canada / Ontario / Brampton	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-SB-01/2020	EPI_ISL_755742	2020-10-21	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.26	GH
hCoV-19/Canada/ON-SB-04/2020	EPI_ISL_755744	2020-10-21	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.26	GH
hCoV-19/Canada/ON-SB-06/2020	EPI_ISL_755745	2020-10-14	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.26	GH
hCoV-19/Canada/ON-SB-09/2020	EPI_ISL_755748	2020-10-23	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.26	GH
hCoV-19/Canada/ON-SB-10/2020	EPI_ISL_755749	2020-10-21	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.26	GH
hCoV-19/Canada/ON-S1636/2020	EPI_ISL_755757	2020-09-15	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.26	GH
hCoV-19/Canada/ON-S1761/2020	EPI_ISL_755762	2020-11-09	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.26	GH
hCoV-19/Canada/ON-S1763/2020	EPI_ISL_755764	2020-11-08	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1775/2020	EPI_ISL_755775	2020-11-08	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.523	GH
hCoV-19/Canada/ON-S1780/2020	EPI_ISL_755778	2020-11-08	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-S1789/2020	EPI_ISL_755785	2020-11-15	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1797/2020	EPI_ISL_755792	2020-11-15	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Finland/3LS18AG4/2020	EPI_ISL_756100	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/3LS20H5/2020	EPI_ISL_756101	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/3LS2AD11/2020	EPI_ISL_756103	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/3LS2AF5/2020	EPI_ISL_756104	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/3LS3AA4/2020	EPI_ISL_756105	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/3LS5A11/2020	EPI_ISL_756107	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/3LS5B11/2020	EPI_ISL_756108	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/3LS5BF1/2020	EPI_ISL_756109	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36	GH
hCoV-19/Finland/3LS6E7/2020	EPI_ISL_756110	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/3LS7BD7/2020	EPI_ISL_756111	2020-10-03	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/2LS12D1/2020	EPI_ISL_756112	2020-10-02	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/2LS12G2/2020	EPI_ISL_756113	2020-10-02	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/2LS13A11/2020	EPI_ISL_756114	2020-10-02	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/2LS13A7/2020	EPI_ISL_756116	2020-10-02	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/2LS16E1/2020	EPI_ISL_756118	2020-10-02	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/2LS2F1/2020	EPI_ISL_756120	2020-10-02	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/2LS3B11/2020	EPI_ISL_756121	2020-10-02	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/2LS5A3/2020	EPI_ISL_756122	2020-10-02	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/2LS5E11/2020	EPI_ISL_756123	2020-10-02	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/2LS7A3/2020	EPI_ISL_756124	2020-10-02	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/2LS9F6/2020	EPI_ISL_756125	2020-10-02	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/15ES15BE1/2020	EPI_ISL_756165	2020-08-15	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/15LS14AA11/2020	EPI_ISL_756167	2020-10-15	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/15LS14AE7/2020	EPI_ISL_756169	2020-10-15	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/15LS3AA11/2020	EPI_ISL_756171	2020-10-15	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/15LS4BD7/2020	EPI_ISL_756174	2020-10-15	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/15LS4BF5/2020	EPI_ISL_756175	2020-10-15	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/15LS4BG11/2020	EPI_ISL_756176	2020-10-15	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/15LS6BB7/2020	EPI_ISL_756177	2020-10-15	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/15LS6BE3/2020	EPI_ISL_756178	2020-10-15	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/15LS7AA11/2020	EPI_ISL_756179	2020-10-15	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina Novaseq	BWA-MEM			B.1.463	GH
hCoV-19/Denmark/DCGC-22609/2020	EPI_ISL_757495	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/SHEF-10C8F9B/2020	EPI_ISL_765159	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.24	GH
hCoV-19/England/SHEF-10CD312/2020	EPI_ISL_765170	2020-12-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.24	GH
hCoV-19/Bangladesh/DNAS_DRICM_isl_OPS_3/2020	EPI_ISL_774997	2020-06-28	Asia / Bangladesh / Dhaka	Human	Original	Oropharyngeal swab		Ion Torrent	IRMA			B.1.36.8	GH
hCoV-19/Norway/7099/2020	EPI_ISL_775278	2020-12-17	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36.21	GH
hCoV-19/England/QEUH-C66DF6/2020	EPI_ISL_777148	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.469	GH
hCoV-19/England/ALDP-C8BC49/2020	EPI_ISL_777171	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/MILK-C6CC3F/2020	EPI_ISL_778418	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-C6B869/2020	EPI_ISL_778454	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/Japan/IC-0616/2020	EPI_ISL_779702	2020-11-11	Asia / Japan	Human	Original		COVID-19 positive case who entered from Indonesia.	Illumina iSeq	A5-miseq v. 20140604			B.1.468	GH
hCoV-19/England/CAMC-CF9A3D/2020	EPI_ISL_781181	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/QEUH-CCDC69/2020	EPI_ISL_782438	2020-12-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/USA/TX-HMH-MCoV-13953/2020	EPI_ISL_787245	2020-08-15	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.36	GH
hCoV-19/Canada/ON-SK-20H-328MM0777/2020	EPI_ISL_791492	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC-nanopolish 1.1.3			B.1.36.38	GH
hCoV-19/Canada/ON-SK-20H-328MM0785/2020	EPI_ISL_791493	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC-nanopolish 1.1.3			B.1.36.38	GH
hCoV-19/Canada/ON-SK-20H-328MM0914/2020	EPI_ISL_791498	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC-nanopolish 1.1.3			B.1.36.38	GH
hCoV-19/Denmark/DCGC-22859/2020	EPI_ISL_794423	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-22881/2020	EPI_ISL_794424	2020-11-30	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-22682/2020	EPI_ISL_794453	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-22751/2020	EPI_ISL_794493	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-22757/2020	EPI_ISL_794496	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-24741/2020	EPI_ISL_795708	2020-12-28	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-24785/2020	EPI_ISL_795732	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-24888/2020	EPI_ISL_795792	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/CAMC-D3A3DA/2020	EPI_ISL_799238	2020-12-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/England/QEUH-C18C7E/2020	EPI_ISL_800759	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-B7FC94/2020	EPI_ISL_801273	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B7FC67/2020	EPI_ISL_801278	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B7FA6D/2020	EPI_ISL_801287	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/England/QEUH-B803F5/2020	EPI_ISL_801295	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B81F2D/2020	EPI_ISL_801301	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-B7F9F7/2020	EPI_ISL_801340	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/England/QEUH-B801CE/2020	EPI_ISL_801348	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B7FBA6/2020	EPI_ISL_801355	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/QEUH-B803B9/2020	EPI_ISL_801370	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/Singapore/1530/2020	EPI_ISL_803966	2020-12-29	Asia / Singapore	Human	Original			Illumina MiSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Singapore/3/2021	EPI_ISL_803967	2021-01-01	Asia / Singapore	Human	Original			Illumina MiSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Singapore/4/2021	EPI_ISL_803968	2021-01-01	Asia / Singapore	Human	Original			Illumina MiSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Singapore/1517/2020	EPI_ISL_803969	2020-12-31	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.456	GH
hCoV-19/Singapore/1520/2020	EPI_ISL_803972	2020-12-31	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.470	GH
hCoV-19/Singapore/1521/2020	EPI_ISL_803973	2020-12-31	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.470	GH
hCoV-19/Singapore/1524/2020	EPI_ISL_803976	2020-12-30	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.466.2	GH
hCoV-19/Singapore/1501ilmn/2020	EPI_ISL_803979	2020-12-30	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.466.2	GH
hCoV-19/Singapore/1528/2020	EPI_ISL_803980	2020-12-29	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.19	GH
hCoV-19/Singapore/1529/2020	EPI_ISL_803981	2020-12-29	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.19	GH
hCoV-19/Singapore/1535/2020	EPI_ISL_803986	2020-12-28	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.19	GH
hCoV-19/Singapore/1536/2020	EPI_ISL_803987	2020-12-28	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.19	GH
hCoV-19/Singapore/1537/2020	EPI_ISL_803988	2020-12-28	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Singapore/1/2021	EPI_ISL_803989	2021-01-01	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.8	GH
hCoV-19/Singapore/2/2021	EPI_ISL_803990	2021-01-01	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.8	GH
hCoV-19/Singapore/5/2021	EPI_ISL_803991	2021-01-01	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Singapore/6/2021	EPI_ISL_803992	2021-01-01	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.470	GH
hCoV-19/Singapore/11/2021	EPI_ISL_803994	2021-01-04	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.466.2	GH
hCoV-19/Singapore/12/2021	EPI_ISL_803995	2021-01-04	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.466.2	GH
hCoV-19/Singapore/13/2021	EPI_ISL_803996	2021-01-04	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.466.2	GH
hCoV-19/Singapore/15/2021	EPI_ISL_803997	2021-01-04	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.466.2	GH
hCoV-19/Singapore/17/2021	EPI_ISL_803999	2021-01-05	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.466.2	GH
hCoV-19/Denmark/DCGC-27885/2020	EPI_ISL_815960	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-26476/2021	EPI_ISL_817582	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-26485/2021	EPI_ISL_817586	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1	GH
hCoV-19/Denmark/DCGC-26502/2021	EPI_ISL_817595	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-26503/2021	EPI_ISL_817596	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-25617/2021	EPI_ISL_818870	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-25908/2021	EPI_ISL_818897	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-25456/2021	EPI_ISL_818938	2021-01-04	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/205241792/2020	EPI_ISL_837211	2020-12-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.471	GH
hCoV-19/Denmark/DCGC-29810/2020	EPI_ISL_843857	2020-12-28	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-29828/2020	EPI_ISL_843875	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-30498/2021	EPI_ISL_847374	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-30585/2021	EPI_ISL_847375	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-30576/2021	EPI_ISL_847396	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.469	GH
hCoV-19/Denmark/DCGC-31099/2021	EPI_ISL_847489	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/South Korea/KDCA0541/2020	EPI_ISL_850233	2020-07-15	Asia / South Korea	Human	Original			Illumina Miseq				B.1	GH
hCoV-19/South Korea/KDCA0576/2020	EPI_ISL_850262	2020-08-04	Asia / South Korea	Human	Original			Illumina Miseq				B.1	GH
hCoV-19/Canada/ON-PPS-00085/2020	EPI_ISL_852864	2020-11-24	North America / Canada / Ontario	Human	Original			Illumina	ncov2019-artic-nf (OICR v1.6)	Gap of 7 nucleotides when compared to the reference sequence. NSP11 without BLAST coverage.	info	B.1.36.18	GH
hCoV-19/Denmark/DCGC-31459/2021	EPI_ISL_855839	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-31985/2021	EPI_ISL_856401	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-32721/2021	EPI_ISL_869725	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-33696/2021	EPI_ISL_870706	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.469	GH
hCoV-19/Denmark/DCGC-33733/2021	EPI_ISL_870743	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-33750/2021	EPI_ISL_870760	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.469	GH
hCoV-19/Denmark/DCGC-34036/2021	EPI_ISL_871046	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-34055/2021	EPI_ISL_871065	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-34061/2021	EPI_ISL_871071	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-34083/2021	EPI_ISL_871093	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/New Zealand/21CV0059/2021	EPI_ISL_877205	2021-01-06	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36	GH
hCoV-19/Indonesia/JI-ITDua-34158NT/2020	EPI_ISL_882769	2020-12-18	Asia / Indonesia / East Java / Surabaya	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.456	GH
hCoV-19/Indonesia/JI-ITDua-34618NT/2020	EPI_ISL_882770	2020-12-22	Asia / Indonesia / East Java / Surabaya	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JI-ITDua-35340NT/2020	EPI_ISL_882771	2020-12-28	Asia / Indonesia / East Java / Sidoarjo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20 and Genetyx Ver. 14	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Thailand/Bangkok-CONI-0417/2020	EPI_ISL_882781	2020-12-30	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0450/2021	EPI_ISL_882782	2021-01-11	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0422/2021	EPI_ISL_882783	2021-01-05	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0423/2021	EPI_ISL_882784	2021-01-05	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0425/2021	EPI_ISL_882785	2021-01-05	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0427/2021	EPI_ISL_882786	2021-01-05	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0429/2021	EPI_ISL_882787	2021-01-05	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0430/2021	EPI_ISL_882788	2021-01-05	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0431/2021	EPI_ISL_882789	2021-01-05	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0432/2021	EPI_ISL_882790	2021-01-05	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0433/2021	EPI_ISL_882791	2021-01-05	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0411/2021	EPI_ISL_882792	2021-01-04	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0412/2021	EPI_ISL_882793	2021-01-04	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0413/2021	EPI_ISL_882794	2021-01-04	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/AngThong-CONI-0442/2021	EPI_ISL_882795	2021-01-04	Asia / Thailand / Ang Thong	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/AngThong-CONI-0444/2021	EPI_ISL_882796	2021-01-04	Asia / Thailand / Ang Thong	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/AngThong-CONI-0445/2021	EPI_ISL_882797	2021-01-04	Asia / Thailand / Ang Thong	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/AngThong-CONI-0446/2021	EPI_ISL_882798	2021-01-04	Asia / Thailand / Ang Thong	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/AngThong-CONI-0447/2021	EPI_ISL_882799	2021-01-04	Asia / Thailand / Ang Thong	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/England/ALDP-10B64DD/2021	EPI_ISL_885671	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-10B6877/2021	EPI_ISL_885682	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-10B67C5/2021	EPI_ISL_885691	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-10B62B5/2021	EPI_ISL_885727	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/Belgium/rega-1610/2020	EPI_ISL_890278	2020-12-06	Europe / Belgium / Bree	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods			B.1.469	GH
hCoV-19/Japan/PG-11405/2020	EPI_ISL_898269	2020-10-28	Asia / Japan / Mie	Human	Original			illumina NextSeq500	SKESA v. 2.3.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/PG-11406/2020	EPI_ISL_898270	2020-11-02	Asia / Japan / Mie	Human	Original			illumina NextSeq500	SKESA v. 2.3.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/PG-11407/2020	EPI_ISL_898271	2020-11-04	Asia / Japan / Mie	Human	Original			illumina NextSeq500	SKESA v. 2.3.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/PG-11408/2020	EPI_ISL_898272	2020-11-05	Asia / Japan / Mie	Human	Original			illumina NextSeq500	SKESA v. 2.3.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/PG-11409/2020	EPI_ISL_898273	2020-11-05	Asia / Japan / Mie	Human	Original			illumina NextSeq500	SKESA v. 2.3.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/PG-11410/2020	EPI_ISL_898274	2020-11-05	Asia / Japan / Mie	Human	Original			illumina NextSeq500	SKESA v. 2.3.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/PG-11411/2020	EPI_ISL_898275	2020-11-05	Asia / Japan / Mie	Human	Original			illumina NextSeq500	bwa v. 0.7.13-r1126, picard v. 2.10.10, GATK v. 3.8.0, VarScan v. 2.4.3, VCFtools v. 0.1.12b, SKESA v. 2.3.0, A5-miseq v. 20140604	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Switzerland/BL-ETHZ-451490/2021	EPI_ISL_899500	2021-01-11	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BS-ETHZ-450338/2021	EPI_ISL_899530	2021-01-11	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/GR-ETHZ-431100/2020	EPI_ISL_899548	2020-12-29	Europe / Switzerland / Grisons	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Indonesia/YO-UGM-124763/2020	EPI_ISL_911707	2020-12-23	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.459	GH
hCoV-19/Indonesia/KB-TUH-C2139958/2020	EPI_ISL_911708	2020-11-28	Asia / Indonesia / West Kalimantan	Human	Original	Nasopharyngeal Swab		Oxford Nanopore				B.1.459	GH
hCoV-19/Indonesia/YO-UGM-124762/2020	EPI_ISL_911709	2020-12-23	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.459	GH
hCoV-19/Indonesia/KB-TUH-C2138669/2020	EPI_ISL_911732	2020-10-22	Asia / Indonesia / West Kalimantan	Human	Original	Nasopharyngeal Swab		Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Indonesia/KB-TUH-C2139628/2020	EPI_ISL_911750	2020-11-26	Asia / Indonesia / West Kalimantan	Human	Original			Oxford Nanopore	EPI2MELabs	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Sweden/21-50096/2021	EPI_ISL_913330	2021-01-04	Europe / Sweden / Vasternorrland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with fill from reference and majority wins			B.1.469	GH
hCoV-19/Sweden/21-50067/2021	EPI_ISL_913387	2021-01-03	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with fill from reference and majority wins			B.1.469	GH
hCoV-19/England/LOND-1325764/2020	EPI_ISL_920512	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/Wales/QEUH-A620B7/2020	EPI_ISL_924078	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Denmark/DCGC-35546/2021	EPI_ISL_926687	2021-01-25	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-36095/2021	EPI_ISL_927236	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-37396/2021	EPI_ISL_928537	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-37441/2021	EPI_ISL_928582	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.469	GH
hCoV-19/Denmark/DCGC-37445/2021	EPI_ISL_928586	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.469	GH
hCoV-19/Denmark/DCGC-38746/2021	EPI_ISL_929888	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/India/un-NRCE-6868/2020	EPI_ISL_930839	2020-06-30	Asia / India	Human	Original			Illumina	BWA v. 0.7.17-r1188			B.1.36	GH
hCoV-19/England/CAMC-1105A36/2021	EPI_ISL_933155	2021-01-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E19stop results in 85.1% truncation of the protein sequence. Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/Canada/MB-NML-1414/2020	EPI_ISL_935757	2020-08-14	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1421/2020	EPI_ISL_935764	2020-08-28	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1425/2020	EPI_ISL_935766	2020-08-26	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1426/2020	EPI_ISL_935767	2020-08-25	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1428/2020	EPI_ISL_935768	2020-08-25	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1430/2020	EPI_ISL_935769	2020-08-25	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1431/2020	EPI_ISL_935770	2020-08-25	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1438/2020	EPI_ISL_935776	2020-08-25	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1439/2020	EPI_ISL_935777	2020-08-25	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1441/2020	EPI_ISL_935779	2020-08-25	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1446/2020	EPI_ISL_935782	2020-08-24	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1451/2020	EPI_ISL_935786	2020-08-23	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1452/2020	EPI_ISL_935787	2020-08-22	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1464/2020	EPI_ISL_935790	2020-08-07	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1467/2020	EPI_ISL_935792	2020-08-10	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1471/2020	EPI_ISL_935795	2020-08-10	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1475/2020	EPI_ISL_935796	2020-08-10	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1477/2020	EPI_ISL_935797	2020-08-13	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1478/2020	EPI_ISL_935798	2020-08-14	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1479/2020	EPI_ISL_935799	2020-08-14	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/England/CAMC-C9AF4E/2020	EPI_ISL_945089	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/ALDP-114DFAC/2021	EPI_ISL_947784	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/ALDP-114E05D/2021	EPI_ISL_948042	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/ALDP-114E1C3/2021	EPI_ISL_948048	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/BIRM-6B6D4/2020	EPI_ISL_949364	2020-11-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.28	GH
hCoV-19/Bosnia and Herzegovina/VFS-UNSA-LMGFI016/2021	EPI_ISL_955185	2021-01-07	Europe / Bosnia and Herzegovina / Sarajevo	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION	ARTIC Network			B.1.36.1	GH
hCoV-19/Bosnia and Herzegovina/VFS-UNSA-LMGFI019/2021	EPI_ISL_955188	2021-01-21	Europe / Bosnia and Herzegovina / Zenica	Human	Original	Nasopharyngeal and oropharyngeal swab		Nanopore MinION	ARTIC Network			B.1.36.1	GH
hCoV-19/Canada/BC-BCCDC-4120/2020	EPI_ISL_969168	2020-08-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-4121/2020	EPI_ISL_969169	2020-08-22	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4050/2020	EPI_ISL_969178	2020-08-23	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-3916/2020	EPI_ISL_970116	2020-09-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.18	GH
hCoV-19/Canada/BC-BCCDC-3918/2020	EPI_ISL_970121	2020-09-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.18	GH
hCoV-19/Canada/BC-BCCDC-3919/2020	EPI_ISL_970123	2020-09-05	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.18	GH
hCoV-19/Canada/BC-BCCDC-4489/2020	EPI_ISL_970194	2020-09-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4788/2020	EPI_ISL_970716	2020-09-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5857/2020	EPI_ISL_971414	2020-09-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4825/2020	EPI_ISL_971424	2020-09-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-4831/2020	EPI_ISL_971438	2020-09-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-4949/2020	EPI_ISL_971459	2020-09-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Denmark/DCGC-39813/2021	EPI_ISL_971490	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-41108/2021	EPI_ISL_972785	2021-02-01	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Canada/BC-BCCDC-6783/2020	EPI_ISL_974210	2020-10-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6324/2020	EPI_ISL_974215	2020-10-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6325/2020	EPI_ISL_974216	2020-10-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6787/2020	EPI_ISL_974223	2020-10-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7013/2020	EPI_ISL_974224	2020-10-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7014/2020	EPI_ISL_974225	2020-10-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	NS7a_E95stop results in 22.3% truncation of the protein sequence.	info	B.1.36.8	GH
hCoV-19/Canada/BC-BCCDC-9938/2020	EPI_ISL_974227	2020-10-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5714/2020	EPI_ISL_974229	2020-10-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5885/2020	EPI_ISL_974230	2020-10-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5981/2020	EPI_ISL_974232	2020-10-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6039/2020	EPI_ISL_974233	2020-10-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6040/2020	EPI_ISL_974234	2020-10-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6248/2020	EPI_ISL_974241	2020-10-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6529/2020	EPI_ISL_974243	2020-10-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	NS8_Q18stop results in 86.0% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6901/2020	EPI_ISL_974244	2020-10-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9926/2020	EPI_ISL_974246	2020-10-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6253/2020	EPI_ISL_974254	2020-10-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6141/2020	EPI_ISL_974271	2020-10-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6912/2020	EPI_ISL_974276	2020-10-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6913/2020	EPI_ISL_974277	2020-10-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6915/2020	EPI_ISL_974279	2020-10-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6998/2020	EPI_ISL_974282	2020-10-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6142/2020	EPI_ISL_974296	2020-10-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7036/2020	EPI_ISL_975000	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7037/2020	EPI_ISL_975001	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7039/2020	EPI_ISL_975003	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7215/2020	EPI_ISL_975009	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7216/2020	EPI_ISL_975010	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/Canada/BC-BCCDC-7330/2020	EPI_ISL_975012	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7337/2020	EPI_ISL_975013	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7526/2020	EPI_ISL_975020	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7618/2020	EPI_ISL_975022	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7814/2020	EPI_ISL_975023	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7815/2020	EPI_ISL_975024	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	G
hCoV-19/Canada/BC-BCCDC-7816/2020	EPI_ISL_975025	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8098/2020	EPI_ISL_975028	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8099/2020	EPI_ISL_975029	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9378/2020	EPI_ISL_975032	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-9957/2020	EPI_ISL_975033	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-10600/2020	EPI_ISL_975037	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10642/2020	EPI_ISL_975039	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10643/2020	EPI_ISL_975040	2020-11-06	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-6888/2020	EPI_ISL_975041	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7042/2020	EPI_ISL_975043	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7044/2020	EPI_ISL_975045	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7046/2020	EPI_ISL_975046	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7054/2020	EPI_ISL_975053	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7055/2020	EPI_ISL_975054	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7107/2020	EPI_ISL_975056	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7223/2020	EPI_ISL_975062	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7313/2020	EPI_ISL_975064	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7336/2020	EPI_ISL_975065	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7344/2020	EPI_ISL_975066	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7346/2020	EPI_ISL_975067	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7619/2020	EPI_ISL_975068	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7818/2020	EPI_ISL_975078	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7597/2020	EPI_ISL_975507	2020-11-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7598/2020	EPI_ISL_975508	2020-11-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7772/2020	EPI_ISL_975509	2020-11-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7774/2020	EPI_ISL_975511	2020-11-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7852/2020	EPI_ISL_975516	2020-11-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7968/2020	EPI_ISL_975520	2020-11-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7969/2020	EPI_ISL_975521	2020-11-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8218/2020	EPI_ISL_975530	2020-11-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8330/2020	EPI_ISL_975537	2020-11-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9851/2020	EPI_ISL_975539	2020-11-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10580/2020	EPI_ISL_975540	2020-11-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-10622/2020	EPI_ISL_975545	2020-11-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7611/2020	EPI_ISL_975557	2020-11-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7612/2020	EPI_ISL_975558	2020-11-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7862/2020	EPI_ISL_975570	2020-11-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7971/2020	EPI_ISL_975571	2020-11-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7974/2020	EPI_ISL_975574	2020-11-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7977/2020	EPI_ISL_975576	2020-11-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7981/2020	EPI_ISL_975580	2020-11-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8331/2020	EPI_ISL_975586	2020-11-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8335/2020	EPI_ISL_975587	2020-11-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8434/2020	EPI_ISL_975589	2020-11-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10630/2020	EPI_ISL_975596	2020-11-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8729/2020	EPI_ISL_976303	2020-12-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8913/2020	EPI_ISL_976306	2020-12-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8915/2020	EPI_ISL_976307	2020-12-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Canada/BC-BCCDC-8919/2020	EPI_ISL_976311	2020-12-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8997/2020	EPI_ISL_976314	2020-12-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8998/2020	EPI_ISL_976315	2020-12-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8999/2020	EPI_ISL_976316	2020-12-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8920/2020	EPI_ISL_976343	2020-12-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8921/2020	EPI_ISL_976344	2020-12-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9088/2020	EPI_ISL_976355	2020-12-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9457/2020	EPI_ISL_976367	2020-12-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9182/2020	EPI_ISL_976388	2020-12-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9997/2020	EPI_ISL_976842	2020-12-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10109/2020	EPI_ISL_976844	2020-12-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9719/2020	EPI_ISL_976851	2020-12-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9721/2020	EPI_ISL_976852	2020-12-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9722/2020	EPI_ISL_976853	2020-12-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9725/2020	EPI_ISL_976856	2020-12-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9726/2020	EPI_ISL_976857	2020-12-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10000/2020	EPI_ISL_976858	2020-12-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10001/2020	EPI_ISL_976859	2020-12-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10189/2020	EPI_ISL_976861	2020-12-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9728/2020	EPI_ISL_976864	2020-12-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9731/2020	EPI_ISL_976866	2020-12-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9732/2020	EPI_ISL_976875	2020-12-31	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9733/2020	EPI_ISL_976876	2020-12-31	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9827/2020	EPI_ISL_976878	2020-12-31	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10203/2020	EPI_ISL_976882	2020-12-31	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9647/2021	EPI_ISL_976883	2021-01-01	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9649/2021	EPI_ISL_976886	2021-01-02	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/ON-PPS-21012021_0333/2021	EPI_ISL_982783	2021-01-20	North America / Canada / Ontario	Human	Original		Screened for Variants of Concern (VoC) with C19-SPAR-Seq	Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Turkey/37-Ankara-GUMV-50768/2020	EPI_ISL_984739	2020-11-20	Europe / Turkey / Ankara	Human	Original			Illumina iSeq 100		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Turkey/43-Ankara-GUMV-50892/2020	EPI_ISL_984741	2020-11-21	Europe / Turkey / Ankara	Human	Original			Illumina iSeq 100		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Turkey/15-Ankara-GUMV-49780/2020	EPI_ISL_984743	2020-11-17	Europe / Turkey / Ankara	Human	Original			Illumina iSeq 100				B.1.36.1	GH
hCoV-19/Turkey/33-Ankara-GUMV-50642/2020	EPI_ISL_984750	2020-11-20	Europe / Turkey / Ankara	Human	Original			Illumina iSeq 100				B.1.469	GH
hCoV-19/Turkey/35-Ankara-GUMV-50667/2020	EPI_ISL_984751	2020-11-20	Europe / Turkey / Ankara	Human	Original			Illumina iSeq 100				B.1.36.1	GH
hCoV-19/Switzerland/AG-ETHZ-461219/2021	EPI_ISL_1003297	2021-01-20	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BL-ETHZ-441155/2021	EPI_ISL_1004271	2021-01-07	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BS-ETHZ-441123/2021	EPI_ISL_1004276	2021-01-07	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BE-ETHZ-440716/2021	EPI_ISL_1004501	2021-01-03	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/USA/NY-Wadsworth-21018777-01/2021	EPI_ISL_1016231	2021-01-31	North America / USA / New York / Bronx	Human	Original			Illumina NextSeq	ARTIC nf pipeline			B.1.36	GH
hCoV-19/USA/CT-Yale-1284/2020	EPI_ISL_1017585	2020-08-17	North America / USA / Connecticut	Human	Original	Nasopharyngeal swab		Illumina NovaSeq				B.1.36.8	GH
hCoV-19/Singapore/195/2021	EPI_ISL_1034263	2021-02-11	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.16	GH
hCoV-19/Singapore/202/2021	EPI_ISL_1034270	2021-02-12	Asia / Singapore	Human	Original			Illumina MiSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Singapore/205/2021	EPI_ISL_1034273	2021-02-11	Asia / Singapore	Human	Original			Illumina MiSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Norway/7238/2020	EPI_ISL_1034322	2020-12-28	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	Gap of 15 nucleotides when compared to the reference sequence.	info	B.1.36.21	GH
hCoV-19/Norway/0070/2021	EPI_ISL_1034327	2021-01-02	Europe / Norway / Innlandet	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/0505/2021	EPI_ISL_1034339	2021-01-11	Europe / Norway / Nordland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.22	GH
hCoV-19/Norway/0874/2021	EPI_ISL_1034342	2021-01-18	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/7550/2020	EPI_ISL_1034347	2020-12-02	Europe / Norway / Trondelag	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/0904/2021	EPI_ISL_1034362	2021-01-14	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.1	GH
hCoV-19/Norway/0905/2021	EPI_ISL_1034363	2021-01-14	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.1	GH
hCoV-19/Norway/0873/2021	EPI_ISL_1034365	2021-01-16	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/England/TFCI-2706726/2020	EPI_ISL_1054848	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/Belgium/rega-2973/2021	EPI_ISL_1057017	2021-02-04	Europe / Belgium / Geel	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic Network methods	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Switzerland/BE-ETHZ-461519/2021	EPI_ISL_1059582	2021-01-20	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BE-ETHZ-461459/2021	EPI_ISL_1059587	2021-01-19	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BE-ETHZ-481486/2021	EPI_ISL_1059616	2021-01-04	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/LU-ETHZ-461437/2021	EPI_ISL_1059665	2021-01-19	Europe / Switzerland / Lucerne	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/SH-ETHZ-471402/2021	EPI_ISL_1059690	2021-01-28	Europe / Switzerland / Schaffhausen	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Denmark/DCGC-47282/2020	EPI_ISL_1066817	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/India/PB-ICMR-19789/2020	EPI_ISL_1069083	2020-06-16	Asia / India / Punjab	Human	Original			Illumina MiniSeq	CLC Genomics Workbench 11.0	NS8_G8stop results in 94.2% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/India/CH-ICMR-20323/2020	EPI_ISL_1069084	2020-06-18	Asia / India / Chandigarh	Human	Original	Throat / Nasal swab		Illumina MiniSeq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/India/CH-ICMR-53854/2020	EPI_ISL_1070020	2020-08-29	Asia / India / Chandigarh	Human	Original	Nasopharyngeal swab		Illumina Miniseq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/India/CH-ICMR-53929/2020	EPI_ISL_1071223	2020-08-29	Asia / India / Chandigarh	Human	Original	Nasopharyngeal swab		Illumina Miniseq	CLC Genomics Workbench 11.0			B.1.36	GH
hCoV-19/Thailand/SamutSakhon-CONI-0468/2021	EPI_ISL_1073966	2021-01-10	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2	Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0451/2021	EPI_ISL_1073967	2021-01-19	Asia / Thailand / Bangkok	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0452/2021	EPI_ISL_1073968	2021-01-19	Asia / Thailand / Bangkok	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0456/2021	EPI_ISL_1073969	2021-01-19	Asia / Thailand / Bangkok	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0457/2021	EPI_ISL_1073970	2021-01-19	Asia / Thailand / Bangkok	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0458/2021	EPI_ISL_1073971	2021-01-20	Asia / Thailand / Bangkok	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0459/2021	EPI_ISL_1073972	2021-01-20	Asia / Thailand / Bangkok	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0461/2021	EPI_ISL_1073973	2021-01-23	Asia / Thailand / Bangkok	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0462/2021	EPI_ISL_1073974	2021-01-30	Asia / Thailand / Bangkok	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0464/2021	EPI_ISL_1073975	2021-01-21	Asia / Thailand / Bangkok	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0466/2021	EPI_ISL_1073976	2021-01-09	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0467/2021	EPI_ISL_1073977	2021-01-09	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0469/2021	EPI_ISL_1073978	2021-01-11	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0470/2021	EPI_ISL_1073979	2021-01-12	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/SamutSakhon-CONI-0471/2021	EPI_ISL_1073980	2021-01-12	Asia / Thailand / Samut Sakhon	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0488/2021	EPI_ISL_1073981	2021-01-02	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0490/2021	EPI_ISL_1073982	2021-01-02	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0491/2021	EPI_ISL_1073983	2021-01-02	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0492/2021	EPI_ISL_1073984	2021-01-08	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0493/2021	EPI_ISL_1073985	2021-01-08	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0494/2021	EPI_ISL_1073986	2021-01-10	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0496/2021	EPI_ISL_1073987	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0497/2021	EPI_ISL_1073988	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0498/2021	EPI_ISL_1073989	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0500/2021	EPI_ISL_1073990	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0501/2021	EPI_ISL_1073991	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0502/2021	EPI_ISL_1073992	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0503/2021	EPI_ISL_1073993	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0504/2021	EPI_ISL_1073994	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0505/2021	EPI_ISL_1073995	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0506/2021	EPI_ISL_1073996	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0509/2021	EPI_ISL_1073997	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0510/2021	EPI_ISL_1073998	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/PathumThani-CONI-0511/2021	EPI_ISL_1073999	2021-02-09	Asia / Thailand / Pathum Thani	Human	Original			Illumina MiSeq, ARTIC V3, Nextera Flex	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/France/un-HMN-21022180311/2021	EPI_ISL_1085932	2021-02-16	Europe / France	Human	Original	Nasopharyngeal swab		Illumina NextSeq500	Illumina DRAGEN COVIDSeq Test Pipeline v.1.2.2			B.1.36.1	GH
hCoV-19/Russia/StPetersburg-3524/2020	EPI_ISL_415710	2020-03-15	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	UGENE v. 33			B.1	GH
hCoV-19/Portugal/PT0060/2020	EPI_ISL_421463	2020-03-20	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.22	GH
hCoV-19/Netherlands/NA_210/2020	EPI_ISL_422745	2020-03-25	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_258/2020	EPI_ISL_422792	2020-03-30	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Scotland/EDB1112/2020	EPI_ISL_433402	2020-04-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.465	GH
hCoV-19/Austria/Graz-MUG4/2020	EPI_ISL_437200	2020-03-31	Europe / Austria / Styria	Human	Original	lung swab	primary patient sample	Ion Torrent				B.1.465	O
hCoV-19/Austria/Graz-MUG6/2020	EPI_ISL_437202	2020-04-03	Europe / Austria / Styria	Human	Original	nose swab	primary patient sample	Ion Torrent				B.1.465	O
hCoV-19/Austria/Graz-MUG8/2020	EPI_ISL_437298	2020-04-08	Europe / Austria / Styria	Human	Original	nose swab	primary patient sample	Ion Torrent				B.1.465	O
hCoV-19/Austria/Graz-MUG9/2020	EPI_ISL_437299	2020-04-09	Europe / Austria / Styria	Human	Original	lung swab	primary patient sample	Ion Torrent				B.1.465	O
hCoV-19/England/CAMB-810CB/2020	EPI_ISL_438566	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/India/GJ-GBRC25/2020	EPI_ISL_444456	2020-04-26	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/Scotland/EDB3986/2020	EPI_ISL_449272	2020-05-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/India/GJ-GBRC120/2020	EPI_ISL_455017	2020-05-02	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC124/2020	EPI_ISL_455021	2020-05-02	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC126/2020	EPI_ISL_455023	2020-05-02	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC130/2020	EPI_ISL_455027	2020-05-02	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/Australia/NSW551/2020	EPI_ISL_455090	2020-05-12	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1	GH
hCoV-19/New Zealand/20VR1277/2020	EPI_ISL_456202	2020-03-20	Oceania / New Zealand / Auckland	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.22	GH
hCoV-19/England/SHEF-CEE8C/2020	EPI_ISL_457667	2020-05-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	O
hCoV-19/Estonia/ChVir4285/2020	EPI_ISL_457723	2020-03	Europe / Estonia	Human	Original			Illumina NextSeq	bowtie2			B.1.465	GH
hCoV-19/India/GJ-GBRC171/2020	EPI_ISL_467033	2020-06-05	Asia / India / Gujarat / Gandhinagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC172/2020	EPI_ISL_467034	2020-06-05	Asia / India / Gujarat / Kalol	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC177a/2020	EPI_ISL_467041	2020-06-03	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC179a/2020	EPI_ISL_467045	2020-06-03	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC183a/2020	EPI_ISL_467053	2020-06-03	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/England/CAMB-7BEBB/2020	EPI_ISL_470520	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/SHEF-D277B/2020	EPI_ISL_475504	2020-04-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	O
hCoV-19/India/GJ-GBRC226/2020	EPI_ISL_476863	2020-06-11	Asia / India / Gujarat / Dahegam	Human	Original			Ion Torrent	CLC Genomics Workbench 12	NS7b_W29stop results in 34.9% truncation of the protein sequence.	info	B.1.36.8	GH
hCoV-19/India/GJ-GBRC227/2020	EPI_ISL_476864	2020-06-11	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12	NS7b_E3stop results in 95.3% truncation of the protein sequence.	info	B.1.36.8	GH
hCoV-19/India/GJ-GBRC228a/2020	EPI_ISL_476865	2020-06-11	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC228b/2020	EPI_ISL_476866	2020-06-11	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC229a/2020	EPI_ISL_476867	2020-06-12	Asia / India / Gujarat / Palanpur	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/MP-DRDE-3987/2020	EPI_ISL_476889	2020-05-16	Asia / India / Madhya Pradesh	Human	Original			Nanopore				B.1	G
hCoV-19/India/DL-NCDC5725-CSIR-IGIB/2020	EPI_ISL_482612	2020-05-23	Asia / India / Delhi	Human	Original			Nanopore MinION	Reference based			B.1.36	G
hCoV-19/India/DL-NCDC7104-CSIR-IGIB/2020	EPI_ISL_482631	2020-05-27	Asia / India / Delhi	Human	Original			Nanopore MinION	Reference based			B.1.36	G
hCoV-19/India/DL-NCDC7515-CSIR-IGIB/2020	EPI_ISL_482635	2020-05-28	Asia / India / Delhi	Human	Original			Nanopore MinION	Reference based			B.1	O
hCoV-19/India/DL-NCDC7549-CSIR-IGIB/2020	EPI_ISL_482640	2020-05-27	Asia / India / Delhi	Human	Original			Nanopore MinION	Reference based			B.1.36	G
hCoV-19/India/DL-NCDC7554-CSIR-IGIB/2020	EPI_ISL_482641	2020-05-27	Asia / India / Delhi	Human	Original			Nanopore MinION	Reference based			B.1.36	O
hCoV-19/India/DL-NCDC7757-CSIR-IGIB/2020	EPI_ISL_482669	2020-05-28	Asia / India / Delhi	Human	Original			Nanopore MinION	Reference based			B.1.36	O
hCoV-19/India/GJ-GBRC239/2020	EPI_ISL_483820	2020-06-11	Asia / India / Gujarat / Gandhinagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.465	GH
hCoV-19/India/GJ-GBRC240/2020	EPI_ISL_483821	2020-06-05	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC243/2020	EPI_ISL_483824	2020-06-14	Asia / India / Gujarat / Himatnagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC244/2020	EPI_ISL_483825	2020-06-14	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC247/2020	EPI_ISL_483828	2020-06-19	Asia / India / Gujarat / Talod	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC248a/2020	EPI_ISL_483829	2020-06-12	Asia / India / Gujarat / Rajkot	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC248b/2020	EPI_ISL_483830	2020-06-12	Asia / India / Gujarat / Rajkot	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC249a/2020	EPI_ISL_483831	2020-06-12	Asia / India / Gujarat / Rajkot	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC250a/2020	EPI_ISL_483833	2020-06-12	Asia / India / Gujarat / Chuda	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC253a/2020	EPI_ISL_483838	2020-06-12	Asia / India / Gujarat / Rajkot	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.113	GH
hCoV-19/USA/CA-CZB-2050/2020	EPI_ISL_486294	2020-04-21	North America / USA / California / San Joaquin County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.110	GH
hCoV-19/Australia/VIC2119/2020	EPI_ISL_487271	2020-06-17	Oceania / Australia / Victoria	Human	unknown			Illumina	ARTIC v. 3; minimap2 v. 2.17; iVar v. 1.1;	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/India/GJ-GBRC288/2020	EPI_ISL_500946	2020-06-15	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC317/2020	EPI_ISL_500947	2020-06-17	Asia / India / Gujarat / Surat	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/Australia/WA64/2020	EPI_ISL_512717	2020-05-30	Oceania / Australia / Western Australia	Human	Original			Illumina MiSeq				B.1.160	GH
hCoV-19/Singapore/799/2020	EPI_ISL_512835	2020-07-17	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/800/2020	EPI_ISL_512836	2020-07-17	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/803/2020	EPI_ISL_512839	2020-07-27	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.470	GH
hCoV-19/Singapore/804/2020	EPI_ISL_512840	2020-07-27	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.470	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH1000/2020	EPI_ISL_512874	2020-06-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH1001/2020	EPI_ISL_512875	2020-06-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH1003/2020	EPI_ISL_512877	2020-06-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH1010/2020	EPI_ISL_512881	2020-06-17	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH1012/2020	EPI_ISL_512883	2020-06-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH1016/2020	EPI_ISL_512887	2020-06-17	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH1022/2020	EPI_ISL_512892	2020-06-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH1025/2020	EPI_ISL_512895	2020-06-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH1033/2020	EPI_ISL_512902	2020-06-23	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH313/2020	EPI_ISL_512908	2020-04-15	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH317/2020	EPI_ISL_512909	2020-04-15	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH322/2020	EPI_ISL_512911	2020-04-15	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH323/2020	EPI_ISL_512912	2020-04-15	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1.36.8	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH324/2020	EPI_ISL_512913	2020-04-15	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH329/2020	EPI_ISL_512914	2020-04-16	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH330/2020	EPI_ISL_512915	2020-04-12	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH331/2020	EPI_ISL_512916	2020-04-15	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH456/2020	EPI_ISL_512918	2020-04-15	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH457/2020	EPI_ISL_512919	2020-04-15	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH462/2020	EPI_ISL_512920	2020-08-04	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH466/2020	EPI_ISL_512921	2020-08-04	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH469/2020	EPI_ISL_512924	2020-08-04	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH471/2020	EPI_ISL_512926	2020-08-04	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH473/2020	EPI_ISL_512927	2020-08-04	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH482/2020	EPI_ISL_512929	2020-04-01	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina MiSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH483/2020	EPI_ISL_512930	2020-04-02	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH486/2020	EPI_ISL_512931	2020-04-08	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH487/2020	EPI_ISL_512932	2020-04-06	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH488/2020	EPI_ISL_512933	2020-04-08	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH492/2020	EPI_ISL_512935	2020-04-09	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.471	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH493/2020	EPI_ISL_512936	2020-04-09	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	G
hCoV-19/Saudi Arabia/KAUST-JEDDAH496/2020	EPI_ISL_512938	2020-04-09	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH497/2020	EPI_ISL_512939	2020-04-09	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH504/2020	EPI_ISL_512941	2020-04-16	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-JEDDAH505/2020	EPI_ISL_512942	2020-04-16	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1	GH
hCoV-19/Netherlands/NH-EMC-47/2020	EPI_ISL_523416	2020-07-04	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/OV-EMC-36/2020	EPI_ISL_523420	2020-04-16	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/OV-EMC-39/2020	EPI_ISL_523423	2020-04-17	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/OV-EMC-41/2020	EPI_ISL_523425	2020-04-21	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/OV-EMC-43/2020	EPI_ISL_523427	2020-04-28	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/OV-EMC-46/2020	EPI_ISL_523430	2020-04-29	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/OV-EMC-47/2020	EPI_ISL_523431	2020-04-29	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/OV-EMC-48/2020	EPI_ISL_523432	2020-04-29	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/OV-EMC-49/2020	EPI_ISL_523433	2020-05-03	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/un-EMC-738/2020	EPI_ISL_523493	2020-06-10	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/un-EMC-739/2020	EPI_ISL_523494	2020-06-10	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/un-EMC-752/2020	EPI_ISL_523508	2020-06-27	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/un-EMC-762/2020	EPI_ISL_523518	2020	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/un-EMC-764/2020	EPI_ISL_523520	2020	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/un-EMC-765/2020	EPI_ISL_523521	2020	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/UT-EMC-51/2020	EPI_ISL_523528	2020-05-26	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZE-EMC-57/2020	EPI_ISL_523556	2020-06-15	Europe / Netherlands / Zeeland	Human	Original			Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence.	info	B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-227/2020	EPI_ISL_523569	2020-05-15	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-228/2020	EPI_ISL_523570	2020-05-17	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-229/2020	EPI_ISL_523571	2020-05-18	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-230/2020	EPI_ISL_523572	2020-05-09	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-231/2020	EPI_ISL_523573	2020-05-12	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-238/2020	EPI_ISL_523580	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-241/2020	EPI_ISL_523583	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-242/2020	EPI_ISL_523584	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-243/2020	EPI_ISL_523585	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-244/2020	EPI_ISL_523586	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-245/2020	EPI_ISL_523587	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-246/2020	EPI_ISL_523588	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-249/2020	EPI_ISL_523591	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-250/2020	EPI_ISL_523592	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-251/2020	EPI_ISL_523593	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-255/2020	EPI_ISL_523597	2020-06-30	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/India/GJ-GBRC-363/2020	EPI_ISL_524715	2020-06-18	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-364a/2020	EPI_ISL_524716	2020-06-18	Asia / India / Gujarat / Daskroi	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-364b/2020	EPI_ISL_524717	2020-06-18	Asia / India / Gujarat / Daskroi	Human	Original			Ion Torrent	CLC Genomics Workbench 12	NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.36.8	GH
hCoV-19/India/GJ-GBRC-365/2020	EPI_ISL_524718	2020-06-18	Asia / India / Gujarat / Daskroi	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-366a/2020	EPI_ISL_524719	2020-06-18	Asia / India / Gujarat / Dhandhuka	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC-367a/2020	EPI_ISL_524721	2020-06-18	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12	NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.36.8	GH
hCoV-19/India/GJ-GBRC-367b/2020	EPI_ISL_524722	2020-06-18	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-368a/2020	EPI_ISL_524723	2020-06-18	Asia / India / Gujarat / Dahegam	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-368b/2020	EPI_ISL_524724	2020-06-18	Asia / India / Gujarat / Dahegam	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36	GH
hCoV-19/India/GJ-GBRC-369/2020	EPI_ISL_524725	2020-06-18	Asia / India / Gujarat / Daskroi	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC-371/2020	EPI_ISL_524727	2020-06-18	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-372/2020	EPI_ISL_524728	2020-06-18	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-373/2020	EPI_ISL_524729	2020-06-18	Asia / India / Gujarat / Ahmedabad	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.523	GH
hCoV-19/India/GJ-GBRC-374a/2020	EPI_ISL_524730	2020-06-15	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-374b/2020	EPI_ISL_524731	2020-06-15	Asia / India / Gujarat / Vadodara	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-377a/2020	EPI_ISL_524735	2020-07-11	Asia / India / Gujarat / Khambhaliya	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-378/2020	EPI_ISL_524737	2020-06-18	Asia / India / Gujarat / Gandhinagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-379/2020	EPI_ISL_524738	2020-06-18	Asia / India / Gujarat / Mansa	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-380a/2020	EPI_ISL_524739	2020-06-18	Asia / India / Gujarat / Gandhinagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.184	GH
hCoV-19/India/GJ-GBRC-381/2020	EPI_ISL_524741	2020-06-18	Asia / India / Gujarat / Gandhinagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-383a/2020	EPI_ISL_524742	2020-06-18	Asia / India / Gujarat / Gandhinagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-386a/2020	EPI_ISL_524747	2020-07-11	Asia / India / Gujarat / Jamnagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-386b/2020	EPI_ISL_524748	2020-07-11	Asia / India / Gujarat / Jamnagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-388/2020	EPI_ISL_524751	2020-07-11	Asia / India / Gujarat / Jamnagar	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-389a/2020	EPI_ISL_524752	2020-07-06	Asia / India / Gujarat / Patan	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.465	GH
hCoV-19/India/GJ-GBRC-389b/2020	EPI_ISL_524753	2020-07-06	Asia / India / Gujarat / Patan	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.465	GH
hCoV-19/India/GJ-GBRC-390a/2020	EPI_ISL_524754	2020-07-06	Asia / India / Gujarat / Patan	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-391a/2020	EPI_ISL_524756	2020-07-06	Asia / India / Gujarat / Patan	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/India/GJ-GBRC-392a/2020	EPI_ISL_524758	2020-07-06	Asia / India / Gujarat / Patan	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC-392b/2020	EPI_ISL_524759	2020-07-06	Asia / India / Gujarat / Patan	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC-394a/2020	EPI_ISL_524762	2020-07-06	Asia / India / Gujarat / Patan	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC-394b/2020	EPI_ISL_524763	2020-07-06	Asia / India / Gujarat / Patan	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	GH
hCoV-19/India/GJ-GBRC-396/2020	EPI_ISL_524766	2020-07-06	Asia / India / Gujarat / Siddhpur	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.36.8	GH
hCoV-19/Ireland/LK-NVRL-72IRL07419/2020	EPI_ISL_528443	2020-08-09	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/LK-NVRL-72IRL07430/2020	EPI_ISL_528444	2020-08-09	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/LK-NVRL-72IRL07432/2020	EPI_ISL_528445	2020-08-09	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/LK-NVRL-72IRL07454/2020	EPI_ISL_528446	2020-08-10	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/CO-NVRL-72IRL13552/2020	EPI_ISL_528471	2020-08-12	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Ireland/LK-NVRL-72IRL16602/2020	EPI_ISL_528475	2020-08-12	Europe / Ireland / Limerick	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.36.22	GH
hCoV-19/Wales/PHWC-169E82/2020	EPI_ISL_529707	2020-08-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Wales/PHWC-169EDD/2020	EPI_ISL_529710	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.36.1	GH
hCoV-19/England/QEUH-969C08/2020	EPI_ISL_530841	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-969CF9/2020	EPI_ISL_530842	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-96C607/2020	EPI_ISL_530882	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Sweden/20-08939/2020	EPI_ISL_534229	2020-07-15	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1	GH
hCoV-19/England/LEED-2A867F/2020	EPI_ISL_539083	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/LEED-2A8DE3/2020	EPI_ISL_539167	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/LEED-2A8563/2020	EPI_ISL_539171	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/QEUH-998990/2020	EPI_ISL_540083	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Netherlands/GE-RIVM-10112/2020	EPI_ISL_547464	2020-03-16	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/LI-RIVM-10151/2020	EPI_ISL_547479	2020-04-24	Europe / Netherlands / Limburg	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/OV-RIVM-10149/2020	EPI_ISL_547512	2020	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/OV-RIVM-10152/2020	EPI_ISL_547513	2020-07-21	Europe / Netherlands / Overijssel	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10060/2020	EPI_ISL_547518	2020-03-30	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10153/2020	EPI_ISL_547540	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10154/2020	EPI_ISL_547541	2020-07-31	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10155/2020	EPI_ISL_547542	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10156/2020	EPI_ISL_547543	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10157/2020	EPI_ISL_547544	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10158/2020	EPI_ISL_547545	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10159/2020	EPI_ISL_547546	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10160/2020	EPI_ISL_547547	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10161/2020	EPI_ISL_547548	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10162/2020	EPI_ISL_547549	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10163/2020	EPI_ISL_547550	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10164/2020	EPI_ISL_547551	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10165/2020	EPI_ISL_547552	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10166/2020	EPI_ISL_547553	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10167/2020	EPI_ISL_547554	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10168/2020	EPI_ISL_547555	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/UT-RIVM-10169/2020	EPI_ISL_547556	2020	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/India/HR-IMT-BZ16/2020	EPI_ISL_547585	2020-08-25	Asia / India / Haryana	Human	Original	Nasopharyngeal swab		Nanopore, MinION	EzCOVID19			B.1.36	GH
hCoV-19/India/HR-IMT-BZ140/2020	EPI_ISL_547588	2020-08-25	Asia / India / Haryana	Human	Original	Nasopharyngeal swab		Nanopore, MinION	EzCOVID19			B.1.36	GH
hCoV-19/India/HR-IMT-CB29/2020	EPI_ISL_547589	2020-08-27	Asia / India / Haryana	Human	Original	Nasopharyngeal swab		Nanopore, MinION	EzCOVID19	NSP14_Y420stop results in 20.5% truncation of the protein sequence.	info	B.1.36.8	GH
hCoV-19/India/HR-IMT-CB44/2020	EPI_ISL_547590	2020-08-27	Asia / India / Haryana	Human	Original	Nasopharyngeal swab		Nanopore, MinION	EzCOVID19			B.1.36.8	O
hCoV-19/India/HR-IMT-CB130/2020	EPI_ISL_547592	2020-08-27	Asia / India / Haryana	Human	Original	Nasopharyngeal swab		Nanopore, MinION	EzCOVID19			B.1.36	O
hCoV-19/England/MILK-992BAF/2020	EPI_ISL_552027	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-992B90/2020	EPI_ISL_552120	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-992EC4/2020	EPI_ISL_552137	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9705B8/2020	EPI_ISL_553237	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-9707C1/2020	EPI_ISL_553266	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-9536A9/2020	EPI_ISL_554571	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/ALDP-9533DF/2020	EPI_ISL_554598	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/ALDP-9441F5/2020	EPI_ISL_554692	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/ALDP-944201/2020	EPI_ISL_554777	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/MILK-5642D2/2020	EPI_ISL_558239	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/MILK-9C27B1/2020	EPI_ISL_566546	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C2A7C/2020	EPI_ISL_566562	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C2C94/2020	EPI_ISL_566565	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C2E9E/2020	EPI_ISL_566669	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C3677/2020	EPI_ISL_566684	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C42FA/2020	EPI_ISL_566713	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C3194/2020	EPI_ISL_566723	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-9C455B/2020	EPI_ISL_566732	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C4157/2020	EPI_ISL_566761	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-9C4579/2020	EPI_ISL_566781	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.36.28	GH
hCoV-19/England/MILK-9C32CE/2020	EPI_ISL_566816	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Canada/ON-UHTC-0270/2020	EPI_ISL_570002	2020-06-19	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.36	GH
hCoV-19/Scotland/QEUH-9B3E54/2020	EPI_ISL_573808	2020-09-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.36.20	GH
hCoV-19/Scotland/QEUH-9B3F7F/2020	EPI_ISL_573809	2020-09-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.36.23	GH
hCoV-19/Scotland/QEUH-9BA6DD/2020	EPI_ISL_573825	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.36.20	GH
hCoV-19/Scotland/QEUH-9BAD9C/2020	EPI_ISL_573839	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.36.20	GH
hCoV-19/Scotland/QEUH-9BAFE1/2020	EPI_ISL_573854	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.36.20	GH
hCoV-19/Wales/PHWC-16B758/2020	EPI_ISL_573896	2020-09-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/QEUH-9D1685/2020	EPI_ISL_577295	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/Scotland/QEUH-9AE654/2020	EPI_ISL_577363	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.523	GH
hCoV-19/Scotland/QEUH-9D15C4/2020	EPI_ISL_577380	2020-09-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/QEUH-9E4F48/2020	EPI_ISL_579874	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-9DCBB8/2020	EPI_ISL_580863	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-9DC954/2020	EPI_ISL_580871	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DCB30/2020	EPI_ISL_580973	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-9DCBC7/2020	EPI_ISL_580983	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/QEUH-9DC7F0/2020	EPI_ISL_580984	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-9DC5BA/2020	EPI_ISL_580994	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9E0F6A/2020	EPI_ISL_580998	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/USA/MI-UM-10036036877/2020	EPI_ISL_583379	2020-09-19	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.8	GH
hCoV-19/Wales/PHWC-16EF20/2020	EPI_ISL_585886	2020-09-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.471	GH
hCoV-19/England/ALDP-9FC9C7/2020	EPI_ISL_588038	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9E5C8C/2020	EPI_ISL_589292	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9E5C40/2020	EPI_ISL_589317	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9E5958/2020	EPI_ISL_589398	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-9B59AC/2020	EPI_ISL_590263	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-9B59E8/2020	EPI_ISL_590283	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-9B5229/2020	EPI_ISL_590294	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9B5854/2020	EPI_ISL_590321	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-9B4CB3/2020	EPI_ISL_590330	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B4E53/2020	EPI_ISL_590341	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/QEUH-9B4EAE/2020	EPI_ISL_590344	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/QEUH-9B51B3/2020	EPI_ISL_590348	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B4DFC/2020	EPI_ISL_590365	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/NOTT-1155CC/2020	EPI_ISL_595251	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Australia/WA136/2020	EPI_ISL_596699	2020-08-11	Oceania / Australia / Western Australia	Human	Original			Illumina MiSeq				B.1.36.1	GH
hCoV-19/England/MILK-A057A2/2020	EPI_ISL_600121	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A06A7B/2020	EPI_ISL_600125	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-9FF8F4/2020	EPI_ISL_600161	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_E41stop results in 66.9% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/QEUH-A0083B/2020	EPI_ISL_600267	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/QEUH-A0026A/2020	EPI_ISL_600272	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9FFB28/2020	EPI_ISL_600279	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-9DA507/2020	EPI_ISL_601454	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.23	GH
hCoV-19/England/MILK-9D3EA9/2020	EPI_ISL_601529	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9D492F/2020	EPI_ISL_601563	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9D3F5B/2020	EPI_ISL_601568	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9D4093/2020	EPI_ISL_601626	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-9D4901/2020	EPI_ISL_601644	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9D451C/2020	EPI_ISL_601669	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-9D21DE/2020	EPI_ISL_601673	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A7D2E0/2020	EPI_ISL_606304	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A7C72E/2020	EPI_ISL_606394	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-A7C1E4/2020	EPI_ISL_606437	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A7C111/2020	EPI_ISL_606439	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-A7D523/2020	EPI_ISL_606450	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A6E974/2020	EPI_ISL_607633	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-A6F3B1/2020	EPI_ISL_607637	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A6E929/2020	EPI_ISL_607689	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-A6E886/2020	EPI_ISL_607732	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A680A2/2020	EPI_ISL_608914	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/CAMC-A64677/2020	EPI_ISL_608968	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/BIRM-65B9F/2020	EPI_ISL_612209	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/BIRM-65BDB/2020	EPI_ISL_612212	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-65C23/2020	EPI_ISL_612213	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-65CC9/2020	EPI_ISL_612219	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-65D20/2020	EPI_ISL_612221	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-65D3F/2020	EPI_ISL_612222	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36	GH
hCoV-19/England/BIRM-65D5D/2020	EPI_ISL_612224	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-65D99/2020	EPI_ISL_612226	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-65DD5/2020	EPI_ISL_612229	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.523	GH
hCoV-19/England/BIRM-6619C/2020	EPI_ISL_612242	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-66396/2020	EPI_ISL_612260	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/Scotland/EDB8328/2020	EPI_ISL_612322	2020-09-28	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.36.23	GH
hCoV-19/Gibraltar/204421247/2020	EPI_ISL_613570	2020-10-27	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/Denmark/DCGC-1006/2020	EPI_ISL_614777	2020-04-20	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.465	GH
hCoV-19/Denmark/DCGC-920/2020	EPI_ISL_614885	2020-03-30	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.465	GH
hCoV-19/Denmark/DCGC-8049/2020	EPI_ISL_617047	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-8221/2020	EPI_ISL_617048	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-8222/2020	EPI_ISL_617049	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-8289/2020	EPI_ISL_617050	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-8297/2020	EPI_ISL_617051	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-8364/2020	EPI_ISL_617052	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-8365/2020	EPI_ISL_617053	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-8375/2020	EPI_ISL_617054	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-1953/2020	EPI_ISL_618327	2020-07-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-2443/2020	EPI_ISL_618364	2020-08-03	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Denmark/DCGC-2444/2020	EPI_ISL_618365	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1	GH
hCoV-19/Denmark/DCGC-6917/2020	EPI_ISL_619763	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.8	GH
hCoV-19/England/ALDP-AA2B32/2020	EPI_ISL_624109	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA0E86/2020	EPI_ISL_624129	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA0E4A/2020	EPI_ISL_624151	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA230D/2020	EPI_ISL_624259	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA2376/2020	EPI_ISL_624297	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA1F19/2020	EPI_ISL_624312	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/Australia/NSW1148/2020	EPI_ISL_629001	2020-09-17	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36	GH
hCoV-19/England/MILK-ACE259/2020	EPI_ISL_629173	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-ACE2D1/2020	EPI_ISL_629189	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-ACE417/2020	EPI_ISL_629197	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ACDF17/2020	EPI_ISL_630015	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-AC93F1/2020	EPI_ISL_630049	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ACE022/2020	EPI_ISL_630065	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-ACCB23/2020	EPI_ISL_630073	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-ACDD68/2020	EPI_ISL_630076	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-ACDD0E/2020	EPI_ISL_630082	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/MILK-ACD102/2020	EPI_ISL_630083	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Netherlands/UT-EMC-119/2020	EPI_ISL_632644	2020-10-04	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Netherlands/GE-EMC-321/2020	EPI_ISL_632653	2020-10-06	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Netherlands/UT-EMC-122/2020	EPI_ISL_632654	2020-10-06	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-820/2020	EPI_ISL_632695	2020-10-16	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.36	GH
hCoV-19/England/QEUH-AD4FB3/2020	EPI_ISL_633989	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/USA/CA-ALSR-3811/2020	EPI_ISL_636216	2020-07-01	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1	G
hCoV-19/Jordan/IR-ALSR-3902/2020	EPI_ISL_636268	2020-09-30	Asia / Jordan / Irbid	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-3908/2020	EPI_ISL_636274	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-3912/2020	EPI_ISL_636278	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/IR-ALSR-3917/2020	EPI_ISL_636283	2020-09-30	Asia / Jordan / Irbid	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-3918/2020	EPI_ISL_636284	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-3919/2020	EPI_ISL_636285	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-3926/2020	EPI_ISL_636291	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.36.10	GH
hCoV-19/England/QEUH-A36E2B/2020	EPI_ISL_638718	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-A79053/2020	EPI_ISL_638781	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36	GH
hCoV-19/England/SHEF-C392C/2020	EPI_ISL_638882	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/QEUH-B0E4CF/2020	EPI_ISL_642053	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-B0DE3B/2020	EPI_ISL_642060	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-B0D062/2020	EPI_ISL_643332	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B0AF86/2020	EPI_ISL_643339	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B08999/2020	EPI_ISL_643342	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B0B36B/2020	EPI_ISL_643343	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B0C898/2020	EPI_ISL_643348	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/CAMC-B08577/2020	EPI_ISL_643386	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B085A4/2020	EPI_ISL_643392	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/England/CAMC-B0B41D/2020	EPI_ISL_643483	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B22595/2020	EPI_ISL_645905	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/CAMC-B2261A/2020	EPI_ISL_645987	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B22225/2020	EPI_ISL_645994	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/MILK-B0212E/2020	EPI_ISL_649550	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B23109/2020	EPI_ISL_651718	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/ALDP-B5BAC1/2020	EPI_ISL_655298	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.38	GH
hCoV-19/England/ALDP-B5B40F/2020	EPI_ISL_655305	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/ALDP-B5BAEF/2020	EPI_ISL_655322	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-B5BB37/2020	EPI_ISL_655349	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B5BB82/2020	EPI_ISL_655367	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/ALDP-B627FD/2020	EPI_ISL_656631	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Wales/ALDP-B63862/2020	EPI_ISL_656654	2020-11-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B626F0/2020	EPI_ISL_656658	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-B6202F/2020	EPI_ISL_656662	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/ALDP-B620C5/2020	EPI_ISL_656664	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B635A7/2020	EPI_ISL_656680	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B54239/2020	EPI_ISL_656692	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B53FF7/2020	EPI_ISL_656782	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-B54F23/2020	EPI_ISL_657923	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B554C9/2020	EPI_ISL_657925	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B51DB3/2020	EPI_ISL_657949	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/MILK-B554BA/2020	EPI_ISL_657961	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B52453/2020	EPI_ISL_657974	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.22	GH
hCoV-19/England/CAMC-B51C01/2020	EPI_ISL_657994	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B51481/2020	EPI_ISL_657998	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/MILK-B55441/2020	EPI_ISL_657999	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/New Zealand/20CV0594/2020	EPI_ISL_661264	2020-11-20	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.36.39	GH
hCoV-19/England/QEUH-B6B1D8/2020	EPI_ISL_662490	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-B6694E/2020	EPI_ISL_662542	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-B6A6E9/2020	EPI_ISL_662563	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-B6B044/2020	EPI_ISL_662587	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-B668BA/2020	EPI_ISL_662595	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-AF0D99/2020	EPI_ISL_666004	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/Denmark/DCGC-10340/2020	EPI_ISL_669910	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-10415/2020	EPI_ISL_669955	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.471	GH
hCoV-19/Denmark/DCGC-11418/2020	EPI_ISL_670907	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-11476/2020	EPI_ISL_670941	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.1	GH
hCoV-19/Denmark/DCGC-11479/2020	EPI_ISL_670944	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.471	GH
hCoV-19/Denmark/DCGC-11486/2020	EPI_ISL_670950	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-11488/2020	EPI_ISL_670952	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/England/CAMC-B0A4E1/2020	EPI_ISL_673127	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-B0A51B/2020	EPI_ISL_673140	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-B09594/2020	EPI_ISL_673154	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B09DBA/2020	EPI_ISL_673161	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B09D6F/2020	EPI_ISL_673183	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-B09770/2020	EPI_ISL_673184	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/CAMC-B08D33/2020	EPI_ISL_673205	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B08E5E/2020	EPI_ISL_673223	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B8442B/2020	EPI_ISL_674474	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B8E3D9/2020	EPI_ISL_674507	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B8E430/2020	EPI_ISL_674519	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/MILK-B8E4B8/2020	EPI_ISL_674523	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B8F842/2020	EPI_ISL_674531	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/MILK-B8DFB8/2020	EPI_ISL_674580	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/MILK-B8F709/2020	EPI_ISL_674586	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-B83116/2020	EPI_ISL_675710	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/ALDP-B84E3C/2020	EPI_ISL_675825	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-B8970F/2020	EPI_ISL_675837	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B889A0/2020	EPI_ISL_675844	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-B89796/2020	EPI_ISL_675891	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-B8484D/2020	EPI_ISL_675897	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1269/2020	EPI_ISL_678004	2020-06-25	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1277/2020	EPI_ISL_678007	2020-06-25	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1283/2020	EPI_ISL_678008	2020-06-25	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1284/2020	EPI_ISL_678009	2020-06-25	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1362/2020	EPI_ISL_678010	2020-06-11	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1363/2020	EPI_ISL_678011	2020-06-11	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	G
hCoV-19/Saudi Arabia/KAUST-MADINAH1366/2020	EPI_ISL_678012	2020-06-04	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.36.22	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1367/2020	EPI_ISL_678013	2020-06-04	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.36.24	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1373/2020	EPI_ISL_678015	2020-06-04	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1374/2020	EPI_ISL_678016	2020-06-04	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1375/2020	EPI_ISL_678017	2020-06-04	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1379/2020	EPI_ISL_678018	2020-06-11	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1381/2020	EPI_ISL_678019	2020-06-04	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1478/2020	EPI_ISL_678020	2020-06-19	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1483/2020	EPI_ISL_678022	2020-06-19	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1484/2020	EPI_ISL_678023	2020-06-19	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH1487/2020	EPI_ISL_678024	2020-06-19	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH250/2020	EPI_ISL_678027	2020-04-02	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH268/2020	EPI_ISL_678028	2020-04-01	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH451/2020	EPI_ISL_678030	2020-04-21	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH453/2020	EPI_ISL_678031	2020-04-21	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH602/2020	EPI_ISL_678032	2020-04-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH654/2020	EPI_ISL_678034	2020-05-08	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.36	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH663/2020	EPI_ISL_678036	2020-04-01	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MADINAH665/2020	EPI_ISL_678037	2020-03-26	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MADINAH673/2020	EPI_ISL_678038	2020-04-01	Asia / Saudi Arabia / Madinah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH176/2020	EPI_ISL_678073	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH191/2020	EPI_ISL_678074	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH221/2020	EPI_ISL_678075	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH1404/2020	EPI_ISL_678088	2020-06-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	G
hCoV-19/Saudi Arabia/KAUST-MAKKAH1415/2020	EPI_ISL_678092	2020-06-28	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	G
hCoV-19/Saudi Arabia/KAUST-MAKKAH1421/2020	EPI_ISL_678093	2020-06-29	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH150/2020	EPI_ISL_678096	2020-03-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH1504/2020	EPI_ISL_678098	2020-04-14	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH1515/2020	EPI_ISL_678099	2020-04-14	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH1517/2020	EPI_ISL_678100	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH1520/2020	EPI_ISL_678101	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH1525/2020	EPI_ISL_678102	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH1527/2020	EPI_ISL_678103	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH1537/2020	EPI_ISL_678105	2020-04-13	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH1539/2020	EPI_ISL_678106	2020-04-13	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH1549/2020	EPI_ISL_678108	2020-04-13	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH1554/2020	EPI_ISL_678109	2020-04-13	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH1557/2020	EPI_ISL_678110	2020-04-14	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH1559/2020	EPI_ISL_678112	2020-04-14	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	G
hCoV-19/Saudi Arabia/KAUST-MAKKAH1560/2020	EPI_ISL_678113	2020-04-14	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH1562/2020	EPI_ISL_678114	2020-04-14	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH1566/2020	EPI_ISL_678115	2020-04-14	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH1588/2020	EPI_ISL_678118	2020-04-14	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH1592/2020	EPI_ISL_678119	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH1595/2020	EPI_ISL_678120	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH1596/2020	EPI_ISL_678121	2020-04-13	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH1602/2020	EPI_ISL_678122	2020-04-14	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH1604/2020	EPI_ISL_678123	2020-04-14	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH1605/2020	EPI_ISL_678124	2020-04-26	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH1617/2020	EPI_ISL_678126	2020-04-26	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH162/2020	EPI_ISL_678127	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH1623/2020	EPI_ISL_678129	2020-04-26	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH1632/2020	EPI_ISL_678133	2020-04-26	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	O
hCoV-19/Saudi Arabia/KAUST-MAKKAH167/2020	EPI_ISL_678135	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH172/2020	EPI_ISL_678136	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1	GH
hCoV-19/Saudi Arabia/KAUST-MAKKAH206/2020	EPI_ISL_678138	2020-04-06	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.260	GH
hCoV-19/England/CAMC-BBCD10/2020	EPI_ISL_679276	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.39	GH
hCoV-19/England/MILK-BAABC0/2020	EPI_ISL_681594	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BAA98A/2020	EPI_ISL_681601	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/MILK-BAB45B/2020	EPI_ISL_681605	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-BAC672/2020	EPI_ISL_681613	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BAB224/2020	EPI_ISL_681624	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/ALDP-B853E1/2020	EPI_ISL_681665	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/Chile/MA-CADIUMAG-15/2020	EPI_ISL_681681	2020-04-30	South America / Chile / Magallanes / Puerto Wiilliams	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP-v1.1.0			B.1.110	GH
hCoV-19/England/204561454/2020	EPI_ISL_686544	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/India/MH-ACTREC-062/2020	EPI_ISL_699718	2020-05-16	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/India/MH-ACTREC-094/2020	EPI_ISL_699750	2020-05-22	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1	GH
hCoV-19/India/MH-ACTREC-167/2020	EPI_ISL_699823	2020-06-06	Asia / India / Maharashtra / Mumbai	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1	GH
hCoV-19/India/MH-ACTREC-174/2020	EPI_ISL_699829	2020-06-13	Asia / India / Maharashtra / Mumbai Suburban	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq		NS3_G254stop results in 8.0% truncation of the protein sequence.	info	B.1	GH
hCoV-19/India/MH-ACTREC-194/2020	EPI_ISL_699848	2020-06-22	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/India/MH-ACTREC-195/2020	EPI_ISL_699849	2020-06-22	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/India/MH-ACTREC-196/2020	EPI_ISL_699850	2020-06-22	Asia / India / Maharashtra / Raigad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq				B.1.36	GH
hCoV-19/England/QEUH-BCD990/2020	EPI_ISL_704213	2020-11-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-B5D977/2020	EPI_ISL_705532	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMC-BBBF93/2020	EPI_ISL_705579	2020-11-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.39	GH
hCoV-19/England/CAMC-BBDE2B/2020	EPI_ISL_705625	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.469	GH
hCoV-19/England/CAMC-BC35B4/2020	EPI_ISL_705635	2020-11-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.460	GH
hCoV-19/England/QEUH-A620C6/2020	EPI_ISL_706957	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-A620E4/2020	EPI_ISL_706958	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36	GH
hCoV-19/England/QEUH-A6257C/2020	EPI_ISL_706970	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Australia/NSW1221/2020	EPI_ISL_710120	2020-11-08	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36	GH
hCoV-19/Australia/NSW1229/2020	EPI_ISL_710127	2020-12-01	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36	GH
hCoV-19/Denmark/DCGC-13932/2020	EPI_ISL_711462	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-13965/2020	EPI_ISL_711481	2020-11-30	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.8	GH
hCoV-19/England/ALDP-C49922/2020	EPI_ISL_718979	2020-12-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/India/MH-NCCS-NR-12775/2020	EPI_ISL_722180	2020-07-18	Asia / India / Maharashtra	Human	Original			Illumina MiSeq		Gap of 1 nucleotide found at refpos 942 (frameshift confirmed by the submitter). Gap of 1 nucleotide found at refpos 28085 (frameshift confirmed by the submitter). Gap of 1 nucleotide found at refpos 28985 (frameshift confirmed by the submitter). Gap of 3 nucleotides when compared to the reference sequence. N without BLAST coverage. NS8 without BLAST coverage.	info	B.1.36	GH
hCoV-19/England/LOND-DAEF6/2020	EPI_ISL_724728	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.471	GH
hCoV-19/England/LOND-DB4A8/2020	EPI_ISL_724772	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/LOND-DC52C/2020	EPI_ISL_724777	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/Malaysia/IMR-WC268890/2020	EPI_ISL_728244	2020-11-11	Asia / Malaysia	Human	Original			Illumina NextSeq 500				B.1.36.16	GH
hCoV-19/Italy/LAZ-INMI-113/2020	EPI_ISL_728286	2020-11-26	Europe / Italy / Lazio / Rome	Human	Original	Nasopharyngeal swab		Ion Torrent	BWA 0.7.12 + Samtools 1.3.1 + IRMA			B.1.462	GH
hCoV-19/Germany/TH-IIMK-CaSe-6/2020	EPI_ISL_728296	2020-05-19	Europe / Germany / Thuringia	Human	Original			Nanopore MinION	ARTIC			B.1.22	GH
hCoV-19/Germany/BE-ChVir9004/2020	EPI_ISL_729601	2020-09-22	Europe / Germany / Berlin	Human	Original			MiSeq	bowtie2			B.1.22	GH
hCoV-19/Jordan/AQ-ALSR-5268/2020	EPI_ISL_730506	2020-10-07	Asia / Jordan / Aqaba	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AQ-ALSR-5269/2020	EPI_ISL_730507	2020-10-18	Asia / Jordan / Aqaba	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5286/2020	EPI_ISL_730523	2020-11-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5287/2020	EPI_ISL_730524	2020-11-04	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5290/2020	EPI_ISL_730527	2020-10-31	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5292/2020	EPI_ISL_730529	2020-11-04	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AZ-ALSR-5297/2020	EPI_ISL_730533	2020-11-01	Asia / Jordan / Zarqa	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5308/2020	EPI_ISL_730544	2020-11-02	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5313/2020	EPI_ISL_730549	2020-11-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5314/2020	EPI_ISL_730550	2020-11-04	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5320/2020	EPI_ISL_730556	2020-11-04	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Jordan/AM-ALSR-5323/2020	EPI_ISL_730559	2020-11-07	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.36.10	GH
hCoV-19/Turkey/Ankara_GUMV_42541/2020	EPI_ISL_730577	2020-10-24	Europe / Turkey / Ankara	Human	Original			Illumina ISeq 100				B.1.36.1	GH
hCoV-19/England/ALDP-C3AEE9/2020	EPI_ISL_730663	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-C3B255/2020	EPI_ISL_731840	2020-12-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/ALDP-C3BFA9/2020	EPI_ISL_731853	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-C3C861/2020	EPI_ISL_731880	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/MILK-BFFA74/2020	EPI_ISL_731892	2020-11-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-C342E3/2020	EPI_ISL_734105	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/Bangladesh/CU-CTG-24/2020	EPI_ISL_735496	2020-11-23	Asia / Bangladesh / Chittagong / Khagrachari	Human	Original			Illumina MiniSeq	DRAGEN RNA Pathogen Detection 3.5.15			B.1.36.8	GH
hCoV-19/England/LOND-12673CD/2020	EPI_ISL_741282	2020-12-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.28	GH
hCoV-19/England/LOND-12674CA/2020	EPI_ISL_741297	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/MILK-B3D9E6/2020	EPI_ISL_741377	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.39	GH
hCoV-19/England/MILK-B3DB4A/2020	EPI_ISL_741391	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.39	GH
hCoV-19/England/MILK-B3DDDB/2020	EPI_ISL_741397	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/South Korea/KDCA0104/2020	EPI_ISL_747340	2020-09-18	Asia / South Korea	Human	Original		Imported case from Iraq	Illumina MiSeq				B.1.36	GH
hCoV-19/South Korea/KDCA0107/2020	EPI_ISL_747343	2020-09-25	Asia / South Korea	Human	Original		Imported case from Indonesia	Illumina MiSeq				B.1.468	GH
hCoV-19/South Korea/KDCA0109/2020	EPI_ISL_747345	2020-09-25	Asia / South Korea	Human	Original		Imported case from India	Illumina MiSeq				B.1.36	GH
hCoV-19/Denmark/DCGC-18967/2020	EPI_ISL_748671	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-18980/2020	EPI_ISL_748680	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-19078/2020	EPI_ISL_748741	2020-12-07	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-19111/2020	EPI_ISL_748762	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-19185/2020	EPI_ISL_748799	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-17452/2020	EPI_ISL_750993	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/USA/CA-CHLA-PLM38823258/2020	EPI_ISL_753398	2020-11-20	North America / USA / California / Los Angeles	Human	Original			Illumina NextSeq	Novoalign v4.02.00 + LUBA consensus			B.1.36.8	GH
hCoV-19/Canada/ON-S2016/2020	EPI_ISL_755802	2020-11-28	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2017/2020	EPI_ISL_755803	2020-12-01	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2031/2020	EPI_ISL_755812	2020-12-21	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S2032/2020	EPI_ISL_755813	2020-12-21	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-S1499/2020	EPI_ISL_755888	2020-08-29	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/ON-S1533/2020	EPI_ISL_755906	2020-09-01	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/ON-S1565/2020	EPI_ISL_755920	2020-09-02	North America / Canada / Ontario / Toronto	Human	Original			Illumina MiSeq				B.1.36.8	GH
hCoV-19/Finland/9LS11AA9/2020	EPI_ISL_755943	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/9LS11AH3/2020	EPI_ISL_755945	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/9LS12AG7/2020	EPI_ISL_755946	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/9LS13BF7/2020	EPI_ISL_755947	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/9LS15AF9/2020	EPI_ISL_755948	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/9LS16AA8/2020	EPI_ISL_755949	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/9LS16AA9/2020	EPI_ISL_755950	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/9LS18AA2/2020	EPI_ISL_755952	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/9LS18AF1/2020	EPI_ISL_755953	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/9LS18AH6/2020	EPI_ISL_755954	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/9LS5AC9/2020	EPI_ISL_755958	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/9LS5AH4/2020	EPI_ISL_755959	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/9LS7BD8/2020	EPI_ISL_755960	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/9LS7BE11/2020	EPI_ISL_755961	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/9LS8BC1/2020	EPI_ISL_755962	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/9LS8BF5/2020	EPI_ISL_755963	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/9LS9AF1/2020	EPI_ISL_755964	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/9LS9AF5/2020	EPI_ISL_755965	2020-10-09	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/9SS15E8/2020	EPI_ISL_755967	2020-09-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/9SS20H11/2020	EPI_ISL_755968	2020-09-10	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/8ES4A11/2020	EPI_ISL_755969	2020-08-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/8LS10A12/2020	EPI_ISL_755970	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/8LS12G9/2020	EPI_ISL_755972	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/8LS13D11/2020	EPI_ISL_755973	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/8LS13F1/2020	EPI_ISL_755974	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/8LS15F6/2020	EPI_ISL_755975	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/8LS18AE10/2020	EPI_ISL_755976	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.1	GH
hCoV-19/Finland/8LS18AF7/2020	EPI_ISL_755977	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/8LS18E1/2020	EPI_ISL_755978	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/8LS18H1/2020	EPI_ISL_755979	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/8LS19AD6/2020	EPI_ISL_755980	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/8LS19AG10/2020	EPI_ISL_755981	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/8LS19AG8/2020	EPI_ISL_755983	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/8LS2H5/2020	EPI_ISL_755986	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/8LS5E7/2020	EPI_ISL_755987	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/8LS6AF10/2020	EPI_ISL_755988	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/8LS6AF1/2020	EPI_ISL_755989	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/8LS6AG5/2020	EPI_ISL_755990	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Finland/8LS9BB4/2020	EPI_ISL_755991	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/8LS9BH3/2020	EPI_ISL_755992	2020-10-08	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/4LS11C5/2020	EPI_ISL_755995	2020-10-04	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Finland/4LS12E2/2020	EPI_ISL_755996	2020-10-04	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.463	GH
hCoV-19/Denmark/DCGC-21463/2020	EPI_ISL_758074	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-21476/2020	EPI_ISL_758075	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-21497/2020	EPI_ISL_758076	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-21520/2020	EPI_ISL_758077	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-21603/2020	EPI_ISL_758079	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-20738/2020	EPI_ISL_759334	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-20742/2020	EPI_ISL_759337	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-20817/2020	EPI_ISL_759382	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-20862/2020	EPI_ISL_759413	2020-12-21	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-20936/2020	EPI_ISL_759457	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/ALDP-CC0905/2020	EPI_ISL_760386	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-CB4F7B/2020	EPI_ISL_761697	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/SHEF-10D85C3/2020	EPI_ISL_765207	2020-12-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.24	GH
hCoV-19/England/205240596/2020	EPI_ISL_766505	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.34	GH
hCoV-19/Australia/NSW1285/2020	EPI_ISL_767851	2020-11-20	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36.19	GH
hCoV-19/Australia/NSW1286/2020	EPI_ISL_767852	2020-11-20	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36.19	GH
hCoV-19/Australia/NSW1293/2020	EPI_ISL_767859	2020-11-20	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Australia/NSW1294/2020	EPI_ISL_767860	2020-11-20	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Australia/NSW1300/2020	EPI_ISL_767866	2020-11-08	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.36	GH
hCoV-19/Bangladesh/DNAS_DRCIM_isl_MMC-01/2020	EPI_ISL_774963	2020-06-28	Asia / Bangladesh / Dhaka	Human	Original	Oropharyngeal swab		Ion Torrent	IRMA			B.1.36.8	GH
hCoV-19/Bangladesh/DNAS_DRCIM_isl_MMC-02/2020	EPI_ISL_774964	2020-06-28	Asia / Bangladesh / Dhaka	Human	Original	Oropharyngeal swab		Ion Torrent	IRMA			B.1.36.8	GH
hCoV-19/Bangladesh/DNAS_DRICM_isl_SIBL_12/2020	EPI_ISL_774979	2020-06-28	Asia / Bangladesh / Dhaka	Human	Original	Oropharyngeal swab		Ion Torrent	IRMA			B.1.36.8	GH
hCoV-19/Bangladesh/DNAS_DRICM_isl_R-138/2020	EPI_ISL_774993	2020-07-12	Asia / Bangladesh / Dhaka	Human	Original	Oropharyngeal swab		Ion Torrent	IRMA	NSP11 without BLAST coverage.	warn	B.1.36.16	GH
hCoV-19/Bangladesh/DNAS_DRICM_isl_EK-91/2020	EPI_ISL_774994	2020-07-10	Asia / Bangladesh / Dhaka	Human	Original	Oropharyngeal swab		Ion Torrent	IRMA			B.1.36.16	GH
hCoV-19/Bangladesh/DNAS_DRICM_isl_Enayet/2020	EPI_ISL_774995	2020-07-10	Asia / Bangladesh / Dhaka	Human	Original	Oropharyngeal swab		Ion Torrent	IRMA			B.1.36.16	GH
hCoV-19/Germany/HH-hpi-p1503/2020	EPI_ISL_776009	2020-03-14	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.22	GH
hCoV-19/Germany/HH-hpi-p1504/2020	EPI_ISL_776010	2020-03-14	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.465	GH
hCoV-19/England/QEUH-C93965/2020	EPI_ISL_777235	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/England/QEUH-C91448/2020	EPI_ISL_777284	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/ALDP-C6B8C3/2020	EPI_ISL_778517	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-C6C9A1/2020	EPI_ISL_778546	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/MILK-C307F7/2020	EPI_ISL_783021	2020-12-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-BABDC9/2020	EPI_ISL_783116	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BAB39A/2020	EPI_ISL_783119	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/MILK-BAA2CB/2020	EPI_ISL_783170	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/USA/TX-HMH-MCoV-18108/2020	EPI_ISL_784456	2020-11-17	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.36	GH
hCoV-19/USA/TX-HMH-MCoV-12877/2020	EPI_ISL_788029	2020-08-18	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1	GH
hCoV-19/Canada/ON-SK-20H-328MM1138/2020	EPI_ISL_791503	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC-nanopolish 1.1.3			B.1.36.18	GH
hCoV-19/Canada/ON-SK-20H-329MM0157/2020	EPI_ISL_791506	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC-nanopolish 1.1.3			B.1.36.38	GH
hCoV-19/Canada/ON-SK-20H-329MM0163/2020	EPI_ISL_791507	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC-nanopolish 1.1.3			B.1.471	GH
hCoV-19/Canada/ON-SK-20H-329MM0239/2020	EPI_ISL_791509	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC-nanopolish 1.1.3			B.1.36.18	GH
hCoV-19/Canada/ON-SK-20H-329MM0254/2020	EPI_ISL_791510	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC-nanopolish 1.1.3			B.1.36.18	GH
hCoV-19/Canada/ON-SK-20H-329MM0281/2020	EPI_ISL_791512	2020-11-24	North America / Canada / Ontario / Toronto	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC-nanopolish 1.1.3			B.1.36.38	GH
hCoV-19/Denmark/DCGC-24102/2020	EPI_ISL_792835	2020-12-14	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/Switzerland/AG-ETHZ-430050/2020	EPI_ISL_796352	2020-12-25	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/AG-ETHZ-430119/2020	EPI_ISL_796360	2020-12-25	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BE-ETHZ-430734/2020	EPI_ISL_796391	2020-12-31	Europe / Switzerland / Bern	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B	O
hCoV-19/Switzerland/SO-ETHZ-430117/2020	EPI_ISL_796487	2020-12-25	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36	GH
hCoV-19/India/KA-NIMH-SEQ-4/2020	EPI_ISL_803904	2020-12-19	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS3_E261stop results in 5.5% truncation of the protein sequence. NS8_E106stop results in 13.2% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.29	GH
hCoV-19/Japan/IC-0634/2020	EPI_ISL_803918	2020-11-26	Asia / Japan	Human	Original			Illumina iSeq	A5-miseq v. 20140604	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Japan/IC-0650/2021	EPI_ISL_803919	2021-01-05	Asia / Japan	Human	Original			Illumina iSeq	SKESA v. 2.3.0	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Japan/IC-0629/2020	EPI_ISL_803921	2020-11-20	Asia / Japan	Human	Original			Illumina iSeq	A5-miseq v. 20140604	Gap of 11 nucleotides found at refpos 27386 (frameshift confirmed by the submitter). NS3_E241stop results in 12.7% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/Japan/IC-0628/2020	EPI_ISL_803932	2020-11-19	Asia / Japan	Human	Original			Illumina iSeq	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/IC-0635/2020	EPI_ISL_803937	2020-11-26	Asia / Japan	Human	Original			Illumina iSeq	SKESA v. 2.3.0			B.1.459	GH
hCoV-19/Japan/IC-0636/2020	EPI_ISL_803938	2020-11-26	Asia / Japan	Human	Original			Illumina iSeq	A5-miseq v. 20140604			B.1.459	GH
hCoV-19/Japan/IC-0638/2020	EPI_ISL_803939	2020-11-30	Asia / Japan	Human	Original			Illumina iSeq	A5-miseq v. 20140604			B.1.36.22	GH
hCoV-19/Japan/IC-0641/2020	EPI_ISL_803943	2020-12-04	Asia / Japan	Human	Original			Illumina iSeq	A5-miseq v. 20140604			B.1.459	GH
hCoV-19/Japan/IC-0648/2020	EPI_ISL_803949	2020-12-11	Asia / Japan	Human	Original			Illumina iSeq	A5-miseq v. 20140604			B.1.470	GH
hCoV-19/England/ALDP-C69C50/2020	EPI_ISL_820419	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/NORW-22383A/2020	EPI_ISL_820528	2020-12-31	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/Netherlands/UT-RIVM-21194/2020	EPI_ISL_824114	2020-12-29	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Japan/IC-0660/2021	EPI_ISL_825394	2021-01-06	Asia / Japan	Human	Original			Illumina iSeq	A5-miseq v. 20140604	NS7b_E39stop results in 11.6% truncation of the protein sequence. Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/Japan/IC-0667/2021	EPI_ISL_825402	2021-01-08	Asia / Japan	Human	Original			Illumina iSeq	SKESA v. 2.3.0	Gap of 1 nucleotide found at refpos 28254 (frameshift confirmed by the submitter). Insertion of 6 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/IC-0659/2021	EPI_ISL_825407	2021-01-06	Asia / Japan	Human	Original			Illumina iSeq	A5-miseq v. 20140604			B.1.466.2	GH
hCoV-19/Japan/IC-0696/2021	EPI_ISL_825429	2021-01-11	Asia / Japan	Human	Original			Illumina iSeq	SKESA v. 2.3.0			B.1.36.34	GH
hCoV-19/Germany/NW-RKI-I-0062/2020	EPI_ISL_831371	2020-12-20	Europe / Germany / North Rhine-Westphalia	Human	Original			Illumina Iseq	covpipe			B.1.36.1	GH
hCoV-19/Ireland/G-NVRL-20IRL11352/2020	EPI_ISL_837426	2020-12-12	Europe / Ireland / Galway	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	ARTIC v3 Protocol			B.1.562	GH
hCoV-19/Denmark/DCGC-29215/2021	EPI_ISL_843262	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Canada/ON-MMU-S2080/2020	EPI_ISL_845714	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-MMU-S2053/2021	EPI_ISL_845723	2021-01	North America / Canada / Ontario	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-MMU-S2083/2021	EPI_ISL_845729	2021-01	North America / Canada / Ontario	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/Canada/ON-MMU-S2064/2021	EPI_ISL_845743	2021-01	North America / Canada / Ontario	Human	Original			Illumina MiniSeq				B.1.36.18	GH
hCoV-19/India/KA-NIMH-SEQ-53/2020	EPI_ISL_845885	2020-12-30	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)			B.1.36	GH
hCoV-19/India/KA-NIMH-SEQ-54/2020	EPI_ISL_845886	2020-12-30	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)			B.1.36	GH
hCoV-19/South Korea/KDCA0604/2020	EPI_ISL_850289	2020-08-10	Asia / South Korea	Human	Original			Illumina Miseq				B.1	GH
hCoV-19/South Korea/KDCA0649/2020	EPI_ISL_850331	2020-08-08	Asia / South Korea	Human	Original			Illumina Miseq				B.1	GH
hCoV-19/South Korea/KDCA0661/2020	EPI_ISL_850343	2020-08-10	Asia / South Korea	Human	Original			Illumina Miseq				B.1	GH
hCoV-19/South Korea/KDCA0681/2020	EPI_ISL_850362	2020-08-17	Asia / South Korea	Human	Original			Illumina Miseq				B.1	GH
hCoV-19/Denmark/DCGC-32094/2021	EPI_ISL_856510	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-32145/2021	EPI_ISL_856561	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-32162/2021	EPI_ISL_856578	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26161 (frameshift confirmed by the submitter). NS3 without BLAST coverage.	info	B.1.36	GH
hCoV-19/India/AP-CS0319/2020	EPI_ISL_862313	2020-07-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_G254stop results in 8.0% truncation of the protein sequence. NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0890/2020	EPI_ISL_862314	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0892/2020	EPI_ISL_862315	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0893/2020	EPI_ISL_862316	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0894/2020	EPI_ISL_862317	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0895/2020	EPI_ISL_862318	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0897/2020	EPI_ISL_862319	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0898/2020	EPI_ISL_862320	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0899/2020	EPI_ISL_862321	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0900/2020	EPI_ISL_862322	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0901/2020	EPI_ISL_862323	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0902/2020	EPI_ISL_862324	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0903/2020	EPI_ISL_862325	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0904/2020	EPI_ISL_862326	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	G
hCoV-19/India/AP-CS0905/2020	EPI_ISL_862327	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0906/2020	EPI_ISL_862328	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0907/2020	EPI_ISL_862329	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0908/2020	EPI_ISL_862330	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0909/2020	EPI_ISL_862331	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0910/2020	EPI_ISL_862332	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0912/2020	EPI_ISL_862333	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0913/2020	EPI_ISL_862334	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	G
hCoV-19/India/AP-CS0915/2020	EPI_ISL_862335	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0916/2020	EPI_ISL_862336	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0917/2020	EPI_ISL_862337	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0918/2020	EPI_ISL_862338	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0919/2020	EPI_ISL_862339	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	G
hCoV-19/India/AP-CS0931/2020	EPI_ISL_862340	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0934/2020	EPI_ISL_862341	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0936/2020	EPI_ISL_862342	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0939/2020	EPI_ISL_862343	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0792/2020	EPI_ISL_862344	2020-07-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0945/2020	EPI_ISL_862345	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0946/2020	EPI_ISL_862346	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0947/2020	EPI_ISL_862347	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0949/2020	EPI_ISL_862348	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0950/2020	EPI_ISL_862349	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0951/2020	EPI_ISL_862350	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0953/2020	EPI_ISL_862351	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0954/2020	EPI_ISL_862352	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0955/2020	EPI_ISL_862353	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0956/2020	EPI_ISL_862354	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0957/2020	EPI_ISL_862355	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0959/2020	EPI_ISL_862356	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0794/2020	EPI_ISL_862357	2020-07-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0960/2020	EPI_ISL_862358	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0961/2020	EPI_ISL_862359	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0962/2020	EPI_ISL_862360	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0963/2020	EPI_ISL_862361	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0964/2020	EPI_ISL_862362	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0966/2020	EPI_ISL_862363	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0968/2020	EPI_ISL_862364	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0969/2020	EPI_ISL_862365	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0972/2020	EPI_ISL_862366	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0974/2020	EPI_ISL_862367	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0977/2020	EPI_ISL_862368	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0979/2020	EPI_ISL_862369	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0796/2020	EPI_ISL_862370	2020-07-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0982/2020	EPI_ISL_862371	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0989/2020	EPI_ISL_862372	2020-08-03	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0991/2020	EPI_ISL_862373	2020-08-03	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0992/2020	EPI_ISL_862374	2020-08-03	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0994/2020	EPI_ISL_862375	2020-08-03	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0995/2020	EPI_ISL_862376	2020-08-03	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0996/2020	EPI_ISL_862377	2020-08-03	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0997/2020	EPI_ISL_862378	2020-08-03	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0999/2020	EPI_ISL_862379	2020-08-03	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS1000/2020	EPI_ISL_862380	2020-08-03	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS1001/2020	EPI_ISL_862381	2020-08-03	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0780/2020	EPI_ISL_862382	2020-07-28	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	G
hCoV-19/India/AP-CS1002/2020	EPI_ISL_862383	2020-08-03	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS1003/2020	EPI_ISL_862384	2020-08-03	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0801/2020	EPI_ISL_862385	2020-07-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0802/2020	EPI_ISL_862386	2020-07-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0807/2020	EPI_ISL_862387	2020-07-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0781/2020	EPI_ISL_862388	2020-07-28	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	G
hCoV-19/India/AP-CS0809/2020	EPI_ISL_862389	2020-07-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0810/2020	EPI_ISL_862390	2020-07-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0811/2020	EPI_ISL_862391	2020-07-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0813/2020	EPI_ISL_862392	2020-07-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0814/2020	EPI_ISL_862393	2020-07-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0815/2020	EPI_ISL_862394	2020-07-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0817/2020	EPI_ISL_862395	2020-07-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0818/2020	EPI_ISL_862396	2020-07-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0782/2020	EPI_ISL_862397	2020-07-28	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	G
hCoV-19/India/AP-CS0819/2020	EPI_ISL_862398	2020-07-30	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0829/2020	EPI_ISL_862399	2020-07-30	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/SHEF-10D4CD1/2021	EPI_ISL_868623	2021-01-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.24	GH
hCoV-19/England/SHEF-10D797D/2021	EPI_ISL_868687	2021-01-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.24	GH
hCoV-19/Denmark/DCGC-32848/2021	EPI_ISL_869852	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-32873/2021	EPI_ISL_869877	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-32976/2021	EPI_ISL_869980	2021-01-11	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-32985/2021	EPI_ISL_869989	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-33861/2021	EPI_ISL_870871	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-33876/2021	EPI_ISL_870886	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-33881/2021	EPI_ISL_870891	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36.25	GH
hCoV-19/Denmark/DCGC-33889/2021	EPI_ISL_870899	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-33962/2021	EPI_ISL_870972	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.469	GH
hCoV-19/England/ALDP-FC1118/2021	EPI_ISL_874286	2021-01-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/England/ALDP-109260E/2021	EPI_ISL_878027	2021-01-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/CAMC-106DE9B/2021	EPI_ISL_879327	2021-01-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/Thailand/Bangkok-CONI-0415/2020	EPI_ISL_882800	2020-12-30	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0416/2020	EPI_ISL_882801	2020-12-30	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0418/2020	EPI_ISL_882802	2020-12-30	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0420/2020	EPI_ISL_882803	2020-12-30	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Thailand/Bangkok-CONI-0421/2020	EPI_ISL_882804	2020-12-30	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC V3, Nextera Flex prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.2.2			B.1.36.16	GH
hCoV-19/Indonesia/JK-EIJK132/2021	EPI_ISL_888979	2021-01-06	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JB-EIJK98/2020	EPI_ISL_888980	2020-12-07	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JK-EIJK112/2020	EPI_ISL_888981	2020-12-18	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JK-EIJK60/2020	EPI_ISL_888983	2020-11-05	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.468	GH
hCoV-19/Indonesia/JB-EIJK61/2020	EPI_ISL_888984	2020-11-05	Asia / Indonesia / West Java / Depok	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.468	GH
hCoV-19/Indonesia/BT-EIJK67/2020	EPI_ISL_888985	2020-11-10	Asia / Indonesia / Banten / South Tangerang	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.459	GH
hCoV-19/Indonesia/JB-EIJK70/2020	EPI_ISL_888986	2020-11-12	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.466.2	GH
hCoV-19/Indonesia/JB-EIJK71/2020	EPI_ISL_888987	2020-11-12	Asia / Indonesia / West Java / Depok	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.36.19	GH
hCoV-19/Indonesia/BT-EIJK75/2020	EPI_ISL_888988	2020-11-18	Asia / Indonesia / Banten / Tangerang	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.466.2	GH
hCoV-19/Indonesia/BT-EIJK77/2020	EPI_ISL_888989	2020-11-19	Asia / Indonesia / Banten / South Tangerang	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.459	GH
hCoV-19/Indonesia/BT-EIJK79/2020	EPI_ISL_888990	2020-11-23	Asia / Indonesia / Banten / South Tangerang	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.459	GH
hCoV-19/Indonesia/BT-EIJK81/2020	EPI_ISL_888991	2020-11-25	Asia / Indonesia / Banten / Tangerang	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.470	GH
hCoV-19/Indonesia/BT-EIJK88/2020	EPI_ISL_888992	2020-12-02	Asia / Indonesia / Banten / Tangerang	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.459	GH
hCoV-19/Indonesia/JB-EIJK100/2020	EPI_ISL_888993	2020-12-10	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.466.2	GH
hCoV-19/Indonesia/JK-EIJK115/2020	EPI_ISL_888994	2020-12-29	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.466.2	GH
hCoV-19/Indonesia/JK-EIJK116/2020	EPI_ISL_888995	2020-12-29	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.470	GH
hCoV-19/Indonesia/JB-EIJK117/2020	EPI_ISL_888996	2020-12-29	Asia / Indonesia / West Java / Bekasi	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.459	GH
hCoV-19/Indonesia/JB-EIJK122/2021	EPI_ISL_888997	2021-01-04	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.470	GH
hCoV-19/Indonesia/JB-EIJK123/2021	EPI_ISL_888998	2021-01-04	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.459	GH
hCoV-19/Indonesia/JB-EIJK124/2021	EPI_ISL_888999	2021-01-04	Asia / Indonesia / West Java / Bogor	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 550	custom BWA-MEM + iVar pipeline			B.1.36.19	GH
hCoV-19/Switzerland/BS-ETHZ-430912/2020	EPI_ISL_899516	2020-12-26	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/SO-ETHZ-430856/2020	EPI_ISL_899648	2020-12-25	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36	GH
hCoV-19/Switzerland/SO-ETHZ-430921/2020	EPI_ISL_899662	2020-12-26	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Egypt/CUNCI-HGC10I009/2020	EPI_ISL_907098	2020-12-25	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1	GH
hCoV-19/England/ALDP-F90B05/2021	EPI_ISL_909596	2021-01-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/USA/DC-HP01512/2021	EPI_ISL_911834	2021-01-22	North America / USA / District of Columbia	Human	Original			Nanopore GridION	ARTIC / medaka MN908947.3			B.1.471	GH
hCoV-19/Japan/Donner197/2020	EPI_ISL_915387	2020-04-13	Asia / Japan / Kanto	Human	Original	Pharyngeal swab		Illumina MiSeq				B.1	GH
hCoV-19/Scotland/QEUH-10672A4/2021	EPI_ISL_917869	2021-01-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.36.37	GH
hCoV-19/Scotland/QEUH-1067B30/2021	EPI_ISL_917933	2021-01-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/Denmark/DCGC-34926/2021	EPI_ISL_926066	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-34928/2021	EPI_ISL_926068	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/Denmark/DCGC-34957/2021	EPI_ISL_926097	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-36191/2021	EPI_ISL_927332	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-36199/2021	EPI_ISL_927340	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-36235/2021	EPI_ISL_927376	2021-01-18	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-37471/2021	EPI_ISL_928612	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-38658/2021	EPI_ISL_929800	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-38672/2021	EPI_ISL_929814	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-38694/2021	EPI_ISL_929836	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.469	GH
hCoV-19/India/un-NRCE-4549/2020	EPI_ISL_930836	2020-06-30	Asia / India	Human	Original			Illumina	BWA v. 0.7.17-r1188			B.1.36	O
hCoV-19/Sweden/21-20041/2021	EPI_ISL_934387	2021-01-18	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction from NC_045512 using torrent suite variantCaller with majority wins and positions <20x coverage masked with N	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.1	GH
hCoV-19/Canada/MB-NML-1481/2020	EPI_ISL_935800	2020-08-12	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1482/2020	EPI_ISL_935801	2020-08-10	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1484/2020	EPI_ISL_935803	2020-08-11	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1489/2020	EPI_ISL_935808	2020-08-13	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1490/2020	EPI_ISL_935809	2020-08-28	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1491/2020	EPI_ISL_935810	2020-08-25	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1493/2020	EPI_ISL_935811	2020-08-24	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1495/2020	EPI_ISL_935812	2020-08-24	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1498/2020	EPI_ISL_935813	2020-08-24	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1499/2020	EPI_ISL_935814	2020-08-27	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1501/2020	EPI_ISL_935815	2020-08-28	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1502/2020	EPI_ISL_935816	2020-08-28	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1508/2020	EPI_ISL_935822	2020-09-07	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1511/2020	EPI_ISL_935823	2020-08-31	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1514/2020	EPI_ISL_935825	2020-09-07	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1530/2020	EPI_ISL_935831	2020-08-22	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1537/2020	EPI_ISL_935838	2020-09-14	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1538/2020	EPI_ISL_935839	2020-09-14	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1539/2020	EPI_ISL_935840	2020-09-02	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1541/2020	EPI_ISL_935841	2020-09-03	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1	Gap of 18 nucleotides when compared to the reference sequence.	info	B.1.36.8	GH
hCoV-19/Canada/MB-NML-1542/2020	EPI_ISL_935842	2020-09-11	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.38	GH
hCoV-19/Canada/MB-NML-1549/2020	EPI_ISL_935846	2020-08-15	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1554/2020	EPI_ISL_935850	2020-08-19	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1555/2020	EPI_ISL_935851	2020-09-10	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1556/2020	EPI_ISL_935852	2020-09-05	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1563/2020	EPI_ISL_935856	2020-08-28	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1566/2020	EPI_ISL_935859	2020-08-18	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1567/2020	EPI_ISL_935860	2020-08-29	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-1568/2020	EPI_ISL_935861	2020-08-26	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Canada/MB-NML-2814/2020	EPI_ISL_935881	2020-11-16	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-2816/2020	EPI_ISL_935882	2020-11-25	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-2820/2020	EPI_ISL_935885	2020-11-24	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-2829/2020	EPI_ISL_935894	2020-11-26	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-2830/2020	EPI_ISL_935895	2020-11-25	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-2928/2020	EPI_ISL_935968	2020-11-14	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Indonesia/JK-NIHRD-C002100528/2021	EPI_ISL_942960	2021-01-04	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.470	GH
hCoV-19/Indonesia/JK-NIHRD-C002100677/2021	EPI_ISL_942971	2021-01-04	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14			B.1.466.2	GH
hCoV-19/England/MILK-F0B516/2020	EPI_ISL_945342	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/ALDP-118AA2A/2021	EPI_ISL_946560	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/Germany/HH-HPI-p2847/2020	EPI_ISL_959920	2020-10-01	Europe / Germany / Hamburg	Human	Original			Illumina Miseq				B.1.22	O
hCoV-19/Germany/HH-HPI-p2850/2020	EPI_ISL_959926	2020-09-29	Europe / Germany / Hamburg	Human	Original			Illumina Miseq				B.1.22	O
hCoV-19/England/ALDP-11CCC62/2021	EPI_ISL_963001	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-11BA317/2021	EPI_ISL_964241	2021-01-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/Norway/1288/2021	EPI_ISL_964259	2021-01-20	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/Canada/BC-BCCDC-3301/2020	EPI_ISL_969062	2020-08-20	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4077/2020	EPI_ISL_969209	2020-08-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4172/2020	EPI_ISL_969346	2020-08-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4184/2020	EPI_ISL_969356	2020-08-28	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-3908/2020	EPI_ISL_970046	2020-09-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4649/2020	EPI_ISL_970056	2020-09-04	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5334/2020	EPI_ISL_970325	2020-09-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.18	GH
hCoV-19/Canada/BC-BCCDC-5335/2020	EPI_ISL_970327	2020-09-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.8	GH
hCoV-19/Canada/BC-BCCDC-5696/2020	EPI_ISL_970333	2020-09-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-3672/2020	EPI_ISL_970379	2020-09-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4815/2020	EPI_ISL_971303	2020-09-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4985/2020	EPI_ISL_971359	2020-09-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4987/2020	EPI_ISL_971367	2020-09-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-4988/2020	EPI_ISL_971369	2020-09-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-4990/2020	EPI_ISL_971374	2020-09-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4994/2020	EPI_ISL_971386	2020-09-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5143/2020	EPI_ISL_971396	2020-09-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5304/2020	EPI_ISL_971403	2020-09-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Denmark/DCGC-39985/2021	EPI_ISL_971662	2021-01-25	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5321/2020	EPI_ISL_973953	2020-09-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-5323/2020	EPI_ISL_973954	2020-09-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-5409/2020	EPI_ISL_973955	2020-09-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5422/2020	EPI_ISL_973966	2020-09-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5425/2020	EPI_ISL_973968	2020-09-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5429/2020	EPI_ISL_973971	2020-09-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5978/2020	EPI_ISL_973978	2020-09-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6610/2020	EPI_ISL_973981	2020-09-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5273/2020	EPI_ISL_973990	2020-10-01	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-5343/2020	EPI_ISL_973995	2020-10-01	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-5344/2020	EPI_ISL_973996	2020-10-01	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5481/2020	EPI_ISL_973997	2020-10-01	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-5551/2020	EPI_ISL_973998	2020-10-01	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7621/2020	EPI_ISL_975070	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7623/2020	EPI_ISL_975072	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7625/2020	EPI_ISL_975074	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7817/2020	EPI_ISL_975077	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8103/2020	EPI_ISL_975081	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8106/2020	EPI_ISL_975083	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9638/2020	EPI_ISL_975088	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10220/2020	EPI_ISL_975091	2020-11-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-6985/2020	EPI_ISL_975098	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10464/2020	EPI_ISL_976216	2020-12-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10465/2020	EPI_ISL_976217	2020-12-07	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8767/2020	EPI_ISL_976219	2020-12-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8770/2020	EPI_ISL_976221	2020-12-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8773/2020	EPI_ISL_976223	2020-12-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8774/2020	EPI_ISL_976224	2020-12-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8775/2020	EPI_ISL_976225	2020-12-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8777/2020	EPI_ISL_976227	2020-12-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8780/2020	EPI_ISL_976228	2020-12-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8781/2020	EPI_ISL_976229	2020-12-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8870/2020	EPI_ISL_976235	2020-12-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Canada/BC-BCCDC-8873/2020	EPI_ISL_976238	2020-12-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Canada/BC-BCCDC-8875/2020	EPI_ISL_976240	2020-12-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9063/2020	EPI_ISL_976246	2020-12-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8676/2020	EPI_ISL_976262	2020-12-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8687/2020	EPI_ISL_976271	2020-12-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9068/2020	EPI_ISL_976278	2020-12-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9069/2020	EPI_ISL_976279	2020-12-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-10011/2020	EPI_ISL_976299	2020-12-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Malaysia/HPUPM_ML5556/2020	EPI_ISL_977587	2020-10-21	Asia / Malaysia	Human	Original			Illumina Miseq	MEGAHIT v1.2.9	NS9c_Q41stop results in 45.2% truncation of the protein sequence.	info	B.1.36.16	GH
hCoV-19/Malaysia/HPUPM_ML6794/2020	EPI_ISL_977590	2020-11-05	Asia / Malaysia	Human	Original			Illumina Miseq	MEGAHIT v1.2.9	NS9c_Q41stop results in 45.2% truncation of the protein sequence.	info	B.1.36.16	GH
hCoV-19/Malaysia/MGI_M0684/2020	EPI_ISL_977593	2020-11-05	Asia / Malaysia / Negeri Sembilan	Human	Original			Illumina Miseq	MEGAHIT v1.2.9	NS9c_Q41stop results in 45.2% truncation of the protein sequence.	info	B.1.36.16	GH
hCoV-19/Singapore/168/2021	EPI_ISL_981017	2021-02-04	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Singapore/177/2021	EPI_ISL_981026	2021-02-06	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/180/2021	EPI_ISL_981029	2021-02-06	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/England/ALDP-115C2B0/2021	EPI_ISL_991839	2021-01-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/Switzerland/BS-ETHZ-460840/2021	EPI_ISL_1003058	2021-01-16	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/SO-ETHZ-460903/2021	EPI_ISL_1003077	2021-01-16	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Indonesia/JT-UGM-58634/2020	EPI_ISL_1005696	2020-09-18	Asia / Indonesia / Central Java	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.1.37			B.1.459	GH
hCoV-19/Indonesia/JT-UGM-53311/2020	EPI_ISL_1005697	2020-09-09	Asia / Indonesia / Central Java	Human	Original			Illumina MiSeq	UGENE v.1.37			B.1.459	GH
hCoV-19/Indonesia/JT-UGM-60896/2020	EPI_ISL_1005698	2020-09-22	Asia / Indonesia / Central Java	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.1.37			B.1.459	GH
hCoV-19/USA/NY-Wadsworth-21010214-01/2021	EPI_ISL_1016396	2021-01-06	North America / USA / New York / New York County	Human	Original			Illumina NextSeq	ARTIC nf pipeline			B.1.36	GH
hCoV-19/England/CAMC-1263B05/2021	EPI_ISL_1018849	2021-02-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/Denmark/DCGC-43109/2021	EPI_ISL_1023387	2021-02-08	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-43207/2021	EPI_ISL_1023498	2021-02-08	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-43228/2021	EPI_ISL_1023519	2021-02-08	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (FRAMESHIFT confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-43231/2021	EPI_ISL_1023522	2021-02-08	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (FRAMESHIFT confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-44346/2021	EPI_ISL_1024724	2021-02-01	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-44403/2021	EPI_ISL_1024781	2021-02-01	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-44412/2021	EPI_ISL_1024790	2021-02-01	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/USA/ME-HETL-J1472/2020	EPI_ISL_1048620	2020-11-20	North America / USA / Maine	Human	Original			Illumina NextSeq	github:tewhey-lab/SARS-CoV-2-Consensus	Gap of 10 nucleotides when compared to the reference sequence.	info	B.1.466.1	GH
hCoV-19/Switzerland/AG-ETHZ-461495/2021	EPI_ISL_1059480	2021-01-20	Europe / Switzerland / Aargau	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/BL-ETHZ-490723/2021	EPI_ISL_1059494	2021-02-09	Europe / Switzerland / Basel-Landschaft	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.22	GH
hCoV-19/Denmark/DCGC-45820/2020	EPI_ISL_1065330	2020-12-28	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.24	GH
hCoV-19/Turkey/HSGM-1940/2021	EPI_ISL_1073796	2021-01-27	Europe / Turkey	Human	Orginal	Oropharyngeal swab		Illumina Miseq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.469	GH
hCoV-19/USA/TX-HMH-MCoV-20532/2021	EPI_ISL_1074974	2021-01-04	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.36	GH
hCoV-19/USA/TX-HMH-MCoV-22773/2020	EPI_ISL_1077301	2020-12-29	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.36.10	GH
hCoV-19/USA/TX-HMH-MCoV-22800/2020	EPI_ISL_1077328	2020-12-28	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.2	G
hCoV-19/Spain/CT-HUVH-66116/2021	EPI_ISL_1080834	2021-02-11	Europe / Spain / Catalunya	Human	Original			Illumina MiSeq				B.1.36.24	GH
hCoV-19/England/SHEF-C0716/2020	EPI_ISL_420223	2020-03-26	Europe / United Kingdom / England / South Yorkshire	Human	Original	Nose-Throat		Nanopore				B.1.465	GH
hCoV-19/France/IDF-3345/2020	EPI_ISL_421513	2020-03-23	Europe / France / le-de-France / Orsay	Human	Original	Oropharyngeal swab		Illumina NextSeq 500	CLC Genomics Suite			B.1	GH
hCoV-19/Netherlands/NA_168/2020	EPI_ISL_422703	2020-03-16	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_174/2020	EPI_ISL_422709	2020-03-22	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NA_52/2020	EPI_ISL_422813	2020-03-14	Europe / Netherlands	Human	Original			Nanopore				B.1.22	G
hCoV-19/Australia/NSW170/2020	EPI_ISL_427676	2020-03-22	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.465	GH
hCoV-19/Russia/Chechenya-83801/2020	EPI_ISL_428909	2020-03-26	Europe / Russia / Chechen	Human	Vero	Oropharyngeal swab		Illumina MiSeq	bwa v0.7.15, IGV v2.4.14			B.1	GH
hCoV-19/Chile/LL-ISPCH-3/2020	EPI_ISL_445335	2020-03-29	South America / Chile / Los Lagos / Llanquihue / Puerto Montt	Human	Original	Throat swab		Illumina MiSeq	IRMA v0.9.3			B.1.110	GH
hCoV-19/Chile/AR-ISPCH-8/2020	EPI_ISL_445343	2020-03-25	South America / Chile / La Araucania / Temuco	Human	Original	Throat swab		Illumina MiSeq	IRMA v0.9.3			B.1.110	GH
hCoV-19/Chile/AR-ISPCH-11/2020	EPI_ISL_445345	2020-03-27	South America / Chile / La Araucania / Temuco	Human	Original	Throat swab		Illumina MiSeq	IRMA v0.9.3			B.1.110	GH
hCoV-19/Chile/AR-ISPCH-12/2020	EPI_ISL_445346	2020-03-25	South America / Chile / La Araucania / Temuco	Human	Original	Throat swab		Illumina MiSeq	IRMA v0.9.3			B.1.110	GH
hCoV-19/England/CAMB-1AD20E/2020	EPI_ISL_447979	2020-04-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/England/NORT-289234/2020	EPI_ISL_458618	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/NORT-28929E/2020	EPI_ISL_458644	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/Netherlands/Gelderland_30/2020	EPI_ISL_460930	2020-04-06	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_36/2020	EPI_ISL_460936	2020-04-15	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_42/2020	EPI_ISL_460942	2020-04-28	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_43/2020	EPI_ISL_460943	2020-04-28	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_44/2020	EPI_ISL_460944	2020-05-01	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_45/2020	EPI_ISL_460945	2020-05-04	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_46/2020	EPI_ISL_460946	2020-04-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_47/2020	EPI_ISL_460947	2020-04-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_52/2020	EPI_ISL_460951	2020-05-08	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_53/2020	EPI_ISL_460952	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_54/2020	EPI_ISL_460953	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_56/2020	EPI_ISL_460955	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_57/2020	EPI_ISL_460956	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_61/2020	EPI_ISL_460960	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_62/2020	EPI_ISL_460961	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_63/2020	EPI_ISL_460962	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_64/2020	EPI_ISL_460963	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_65/2020	EPI_ISL_460964	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_66/2020	EPI_ISL_460965	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_67/2020	EPI_ISL_460966	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_68/2020	EPI_ISL_460967	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_69/2020	EPI_ISL_460968	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_70/2020	EPI_ISL_460969	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_71/2020	EPI_ISL_460970	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_72/2020	EPI_ISL_460971	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_73/2020	EPI_ISL_460972	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_74/2020	EPI_ISL_460973	2020-05-19	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NS6_Q56stop results in 9.8% truncation of the protein sequence. NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_75/2020	EPI_ISL_460974	2020-05-18	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_76/2020	EPI_ISL_460975	2020-05-19	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_77/2020	EPI_ISL_460976	2020-05-19	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_78/2020	EPI_ISL_460977	2020-05-19	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_79/2020	EPI_ISL_460978	2020-05-19	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_80/2020	EPI_ISL_460979	2020-05-19	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_81/2020	EPI_ISL_460980	2020-05-19	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_82/2020	EPI_ISL_460981	2020-05-19	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_83/2020	EPI_ISL_460982	2020-05-19	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_84/2020	EPI_ISL_460983	2020-05-19	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_85/2020	EPI_ISL_460984	2020-05-19	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_86/2020	EPI_ISL_460985	2020-05-19	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_87/2020	EPI_ISL_460986	2020-05-20	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_91/2020	EPI_ISL_460990	2020-05-22	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_94/2020	EPI_ISL_460993	2020-05-21	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_95/2020	EPI_ISL_460994	2020-05-21	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_96/2020	EPI_ISL_460995	2020-05-21	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_97/2020	EPI_ISL_460996	2020-05-21	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/Netherlands/Gelderland_98/2020	EPI_ISL_460997	2020-05-21	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/Gelderland_99/2020	EPI_ISL_460998	2020-05-21	Europe / Netherlands / Gelderland	Human	Original			Nanopore		NSP11 without BLAST coverage.	warn	B.1.22	GH
hCoV-19/England/SHEF-C9F9D/2020	EPI_ISL_462043	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/Egypt/CUNCI-HGC008/2020	EPI_ISL_468044	2020-05-02	Africa / Egypt	Human	Original	Nasal swab		IonTorrent	Torrent Suite v. 5.12			B.1	GH
hCoV-19/Egypt/CUNCI-HGC002/2020	EPI_ISL_468045	2020-05-02	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1	GH
hCoV-19/Egypt/CUNCI-HGC007/2020	EPI_ISL_468046	2020-05-02	Africa / Egypt	Human	Original	Nasal swab		IonTorrent	Torrent Suite v. 5.12			B.1	GH
hCoV-19/Egypt/CUNCI-HGC003/2020	EPI_ISL_468049	2020-05-02	Africa / Egypt	Human	Original	Nasal swab		IonTorrent	Torrent Suite v. 5.12			B.1	GH
hCoV-19/Egypt/CUNCI-HGC006/2020	EPI_ISL_468050	2020-05-02	Africa / Egypt	Human	Original	Nasal swab		IonTorrent	Torrent Suite v. 5.12			B.1	GH
hCoV-19/Egypt/CUNCI-HGC007-2/2020	EPI_ISL_468054	2020-05-02	Africa / Egypt	Human	Original	Nasal swab		IonTorrent	Torrent Suite v. 5.12			B.1	GH
hCoV-19/Egypt/CUNCI-HGC015/2020	EPI_ISL_468056	2020-05-02	Africa / Egypt	Human	Original	Nasal swab		IonTorrent	Torrent Suite v. 5.12			B.1	G
hCoV-19/Egypt/CUNCI-HGC023/2020	EPI_ISL_468057	2020-05-02	Africa / Egypt	Human	Original	Nasal swab		IonTorrent	Torrent Suite v. 5.12			B.1	G
hCoV-19/Egypt/CUNCI-HGC016/2020	EPI_ISL_468058	2020-05-02	Africa / Egypt	Human	Original	Nasal swab		IonTorrent	Torrent Suite v. 5.12			B.1	GH
hCoV-19/England/CAMB-1AB482/2020	EPI_ISL_470312	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/CAMB-1AB1B8/2020	EPI_ISL_470313	2020-04-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/CAMB-1ABA80/2020	EPI_ISL_470341	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/India/TG-CCMB-L1469/2020	EPI_ISL_471600	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/India/TG-CCMB-L1471/2020	EPI_ISL_471602	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/India/TG-CCMB-L1475/2020	EPI_ISL_471603	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/India/TG-CCMB-L1476/2020	EPI_ISL_471604	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/India/TG-CCMB-L1477/2020	EPI_ISL_471605	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.458	GH
hCoV-19/India/TG-CCMB-L1478/2020	EPI_ISL_471606	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.458	GH
hCoV-19/India/TG-CCMB-L1484/2020	EPI_ISL_471607	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.458	GH
hCoV-19/India/TG-CCMB-L1487/2020	EPI_ISL_471608	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/India/TG-CCMB-L1492/2020	EPI_ISL_471609	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/India/TG-CCMB-L1494/2020	EPI_ISL_471610	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/India/TG-CCMB-L1495/2020	EPI_ISL_471611	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1.458	GH
hCoV-19/India/TG-CCMB-L1496/2020	EPI_ISL_471612	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/India/TG-CCMB-L1497/2020	EPI_ISL_471613	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/India/TG-CCMB-L1499/2020	EPI_ISL_471614	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/India/TG-CCMB-L1500/2020	EPI_ISL_471615	2020-05-25	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/India/TG-CCMB-L1510/2020	EPI_ISL_471616	2020-05-26	Asia / India / Telangana / Hyderabad	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq 6000	Reference based			B.1	GH
hCoV-19/England/SHEF-C0BCF/2020	EPI_ISL_475347	2020-05-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/England/SHEF-C232F/2020	EPI_ISL_475360	2020-04-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	O
hCoV-19/England/SHEF-C4C8C/2020	EPI_ISL_475379	2020-05-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/India/OR-ILSCV29959/2020	EPI_ISL_481132	2020-05-23	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1.36.8	GH
hCoV-19/India/OR-ILSCV29960/2020	EPI_ISL_481133	2020-05-23	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1.36.8	GH
hCoV-19/India/OR-ILSCV29961/2020	EPI_ISL_481134	2020-05-23	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1.36.8	GH
hCoV-19/India/OR-ILSCV29962/2020	EPI_ISL_481135	2020-05-23	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1.36.8	GH
hCoV-19/India/OR-ILSCV32007/2020	EPI_ISL_481154	2020-05-29	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1	GH
hCoV-19/India/OR-ILSCV32652/2020	EPI_ISL_481160	2020-06-03	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1	G
hCoV-19/India/DL-NCDC1580-CSIR-IGIB/2020	EPI_ISL_482498	2020-05-16	Asia / India / Delhi	Human	Original			Nanopore MinION	Reference based			B.1.36.10	O
hCoV-19/Bangladesh/BCSIR-NILMRC-204/2020	EPI_ISL_483686	2020-06-26	Asia / Bangladesh / Chittagong / Chandpur	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.36.16	GH
hCoV-19/Bangladesh/BCSIR-NILMRC-186/2020	EPI_ISL_483694	2020-06-16	Asia / Bangladesh / Chittagong / Brahmanbaria	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.36.8	GH
hCoV-19/Bangladesh/BCSIR-NILMRC-216/2020	EPI_ISL_483703	2020-06-24	Asia / Bangladesh / Sylhet / Moulvibazar	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.36.8	GH
hCoV-19/Bangladesh/BCSIR-NILMRC-220/2020	EPI_ISL_483710	2020-06-24	Asia / Bangladesh / Sylhet / Habiganj	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.36.16	GH
hCoV-19/Bangladesh/BCSIR-NILMRC-232/2020	EPI_ISL_487375	2020-07-06	Asia / Bangladesh / Barishal	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14	Gap of 2 nucleotides when compared to the reference sequence.	info	B.1.36.16	GH
hCoV-19/England/NORT-2837FF/2020	EPI_ISL_488529	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/NORT-283926/2020	EPI_ISL_488693	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/Saudi Arabia/477/2020	EPI_ISL_489996	2020-02-03	Asia / Saudi Arabia	Human	Original	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Saudi Arabia/492/2020	EPI_ISL_489997	2020-02-04	Asia / Saudi Arabia	Human	Original	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Saudi Arabia/518/2020	EPI_ISL_489999	2020-02-10	Asia / Saudi Arabia	Human	Original	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	GH
hCoV-19/Australia/NSW2292/2020	EPI_ISL_500703	2020-05-12	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1	GH
hCoV-19/France/ARA-18066/2020	EPI_ISL_509015	2020-04-01	Europe / France / Auvergne-Rhone-Alpes / Villefranche	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1	GH
hCoV-19/Indonesia/TNG-LIPI001/2020	EPI_ISL_518819	2020-08-13	Asia / Indonesia / Banten / Tangerang	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore				B.1.470	GH
hCoV-19/Australia/VIC2388/2020	EPI_ISL_522106	2020-06-29	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1	GH
hCoV-19/Australia/VIC2390/2020	EPI_ISL_522108	2020-06-29	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Netherlands/NB-EMC-178/2020	EPI_ISL_523301	2020-06-07	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore		Gap of 2 nucleotides when compared to the reference sequence.	info	B.1.22	GH
hCoV-19/Netherlands/NB-EMC-210/2020	EPI_ISL_523333	2020	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-217/2020	EPI_ISL_523340	2020-06-15	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Netherlands/NB-EMC-218/2020	EPI_ISL_523341	2020-06-02	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Netherlands/NB-EMC-219/2020	EPI_ISL_523342	2020-06-02	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Netherlands/NB-EMC-220/2020	EPI_ISL_523343	2020-06-02	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Netherlands/NB-EMC-222/2020	EPI_ISL_523345	2020-07-03	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-224/2020	EPI_ISL_523347	2020-07-06	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-225/2020	EPI_ISL_523348	2020-07-09	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-226/2020	EPI_ISL_523349	2020-07-11	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-227/2020	EPI_ISL_523350	2020-06-18	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-228/2020	EPI_ISL_523351	2020-07-09	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-233/2020	EPI_ISL_523356	2020-05-08	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-243/2020	EPI_ISL_523366	2020-06-19	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-263/2020	EPI_ISL_523386	2020	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/NB-EMC-272/2020	EPI_ISL_523394	2020	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/OV-EMC-62/2020	EPI_ISL_523446	2020-05-26	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/OV-EMC-63/2020	EPI_ISL_523447	2020-05-28	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/OV-EMC-64/2020	EPI_ISL_523448	2020-05-28	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/OV-EMC-65/2020	EPI_ISL_523449	2020-05-29	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/OV-EMC-68/2020	EPI_ISL_523452	2020-06-13	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/OV-EMC-72/2020	EPI_ISL_523456	2020-06-19	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/un-EMC-711/2020	EPI_ISL_523466	2020-05-27	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/un-EMC-712/2020	EPI_ISL_523467	2020-05-09	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/un-EMC-713/2020	EPI_ISL_523468	2020-04-28	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/un-EMC-715/2020	EPI_ISL_523470	2020-03-15	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/un-EMC-717/2020	EPI_ISL_523472	2020-03-19	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/un-EMC-731/2020	EPI_ISL_523486	2020-06-15	Europe / Netherlands	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Australia/NSW2480/2020	EPI_ISL_527021	2020-07-02	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.36.38	GH
hCoV-19/Australia/NSW2513/2020	EPI_ISL_527033	2020-07-05	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)	Gap of 3 nucleotides found at refpos 22189.	info	B.1.36	GH
hCoV-19/England/ALDP-97FB3F/2020	EPI_ISL_529534	2020-08-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/ALDP-9805B5/2020	EPI_ISL_529539	2020-08-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/ALDP-980B68/2020	EPI_ISL_529542	2020-08-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/ALDP-980F02/2020	EPI_ISL_529544	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/ALDP-981E7D/2020	EPI_ISL_529548	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/ALDP-982674/2020	EPI_ISL_529550	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/ALDP-984C43/2020	EPI_ISL_529567	2020-08-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/ALDP-98634C/2020	EPI_ISL_529573	2020-08-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/ALDP-986731/2020	EPI_ISL_529576	2020-08-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/ALDP-98733C/2020	EPI_ISL_529577	2020-08-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/ALDP-987703/2020	EPI_ISL_529579	2020-08-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/ALDP-987712/2020	EPI_ISL_529580	2020-08-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/ALDP-988483/2020	EPI_ISL_529587	2020-08-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/ALDP-9884B0/2020	EPI_ISL_529588	2020-08-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/ALDP-988C4F/2020	EPI_ISL_529589	2020-08-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/BIRM-61D51/2020	EPI_ISL_529607	2020-03-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.465	GH
hCoV-19/England/BIRM-62831/2020	EPI_ISL_529623	2020-08-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-628C8/2020	EPI_ISL_529626	2020-08-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-6292F/2020	EPI_ISL_529629	2020-08-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-6293E/2020	EPI_ISL_529630	2020-08-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-6295C/2020	EPI_ISL_529631	2020-08-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-6297A/2020	EPI_ISL_529633	2020-08-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-62998/2020	EPI_ISL_529634	2020-08-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-629E3/2020	EPI_ISL_529636	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-62A3B/2020	EPI_ISL_529637	2020-08-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-62A86/2020	EPI_ISL_529638	2020-09-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-62AA4/2020	EPI_ISL_529639	2020-09-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-62AE0/2020	EPI_ISL_529643	2020-09-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/QEUH-962E90/2020	EPI_ISL_531819	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/QEUH-962EAF/2020	EPI_ISL_531837	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-962504/2020	EPI_ISL_531841	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/LEED-2A826C/2020	EPI_ISL_539003	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/LEED-2A8CE6/2020	EPI_ISL_539008	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/LEED-2A8949/2020	EPI_ISL_539023	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/England/LEED-2A88A6/2020	EPI_ISL_539051	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	GH
hCoV-19/Netherlands/NH-RIVM-10067/2020	EPI_ISL_547496	2020-04-21	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/NH-RIVM-10070/2020	EPI_ISL_547497	2020-05-01	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Netherlands/NH-RIVM-10071/2020	EPI_ISL_547498	2020-05-01	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/England/MILK-99CF21/2020	EPI_ISL_549924	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-9A52C2/2020	EPI_ISL_549952	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-9A6B4E/2020	EPI_ISL_549954	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	O
hCoV-19/England/MILK-9A8BD3/2020	EPI_ISL_549986	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9A9F6D/2020	EPI_ISL_550906	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-9AA333/2020	EPI_ISL_550911	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/England/MILK-9AA8CB/2020	EPI_ISL_550925	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9AA2FA/2020	EPI_ISL_550932	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/England/MILK-9AA8AD/2020	EPI_ISL_550980	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9AADEA/2020	EPI_ISL_550989	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-99331F/2020	EPI_ISL_552011	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9705C7/2020	EPI_ISL_553146	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-97103E/2020	EPI_ISL_553151	2020-08-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/MILK-970248/2020	EPI_ISL_553155	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-9705A9/2020	EPI_ISL_553180	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/MILK-9707A3/2020	EPI_ISL_553181	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-970CE0/2020	EPI_ISL_553201	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.23	GH
hCoV-19/England/ALDP-90CA0D/2020	EPI_ISL_553297	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/ALDP-90CAB2/2020	EPI_ISL_553302	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/ALDP-950C9B/2020	EPI_ISL_554545	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GH
hCoV-19/England/ALDP-944210/2020	EPI_ISL_554681	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/England/CAMC-949BD4/2020	EPI_ISL_555910	2020-07-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-94CF20/2020	EPI_ISL_555964	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1	GH
hCoV-19/England/MILK-64FFB7/2020	EPI_ISL_558041	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-4A4E88/2020	EPI_ISL_559479	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.465	O
hCoV-19/India/UT-IMT-AN32/2020	EPI_ISL_560319	2020-06-16	Asia / India / Uttarakhand	Human	Original	Nasopharyngeal swab		Illumina, MiSeq				B.1.36	GH
hCoV-19/India/UT-IMT-AT52/2020	EPI_ISL_560320	2020-07-03	Asia / India / Uttarakhand	Human	Original	Nasopharyngeal swab		Illumina, MiSeq				B.1.36	GH
hCoV-19/India/UT-IMT-BB45/2020	EPI_ISL_560321	2020-07-17	Asia / India / Uttarakhand	Human	Original	Nasopharyngeal swab		Illumina, MiSeq				B.1.36	GH
hCoV-19/India/HR-IMT-CB117/2020	EPI_ISL_560324	2020-08-27	Asia / India / Haryana	Human	Original	Nasopharyngeal swab		Nanopore, MinION	EzCOVID19			B.1.36	GH
hCoV-19/Switzerland/BS-ETHZ-280043/2020	EPI_ISL_560470	2020-09-05	Europe / Switzerland / Basel-Stadt	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/MILK-9C21A4/2020	EPI_ISL_566430	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C2C3A/2020	EPI_ISL_566450	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C2F22/2020	EPI_ISL_566475	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-9C2B88/2020	EPI_ISL_566506	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/CAMC-9B1C6B/2020	EPI_ISL_566528	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C2BC4/2020	EPI_ISL_566532	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.36.28	GH
hCoV-19/England/MILK-9C206B/2020	EPI_ISL_566540	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-9B1D77/2020	EPI_ISL_566543	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C29AC/2020	EPI_ISL_566616	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	O
hCoV-19/England/MILK-9C253F/2020	EPI_ISL_566658	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/England/CAMC-9B1C4D/2020	EPI_ISL_566659	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-9B22A4/2020	EPI_ISL_566662	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9C1F23/2020	EPI_ISL_566665	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C5C55/2020	EPI_ISL_567758	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C4BE0/2020	EPI_ISL_567762	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C636E/2020	EPI_ISL_567779	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C5E9B/2020	EPI_ISL_567787	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C4B68/2020	EPI_ISL_567789	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-9C5402/2020	EPI_ISL_567797	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-9C4B86/2020	EPI_ISL_567804	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-9C5323/2020	EPI_ISL_567809	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-9C5DAD/2020	EPI_ISL_567810	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C5FC5/2020	EPI_ISL_567823	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C5E04/2020	EPI_ISL_567826	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9C4BA4/2020	EPI_ISL_567830	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-9C5314/2020	EPI_ISL_567843	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-9C4D17/2020	EPI_ISL_567854	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-9C5DE9/2020	EPI_ISL_567857	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9BE949/2020	EPI_ISL_567953	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9BE439/2020	EPI_ISL_567962	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9BEC6E/2020	EPI_ISL_567994	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-9BA9B6/2020	EPI_ISL_573615	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-9BABA1/2020	EPI_ISL_573628	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-9BACCC/2020	EPI_ISL_573633	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/QEUH-9BAF5A/2020	EPI_ISL_573640	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/England/SHEF-D3112/2020	EPI_ISL_573756	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/NORW-F048F/2020	EPI_ISL_577102	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.2	GH
hCoV-19/England/NOTT-114008/2020	EPI_ISL_577130	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/NOTT-1143D2/2020	EPI_ISL_577161	2020-10-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/NOTT-1143F0/2020	EPI_ISL_577162	2020-10-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/NOTT-11469D/2020	EPI_ISL_577187	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/QEUH-9E4986/2020	EPI_ISL_579785	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.23	GH
hCoV-19/England/QEUH-9E45DD/2020	EPI_ISL_579826	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/QEUH-9E4AB0/2020	EPI_ISL_579854	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/QEUH-9E5545/2020	EPI_ISL_579879	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9E4221/2020	EPI_ISL_579909	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9EA3CE/2020	EPI_ISL_579968	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-9F06DB/2020	EPI_ISL_580839	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/QEUH-9DC9AF/2020	EPI_ISL_580880	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DC5C9/2020	EPI_ISL_580901	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DC611/2020	EPI_ISL_580905	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DC365/2020	EPI_ISL_580916	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DC990/2020	EPI_ISL_580922	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-9DCB4F/2020	EPI_ISL_580924	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DC866/2020	EPI_ISL_580930	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-9DC374/2020	EPI_ISL_580932	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DC7A5/2020	EPI_ISL_580958	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMB-1B69D0/2020	EPI_ISL_584321	2020-10-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMC-9D6D5E/2020	EPI_ISL_584324	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMC-9D6E88/2020	EPI_ISL_584330	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMC-9D6E97/2020	EPI_ISL_584331	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMC-9D70BE/2020	EPI_ISL_584345	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMC-9D736A/2020	EPI_ISL_584363	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-9D7476/2020	EPI_ISL_584373	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMC-9D74B2/2020	EPI_ISL_584375	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.28	GH
hCoV-19/England/CAMC-9EB8CE/2020	EPI_ISL_584382	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-9EBA7D/2020	EPI_ISL_584393	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMC-9EBB7A/2020	EPI_ISL_584401	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/CAMC-9EBC95/2020	EPI_ISL_584410	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMC-9EBEF9/2020	EPI_ISL_584429	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.22	GH
hCoV-19/England/CAMC-9EBF50/2020	EPI_ISL_584433	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/CAMC-9EBF7E/2020	EPI_ISL_584434	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Wales/PHWC-16E737/2020	EPI_ISL_585762	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.471	GH
hCoV-19/England/ALDP-A2F1E0/2020	EPI_ISL_586945	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A2E8CE/2020	EPI_ISL_586962	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-A2F924/2020	EPI_ISL_586965	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-A2ED47/2020	EPI_ISL_586972	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A2EB89/2020	EPI_ISL_586982	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A2EE26/2020	EPI_ISL_586996	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A2F881/2020	EPI_ISL_586999	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9F9C1C/2020	EPI_ISL_589125	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/MILK-9F29C1/2020	EPI_ISL_589133	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-9F276D/2020	EPI_ISL_589195	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/QEUH-9CEDE0/2020	EPI_ISL_590117	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9CE76A/2020	EPI_ISL_590169	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-9B58DC/2020	EPI_ISL_590215	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9B46C4/2020	EPI_ISL_590229	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Japan/IC-0062/2020	EPI_ISL_591404	2020-06-17	Asia / Japan	Human	Original		COVID-19 positive case who entered from India.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/IC-0064/2020	EPI_ISL_591406	2020-06-20	Asia / Japan	Human	Original		COVID-19 positive case who entered from India.	Illumina NextSeq500	SKESA v. 2.3.0			B.1	GH
hCoV-19/Japan/IC-0065/2020	EPI_ISL_591407	2020-06-22	Asia / Japan	Human	Original		COVID-19 positive case who entered from India.	Illumina NextSeq500	A5-miseq v. 20140604			B.1.36	GH
hCoV-19/Japan/IC-0103/2020	EPI_ISL_591444	2020-07-21	Asia / Japan	Human	Original		COVID-19 positive case who entered from Islamic Republic of Iran.	Illumina NextSeq2000	A5-miseq v. 20140604	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Japan/IC-0090/2020	EPI_ISL_591539	2020-07-15	Asia / Japan	Human	Original		COVID-19 positive case who entered from Pakistan.	Illumina NextSeq2000	SKESA v. 2.3.0	Gap of 7 nucleotide(s) found at refpos 27616 (FRAMESHIFT). Gap of 10 nucleotides when compared to the reference sequence. NS7a without BLAST coverage. Submitter Note: Submitter confirmed sequence contains frameshift.	info	B.1.471	GH
hCoV-19/England/MILK-A55E80/2020	EPI_ISL_595116	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.17	GH
hCoV-19/Singapore/1066/2020	EPI_ISL_596456	2020-10-03	Asia / Singapore	Human	Original			Illumina MiSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Singapore/1071/2020	EPI_ISL_596461	2020-10-02	Asia / Singapore	Human	Original			Illumina MiSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/Singapore/1080/2020	EPI_ISL_596470	2020-09-22	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36	GH
hCoV-19/Singapore/1088/2020	EPI_ISL_596478	2020-10-06	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.470	GH
hCoV-19/Singapore/1096/2020	EPI_ISL_596486	2020-10-14	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.16	GH
hCoV-19/Singapore/1099/2020	EPI_ISL_596489	2020-10-16	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.470	GH
hCoV-19/Singapore/1100/2020	EPI_ISL_596490	2020-10-10	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/Singapore/1103/2020	EPI_ISL_596493	2020-10-14	Asia / Singapore	Human	Original			Illumina MiSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/ALDP-A4F979/2020	EPI_ISL_597606	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/ALDP-A50CE5/2020	EPI_ISL_597628	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A4FBA0/2020	EPI_ISL_597640	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A4FCE9/2020	EPI_ISL_597683	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A50632/2020	EPI_ISL_597689	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A50104/2020	EPI_ISL_597721	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A50799/2020	EPI_ISL_597734	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-A50FBF/2020	EPI_ISL_597743	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-A4FF77/2020	EPI_ISL_597744	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-A50C03/2020	EPI_ISL_597750	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-A4FDF5/2020	EPI_ISL_597761	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-A50A18/2020	EPI_ISL_597791	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A4FCF8/2020	EPI_ISL_597797	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/MILK-A053DB/2020	EPI_ISL_600002	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A057C0/2020	EPI_ISL_600010	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-A05E43/2020	EPI_ISL_600014	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-A05784/2020	EPI_ISL_600032	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-A056B4/2020	EPI_ISL_600057	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A06088/2020	EPI_ISL_600058	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A06A5D/2020	EPI_ISL_600060	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-A0648C/2020	EPI_ISL_600062	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A059AC/2020	EPI_ISL_600109	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A06228/2020	EPI_ISL_600111	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DBD86/2020	EPI_ISL_601300	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DC2B3/2020	EPI_ISL_601309	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DC268/2020	EPI_ISL_601323	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-9E0753/2020	EPI_ISL_601324	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/QEUH-9DB023/2020	EPI_ISL_601339	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DC2A4/2020	EPI_ISL_601342	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-9DBD68/2020	EPI_ISL_601386	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/QEUH-9DC040/2020	EPI_ISL_601387	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DAF27/2020	EPI_ISL_601391	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-9DA543/2020	EPI_ISL_601416	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-9E0595/2020	EPI_ISL_601438	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.12	GH
hCoV-19/USA/CA-QDX-1625/2020	EPI_ISL_603907	2020-03-19	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.170	GH
hCoV-19/England/ALDP-A8775D/2020	EPI_ISL_606126	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-A878A5/2020	EPI_ISL_606208	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/MILK-A7CD59/2020	EPI_ISL_606335	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A7BF27/2020	EPI_ISL_607435	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A7BDA5/2020	EPI_ISL_607436	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-A7B455/2020	EPI_ISL_607444	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A7BD87/2020	EPI_ISL_607471	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A7B798/2020	EPI_ISL_607484	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.39	GH
hCoV-19/England/MILK-A7BDE1/2020	EPI_ISL_607533	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-A7C8D0/2020	EPI_ISL_607553	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-A7B428/2020	EPI_ISL_607558	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.39	GH
hCoV-19/England/MILK-A7BFEB/2020	EPI_ISL_607565	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-A7C964/2020	EPI_ISL_607571	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-A7C797/2020	EPI_ISL_607584	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/MILK-A7B09D/2020	EPI_ISL_607593	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A7BE57/2020	EPI_ISL_607616	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-A7BB14/2020	EPI_ISL_607620	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/MILK-A6AEC4/2020	EPI_ISL_608765	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-A69E2F/2020	EPI_ISL_608776	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A6B528/2020	EPI_ISL_608815	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/MILK-A69C9E/2020	EPI_ISL_608838	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-A6BFEE/2020	EPI_ISL_608954	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-A67FE2/2020	EPI_ISL_608985	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/SHEF-C8B6D/2020	EPI_ISL_612196	2020-10-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/Denmark/DCGC-1578/2020	EPI_ISL_618148	2020-06-15	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.471	GH
hCoV-19/Denmark/DCGC-1559/2020	EPI_ISL_618149	2020-06-15	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.471	GH
hCoV-19/Denmark/DCGC-2016/2020	EPI_ISL_618242	2020-07-27	Europe / Denmark	Human	Original			Nanopore MinION				B.1	GH
hCoV-19/Denmark/DCGC-2076/2020	EPI_ISL_618244	2020-07-27	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Denmark/DCGC-2034/2020	EPI_ISL_618254	2020-07-27	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.471	GH
hCoV-19/Denmark/DCGC-2039/2020	EPI_ISL_618264	2020-07-27	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Denmark/DCGC-2041/2020	EPI_ISL_618266	2020-07-27	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Denmark/DCGC-2042/2020	EPI_ISL_618267	2020-07-27	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.22	GH
hCoV-19/Denmark/DCGC-1966/2020	EPI_ISL_618287	2020-07-13	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/Denmark/DCGC-6798/2020	EPI_ISL_619495	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-6656/2020	EPI_ISL_619559	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Denmark/DCGC-6600/2020	EPI_ISL_619648	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.36.1	GH
hCoV-19/England/ALDP-AA0F29/2020	EPI_ISL_624016	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence. Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/ALDP-AA0F47/2020	EPI_ISL_624023	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA3357/2020	EPI_ISL_624080	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-AA56B6/2020	EPI_ISL_624097	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Singapore/1128/2020	EPI_ISL_626640	2020-10-29	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.36.16	GH
hCoV-19/Singapore/1130/2020	EPI_ISL_626642	2020-10-30	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.468	GH
hCoV-19/England/MILK-ABBB63/2020	EPI_ISL_631125	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/MILK-ABBD21/2020	EPI_ISL_631153	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-ABC2A9/2020	EPI_ISL_631168	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-ABBF2B/2020	EPI_ISL_631170	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-AAF91D/2020	EPI_ISL_631171	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/MILK-ABC485/2020	EPI_ISL_631232	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-ABBC60/2020	EPI_ISL_631259	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-AAF5A0/2020	EPI_ISL_631268	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.2	GH
hCoV-19/Netherlands/GE-EMC-334/2020	EPI_ISL_632482	2020-10-21	Europe / Netherlands / Gelderland	Human	Original			Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Netherlands/ZH-EMC-652/2020	EPI_ISL_632494	2020-09-28	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.523	GH
hCoV-19/Netherlands/ZH-EMC-678/2020	EPI_ISL_632518	2020-10-02	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.36	GH
hCoV-19/Netherlands/ZH-EMC-689/2020	EPI_ISL_632543	2020-08-07	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-734/2020	EPI_ISL_632577	2020-09-07	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-736/2020	EPI_ISL_632578	2020-09-13	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-737/2020	EPI_ISL_632579	2020-09-11	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-738/2020	EPI_ISL_632580	2020-09-11	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-739/2020	EPI_ISL_632581	2020-09-16	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/Netherlands/ZH-EMC-742/2020	EPI_ISL_632583	2020-09-12	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.22	GH
hCoV-19/England/QEUH-AD147B/2020	EPI_ISL_633719	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-AD28AB/2020	EPI_ISL_633728	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-AD337C/2020	EPI_ISL_633762	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-AD152D/2020	EPI_ISL_633817	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-AD2805/2020	EPI_ISL_633826	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-AD12EA/2020	EPI_ISL_633850	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-AD0A10/2020	EPI_ISL_633882	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-9ADFC3/2020	EPI_ISL_638618	2020-09-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/QEUH-9AE36C/2020	EPI_ISL_638635	2020-09-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/QEUH-9AE37B/2020	EPI_ISL_638636	2020-09-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/QEUH-9F4FBE/2020	EPI_ISL_638647	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/QEUH-A8B9BD/2020	EPI_ISL_643187	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-A8C06C/2020	EPI_ISL_643194	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-A8B5E6/2020	EPI_ISL_643248	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/ALDP-B1B31D/2020	EPI_ISL_645805	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-B21D34/2020	EPI_ISL_645869	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/England/CAMC-B21C37/2020	EPI_ISL_645882	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B50534/2020	EPI_ISL_649386	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/ALDP-B487A2/2020	EPI_ISL_649468	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/ALDP-B4912B/2020	EPI_ISL_649476	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/BIRM-66ED1/2020	EPI_ISL_651601	2020-10-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-674CF/2020	EPI_ISL_651611	2020-10-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/BIRM-674DE/2020	EPI_ISL_651612	2020-10-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.471	GH
hCoV-19/England/BIRM-67553/2020	EPI_ISL_651615	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-67571/2020	EPI_ISL_651616	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/England/BIRM-6A990/2020	EPI_ISL_651634	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.460	GH
hCoV-19/England/BIRM-6A9CD/2020	EPI_ISL_651636	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.460	GH
hCoV-19/England/CAMB-1B87E3/2020	EPI_ISL_651660	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.28	GH
hCoV-19/England/QEUH-AACC80/2020	EPI_ISL_652909	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.471	GH
hCoV-19/England/QEUH-AAD00B/2020	EPI_ISL_652933	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.460	GH
hCoV-19/England/QEUH-AAD083/2020	EPI_ISL_652936	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.471	GH
hCoV-19/England/QEUH-AAD117/2020	EPI_ISL_652941	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.471	GH
hCoV-19/Scotland/QEUH-AAE2F5/2020	EPI_ISL_652968	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.466	GH
hCoV-19/England/QEUH-B682C9/2020	EPI_ISL_655101	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.34	GH
hCoV-19/England/QEUH-B6A26D/2020	EPI_ISL_655147	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B5B232/2020	EPI_ISL_655277	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/ALDP-B63370/2020	EPI_ISL_656431	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/ALDP-B638EA/2020	EPI_ISL_656500	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/ALDP-B62511/2020	EPI_ISL_656551	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/ALDP-B633AD/2020	EPI_ISL_656559	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/ALDP-B627EE/2020	EPI_ISL_656566	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B6362C/2020	EPI_ISL_656581	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B52B8B/2020	EPI_ISL_657708	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/CAMC-B5164F/2020	EPI_ISL_657726	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.8	GH
hCoV-19/England/CAMC-B51FCC/2020	EPI_ISL_657728	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-B51560/2020	EPI_ISL_657762	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B5520B/2020	EPI_ISL_657789	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B54DB0/2020	EPI_ISL_657794	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/CAMC-B52110/2020	EPI_ISL_657805	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/QEUH-B68F4A/2020	EPI_ISL_662268	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-B66850/2020	EPI_ISL_662335	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/QEUH-B6735E/2020	EPI_ISL_662337	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-B77300/2020	EPI_ISL_664936	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36	GH
hCoV-19/England/CAMB-1BAE82/2020	EPI_ISL_664999	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.17	GH
hCoV-19/Norway/4460/2020	EPI_ISL_668405	2020-10-12	Europe / Norway / Vestland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.1	GH
hCoV-19/Norway/4810/2020	EPI_ISL_668410	2020-10-26	Europe / Norway / Oslo	Human	Original	Throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/4811/2020	EPI_ISL_668411	2020-10-26	Europe / Norway / Oslo	Human	Original	Nasopharyngeal swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/4948/2020	EPI_ISL_668436	2020-10-29	Europe / Norway / Oslo	Human	Original	Throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/3780/2020	EPI_ISL_668438	2020-08-30	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3784/2020	EPI_ISL_668439	2020-09-29	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Norway/3787/2020	EPI_ISL_668440	2020-09-02	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	GH
hCoV-19/Denmark/DCGC-10474/2020	EPI_ISL_669736	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-10959/2020	EPI_ISL_669743	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-11053/2020	EPI_ISL_669746	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-11066/2020	EPI_ISL_669747	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Denmark/DCGC-10222/2020	EPI_ISL_669841	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-10239/2020	EPI_ISL_669852	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-11269/2020	EPI_ISL_670804	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-11302/2020	EPI_ISL_670826	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/CAMC-B08EC7/2020	EPI_ISL_673020	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/CAMC-B09673/2020	EPI_ISL_673087	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/CAMC-B09DF6/2020	EPI_ISL_673094	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/CAMC-B0A00B/2020	EPI_ISL_673103	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-B84090/2020	EPI_ISL_674281	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/ALDP-B851E7/2020	EPI_ISL_674318	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-B8BFF6/2020	EPI_ISL_674331	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/ALDP-B8519C/2020	EPI_ISL_674357	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/ALDP-B85141/2020	EPI_ISL_674367	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-B8C57B/2020	EPI_ISL_674403	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/ALDP-B8436A/2020	EPI_ISL_674435	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/MILK-B8C256/2020	EPI_ISL_674448	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B8433D/2020	EPI_ISL_674454	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B83082/2020	EPI_ISL_675567	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/ALDP-B83161/2020	EPI_ISL_675632	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/ALDP-B83565/2020	EPI_ISL_675692	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-B89CA6/2020	EPI_ISL_675693	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-B88BAA/2020	EPI_ISL_675724	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/ALDP-B85A0A/2020	EPI_ISL_675759	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMB-1B9ACB/2020	EPI_ISL_679149	2020-11-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.39	GH
hCoV-19/England/CAMC-BBC86A/2020	EPI_ISL_679249	2020-11-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.469	GH
hCoV-19/England/MILK-BA9A88/2020	EPI_ISL_681408	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-BAABDF/2020	EPI_ISL_681448	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-BAA225/2020	EPI_ISL_681469	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-BAA173/2020	EPI_ISL_681540	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/Denmark/DCGC-12612/2020	EPI_ISL_682793	2020-11-16	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/ALDP-BB280A/2020	EPI_ISL_703221	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/QEUH-BCB543/2020	EPI_ISL_704453	2020-11-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/England/LIVE-DC296C/2020	EPI_ISL_705829	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.471	GH
hCoV-19/England/LIVE-DC3F87/2020	EPI_ISL_705882	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36.1	GH
hCoV-19/Norway/3576/2020	EPI_ISL_708026	2020-08-06	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/3597/2020	EPI_ISL_708027	2020-07-31	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36	GH
hCoV-19/Norway/4995/2020	EPI_ISL_708034	2020-10-23	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5059/2020	EPI_ISL_708035	2020-10-29	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5210/2020	EPI_ISL_708050	2020-10-31	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5217/2020	EPI_ISL_708053	2020-10-28	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5239/2020	EPI_ISL_708055	2020-11-01	Europe / Norway / Agder	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5242/2020	EPI_ISL_708056	2020-11-01	Europe / Norway / Agder	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5325/2020	EPI_ISL_708058	2020-11-04	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5329/2020	EPI_ISL_708060	2020-11-02	Europe / Norway / Vestfold og Telemark	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5330/2020	EPI_ISL_708061	2020-11-02	Europe / Norway / Vestfold og Telemark	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5380/2020	EPI_ISL_708071	2020-10-28	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5397/2020	EPI_ISL_708077	2020-11-04	Europe / Norway / Vestland	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5436/2020	EPI_ISL_708095	2020-10-27	Europe / Norway / Troms og Finnmark	Human	Original	Nasopharyngeal swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/Norway/5452/2020	EPI_ISL_708096	2020-11-03	Europe / Norway	Human	Original			Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.36.21	GH
hCoV-19/England/QEUH-BF0A19/2020	EPI_ISL_709215	2020-12-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/QEUH-C14B48/2020	EPI_ISL_709360	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-C05FB7/2020	EPI_ISL_709375	2020-12-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Denmark/DCGC-14138/2020	EPI_ISL_711589	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-14189/2020	EPI_ISL_711614	2020-11-30	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-14231/2020	EPI_ISL_711643	2020-11-30	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-14267/2020	EPI_ISL_711664	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-14310/2020	EPI_ISL_711686	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-13716/2020	EPI_ISL_712978	2020-11-30	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Australia/NSW3631/2020	EPI_ISL_717703	2020-12-08	Oceania / Australia / New South Wales / Sydney	Human	Original			Oxford Nanopore				B.1.36	GH
hCoV-19/Australia/NSW3642/2020	EPI_ISL_717707	2020-12-12	Oceania / Australia / New South Wales / Sydney	Human	Original			Oxford Nanopore				B.1.36.1	GH
hCoV-19/Australia/NSW3648/2020	EPI_ISL_717712	2020-12-08	Oceania / Australia / New South Wales / Sydney	Human	Original			Oxford Nanopore				B.1.36	GH
hCoV-19/Australia/NSW3664/2020	EPI_ISL_717713	2020-12-09	Oceania / Australia / New South Wales / Sydney	Human	Original			Oxford Nanopore				B.1.36	GH
hCoV-19/Canada/ON-SLB3242/2020	EPI_ISL_717734	2020-11-24	North America / Canada / Ontario	Human	Original			Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-SLB3243/2020	EPI_ISL_717737	2020-11-24	North America / Canada / Ontario	Human	Original			Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.8	GH
hCoV-19/Canada/ON-SLB3245/2020	EPI_ISL_717752	2020-11-24	North America / Canada / Ontario	Human	Original			Illumina	ncov2019-artic-nf (OICR v1.6)			B.1.36.18	GH
hCoV-19/England/ALDP-B1D041/2020	EPI_ISL_723531	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-B5DC6F/2020	EPI_ISL_723578	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.39	GH
hCoV-19/England/ALDP-B5DD6C/2020	EPI_ISL_723589	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.39	GH
hCoV-19/England/ALDP-B5DFA2/2020	EPI_ISL_723619	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.28	GH
hCoV-19/England/ALDP-B5E369/2020	EPI_ISL_723653	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.523	GH
hCoV-19/England/ALDP-B5E5BE/2020	EPI_ISL_723669	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.8	GH
hCoV-19/Wales/PHWC-498BEA/2020	EPI_ISL_727185	2020-11-23	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1	GH
hCoV-19/England/ALDP-C3DD70/2020	EPI_ISL_730722	2020-12-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/MILK-C61256/2020	EPI_ISL_735534	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-C61353/2020	EPI_ISL_735535	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.28	GH
hCoV-19/England/MILK-C615A8/2020	EPI_ISL_735592	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/MILK-C61DCE/2020	EPI_ISL_735598	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-C62D09/2020	EPI_ISL_735622	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.462	GH
hCoV-19/England/MILK-C61229/2020	EPI_ISL_735646	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-C61238/2020	EPI_ISL_735657	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.17	GH
hCoV-19/Japan/IC-0391/2020	EPI_ISL_736902	2020-12-11	Asia / Japan	Human	Original			Illumina iSeq	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/Japan/IC-0415/2020	EPI_ISL_736921	2020-12-18	Asia / Japan	Human	Original	Saliva		Illumina iSeq	SKESA v. 2.3.0			B.1.36	GH
hCoV-19/England/MILK-B3D421/2020	EPI_ISL_741371	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence. NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/MILK-B3DF7B/2020	EPI_ISL_741413	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.36	GH
hCoV-19/England/MILK-B3DFA8/2020	EPI_ISL_741416	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.460	GH
hCoV-19/England/NORW-21FA0E/2020	EPI_ISL_741458	2020-12-14	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-21FBCF/2020	EPI_ISL_741466	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-21FC26/2020	EPI_ISL_741469	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-220B8F/2020	EPI_ISL_741490	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-222516/2020	EPI_ISL_741499	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/NORW-222C99/2020	EPI_ISL_741511	2020-12-19	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/Israel/CVL-45080/2020	EPI_ISL_745036	2020-12-02	Asia / Israel / Northern	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.36.8	GH
hCoV-19/Denmark/DCGC-19187/2020	EPI_ISL_748801	2020-12-07	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-19216/2020	EPI_ISL_748820	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-19438/2020	EPI_ISL_748946	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-19455/2020	EPI_ISL_748958	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-19482/2020	EPI_ISL_748980	2020-12-07	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.24	GH
hCoV-19/Finland/4LS1E1/2020	EPI_ISL_755999	2020-10-04	Europe / Finland / Uusimaa	Human	Original	Nasopharygeal swab		Illumina NovaSeq	BWA-MEM			B.1.36.22	GH
hCoV-19/Denmark/DCGC-21601/2020	EPI_ISL_758257	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-21633/2020	EPI_ISL_758276	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-21707/2020	EPI_ISL_758320	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-21822/2020	EPI_ISL_758387	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-21016/2020	EPI_ISL_759503	2020-12-21	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-21093/2020	EPI_ISL_759550	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-21097/2020	EPI_ISL_759553	2020-12-21	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-21299/2020	EPI_ISL_759659	2020-12-21	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/QEUH-CAEBCB/2020	EPI_ISL_760542	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/QEUH-CC33AA/2020	EPI_ISL_760674	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.38	GH
hCoV-19/England/QEUH-CC2A4C/2020	EPI_ISL_760694	2020-12-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.1	GH
hCoV-19/England/QEUH-C92F46/2020	EPI_ISL_761957	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/PORT-2D55B8/2020	EPI_ISL_764118	2020-12-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/PORT-2D55D6/2020	EPI_ISL_764119	2020-12-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/PORT-2D5819/2020	EPI_ISL_764120	2020-12-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/PORT-2D58CE/2020	EPI_ISL_764121	2020-12-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/PORT-2D59DA/2020	EPI_ISL_764122	2020-12-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/PORT-2D5A8C/2020	EPI_ISL_764123	2020-12-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/PORT-2D5CD1/2020	EPI_ISL_764124	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/PORT-2D5E44/2020	EPI_ISL_764125	2020-12-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/NORW-2228B3/2020	EPI_ISL_764126	2020-12-20	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.36.2	GH
hCoV-19/England/CAMC-C72207/2020	EPI_ISL_769018	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/CAMC-C7203A/2020	EPI_ISL_769052	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/CAMC-C70CB0/2020	EPI_ISL_769060	2020-12-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/Latvia/210/2020	EPI_ISL_770046	2020-09-12	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.36.22	GH
hCoV-19/Germany/HH-hpi-p1620/2020	EPI_ISL_776073	2020-03-17	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.22	GH
hCoV-19/Germany/HH-hpi-p1691/2020	EPI_ISL_776100	2020-03-18	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.22	GH
hCoV-19/Germany/HH-hpi-p1844/2020	EPI_ISL_776195	2020-03-22	Europe / Germany / Hamburg	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.22	GH
hCoV-19/England/ALDP-C8D98C/2020	EPI_ISL_777458	2020-12-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.28	GH
hCoV-19/England/MILK-C6F838/2020	EPI_ISL_778637	2020-12-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/England/MILK-BAC706/2020	EPI_ISL_783209	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/MILK-BAA692/2020	EPI_ISL_783240	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.39	GH
hCoV-19/England/MILK-BAA29E/2020	EPI_ISL_783241	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/MILK-BA9C19/2020	EPI_ISL_783245	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.523	GH
hCoV-19/England/MILK-BAFA64/2020	EPI_ISL_783306	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/MILK-BAA270/2020	EPI_ISL_783322	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.460	GH
hCoV-19/England/MILK-BABDE7/2020	EPI_ISL_783364	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/USA/TX-HMH-MCoV-18182/2020	EPI_ISL_784530	2020-11-14	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.36	GH
hCoV-19/USA/TX-HMH-MCoV-18189/2020	EPI_ISL_784537	2020-11-14	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1.36	GH
hCoV-19/USA/TX-HMH-MCoV-12873/2020	EPI_ISL_788025	2020-08-18	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1	G
hCoV-19/USA/TX-HMH-MCoV-12899/2020	EPI_ISL_788051	2020-08-18	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1	G
hCoV-19/USA/TX-HMH-MCoV-12908/2020	EPI_ISL_788060	2020-08-18	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3			B.1	GH
hCoV-19/USA/TX-HMH-MCoV-12910/2020	EPI_ISL_788062	2020-08-18	North America / USA / Texas / Houston	Human	Original			Illumina	ARTIC V3	Spike_S1097stop results in 13.9% truncation of the protein sequence.	info	B.1	GH
hCoV-19/Denmark/DCGC-24205/2020	EPI_ISL_792991	2020-12-07	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Switzerland/ZH-ETHZ-430390/2020	EPI_ISL_796584	2020-12-28	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Switzerland/ZH-ETHZ-430575/2020	EPI_ISL_796610	2020-12-31	Europe / Switzerland / Zurich	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.221	G
hCoV-19/Norway/7213/2020	EPI_ISL_796674	2020-12-26	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.1	GH
hCoV-19/Norway/6899/2020	EPI_ISL_796687	2020-12-18	Europe / Norway / Trondelag	Human	Original	Nasopharyngeal and throat swab		Nanopore GridIon, ARTIC protocol v3	Assembly by reference based mapping using the Artic Nanopore protocol			B.1.36.21	GH
hCoV-19/England/QEUH-D83FDE/2020	EPI_ISL_797862	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/QEUH-D88F15/2020	EPI_ISL_797917	2020-12-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/England/KGHT-2684E2C/2020	EPI_ISL_813655	2020-12-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.39	GH
hCoV-19/Denmark/DCGC-25849/2021	EPI_ISL_818438	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.25	GH
hCoV-19/Denmark/DCGC-25688/2021	EPI_ISL_818451	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-25786/2021	EPI_ISL_818481	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-25684/2021	EPI_ISL_818482	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/Denmark/DCGC-26186/2021	EPI_ISL_818483	2021-01-04	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 1 nucleotide(s) found at refpos 26305 (frameshift confirmed by the submitter). E without BLAST coverage.	info	B.1.523	GH
hCoV-19/England/OXON-F438CE/2020	EPI_ISL_819721	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/OXON-F438DD/2020	EPI_ISL_819722	2020-12-17	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/OXON-F419FA/2020	EPI_ISL_819797	2020-12-18	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.7	GH
hCoV-19/England/MILK-EB78C6/2021	EPI_ISL_820654	2021-01-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.469	GH
hCoV-19/USA/NY-NYCPHL-001762/2020	EPI_ISL_824297	2020-12-11	North America / USA / New York / New York	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/England/204160958/2020	EPI_ISL_825577	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204160959/2020	EPI_ISL_825578	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/England/204241446/2020	EPI_ISL_825581	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.36.17	GH
hCoV-19/Denmark/DCGC-29374/2021	EPI_ISL_843421	2021-01-04	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-29430/2021	EPI_ISL_843477	2021-01-04	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Canada/ON-LTRI-1064/2020	EPI_ISL_848190	2020-12-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina NextSeq	CLC Genomics Workbench 21			B.1.36.18	GH
hCoV-19/Canada/ON-LTRI-1093/2020	EPI_ISL_848193	2020-12-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina NextSeq	CLC Genomics Workbench 21			B.1.469	GH
hCoV-19/Canada/ON-LTRI-1105/2020	EPI_ISL_848194	2020-12-24	North America / Canada / Ontario / Toronto	Human	Original			Illumina NextSeq	CLC Genomics Workbench 21			B.1.469	GH
hCoV-19/South Korea/KDCA0746/2020	EPI_ISL_850424	2020-08-22	Asia / South Korea	Human	Original			Illumina Miseq				B.1	GH
hCoV-19/South Korea/KDCA0768/2020	EPI_ISL_850445	2020-08-24	Asia / South Korea	Human	Original			Illumina Miseq				B.1	GH
hCoV-19/India/AP-CS0832/2020	EPI_ISL_862400	2020-07-30	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0833/2020	EPI_ISL_862401	2020-07-30	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0834/2020	EPI_ISL_862402	2020-07-30	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0837/2020	EPI_ISL_862403	2020-07-30	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0847/2020	EPI_ISL_862404	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0784/2020	EPI_ISL_862405	2020-07-28	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0848/2020	EPI_ISL_862406	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0849/2020	EPI_ISL_862407	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0850/2020	EPI_ISL_862408	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0851/2020	EPI_ISL_862409	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0852/2020	EPI_ISL_862410	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0853/2020	EPI_ISL_862411	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0854/2020	EPI_ISL_862412	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0855/2020	EPI_ISL_862413	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0856/2020	EPI_ISL_862414	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0857/2020	EPI_ISL_862415	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0785/2020	EPI_ISL_862416	2020-07-28	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0858/2020	EPI_ISL_862417	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0859/2020	EPI_ISL_862418	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0861/2020	EPI_ISL_862419	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0862/2020	EPI_ISL_862420	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0863/2020	EPI_ISL_862421	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0864/2020	EPI_ISL_862422	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0865/2020	EPI_ISL_862423	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0866/2020	EPI_ISL_862424	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0786/2020	EPI_ISL_862425	2020-07-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0871/2020	EPI_ISL_862426	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0873/2020	EPI_ISL_862427	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0876/2020	EPI_ISL_862428	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0878/2020	EPI_ISL_862429	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0879/2020	EPI_ISL_862430	2020-08-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0883/2020	EPI_ISL_862431	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0884/2020	EPI_ISL_862432	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0886/2020	EPI_ISL_862433	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0887/2020	EPI_ISL_862434	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0888/2020	EPI_ISL_862435	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0889/2020	EPI_ISL_862436	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0323/2020	EPI_ISL_862437	2020-06-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0338/2020	EPI_ISL_862438	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0343/2020	EPI_ISL_862439	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0344/2020	EPI_ISL_862440	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0345/2020	EPI_ISL_862441	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0347/2020	EPI_ISL_862442	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0350/2020	EPI_ISL_862443	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0351/2020	EPI_ISL_862444	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0364/2020	EPI_ISL_862445	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0365/2020	EPI_ISL_862446	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0366/2020	EPI_ISL_862447	2020-06-30	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0368/2020	EPI_ISL_862448	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0369/2020	EPI_ISL_862449	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0371/2020	EPI_ISL_862450	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0372/2020	EPI_ISL_862451	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0373/2020	EPI_ISL_862452	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0374/2020	EPI_ISL_862453	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0376/2020	EPI_ISL_862454	2020-07-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0377/2020	EPI_ISL_862455	2020-07-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0378/2020	EPI_ISL_862456	2020-07-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0380/2020	EPI_ISL_862457	2020-07-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0381/2020	EPI_ISL_862458	2020-06-30	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0383/2020	EPI_ISL_862459	2020-06-30	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0384/2020	EPI_ISL_862460	2020-06-30	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0386/2020	EPI_ISL_862461	2020-06-30	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0388/2020	EPI_ISL_862462	2020-07-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0390/2020	EPI_ISL_862463	2020-07-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0391/2020	EPI_ISL_862464	2020-07-01	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0392/2020	EPI_ISL_862465	2020-06-27	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0393/2020	EPI_ISL_862466	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/AP-CS0793/2020	EPI_ISL_862478	2020-07-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly			B.1	GH
hCoV-19/India/AP-CS0967/2020	EPI_ISL_862480	2020-08-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly			B.1	GH
hCoV-19/India/AP-CS0798/2020	EPI_ISL_862496	2020-07-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly			B.1.36	GH
hCoV-19/India/AP-CS0835/2020	EPI_ISL_862502	2020-07-30	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly			B.1	GH
hCoV-19/India/AP-CS0836/2020	EPI_ISL_862503	2020-07-30	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly			B.1	GH
hCoV-19/India/AP-CS0325/2020	EPI_ISL_862513	2020-06-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly			B.1	GH
hCoV-19/India/AP-CS0327/2020	EPI_ISL_862515	2020-06-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly			B.1	GH
hCoV-19/India/AP-CS0328/2020	EPI_ISL_862516	2020-06-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly			B.1	GH
hCoV-19/India/AP-CS0329/2020	EPI_ISL_862517	2020-06-29	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly			B.1	GH
hCoV-19/India/AP-CS0352/2020	EPI_ISL_862525	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly			B.1	GH
hCoV-19/India/AP-CS0362/2020	EPI_ISL_862530	2020-07-04	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly			B.1	GH
hCoV-19/India/AP-CS0379/2020	EPI_ISL_862533	2020-07-02	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly			B.1.36.8	GH
hCoV-19/India/AP-CS0385/2020	EPI_ISL_862535	2020-06-30	Asia / India / Andhra Pradesh	Human	Original			Illumina NovaSeq	Reference-based assembly			B.1.36.38	GH
hCoV-19/England/TFCI-26FEA65/2020	EPI_ISL_868796	2020-10-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.36.39	GH
hCoV-19/Denmark/DCGC-32902/2021	EPI_ISL_869906	2021-01-11	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.469	GH
hCoV-19/Denmark/DCGC-33910/2021	EPI_ISL_870920	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/USA/MI-UM-10037837510/2021	EPI_ISL_873158	2021-01-14	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.36.8	GH
hCoV-19/Canada/ON-PHL-21-00186/2020	EPI_ISL_875703	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00058/2020	EPI_ISL_875704	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00267/2020	EPI_ISL_875709	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00075/2020	EPI_ISL_875713	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00074/2020	EPI_ISL_875714	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00049/2020	EPI_ISL_875715	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00029/2020	EPI_ISL_875716	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00051/2020	EPI_ISL_875717	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00066/2020	EPI_ISL_875719	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00067/2020	EPI_ISL_875720	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/ON-PHL-21-00031/2020	EPI_ISL_875721	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00032/2020	EPI_ISL_875722	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00023/2020	EPI_ISL_875724	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00040/2020	EPI_ISL_875730	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00024/2020	EPI_ISL_875731	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00021/2020	EPI_ISL_875732	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/ON-PHL-21-00044/2020	EPI_ISL_875733	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00027/2020	EPI_ISL_875734	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00041/2020	EPI_ISL_875736	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00046/2020	EPI_ISL_875744	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00246/2020	EPI_ISL_875745	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00178/2020	EPI_ISL_875747	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00172/2020	EPI_ISL_875748	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00262/2020	EPI_ISL_875749	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00272/2020	EPI_ISL_875754	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00183/2020	EPI_ISL_875756	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00176/2020	EPI_ISL_875758	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36	GH
hCoV-19/Canada/ON-PHL-21-00180/2020	EPI_ISL_875763	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/ON-PHL-21-00235/2020	EPI_ISL_875769	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00221/2020	EPI_ISL_875772	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00239/2020	EPI_ISL_875774	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00304/2020	EPI_ISL_875775	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00194/2020	EPI_ISL_875777	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00182/2020	EPI_ISL_875781	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00287/2020	EPI_ISL_875785	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00006/2020	EPI_ISL_875787	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00007/2020	EPI_ISL_875789	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00009/2020	EPI_ISL_875791	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00010/2020	EPI_ISL_875792	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00016/2020	EPI_ISL_875793	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00017/2020	EPI_ISL_875794	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00013/2020	EPI_ISL_875795	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00018/2020	EPI_ISL_875796	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00019/2020	EPI_ISL_875797	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00250/2020	EPI_ISL_875799	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00252/2020	EPI_ISL_875800	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00251/2020	EPI_ISL_875801	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00247/2020	EPI_ISL_875802	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00249/2020	EPI_ISL_875803	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00248/2020	EPI_ISL_875804	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00014/2020	EPI_ISL_875807	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00268/2020	EPI_ISL_875809	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00173/2020	EPI_ISL_875810	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00306/2020	EPI_ISL_875813	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.22	GH
hCoV-19/Canada/ON-PHL-21-00274/2020	EPI_ISL_875814	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00276/2020	EPI_ISL_875815	2020-11	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00060/2020	EPI_ISL_875822	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00277/2020	EPI_ISL_875823	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00279/2020	EPI_ISL_875824	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00281/2020	EPI_ISL_875826	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00054/2020	EPI_ISL_875827	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00255/2020	EPI_ISL_875829	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00256/2020	EPI_ISL_875839	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00047/2020	EPI_ISL_875840	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00305/2020	EPI_ISL_875843	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00308/2020	EPI_ISL_875846	2020-12	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00179/2020	EPI_ISL_875847	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00283/2020	EPI_ISL_875849	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.26	GH
hCoV-19/Canada/ON-PHL-21-00231/2020	EPI_ISL_875851	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.38	GH
hCoV-19/Canada/ON-PHL-21-00189/2020	EPI_ISL_875853	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00190/2020	EPI_ISL_875854	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00205/2020	EPI_ISL_875856	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00192/2020	EPI_ISL_875857	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00210/2020	EPI_ISL_875859	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00196/2020	EPI_ISL_875865	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00237/2020	EPI_ISL_875866	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00184/2020	EPI_ISL_875868	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/Canada/ON-PHL-21-00020/2020	EPI_ISL_875870	2020-12	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.6)			B.1.36.18	GH
hCoV-19/USA/AL-St.Clair-JEFQ/2020	EPI_ISL_875890	2020-11-03	North America / USA / Alabama / St.Clair County	Human	Original	Nasal		Illumina NovaSeq 6000	bwa mem v0.7.17-r1188 iVar v1.3			B.1.596	GH
hCoV-19/Indonesia/YO-UGM-10014/2020	EPI_ISL_885142	2020-12-27	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1	GH
hCoV-19/Iraq/NN_Erbil/2021	EPI_ISL_885143	2021-01-20	Asia / Iraq / Erbil	Human	Original	Nasopharyngeal swab	Middle aged lady with signs and symptoms of upper respiratory tract infection	Sanger				B.1.36.1	GH
hCoV-19/Turkey/IST-GLAB-N038/2021	EPI_ISL_885146	2021-01-14	Europe / Turkey / Istanbul	Human	Original	Oropharyngeal swab		Illumina NextSeq	BWA-MEM	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.469	GH
hCoV-19/Indonesia/YO-UGM-209459/2020	EPI_ISL_891151	2020-12-23	Asia / Indonesia / Special Region of Yogyakarta	Human	Original	Nasopharyngeal swab		Illumina MiSeq	UGENE v.37			B.1.36.19	GH
hCoV-19/India/RJ-SMS-SQ-1/2020	EPI_ISL_891152	2020-12-26	Asia / India / Rajasthan / Jaipur	Human	Original	Nasopharyngeal swab		Ion torrent				B.1.36	GH
hCoV-19/Switzerland/SO-ETHZ-451528/2021	EPI_ISL_899754	2021-01-11	Europe / Switzerland / Solothurn	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina	V-pipe			B.1.36.1	GH
hCoV-19/Egypt/CUNCI-HGC11I030/2021	EPI_ISL_907108	2021-01-03	Africa / Egypt	Human	Original	Nasopharyngeal swab		IonTorrent	Torrent Suite v. 5.12			B.1.466	GH
hCoV-19/Indonesia/JK-NIHRD-C0050015/2020	EPI_ISL_909772	2020-09-11	Asia / Indonesia / Jakarta	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Dragen RNA Pathogen Detection 3.5.14	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.470	GH
hCoV-19/USA/WY-WPHL-21005438/2021	EPI_ISL_911965	2021-01-14	North America / USA / Wyoming	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.36.8	GH
hCoV-19/England/ALDP-BC90EA/2020	EPI_ISL_915506	2020-11-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/England/ALDP-BCB30D/2020	EPI_ISL_915565	2020-11-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.9	GH
hCoV-19/England/ALDP-BC8E78/2020	EPI_ISL_915567	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/ALDP-BC9E2C/2020	EPI_ISL_915611	2020-11-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GH
hCoV-19/Denmark/DCGC-34999/2021	EPI_ISL_926139	2021-01-11	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Denmark/DCGC-35019/2021	EPI_ISL_926159	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-35075/2021	EPI_ISL_926215	2021-01-18	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.469	GH
hCoV-19/Denmark/DCGC-35112/2020	EPI_ISL_926252	2020-11-30	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1	GH
hCoV-19/Denmark/DCGC-36308/2021	EPI_ISL_927449	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-36410/2021	EPI_ISL_927551	2021-01-11	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36	GH
hCoV-19/Denmark/DCGC-37593/2021	EPI_ISL_928734	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-37637/2020	EPI_ISL_928778	2020-12-14	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-37691/2021	EPI_ISL_928832	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Denmark/DCGC-37727/2021	EPI_ISL_928868	2021-01-18	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/England/MILK-D26B42/2020	EPI_ISL_933480	2020-12-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-C516F3/2020	EPI_ISL_933484	2020-12-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/MILK-BFCE8A/2020	EPI_ISL_933497	2020-12-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.17	GH
hCoV-19/Canada/MB-NML-2849/2020	EPI_ISL_935911	2020-11-25	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-2850/2020	EPI_ISL_935912	2020-11-26	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-2852/2020	EPI_ISL_935913	2020-11-26	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-2857/2020	EPI_ISL_935916	2020-11-26	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-2860/2020	EPI_ISL_935919	2020-11-16	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-2861/2020	EPI_ISL_935920	2020-11-16	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-2863/2020	EPI_ISL_935922	2020-11-16	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-2883/2020	EPI_ISL_935935	2020-11-19	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-2884/2020	EPI_ISL_935936	2020-11-18	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-2885/2020	EPI_ISL_935937	2020-11-17	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-2890/2020	EPI_ISL_935941	2020-11-17	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-2891/2020	EPI_ISL_935942	2020-11-19	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.18	GH
hCoV-19/Canada/MB-NML-2914/2020	EPI_ISL_935957	2020-11-14	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.36.8	GH
hCoV-19/Belgium/Jessa_55-2104-000535/2021	EPI_ISL_940592	2021-01-26	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.36.38	GH
hCoV-19/Belgium/Jessa_55-2104-000552/2021	EPI_ISL_940595	2021-01-26	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.36.38	GH
hCoV-19/England/ALDP-1195DAB/2021	EPI_ISL_946771	2021-01-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36.24	GH
hCoV-19/England/PORT-2D953C/2021	EPI_ISL_952408	2021-01-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/PORT-2D9587/2021	EPI_ISL_952411	2021-01-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/England/PORT-2D9648/2021	EPI_ISL_952421	2021-01-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS7b_E33stop results in 25.6% truncation of the protein sequence.	info	B.1.36.17	GH
hCoV-19/Switzerland/GE-33022323/2021	EPI_ISL_953728	2021-01-20	Europe / Switzerland / Geneve	Human	Original			Illumina NovaSeq				B.1.36	GH
hCoV-19/England/ALDP-11D55E3/2021	EPI_ISL_963150	2021-01-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.471	GH
hCoV-19/Canada/BC-BCCDC-4226/2020	EPI_ISL_969229	2020-08-24	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4093/2020	EPI_ISL_969236	2020-08-25	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-4310/2020	EPI_ISL_969411	2020-08-29	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-4318/2020	EPI_ISL_969432	2020-08-30	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-3727/2020	EPI_ISL_970210	2020-09-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.38	GH
hCoV-19/Canada/BC-BCCDC-5327/2020	EPI_ISL_970236	2020-09-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-3730/2020	EPI_ISL_970280	2020-09-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.18	GH
hCoV-19/Canada/BC-BCCDC-3733/2020	EPI_ISL_970286	2020-09-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.18	GH
hCoV-19/Canada/BC-BCCDC-5333/2020	EPI_ISL_970322	2020-09-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.18	GH
hCoV-19/Denmark/DCGC-39864/2021	EPI_ISL_971541	2021-01-25	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.36.25	GH
hCoV-19/Canada/BC-BCCDC-7068/2020	EPI_ISL_975106	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7070/2020	EPI_ISL_975108	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7317/2020	EPI_ISL_975111	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7358/2020	EPI_ISL_975117	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7360/2020	EPI_ISL_975119	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7628/2020	EPI_ISL_975120	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7630/2020	EPI_ISL_975122	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7631/2020	EPI_ISL_975123	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7632/2020	EPI_ISL_975124	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7639/2020	EPI_ISL_975129	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7889/2020	EPI_ISL_975136	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7890/2020	EPI_ISL_975137	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7895/2020	EPI_ISL_975140	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8110/2020	EPI_ISL_975142	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10223/2020	EPI_ISL_975147	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10225/2020	EPI_ISL_975148	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10490/2020	EPI_ISL_975151	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10616/2020	EPI_ISL_975153	2020-11-08	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7341/2020	EPI_ISL_975165	2020-11-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7345/2020	EPI_ISL_975166	2020-11-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7361/2020	EPI_ISL_975167	2020-11-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7362/2020	EPI_ISL_975168	2020-11-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7363/2020	EPI_ISL_975169	2020-11-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7364/2020	EPI_ISL_975170	2020-11-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7366/2020	EPI_ISL_975172	2020-11-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7902/2020	EPI_ISL_975184	2020-11-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7903/2020	EPI_ISL_975185	2020-11-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7908/2020	EPI_ISL_975189	2020-11-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7913/2020	EPI_ISL_975192	2020-11-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7917/2020	EPI_ISL_975194	2020-11-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7919/2020	EPI_ISL_975196	2020-11-09	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7140/2020	EPI_ISL_975210	2020-11-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7261/2020	EPI_ISL_975211	2020-11-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7353/2020	EPI_ISL_975215	2020-11-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7394/2020	EPI_ISL_975221	2020-11-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7398/2020	EPI_ISL_975223	2020-11-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7679/2020	EPI_ISL_975227	2020-11-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7738/2020	EPI_ISL_975228	2020-11-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7741/2020	EPI_ISL_975229	2020-11-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7842/2020	EPI_ISL_975234	2020-11-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7848/2020	EPI_ISL_975240	2020-11-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-8036/2020	EPI_ISL_975247	2020-11-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9835/2020	EPI_ISL_975249	2020-11-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.469	GH
hCoV-19/Canada/BC-BCCDC-9836/2020	EPI_ISL_975250	2020-11-10	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.18	GH
hCoV-19/Canada/BC-BCCDC-7156/2020	EPI_ISL_975263	2020-11-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7157/2020	EPI_ISL_975264	2020-11-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7163/2020	EPI_ISL_975268	2020-11-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7165/2020	EPI_ISL_975269	2020-11-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-7166/2020	EPI_ISL_975270	2020-11-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7356/2020	EPI_ISL_975271	2020-11-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7487/2020	EPI_ISL_975276	2020-11-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7680/2020	EPI_ISL_975282	2020-11-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-7748/2020	EPI_ISL_975285	2020-11-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-7751/2020	EPI_ISL_975288	2020-11-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8694/2020	EPI_ISL_975294	2020-11-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8695/2020	EPI_ISL_975295	2020-11-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9940/2020	EPI_ISL_975298	2020-11-11	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9965/2020	EPI_ISL_976400	2020-12-12	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8822/2020	EPI_ISL_976403	2020-12-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9078/2020	EPI_ISL_976413	2020-12-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9222/2020	EPI_ISL_976416	2020-12-13	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8932/2020	EPI_ISL_976431	2020-12-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-8934/2020	EPI_ISL_976433	2020-12-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9021/2020	EPI_ISL_976435	2020-12-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Insertion of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9230/2020	EPI_ISL_976440	2020-12-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9235/2020	EPI_ISL_976444	2020-12-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9236/2020	EPI_ISL_976445	2020-12-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9383/2020	EPI_ISL_976453	2020-12-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9559/2020	EPI_ISL_976455	2020-12-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9743/2020	EPI_ISL_976461	2020-12-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10017/2020	EPI_ISL_976474	2020-12-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-10025/2020	EPI_ISL_976481	2020-12-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10124/2020	EPI_ISL_976485	2020-12-14	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9109/2020	EPI_ISL_976490	2020-12-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9656/2020	EPI_ISL_976494	2020-12-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9657/2020	EPI_ISL_976495	2020-12-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.37	GH
hCoV-19/Canada/BC-BCCDC-9658/2020	EPI_ISL_976496	2020-12-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9975/2020	EPI_ISL_976504	2020-12-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10035/2020	EPI_ISL_976509	2020-12-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10036/2020	EPI_ISL_976510	2020-12-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10038/2020	EPI_ISL_976511	2020-12-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10042/2020	EPI_ISL_976513	2020-12-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10126/2020	EPI_ISL_976518	2020-12-15	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-8940/2020	EPI_ISL_976521	2020-12-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9662/2020	EPI_ISL_976522	2020-12-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9760/2020	EPI_ISL_976527	2020-12-16	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9242/2020	EPI_ISL_976537	2020-12-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9664/2020	EPI_ISL_976540	2020-12-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9665/2020	EPI_ISL_976541	2020-12-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10061/2020	EPI_ISL_976554	2020-12-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-10067/2020	EPI_ISL_976557	2020-12-17	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9310/2020	EPI_ISL_976561	2020-12-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9313/2020	EPI_ISL_976564	2020-12-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9393/2020	EPI_ISL_976571	2020-12-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9667/2020	EPI_ISL_976579	2020-12-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9775/2020	EPI_ISL_976584	2020-12-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36	GH
hCoV-19/Canada/BC-BCCDC-10076/2020	EPI_ISL_976590	2020-12-18	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1			B.1.36.36	GH
hCoV-19/Canada/BC-BCCDC-9320/2020	EPI_ISL_976595	2020-12-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 8 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9404/2020	EPI_ISL_976597	2020-12-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9405/2020	EPI_ISL_976598	2020-12-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/Canada/BC-BCCDC-9406/2020	EPI_ISL_976599	2020-12-19	North America / Canada / British Columbia	Human	Original			Illumina MiSeq, 1200bp	BCCDC Artic 1.1	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36	GH
hCoV-19/England/ALDP-12201D5/2021	EPI_ISL_987132	2021-02-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.36	G
hCoV-19/Belgium/Jessa_11-2106-001174/2021	EPI_ISL_995505	2021-02-08	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.36.38	GH
hCoV-19/Belgium/Jessa_55-2105-001283/2021	EPI_ISL_995516	2021-02-05	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.36.38	O
hCoV-19/Belgium/Jessa_55-2106-000071/2021	EPI_ISL_995532	2021-02-08	Europe / Belgium / Hasselt	Human	Original			Illumina MiSeq				B.1.36.38	GH
hCoV-19/Belgium/rega-2699/2021	EPI_ISL_995556	2021-01-28	Europe / Belgium / Turnhout	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/Belgium/rega-2729/2021	EPI_ISL_995586	2021-02-01	Europe / Belgium / Turnhout	Human	Original	Oropharyngeal swab	Baseline Surveillance	Nanopore MinION	Artic Network methods	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.36.33	GH
hCoV-19/India/KA-NIMH-SEQ-119/2021	EPI_ISL_995701	2021-01-11	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/KA-NIMH-SEQ-132/2020	EPI_ISL_995715	2020-12-13	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/KA-NIMH-SEQ-142/2021	EPI_ISL_995723	2021-01-08	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/KA-NIMH-SEQ-145/2021	EPI_ISL_995726	2021-01-13	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.36.29	GH
hCoV-19/India/KA-NIMH-SEQ-149/2021	EPI_ISL_995730	2021-01-16	Asia / India / Karnataka	Human	Original			Nanopore MinION	Geneious 2020.0.3 (Minimap2 ver 2.17)	NS3_E261stop results in 5.5% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.36.29	GH
